Citrus Sinensis ID: 001865
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1002 | 2.2.26 [Sep-21-2011] | |||||||
| O48963 | 996 | Phototropin-1 OS=Arabidop | yes | no | 0.977 | 0.982 | 0.730 | 0.0 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | yes | no | 0.900 | 0.979 | 0.632 | 0.0 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | yes | no | 0.900 | 0.979 | 0.633 | 0.0 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.842 | 0.922 | 0.613 | 0.0 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.791 | 0.874 | 0.65 | 0.0 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.330 | 0.354 | 0.457 | 8e-94 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.378 | 0.643 | 0.428 | 1e-92 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.378 | 0.643 | 0.428 | 2e-92 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.330 | 0.543 | 0.45 | 2e-91 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.338 | 0.586 | 0.435 | 5e-87 |
| >sp|O48963|PHOT1_ARATH Phototropin-1 OS=Arabidopsis thaliana GN=PHOT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1463 bits (3788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/1014 (73%), Positives = 838/1014 (82%), Gaps = 35/1014 (3%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 174
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 232
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 233 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 292
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 293 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 352
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 353 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 412
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 413 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 470
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 471 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 530
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 531 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 591 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 650
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 651 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 711 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 831 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 889 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG EG
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFEG 942
Query: 949 ANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
ANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 943 ANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Required for blue-light mediated mRNA destabilization. Mediates calcium spiking of extracellular origin in response to low rate of blue light. Mediates also rapid membrane depolarization and growth inhibition in response to blue light. Necessary for root phototropism. Involved in hypocotyl phototropism under low rate but not under high rate blue light. Contributes to the chloroplast accumulation but seems to be not required for chloroplast translocation. Regulates stomata opening and photomorphogenesis response of leaf tissue. Confers sensitivity to drought. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1258 bits (3256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/998 (63%), Positives = 757/998 (75%), Gaps = 96/998 (9%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 64
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 65 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 124
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 125 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 183
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 960 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 997
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1258 bits (3256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/998 (63%), Positives = 756/998 (75%), Gaps = 96/998 (9%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPEPEH 64
E+ +Q + + P RDSRGSLEVFNPS+ S+ FR
Sbjct: 14 ERKEQQQQRGYQLP--RDSRGSLEVFNPSSASS------FR------------------- 46
Query: 65 AKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRA 124
+ ++ + + ++A+ D+E+ V Q QRA
Sbjct: 47 ----TAAAAPKSASPFLAIP------------------DREEDNVVAQ---------QRA 75
Query: 125 AEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKE-KG 183
AEWGLVL+TD TG PQ V AR S G S R+S E + + +
Sbjct: 76 AEWGLVLQTDHHTGLPQGVSARPSSG----------------SARTSSEDNPQQQQSAAA 119
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNN-TLKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSR-SGTRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMEGDDD--YESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ D+D +SDDERP+S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 960 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 997
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 1088 bits (2815), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 550/897 (61%), Positives = 658/897 (73%), Gaps = 53/897 (5%)
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMS 175
++ +R AEWGL + V SG D + K + S N +
Sbjct: 62 DSAKITERTAEWGL------------SAVKPDSGDDGISFKLSSEVERSKN-MSRRSSEE 108
Query: 176 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR 235
+ PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGR
Sbjct: 109 STSSESGAFPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGR 168
Query: 236 NCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLK 295
NCRFLQG TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +K
Sbjct: 169 NCRFLQGPDTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIK 228
Query: 296 FIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS-LSE 354
FIGMQVEVSK+TEG DK LRPNGL +SLIRYDARQKE A S+TE+VQ ++ +S + E
Sbjct: 229 FIGMQVEVSKYTEGVNDKALRPNGLSKSLIRYDARQKEKALDSITEVVQTIRHRKSQVQE 288
Query: 355 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 414
S + +++ S P P R + R S+ K +
Sbjct: 289 SVSNDTMVKPD----------------SSTTPTPGRQT----------RQSDEASKSFRT 322
Query: 415 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE--RPDSVDDKVRQKEMRKGI 472
GR S G K +S+++ E+ + ME ++ S + + DS D R++++R+GI
Sbjct: 323 PGRVS--TPTGSKLKSSNNR--HEDLLRMEPEELMLSTEVIGQRDSWDLSDRERDIRQGI 378
Query: 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 532
DLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD AT
Sbjct: 379 DLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDQAT 438
Query: 533 VRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592
V+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EP
Sbjct: 439 VQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEP 498
Query: 593 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPP 652
L+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK V+P PH K+S
Sbjct: 499 LQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSKPVYPLPHNKESTS 558
Query: 653 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 712
WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AMKAM+K +MLNRNK
Sbjct: 559 WKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEKTMMLNRNK 618
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF LLDRQP K+L ED+
Sbjct: 619 AHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKILTEDS 678
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS +T+C PQL++P
Sbjct: 679 ARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCTPQLIIPAA 738
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+DWWALGILLYEML
Sbjct: 739 PSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILLYEML 798
Query: 893 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952
YG TPFRGK RQKTFANILHKDL FPSS P SL +QL+ LL+RDP SRLGS GANEI
Sbjct: 799 YGRTPFRGKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDPSSRLGSKGGANEI 858
Query: 953 KKHPFFKGVNWALVRCMNPPELDAPLFATDTE---KEYKVVDPGM----QDLQQNVF 1002
K+H FF+G+NW L+R M+PP LDAPL + + K+ K D G+ DL ++F
Sbjct: 859 KQHAFFRGINWPLIRGMSPPPLDAPLSIIEKDPNAKDIKWEDDGVLVNSTDLDIDLF 915
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1067 bits (2760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/800 (65%), Positives = 616/800 (77%), Gaps = 7/800 (0%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY+ +EVVGRNCRFLQG
Sbjct: 86 LPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGYSPREVVGRNCRFLQGP 145
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+DD GKV+KFIGMQVEV
Sbjct: 146 DTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIRDDNGKVIKFIGMQVEV 205
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTN----RP 359
SK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K+PR + P
Sbjct: 206 SKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVKQPRGARAPADAALLTP 265
Query: 360 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 419
P + ++ A G S + R+S + +K SGR S
Sbjct: 266 PKMSDADKMAAMSPVVAPGTPSGGGGGAGSFKSPLWDLKKEESRLSRLASGRK--SGRSS 323
Query: 420 FMGL-IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTL 478
MG IG++S E ER DS + R+K++R+GIDLATTL
Sbjct: 324 LMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDSWERAEREKDIRQGIDLATTL 383
Query: 479 ERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRA 538
ERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGRNCRFLQGPETD TV KIR
Sbjct: 384 ERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGRNCRFLQGPETDQGTVDKIRE 443
Query: 539 AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIP 598
AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYFIGVQLDGS+H+EPLRN +
Sbjct: 444 AIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYFIGVQLDGSDHVEPLRNRLS 503
Query: 599 EATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQK 658
E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS V PKPH++++P W AI+K
Sbjct: 504 ENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHSMRVSPKPHKRNNPSWIAIEK 563
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 718
+ GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FAMKAMDK VMLNRNKVHRAC
Sbjct: 564 ATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMDKSVMLNRNKVHRACI 623
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF +LDRQP K+ +E+ RFYAA
Sbjct: 624 EREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAA 683
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
EVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS LT+ KP ++ +T+ K+RR
Sbjct: 684 EVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSKPHVIKNSTSLKRRR 743
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ P F++EP SNSFVGTEEYIAPE+I GAGHTSA+DWWALGILLYEMLYG TPF
Sbjct: 744 SQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSAIDWWALGILLYEMLYGRTPF 803
Query: 899 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
RGK R+KTF NILHKDL FPSS P SL AKQL++ LL RDP +R+GS+ GAN+IK+H FF
Sbjct: 804 RGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRDPSNRIGSNAGANDIKQHSFF 863
Query: 959 KGVNWALVRCMNPPELDAPL 978
+ +NW L+RCM+PPELD PL
Sbjct: 864 QDINWPLIRCMSPPELDVPL 883
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (886), Expect = 8e-94, Method: Compositional matrix adjust.
Identities = 176/385 (45%), Positives = 232/385 (60%), Gaps = 54/385 (14%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KPH W+AI+ I + L+HF +K LG GD G+V+L EL G+ FA+K MD
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
+ R K RA AEREIL MLDHPF+P LYA F + CL+ +YCPGG+L +L +Q
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 818
+ E A RFY AE+++ALEYLH GIIYRDLKPEN+L++ +GH+ LTDFDLS
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 819 -------------------------------CLT--SCKPQLLLP--TTNEKKRR----- 838
C+T SC+ P ++N+++ R
Sbjct: 691 NPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRG 750
Query: 839 --------HKGQQNPVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
H + P +AEP A SNSFVGT EY+APEII G GH +AVDWW G+LLY
Sbjct: 751 DHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLY 810
Query: 890 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949
E+LYG TPF+G +T AN++ ++LKFP S S AK L+ LL ++P++RLGS +G+
Sbjct: 811 ELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGS 870
Query: 950 NEIKKHPFFKGVNWALVRCMNPPEL 974
EIK+HPFF+G+NWAL+RC PPEL
Sbjct: 871 VEIKRHPFFEGLNWALIRCAIPPEL 895
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 185/432 (42%), Positives = 246/432 (56%), Gaps = 53/432 (12%)
Query: 600 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 657
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 658 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 717
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 828
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 829 --------------------------LPTT---------NEKKRRHKGQQN------PVF 847
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 848 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966
N++ + L+FP S A+ L+ LL ++P+ RLG GA EIK+HPFF+GVNWAL+
Sbjct: 482 LFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALI 541
Query: 967 RCMNPPELDAPL 978
RC +PPE+ P+
Sbjct: 542 RCASPPEVPRPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 185/432 (42%), Positives = 246/432 (56%), Gaps = 53/432 (12%)
Query: 600 ATAEESEKLV--KQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQ 657
A+A S +LV +T E + + P + D A S KPH+ + W+AIQ
Sbjct: 122 ASASGSARLVGRSETGERGFSSSRCRPSTSSDVSDESACSSISSVTKPHKANDSRWEAIQ 181
Query: 658 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC 717
I + L HF+ +K LG GD GSV+L EL G+ YFAMK MDK + +R K+ RA
Sbjct: 182 MIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLLRAQ 241
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E+EIL LDHPF+P LY F+T CL+ ++CPGG+L L RQ K E AV+FY
Sbjct: 242 TEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKFYV 301
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--------- 828
AE+++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS + P L+
Sbjct: 302 AEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLIRSSNPDAEA 361
Query: 829 --------------------------LPTT---------NEKKRRHKGQQN------PVF 847
PTT ++K R+ K + P
Sbjct: 362 LRKNNQAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVVNQVSPWPEL 421
Query: 848 MAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G TPF+G + T
Sbjct: 422 IAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRAT 481
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966
N++ + L+FP S A+ L+ LL ++P+ RLG GA EIK+HPFF+GVNWAL+
Sbjct: 482 LFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPFFEGVNWALI 541
Query: 967 RCMNPPELDAPL 978
RC +PPE+ P+
Sbjct: 542 RCASPPEVPRPV 553
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (865), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 171/380 (45%), Positives = 223/380 (58%), Gaps = 49/380 (12%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KPH+ + W+AIQ + + ++HFR +K LG GD GSV+L EL G+ FAMK M+
Sbjct: 202 KPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMN 261
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
K + NR K+ RA EREIL LDHPF+P LY F+T+ CL+ ++CPGG+L L RQ
Sbjct: 262 KTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQ 321
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
P K E AVRFY AEV+++LEYLH GIIYRDLKPENVL++ +GH+ L+DFDLS S
Sbjct: 322 PGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSV 381
Query: 824 KPQLLLPTTNEKKRRH-------------------------------------------- 839
P L+ + N + +
Sbjct: 382 SPTLVKSSNNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKN 441
Query: 840 --KGQQNPV--FMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894
Q P+ +AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G
Sbjct: 442 DMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 501
Query: 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
TPF+G + T N++ + L+FP S S A+ L+ LL ++P+ RL GA EIK+
Sbjct: 502 RTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQ 561
Query: 955 HPFFKGVNWALVRCMNPPEL 974
HPFF+ VNWAL+RC PPE+
Sbjct: 562 HPFFQNVNWALIRCATPPEV 581
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 169/388 (43%), Positives = 230/388 (59%), Gaps = 49/388 (12%)
Query: 644 KPHRKDSPP-WKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
KPHR ++ W AIQ++ G + + F+ IK LG GD G+V+L EL G+G FA+K
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 702 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 761
M+K + R K+ RA E+EIL LDHPF+P LY+ F+T+ + CL+ ++CPGG+L L
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 762 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
+Q K E A RFY AEV++A+EYLH GIIYRDLKPENVL++ +GH+ L+DFDLS
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 822 SCKPQL----------------LLPTTNEK---------------------KRRHKGQQN 844
+ P L + PT ++ K +H+ + N
Sbjct: 333 AVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPVCFTPRFLSKGKHRKKSN 392
Query: 845 ---------PVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894
P +AEP A S SFVGT EY+APEII G GH SAVDWW GI LYE+L+G
Sbjct: 393 DMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 452
Query: 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
TPFRG + T N++ + L+FP S A+ L+ LL ++P+ RL GA EIK+
Sbjct: 453 ITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQ 512
Query: 955 HPFFKGVNWALVRCMNPPELDAPLFATD 982
HPFF+ VNWAL+RC +PP++ P+ D
Sbjct: 513 HPFFQSVNWALIRCTSPPQIPQPVKPMD 540
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1002 | ||||||
| 225435157 | 1004 | PREDICTED: phototropin-1-like [Vitis vin | 0.987 | 0.985 | 0.799 | 0.0 | |
| 297746173 | 958 | unnamed protein product [Vitis vinifera] | 0.949 | 0.992 | 0.787 | 0.0 | |
| 224055599 | 977 | predicted protein [Populus trichocarpa] | 0.968 | 0.992 | 0.785 | 0.0 | |
| 401782496 | 1028 | phototropin 1 [Fragaria x ananassa] | 0.975 | 0.950 | 0.762 | 0.0 | |
| 255582071 | 1006 | serine/threonine protein kinase, putativ | 0.981 | 0.977 | 0.772 | 0.0 | |
| 350535803 | 1018 | phototropin-1 [Solanum lycopersicum] gi| | 0.973 | 0.957 | 0.738 | 0.0 | |
| 449460993 | 952 | PREDICTED: phototropin-1-like [Cucumis s | 0.879 | 0.925 | 0.806 | 0.0 | |
| 60099454 | 976 | phototropin [Phaseolus vulgaris] | 0.960 | 0.985 | 0.734 | 0.0 | |
| 356542583 | 977 | PREDICTED: phototropin-1-like [Glycine m | 0.961 | 0.985 | 0.738 | 0.0 | |
| 15231245 | 996 | non-specific serine/threonine protein ki | 0.977 | 0.982 | 0.730 | 0.0 |
| >gi|225435157|ref|XP_002281752.1| PREDICTED: phototropin-1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1634 bits (4231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 809/1012 (79%), Positives = 891/1012 (88%), Gaps = 23/1012 (2%)
Query: 2 DQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPE 61
D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R +PE
Sbjct: 5 DDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPRGTPE 59
Query: 62 PEHA-KLNSKSSR-AEEITSWMALKDPAPQ------KPSLPPLIQKMTNDQEKSTVTKQL 113
E + +L+SKS R A+EITSWMALK+P+P + S+ P + ++K T QL
Sbjct: 60 REGSPELSSKSGRSADEITSWMALKEPSPAPPLPLAQKSVSPAFNVQDDTRQKPTRKTQL 119
Query: 114 SGEAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGE 173
SGE AAQRAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGE
Sbjct: 120 SGEVDNAAQRAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGE 179
Query: 174 MSDEGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
MSDEGG K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKE
Sbjct: 180 MSDEGGAGKDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKE 239
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
V+GRNCRFLQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G
Sbjct: 240 VIGRNCRFLQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENG 299
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
VLKFIGMQVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRS
Sbjct: 300 NVLKFIGMQVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRS 359
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSES++RP +RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK
Sbjct: 360 LSESSDRP-FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKK 416
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG 471
+KS R SFM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+G
Sbjct: 417 PRKSSRLSFMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRG 472
Query: 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 531
IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA
Sbjct: 473 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPA 532
Query: 532 TVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591
TVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+E
Sbjct: 533 TVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVE 592
Query: 592 PLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSP 651
PL N IPE+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S
Sbjct: 593 PLHNCIPESTAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESS 652
Query: 652 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN 711
WKAIQKIL+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRN
Sbjct: 653 AWKAIQKILEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRN 712
Query: 712 KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
KVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKED
Sbjct: 713 KVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKED 772
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
AVRFYAAEVVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P
Sbjct: 773 AVRFYAAEVVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPN 832
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
TNEKKR+HKGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEM
Sbjct: 833 TNEKKRQHKGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEM 892
Query: 892 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
LYGYTPFRGKTRQKTFANILHKDLKFPSS SL+AKQLMYRLLHRDPK+RLGS EGANE
Sbjct: 893 LYGYTPFRGKTRQKTFANILHKDLKFPSSISVSLNAKQLMYRLLHRDPKNRLGSREGANE 952
Query: 952 IKKHPFFKGVNWALVRCMNPPELDA-PLFATDTEKEYKVVDPGMQDLQQNVF 1002
IK+HPFF+GVNWALVRCMNPPELDA PL TD EKE K VDP + DLQ N+F
Sbjct: 953 IKRHPFFRGVNWALVRCMNPPELDAPPLETTDAEKEVKSVDPELLDLQTNIF 1004
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746173|emb|CBI16229.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1593 bits (4125), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 791/1004 (78%), Positives = 865/1004 (86%), Gaps = 53/1004 (5%)
Query: 2 DQSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWMEQRESPE 61
D S KSP + PL RDSRGSLEVFNPST+STRPTN FRPQPTW++W E R S
Sbjct: 5 DDSAKSP-----SLIPPLPRDSRGSLEVFNPSTYSTRPTNQAFRPQPTWKSWAEPRRS-- 57
Query: 62 PEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAA 121
A+EITSWMALK+P+ +KS
Sbjct: 58 ------------ADEITSWMALKEPS---------PAPPLPLAQKS-------------- 82
Query: 122 QRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGG-- 179
RAAEWGL+LKTDTETGKPQ V RTSGGD+PN K GTSRRNS NSVRSSGEMSDEGG
Sbjct: 83 -RAAEWGLMLKTDTETGKPQGVAVRTSGGDEPNYKTGTSRRNSGNSVRSSGEMSDEGGAG 141
Query: 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 239
K++ PRVS+ +KDALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 142 KDRAFPRVSEDLKDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 201
Query: 240 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
LQG+GTDPEDVAKIRE L G SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G VLKFIGM
Sbjct: 202 LQGSGTDPEDVAKIREALHAGNSYCGRLLNYKKDGTPFWNLLTISPIKDENGNVLKFIGM 261
Query: 300 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRP 359
QVEVSKHTEG+K+KM RPNGLPESLIRYDARQK+MAT+SV+ELVQA+KKPRSLSES++RP
Sbjct: 262 QVEVSKHTEGSKEKMTRPNGLPESLIRYDARQKDMATNSVSELVQAVKKPRSLSESSDRP 321
Query: 360 PIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRS 419
+RKSE G E+ER A GRR SE+V PPRRNS G R SMQRISE+PEKK +KS R S
Sbjct: 322 -FMRKSEDG-EQERPEAPGRRNSESVAPPRRNSQSGR-RASMQRISELPEKKPRKSSRLS 378
Query: 420 FMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLE 479
FM ++ RKSQ+ + F+ E++++ D DDERPDS+D+K RQ+EMR+GIDLATTLE
Sbjct: 379 FMRIM-RKSQAHTEE--FDTEVLVD-DTSDSEDDERPDSIDNKTRQREMRRGIDLATTLE 434
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR A
Sbjct: 435 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREA 494
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EPL N IPE
Sbjct: 495 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPLHNCIPE 554
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
+TA+ES KLVK+TAEN+++AV+ELPDANL PEDLW+NHSKVV PKPHRK+S WKAIQKI
Sbjct: 555 STAKESAKLVKETAENIDDAVRELPDANLKPEDLWSNHSKVVLPKPHRKESSAWKAIQKI 614
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+ GEQI L+HFRP+KPLGSGDTGSVHLVELCG+G+YFAMKAMDK VMLNRNKVHRACAE
Sbjct: 615 LEDGEQIGLKHFRPVKPLGSGDTGSVHLVELCGTGEYFAMKAMDKNVMLNRNKVHRACAE 674
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
REILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE
Sbjct: 675 REILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 734
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQG+IYRDLKPENVLLQ +GHV+LTDFDLSCLTSCKPQLL+P TNEKKR+H
Sbjct: 735 VVVALEYLHCQGVIYRDLKPENVLLQSSGHVALTDFDLSCLTSCKPQLLMPNTNEKKRQH 794
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
KGQQNP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 795 KGQQNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 854
Query: 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
GKTRQKTFANILHKDLKFPSS SL+AKQLMYRLLHRDPK+RLGS EGANEIK+HPFF+
Sbjct: 855 GKTRQKTFANILHKDLKFPSSISVSLNAKQLMYRLLHRDPKNRLGSREGANEIKRHPFFR 914
Query: 960 GVNWALVRCMNPPELDA-PLFATDTEKEYKVVDPGMQDLQQNVF 1002
GVNWALVRCMNPPELDA PL TD EKE K VDP + DLQ N+F
Sbjct: 915 GVNWALVRCMNPPELDAPPLETTDAEKEVKSVDPELLDLQTNIF 958
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224055599|ref|XP_002298559.1| predicted protein [Populus trichocarpa] gi|222845817|gb|EEE83364.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1581 bits (4094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 793/1009 (78%), Positives = 868/1009 (86%), Gaps = 39/1009 (3%)
Query: 1 MDQSEKSPKQSSKACESPLSRDSRGSLEVFNPST-FSTRPTNPVFRP-QPTWQTWMEQ-- 56
M+ ++KS KQSS PL RDSRGSLEVFNPS+ + RPTNP FR PTW++W++
Sbjct: 1 MEATDKSSKQSSGNV-PPLPRDSRGSLEVFNPSSAYLNRPTNPAFRSSNPTWKSWVDSSA 59
Query: 57 RESPEPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
+ PEPE A + TSWMALKDP +KP +QLSGE
Sbjct: 60 KNEPEPEEAPIT---------TSWMALKDP--KKPK------------------QQLSGE 90
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSD 176
G A +RAAEWGLVLKTD ETGKPQ V RTSGGDDPN KPGTSRR+SNNSVR+SGE+SD
Sbjct: 91 IGVATKRAAEWGLVLKTDDETGKPQGVSVRTSGGDDPNAKPGTSRRDSNNSVRNSGELSD 150
Query: 177 EGG--KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 234
+GG +PRVS+ +++ALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+G
Sbjct: 151 DGGTSNNSNIPRVSEDIRNALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIG 210
Query: 235 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 294
RNCRFLQGAGTDPEDVAKIRE L+ +YCGRLLNYKKDG+PFWNLLTIAPIKDD GKVL
Sbjct: 211 RNCRFLQGAGTDPEDVAKIREALRGEGTYCGRLLNYKKDGSPFWNLLTIAPIKDDSGKVL 270
Query: 295 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 354
KFIGM VEVSKHTEG+KDK LRPNGLP SLIRYDARQKEMATSSVTELVQA+ +PR+LSE
Sbjct: 271 KFIGMLVEVSKHTEGSKDKTLRPNGLPGSLIRYDARQKEMATSSVTELVQAVNRPRALSE 330
Query: 355 STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQK 414
STNRP ++RKSEGG E ER GA+GRR SENV P RRNS+ G R SMQRISE+PEKK +K
Sbjct: 331 STNRP-LMRKSEGGGEGERKGAIGRRNSENVAPNRRNSHRG-TRNSMQRISELPEKKPRK 388
Query: 415 SGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDL 474
S R SFMGL+ + + S D+ + + + D + DD R DS+DDKVR+KEMRKGIDL
Sbjct: 389 SSRLSFMGLMRKSTHSNDESFDVGITLDDDFESDDDDDDARLDSLDDKVRKKEMRKGIDL 448
Query: 475 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 534
ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR
Sbjct: 449 ATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 508
Query: 535 KIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 594
KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH+EP
Sbjct: 509 KIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHVEPRT 568
Query: 595 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 654
NSIPEATA ESE+LVKQTAENV++A +ELPDAN+ PEDLWANHSKVV+PKPHRKDSP WK
Sbjct: 569 NSIPEATAIESEQLVKQTAENVDDAARELPDANMRPEDLWANHSKVVYPKPHRKDSPSWK 628
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
AIQKIL+SGEQ+ L+HFRP+KPLGSGDTGSVHLVEL G+GQ+FAMK MDK MLNRNKVH
Sbjct: 629 AIQKILESGEQLGLKHFRPVKPLGSGDTGSVHLVELYGTGQFFAMKTMDKAAMLNRNKVH 688
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 774
RACAEREILDMLDHPF+PALYASFQTKTH+CLITDYCPGGELFLLLDRQP KVLKEDAVR
Sbjct: 689 RACAEREILDMLDHPFLPALYASFQTKTHICLITDYCPGGELFLLLDRQPKKVLKEDAVR 748
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
FYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTSCKPQLL+P+TNE
Sbjct: 749 FYAAEVVIALEYLHCQGIIYRDLKPENVLLQSNGHVALTDFDLSCLTSCKPQLLIPSTNE 808
Query: 835 KKRRHKGQQN-PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
KKR K QQ PVFMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLY
Sbjct: 809 KKRHRKHQQAPPVFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLY 868
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953
GYTPFRGKTRQKTFANILHKDLKFP S P SL+AKQLMYRLLHRDPK+RLGS EGAN+IK
Sbjct: 869 GYTPFRGKTRQKTFANILHKDLKFPGSIPVSLNAKQLMYRLLHRDPKNRLGSREGANDIK 928
Query: 954 KHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
+HPFFKGVNWALVRC+NPPEL+AP + EKE KVVDPGMQDLQ N+F
Sbjct: 929 RHPFFKGVNWALVRCLNPPELEAPFLESGEEKEAKVVDPGMQDLQTNIF 977
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|401782496|dbj|BAM36551.1| phototropin 1 [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 1541 bits (3989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 779/1021 (76%), Positives = 855/1021 (83%), Gaps = 44/1021 (4%)
Query: 18 PLSRDSRGSLEVFNPSTFSTRPTNPV-FRPQ--PTWQTWMEQRES-----PEPEHAKLNS 69
PL RDSRGSLE+FNPS STRP +P FR TW+TW++ R++ S
Sbjct: 16 PLPRDSRGSLEIFNPS--STRPASPPPFRQSKPATWKTWLDPRDTLNPKPDPSPPPIPAS 73
Query: 70 KSSRAE-EITSWMALKD----------PAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAG 118
KS R + ITSWMALKD P+ Q PP IQ+ + V + + E G
Sbjct: 74 KSGRDDGTITSWMALKDFPPTPPPPSKPSKQSQQAPPYIQQQQTIS--AAVNDKSTPEHG 131
Query: 119 AAAQRAAEWGLVLKTDTETGKPQAVVARTSGG-DDPNGKPGTSRRNSNNSVRSSGEMSDE 177
AAQRAAEWGLVLKTDTETGKPQ V R SGG +DP+ KPGTSRRNSNNSVRSSGE+SD+
Sbjct: 132 DAAQRAAEWGLVLKTDTETGKPQGVTTRNSGGPEDPSHKPGTSRRNSNNSVRSSGELSDD 191
Query: 178 GGKEKG----LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVV 233
GG G PRVS+ +K+ LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+
Sbjct: 192 GGGGGGIGKGFPRVSEDLKNVLSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVI 251
Query: 234 GRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKV 293
GRNCRFLQGA TDPEDVA++RE L SYCGRLLNYKKDGTPFWNLLTIAPIKD+ GKV
Sbjct: 252 GRNCRFLQGADTDPEDVAQLREALAKNTSYCGRLLNYKKDGTPFWNLLTIAPIKDETGKV 311
Query: 294 LKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLS 353
LKFIGMQVEVSKHTEG+KDKMLRPNGLPESLIRYDARQKE AT SVTELVQA+++PRSLS
Sbjct: 312 LKFIGMQVEVSKHTEGSKDKMLRPNGLPESLIRYDARQKEKATHSVTELVQAVRRPRSLS 371
Query: 354 ESTNRPPIIRKSEGGVEEER---------AGALGRRKSENVPPPRRNSYGGGCRTSMQRI 404
ESTNRP RKS GG E + +L RR SE+V PPRRNS G SM I
Sbjct: 372 ESTNRP--FRKSGGGGRGEEVIEAHARPSSESLPRRNSESVAPPRRNSLGDA-NFSMHSI 428
Query: 405 SEVPEKKKQKSGRRSFMGLIGRKSQSTD--DHDSFENEIIMEGDDDYESDDERPDSVDDK 462
EVPEKK++K RRSFMG++ +KSQ+ + D D+F+ E D +DERP S+DDK
Sbjct: 429 KEVPEKKQKKPRRRSFMGIM-KKSQTQNQLDDDTFDEFGASEDVRDDSDNDERPMSLDDK 487
Query: 463 VRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 522
VR+KEMRKG+DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF
Sbjct: 488 VRKKEMRKGMDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF 547
Query: 523 LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
LQGPETDPATV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGV
Sbjct: 548 LQGPETDPATVKKIREAIDNQTEVTVQLINYTKSGKKFWNVFHLQPMRDQKGEVQYFIGV 607
Query: 583 QLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVH 642
QLDGS+H+EPL+NSIPE A+ESEKLVK+TA NV+EA +ELPDAN+ PEDLW NHSKVVH
Sbjct: 608 QLDGSQHIEPLQNSIPEVAAKESEKLVKETAVNVDEAARELPDANMKPEDLWMNHSKVVH 667
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
PKPHRKDSPPW AIQKILDSGEQI L+HF+PIKPLGSGDTGSVHLV+LCG+ QYFAMKAM
Sbjct: 668 PKPHRKDSPPWIAIQKILDSGEQIGLKHFKPIKPLGSGDTGSVHLVQLCGTDQYFAMKAM 727
Query: 703 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR 762
DK +MLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDY PGGELFLLLD
Sbjct: 728 DKNIMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYYPGGELFLLLDT 787
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
QPTKVLKE++VRFY AEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTDFDLSCLTS
Sbjct: 788 QPTKVLKENSVRFYVAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVTLTDFDLSCLTS 847
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
CKPQLLLPT NEKKR HK Q +P+FMAEPMRASNSFVGTEEYIAPEII GAGH+SAVDWW
Sbjct: 848 CKPQLLLPTINEKKRHHKRQHDPIFMAEPMRASNSFVGTEEYIAPEIITGAGHSSAVDWW 907
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
ALGIL+YEMLYGYTPFRGKTRQKTFANILHKDLKFP S P SL AKQLMYRLLHRDPK+R
Sbjct: 908 ALGILIYEMLYGYTPFRGKTRQKTFANILHKDLKFPGSIPASLQAKQLMYRLLHRDPKNR 967
Query: 943 LGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFA-TDTEKEYKVVDPGMQDLQQNV 1001
LGS EGANEIK+HPFF+GVNWALVRCMNPP+LD+PLF T+ EK K+VDP MQDLQ N+
Sbjct: 968 LGSLEGANEIKRHPFFRGVNWALVRCMNPPQLDSPLFGTTEAEKGAKLVDPEMQDLQTNI 1027
Query: 1002 F 1002
F
Sbjct: 1028 F 1028
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582071|ref|XP_002531832.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223528528|gb|EEF30552.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1526 bits (3951), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 786/1018 (77%), Positives = 872/1018 (85%), Gaps = 35/1018 (3%)
Query: 3 QSEKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPT-NPVFRPQPTWQTWMEQ-RESP 60
+S S KQS +PL RD RGSLEVFNPS+ S+ + N +RP W+TW+E+ + P
Sbjct: 6 RSSSSNKQSPPVI-TPLPRDPRGSLEVFNPSSTSSTRSTNLAYRPNTNWKTWVEKPHDGP 64
Query: 61 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLI-----QKMTNDQEKSTVTKQLSG 115
+ KS RAEE T+WMA+KDPAP P+LP L Q + NDQ+K+ T +LSG
Sbjct: 65 NTQSP---PKSGRAEEATTWMAIKDPAPS-PTLPLLSSPSHSQLIGNDQDKNPAT-ELSG 119
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPN-GKPGTSRRNSNNSVRSSG-E 173
EA AA+RAAEWGLVLK +T+ GKPQ V R+SGGD+PN KPGTSRRNSNNSV+SSG +
Sbjct: 120 EAEMAARRAAEWGLVLKPETQEGKPQVGV-RSSGGDEPNSNKPGTSRRNSNNSVQSSGGD 178
Query: 174 MS-DEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
+S D+GGKE KG+PRVS+ +K+ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE
Sbjct: 179 LSEDDGGKENKGIPRVSEDIKNALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 238
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
V+GRNCRFLQGA TDPEDVAKIRE LQ+ SYCGRLLNYKKDGTPFWNLLTI+PIKD+ G
Sbjct: 239 VIGRNCRFLQGADTDPEDVAKIREALQSENSYCGRLLNYKKDGTPFWNLLTISPIKDESG 298
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
KVLK+IGMQVEVSK TEG+KDKMLRPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRS
Sbjct: 299 KVLKYIGMQVEVSKFTEGSKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRS 358
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSE+T+RP ++RKSE G E+ER GALGRR SENVP RRNS GG R SMQ I+E+PEKK
Sbjct: 359 LSEATSRP-LMRKSESGGEDERKGALGRRNSENVPSNRRNSLGGA-RNSMQSINELPEKK 416
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE------RPDSVDDKVRQ 465
+KS R SFMGL+ +KS + + DSF++ +I+ GDDD DDE RP+SVDDKVR+
Sbjct: 417 PRKSIRLSFMGLM-KKSSTQSNADSFDDALILNGDDDDVDDDEESEIDERPNSVDDKVRK 475
Query: 466 KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG 525
KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG
Sbjct: 476 KEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG 535
Query: 526 PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
PETDPATVRKIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD
Sbjct: 536 PETDPATVRKIREAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 595
Query: 586 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 645
GSEH+EP N IPE TA+ESEKLVKQTAENV+EAV+ELPDAN PEDLWANHSK VH KP
Sbjct: 596 GSEHVEPRSNCIPEETAQESEKLVKQTAENVDEAVRELPDANSKPEDLWANHSKAVHAKP 655
Query: 646 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
HRKD+P WKAIQKILD GE I L+HFRP+KPLGSGDTGSVHLVEL G+ +FAMKAMDK
Sbjct: 656 HRKDTPSWKAIQKILDDGEPIGLKHFRPVKPLGSGDTGSVHLVELSGTDHHFAMKAMDKN 715
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
VMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDYC GGELF+LLDRQPT
Sbjct: 716 VMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYCSGGELFMLLDRQPT 775
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
KVLKEDA RFYAAEVV+ALEYLHCQGIIYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKP
Sbjct: 776 KVLKEDAARFYAAEVVIALEYLHCQGIIYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKP 835
Query: 826 QLLLPTTNEKKR-RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
QLL+PT +EKK+ R QQ+P+FMAEPMRASNSFVGTEEYIAP +I +A
Sbjct: 836 QLLIPTVDEKKKHRKHHQQDPIFMAEPMRASNSFVGTEEYIAPVLIFHF-------IFAT 888
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 944
GILLYEMLYGYTPFRGKTRQKTFAN+LHKDLKFP S SLHAKQLMYRLLHRDPK+RLG
Sbjct: 889 GILLYEMLYGYTPFRGKTRQKTFANVLHKDLKFPRSRQVSLHAKQLMYRLLHRDPKNRLG 948
Query: 945 SHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
SHEGANEIK+HPFFKGVNWALVRCMNPPELD P+F + EKE K++DP + DLQ NVF
Sbjct: 949 SHEGANEIKRHPFFKGVNWALVRCMNPPELDTPIFENEAEKEAKLIDPELLDLQNNVF 1006
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350535803|ref|NP_001234214.1| phototropin-1 [Solanum lycopersicum] gi|151176133|gb|ABN42185.2| phototropin-1 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 1495 bits (3870), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 750/1016 (73%), Positives = 837/1016 (82%), Gaps = 41/1016 (4%)
Query: 18 PLSRDSRGSLEVFNPSTFSTRPTNPVFRPQPTWQTWM-----------------EQRESP 60
PL RD RGSLEVFNPST+S+R TNPVFR QP+W+ W EQ P
Sbjct: 13 PLPRDPRGSLEVFNPSTYSSRSTNPVFRSQPSWKNWTAADPITRSTIPETEEKTEQIAIP 72
Query: 61 EPEHAKLNSKSSRAEEITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAA 120
+ K+N + W L+ Q+ L L++ + +K E GAA
Sbjct: 73 QIRVTKMNKSL-----LHGWQLLR---LQRNWLLRLLKNQLPVVRRFN-SKAAVDEVGAA 123
Query: 121 AQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEG-G 179
AQRAAEWGLVLKTD ETGK Q V RTSG DD NGK TSRR+S NS RSSGE SD+G G
Sbjct: 124 AQRAAEWGLVLKTDDETGKLQGVKVRTSG-DDTNGKTETSRRDSGNSGRSSGEFSDDGAG 182
Query: 180 KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF 239
KE+G+PRVS+ ++DALSTFQQTFVVSDATKPDYPI+YASAGFFKMTGYTSKEV+GRNCRF
Sbjct: 183 KERGIPRVSEDLRDALSTFQQTFVVSDATKPDYPILYASAGFFKMTGYTSKEVIGRNCRF 242
Query: 240 LQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+QG+GTDPEDVA IRE LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD GKVLKFIGM
Sbjct: 243 MQGSGTDPEDVATIREALQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDAGKVLKFIGM 302
Query: 300 QVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPR---SLSEST 356
QVEVSKHTEG+K+K +RPNGLPESLIRYD RQKEMA++SV EL++ +K PR +LSEST
Sbjct: 303 QVEVSKHTEGSKEKTVRPNGLPESLIRYDVRQKEMASNSVNELLEEIKNPRRARALSEST 362
Query: 357 N-RPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSM--QRISEVPEKKKQ 413
N RP +RKSEG E+ + N P RR+S+ G T+M ++I+EVPEKK +
Sbjct: 363 NNRPTFMRKSEGDQVEQDKQDTHKLNLVNKAPARRHSHAGTRTTTMKMEKINEVPEKKPK 422
Query: 414 KSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDE---RPDSVDDKVRQKE 467
KS R SFMG++ +K ST FE + M+ DDD + + + RP SVDDKVR+KE
Sbjct: 423 KSARLSFMGIMKKKRSSTTMTTDDDDFEARMTMDNDDDDDDESDNDGRPVSVDDKVRKKE 482
Query: 468 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 527
MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE
Sbjct: 483 MRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE 542
Query: 528 TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587
TDPATV+KIR AIDNQTDVTVQLINYTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS
Sbjct: 543 TDPATVKKIRQAIDNQTDVTVQLINYTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 602
Query: 588 EHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHR 647
+H+EPL+NSIPE A ES KL+K+TA NV+EAV+ELPDAN PEDLW NHSKVV PKPHR
Sbjct: 603 QHVEPLQNSIPEDKATESAKLIKETAGNVDEAVRELPDANSKPEDLWRNHSKVVQPKPHR 662
Query: 648 KDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM 707
KDSP WKAIQKIL+SGE I L+HF+PIKPLGSGDTGSVHLVELCG+ Q+FAMKAMDK +M
Sbjct: 663 KDSPSWKAIQKILESGEPIGLKHFKPIKPLGSGDTGSVHLVELCGTDQHFAMKAMDKSIM 722
Query: 708 LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
LNRNKVHRACAEREILDMLDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQ TKV
Sbjct: 723 LNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQQTKV 782
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
LKEDA RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ GHVSLTDFDLSCLTSCKPQL
Sbjct: 783 LKEDAARFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSGGHVSLTDFDLSCLTSCKPQL 842
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
L+P NEKK+ KGQ NP+FMAEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGIL
Sbjct: 843 LVPEINEKKKHQKGQHNPIFMAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGIL 902
Query: 888 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
LYEMLYGYTPFRGKTRQKTF+NILHKDLKFP S +SLHAKQLMYRLLHRDPK+RLGS E
Sbjct: 903 LYEMLYGYTPFRGKTRQKTFSNILHKDLKFPGSIQSSLHAKQLMYRLLHRDPKNRLGSRE 962
Query: 948 GANEIKKHPFFKGVNWALVRCMNPPELD-APLFATDTEKEYKVVDPGMQDLQQNVF 1002
GANEIK+HPFF+GVNWAL+RCMNPP+LD AP T++EKE K ++P M+DLQ NVF
Sbjct: 963 GANEIKQHPFFRGVNWALIRCMNPPKLDSAPFLGTESEKEGKDINPEMEDLQTNVF 1018
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460993|ref|XP_004148228.1| PREDICTED: phototropin-1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1477 bits (3823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/910 (80%), Positives = 795/910 (87%), Gaps = 29/910 (3%)
Query: 116 EAGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGGDDPNGKPGTSRRNSNNSVRSSG-EM 174
E G+AA RAAEWGLVLKTDTETGKPQ V RTSGGD+PN K SRR SNNSVRSSG EM
Sbjct: 49 EVGSAALRAAEWGLVLKTDTETGKPQGVGVRTSGGDEPNTKQENSRRTSNNSVRSSGDEM 108
Query: 175 SDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVG 234
S+EGG+E+G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+G
Sbjct: 109 SEEGGRERGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIG 168
Query: 235 RNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVL 294
RNCRFLQGA TDPEDVAKIRE LQ G SYCGRLLNYKKDGTPFWNLLTI+PIKDD+GKVL
Sbjct: 169 RNCRFLQGADTDPEDVAKIREALQAGTSYCGRLLNYKKDGTPFWNLLTISPIKDDDGKVL 228
Query: 295 KFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSE 354
K IGMQVEVSKHTEG KDKM+RPNGLPESLIRYDARQKEMATSSVTELVQA+K+PRSLSE
Sbjct: 229 KLIGMQVEVSKHTEGFKDKMVRPNGLPESLIRYDARQKEMATSSVTELVQAVKRPRSLSE 288
Query: 355 --------STNRPPIIRKSEGGVEEERAG----------ALGRRKSENVPPPRRNSYGGG 396
S NR + RKS GG G + RRKSE+ P GG
Sbjct: 289 YRPRALSESMNRR-LFRKSGGGGGGGEGGGKDEKDKLEPTMVRRKSESAAAPAGRRSQGG 347
Query: 397 CRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDE-- 454
R SMQRI+EVP+KK +KS RSFMG++ RKSQS + +SF+ I EG DD D+
Sbjct: 348 SRRSMQRINEVPDKKPKKSSHRSFMGIM-RKSQS-NVEESFD---IEEGSDDENESDDDV 402
Query: 455 RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 514
RPDSVDDKVRQ+EMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE
Sbjct: 403 RPDSVDDKVRQREMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREE 462
Query: 515 ILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 574
ILGRNCRFLQGPETD TV+KIR AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG
Sbjct: 463 ILGRNCRFLQGPETDRTTVKKIRDAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKG 522
Query: 575 EVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW 634
EVQYFIGVQLDGS+H+EPL N I E+TA+E EKL+K+TAENV+ A +ELPDANLTPEDLW
Sbjct: 523 EVQYFIGVQLDGSQHVEPLSNCIAESTAKEGEKLIKETAENVDLAARELPDANLTPEDLW 582
Query: 635 ANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG 694
ANHSK+V PKPHRKDSP W+AIQKILD GEQI L+HF+P+KPLGSGDTGSVHLVELCG+
Sbjct: 583 ANHSKLVQPKPHRKDSPSWQAIQKILDGGEQIGLKHFKPVKPLGSGDTGSVHLVELCGTD 642
Query: 695 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754
QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF+PALYASFQTKTHVCLITDYCPGG
Sbjct: 643 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFLPALYASFQTKTHVCLITDYCPGG 702
Query: 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
ELFLLLDRQPTKV+KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ NGHV+LTD
Sbjct: 703 ELFLLLDRQPTKVIKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQSNGHVALTD 762
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
FDLSCLTSCKPQLLLP NEKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII GAG
Sbjct: 763 FDLSCLTSCKPQLLLPAANEKKKQSKTQQTPIFMAEPMRASNSFVGTEEYIAPEIITGAG 822
Query: 875 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRL 934
HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP S SL+AKQL++RL
Sbjct: 823 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPRSISASLNAKQLIFRL 882
Query: 935 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF-ATDTEKEY-KVVDP 992
LHRDPK+RLGS EGA+EIK+HPFF+GVNWALVRCMNPPEL+APLF TD EK+ K D
Sbjct: 883 LHRDPKNRLGSREGASEIKRHPFFRGVNWALVRCMNPPELEAPLFQTTDGEKDANKASDF 942
Query: 993 GMQDLQQNVF 1002
++L+ +VF
Sbjct: 943 DPKELELSVF 952
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|60099454|dbj|BAD89966.1| phototropin [Phaseolus vulgaris] | Back alignment and taxonomy information |
|---|
Score = 1469 bits (3802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 728/991 (73%), Positives = 818/991 (82%), Gaps = 29/991 (2%)
Query: 21 RDSRGSLEVFNPSTFSTRPTNPVFRP---QPTWQTWMEQRESPEPEHAKLNSKSSRAEEI 77
RD RGSLEVFNPS+ S PV P Q TW+TW++ R +PE + + +E+
Sbjct: 6 RDQRGSLEVFNPSSSSYSNEKPVISPLRTQSTWKTWVDSRVEEQPEKQQ---RGGGPDEV 62
Query: 78 T--SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDT 135
T SWMALKD P PS Q + V + E G AA+RAAEWGLVLKTDT
Sbjct: 63 TATSWMALKDSTPPPPS-----------QTLAAVLGEPPAEVGNAAKRAAEWGLVLKTDT 111
Query: 136 ETGKPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKD 193
ETGKPQ V +TSGG++P K G SRR+S NSVRSSGE SD+G + +G +PRVS+ ++D
Sbjct: 112 ETGKPQGVAVQTSGGEEPGVKVTGGSRRDSGNSVRSSGESSDDGREYRGGIPRVSEDLRD 171
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
ALS FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKI
Sbjct: 172 ALSAFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKI 231
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDK 313
RE LQ GQ+YCGRLLNYKKDGTPFWNLLTIAPIKD +G+VLKFIGMQVEVSKHTEG K+
Sbjct: 232 REALQTGQTYCGRLLNYKKDGTPFWNLLTIAPIKDHDGRVLKFIGMQVEVSKHTEGNKEN 291
Query: 314 MLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGGVEEER 373
MLRPNGLPESLIRYDARQKE A SSV+EL+ A+++PR+LSES RP I + + G ++++
Sbjct: 292 MLRPNGLPESLIRYDARQKEKANSSVSELLLAVRRPRALSESGGRPLIRKSASGDDDQDK 351
Query: 374 AGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDD 433
RRKSE+V RR S+ G RTSM++I+E+PE K + S RRSFMG I RK+QS
Sbjct: 352 PEKSSRRKSESVASFRRKSHAGD-RTSMEKITEIPENKHKTSRRRSFMGFI-RKNQSK-- 407
Query: 434 HDSFENEIIMEGDDDYESDD-ERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRL 492
SF +E ++EG + +D ER S D KV++KE RKG+DLATTLERIEKNFVITDPRL
Sbjct: 408 FGSFNDEAVIEGSSESSDEDGERSGSFDGKVQRKEKRKGLDLATTLERIEKNFVITDPRL 467
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552
PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AID QTDVTVQLIN
Sbjct: 468 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDTQTDVTVQLIN 527
Query: 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQT 612
YTK+GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E EKLVK T
Sbjct: 528 YTKTGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIAENTAKEGEKLVKDT 587
Query: 613 AENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFR 672
AENV++A++ELPDANL PEDLW NHSKVVHPKPHR+D WKAIQKIL+SGEQI L HF+
Sbjct: 588 AENVDDALRELPDANLKPEDLWMNHSKVVHPKPHRRDEAAWKAIQKILESGEQIGLNHFK 647
Query: 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
P+KPLGSGDTGSV+LVEL +GQYFAMKAM+KG+MLNRNKVHRAC EREILDMLDHPF+P
Sbjct: 648 PVKPLGSGDTGSVYLVELGETGQYFAMKAMEKGIMLNRNKVHRACTEREILDMLDHPFLP 707
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
ALYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGI
Sbjct: 708 ALYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGI 767
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
IYRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P+ NEKK+ KG Q P+FMAEPM
Sbjct: 768 IYRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPSINEKKKAQKGHQPPIFMAEPM 827
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
RASNSFVGTEEYIAPEII G+GH+SAVDWWALGILLYEM +GYTPFRGKTRQ+TF NILH
Sbjct: 828 RASNSFVGTEEYIAPEIITGSGHSSAVDWWALGILLYEMFFGYTPFRGKTRQRTFTNILH 887
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 972
KDLKFP S S AKQLMYRLL+RDPKSRLGS EGANEIK HPFF+GVNWALVRC PP
Sbjct: 888 KDLKFPKSKQVSFSAKQLMYRLLNRDPKSRLGSREGANEIKNHPFFRGVNWALVRCTKPP 947
Query: 973 ELDAPLF-ATDTEKEYKVVDPGMQDLQQNVF 1002
ELDAPLF T EKE D +++ NVF
Sbjct: 948 ELDAPLFDTTRGEKEANFEDQVQEEM--NVF 976
|
Source: Phaseolus vulgaris Species: Phaseolus vulgaris Genus: Phaseolus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542583|ref|XP_003539746.1| PREDICTED: phototropin-1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1465 bits (3793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 732/991 (73%), Positives = 828/991 (83%), Gaps = 28/991 (2%)
Query: 21 RDSRGSLEVFNPST-FST-RPTNPVFRPQPTWQTWMEQRESPEPEHAKLNSKSSRAEEIT 78
RD RGSLEVFNPS+ +ST + N R Q TW+TW++ E PE + + ++ T
Sbjct: 6 RDQRGSLEVFNPSSSYSTEKSVNSPVRVQSTWKTWID--ELPEQQQQQQCGGTNEVT-AT 62
Query: 79 SWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGEAGAAAQRAAEWGLVLKTDTETG 138
SWMALKD AP P+L ++ + + GE G AA+RAAEWGLVLKTDTETG
Sbjct: 63 SWMALKDSAPPPPTLAAVLGESLS---------AAVGEVGNAAKRAAEWGLVLKTDTETG 113
Query: 139 KPQAVVARTSGGDDPNGK-PGTSRRNSNNSVRSSGEMSDEGGKEKG-LPRVSDIVKDALS 196
KPQ V RTSGG++P+ K G SRR+S+NSVRSSGE SD+G + +G +PRVS+ ++DALS
Sbjct: 114 KPQGVKVRTSGGEEPSAKVTGGSRRDSSNSVRSSGESSDDGREYRGGIPRVSEDLRDALS 173
Query: 197 TFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRET 256
FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV+GRNCRF+QGA TDP+DVAKIRE
Sbjct: 174 AFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVIGRNCRFMQGADTDPDDVAKIREA 233
Query: 257 LQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLR 316
LQ+G +YCGRLLNYKKDGTPFWNLLTIAPIKDD+G+VLKFIGMQVEVSKHTEGAK+KMLR
Sbjct: 234 LQSGSTYCGRLLNYKKDGTPFWNLLTIAPIKDDDGRVLKFIGMQVEVSKHTEGAKEKMLR 293
Query: 317 PNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIRKSEGG--VEEERA 374
PNGLPESLIRYDARQKE A S+V+EL+ A+++PR+LSES RP +I+KS G +++
Sbjct: 294 PNGLPESLIRYDARQKEKANSTVSELLLAVRRPRALSESAGRP-MIKKSASGDDAQDKPP 352
Query: 375 GALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDH 434
RRKSE+V RR S+ G R+SM+RI+E+PEKK + S RRSFMG I RKSQS +
Sbjct: 353 EKSSRRKSESVASFRRKSHAGD-RSSMERITELPEKKHKSSRRRSFMGFI-RKSQS--NF 408
Query: 435 DSFENEIIMEGDDDYESDDE-RPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLP 493
SF +E ++E + +D+ RP+S D KV++KE RKG+DLATTLERIEKNFVITDPRLP
Sbjct: 409 GSFNDEAVVENSSESSDEDDERPESFDGKVQKKEKRKGLDLATTLERIEKNFVITDPRLP 468
Query: 494 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553
DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR AIDNQTDVTVQLINY
Sbjct: 469 DNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIREAIDNQTDVTVQLINY 528
Query: 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTA 613
TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I + TA+E E+LVK TA
Sbjct: 529 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNRIADDTAKEGEQLVKDTA 588
Query: 614 ENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRP 673
ENV++A++ELPDAN+ PEDLW NHSKVVHPKPHR+D WKAIQ+IL+SGEQI L HFRP
Sbjct: 589 ENVDDALRELPDANMKPEDLWMNHSKVVHPKPHRRDEAAWKAIQQILNSGEQIGLNHFRP 648
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+KPLGSGDTGSV+LVEL +G YFAMKAM+KGVMLNRNKVHRAC EREILDMLDHPF+PA
Sbjct: 649 VKPLGSGDTGSVYLVELGETGHYFAMKAMEKGVMLNRNKVHRACTEREILDMLDHPFLPA 708
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LYASFQTKTHVCLITDYC GGELFLLLDRQP KVL+EDAVRFYAAEVVVALEYLHCQGII
Sbjct: 709 LYASFQTKTHVCLITDYCSGGELFLLLDRQPAKVLREDAVRFYAAEVVVALEYLHCQGII 768
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPENVLLQ +GHVSLTDFDLSCLTSCKPQLL+P NEKK+ KG P+FMAEPMR
Sbjct: 769 YRDLKPENVLLQSSGHVSLTDFDLSCLTSCKPQLLVPVINEKKKAQKGPHAPIFMAEPMR 828
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
ASNSFVGTEEYIAPEII G+GHTSAVDWWALGILLYEM YGYTPFRGKTRQ+TF NILHK
Sbjct: 829 ASNSFVGTEEYIAPEIITGSGHTSAVDWWALGILLYEMFYGYTPFRGKTRQRTFTNILHK 888
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 973
DLKFP S S AKQLMYRLL+RDPKSRLGS EGANEIK HPFF+GVNWALVRC PPE
Sbjct: 889 DLKFPKSKQVSFSAKQLMYRLLNRDPKSRLGSREGANEIKNHPFFRGVNWALVRCTKPPE 948
Query: 974 LDAPLFATDT--EKEYKVVDPGMQDLQQNVF 1002
LDAPL T EKE K + +D+ NVF
Sbjct: 949 LDAPLLETTEGGEKEAKFENQVQEDM--NVF 977
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231245|ref|NP_190164.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|79314333|ref|NP_001030814.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|25090817|sp|O48963.1|PHOT1_ARATH RecName: Full=Phototropin-1; AltName: Full=Non-phototropic hypocotyl protein 1; AltName: Full=Root phototropism protein 1 gi|13430612|gb|AAK25928.1|AF360218_1 putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|2832241|gb|AAC01753.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|7019644|emb|CAB75791.1| nonphototropic hypocotyl 1 [Arabidopsis thaliana] gi|14532876|gb|AAK64120.1| putative nonphototropic hypocotyl 1 protein [Arabidopsis thaliana] gi|332644551|gb|AEE78072.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] gi|332644552|gb|AEE78073.1| non-specific serine/threonine protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1463 bits (3788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/1014 (73%), Positives = 838/1014 (82%), Gaps = 35/1014 (3%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAEE----ITSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSGE 116
P+ S R+++ TSWMALKDP+P+ S +K+ ++
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPETIS------------KKTITAEKPQKS 109
Query: 117 AGAAAQRAAEWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTSRRNSNNSVRSSGEM 174
A AA QRAAEWGLVLKTDT+TGKPQ V R SGG +DPNGK TS+RNS NS RSSGEM
Sbjct: 110 AVAAEQRAAEWGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SDEG--GKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV 232
SD G G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKEV
Sbjct: 170 SDGDVPGGRSGIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKEV 229
Query: 233 VGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGK 292
VGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ GK
Sbjct: 230 VGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESGK 289
Query: 293 VLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSL 352
VLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+L
Sbjct: 290 VLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRAL 349
Query: 353 SESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKK 412
SESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 350 SESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKKS 406
Query: 413 QKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEG--DDDYESDDERPDSVDDKVRQKEMRK 470
+KS SFMG I +KS+S D+ S ++ I G DD+ DERP+SVDDKVRQKEMRK
Sbjct: 407 RKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMRK 462
Query: 471 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDP 530
GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 463 GIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDL 522
Query: 531 ATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H+
Sbjct: 523 TTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKHV 582
Query: 591 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 650
EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKDS
Sbjct: 583 EPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKDS 642
Query: 651 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
PPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLNR
Sbjct: 643 PPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLNR 702
Query: 711 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
NKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLKE
Sbjct: 703 NKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLKE 762
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830
DAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+P
Sbjct: 763 DAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLIP 822
Query: 831 TTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ +E KK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL+
Sbjct: 823 SIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGILM 882
Query: 889 YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948
YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG EG
Sbjct: 883 YEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFEG 942
Query: 949 ANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
ANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 943 ANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1002 | ||||||
| TAIR|locus:2102674 | 996 | PHOT1 "phototropin 1" [Arabido | 0.976 | 0.981 | 0.714 | 0.0 | |
| UNIPROTKB|Q8H935 | 963 | Vfphot1a "Phototropin" [Vicia | 0.943 | 0.981 | 0.675 | 0.0 | |
| UNIPROTKB|Q2QYY8 | 921 | PHOT1A "Phototropin-1A" [Oryza | 0.795 | 0.865 | 0.702 | 0.0 | |
| UNIPROTKB|Q2RBR1 | 921 | PHOT1B "Phototropin-1B" [Oryza | 0.795 | 0.865 | 0.701 | 0.0 | |
| TAIR|locus:2155821 | 915 | PHOT2 "phototropin 2" [Arabido | 0.632 | 0.692 | 0.635 | 1.8e-287 | |
| UNIPROTKB|Q9ST27 | 907 | PHOT2 "Phototropin-2" [Oryza s | 0.809 | 0.894 | 0.630 | 9.5e-279 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.211 | 0.302 | 0.483 | 1.4e-93 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.249 | 0.326 | 0.434 | 5.7e-91 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.203 | 0.403 | 0.495 | 4.3e-89 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.197 | 0.396 | 0.505 | 9.8e-89 |
| TAIR|locus:2102674 PHOT1 "phototropin 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3643 (1287.5 bits), Expect = 0., P = 0.
Identities = 725/1015 (71%), Positives = 815/1015 (80%)
Query: 5 EKSPKQSSKACESPLSRDSRGSLEVFNPSTFSTRPTNPVFRPQP-TWQTWMEQRES---P 60
E + K S+K L RD+RGSLEVFNPST TRP NPVFRP+P WQ + R + P
Sbjct: 2 EPTEKPSTKPSSRTLPRDTRGSLEVFNPSTQLTRPDNPVFRPEPPAWQNLSDPRGTSPQP 61
Query: 61 EPEHAKLNSKSSRAE-EI---TSWMALKDPAPQKPSLPPLIQKMTNDQEKSTVTKQLSXX 116
P+ S R++ EI TSWMALKDP+P+ I K T EK Q S
Sbjct: 62 RPQQEPAPSNPVRSDQEIAVTTSWMALKDPSPET------ISKKTITAEKP----QKSAV 111
Query: 117 XXXXXXXXXXWGLVLKTDTETGKPQAVVARTSGG--DDPNGKPGTXXXXXXXXXXXXGEM 174
WGLVLKTDT+TGKPQ V R SGG +DPNGK T GEM
Sbjct: 112 AAEQRAAE--WGLVLKTDTKTGKPQGVGVRNSGGTENDPNGKKTTSQRNSQNSCRSSGEM 169
Query: 175 SD---EGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKE 231
SD GG+ G+PRVS+ +KDALSTFQQTFVVSDATKPDYPIMYASAGFF MTGYTSKE
Sbjct: 170 SDGDVPGGRS-GIPRVSEDLKDALSTFQQTFVVSDATKPDYPIMYASAGFFNMTGYTSKE 228
Query: 232 VVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG 291
VVGRNCRFLQG+GTD +++AKIRETL G +YCGR+LNYKKDGT FWNLLTIAPIKD+ G
Sbjct: 229 VVGRNCRFLQGSGTDADELAKIRETLAAGNNYCGRILNYKKDGTSFWNLLTIAPIKDESG 288
Query: 292 KVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351
KVLKFIGMQVEVSKHTEGAK+K LRPNGLPESLIRYDARQK+MAT+SVTELV+A+K+PR+
Sbjct: 289 KVLKFIGMQVEVSKHTEGAKEKALRPNGLPESLIRYDARQKDMATNSVTELVEAVKRPRA 348
Query: 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKK 411
LSESTN P + KSE +E RR SENV P R + GGG R SMQRI+E+PEKK
Sbjct: 349 LSESTNLHPFMTKSES---DELPKKPARRMSENVVPSGRRNSGGGRRNSMQRINEIPEKK 405
Query: 412 KQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMR 469
+KS SFMG I +KS+S D+ S ++ I SVDDKVRQKEMR
Sbjct: 406 SRKSSL-SFMG-IKKKSESLDE--SIDDGFIEYGEEDDEISDRDERPESVDDKVRQKEMR 461
Query: 470 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 529
KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD
Sbjct: 462 KGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETD 521
Query: 530 PATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589
TV+KIR AIDNQT+VTVQLINYTKSGKKFWN+FHLQPMRDQKGEVQYFIGVQLDGS+H
Sbjct: 522 LTTVKKIRNAIDNQTEVTVQLINYTKSGKKFWNIFHLQPMRDQKGEVQYFIGVQLDGSKH 581
Query: 590 LEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKD 649
+EP+RN I E +E E LVK+TA N++EAV+ELPDAN+TPEDLWANHSKVVH KPHRKD
Sbjct: 582 VEPVRNVIEETAVKEGEDLVKKTAVNIDEAVRELPDANMTPEDLWANHSKVVHCKPHRKD 641
Query: 650 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 709
SPPW AIQK+L+SGE I L+HF+P+KPLGSGDTGSVHLVEL G+ Q FAMKAMDK VMLN
Sbjct: 642 SPPWIAIQKVLESGEPIGLKHFKPVKPLGSGDTGSVHLVELVGTDQLFAMKAMDKAVMLN 701
Query: 710 RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 769
RNKVHRA AEREILD+LDHPF+PALYASFQTKTH+CLITDY PGGELF+LLDRQP KVLK
Sbjct: 702 RNKVHRARAEREILDLLDHPFLPALYASFQTKTHICLITDYYPGGELFMLLDRQPRKVLK 761
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
EDAVRFYAA+VVVALEYLHCQGIIYRDLKPENVL+QGNG +SL+DFDLSCLTSCKPQLL+
Sbjct: 762 EDAVRFYAAQVVVALEYLHCQGIIYRDLKPENVLIQGNGDISLSDFDLSCLTSCKPQLLI 821
Query: 830 PTTNEKKRR--HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
P+ +EKK++ K QQ P+FMAEPMRASNSFVGTEEYIAPEII+GAGHTSAVDWWALGIL
Sbjct: 822 PSIDEKKKKKQQKSQQTPIFMAEPMRASNSFVGTEEYIAPEIISGAGHTSAVDWWALGIL 881
Query: 888 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
+YEMLYGYTPFRGKTRQKTF N+L KDLKFP+S P SL KQL++RLL RDPK RLG E
Sbjct: 882 MYEMLYGYTPFRGKTRQKTFTNVLQKDLKFPASIPASLQVKQLIFRLLQRDPKKRLGCFE 941
Query: 948 GANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
GANE+K+H FFKG+NWAL+RC NPPEL+ P+F+ + E KVVDP ++DLQ NVF
Sbjct: 942 GANEVKQHSFFKGINWALIRCTNPPELETPIFSGEAENGEKVVDPELEDLQTNVF 996
|
|
| UNIPROTKB|Q8H935 Vfphot1a "Phototropin" [Vicia faba (taxid:3906)] | Back alignment and assigned GO terms |
|---|
Score = 3296 (1165.3 bits), Expect = 0., Sum P(2) = 0.
Identities = 661/979 (67%), Positives = 744/979 (75%)
Query: 32 PSTFSTRPTNPVFRPQPTWQTWMEQ-RESPEPEHAKLNSKSSRAEEITSWM--ALKDPAP 88
P T R + VF P + +P P ++ SSR E + D P
Sbjct: 3 PFTRDHRGSLEVFNPSSSETNGTPNPNPNPNPSNSWNTGTSSRGTEAPPLRDSIISDEVP 62
Query: 89 QKPSLPPLIQKMTNDQEKSTVTKQLSXXXXXXXXXXXXWGLVLKTDTETGKPQAVVARTS 148
S L K T KS + ++ WGLVLKTD+ETGKPQ V R S
Sbjct: 63 TATSWMAL--KETTPSPKSGESGSVAEQRAAE------WGLVLKTDSETGKPQGVGVRGS 114
Query: 149 GGDDPNGKPGTXXXXXXXXXXXXGEMSDEGGKE-KGLPRVSDIVKDALSTFQQTFVVSDA 207
GG G GE SD+G + +G+PRVS+ ++DALS FQQTFVVSDA
Sbjct: 115 GGG------GGSRRDSNNSVRSSGESSDDGREGGRGIPRVSEDLRDALSAFQQTFVVSDA 168
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
TKPDYPIMYASAGFF MTGYTSKEV+GRNCRF+QGA TDP DVAKIRE L G SYCGRL
Sbjct: 169 TKPDYPIMYASAGFFSMTGYTSKEVIGRNCRFMQGADTDPNDVAKIREALAAGTSYCGRL 228
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRY 327
LNYKKDGT FWNLLTIAPIKD+ GK+LK IGMQVEVSKHTEG K+KMLRPNGLPESLIRY
Sbjct: 229 LNYKKDGTTFWNLLTIAPIKDEHGKILKLIGMQVEVSKHTEGTKEKMLRPNGLPESLIRY 288
Query: 328 DARQKEMATSSVTELVQAM-KKPRSLSESTNRPPIIRKSEGGVEEE----RAGALGRRKS 382
DARQKE A SSVTELV+A+ K+PRSLSES NR P +K G + + + R+
Sbjct: 289 DARQKEKANSSVTELVEAVSKRPRSLSESANRLPFNKKPTNGSNDHATPPNSESSSRKSG 348
Query: 383 ENVPPPRRNSYGG-GCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEI 441
+ RR S+ G G SM I+E+PE KS RRSFMG + RKS S ++ F +E
Sbjct: 349 STLRSFRRKSHSGAGNSNSMHPITELPENNN-KSRRRSFMGFM-RKSLSNNER--FNHEQ 404
Query: 442 IMXXXXXXXXXXXXXXSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 501
++ + +++E RKG DLATTLERIEKNFVITDPRLPDNPIIFAS
Sbjct: 405 VIDRNSSEDEDRLDSFDEQNIAQKREKRKGFDLATTLERIEKNFVITDPRLPDNPIIFAS 464
Query: 502 DSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561
DSFLELTEYSREEILGRNCRFLQGPETDPATV+KIR AIDNQT+VTVQLINYTK+GKKFW
Sbjct: 465 DSFLELTEYSREEILGRNCRFLQGPETDPATVKKIRYAIDNQTEVTVQLINYTKTGKKFW 524
Query: 562 NLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVK 621
NLFHLQPMRDQKGEVQYFIGVQLDGS+H+EPL N I E TA+E E LVK+TAENV++A++
Sbjct: 525 NLFHLQPMRDQKGEVQYFIGVQLDGSQHVEPLHNGIAEDTAKEGENLVKKTAENVDDALR 584
Query: 622 ELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGD 681
ELPDAN+ PEDLW NHSKVVHPKPHR++ W+AIQKI++SGEQI L+HF+PIKPLGSGD
Sbjct: 585 ELPDANMKPEDLWMNHSKVVHPKPHRREDSAWRAIQKIMESGEQIGLKHFKPIKPLGSGD 644
Query: 682 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741
TGSVHLVELCG+ +FAMKAMDKGVM NRNKVHRAC EREILDMLDHPF+PALYASFQTK
Sbjct: 645 TGSVHLVELCGTDHHFAMKAMDKGVMPNRNKVHRACTEREILDMLDHPFLPALYASFQTK 704
Query: 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801
TH+CLITDYCPGGELF+LLDRQP KVLKEDAVRFYA EVVVALEYLHCQGIIYRDLKPEN
Sbjct: 705 THICLITDYCPGGELFMLLDRQPAKVLKEDAVRFYATEVVVALEYLHCQGIIYRDLKPEN 764
Query: 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 861
VLLQ GHVSLTDFDLSCLTSCKP+L++P+TN+KK KGQ P+FMAEPMRASNSFVGT
Sbjct: 765 VLLQSTGHVSLTDFDLSCLTSCKPELIVPSTNDKK---KGQHGPIFMAEPMRASNSFVGT 821
Query: 862 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST 921
EEYIAPEII G+GHT AVDWWALGILLYEM YGYTPFRGK RQ+TFANILHKDLK P S
Sbjct: 822 EEYIAPEIITGSGHTCAVDWWALGILLYEMFYGYTPFRGKNRQRTFANILHKDLKLPKSK 881
Query: 922 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 981
SL AKQL+Y LL RDP SRLGS GAN+IK H FFKG+NWALVRC PPELDAPLF T
Sbjct: 882 QVSLSAKQLIYHLLQRDPTSRLGSKGGANDIKHHSFFKGINWALVRCTKPPELDAPLFDT 941
Query: 982 ---DTEKEYKVVDPGMQDL 997
+ EK+ K VD G +D+
Sbjct: 942 NKEEKEKDDKYVDNGQEDM 960
|
|
| UNIPROTKB|Q2QYY8 PHOT1A "Phototropin-1A" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 3002 (1061.8 bits), Expect = 0., Sum P(2) = 0.
Identities = 575/818 (70%), Positives = 675/818 (82%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSAFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMTEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQGNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL PEDLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPEDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 960 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 997
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
|
| UNIPROTKB|Q2RBR1 PHOT1B "Phototropin-1B" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2999 (1060.8 bits), Expect = 0., Sum P(2) = 0.
Identities = 574/818 (70%), Positives = 676/818 (82%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
+PRVS+ ++ ALS FQQTFVVSDAT P++PIMYASAGFF MTGYTSKEVVGRNCRFLQG+
Sbjct: 120 IPRVSEELRAALSVFQQTFVVSDATHPNHPIMYASAGFFNMTGYTSKEVVGRNCRFLQGS 179
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
GTDP ++ KIR++L NG +YCGR+LNYKKDGTPFWNLLTIAPIKD++G++LKFIGMQVEV
Sbjct: 180 GTDPHEIDKIRQSLANGSNYCGRILNYKKDGTPFWNLLTIAPIKDEDGRLLKFIGMQVEV 239
Query: 304 SKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRSLSESTNRPPIIR 363
SK+TEG KD ++RPNGL ESLI+YDARQK+ A SSV+EL+ A+K PRSLSES+N + R
Sbjct: 240 SKYTEGKKDTVVRPNGLSESLIKYDARQKDHARSSVSELLLALKNPRSLSESSNNT-LKR 298
Query: 364 KSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEK--KKQKSGRRSFM 421
KS+ + + +R SE+ RRNS G R+S+Q+I+EVP++ + +KSG R+FM
Sbjct: 299 KSQESLSMSMSEVPSKRSSES--GSRRNSRSG-TRSSLQKINEVPDQVNRTRKSGLRAFM 355
Query: 422 GLIGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXX--SVDDKVRQKEMRKGIDLATTLE 479
G +G H S E ++ S +D+ R+KEMR+GIDLATTLE
Sbjct: 356 GFLGM------GHGSVEKNMLKPRDEDPLIDSDDERPESFEDEFRRKEMRRGIDLATTLE 409
Query: 480 RIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAA 539
RIEKNFVITDPRLPDNPIIFASDSFL+LTEY+REEILGRNCRFLQGPETD ATVRKIR A
Sbjct: 410 RIEKNFVITDPRLPDNPIIFASDSFLQLTEYNREEILGRNCRFLQGPETDRATVRKIRDA 469
Query: 540 IDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPE 599
IDNQ +VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH++ +
Sbjct: 470 IDNQAEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVQ-------D 522
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKI 659
A+E LVK+TA+N++EA KELPDANL P+DLWANHSKVV P PH KD+ W+AIQK+
Sbjct: 523 DAAKEGVVLVKKTADNIDEAAKELPDANLRPKDLWANHSKVVLPNPHMKDTASWRAIQKV 582
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
L+SGE I L+HFRP+KPLGSGDTGSVHLVEL +G+YFAMKAMDK +MLNRNKVHRA AE
Sbjct: 583 LESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSIMLNRNKVHRATAE 642
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
R+ILD+LDHPF+P LYASFQTKTH+CLITDYCPGGELF+LLD QP KVL EDAVRFYAAE
Sbjct: 643 RQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGELFVLLDNQPLKVLHEDAVRFYAAE 702
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
VVVALEYLHCQGIIYRDLKPEN+LL +GH+SLTDFDLSCLTSC+PQ+ LP ++K+
Sbjct: 703 VVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFDLSCLTSCRPQVFLPEDADEKKGR 762
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
K P+F AEPMRASNSFVGTEEYIAPEII GAGHTSAVDWWALGILLYEMLYGYTPFR
Sbjct: 763 KNGSYPIFFAEPMRASNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFR 822
Query: 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
GKTRQ+TFANILHKD++FP+S SL A+QLMYRLLHRDP +RLGS+EGANEIK HPFF+
Sbjct: 823 GKTRQRTFANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFR 882
Query: 960 GVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDL 997
G+NW L+R PP+L+ PLF+ D ++ +V D+
Sbjct: 883 GINWPLIRATAPPKLEIPLFSKDDMEKKGLVTNNRTDM 920
|
|
| TAIR|locus:2155821 PHOT2 "phototropin 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2099 (743.9 bits), Expect = 1.8e-287, Sum P(3) = 1.8e-287
Identities = 418/658 (63%), Positives = 494/658 (75%)
Query: 345 AMKKPRSLSESTNRPPIIRKSEGGVEEERAG-ALGRRKSENVPPPRRNSYGGGCRTSMQR 403
A +K ++L T IR + V+E + + + S P P R + R
Sbjct: 262 ARQKEKALDSITEVVQTIRHRKSQVQESVSNDTMVKPDSSTTPTPGRQT----------R 311
Query: 404 ISEVPEKKKQKSGRRSFMGLIGRKSQSTDD-HDSF---ENEIIMXXXXXXXXXXXXXXSV 459
S+ K + GR S G K +S+++ H+ E E +M S
Sbjct: 312 QSDEASKSFRTPGRVSTP--TGSKLKSSNNRHEDLLRMEPEELMLSTEVIGQRD----SW 365
Query: 460 DDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN 519
D R++++R+GIDLATTLERIEKNFVI+DPRLPDNPIIFASDSFLELTEYSREEILGRN
Sbjct: 366 DLSDRERDIRQGIDLATTLERIEKNFVISDPRLPDNPIIFASDSFLELTEYSREEILGRN 425
Query: 520 CRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYF 579
CRFLQGPETD ATV+KIR AI +Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QYF
Sbjct: 426 CRFLQGPETDQATVQKIRDAIRDQREITVQLINYTKSGKKFWNLFHLQPMRDQKGELQYF 485
Query: 580 IGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSK 639
IGVQLDGS+H+EPL+N + E T +S KLVK TA NV+EAV+ELPDAN PEDLWA HSK
Sbjct: 486 IGVQLDGSDHVEPLQNRLSERTEMQSSKLVKATATNVDEAVRELPDANTRPEDLWAAHSK 545
Query: 640 VVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAM 699
V+P PH K+S WKAI+KI SGE + L HF+PIKPLGSGDTGSVHLVEL G+G+ +AM
Sbjct: 546 PVYPLPHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAM 605
Query: 700 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
KAM+K +MLNRNK HRAC EREI+ +LDHPF+P LYASFQT THVCLITD+CPGGELF L
Sbjct: 606 KAMEKTMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFAL 665
Query: 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819
LDRQP K+L ED+ RFYAAEVV+ LEYLHC GI+YRDLKPEN+LL+ +GH+ L DFDLS
Sbjct: 666 LDRQPMKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSF 725
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+T+C PQL++P K+RR K Q P F+AEP SNSFVGTEEYIAPEII GAGHTSA+
Sbjct: 726 MTTCTPQLIIPAAPSKRRRSKSQPLPTFVAEPSTQSNSFVGTEEYIAPEIITGAGHTSAI 785
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDP 939
DWWALGILLYEMLYG TPFRGK RQKTFANILHKDL FPSS P SL +QL+ LL+RDP
Sbjct: 786 DWWALGILLYEMLYGRTPFRGKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDP 845
Query: 940 KSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTE---KEYKVVDPGM 994
SRLGS GANEIK+H FF+G+NW L+R M+PP LDAPL + + K+ K D G+
Sbjct: 846 SSRLGSKGGANEIKQHAFFRGINWPLIRGMSPPPLDAPLSIIEKDPNAKDIKWEDDGV 903
|
|
| UNIPROTKB|Q9ST27 PHOT2 "Phototropin-2" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 2679 (948.1 bits), Expect = 9.5e-279, P = 9.5e-279
Identities = 523/830 (63%), Positives = 629/830 (75%)
Query: 172 GEMSDEGG----KEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGY 227
G+ S +GG LPRVS +KDALS+ QQTFVVSDAT+PD PI+YAS GFF MTGY
Sbjct: 70 GKSSVDGGVGRASHDSLPRVSQELKDALSSLQQTFVVSDATRPDCPIIYASEGFFTMTGY 129
Query: 228 TSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 287
+ +EVVGRNCRFLQG TD +VAKIR+ +++G+S+CGRLLNY+KDG PFWNLLT+ PI+
Sbjct: 130 SPREVVGRNCRFLQGPDTDAAEVAKIRDAVKHGRSFCGRLLNYRKDGAPFWNLLTVTPIR 189
Query: 288 DDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 347
DD GKV+KFIGMQVEVSK+TEG DK +RPN LP SLIRYD RQK+ A SS+TE+VQ +K
Sbjct: 190 DDNGKVIKFIGMQVEVSKYTEGLSDKRMRPNELPVSLIRYDERQKDKAMSSMTEVVQTVK 249
Query: 348 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEV 407
+PR + + + ++ A+ S V P + GGG + + ++
Sbjct: 250 QPRGARAPADAALLTPPKMS--DADKMAAM----SPVVAPGTPSGGGGGAGSFKSPLWDL 303
Query: 408 PEKKKQ--------KSGRRSFMGL-IGRKSQSTDDHDSFENEIIMXXXXXXXXXXXXXXS 458
+++ + KSGR S MG IG++S E S
Sbjct: 304 KKEESRLSRLASGRKSGRSSLMGFKIGKRSSVGSREAPAVVEEPAPAPPPAPEVVERTDS 363
Query: 459 VDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGR 518
+ R+K++R+GIDLATTLERIEKNFVITDPR+PDNPIIFASDSFLELTEY+REEILGR
Sbjct: 364 WERAEREKDIRQGIDLATTLERIEKNFVITDPRIPDNPIIFASDSFLELTEYTREEILGR 423
Query: 519 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 578
NCRFLQGPETD TV KIR AI Q ++TVQLINYTKSGKKFWNLFHLQPMRDQKGE+QY
Sbjct: 424 NCRFLQGPETDQGTVDKIREAIREQKEITVQLINYTKSGKKFWNLFHLQPMRDQKGELQY 483
Query: 579 FIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHS 638
FIGVQLDGS+H+EPLRN + E T +S KLVK TAENV++AV+ELPDANL PEDLWA HS
Sbjct: 484 FIGVQLDGSDHVEPLRNRLSENTEIQSAKLVKATAENVDDAVRELPDANLRPEDLWAIHS 543
Query: 639 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 698
V PKPH++++P W AI+K + GE+I L+HF+P+KPLG GDTGSVHLVEL GSG+ FA
Sbjct: 544 MRVSPKPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFA 603
Query: 699 MKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 758
MKAMDK VMLNRNKVHRAC EREI +LDHPF+P LY SFQT THVCLITD+CPGGELF
Sbjct: 604 MKAMDKSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFA 663
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
+LDRQP K+ +E+ RFYAAEVV+ LEYLHC GIIYRDLKPEN+LLQ +GH+ LTDFDLS
Sbjct: 664 VLDRQPMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLS 723
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
LT+ KP ++ +T+ K+RR + P F++EP SNSFVGTEEYIAPE+I GAGHTSA
Sbjct: 724 FLTTSKPHVIKNSTSLKRRRSQEFLPPTFVSEPSTPSNSFVGTEEYIAPEVITGAGHTSA 783
Query: 879 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 938
+DWWALGILLYEMLYG TPFRGK R+KTF NILHKDL FPSS P SL AKQL++ LL RD
Sbjct: 784 IDWWALGILLYEMLYGRTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRD 843
Query: 939 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYK 988
P +R+GS+ GAN+IK+H FF+ +NW L+RCM+PPELD PL E + K
Sbjct: 844 PSNRIGSNAGANDIKQHSFFQDINWPLIRCMSPPELDVPLKLIGKETQPK 893
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 1.4e-93, Sum P(3) = 1.4e-93
Identities = 103/213 (48%), Positives = 142/213 (66%)
Query: 626 ANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSV 685
+ L+ + W+N + + KPH+ + P WKAI I + + HF+ +K LG GD GSV
Sbjct: 264 SGLSDDSNWSNITGSAN-KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSV 322
Query: 686 HLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745
+L EL G+ YFAMK MDK + +R K+ RA EREIL +LDHPF+P LY F+T C
Sbjct: 323 YLSELSGTRCYFAMKVMDKASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSC 382
Query: 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ 805
L+ +YCPGG+L L RQP K E A RFYAAEV++ALEYLH G++YRDLKPENVL++
Sbjct: 383 LVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVR 442
Query: 806 GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+GH+ L+DFDLS + P L+ ++++ +R
Sbjct: 443 DDGHIMLSDFDLSLRCAVSPTLIRISSDDPSKR 475
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 537 (194.1 bits), Expect = 5.7e-91, Sum P(2) = 5.7e-91
Identities = 110/253 (43%), Positives = 156/253 (61%)
Query: 603 EESEKLVKQTAENVNEAVKELPDAN-LTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILD 661
+ S +V + E+ + D++ L+ E W+N + ++ KPH+ + P W AI I
Sbjct: 295 DRSISMVLDSFESTKTSASRASDSSGLSEESSWSNFTGSLN-KPHKGNDPWWNAILAIRT 353
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + HF+ +K LG GD GSV+L EL G+ +FA+K MDK + +R K++RA ER+
Sbjct: 354 RDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRKKLNRAQTERD 413
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
IL +LDHPF+P LY F+T CL+ +YCPGG+L L RQP K E A RFYAAEV+
Sbjct: 414 ILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVL 473
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ALEYLH G++YRDLKPENVL++ +GH+ L+DFDLS + P L+ ++ RR
Sbjct: 474 LALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIKTFDSDPSRRGAF 533
Query: 842 QQNPVFMAEPMRA 854
P M EP A
Sbjct: 534 CVQPACM-EPTSA 545
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 528 (190.9 bits), Expect = 4.3e-89, Sum P(2) = 4.3e-89
Identities = 103/208 (49%), Positives = 138/208 (66%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KPH+ + W+AIQ + + L HFR +K LG GD G+VHL EL G+ +FAMK MD
Sbjct: 96 KPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMD 155
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
KG + +R K+ RA EREIL LDHPF+P LY+ F+T+ CL+ ++CPGG+L L RQ
Sbjct: 156 KGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 215
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
P K E A +FY AEV++A+EYLH GIIYRDLKPENVL++ +GHV L+DFDLS +
Sbjct: 216 PGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 275
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
P ++ T + GQ+N + A+P
Sbjct: 276 SPTVVRSTVLASE----GQKNSGYCAQP 299
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 520 (188.1 bits), Expect = 9.8e-89, Sum P(2) = 9.8e-89
Identities = 101/200 (50%), Positives = 138/200 (69%)
Query: 635 ANHSKVVHP-KPHRKDSPPWKAIQKILDS-GEQINLQHFRPIKPLGSGDTGSVHLVELCG 692
AN +V P KPH+ + W AIQ + S E + L HFR +K LG GD GSV+L EL
Sbjct: 76 ANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELRE 135
Query: 693 SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752
G +FAMK MDKG+++ R K+ RA EREIL +LDHPF+P LY+ F+T+ CL+ ++C
Sbjct: 136 MGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCS 195
Query: 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812
GG+L +L +QP K E A RFYA+EV++ALEYLH G++YRDLKPENV+++ +GH+ L
Sbjct: 196 GGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIML 255
Query: 813 TDFDLSCLTSCKPQLLLPTT 832
+DFDLS + P L+ T+
Sbjct: 256 SDFDLSLQSFVSPTLIQSTS 275
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q2QYY8 | PHT1A_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6332 | 0.9001 | 0.9793 | yes | no |
| Q2RBR1 | PHT1B_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.6322 | 0.9001 | 0.9793 | yes | no |
| O48963 | PHOT1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7307 | 0.9770 | 0.9829 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| gw1.I.2683.1 | hypothetical protein (971 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1002 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-180 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-106 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-91 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-91 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-89 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-83 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-76 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-74 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-74 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-74 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-72 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-72 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-72 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-71 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-68 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-68 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-67 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-66 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-66 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-66 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-66 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-66 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-66 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-65 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-64 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-63 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-62 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-61 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-61 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-61 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-60 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-59 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-59 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-58 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-58 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-58 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-58 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-57 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-57 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-55 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-55 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-55 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-55 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-54 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-53 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-52 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-51 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-50 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-50 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-49 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-49 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-49 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-49 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-48 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-47 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-47 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-47 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-47 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-46 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-45 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-45 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-44 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-43 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-42 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-41 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-41 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-40 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 5e-39 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 2e-38 | |
| PRK13559 | 361 | PRK13559, PRK13559, hypothetical protein; Provisio | 2e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 3e-31 | |
| PRK13558 | 665 | PRK13558, PRK13558, bacterio-opsin activator; Prov | 7e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| PRK13557 | 540 | PRK13557, PRK13557, histidine kinase; Provisional | 2e-30 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-29 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-29 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-26 | |
| pfam13426 | 101 | pfam13426, PAS_9, PAS domain | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-18 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-12 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 1e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-11 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-09 | |
| cd00130 | 103 | cd00130, PAS, PAS domain; PAS motifs appear in arc | 7e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 2e-08 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-08 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-08 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 1e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| TIGR02938 | 494 | TIGR02938, nifL_nitrog, nitrogen fixation negative | 3e-07 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-06 | |
| COG2202 | 232 | COG2202, AtoS, FOG: PAS/PAC domain [Signal transdu | 3e-06 | |
| pfam00989 | 113 | pfam00989, PAS, PAS fold | 3e-06 | |
| TIGR00229 | 124 | TIGR00229, sensory_box, PAS domain S-box | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-05 | |
| pfam08447 | 90 | pfam08447, PAS_3, PAS fold | 2e-05 | |
| smart00086 | 43 | smart00086, PAC, Motif C-terminal to PAS motifs (l | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.001 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.001 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| smart00091 | 67 | smart00091, PAS, PAS domain | 0.002 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 0.002 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 525 bits (1354), Expect = e-180
Identities = 181/316 (57%), Positives = 223/316 (70%), Gaps = 2/316 (0%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+HF+ IK LG GD G V LV L G+G+ FA+K +DK M+ RNKV R E+EIL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
PF+P LYASFQT+T++CL+ DYCPGGELF LL RQP K L E+ RFYAAEV++ALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT--TNEKKRRHKGQQNPV 846
GI+YRDLKPEN+LL +GH+ L+DFDLS + +P + ++ +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
F EP SNSFVGTEEYIAPE+I+G GH SAVDWW LGILLYEMLYG TPF+G R +T
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966
F+NIL K++ FP S P S A+ L+ +LL +DP RLGS GA EIK+HPFF+GVNWAL+
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300
Query: 967 RCMNPPELDAPLFATD 982
R PP + P D
Sbjct: 301 RHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 331 bits (851), Expect = e-106
Identities = 123/282 (43%), Positives = 164/282 (58%), Gaps = 32/282 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V LV +G+ +AMK + K ++ R +V ER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+FQT+ + L+ +Y PGGELF L ++ E+ RFYAAE+V+ALEYLH GIIYRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKPEN+LL +GH+ LTDF L+ +E R N
Sbjct: 119 LKPENILLDADGHIKLTDFGLAK--------------------------ELSSEGSRT-N 151
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
+F GT EY+APE++ G G+ AVDWW+LG+LLYEML G PF + R++ + IL L+
Sbjct: 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211
Query: 917 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
FP S A+ L+ LL +DP RLGS GA EIK HPFF
Sbjct: 212 FPEF--LSPEARDLISGLLQKDPTKRLGSG-GAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 290 bits (744), Expect = 6e-91
Identities = 119/287 (41%), Positives = 169/287 (58%), Gaps = 22/287 (7%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+ G G V L + +G +A+K + K M+ +N+V + ER+IL P+V LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
SFQ K ++ L+ +Y PGG+L LL+ L ED R Y AE+V+ALEYLH GII+RD
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN--VGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKP+N+L+ NGH+ LTDF LS + + Q+ L ++ +R
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR------------------ 160
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
VGT +YIAPE+I G GH+ VDWW+LG +LYE L G PF G+T ++ F NIL+ ++
Sbjct: 161 -IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219
Query: 917 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
+P S A L+ +LL DP+ RLG+ + EIK HPFFKG++W
Sbjct: 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 7e-91
Identities = 121/296 (40%), Positives = 162/296 (54%), Gaps = 35/296 (11%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
F IK LG+G G V LV GSG+Y+A+K + K ++ +V E+ IL + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
PF+ LY SFQ +++ L+ +Y PGGELF L + + E RFYAA+VV+ALEYLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
I+YRDLKPEN+LL +G++ +TDF + KR
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFA-----------------KRVKGRTY----- 156
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
+ GT EY+APEII G+ AVDWWALGIL+YEML GY PF + +
Sbjct: 157 --------TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208
Query: 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 963
IL ++FPS S AK L+ LL D RLG+ G N+IK HP+F G++W
Sbjct: 209 KILEGKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 4e-89
Identities = 104/290 (35%), Positives = 150/290 (51%), Gaps = 38/290 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++ LG G G V+L +G+ A+K + K + + R E +IL L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ LY F+ + + L+ +YC GG+LF LL ++ L ED RFY +++ ALEYLH +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLHSK 116
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GI++RDLKPEN+LL +GHV L DF L+ +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLAR---------------------------QLDP 149
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-TRQKTFAN 909
+ +FVGT EY+APE++ G G+ AVD W+LG++LYE+L G PF G + F
Sbjct: 150 GEKL-TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
Query: 910 ILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
I FP S AK L+ +LL +DP+ RL A E +HPFF
Sbjct: 209 IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 5e-83
Identities = 131/313 (41%), Positives = 180/313 (57%), Gaps = 24/313 (7%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK +G G G V LV +GQ +AMK + K M+ RN++ AER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ LY SFQ + H+ L+ +Y PGG+L LL R+ V E+ RFY AE+V+AL+ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLS---------CLTSCKPQLLLPTTNEKKRRHKG 841
G I+RD+KP+N+L+ +GH+ L DF L LL N RR
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+Q V +NS VGT +YIAPE++ G + DWW+LG++LYEMLYG+ PF
Sbjct: 181 KQRRVR-------ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 902 TRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
T Q+T+ I++ + L+FP P S A L+ RLL DP+ RLGS E EIK HPFFK
Sbjct: 234 TLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFE---EIKSHPFFK 289
Query: 960 GVNWALVRCMNPP 972
G++W +R PP
Sbjct: 290 GIDWENLRETKPP 302
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 2e-81
Identities = 108/292 (36%), Positives = 162/292 (55%), Gaps = 18/292 (6%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HP 729
F+ K +G G +V L + + + +A+K +DK ++ KV E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ LY +FQ + ++ + +Y P GEL + + + L E RFYAAE+++ALEYLH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLHS 120
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL---TSCKPQLLLPTTNEKKRRHKGQQNPV 846
+GII+RDLKPEN+LL + H+ +TDF + + S TN + K ++
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF- 179
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
SFVGT EY++PE++ + D WALG ++Y+ML G PFRG T
Sbjct: 180 ---------ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
F IL + FP + P AK L+ +LL DP+ RLG +EG +E+K HPFF
Sbjct: 231 FQKILKLEYSFPPNFP--PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 249 bits (638), Expect = 7e-76
Identities = 101/294 (34%), Positives = 145/294 (49%), Gaps = 40/294 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++ LGSG G+V+ + G+G+ A+K + K K A E IL L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L +F+ K H+ L+ +YC GG+LF L R L ED + A +++ LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN 117
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GII+RDLKPEN+LL NG V + DF L+ L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---------------------- 155
Query: 851 PMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR---QKT 906
+FVGT Y+APE++ G G+ VD W+LG++LYE+L G PF G+ +
Sbjct: 156 -----TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL 210
Query: 907 FANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
IL L+F +S AK L+ + L++DP R A EI +HP+F
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 3e-74
Identities = 112/293 (38%), Positives = 164/293 (55%), Gaps = 39/293 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V LV++ + FA+K + K ++ + +E+EIL+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 737 SFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+F+ K ++ ++ +YC GGEL+ +L DR + E RFY A VV+A EYLH +GIIYR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLKPEN+LL NG+V L DF + K K +
Sbjct: 118 DLKPENLLLDSNGYVKLVDFG--------------FAKKLKSGQK--------------T 149
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--KTRQKTFANILH- 912
+F GT EY+APEII G+ +VD+W+LGILLYE+L G PF + + + +IL
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209
Query: 913 -KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW 963
L+FP+ + AK L+ +LL R+P+ RLG+ + G +IKKH +F G +W
Sbjct: 210 NGKLEFPNYIDKA--AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 4e-74
Identities = 113/293 (38%), Positives = 159/293 (54%), Gaps = 37/293 (12%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVP 732
+KP+ G GSV+L + +G YFA+K + K M+ +N+V AER I+ + P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
LY SFQ+K ++ L+ +Y GG+ L+ + L ED + Y AEVV+ +E LH +GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
I+RD+KPEN+L+ GH+ LTDF LS G +N
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS--------------------RNGLENK------- 151
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
FVGT +Y+APE I G G DWW+LG +++E L+GY PF +T F NIL
Sbjct: 152 ----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207
Query: 913 KDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
+ + +P A L+ RLL DP RLG++ G EIK HPFFK +NW
Sbjct: 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN-GYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 9e-74
Identities = 121/343 (35%), Positives = 180/343 (52%), Gaps = 46/343 (13%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
K LG G G V L EL G+ + +A+K + K V+L + V E+ +L + HPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L++ FQTK + + +Y GG+L + R E RFYAAE+V+ L++LH +GII
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +NVLL GH+ + DF + CK +L T
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGM-----CKEGILGGVT--------------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT +YIAPEI++ + AVDWWALG+LLYEML G +PF G + F +IL
Sbjct: 153 -TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW-ALVRC-MN 970
++++P S AK ++ L ++P+ RLG G +IK HPFF+ ++W L R +
Sbjct: 212 EVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIK 269
Query: 971 PP-------ELDAPLFATDTEKEYKVVDPG----MQDLQQNVF 1002
PP D F + KE V+ P ++++ Q F
Sbjct: 270 PPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEF 312
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 3e-72
Identities = 114/307 (37%), Positives = 167/307 (54%), Gaps = 37/307 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--- 727
FR + LG G G V L E +G+ +A+KA+ KG ++ R++V E+ I + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HPF+ L+A FQT+ HVC + +Y GG+L + + V E FYAA VV+ L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H I+YRDLK +N+LL G V + DF L CK
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL-----CKEG--------------------- 151
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
M R S +F GT E++APE++ +T AVDWW LG+L+YEML G +PF G ++ F
Sbjct: 152 MGFGDRTS-TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
Query: 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW-AL 965
+I++ ++++P A +M RLL R+P+ RLGS E A ++KK PFF+ +NW L
Sbjct: 211 DSIVNDEVRYPRFLSRE--AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
Query: 966 VRCMNPP 972
+ P
Sbjct: 269 LARKIKP 275
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 243 bits (621), Expect = 4e-72
Identities = 129/335 (38%), Positives = 184/335 (54%), Gaps = 35/335 (10%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK +G G G V LV+ +G +AMK + K ML + +V AER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V LY SFQ + ++ LI +Y PGG++ LL ++ T E+ RFY AE ++A++ +H
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR---HKGQQNPVF 847
G I+RD+KP+N+LL GH+ L+DF L C L E R F
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGL-----CTG-LKKSHRTEFYRILSHALPSNFLDF 174
Query: 848 MAEPM----RASN----------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
+++PM +A S VGT +YIAPE+ G+ DWW+LG+++YEML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
Query: 894 GYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
GY PF Q+T+ I++ + L+FP P S AK L+ RL + + RLG++ G NE
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNN-GVNE 292
Query: 952 IKKHPFFKGVNWALVRCMNP---PELDAPLFATDT 983
IK HPFFKGV+W +R PEL + TDT
Sbjct: 293 IKSHPFFKGVDWEHIRERPAPIIPELKSI---TDT 324
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 6e-72
Identities = 136/334 (40%), Positives = 184/334 (55%), Gaps = 47/334 (14%)
Query: 674 IKPLGSGDTGSVHLVE-LCGS--GQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHP 729
+K LG G G V V + G+ G+ FAMK + K ++ N+ AER IL+ + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L +FQT + LI +Y GGELF+ L+R+ + ED FY +E+ +ALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
QGIIYRDLKPEN+LL GHV LTDF L CK + H+G
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL-----CKESI-----------HEGT------- 155
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML G PF + R+KT
Sbjct: 156 ----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
Query: 910 ILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNW--AL 965
IL L P TP A+ L+ +LL R+P SRLG+ G A E++ HPFF+ VNW L
Sbjct: 212 ILKGKLNLPPYLTP---EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLL 268
Query: 966 VRCMNPP-------ELDAPLFATDTEKEYKVVDP 992
R + PP E D F + ++ V P
Sbjct: 269 ARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSP 302
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 1e-71
Identities = 122/305 (40%), Positives = 176/305 (57%), Gaps = 29/305 (9%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK + +G G+V+LV + Q FAMK ++K ++ RN++ + ER+IL ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +++ SF+TK H+C++ +Y GG+ LL L D R Y AE V+ALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNY 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN------EKKRRHKGQQN 844
GI++RDLKP+N+L+ GH+ LTDF LS K L+ TTN EK R
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS-----KIGLMSLTTNLYEGHIEKDTRE----- 170
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
F+ GT EYIAPE+I G+ VDWWA+GI+LYE L G PF G T +
Sbjct: 171 --FL------DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
Query: 905 KTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
+ F ++ D+++P A+ L+ RLL ++P RLG+ GA E+K+H FF G++W
Sbjct: 223 ELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDW 281
Query: 964 -ALVR 967
L+R
Sbjct: 282 NGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 3e-68
Identities = 122/309 (39%), Positives = 170/309 (55%), Gaps = 44/309 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDML 726
F ++ LG+G G V LV G +G+ +AMK + K ++ + K ER++L+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 727 DH-PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVAL 784
PF+ L+ +FQT T + LI DY GGELF L R+ E VR Y AE+V+AL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLAL 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
++LH GIIYRD+K EN+LL GHV LTDF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS-------------------------- 152
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR--- 899
F+AE + SF GT EY+APE+I G GH AVDWW+LG+L +E+L G +PF
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
Query: 900 GKTRQKTFAN-ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
+ Q + IL FP + S A+ + +LL +DPK RLG++ GA+EIK HPFF
Sbjct: 213 EQNSQSEISRRILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGAN-GADEIKNHPFF 269
Query: 959 KGVNWALVR 967
+G++W +
Sbjct: 270 QGIDWDDLA 278
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (586), Expect = 4e-68
Identities = 114/307 (37%), Positives = 160/307 (52%), Gaps = 37/307 (12%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
IK +G+G G VHLV S Y+A+K M ++ + E+ +L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
PF+ L+ + + + ++ +Y PGGELF L + + FYA+E+V ALEYLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ I+YRDLKPEN+LL GH+ LTDF + KK R +
Sbjct: 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFA----------------KKLRDR-------- 154
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
+ + GT EY+APE+I GH AVDWWALGIL+YEML GY PF +
Sbjct: 155 ------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208
Query: 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV- 966
IL L+FP L+AK L+ +LL D RLG+ + GA+++K H +FK V+W V
Sbjct: 209 KILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVP 266
Query: 967 -RCMNPP 972
R + PP
Sbjct: 267 QRKLKPP 273
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-67
Identities = 100/292 (34%), Positives = 155/292 (53%), Gaps = 37/292 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
HF ++ +G G G V +V+ + + FAMK M+K + + V ER IL L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L+ SFQ + ++ L+ D GG+L L ++ E+ V+F+ E+V+ALEYLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS 118
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GII+RD+KP+N+LL GHV +TDF+++
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIAT----------------------------KV 150
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 906
P + S GT Y+APE++ G++ AVDWW+LG+ YE L G P+RG +R
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
A D+ +P++ T A + +LL RDP+ RLG + ++K HP+F
Sbjct: 211 RAKQETADVLYPATWSTE--AIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 1e-66
Identities = 114/301 (37%), Positives = 160/301 (53%), Gaps = 34/301 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L + G+++A+K + K +L + + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH II
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GHV LTDF L CK + E +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGI----------------------EHSK 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA--LVRCMNP 971
L+ + S+ A+ L+ LL +D RLG+ + EIK H FF +NW + + + P
Sbjct: 212 PLRLKPN--ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
Query: 972 P 972
P
Sbjct: 270 P 270
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 2e-66
Identities = 123/305 (40%), Positives = 177/305 (58%), Gaps = 38/305 (12%)
Query: 674 IKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+K LG G G V LV ++ G +GQ +AMK + K + R++V R ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V+FY AE+ +AL++LH
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GIIYRDLKPEN+LL GH+ LTDF LS +EKK
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS---------KESIDHEKK-------------- 154
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
+ SF GT EY+APE++ GHT + DWW+ G+L++EML G PF+GK R++T I
Sbjct: 155 ----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 911 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALV--R 967
L L P S A+ L+ L R+P +RLG+ +G EIK+HPFF ++W + R
Sbjct: 211 LKAKLGMPQF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRR 268
Query: 968 CMNPP 972
+ PP
Sbjct: 269 EIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 3e-66
Identities = 116/329 (35%), Positives = 162/329 (49%), Gaps = 50/329 (15%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 706
+ D+ WK L F + LG+G G V + + G+G+Y+A+K + K
Sbjct: 9 KPDTSSWK-------------LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKRE 55
Query: 707 MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK 766
+L +V E+ IL L HPF+ + SFQ + V + ++ GGELF L R+ +
Sbjct: 56 ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGR 114
Query: 767 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
D +FY AE+V+A EYLH + IIYRDLKPEN+LL GHV +TDF +
Sbjct: 115 -FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA-------- 165
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
KK + + + GT EY+APE+I GH AVDWW +G+
Sbjct: 166 --------KKVPDR--------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGV 203
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS- 945
LLYE + GY PF T + + IL LKFP+ A+ L+ LL D RLG+
Sbjct: 204 LLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKRLGTL 261
Query: 946 HEGANEIKKHPFFKGVNW--ALVRCMNPP 972
G ++K HP+F G NW R P
Sbjct: 262 KGGVADVKNHPYFHGANWDKLYARYYPAP 290
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 3e-66
Identities = 120/315 (38%), Positives = 170/315 (53%), Gaps = 34/315 (10%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL YLH ++Y
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RDLK EN++L +GH+ +TDF L CK + T
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGISDGAT---------------------- 151
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL ++
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNW-ALVRCMNPP 972
++FP + S AK L+ LL +DPK RL G E A EI +H FF +NW +V+ P
Sbjct: 212 IRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP 269
Query: 973 ELDAPLFATDTEKEY 987
P ++T+ Y
Sbjct: 270 PFK-PQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 5e-66
Identities = 113/301 (37%), Positives = 167/301 (55%), Gaps = 37/301 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 733
K LG G G V L EL G+ ++FA+KA+ K V+L + V ER +L + +HPF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ +FQTK H+ + +Y GG+L + Q + E RFYAAE++ L++LH +GII
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +NVLL +GH+ + DF + CK +
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGM-----CKENMNGEGK--------------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ + F +IL+
Sbjct: 153 -ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNP 971
FP S AK + +L RDP RLG +I++HPFF+G++W + R + P
Sbjct: 212 RPHFPRW--ISKEAKDCLSKLFERDPTKRLGV---DGDIRQHPFFRGIDWERLEKREIPP 266
Query: 972 P 972
P
Sbjct: 267 P 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 7e-66
Identities = 114/302 (37%), Positives = 171/302 (56%), Gaps = 36/302 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPA 733
+G G G V+ V + + +AMK + K ++ + +V ER IL + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L SFQT + + L+TDY GGELF L Q ED +FY AE+V+ALE+LH I+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GH++L DF LS K L T N+
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS-----KANL---TDNK------------------- 151
Query: 854 ASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
+N+F GT EY+APE++ G+T VD+W+LG+L++EM G++PF + Q+ + NI
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMN 970
++FP + S +Q + LL+R+P+ RLG+H A E+K+HPFF ++W L+ + +
Sbjct: 212 GKVRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
Query: 971 PP 972
PP
Sbjct: 271 PP 272
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 5e-65
Identities = 126/356 (35%), Positives = 179/356 (50%), Gaps = 52/356 (14%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F IK +G G G V LV + +AMK + K +L RN+ AER+IL D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+V LY SFQ K ++ + DY PGG++ LL R + +ED RFY AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDL------------------------------SC 819
G I+RD+KP+N+L+ +GH+ LTDF L S
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+ C+ + L +RR K Q ++S VGT YIAPE++ G+T
Sbjct: 180 IDRCRLKPL-------ERRRKRQHQRC-------LAHSLVGTPNYIAPEVLLRTGYTQLC 225
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHR 937
DWW++G++LYEML G PF T +T +++ L PS S A L+ RL
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-C 284
Query: 938 DPKSRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPPELDAPLFATDTEKEYKVVDP 992
+ RLG + GA+EIK HPFFKG+++A L+R P + TDT + VDP
Sbjct: 285 GAEDRLGKN-GADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSN-FDPVDP 338
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 1e-64
Identities = 132/340 (38%), Positives = 193/340 (56%), Gaps = 50/340 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNK-VHRACAEREILDML 726
F +K LG+G G V LV +G+ +AMK + K ++ + K V ER +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 727 -DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
PF+ L+ +FQT+ + LI DY GGE+F L ++ ED VRFY+ E+++ALE
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALE 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+LH GI+YRD+K EN+LL GHV LTDF LS
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS--------------------------K 153
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
F++E + SF GT EY+APEII G GH AVDWW+LGIL++E+L G +PF + +
Sbjct: 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213
Query: 905 KTFANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGV 961
T + + + LK P+ + A+ L+++LL +DPK RLG+ +GA+EIK+HPFFKG+
Sbjct: 214 NTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273
Query: 962 NWALV--RCMNPP-------ELDAPLFATDTEKEYKVVDP 992
+W + R +NPP ELD FA +E+ ++P
Sbjct: 274 DWEALALRKVNPPFRPSIRNELDVGNFA----EEFTNLEP 309
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 3e-63
Identities = 113/316 (35%), Positives = 173/316 (54%), Gaps = 36/316 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
+FQT +C + +Y GGELF L R+ +V E+ RFY AE+V ALEYLH + ++Y
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RD+K EN++L +GH+ +TDF L CK + ++ +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL-----CKEGI----SDGATMK---------------- 153
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++ F IL ++
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW--ALVRCMNP 971
++FP + S AK L+ LL +DPK RLG A E+ +H FF +NW + + + P
Sbjct: 212 IRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP 269
Query: 972 PELDAPLFATDTEKEY 987
P P ++ + Y
Sbjct: 270 PF--KPQVTSEVDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 3e-62
Identities = 118/336 (35%), Positives = 181/336 (53%), Gaps = 28/336 (8%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F +K +G G G V LV+ +G+ +AMK + K M ++++ AER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +LY SFQ ++ LI ++ PGG+L +L + T ED RFY AE V+A+E +H
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYMAECVLAIEAVHKL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-----LTSCKPQLLLPTTNEKKRRHKGQQNP 845
G I+RD+KP+N+L+ GH+ L+DF LS S Q LL K R + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL-QGKSNKNRIDNRNSV 179
Query: 846 VFMAEPMRASN----------------SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
+ + S+ S VGT +YIAPEI G+ DWW+LG +++
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239
Query: 890 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
E L G+ PF + +T+ I++ + L FP S+ A+ L+ RL+ + ++RLG
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENRLGRG- 297
Query: 948 GANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDT 983
GA+EIK HPFF+GV+W +R + P + TDT
Sbjct: 298 GAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDT 333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 1e-61
Identities = 116/290 (40%), Positives = 154/290 (53%), Gaps = 32/290 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L + G ++A+K + K +L + + + AER +L L HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + DY GGELF L R+ + E RFYAAEV A+ YLH II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GHV LTDF L CK + EP
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGV----------------------EPEE 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
L+ P + A L+ LLH+D + RLG+ EIK H FF +NW
Sbjct: 212 PLQLPGGKTVA--ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 2e-61
Identities = 125/316 (39%), Positives = 174/316 (55%), Gaps = 36/316 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV SG+Y+AMK + K V++ +++V E +L HPF+ +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
SFQTK +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH I+Y
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RDLK EN++L +GH+ +TDF L CK + T +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL-----CKEGITDAATMK-------------------- 153
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +D
Sbjct: 154 --TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNP 971
+KFP + S AK L+ LL +DP RLG + A EI +H FF GVNW V + + P
Sbjct: 212 IKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP 269
Query: 972 PELDAPLFATDTEKEY 987
P P ++T+ Y
Sbjct: 270 PF--KPQVTSETDTRY 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (541), Expect = 2e-61
Identities = 113/330 (34%), Positives = 166/330 (50%), Gaps = 50/330 (15%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F+ + +G G G V L + +G+ A+K M K ++ N+V ER+IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
++ L +FQ ++ L +Y PGG+ LL+ VL ED RFY AE+ A++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHE 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
G I+RDLKPEN L+ +GH+ LTDF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS------------------------------K 149
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +NS VG+ +Y+APE++ G G+ VD+W+LG +LYE L G+ PF G T +T+ N
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209
Query: 910 ILH--KDLKFPSSTPT----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
+ + + L+ P S A L+ +L++ DP R GS E +IK HPFFK V+W
Sbjct: 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLE---DIKNHPFFKEVDW 265
Query: 964 ALVRCMNPP-------ELDAPLFATDTEKE 986
+R + PP E+D F D E E
Sbjct: 266 NELRELKPPFVPELESEIDTGYF-DDFENE 294
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 207 bits (527), Expect = 7e-60
Identities = 120/309 (38%), Positives = 167/309 (54%), Gaps = 34/309 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V V + + +A+K + K +++R++V AER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
SFQ+ + L+ + GGELF L R+ RFY AE++ ALE LH +IYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKPEN+LL GH++L DF L CK L ++ K +N
Sbjct: 119 LKPENILLDYQGHIALCDFGL-----CK----LNMKDDDK------------------TN 151
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
+F GT EY+APE++ G G+T AVDWW LG+LLYEML G PF + + + IL + L+
Sbjct: 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 917 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA--LVRCMNPPEL 974
FP AK L+ LL RDP RLG + GA EIK HPFF ++W L++ + PP
Sbjct: 212 FPDGFDRD--AKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGIQPPFK 268
Query: 975 DAPLFATDT 983
A A DT
Sbjct: 269 PAVSSAIDT 277
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 4e-59
Identities = 122/304 (40%), Positives = 173/304 (56%), Gaps = 38/304 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLV-ELCG--SGQYFAMKAMDKGVMLNRNKV-HRACAEREILDM 725
+F +K LG+G G V LV ++ G SG+ +AMK + K ++ + K ER++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 726 LDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ PF+ L+ +FQT T + LI DY GGELF L ++ + KE V+ Y+ E+V+AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLAL 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
E+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------------------------- 152
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
F + + + SF GT EY+AP+I+ G GH AVDWW++G+L+YE+L G +PF
Sbjct: 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
Query: 903 RQKTFANILHKDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFK 959
+ + A I + LK P + AK ++ RLL +DPK RLG A+EIKKHPFF+
Sbjct: 213 EKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272
Query: 960 GVNW 963
+NW
Sbjct: 273 KINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 6e-59
Identities = 121/317 (38%), Positives = 177/317 (55%), Gaps = 37/317 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF+ AL
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GII 793
SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH + ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK EN++L +GH+ +TDF L CK +G ++ M
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL-----CK---------------EGIKDGATM----- 153
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F IL +
Sbjct: 154 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNWALV--RCMN 970
+++FP + S AK L+ LL +DPK RL G + A EI +H FF G+ W V + +
Sbjct: 212 EIRFPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLV 269
Query: 971 PPELDAPLFATDTEKEY 987
PP P ++T+ Y
Sbjct: 270 PPF--KPQVTSETDTRY 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 117/303 (38%), Positives = 161/303 (53%), Gaps = 33/303 (10%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L + G+ +A+K + K ++LNR + AER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + D+ GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLHSINIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GHV LTDF L CK + T
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL-----CKEGIAQSDT--------------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ +F GT EY+APE+I + + VDWW LG +LYEMLYG PF + + + NILHK
Sbjct: 153 -TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPP 972
L SL A ++ LL +D + RLG+ E EI++HPFF+ ++W L + PP
Sbjct: 212 PLVLRPG--ASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
Query: 973 ELD 975
+
Sbjct: 270 PFN 272
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-58
Identities = 118/323 (36%), Positives = 177/323 (54%), Gaps = 41/323 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC--AEREILDMLDH 728
F +K +G G G V +V++ +GQ +AMK ++K ML R + AC ER++L D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET--ACFREERDVLVNGDR 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVH 119
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
G ++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFG-SCLR-------------------------LL 153
Query: 849 AEPMRASNSFVGTEEYIAPEIIA----GAGHTSA-VDWWALGILLYEMLYGYTPFRGKTR 903
A+ SN VGT +YI+PEI+ G G DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 904 QKTFANIL-HKD-LKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+T+ I+ HK+ +FP S AK L+ RL+ P++RLG + G + K HPFF+G
Sbjct: 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRN-GLQDFKDHPFFEG 271
Query: 961 VNWALVRCMNPPELDAPLFATDT 983
++W +R P + TDT
Sbjct: 272 IDWDNIRNSTAPYVPEVSSPTDT 294
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 6e-58
Identities = 108/319 (33%), Positives = 177/319 (55%), Gaps = 40/319 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
K LG G G V L EL G+ Q+FA+KA+ K V+L + V E+ +L + +HPF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LY +FQTK ++ + +Y GG+L + Q FYAAE++ L++LH +GI+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +N+LL +GH+ + DF + CK +L + K
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM-----CKENML----GDAK----------------- 152
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ +F GT +YIAPEI+ G + ++VDWW+ G+LLYEML G +PF G ++ F +I
Sbjct: 153 -TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNP 971
+ +P + AK ++ +L R+P+ RLG +I++HPFF+ ++W+ + R + P
Sbjct: 212 NPCYPRW--LTREAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREIEP 266
Query: 972 ---PELDAPLFATDTEKEY 987
P++ + ++ +KE+
Sbjct: 267 PFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 9e-58
Identities = 119/331 (35%), Positives = 169/331 (51%), Gaps = 44/331 (13%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPA 733
K LG G G V L EL G+ + +A+K + K V+L + V E+ IL + HPF+ A
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ FQTK + + +Y GG+L + Q ++ E RFYAAEV +AL +LH G+I
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI--QRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLK +N+LL GH L DF + CK +L
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM-----CKEGIL----------------------NGV 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ +F GT +YIAPEI+ + +VDWWALG+L+YEM+ G PF F +ILH
Sbjct: 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG---SHEGANEIKKHPFFKGVNWALV--RC 968
D+ +P S A ++ + ++P RLG S G + IK+HPFFK ++W L+ R
Sbjct: 212 DVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRK 269
Query: 969 MNPP-------ELDAPLFATDTEKEYKVVDP 992
+ PP + D F D KE V+ P
Sbjct: 270 IKPPFKPKIKTKRDVNNFDQDFTKEEPVLTP 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 114/302 (37%), Positives = 167/302 (55%), Gaps = 39/302 (12%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
K LG G G V L EL G G+YFA+KA+ K V+L + V E+ +L + ++PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 734 LYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
LY +FQTK H+ + ++ GG+L F + D+ + + FYAAE+V L++LH +GI
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR---ATFYAAEIVCGLQFLHSKGI 117
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
IYRDLK +NV+L +GH+ + DF + CK + G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGM-----CKENVF------------GDN--------- 151
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
RAS +F GT +YIAPEI+ G +T +VDWW+ G+LLYEML G +PF G + F +I
Sbjct: 152 RAS-TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMN 970
+P + +K ++ +L RDP RLG I+ HPFFK +NW + R ++
Sbjct: 211 DTPHYPRW--ITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKRELD 265
Query: 971 PP 972
PP
Sbjct: 266 PP 267
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 6e-57
Identities = 119/313 (38%), Positives = 177/313 (56%), Gaps = 26/313 (8%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+A +FY AE V+A++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNEKK 836
G I+RD+KP+N+LL GHV L+DF L LT P N K+
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896
+ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML GY
Sbjct: 181 KAETWKKNRRQLAY------STVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 897 PFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
PF +T Q+T+ +++ + L FP P S AK L+ R D ++R+GS+ G EIK
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSN-GVEEIKS 292
Query: 955 HPFFKGVNWALVR 967
HPFF+GV+W +R
Sbjct: 293 HPFFEGVDWGHIR 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 195 bits (496), Expect = 1e-55
Identities = 108/301 (35%), Positives = 158/301 (52%), Gaps = 36/301 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735
LG G G V L L SG+ +A+K + K V+L + V E+ IL + +HPF+ LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
FQT + + ++ GG+L + Q ++ E RFYAAE+ AL +LH +GIIYR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL GH L DF + CK + G + +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM-----CKEGI-----------FNG-----------KTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL 915
++F GT +YIAPEI+ + +VDWWA+G+LLYEML G+ PF + F IL+ ++
Sbjct: 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
Query: 916 KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALV--RCMNP 971
+P T S A ++ + ++P RLGS G I +HPFFK ++W + R + P
Sbjct: 214 VYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEP 271
Query: 972 P 972
P
Sbjct: 272 P 272
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 3e-55
Identities = 96/302 (31%), Positives = 148/302 (49%), Gaps = 32/302 (10%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V ++ +G+ +A K +DK + R A E++IL+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+F+TK +CL+ GG+L + E FYAA+++ LE+LH + I+YRD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKPENVLL +G+V ++D L+ KG +
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV------------------ELKGGKKI----------K 152
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916
GT Y+APE++ G + +VDW+ALG LYEM+ G +PFR + + + + L+
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 917 FPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNWALVRC-MNPP 972
P AK L LL +DP+ RLG G A+E+++HP FK +NW + M P
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272
Query: 973 EL 974
Sbjct: 273 PF 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 4e-55
Identities = 106/304 (34%), Positives = 155/304 (50%), Gaps = 40/304 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V +V +G +AMK M K V+L + V ER+IL + + P++P L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+FQ K ++ L+ +Y PGG+L LL+R + ED +FY AE+V+A+ +H G ++RD
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+KPENVL+ GH+ L DF + + A M S
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--------------------------ANKMVNSK 161
Query: 857 SFVGTEEYIAPEII------AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
VGT +YIAPE++ + DWW+LG++ YEM+YG +PF T KT+ NI
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
Query: 911 L-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 968
+ + LKFP S L+ LL K RLG +EG + HPFF ++W +R
Sbjct: 222 MNFQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLG-YEG---LCCHPFFSKIDWNNIRN 276
Query: 969 MNPP 972
PP
Sbjct: 277 SLPP 280
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 5e-55
Identities = 100/295 (33%), Positives = 151/295 (51%), Gaps = 33/295 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 729
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGM-----CKENIFGGKT----------------- 157
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 963
I+ ++ +P S S A + LL + P RLG G +I++H FF+ ++W
Sbjct: 213 IMEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 4e-54
Identities = 108/290 (37%), Positives = 151/290 (52%), Gaps = 32/290 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
K +G G G V L +++A+K + K +L + + +ER +L + HPF+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L+ SFQT + + DY GGELF L R+ + E RFYAAE+ AL YLH I+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKPEN+LL GH+ LTDF L CK + E
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL-----CKENI----------------------EHNG 151
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+++F GT EY+APE++ + VDWW LG +LYEMLYG PF + + + NIL+K
Sbjct: 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
L+ + S A+ L+ LL +D RLG+ + EIK H FF +NW
Sbjct: 212 PLQLKPNITNS--ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-53
Identities = 106/310 (34%), Positives = 167/310 (53%), Gaps = 45/310 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735
+G G V LVEL + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ FQT++ + + ++ GG+L + RQ + L E+ RFY+AE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL GH+ LTD+ + CK + P +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM-----CKEGI----------------------RPGDTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 906
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWA 964
F IL K ++ P S S+ A ++ L++DPK RLG H G +IK HPFF+ ++W
Sbjct: 214 FQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271
Query: 965 LV--RCMNPP 972
L+ + + PP
Sbjct: 272 LLEQKQVLPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 1e-52
Identities = 109/327 (33%), Positives = 164/327 (50%), Gaps = 41/327 (12%)
Query: 654 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
KA +KI ++ + F IK +G G G V LV S Q +AMK + K M+ R+
Sbjct: 30 KAAEKITKL--RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 714 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 773
ER+I+ + ++ L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWA 144
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
RFY AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMK------------ 191
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS----AVDWWALGILLY 889
A M ++ VGT +YI+PE++ G DWW++G+ LY
Sbjct: 192 -------------MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 890 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
EML G TPF + T++ I+ HK+ L FP S AK L+ L D + RLG +
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL-TDREVRLGRN- 296
Query: 948 GANEIKKHPFFKG--VNWALVRCMNPP 972
G +EIK HPFFK + +R P
Sbjct: 297 GVDEIKSHPFFKNDQWTFDNIRETVAP 323
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 2e-52
Identities = 114/315 (36%), Positives = 174/315 (55%), Gaps = 26/315 (8%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F +K +G G G V LV+ +G +AMK + K ML + +V AER+IL D
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+V ++ SFQ K ++ LI ++ PGG++ LL ++ T L E+ +FY AE V+A++ +H
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSC-------------LTSCKPQ-LLLPTTNE 834
G I+RD+KP+N+LL GHV L+DF L L P N
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894
K++ ++N +A S VGT +YIAPE+ G+ DWW+LG+++YEML G
Sbjct: 179 KRKAETWKRNRRQLA------FSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 895 YTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952
Y PF +T Q+T+ +++ + L FP P S AK L+ R + + R+G+ G EI
Sbjct: 233 YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA-PGVEEI 290
Query: 953 KKHPFFKGVNWALVR 967
K +PFF+GV+W +R
Sbjct: 291 KTNPFFEGVDWEHIR 305
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 84/282 (29%), Positives = 123/282 (43%), Gaps = 69/282 (24%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G+V+L +G+ A+K + K + + + E EIL L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
F+ + H+ L+ +YC GG L LL K L ED + +++ LEYLH GII+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 797 LKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
LKPEN+LL NG V L DF LS +
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSK---------------------------LLTSDKSLL 150
Query: 856 NSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
+ VGT Y+APE++ G G+ + D W+LG++LYE+
Sbjct: 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187
Query: 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
K L+ ++L +DP+ R A EI +H
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-50
Identities = 108/310 (34%), Positives = 166/310 (53%), Gaps = 37/310 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK +G G G V +V++ + + +AMK ++K ML R + ER +L D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A+ +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RD+KP+NVLL NGH+ L DF SCL +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCLK-------------------------MNQD 155
Query: 851 PMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++ +
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
Query: 906 TFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
T+ I++ + +FPS T S AK L+ RL+ + RLG + G + KKH FF+G++
Sbjct: 216 TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRER-RLGQN-GIEDFKKHAFFEGID 273
Query: 963 WALVRCMNPP 972
W +R + P
Sbjct: 274 WENIRNLEAP 283
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 6e-50
Identities = 80/278 (28%), Positives = 132/278 (47%), Gaps = 37/278 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLD 727
+ IK +G G G V+LV G+ + +K +D + N ++ R A E IL L+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALE 785
HP + Y SF+ K +C++ +Y GG+L + +Q + E+ + + ++ +AL+
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH + I++RD+KP+N+ L NG V L DF +S K +
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS---------------------KVLSST 156
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
V +A + VGT Y++PE+ + D W+LG +LYE+ PF G+ +
Sbjct: 157 VDLA------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
Query: 906 TFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSR 942
IL PS + L + L+ LL +DP+ R
Sbjct: 211 LALKILKGQYPPIPSQYSSEL--RNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-49
Identities = 105/306 (34%), Positives = 159/306 (51%), Gaps = 35/306 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 729
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ V L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GIIYRDLK +NV+L GH+ + DF + CK ++ T
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEHMVDGVT----------------- 157
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNWALV-- 966
I+ ++ +P S S A + L+ + P RLG EG +I++H FF+ ++W +
Sbjct: 213 IMEHNVSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLEN 270
Query: 967 RCMNPP 972
R + PP
Sbjct: 271 REIQPP 276
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 1e-49
Identities = 127/353 (35%), Positives = 181/353 (51%), Gaps = 44/353 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK LG G G V L + +AMK + K +L RN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V LY SFQ K ++ + DY PGG++ LL R + ED RFY AE+ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG----QQNPV 846
G I+RD+KP+N+L+ +GH+ LTDF L C T++ K G Q +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL-CTG-------FRWTHDSKYYQSGDHVRQDSMD 172
Query: 847 FMAE--------------PM--RA--------SNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
F E P+ RA ++S VGT YIAPE++ G+T DWW
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANIL--HKDLKFPSSTPTSLHAKQLMYRLLHRDPK 940
++G++LYEML G PF +T +T ++ L P S A L+ +L R P+
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPE 291
Query: 941 SRLGSHEGANEIKKHPFFKGVNWAL-VRCMNPPELDAPLFATDTEKEYKVVDP 992
RLG + GA+EIK HPFFK ++++ +R + P + TDT + VDP
Sbjct: 292 DRLGKN-GADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSN-FDPVDP 342
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 5e-49
Identities = 105/302 (34%), Positives = 161/302 (53%), Gaps = 43/302 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735
+G G V LV L + + +AMK + K ++ + + E+ + + +HPF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKT 906
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG--SHEGANEIKKHPFFKGVNWA 964
F IL K ++ P S S+ A ++ L++DPK RLG G +I+ HPFF+ V+W
Sbjct: 214 FQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271
Query: 965 LV 966
L+
Sbjct: 272 LM 273
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 7e-49
Identities = 106/308 (34%), Positives = 164/308 (53%), Gaps = 43/308 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALY 735
+G G V LV L + Q +AMK + K ++ + + E+ + + +PF+ L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ FQT + + L+ +Y GG+L + RQ + L E+ RFYAAE+ +AL +LH +GIIYR
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
DLK +NVLL +GH+ LTD+ + CK L P +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM-----CKEGL----------------------GPGDTT 153
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-------RGKTRQKTFA 908
++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F
Sbjct: 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213
Query: 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS--HEGANEIKKHPFFKGVNWALV 966
IL K ++ P S+ A ++ L++DPK RLG G ++IK H FF+ ++W L+
Sbjct: 214 VILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271
Query: 967 --RCMNPP 972
+ + PP
Sbjct: 272 EKKQVTPP 279
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 7e-49
Identities = 116/326 (35%), Positives = 180/326 (55%), Gaps = 43/326 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F +K +G G G V +V+L + + FAMK ++K ML R + ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
++ L+ +FQ + ++ L+ DY GG+L LL + + L ED RFY AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVH 119
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
++RD+KP+N+L+ NGH+ L DF SCL M
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFG-SCLK-------------------------LM 153
Query: 849 AEPMRASNSFVGTEEYIAPEIIA----GAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 903
+ S+ VGT +YI+PEI+ G G + DWW+LG+ +YEMLYG TPF ++
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 904 QKTFANIL-HKD-LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+T+ I+ HK+ +FP+ T S AK L+ RL+ + RLG + G + K+HPFF G
Sbjct: 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLIC-SREHRLGQN-GIEDFKQHPFFTG 271
Query: 961 VNWALVR-CMNP--PELDAPLFATDT 983
++W +R C P PE+ +P TDT
Sbjct: 272 IDWDNIRNCEAPYIPEVSSP---TDT 294
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 4e-48
Identities = 105/310 (33%), Positives = 162/310 (52%), Gaps = 42/310 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 733
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ +F T + I D GG+L L + V E +RFYAAE+++ LE++H + ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPH-------------- 153
Query: 854 ASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFAN-- 909
AS VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K +
Sbjct: 154 AS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 968
L ++ P S S + L+ LL RD RLG GA E+K+HPFF+ ++W +V
Sbjct: 211 TLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFL 268
Query: 969 MN-PPELDAP 977
PP L P
Sbjct: 269 QKYPPPLIPP 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 101/295 (34%), Positives = 152/295 (51%), Gaps = 33/295 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP- 729
F + LG G G V L E G+ + +A+K + K V++ + V E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F+ L++ FQT + + +Y GG+L + Q KE FYAAE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENMWDGVT----------------- 157
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G+ + F +
Sbjct: 158 -----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNW 963
I+ ++ +P S S A + L+ + P RLG EG +IK+H FF+ ++W
Sbjct: 213 IMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 1e-47
Identities = 102/320 (31%), Positives = 158/320 (49%), Gaps = 42/320 (13%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDK 704
+KDS K ++ ++ + F I+ LG+G G V L + + A+K +K
Sbjct: 12 KKDSDSTKEPKR----KNKMKYEDFNFIRTLGTGSFGRVILATY-KNEDFPPVAIKRFEK 66
Query: 705 GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 764
++ + +V +ER+IL+ ++HPF LY SF+ ++++ L+ ++ GGE F L R
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN- 125
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
K D FYAA++V+ EYL I+YRDLKPEN+LL +G + +TDF + + +
Sbjct: 126 -KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
+ + GT EYIAPEI+ GH A DWW L
Sbjct: 185 ------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTL 214
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 944
GI +YE+L G PF + IL + FP + K LM +LL D R G
Sbjct: 215 GIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN--CKHLMKKLLSHDLTKRYG 272
Query: 945 S-HEGANEIKKHPFFKGVNW 963
+ +GA +K+HP+F ++W
Sbjct: 273 NLKKGAQNVKEHPWFGNIDW 292
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 2e-47
Identities = 111/326 (34%), Positives = 167/326 (51%), Gaps = 46/326 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F IK LG G G V L + +AMK + K +LNRN+V AER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V LY SFQ K ++ + DY PGG++ LL R +V E RFY AE+ +A+E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSC------------------------------L 820
G I+RD+KP+N+L+ +GH+ LTDF L +
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
++C+ L T ++ + Q+ +A +S VGT YIAPE++ G+T D
Sbjct: 181 SNCRCGDRLKTLEQRATK----QHQRCLA------HSLVGTPNYIAPEVLLRKGYTQLCD 230
Query: 881 WWALGILLYEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRD 938
WW++G++L+EML G PF T +T +++ L P S A L+ +L
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCC-S 289
Query: 939 PKSRLGSHEGANEIKKHPFFKGVNWA 964
+ RLG + GA++IK HPFF V+++
Sbjct: 290 AEERLGRN-GADDIKAHPFFSEVDFS 314
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 4e-47
Identities = 94/296 (31%), Positives = 147/296 (49%), Gaps = 31/296 (10%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +L +++TK +CL+ GG+L + E+ FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+YRDLKPEN+LL GH+ ++D L+ + E
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAV-------------------------EIPEGE 156
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
+R VGT Y+APE++ +T + DWW LG L+YEM+ G +PFR + + +
Sbjct: 157 TIRGR---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 911 LHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW 963
+ + S S A+ + +LL +DP RLG EGA E+K HPFF+ N+
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 3e-46
Identities = 107/316 (33%), Positives = 166/316 (52%), Gaps = 39/316 (12%)
Query: 654 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
K ++KI Q+ + + +K +G G G V LV S + +AMK + K M+ R+
Sbjct: 30 KIVRKI--RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 714 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 773
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWA 144
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+FY AEVV+AL+ +H G+I+RD+KP+N+LL +GH+ L DF +C+
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG-TCM------------- 190
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLY 889
K G M ++ VGT +YI+PE++ G + DWW++G+ L+
Sbjct: 191 --KMDETG----------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLF 238
Query: 890 EMLYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
EML G TPF + T++ I+ HK+ L FP S HAK L+ L D + RLG +
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFL-TDREVRLGRN- 296
Query: 948 GANEIKKHPFFKGVNW 963
G EIK+HPFFK W
Sbjct: 297 GVEEIKQHPFFKNDQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 100/314 (31%), Positives = 161/314 (51%), Gaps = 37/314 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V L +++TK +CL+ GG+L + +E+ FYAAE++ LE LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA--------VKIPEGESIRGR------------ 161
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK----TRQKT 906
VGT Y+APE++ +T + D+W LG L+YEM+ G +PFRG+ R++
Sbjct: 162 --------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWAL 965
+L + + S S AK + LL +DPK RLG E GA E+K+HPFF+ +N+
Sbjct: 214 DRRVLETEEVY--SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271
Query: 966 VRC--MNPPELDAP 977
+ ++PP + P
Sbjct: 272 LEAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 7e-45
Identities = 103/311 (33%), Positives = 158/311 (50%), Gaps = 41/311 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPA 733
+G G G V+ +G+ +AMK +DK + + A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ +F T +C I D GG+L L + V E +RFYA E+++ LE++H + ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
YRDLKP N+LL +GHV ++D L+C S KK+ H
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFS------------KKKPHAS------------ 155
Query: 854 ASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFAN-- 909
VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR KT+ K +
Sbjct: 156 -----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 968
L +++ P S L K L+ LL RD RLG GA E+K+H FFKG++W V
Sbjct: 211 TLTVNVELPDSFSPEL--KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268
Query: 969 MNPPELDAPLF 979
P P
Sbjct: 269 QKYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-44
Identities = 107/315 (33%), Positives = 163/315 (51%), Gaps = 39/315 (12%)
Query: 656 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 715
I KI D ++ + + +K +G G G V LV + + +AMK + K M+ R+
Sbjct: 32 INKIRDL--RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 89
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
ER+I+ + P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RF
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARF 146
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y AEVV+AL+ +H G I+RD+KP+N+LL +GH+ L DF +C+ K
Sbjct: 147 YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNK----------- 194
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEM 891
E M ++ VGT +YI+PE++ G + DWW++G+ LYEM
Sbjct: 195 --------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 892 LYGYTPFRGKTRQKTFANIL-HKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949
L G TPF + T++ I+ HK+ L FP S AK L+ L D + RLG + G
Sbjct: 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN-GV 298
Query: 950 NEIKKHPFFKGVNWA 964
EIK+H FFK WA
Sbjct: 299 EEIKRHLFFKNDQWA 313
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 4e-43
Identities = 101/296 (34%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +L +++TK +CL+ GG+L + +E FYAAE+ LE LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+YRDLKPEN+LL +GH+ ++D L+ + +P K R
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA--------VHVPEGQTIKGR------------ 161
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF--RGKTRQKTFA 908
VGT Y+APE++ +T + DWWALG LLYEM+ G +PF R K ++
Sbjct: 162 --------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNW 963
L K+++ S S A+ L LL +DPK RLG GA E+K+HP FK +N+
Sbjct: 214 ERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 37/289 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F ++ +G G G V+ +G+ A+K + + K+ E +IL HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ Y S+ K + ++ ++C GG L LL + L E + + E++ LEYLH
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS 116
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
GII+RD+K N+LL +G V L DF LS QL
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSA------QL---------------------- 148
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+A N+ VGT ++APE+I G + D W+LGI E+ G P+ K
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208
Query: 910 ILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
I + S K + + L ++P+ R A ++ KHPF
Sbjct: 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 158 bits (399), Expect = 5e-42
Identities = 97/316 (30%), Positives = 150/316 (47%), Gaps = 42/316 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+R ++ LG G G V+L + A+K + K + +V R E +IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 730 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYL 787
+ LY FQ + + L+ +Y GG L LL + K L E F A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 788 HCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
H +GII+RD+KPEN+LL +G V L DF L+ L +P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP---------------------DPG 156
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTR 903
+ ++ VGT Y+APE++ G +S+ D W+LGI LYE+L G PF G+
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 904 QKTFANILHKDLKFPSST-----------PTSLHAKQLMYRLLHRDPKSRLGSHEG-ANE 951
+ L L+ P+ + S A L+ +LL +DPK+RL S +++
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 952 IKKHPFFKGVNWALVR 967
+ H K + + +
Sbjct: 277 LLAHLKLKESDLSDLL 292
|
Length = 384 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 92/306 (30%), Positives = 152/306 (49%), Gaps = 41/306 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V V++ +G+ +A K +DK + ++ A E+EIL+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+F++KTH+CL+ GG+L + + L+ + V Y+A++ + +LH I+YRD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+KPENVLL G+ L+D L+ + L +R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA--------VELKDGKTITQR------------------ 154
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK----TRQKTFANILH 912
GT Y+APEI+ ++ VDW+A+G +YEM+ G TPF+ +++ L
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 972
++KF T +K + L + P+ RLGS E ++ +KH FFK +N+ P
Sbjct: 213 DEVKFEHQNFTE-ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF--------P 263
Query: 973 ELDAPL 978
L+A L
Sbjct: 264 RLEAGL 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLD 727
+ + LG G GSV+L +G+ A+K+++ L+ + A E IL L
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVE----LSGDSEEELEALEREIRILSSLQ 57
Query: 728 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
HP + Y S + + + + +Y GG L LL + L E +R Y +++ L
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLA 115
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH GI++RD+K N+L+ +G V L DF + KR +
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCA-----------------KRLGDIETGE 158
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+ S GT ++APE+I G + A D W+LG + EM G P+ +
Sbjct: 159 --------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW---SELG 207
Query: 906 TFANILHKDLKFPSSTP----TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L+K S AK + + L RDPK R A+E+ +HPF
Sbjct: 208 NPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP----TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-41
Identities = 95/315 (30%), Positives = 151/315 (47%), Gaps = 44/315 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V ++ +G+ +A K ++K + R A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 737 SFQTKTHVCLITDYCPGGEL----FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
+FQTKT +CL+ GG+L + + + P E FY A+++ LE+LH + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
IYRDLKPENVLL +G+V ++D L+ V + +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLA---------------------------VELKDGQ 151
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---KTRQKTFAN 909
+ + GT ++APE++ G + +VD++ALG+ LYEM+ PFR K K
Sbjct: 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 211
Query: 910 -ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA-NEIKKHPFFKGVNWALVR 967
IL+ + +P S +K LL +DP+ RLG +G + ++ HP F+ +NW +
Sbjct: 212 RILNDSVTYPDK--FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLE 269
Query: 968 CMNPPELDAPLFATD 982
P P F D
Sbjct: 270 AGMLP----PPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 97/313 (30%), Positives = 152/313 (48%), Gaps = 35/313 (11%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
FR + LG G G V ++ +G+ +A K ++K + R A E+ IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +L +++TK +CL+ GG+L + E FYAAE+ LE L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+YRDLKPEN+LL GH+ ++D L+ + +P + R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--------VQIPEGETVRGR------------ 161
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
VGT Y+APE+I +T + DWW LG L+YEM+ G +PFR K +++
Sbjct: 162 --------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR-KRKERVKREE 212
Query: 911 LHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLG-SHEGANEIKKHPFFKGVNWALV 966
+ + +K + S AK + LL ++PK RLG GA +K+HP FK +N+ +
Sbjct: 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272
Query: 967 RC--MNPPELDAP 977
+ PP P
Sbjct: 273 EANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 5e-39
Identities = 60/144 (41%), Positives = 84/144 (58%), Gaps = 3/144 (2%)
Query: 446 DDDYESDDERPDSVDD--KVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDS 503
R SVD+ + R I A +E ++TDP PDNPI+FA+ +
Sbjct: 3 SPPEPRPHGRAPSVDESAAGDVSDHRSDIFFAA-VETTRMPMIVTDPNQPDNPIVFANRA 61
Query: 504 FLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563
FLE+T Y+ EEI+G NCRFLQGPETD ATV ++R AI + ++ +++NY K G FWN
Sbjct: 62 FLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEILNYRKDGSSFWNA 121
Query: 564 FHLQPMRDQKGEVQYFIGVQLDGS 587
+ P+ + G++ YF G QLD S
Sbjct: 122 LFVSPVYNDAGDLVYFFGSQLDVS 145
|
Length = 540 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-38
Identities = 56/125 (44%), Positives = 76/125 (60%)
Query: 464 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 523
R G +E+ ITDP PD PI+ A+ +FL+LT Y+ EE++GRNCRFL
Sbjct: 35 RDFRGASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFL 94
Query: 524 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQ 583
QG TDP V KIRAAI + ++ V+L+NY K G+ FWN HL P+ + G + YF G Q
Sbjct: 95 QGAATDPIAVAKIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQ 154
Query: 584 LDGSE 588
D ++
Sbjct: 155 WDVTD 159
|
Length = 361 |
| >gnl|CDD|237427 PRK13559, PRK13559, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 52/113 (46%), Positives = 72/113 (63%), Gaps = 3/113 (2%)
Query: 195 LSTFQQT---FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVA 251
+QT ++D +PD PI+ A+ F +TGY ++EVVGRNCRFLQGA TDP VA
Sbjct: 46 EQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVA 105
Query: 252 KIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
KIR + + LLNY+KDG PFWN L + P+ ++G++L F G Q +V+
Sbjct: 106 KIRAAIAAEREIVVELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVT 158
|
Length = 361 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 87/289 (30%), Positives = 128/289 (44%), Gaps = 41/289 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-EREILDMLDHPFVPALY 735
+G G G V+ +G+ A+K + + N K + A E ++L++L HP + Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
+ V + +YC GG L LL+ ++L E +R Y +++ L YLH GI++R
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
D+KP N+ L NG + L DF C +L TT M E +
Sbjct: 124 DIKPANIFLDHNGVIKLGDF------GCAVKLKNNTTT--------------MGEEV--- 160
Query: 856 NSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
S GT Y+APE+I G GH A D W+LG ++ EM G P+ + F + H
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFH 218
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHR----DPKSRLGSHEGANEIKKHPF 957
P SL L R DPK R A+E+ +HPF
Sbjct: 219 VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP----TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 35/277 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F+ +K LG G GSV+ V+ Q++A+K +D G M ++ + A E IL ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPN 60
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLH 788
+ + +F +C++ +Y P G+L + ++ K++ E + +++ L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
Q I++RDLK N+LL N V + D +S + KK K Q
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------KKNMAKTQ------ 161
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
+GT Y+APE+ G ++ D W+LG LLYEM PF ++ Q
Sbjct: 162 ----------IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY 211
Query: 909 NILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLG 944
+ K+P P S + + +L PK R
Sbjct: 212 KVQRG--KYPPIPPIYSQDLQNFIRSMLQVKPKLRPN 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-31
Identities = 52/123 (42%), Positives = 73/123 (59%), Gaps = 5/123 (4%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
I D LPD P+I+ +D+F +T YS +E+LGRNCRFLQG +T+ V ++R AID +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEES 605
+V+L NY K G FWN + P+RD+ G V +++G Q D +E R A E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTE-----RKEAELALQRER 276
Query: 606 EKL 608
KL
Sbjct: 277 RKL 279
|
Length = 665 |
| >gnl|CDD|237426 PRK13558, PRK13558, bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 7e-31
Identities = 48/106 (45%), Positives = 73/106 (68%)
Query: 203 VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262
++DAT PD P++Y + F ++TGY+ EV+GRNCRFLQG T+ E VA++RE + +
Sbjct: 162 TIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERP 221
Query: 263 YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
L NY+KDG+ FWN + IAPI+D++G V ++G Q +V++ E
Sbjct: 222 TSVELRNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKE 267
|
Length = 665 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 41/296 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+K LG G +G V+ V +G+ +A+K + + + E + L + P
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDG-DEEFRKQLLRELKTLRSCESP 59
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+V Y +F + + ++ +Y GG L LL + + E + + A +++ L+YLH
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHT 117
Query: 790 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ II+RD+KP N+L+ G V + DF +S +L T ++
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQC------------ 157
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
N+FVGT Y++PE I G ++ A D W+LG+ L E G PF Q +F
Sbjct: 158 -------NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL-PPGQPSFF 209
Query: 909 NILHKDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
++ P + S + + L +DPK R A E+ +HPF K
Sbjct: 210 ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRP----SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|237425 PRK13557, PRK13557, histidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 49/118 (41%), Positives = 79/118 (66%)
Query: 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 247
SDI A+ T + +V+D +PD PI++A+ F +MTGY ++E++G NCRFLQG TD
Sbjct: 29 SDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDR 88
Query: 248 EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
VA++R+ + + +LNY+KDG+ FWN L ++P+ +D G ++ F G Q++VS+
Sbjct: 89 ATVAEVRDAIAERREIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSR 146
|
Length = 540 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 39/104 (37%), Positives = 60/104 (57%), Gaps = 3/104 (2%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
++ DP D I++A+D+ L L Y+REE+LG++ R L GP D V ++R A+ N
Sbjct: 1 ILVLDP---DGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+V V+L K G+ F L P+RD+ GEV +G+ D +E
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 75/247 (30%), Positives = 104/247 (42%), Gaps = 57/247 (23%)
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
M D+P LY S T LI DY G+LF LL ++ L E V+ ++V AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEAL 122
Query: 785 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
LH II+ D+K ENVL + + L D+ L CK G
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-----CK--------------IIGTP 163
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG--- 900
+ + GT +Y +PE I G + + DWWA+G+L YE+L G PF+
Sbjct: 164 S------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 901 --------KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952
RQ K L F + S +A + +L + RL ++ NEI
Sbjct: 212 EELDLESLLKRQ-------QKKLPFIKN--VSKNANDFVQSMLKYNINYRLTNY---NEI 259
Query: 953 KKHPFFK 959
KHPF K
Sbjct: 260 IKHPFLK 266
|
Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 80/300 (26%), Positives = 121/300 (40%), Gaps = 45/300 (15%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LD 727
+ I+ +G G T V+ + + A+K +D L + + +E+ M +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQCN 57
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 786
HP V Y SF + L+ Y GG L ++ P L E + EV+ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH G I+RD+K N+LL +G V + DF +S L +K R
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS------LADGGDRTRKVRK------- 164
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+FVGT ++APE++ G+ D W+ GI E+ G P+ K
Sbjct: 165 ----------TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
Query: 906 TFANILHKDLKFPSSTPT-------SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L D P S T S ++++ L +DP R A E+ KH FF
Sbjct: 215 VLMLTLQND---PPSLETGADYKKYSKSFRKMISLCLQKDPSKR----PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-29
Identities = 60/154 (38%), Positives = 92/154 (59%), Gaps = 2/154 (1%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ F +KP+ G G V+L + + +A+K + K M+N+N VH+ AER+ L +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
PF+ LY S Q+ +V L+ +Y GG++ LL E+ Y +EV +AL+YL
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAVKYISEVALALDYL 120
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
H GII+RDLKP+N+L+ GH+ LTDF LS +T
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 84/308 (27%), Positives = 138/308 (44%), Gaps = 43/308 (13%)
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
A++ I+ G+ L ++ ++ +G G +G V+ +G+ A+K M L +
Sbjct: 7 ALKDIVSEGDPREL--YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKE 60
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 774
E I+ HP + Y S+ + ++ +Y GG L ++ + + + E +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIA 119
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+ EV+ LEYLH Q +I+RD+K +N+LL +G V L DF + QL T E
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA------QL----TKE 169
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894
K +R NS VGT ++APE+I + VD W+LGI+ EM G
Sbjct: 170 KSKR-----------------NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
Query: 895 YTPFRGKTRQKTFANILHK---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
P+ + + I K LK P K + + L +DP+ R + E
Sbjct: 213 EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF--KDFLNKCLVKDPEKRPSAE----E 266
Query: 952 IKKHPFFK 959
+ +HPF K
Sbjct: 267 LLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 42/300 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ LG+G++G V V +G+ A+K + + K + E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK--QILRELDILHKCNS 58
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P++ Y +F + + +Y GG L +L + E + A V+ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLH 117
Query: 789 CQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
+ II+RD+KP N+L+ G + L DF +S QL N
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVS------GQL----VNSL------------ 155
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 906
+ +FVGT Y+APE I G ++ D W+LG+ L E+ G P+ +
Sbjct: 156 -------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 907 FANILHKDLKFPS----STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
+L + P S S + + L +DP+ R E+ +HPF K
Sbjct: 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER----PSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 88/298 (29%), Positives = 127/298 (42%), Gaps = 54/298 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
F ++ +G G G V+ + Q A+K +D L + ++EI L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P++ Y SF + + +I +YC GG LL L E + F EV++ LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLH 115
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+G I+RD+K N+LL G V L DF +S QL T+ KR
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS------GQL---TSTMSKR----------- 155
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
N+FVGT ++APE+I +G+ D W+LGI E+ G P +
Sbjct: 156 -------NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208
Query: 909 NILHKDLKFPSSTPTSLHA-------KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
I P + P SL K + L++DPK R A E+ KH F K
Sbjct: 209 LI-------PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP----SAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 85/299 (28%), Positives = 130/299 (43%), Gaps = 55/299 (18%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHR-ACAEREILDML 726
H+ PI+ LG G G L K ++ L R K R A E IL +L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN----LTRLSEKERRDALNEIVILSLL 56
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
HP + A Y F + + +Y GG L+ + RQ ++ +E+ V +Y ++V A+ Y
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
+H GI++RD+K N+ L G + L DF +S K +
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---------------------KILGSEY 155
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
MAE + VGT Y++PE+ G + D WALG +LYE+L T ++T
Sbjct: 156 SMAE------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL---------TLKRT 200
Query: 907 FA--NILHKDLKF------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
F N L+ +K P + S L++ LL +DP+ R A+E+ P
Sbjct: 201 FDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKR----PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 51/291 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREI--LDMLDHPFV 731
LGSG GSV+ G +FA+K + + + + + E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVS---LADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
+ + + ++ + + PGG L LL + E +R Y ++++ LEYLH +
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
++RD+K N+L+ NG V L DF ++ K+
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA----------------KQ------------VVE 154
Query: 852 MRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
+ SF G+ ++APE+IA G + A D W+LG + EM G P+ ++ + A +
Sbjct: 155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAV 211
Query: 911 LH----KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
K+L P S AK + + L RDP R A E+ +HPF
Sbjct: 212 FKIGRSKELP-PIPDHLSDEAKDFILKCLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 31/267 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V V + +AMK +D M NR + A E +L LD ++ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV-RFYAAEVVVALEYLHCQGIIYR 795
SF K + ++ +Y G+L LL Q + L ED V RF+ ++++ L +LH + I++R
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQILLGLAHLHSKKILHR 125
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
D+K N+ L +V + D ++ +LL TN +
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVA-------KLLSDNTN--------------------FA 158
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL 915
N+ VGT Y++PE+ + D WALG++LYE G PF + I+
Sbjct: 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF 218
Query: 916 KFPSSTPTSLHAKQLMYRLLHRDPKSR 942
P S S QL+ + L +D + R
Sbjct: 219 P-PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 83/288 (28%), Positives = 137/288 (47%), Gaps = 43/288 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPAL 734
LG G G+V+LV+ + +K + + + LN N+ +A E ++L LDHP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
+ASF + C+IT+YC G +L L+ + K L E+ V + ++++ + Y+H + I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLT--SCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDLK +N+ L+ N + + DF +S L SC L TT
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCD----LATT------------------ 164
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
F GT Y++PE + G+ S D W+LG +LYEM F G+ I
Sbjct: 165 -------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217
Query: 911 LHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+ P + L++ +M +L++DP R A EI ++PF
Sbjct: 218 VEGPTPSLPETYSRQLNS--IMQSMLNKDPSLRP----SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 70/294 (23%), Positives = 128/294 (43%), Gaps = 44/294 (14%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
++ +G G G+V V G+ K +D G M + K + +E IL L HP +
Sbjct: 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHPNIVR 63
Query: 734 LYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC 789
Y ++ + ++ +YC GG+L L+ + + K ++E+ + ++++AL H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 790 QG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+ +++RDLKP N+ L N +V L DF L+ +L +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA--------KILGHDS----------- 164
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
A ++VGT Y++PE + + D W+LG L+YE+ PF + +
Sbjct: 165 --SFA------KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
Query: 905 KTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+ + I K+ KF S +++ +L+ DP R E+ + P
Sbjct: 217 QLASKI--KEGKFRRIPYRYSSELNEVIKSMLNVDPDKR----PSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|222120 pfam13426, PAS_9, PAS domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 37/104 (35%), Positives = 66/104 (63%), Gaps = 3/104 (2%)
Query: 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261
+V D PD I+YA+ ++ GYT +E++G++ R L G G D E VA++RE L+NG
Sbjct: 1 ILVLD---PDGRIVYANDAALRLLGYTREELLGKSIRDLFGPGDDEEAVARLREALRNGG 57
Query: 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
L +KDG PF L++ +P++D++G+V+ +G+ ++++
Sbjct: 58 EVEVELELRRKDGEPFPVLVSASPVRDEDGEVVGIVGILRDITE 101
|
Length = 101 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/223 (25%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRAC-AEREILDMLDHPFVPALY 735
+G G G V+ +G + A+K + + + + ++ E ++L L HP +
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQIS--LEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYR 795
S +T + +I +Y G L ++ + E V Y +V+ L YLH QG+I+R
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS 855
D+K N+L +G V L DF ++ + + +
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA---------------------------TKLNDVSKDD 156
Query: 856 NSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
S VGT ++APE+I +G ++A D W+LG + E+L G P+
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 53/278 (19%)
Query: 685 VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKT 742
V LV + Q F +K + K +R + L ++ H P + L+ ++
Sbjct: 9 VLLVMDTRTQQTFILKGLRKSSEYSRER----------LTIIPHCVPNMVCLHKYIVSED 58
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
V L+ + GG+L+ + + + E+ V+ +AAE+VVAL+ LH +GI+ RDL P N+
Sbjct: 59 SVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
LL GH+ LT F + + V E +
Sbjct: 117 LLDDRGHIQLTYF-------------------------SRWSEV---EDSCDGEAV--EN 146
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI-LHKDLKFPSST 921
Y APE+ + T A DWW+LG +L+E+L G T + I H L P
Sbjct: 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP-----SGINTHTTLNIPEW- 200
Query: 922 PTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFF 958
S A+ L+ +LL +P RLG+ G +IK HPFF
Sbjct: 201 -VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 50/311 (16%)
Query: 655 AIQKILDSGEQ-INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A+Q ++D G+ L +F I G G TG V + +G+ A+K MD R +
Sbjct: 7 ALQLVVDPGDPRSYLDNFVKI---GEGSTGIVCIATDKSTGRQVAVKKMDL-----RKQQ 58
Query: 714 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
R E++ M D HP + +Y+S+ + ++ ++ GG L D + E+
Sbjct: 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 115
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
+ V+ AL +LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 116 QIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS--------- 166
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
E RR S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 167 -KEVPRR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
Query: 892 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLGSHEG 948
+ G P+ + + I +D P S + + R+L RDP R
Sbjct: 209 VDGEPPYFNEPPLQAMKRI--RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR----AT 262
Query: 949 ANEIKKHPFFK 959
A E+ HPF
Sbjct: 263 AAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 74/316 (23%), Positives = 125/316 (39%), Gaps = 67/316 (21%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 731
+ +G G G V+ +G+ A+K + ++ A REI L L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNHPNI 60
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
L F+ K + L+ ++ L+ DRQ + L E ++ Y +++ L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
I++RDLKPEN+L+ G + L DF L+ +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH--------------------- 157
Query: 852 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR------- 903
+V T Y APE++ G G+++ VD W++G + E+L F GK+
Sbjct: 158 ------YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211
Query: 904 ------------QKTFANILHKDLKFPSSTPTSLH---------AKQLMYRLLHRDPKSR 942
K + + FP L A L+ ++LH DP R
Sbjct: 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKR 271
Query: 943 LGSHEGANEIKKHPFF 958
+ + + HP+F
Sbjct: 272 ITAEQAL----AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 72/273 (26%), Positives = 110/273 (40%), Gaps = 71/273 (26%)
Query: 720 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE--LFLLLDRQPTKVLKEDAVRF 775
REI L L HP + L T+ + L+ +YC + L LD++P L + ++
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP-LSPNLIKS 102
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNE 834
+++ L Y H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI------------ 150
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
P+R V T Y APEI+ G+ H ++AVD W++G + EM+
Sbjct: 151 ----------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
Query: 894 GYTPFRGKTRQ----KTFANIL---------------HKDLKFPSSTPTSLH-------- 926
G F G + K F IL FP P L
Sbjct: 195 GKPLFPGDSEIDQLFKIF-QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP 253
Query: 927 -AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L+ ++L +P R+ A E KHP+F
Sbjct: 254 EGIDLLSKMLQYNPAKRI----SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 70/278 (25%), Positives = 117/278 (42%), Gaps = 42/278 (15%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 728
K LG G G V+ L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
P + L + + ++ +Y PGG+L +L +P ++ D + F A ++ +EY
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSF-ALQIARGMEY 118
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L + I+RDL N L+ N V ++DF LS ++ + KG + P+
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYKVKGGKLPI 168
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 905
++APE + TS D W+ G+LL+E+ G P+ G + +
Sbjct: 169 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212
Query: 906 TFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ L P + P L+ +LM + DP+ R
Sbjct: 213 VLEYLKKGYRLPKPPNCPPELY--KLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ I+ +G G G VHL + +K + M +++ A E ++L +L HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPN 60
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ Y +F + ++ +Y PGG L + ++ +L ED + + ++++AL ++H +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 791 GIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
I++RDLK +N+LL + H V + DF +S + S K
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISKILSSK----------------------- 155
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
+ + VGT YI+PE+ G + D WALG +LYE+ F
Sbjct: 156 -----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA------- 203
Query: 908 ANILHKDLKFPSST--PTSLH----AKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
AN+ LK S T P S +QL+ +L+ DP R ++I P
Sbjct: 204 ANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR----PQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 33/230 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ LG G GSV+ +GQ A+K V+ + E IL D P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQEIIKEISILKQCDSPY 59
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ Y S+ T + ++ +YC G + ++ + K L E+ + + + LEYLH
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+RD+K N+LL G L DF +S GQ +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS----------------------GQLT-----D 151
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
M N+ +GT ++APE+I G+ + D W+LGI EM G P+
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 67/270 (24%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
++ +G G G LV+ S Q +AMK + + + + V + E +L + HP + A
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
SF+ H+ ++ +YC GG+L + Q K+ ED + + ++ + ++++H + ++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RD+K +N+ L NG V L DF + L + P
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARL---------------------------LTSPGA 155
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ ++VGT Y+ PEI + + D W+LG +LYE+ PF+ + + +
Sbjct: 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215
Query: 914 DLK-FPSSTPTSLHAKQLMYRLLHRDPKSR 942
K PS L + L+ ++ R+P+SR
Sbjct: 216 SYKPLPSHYSYELRS--LIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 69/302 (22%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ + +G + A K + + ++ E +IL HP + LY
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
++ + + ++ ++C GG L ++ + + L E +R+ +++ AL +LH +I+RD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LK N+LL +G V L DF +S + ++R
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAK----------NKSTLQKRD----------------- 161
Query: 857 SFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 911
+F+GT ++APE++A + D W+LGI L E+ P
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP-------------- 207
Query: 912 HKD-------LKFPSSTPTSLHA--------KQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
H + LK S P +L + L +DP R A E+ KHP
Sbjct: 208 HHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP----TAAELLKHP 263
Query: 957 FF 958
F
Sbjct: 264 FV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 85/321 (26%), Positives = 147/321 (45%), Gaps = 48/321 (14%)
Query: 655 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A++ ++D G+ + L+++ I G G TG V + SG+ A+K MD R +
Sbjct: 9 ALRMVVDQGDPRSLLENYIKI---GEGSTGIVCIAREKHSGRQVAVKMMDL-----RKQQ 60
Query: 714 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
R E++ M D H V +Y S+ + ++ ++ GG L ++ + L E+
Sbjct: 61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEE 117
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
+ V+ AL YLH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 118 QIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--------- 168
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
+ KR+ S VGT ++APE+I+ + + VD W+LGI++ EM
Sbjct: 169 KDVPKRK------------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 892 LYGYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950
+ G P+ + + + K ++ S + + R+L R+P+ R A
Sbjct: 211 VDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER----ATAQ 266
Query: 951 EIKKHPFFKGVNWALVRCMNP 971
E+ HPF + L C+ P
Sbjct: 267 ELLDHPFL--LQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 93/310 (30%), Positives = 138/310 (44%), Gaps = 50/310 (16%)
Query: 655 AIQKILDSGE-QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A+Q ++D G+ + L +F I G G TG V + + SG+ A+K MD R +
Sbjct: 8 ALQMVVDPGDPRTYLDNFIKI---GEGSTGIVCIATVKSSGKLVAVKKMDL-----RKQQ 59
Query: 714 HRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEE 116
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
+ V+ AL LH QG+I+RD+K +++LL +G V L+DF S
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS--------- 167
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
E RR S VGT ++APE+I+ + VD W+LGI++ EM
Sbjct: 168 -KEVPRR-----------------KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 892 LYGYTPFRGKTRQKTFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948
+ G P+ + K I L LK SL K + RLL RDP R
Sbjct: 210 VDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL--KGFLDRLLVRDPAQR----AT 263
Query: 949 ANEIKKHPFF 958
A E+ KHPF
Sbjct: 264 AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 69/284 (24%), Positives = 129/284 (45%), Gaps = 33/284 (11%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K +G G G LV+ G+ + +K ++ M + + + E +L + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQ 63
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
SF+ ++ ++ DYC GG+L+ ++ Q + ED + + ++ +AL+++H + I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RD+K +N+ L +G + L DF ++ +L +T E R
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA--------RVLNSTVELAR---------------- 159
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
+ +GT Y++PEI + + D WALG +LYEM F + I+
Sbjct: 160 ---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG 216
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
P S+ S + L+ +L R+P+ R N I + F
Sbjct: 217 SYP-PVSSHYSYDLRNLVSQLFKRNPRDR----PSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 6e-23
Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 46/286 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDM 725
++ ++ +G G G+V+ + +G+ A+K ++ L+ + +RE+ L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIIN----LDTPDDDVSDIQREVALLSQLRQ 58
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
P + Y S+ + +I +Y GG + L+ P + E + EV+VAL+
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALK 115
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+H G+I+RD+K N+L+ G+V L DF ++ L N KR
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---------NQNSSKR-------- 158
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
++FVGT ++APE+I G + + D W+LGI +YEM G P+
Sbjct: 159 ----------STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQL---MYRLLHRDPKSRLGSHE 947
+ I P + ++K L + L +PK RL + E
Sbjct: 209 RAMMLIPKSK---PPRLEDNGYSKLLREFVAACLDEEPKERLSAEE 251
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV----MLNRNKVHRACAE--REILDM-- 725
K LG G G V+ G + L E E M
Sbjct: 4 GKKLGEGAFGEVYK------GTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKK 57
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L HP + L + ++T+Y PGG+L L + K+ +D ++ A ++ +E
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKGME 116
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL + ++RDL N L+ N V ++DF LS + + +KR + P
Sbjct: 117 YLESKNFVHRDLAARNCLVTENLVVKISDFGLS-------RDIYEDDYYRKRGGG--KLP 167
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
+ ++APE + TS D W+ G+LL+E+ G P+ G + +
Sbjct: 168 IK----------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE 211
Query: 905 KTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + +D L P + P L+ +LM + DP+ R
Sbjct: 212 EVLELL--EDGYRLPRPENCPDELY--ELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 34/287 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD-KGVMLNRNKVHRA---CAEREI--LDMLDHPF 730
+GSG GSV+L SG+ A+K ++ V + R+ REI L L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ S H+ + +Y PGG + LL+ +E VR + +++ L YLH +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR 125
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
GII+RD+K N+L+ G + ++DF +S +L + + K +
Sbjct: 126 GIIHRDIKGANILVDNKGGIKISDFGIS------KKLEANSLSTKTNGAR---------- 169
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
S G+ ++APE++ +T D W+LG L+ EML G PF T+ + I
Sbjct: 170 -----PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224
Query: 911 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
S +S A + + D R A E+ KHPF
Sbjct: 225 GENASPEIPSNISS-EAIDFLEKTFEIDHNKR----PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 69/278 (24%), Positives = 116/278 (41%), Gaps = 43/278 (15%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVML-NRNKVHRACAEREILDMLDH 728
K LG G G V+ +L G G A+K + + + R E I+ LDH
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKLDH 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
P V L + + ++ +Y GG+L +L R+ L + +A ++ +EY
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEY 117
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L + I+RDL N L+ N V ++DF LS ++ R +G + P+
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRD----------LYDDDYYRKRGGKLPI 167
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQK 905
++APE + TS D W+ G+LL+E+ G P+ G + ++
Sbjct: 168 R----------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211
Query: 906 TFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + L P + P L+ LM + DP+ R
Sbjct: 212 VLEYLKNGYRLPQPPNCPPELY--DLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 76/292 (26%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L +F+ K +G G V+ G+ A+K + M++ E ++L LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 785
HP V ASF + ++ + G+L ++ ++ +++ E + Y ++ ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
++H + I++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ- 904
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 905 -KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS---HEGANEI 952
I D + S + L+ R ++ DP+ R + A E+
Sbjct: 214 YSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-22
Identities = 51/126 (40%), Positives = 74/126 (58%), Gaps = 5/126 (3%)
Query: 859 VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918
+GT +Y+APE++ G H AVDWWALG+ L+E L G PF +T Q+ F NIL++D+ +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 919 SSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977
S++A+ + LL DP R G E+K+HP F GV+W ++ P + P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKR----AGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656
Query: 978 LFATDT 983
TDT
Sbjct: 657 DDETDT 662
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 80/314 (25%), Positives = 124/314 (39%), Gaps = 68/314 (21%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G G V + +G+ A+K + L ++A E + L HP+V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
F + L+ +Y P +L D + + L E V+ Y ++ + Y+H GI++RD
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
LKP N+L+ +G + + DF L+ L S E R +
Sbjct: 125 LKPANLLISADGVLKIADFGLARLFS--------------------------EEEPRLYS 158
Query: 857 SFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH--- 912
V T Y APE++ GA VD WA+G + E+L G F G+ + A +
Sbjct: 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218
Query: 913 ----------KDL------------------KFPSSTPTSLHAKQLMYRLLHRDPKSRLG 944
L FP ++P +L L+ LL DP RL
Sbjct: 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALD---LLKGLLVYDPSKRL- 274
Query: 945 SHEGANEIKKHPFF 958
A E +HP+F
Sbjct: 275 ---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 42/231 (18%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREILDM 725
+ + I+ +GSG G V+ +G+ A+K ++ G + E +L
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-----DDFEIIQQEISMLKE 56
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVA 783
HP + A + S+ + + ++ +YC GG L + R P L E + + E +
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKG 113
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L YLH G I+RD+K N+LL +G V L DF +S QL T KR
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA------QL---TATIAKR------ 158
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 891
SF+GT ++APE+ A G+ D WALGI E+
Sbjct: 159 ------------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 71/291 (24%), Positives = 129/291 (44%), Gaps = 38/291 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
+ IK +G G G ++L + ++ +K +D M + K +++E+ L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK---EASKKEVILLAKMKH 58
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + +ASFQ + ++ +YC GG+L ++RQ + ED + + ++ + L+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 789 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
+ I++RD+K +N+ L NG V+ L DF ++
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--------------------------- 151
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
+ + M + + VGT Y++PEI + + D W+LG +LYE+ PF G +
Sbjct: 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV 211
Query: 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
I P S S + L+ +L P+ R I K PF
Sbjct: 212 LKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDR----PSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-21
Identities = 87/322 (27%), Positives = 133/322 (41%), Gaps = 73/322 (22%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE---ILDMLD 727
++ IK LG G GSV+L +G+ A+K M K RE + + +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L F+ + + +Y G L+ L+ + K E +R +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H G +RDLKPEN+L+ G V + DF L+ +P P T+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP----PYTD-------------- 157
Query: 848 MAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTP-FRGKTR-- 903
+V T Y APEI+ ++S VD WALG ++ E LY P F G +
Sbjct: 158 ----------YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE-LYTLRPLFPGSSEID 206
Query: 904 --QKTFANIL----------HKDL------KFPSSTPTSLH---------AKQLMYRLLH 936
K + +L L +FP PTSLH A L+ +L
Sbjct: 207 QLYKICS-VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLR 265
Query: 937 RDPKSRLGSHEGANEIKKHPFF 958
DPK R A++ +HP+F
Sbjct: 266 WDPKKRP----TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 49/288 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ I LG+G+ GSV V+ +G A K + G + K + E +I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK--QILRELQIMHECRS 62
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAAEVVVALEY 786
P++ + Y +F + ++C+ ++ G L DR K + + + A VV L Y
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 787 LH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
L+ I++RD+KP N+L+ G + L DF +S +L+ N
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS------GELI---------------NS 157
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF------- 898
+ +++FVGT Y++PE I G +T D W+LGI + E+ G PF
Sbjct: 158 I--------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209
Query: 899 RGKTRQKTFANILHKDLKFPSST-PTSL---HAKQLMYRLLHRDPKSR 942
G+ ++L + ++ P P+S + + L +DP R
Sbjct: 210 DGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 74/329 (22%), Positives = 125/329 (37%), Gaps = 83/329 (25%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA------CAEREI-- 722
+ I +G G G V+ +G+ A+K + ++ A REI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKL 51
Query: 723 LDMLDHPFVPALY---ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
L L HP + L S + + ++ +Y +L LLD K E ++ Y +
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGS-IYMVFEYMDH-DLTGLLDSPEVK-FTESQIKCYMKQ 108
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ L+YLH GI++RD+K N+L+ +G + L DF L+ R +
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA------------------RPY 150
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 898
+ + + + V T Y PE++ GA VD W++G +L E+ G F
Sbjct: 151 TKRNSADY--------TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
Query: 899 RGKTRQKTFANILH-------------------KDLKFPSSTPTSL----------HAKQ 929
+G T + I ++LK L A
Sbjct: 203 QGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALD 262
Query: 930 LMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L+ +LL DPK R+ + + H +F
Sbjct: 263 LLDKLLTLDPKKRISADQALQ----HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 65/281 (23%), Positives = 116/281 (41%), Gaps = 43/281 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G G V+ +L G A+K + + + + E ++ L HP V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNV 58
Query: 732 PALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF-----YAAEVVVAL 784
L + + L+ +Y GG+L +L R ++ + +A ++ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + ++RDL N L+ + V ++DF LS + + +++ G+
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--------RDVYDDDYYRKKTGGK-- 168
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
P+R ++APE + TS D W+ G+LL+E+ G TP+ G +
Sbjct: 169 -----LPIR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 904 QKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
++ + K L P P L+ +LM DP+ R
Sbjct: 214 EEVLEYL-RKGYRLPKPEYCPDELY--ELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 71/325 (21%), Positives = 126/325 (38%), Gaps = 87/325 (26%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-----LDMLDHPFV 731
+G G G+V+ +G++ A+K + V L+ + + REI L+ +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTL-REIALLKQLESFEHPNI 63
Query: 732 PALYASFQTK-----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
L + L+ ++ +L L + P L + ++ +++ +++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDL-------SCLTSCKPQLLLPTTNEKKRRH 839
LH I++RDLKP+N+L+ +G V + DF L LTS
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV---------------- 166
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP-F 898
V T Y APE++ + + + VD W++G + E+ + P F
Sbjct: 167 -------------------VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL-FRRRPLF 206
Query: 899 RGKTR----QKTF------------ANILHKDLKFPSSTPTSL---------HAKQLMYR 933
RG + K F N+ FPS TP S L+ +
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKK 266
Query: 934 LLHRDPKSRLGSHEGANEIKKHPFF 958
+L +P R+ + E HP+F
Sbjct: 267 MLTFNPHKRISAFEALQ----HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 57/248 (22%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDML- 726
F ++ +G G G V+ +GQ A+K MD E EI ++L
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----------IIEDEEEEIKEEYNILR 57
Query: 727 ---DHPFVPALYASFQTKTHVC------LITDYCPGGELFLLLD--RQPTKVLKEDAVRF 775
+HP + Y +F K L+ + C GG + L+ R+ K LKE+ + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
E + L YLH +I+RD+K +N+LL N V L DF +S L +T +
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--------QLDSTLGR 169
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYE 890
+ N+F+GT ++APE+IA A + + D W+LGI E
Sbjct: 170 R-------------------NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 891 MLYGYTPF 898
+ G P
Sbjct: 211 LADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 74/281 (26%), Positives = 114/281 (40%), Gaps = 65/281 (23%)
Query: 711 NKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVL 768
++ + A RE+ L L H + L +F+ K + L+ +Y L LL+ P L
Sbjct: 40 DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGG-L 97
Query: 769 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
DAVR Y +++ A+ Y H II+RD+KPEN+L+ +G + L DF + +P
Sbjct: 98 PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGIL 887
+V T Y APE++ G + VD WA+G +
Sbjct: 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191
Query: 888 LYEMLYGYTPFRGKT------------------RQKTF-ANILHKDLKFPS-STPTSLHA 927
+ E+L G F G + Q+ F +N + FP S P SL
Sbjct: 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER 251
Query: 928 K----------QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
+ + L DPK RL E+ +HP+F
Sbjct: 252 RYPGKVSSPALDFLKACLRMDPKERLTCD----ELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 51/300 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
I LG G G V+ + +G A K ++ + ++ E EIL +HP++
Sbjct: 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVK 73
Query: 734 LYASFQTKTHVCLITDYCPGGE---LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L +F + ++ ++CPGG + L LDR L E ++ +++ AL+YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSM 129
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
II+RDLK NVLL +G + L DF +S +RR
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA----------KNVKTLQRR------------ 167
Query: 851 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+SF+GT ++APE++ + D W+LGI L EM P +
Sbjct: 168 -----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
Query: 906 TFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
I + L PS S+ + + L + P++R A ++ +HPF V
Sbjct: 223 VLLKIAKSEPPTLSQPSK--WSMEFRDFLKTALDKHPETR----PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 66/235 (28%), Positives = 106/235 (45%), Gaps = 29/235 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L +FR K +G G V+ G A+K + +++ E ++L L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 785
HP V YASF + ++ + G+L ++ ++ +++ E V Y ++ ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 83/298 (27%), Positives = 129/298 (43%), Gaps = 55/298 (18%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G+ GSV+ V +G AMK + + L+ +K ++ E +IL P++ Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 737 SFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIY 794
+F + V + +Y G L L T+ + ED +R VV L++L + II+
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL--LPTTNEKKRRHKGQQNPVFMAEPM 852
RD+KP NVL+ GNG V L DF +S L+ L TN
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------------- 161
Query: 853 RASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+G + Y+APE I G +T D W+LG+ + EM G P+ +T
Sbjct: 162 ------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215
Query: 907 FAN---ILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
FA I+ D P + P+ S A+ + + L++ P R + HP+
Sbjct: 216 FAQLSAIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE----HPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 84/329 (25%), Positives = 139/329 (42%), Gaps = 56/329 (17%)
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
A+Q ++ G+ ++ +G G TG V + +G+ A+K MD R +
Sbjct: 10 ALQLVVSPGDP--REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL-----RKQQR 62
Query: 715 RACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
R E++ M D H V +Y S+ + ++ ++ GG L D + E+
Sbjct: 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL---TDIVTHTRMNEEQ 119
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ V+ AL YLH QG+I+RD+K +++LL +G + L+DF S
Sbjct: 120 IATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS---------- 169
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
E +R S VGT ++APE+I+ + + VD W+LGI++ EM+
Sbjct: 170 KEVPKR-----------------KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 893 YGYTPFRGKTRQKTFANI---LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949
G P+ + + I L +K + L + +L R+P R A
Sbjct: 213 DGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FLDLMLVREPSQR----ATA 266
Query: 950 NEIKKHPFFKGVNWALVRCMNPPELDAPL 978
E+ +HPF K PP PL
Sbjct: 267 QELLQHPFLK--------LAGPPSCIVPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 70/286 (24%), Positives = 114/286 (39%), Gaps = 32/286 (11%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LG G G V+L +G+ A+K + D + +V+ E ++L L H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
Y + + + +Y PGG + L + L E R Y +++ +EYLH I
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
++RD+K N+L G+V L DF S KR + M
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGAS-----------------KRLQTICSSGTGM---- 164
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
S GT +++PE+I+G G+ D W++G + EML P+ I
Sbjct: 165 ---KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 221
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
+ + S A+ + R + K R A E+ +H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 731
++ +G G G V LV G+ + +K ++ + N ++ R AE+E +L L HP +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLN---LRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 732 PALYASFQTKTHVCLIT-DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
A S++ + + I +C GG+L+ L Q K+L E+ V + ++ +AL+YLH +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I++RDLK +NV L + + D ++ + +N MA
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIA---------------------RVLENQCDMA- 159
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
++ +GT Y++PE+ + + D WALG +YEM F K I
Sbjct: 160 -----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 911 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ L P S +L+ +L + P+ R
Sbjct: 215 IEGKLP-PMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 58/298 (19%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKA--MDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G+ G+V+ + + A+K +D V L + + +E EIL D P++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM----SELEILYKCDSPYIIGF 64
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
Y +F + + + T++ GG L + + P VL AV VV L YL I++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLGRIAV-----AVVKGLTYLWSLKILH 118
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RD+KP N+L+ G V L DF +S QL+ N +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVS------TQLV---------------NSI-------- 149
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF------- 907
+ ++VGT Y+APE I+G + D W+LGI E+ G P+ + +
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 908 ANILHKDLKFPSSTPTSLHAKQLMY---RLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
I+ +D P P +++ ++ + + + PK R + HPF N
Sbjct: 210 QCIVDED---PPVLPVGQFSEKFVHFITQCMRKQPKERP----APENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 83/327 (25%), Positives = 129/327 (39%), Gaps = 80/327 (24%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREI--LDMLD 727
+ K LG G V+ +G+ A+K + G ++ A REI L L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT-ALREIKLLQELK 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV------- 780
HP + L F K+++ L+ ++ D + KV+K+ ++ A++
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-------DLE--KVIKDKSIVLTPADIKSYMLMT 111
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ LEYLH I++RDLKP N+L+ +G + L DF L+
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR--------------------- 150
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF- 898
P R V T Y APE++ GA H VD W++G + E+L PF
Sbjct: 151 ------SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFL 203
Query: 899 RGKT--RQ--KTFANI-------------LHKDLKFPSSTPTSLH---------AKQLMY 932
G + Q K F + L ++F PT L A L+
Sbjct: 204 PGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQ 263
Query: 933 RLLHRDPKSRLGSHEGANEIKKHPFFK 959
RLL +P R+ A + +HP+F
Sbjct: 264 RLLTLNPNKRI----TARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 70/236 (29%), Positives = 98/236 (41%), Gaps = 55/236 (23%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G GSV L +G FA+K + D L + + E EI P++
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR----ELEINKSCKSPYIVKY 64
Query: 735 YASF--QTKTHVCLITDYCPGGELFLLLDRQPTKVLK------EDAVRFYAAEVVVALEY 786
Y +F ++ + + + +YC GG L D KV K E + A V+ L Y
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSL----DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH + II+RD+KP N+LL G V L DF +S G+
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS----------------------GE---- 154
Query: 847 FMAEPMRASNS----FVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
NS F GT Y+APE I G ++ D W+LG+ L E+ PF
Sbjct: 155 -------LVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 50/296 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILD 724
+ + +G G +G+V+ +GQ A+K M+ K +++N V R I++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
LD S+ + ++ +Y GG L D + E + E + AL
Sbjct: 81 YLD---------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQAL 128
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
E+LH +I+RD+K +N+LL +G V LTDF C T E+ +R
Sbjct: 129 EFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF-CAQ---------ITPEQSKR------ 172
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ +
Sbjct: 173 -----------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 905 KTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ I + + + S + + R L D + R A E+ +HPF K
Sbjct: 222 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG----SAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-18
Identities = 87/342 (25%), Positives = 152/342 (44%), Gaps = 50/342 (14%)
Query: 612 TAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK--DSPPWKAIQKILDSGEQINLQ 669
+AE +N+ K P T E+ + + + P+ ++K D P + + + + E
Sbjct: 12 SAELLNQYAKYFPHVLFTSEEAFEKYCADLDPEAYKKCVDLPEGEEVPESNNPRE----- 66
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-VHRACAEREILDMLDH 728
H + L + + V GS K + K VMLN + A +E L DH
Sbjct: 67 HMYVLTTLVGRNPTTAAFVATRGSDP--KEKVVAKFVMLNDERQAAYARSELHCLAACDH 124
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED--------AVRFYAAEV 780
+ + F++ + LI +Y GG+L ++Q + LKE + FY ++
Sbjct: 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDL----NKQIKQRLKEHLPFQEYEVGLLFY--QI 178
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
V+AL+ +H + +++RDLK N+ L G + L DF S K
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---------------------K 217
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ V + ++SF GT Y+APE+ ++ D W+LG++LYE+L + PF+G
Sbjct: 218 QYSDSV----SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
Query: 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
++++ +L+ P P S K L+ LL ++P R
Sbjct: 274 PSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-18
Identities = 79/334 (23%), Positives = 132/334 (39%), Gaps = 89/334 (26%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 726
++ + P+GSG G V +G+ A+K + + ++ +H R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF---QSAIHAKRTYRELRLLKHM 71
Query: 727 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
DH F PA +S + V L+T G +L ++ Q L +D ++F
Sbjct: 72 DHENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVY 125
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ L+Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-------------------R 166
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897
H + M +V T Y APEI+ H VD W++G ++ E+L G T
Sbjct: 167 HT--------DDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL 215
Query: 898 FRG------------------------------KTRQKTFANILHKDLK--FPSSTPTSL 925
F G + ++ + KD K F + P
Sbjct: 216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPL-- 273
Query: 926 HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
A L+ ++L DP R+ A E HP+
Sbjct: 274 -AIDLLEKMLVLDPDKRI----TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 52/298 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMK-------AMDKGVMLNRNKVHRACAEREILDMLDHP 729
+G G G V+L +G+ A+K + ++ V +E E L LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 730 FVPALYASFQTK-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+ Y F+T ++ + +Y PGG + L R + +E VRF+ +V+ L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+GI++RDLK +N+L+ +G ++DF +S K+ N
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS-----------------KKSDDIYDN---- 164
Query: 849 AEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+ S G+ ++APE+I G+++ VD W+LG ++ EM G P+ + ++
Sbjct: 165 ----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEEA 217
Query: 907 FANI--LHKDLKFPSSTP-----TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
A + L P P S A + +P +R A E+ +HPF
Sbjct: 218 IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR----PTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 65/232 (28%), Positives = 106/232 (45%), Gaps = 42/232 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 729
F + LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIR---ELKVLHECNSP 59
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLD---RQPTKVLKEDAVRFYAAEVVVALEY 786
++ Y +F + + + ++ GG L +L R P +L + ++ V+ L Y
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI-----AVLRGLTY 114
Query: 787 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 149
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
+ + M +NSFVGT Y++PE + G +T D W+LG+ L EM G P
Sbjct: 150 --LIDSM--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 49/293 (16%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G G G V+ + + A+K +D + +++ E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ Y S+ T + +I +Y GG LL P L+E + E++ L+YLH +
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR------------- 158
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
N+FVGT ++APE+I + + D W+LGI E+ G P + I
Sbjct: 159 -----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
Query: 911 LHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
P ++P +L K+ + L++DP+ R A E+ KH F
Sbjct: 214 -------PKNSPPTLEGQYSKPFKEFVEACLNKDPRFR----PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 72/245 (29%), Positives = 106/245 (43%), Gaps = 47/245 (19%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E +L D P+V Y S+ T + +I +Y GG LL+ P L E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILR 108
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
E++ L+YLH + I+RD+K NVLL +G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------GQL---TDTQIKR- 158
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 899 RGKTRQKTFANILHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSRLGSHEGANEI 952
K I P + P +L K+ + L+++P R A E+
Sbjct: 202 SELHPMKVLFLI-------PKNNPPTLEGNYSKPLKEFVEACLNKEPSFR----PTAKEL 250
Query: 953 KKHPF 957
KH F
Sbjct: 251 LKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 79/300 (26%), Positives = 128/300 (42%), Gaps = 52/300 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD- 727
+ F I+ +GSG G V+ +G+ A+K V+ A ++EI+ M D
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIK-----VIKLEPGEDFAVVQQEIIMMKDC 63
Query: 728 -HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
H + A + S+ + + + ++C GG L + T L E + + + E + L Y
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY--HVTGPLSESQIAYVSRETLQGLYY 121
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +G ++RD+K N+LL NGHV L DF +S + T K++
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--------ATIAKRK--------- 164
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM------LYGYTP 897
SF+GT ++APE+ A G+ D WA+GI E+ ++ P
Sbjct: 165 ----------SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
Query: 898 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
R T +N LK S H + L ++PK R A ++ +HPF
Sbjct: 215 MRALFLM-TKSNFQPPKLKDKMKWSNSFH--HFVKMALTKNPKKR----PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 29/235 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L +F+ K +G G V+ + A+K + M++ E ++L L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVALE 785
HP V SF + ++ + G+L ++ ++ +++ E V Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
++H + +++RD+KP NV + G V L D L S K TT
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TT------------- 161
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
A++S VGT Y++PE I G+ D W+LG LLYEM +PF G
Sbjct: 162 --------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 76/326 (23%), Positives = 128/326 (39%), Gaps = 69/326 (21%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG--VMLNRNKVHRACAEREILDMLDH 728
++PI+ +GSG G V SG+ A+K + V + R E +IL H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHFKH 63
Query: 729 PFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ A+ + V ++ D ++ QP L E+ +R++ +++ L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGL 120
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+Y+H +I+RDLKP N+L+ + + + DF ++ S P E K
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-------EHKY------- 166
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
FM E +V T Y APE++ + +T+A+D W++G + EML F GK
Sbjct: 167 --FMTE-------YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217
Query: 904 QKTFANIL-------HKDLK-------------FPSSTPTSLH---------AKQLMYRL 934
IL + L P P A L+ ++
Sbjct: 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQM 277
Query: 935 LHRDPKSRLGSHEGANEIKKHPFFKG 960
L DP+ R+ + +HPF
Sbjct: 278 LQFDPEERI----TVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 72/242 (29%), Positives = 102/242 (42%), Gaps = 41/242 (16%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E +L D P+V Y S+ T + +I +Y GG LL P E +
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLK 108
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
E++ L+YLH + I+RD+K NVLL G V L DF ++ QL T + KR
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA------GQL---TDTQIKR- 158
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
N+FVGT ++APE+I + + S D W+LGI E+ G P
Sbjct: 159 -----------------NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
Query: 899 RGKTRQKTFANILHKDLKFPSSTPT---SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955
+ I K T T S K+ + L++DP R A E+ KH
Sbjct: 202 SDMHPMRVLFLI----PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR----PTAKELLKH 253
Query: 956 PF 957
F
Sbjct: 254 KF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-16
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 56/224 (25%)
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
+L++ R+ +++ AL+Y+H +I+RDLKP N+LL + V L DF L+ S
Sbjct: 102 NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWAL 884
+ +NPV + + +V T Y APEI+ G+ T VD W++
Sbjct: 162 E--------------NPENPV-LTD-------YVATRWYRAPEILLGSTRYTKGVDMWSV 199
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANIL-------HKDL-------------KFPSSTPTS 924
G +L EML G F G + I+ +D+ PS
Sbjct: 200 GCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP 259
Query: 925 LH---------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L A L+ +LL +P RL A E +HP+
Sbjct: 260 LDELLPKASDDALDLLKKLLVFNPNKRL----TAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 731 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ Y +F K+ + L+ ++C G + L+ LKED + + E++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L +LH +I+RD+K +NVLL N V L DF +S QL R G++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL---------DRTVGRR 178
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-----DWWALGILLYEMLYGYTPF 898
N+F+GT ++APE+IA + A D W+LGI EM G P
Sbjct: 179 ------------NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 5e-16
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 52/291 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 730
+G G +G+V+ +GQ A+K M+ K +++N V R I++ LD
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 83
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
S+ + ++ +Y GG L D + E + E + AL++LH
Sbjct: 84 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 172
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + +
Sbjct: 173 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-L 226
Query: 911 LHKDLKFPSSTPTSLHA--KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ + P L A + + R L D R GS A E+ +HPF K
Sbjct: 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR-GS---AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 82/329 (24%), Positives = 137/329 (41%), Gaps = 60/329 (18%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
P P S + +L + +GSG G+V+ V +G+ +A+K +
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI 107
Query: 703 ----DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFL 758
+ V R ++ C E EIL ++HP V + F + ++ ++ GG L
Sbjct: 108 YGNHEDTV---RRQI---CREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-- 159
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
+ T + E + A +++ + YLH + I++RD+KP N+L+ +V + DF +S
Sbjct: 160 ----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVS 215
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGA 873
+ +A+ M NS VGT Y++PE I GA
Sbjct: 216 RI---------------------------LAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 874 GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN----ILHKDLKFPSSTPT-SLHAK 928
A D W+LG+ + E G PF G RQ +A+ I P + T S +
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQP--PEAPATASREFR 305
Query: 929 QLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+ L R+P R A ++ +HPF
Sbjct: 306 HFISCCLQREPAKRW----SAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 80/319 (25%), Positives = 126/319 (39%), Gaps = 72/319 (22%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 731
+ +G G G V +GQ A+K K V + V + A REI L L HP +
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLL--LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
L F+ K + L+ +YC + +L L++ P V E ++ + + A+ + H
Sbjct: 63 VNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRGV-PEHLIKKIIWQTLQAVNFCHK 118
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
I+RD+KPEN+L+ G + L DF + ++L
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFA-------RILTG------------------- 152
Query: 850 EPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR----- 903
P +V T Y APE++ G + VD WA+G + E+L G + GK+
Sbjct: 153 -PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
Query: 904 --QKTFANIL--H----------KDLKFPSSTP----------TSLHAKQLMYRLLHRDP 939
+KT +++ H K L P S A + L DP
Sbjct: 212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDP 271
Query: 940 KSRLGSHEGANEIKKHPFF 958
RL E+ +HP+F
Sbjct: 272 TERLSC----EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-16
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 32/285 (11%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAER-EILDMLDHPFVPA 733
LG G G+V+ L GQ A+K +D +L K + E ++L L H +
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ + + ++ PGG + +L+R L E Y +++ + YLH ++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RD+K NV+L NG + L DF C +L + M + M
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDF------GCARRLAWVGLHGTHSN---------MLKSMH 169
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANILH 912
GT ++APE+I +G+ D W++G ++EM G P R F H
Sbjct: 170 ------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+ L S A + L RD R A ++ +H F
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHER----PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 9e-16
Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 53/287 (18%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LGSG TG+V + G+ FA+K +D M + +RA AE L D + +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 737 SFQTK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE-------VV 781
F K + L+ DY G+L RQ K + F E V+
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDL-----RQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+A+ ++H + +I+RD+K N+LL NG V L DF S + + T ++ R
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA-------TVSDDVGR--- 203
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+F GT Y+APEI ++ D ++LG+LLYE+L PF G+
Sbjct: 204 ---------------TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
Query: 902 TRQKTFANILHKDL--KF-PSSTPTSLHAKQLMYRLLHRDPKSRLGS 945
++ ++HK L ++ P S ++++ LL DPK R S
Sbjct: 249 NMEE----VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS 291
|
Length = 496 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 65/290 (22%), Positives = 116/290 (40%), Gaps = 36/290 (12%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD--KGVMLNRNKVHRAC-AEREILDMLDHPFVPA 733
LG+G S + +G A+K + + + +V A E ++ L+HP +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
+ + +H L ++ GG + LL + KE + Y +++ L YLH II
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 794 YRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
+RD+K N+L+ G + + DF + + L +GQ
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFG----AAAR----LAAKGTGAGEFQGQ---------- 167
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
+GT ++APE++ G + + D W++G ++ EM P+ + A I
Sbjct: 168 -----LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
Query: 913 -KDLKFPSSTPTSLH--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
S P L + + R L P+ R + E+ KHP F+
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDR----PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 74/329 (22%), Positives = 126/329 (38%), Gaps = 88/329 (26%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---D 727
++ + +G G V + +G+Y+A+K M K + + + REI +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD----------RQPTKVLKEDAVRFYA 777
HP + L + L +F L+D ++P L E V+ Y
Sbjct: 57 HPNILRLIEVLFDRKTGRLAL-------VFELMDMNLYELIKGRKRP---LPEKRVKSYM 106
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ +L+++H GI +RD+KPEN+L++ + + L DF KP P T
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP----PYT----- 156
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYT 896
++ T Y APE + G + +D WA+G + +E+L +
Sbjct: 157 -------------------EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197
Query: 897 PFRGKTR------------------QKTFANILHKDLKFPSSTPTSL-----HAKQ---- 929
F G K F H + FPS T L +A
Sbjct: 198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLD 257
Query: 930 LMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L+ +LL DP R+ + + HP+F
Sbjct: 258 LLKKLLAYDPDERITAKQALR----HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 84/356 (23%), Positives = 135/356 (37%), Gaps = 79/356 (22%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
P +P+G G G V V G+ A+K M V N R E ++L H
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 731 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
V P F+ + ++T+ +++ QP L D V+ + +++
Sbjct: 61 VLSALDILQPPHIDPFE---EIYVVTELMQSDLHKIIVSPQP---LSSDHVKVFLYQILR 114
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
L+YLH GI++RD+KP N+L+ N + + DF L+ + +H Q
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-----------RVEEPDESKHMTQ 163
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR-- 899
+ V T+ Y APEI+ G+ H TSAVD W++G + E+L F+
Sbjct: 164 E---------------VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
Query: 900 ---------------------GKTRQKTFANILHKDLKFPS-------STPTSLHAKQLM 931
+ A+IL K PS S+ + A L+
Sbjct: 209 SPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLL 268
Query: 932 YRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNP---PELDAPLFATDTE 984
R+L DP R+ A + HP+ CM ++ +D E
Sbjct: 269 CRMLVFDPDKRI----SAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFE 320
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 3e-15
Identities = 75/342 (21%), Positives = 131/342 (38%), Gaps = 97/342 (28%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLD 727
+ +KP+GSG G V +G+ A+K K + + + R E ++L L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLR 57
Query: 728 HP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLD-----RQPTKVLKEDAVR 774
H P F V ++T+ + D + P + L +D ++
Sbjct: 58 HENIIGLLDILRPPSPEDFND---VYIVTEL-------METDLHKVIKSP-QPLTDDHIQ 106
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
++ +++ L+YLH +I+RDLKP N+L+ N + + DF L+
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA---------------- 150
Query: 835 KKRRHKGQQ--NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 891
R F+ E +V T Y APE++ + T A+D W++G + E+
Sbjct: 151 ---RGVDPDEDEKGFLTE-------YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 892 LYGYTPFRGKT-----------------------RQKTFANIL-------HKDL--KFPS 919
L F G+ + N L K L FP
Sbjct: 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG 260
Query: 920 STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
++P ++ L+ ++L DPK R+ A+E HP+ +
Sbjct: 261 ASPEAID---LLEKMLVFDPKKRI----TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 4e-15
Identities = 74/291 (25%), Positives = 125/291 (42%), Gaps = 52/291 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMD------KGVMLNRNKVHRACAEREILDMLDHPF 730
+G G +G+V+ +GQ A++ M+ K +++N V R I++ LD
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD--- 84
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
S+ + ++ +Y GG L D + E + E + ALE+LH
Sbjct: 85 ------SYLVGDELWVVMEYLAGGSL---TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+I+RD+K +N+LL +G V LTDF T E+ +R
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------QITPEQSKR------------ 173
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + +
Sbjct: 174 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-L 227
Query: 911 LHKDLKFPSSTPTSLHA--KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ + P L A + + R L D + R GS A E+ +H F K
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-GS---AKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 4e-15
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 42/286 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G +G+V +GQ A+K ++ + + K E ++ L +P +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
SF + ++ +Y GG L D + E + E + ALE+LH +I+RD
Sbjct: 84 SFLVGDELFVVMEYLAGGSL---TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+K +NVLL +G V LTDF T E+ +R +
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCA----------QITPEQSKR-----------------S 173
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK--- 913
+ VGT ++APE++ + VD W+LGI+ EM+ G P+ + + I
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP 233
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+L+ P + + R L D + R GS A E+ +HPF K
Sbjct: 234 ELQNPEKLSPIF--RDFLNRCLEMDVEKR-GS---AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 74/302 (24%), Positives = 122/302 (40%), Gaps = 65/302 (21%)
Query: 670 HFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNR--NKVHRACAER 720
H + IK LG G G V ELC +G+ A+K LN + HR+ ER
Sbjct: 5 HLKFIKQLGEGHFGKV---ELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFER 55
Query: 721 EILDM--LDHPFVPAL--YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
EI + LDH + + LI +Y P G L L R ++ + + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF- 114
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
++++ ++YL Q I+RDL N+L++ V ++DF L+ +LP +
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA--------KVLPEDKDYY 166
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG- 894
+ ++P+F + APE + + +SA D W+ G+ LYE+ YG
Sbjct: 167 YVKEPGESPIF----------------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210
Query: 895 ------------YTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPK 940
+G+ +L + L P S P ++ LM +P+
Sbjct: 211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY--DLMKLCWEAEPQ 268
Query: 941 SR 942
R
Sbjct: 269 DR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 36/229 (15%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 729
F I LG+G+ G V V+ SG A K + + RN++ R E ++L + P
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
++ Y +F + + + ++ GG L +L + K + E+ + + V+ L YL
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 790 Q-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ I++RD+KP N+L+ G + L DF +S GQ +
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ-----L 154
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
+ M +NSFVGT Y++PE + G ++ D W++G+ L E+ G P
Sbjct: 155 IDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 677 LGSGDTGSVHLVELCGSGQ-YFAMK-------AMDKGVMLNRNKVHRACAEREIL-DMLD 727
LGSG G V+ V +GQ A+K A K + +E I+ + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 728 HPFVPALYASFQTKTHVCLITDY---CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
HP + Y +F + ++ D P GE F L ++ + E+ + ++V+AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLAL 126
Query: 785 EYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
YLH + I++RDL P N++L + V++TDF L+ + K +
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA-------------------KQKQPE 167
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + S VGT Y PEI+ + D WA G +LY+M PF
Sbjct: 168 SKL---------TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 81/322 (25%), Positives = 133/322 (41%), Gaps = 69/322 (21%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML 726
+ P+ +G G G+V+ SG + A+K++ V N + + R A + L+
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAF 59
Query: 727 DHPFVPALY---ASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
DHP + L A+ +T +T V L+ ++ +L LD+ P L + ++ + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L++LH I++RDLKPEN+L+ G V L DF L+ + SC+ L
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-------------- 164
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
PV V T Y APE++ + + + VD W++G + EM F G
Sbjct: 165 --TPV------------VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210
Query: 902 TRQ----KTFANI-LHKDLKFPSSTPTSLHA--------------------KQLMYRLLH 936
+ K F I L + +P A QL+ +L
Sbjct: 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLT 270
Query: 937 RDPKSRLGSHEGANEIKKHPFF 958
+P R+ A +HPFF
Sbjct: 271 FNPHKRI----SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/224 (25%), Positives = 86/224 (38%), Gaps = 67/224 (29%)
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
L E VR Y +++ +E+ H II+RD+KPEN+L+ +G V L DF +
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA--------- 147
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGI 886
+A P +V T Y APE++ G + AVD WA+G
Sbjct: 148 ------------------RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGC 189
Query: 887 LLYEMLYGYTPFRGKT------------------------RQKTFANILHKDLK------ 916
L+ EML G F G + + FA + ++K
Sbjct: 190 LVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLE 249
Query: 917 --FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
FP + L L + L DP R S +++ H FF
Sbjct: 250 KRFPKLSGLVL---DLAKQCLRIDPDDRPSS----SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 86/384 (22%), Positives = 144/384 (37%), Gaps = 108/384 (28%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMK----AMDKGVMLNRNKVHRACAEREIL 723
+ IK LG G G V + + A+K K ++ R A RE+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-------ALREL- 52
Query: 724 DMLDHPFVPALYASFQTKTH---VCL----ITDYCPGGELFL---LLDRQPTKVLK---- 769
L F + H CL I EL+L L++ ++++
Sbjct: 53 -KLLRHF----------RGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP 101
Query: 770 -EDA-VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
DA + + +++ L+Y+H +++RDLKP N+L+ + + + DF L+ S P
Sbjct: 102 LTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-- 159
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGI 886
+N FM E +V T Y APEI ++ +T A+D W++G
Sbjct: 160 --------------GENAGFMTE-------YVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILH----------------------KDL------KFP 918
+L E+L F+GK IL + L F
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE 258
Query: 919 SSTPTSLH-AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977
S P + A L+ +LL DP R+ E +HP+ L +P D P
Sbjct: 259 SIFPNANPLALDLLEKLLAFDPTKRISVEEAL----EHPY-------LAIWHDPD--DEP 305
Query: 978 LFATDTEKEYKVVDPGMQDLQQNV 1001
+ + ++ D M++L+ +
Sbjct: 306 VCQKPFDFSFESED-SMEELRDMI 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 77/332 (23%), Positives = 124/332 (37%), Gaps = 66/332 (19%)
Query: 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LD 724
L+ + + LG G G V+ +G+ A+K K +M N A REI L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIKILK 62
Query: 725 MLDHPFVPAL------YASFQTKTHVC--LITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
L HP V L + ++T Y +L LL+ K L E ++ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVK-LTESQIKCY 120
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLLLPTTNEK 835
+++ + YLH I++RD+K N+L+ G + + DF L+ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP-------- 172
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894
+ R + V T Y PE++ G +T+AVD W +G + EM
Sbjct: 173 -------KGGGGGGT--RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 895 YTPFRGKT---------------RQKTFANI-----LHKDLKFPSSTPT--SLHAKQ--- 929
+GK+ ++T+ F + T K
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 930 ---LMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L+ +LL DP RL A++ +HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRL----TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 73/279 (26%), Positives = 108/279 (38%), Gaps = 78/279 (27%)
Query: 720 REI--LDMLDHPFVPALYASFQTK--THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
REI L L HP + L K + L+ +YC +L LLD PT E V+
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKC 112
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+++ L+YLH II+RDLK N+LL G + + DF L+ + + P
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK---- 168
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894
V T Y APE++ G +T+A+D WA+G +L E+L
Sbjct: 169 -----------------------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
Query: 895 YTPFRGKT----------------------------------RQKTFANILHKDLKFPSS 920
GK+ ++ + N+ H KFP
Sbjct: 206 KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKH---KFPWL 262
Query: 921 TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ L +L+ LL DPK R A E + +FK
Sbjct: 263 SEAGL---RLLNFLLMYDPKKRA----TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 72/278 (25%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ + A+K + + +H E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLKHRNIVQYLG 72
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
S + + PGG L LL + P K E + FY +++ L+YLH I++
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 795 RDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
RD+K +NVL+ +G V ++DF S +R G NP
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTS------------------KRLAG-INPC------- 165
Query: 854 ASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFR--GKTRQKTFAN 909
+ +F GT +Y+APE+I G+ + D W+LG + EM G PF G+ + F
Sbjct: 166 -TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
+ K S AK + R DP R +H+
Sbjct: 225 GMFKIHP-EIPESLSAEAKNFILRCFEPDPDKRASAHD 261
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 35/291 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLDH 728
+R K LG G G V+L +G+ A K + D +V E ++L L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 729 PFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
+ Y + + + + +Y PGG + L + L E R Y +++ + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSY 121
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH I++RD+K N+L G+V L DF S K Q
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS---------------------KRLQTIC 160
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+R S GT +++PE+I+G G+ D W+LG + EML P+
Sbjct: 161 MSGTGIR---SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
I + + S HA+ + + + + R A E+ +HPF
Sbjct: 218 IFKIATQPTNPQLPSHISEHARDFLGCIF-VEARHR----PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 61/270 (22%), Positives = 114/270 (42%), Gaps = 34/270 (12%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K LGSG G VHL + G A+K + +G M + + A +++ L HP +
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEA----KVMMKLSHPNLVQ 63
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LY + + ++T+Y G L L + L + + ++V A+EYL G I
Sbjct: 64 LYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFI 122
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RDL N L+ + V ++DF L+ + +L +++ +G + PV
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA-------RYVL---DDQYTSSQGTKFPV------- 165
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 912
++ PE+ + +S D W+ G+L++E+ G P+ + + ++
Sbjct: 166 ---------KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-S 215
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ +MY H P+ R
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-14
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 31/294 (10%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+Q + I+ +G G G V+L + A+K + + + N R E +I L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA------- 778
HP + +Y+ V Y G L LL Q + KE A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ +EY+H +G+++RDLKP+N+LL G V + D+ + + + LL ++
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE--- 177
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
M VGT +Y+APE + G + + D +ALG++LY+ML P+
Sbjct: 178 ------RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
Query: 899 RGKTRQKTFANILHKD-LKFPSST------PTSLHAKQLMYRLLHRDPKSRLGS 945
R K +K I ++D + P P L Q+ + L DP R S
Sbjct: 232 RRKKGRK----ISYRDVILSPIEVAPYREIPPFL--SQIAMKALAVDPAERYSS 279
|
Length = 932 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 43/240 (17%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G+G G V+ +GQ A+K MD + ++ E +L H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 731 -VPALYASFQTKT------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ Y +F K + L+ ++C G + L+ LKE+ + + E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L +LH +I+RD+K +NVLL N V L DF +S + R G++
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------QLDRTVGRR 168
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPF 898
N+F+GT ++APE+IA A + D W+LGI EM G P
Sbjct: 169 ------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 51/295 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
I LG G G V+ + +G A K +D + ++ E +IL DHP +
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVK 66
Query: 734 LYASFQTKTHVCLITDYCPGGEL---FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L +F + ++ ++ ++C GG + L L+R L E +R + + AL YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYLHEN 122
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
II+RDLK N+L +G + L DF +S T +RR
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA----------KNTRTIQRR------------ 160
Query: 851 PMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+SF+GT ++APE++ + D W+LGI L EM P +
Sbjct: 161 -----DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215
Query: 906 TFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
I + L PS + K + + L ++ +R ++ +HPF
Sbjct: 216 VLLKIAKSEPPTLAQPSRWSSEF--KDFLKKCLEKNVDARW----TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 75/323 (23%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 723
F+ ++ +G G G V+ +G+ A+K + +GV + A REI L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV--------PSTAIREISLL 53
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
L+HP + L T+ + L+ ++ +L +D P + ++ Y +++
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
L + H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA-------------------RAFGV- 152
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 902
P+R V T Y APEI+ G +++AVD W+LG + EM+ F G +
Sbjct: 153 -------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205
Query: 903 RQKTFANILH----------------KDLK--FPSSTPTSLH---------AKQLMYRLL 935
I D K FP + L+ ++L
Sbjct: 206 EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQML 265
Query: 936 HRDPKSRLGSHEGANEIKKHPFF 958
H DP R+ + HPFF
Sbjct: 266 HYDPNKRISAKAALA----HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 48/262 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDMLDHP 729
F I LG+G+ G V V SG A K + + RN++ R E ++L + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEY 786
++ Y +F + + + ++ GG L +L + P ++L + ++ V+ L Y
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIKGLTY 118
Query: 787 LHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
L + I++RD+KP N+L+ G + L DF +S GQ
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----------------------GQ--- 153
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---RGKT 902
+ + M +NSFVGT Y++PE + G ++ D W++G+ L EM G P K
Sbjct: 154 --LIDSM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
Query: 903 RQKTFANILHKDLKFPSSTPTS 924
+ F + D P+ + TS
Sbjct: 210 LELMFGCPVEGD---PAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 4e-13
Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G G G+V+ + + A+K M + K E + L + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 143
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+I+RD+K N+LL G V L DF + + S
Sbjct: 144 HNMIHRDIKAGNILLTEPGQVKLADFGSASIAS--------------------------- 176
Query: 850 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+NSFVGT ++APE+I + VD W+LGI E+ P
Sbjct: 177 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+I + S S + + + L + P+ R S E+ KH F
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTS----EELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-13
Identities = 85/357 (23%), Positives = 144/357 (40%), Gaps = 93/357 (26%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+ ++ +KP+GSG G V G A+K + + N+ RA E +L ++
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVN 78
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFL---LLDRQPTKV----LKEDAVRFYAAEV 780
H + +L F + + D ++L L+D +V L + + + ++
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQD------VYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ +++LH GII+RDLKP N++++ + + + DF L+ T+C TN
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAC--------TN------- 176
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
FM P +V T Y APE+I G G+ VD W++G ++ E++ G F+G
Sbjct: 177 ------FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
Query: 901 KTR----------------------QKTFANI--------------LHKDLKFPSSTP-- 922
Q T N L D FPS +
Sbjct: 225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERD 284
Query: 923 --TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977
+ A+ L+ ++L DP R+ E HP+ W +P E +AP
Sbjct: 285 KLKTSQARDLLSKMLVIDPDKRISVDEALR----HPYIT--VW-----YDPAEAEAP 330
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 71/322 (22%), Positives = 137/322 (42%), Gaps = 73/322 (22%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDH 728
F+ ++ LG G +V+ +G+ A+K + L+ + + A REI M L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE----IHLDAEEGTPSTAIREISLMKELKH 57
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYL 787
+ L+ T+ + L+ +Y +L +D L + V+ + +++ + +
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLA-------------------RAFGI----- 152
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR--- 903
P+ ++ V T Y AP+++ G+ +++++D W++G ++ EM+ G F G
Sbjct: 153 ---PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ 209
Query: 904 -------------------------QKTFANILHKDLK--FPSSTPTSLHAKQLMYRLLH 936
+ TF +DL+ FP + P + L++RLL
Sbjct: 210 LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGI---DLLHRLLQ 266
Query: 937 RDPKSRLGSHEGANEIKKHPFF 958
+P+ R+ +H+ HP+F
Sbjct: 267 LNPELRISAHDALQ----HPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 72/297 (24%), Positives = 119/297 (40%), Gaps = 51/297 (17%)
Query: 671 FRPIKPLGSGDTGSVH----LVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-- 724
IK LGSG G+V+ + E A+K + R + A +EILD
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-------REETSPK-ANKEILDEA 60
Query: 725 ----MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAA 778
+DHP V L + LIT P G L LD R + + +
Sbjct: 61 YVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL---LDYVRNHKDNIGSQYLLNWCV 116
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ + YL + +++RDL NVL++ HV +TDF L+ L +EK+
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD---------VDEKEYH 167
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTP 897
+G + P+ +++A E I +T D W+ G+ ++E M +G P
Sbjct: 168 AEGGKVPI----------------KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
Query: 898 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
+ G ++L K + P ++ ++ + D +SR E NE K
Sbjct: 212 YEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 72/293 (24%), Positives = 110/293 (37%), Gaps = 42/293 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYL 787
P + + L+ +YC G +L + ++P L+E + + L YL
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H I+RD+K N+LL G V L DF + L S
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------------------------- 166
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAG--AGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+NSFVGT ++APE+I G VD W+LGI E+ P
Sbjct: 167 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+I D SS S + + + L + P+ R S E+ KH F
Sbjct: 221 SALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSE----ELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 31/92 (33%), Positives = 56/92 (60%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+YA+ F ++TGYT +E++G+N L T PE + +L + + G+LLN +KD
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
G + LT+AP+ ++ G+ F+GM ++++
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 39/279 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAEREILDML 726
F+ IK LGSG G+V+ G+ A+K + + NK E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 66
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVVAL 784
D+P V L T T V LIT P G LLD R+ + + + ++ +
Sbjct: 67 DNPHVCRLLGICLTST-VQLITQLMPFG---CLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL + +++RDL NVL++ HV +TDF L+ L +EK+ +G +
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL---------GADEKEYHAEGGKV 173
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 903
P+ +++A E I +T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IP 216
Query: 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
++IL K + P ++ +M + D SR
Sbjct: 217 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 255
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 25/138 (18%)
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
T+ L D ++++ +++ L+Y+H +++RDLKP N+LL N + + DF L+ +
Sbjct: 100 TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD-- 157
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWA 883
P + H G F+ E +V T Y APEI + G+T A+D W+
Sbjct: 158 -----PEHD-----HTG-----FLTE-------YVATRWYRAPEIMLNSKGYTKAIDIWS 195
Query: 884 LGILLYEMLYGYTPFRGK 901
+G +L EML F GK
Sbjct: 196 VGCILAEMLSNRPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 82/310 (26%), Positives = 123/310 (39%), Gaps = 69/310 (22%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVP 732
I+ +G G G V+ V G A+K +D + AE IL L +HP V
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDP----ISDVDEEIEAEYNILQSLPNHPNVV 82
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDR----QPTKVLK----------EDAVRFYAA 778
Y F D GG+L+L+L+ T+++K E + +
Sbjct: 83 KFYGMFYK-------ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ L++LH II+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR 185
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLY 893
N+ VGT ++APE+IA + + D W+LGI E+
Sbjct: 186 -----------------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHE---GA 949
G P KT K P + PT LH ++ H + + E
Sbjct: 229 GDPPLFDMHPVKTL-------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281
Query: 950 NEIKKHPFFK 959
+ +HPF K
Sbjct: 282 THLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-12
Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 40/240 (16%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 725
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 79
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 781
++H + L F + + D EL +D +V L + + + +++
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL---MDANLCQVIQMELDHERMSYLLYQML 136
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 177
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
FM P +V T Y APE+I G G+ VD W++G ++ EM+ G F G
Sbjct: 178 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 6e-12
Identities = 85/356 (23%), Positives = 145/356 (40%), Gaps = 91/356 (25%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 725
L+ ++ +KP+GSG G V + A+K + + +N+ H A RE++ M
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF---QNQTHAKRAYRELVLMKC 72
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAVRFYAAEVV 781
++H + +L F + + D EL +D +V L + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMEL---MDANLCQVIQMELDHERMSYLLYQML 129
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+++LH GII+RDLKP N++++ + + + DF L+ R G
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------RTAG 170
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG- 900
FM P +V T Y APE+I G G+ VD W++G ++ EM+ F G
Sbjct: 171 TS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 901 ---------------------KTRQKTFANIL-----HKDLKFPSSTPTSL--------- 925
K Q T N + + L FP P SL
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 926 ----HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977
A+ L+ ++L DP R+ +E +HP+ W +P E++AP
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI----SVDEALQHPYIN--VW-----YDPAEVEAP 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-12
Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 61/215 (28%)
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLLLPT 831
V+ Y+ ++ AL Y+H + I +RDLKP+N+L+ N H + L DF
Sbjct: 172 VKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF---------------- 215
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYE 890
K GQ+ S S++ + Y APE++ GA +T+ +D W+LG ++ E
Sbjct: 216 -GSAKNLLAGQR-----------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263
Query: 891 MLYGYTPFRGKTRQKTFANIL-----------------HKDLKFPSSTPTSLH------- 926
M+ GY F G++ I+ + D+KFP P L
Sbjct: 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGT 323
Query: 927 ---AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
A + + L +P RL E + PFF
Sbjct: 324 PDDAINFISQFLKYEPLKRLNPIEALAD----PFF 354
|
Length = 440 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 44/206 (21%)
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
+ ED + A +V ALEYLH + +I+RD+KP NVL+ NG V L DF +S
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS--- 151
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV-- 879
L + +A+ + A G + Y+APE I +
Sbjct: 152 ---GYL----VDS-------------VAKTIDA-----GCKPYMAPERINPELNQKGYDV 186
Query: 880 --DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST----PTSLHAKQLMYR 933
D W+LGI + E+ G P+ KT L + ++ PS S + + +
Sbjct: 187 KSDVWSLGITMIELATGRFPY---DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK 243
Query: 934 LLHRDPKSRLGSHEGANEIKKHPFFK 959
L ++ K R E+ +HPFF+
Sbjct: 244 CLKKNYKER----PNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 67/277 (24%), Positives = 106/277 (38%), Gaps = 47/277 (16%)
Query: 681 DTGSVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
D S+ L+ G+GQ+ A+K + G M AE +I+ L
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLR 59
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + LYA + + ++T+ G L L + LK + AA+V + YL
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
Q I+RDL NVL+ N + DF L+ + + + R G + P+
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIK---------EDIYEARE-GAKFPI- 168
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 906
++ APE + D W+ GILL E++ YG P+ G T +
Sbjct: 169 ---------------KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213
Query: 907 FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + P P L+ +M DP R
Sbjct: 214 LQQVDQGYRMPCPPGCPKELY--DIMLDCWKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 667 NLQH-FRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDKGVMLNRNKVHRACAEREIL 723
N QH + I+ +GSG G V+ +G+ A+K ++ G + ++EI
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-------SLIQQEIF 58
Query: 724 DMLD--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
+ + H + A + S+ ++ + + +YC GG L + T L E + + E +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETL 116
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L YLH +G ++RD+K N+LL NG V L DF ++ T KR+
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI---------TATIAKRK--- 164
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEM 891
SF+GT ++APE+ A G+ D WA+GI E+
Sbjct: 165 ---------------SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 62/270 (22%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E ++L L + L +F+ + + L+ +Y + LL+ P V + VR Y
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP-EKVRSYIY 107
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ A+ + H I++RD+KPEN+L+ N + L DF + R
Sbjct: 108 QLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA-------------------R 148
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + + E +V T Y +PE++ GA + AVD W++G +L E+ G F
Sbjct: 149 NLSEGSNANYTE-------YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
Query: 899 RGK-------TRQKT------------FANILHKDLKFPSST-PTSLHAK---------- 928
G+ T QK ++N L+FP+ P SL +
Sbjct: 202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLL 261
Query: 929 QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
LM LL +P R + + N HP F
Sbjct: 262 DLMKNLLKLNPTDRYLTEQCLN----HPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 61/238 (25%), Positives = 100/238 (42%), Gaps = 30/238 (12%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E EIL DHP + L K + ++ + PGG L L R+ L + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSL 100
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+ +EYL + I+RDL N L+ N + ++DF +S + + T +
Sbjct: 101 DAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS-----REEEGGIYTVSDGLK 155
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
Q P+ ++ APE + +TS D W+ GILL+E G TP
Sbjct: 156 ----QIPI----------------KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP 195
Query: 898 FRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
+ G + Q+T I + P P ++ +LM + DP++R E NE++
Sbjct: 196 YPGMSNQQTRERIESGYRMPAPQLCPEEIY--RLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/269 (23%), Positives = 107/269 (39%), Gaps = 36/269 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ A+K + + M +V E ++ + HP + L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+ +IT++ G L L + + + + A ++ A+EYL + I+RD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
L N L+ N V + DF LS L T + H G + P+
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL----------MTGDTYTAHAGAKFPI---------- 169
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRGKTRQKTFANILHKDL 915
++ APE +A + D WA G+LL+E+ YG +P+ G + + +L K
Sbjct: 170 ------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKGY 222
Query: 916 KF--PSSTPTSLHAKQLMYRLLHRDPKSR 942
+ P P ++ +LM +P R
Sbjct: 223 RMERPEGCPPKVY--ELMRACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 77/329 (23%), Positives = 130/329 (39%), Gaps = 71/329 (21%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDMLDH 728
++ + P+GSG GSV +G A+K + + ++ +H R E +L + H
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRELRLLKHMKH 75
Query: 729 P--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
F PA S + V L+T + G +L ++ Q L +D V+F ++
Sbjct: 76 ENVIGLLDVFTPA--RSLEEFNDVYLVT-HLMGADLNNIVKCQK---LTDDHVQFLIYQI 129
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 170
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
+ +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 171 DDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219
Query: 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
G + L L+ + L ++ S N I+
Sbjct: 220 GTDH----IDQLKLILRLVGTPGAEL--------------LKKISSESARNYIQSLTQMP 261
Query: 960 GVNWALVRC-MNPPELD--APLFATDTEK 985
+N+A V NP +D + D++K
Sbjct: 262 KMNFANVFIGANPLAVDLLEKMLVLDSDK 290
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 65/316 (20%), Positives = 115/316 (36%), Gaps = 59/316 (18%)
Query: 678 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737
D VHL + + A+K ++ ++ + E L HP + S
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797
F + + +++ G LL + L E A+ F +V+ AL+Y+H +G I+R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 798 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 857
K ++LL G+G V L+ S KR+ P + +
Sbjct: 128 KASHILLSGDGKVVLSGLRYSV----------SMIKHGKRQRVVHDFPKSSVKNL----- 172
Query: 858 FVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF-------------RGKT 902
+++PE++ G+ D +++GI E+ G+ PF RG
Sbjct: 173 -----PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTV 227
Query: 903 R----QKTF----ANILHKDLKFPSSTPT-----------SLHAKQLMYRLLHRDPKSRL 943
+ T+ ++ S H Q + L RDP+SR
Sbjct: 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR- 286
Query: 944 GSHEGANEIKKHPFFK 959
A+++ H FFK
Sbjct: 287 ---PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 38/274 (13%)
Query: 675 KPLGSGDTGSVHL-VELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G+ GSV V L SG+ A+K + + + K E ++ LDHP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 732 PALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L + + + L+ + P G L L R+ V ++ A +V + + YL +
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQVAMGMAYLESK 114
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVLL ++DF +S L ++ R + P+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMS--------RALGAGSDYYRATTAGRWPL---- 162
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 909
++ APE I +S D W+ G+ L+E YG P+ + A
Sbjct: 163 ------------KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210
Query: 910 ILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + L P P ++ +M P+ R
Sbjct: 211 LESGERLPRPEECPQEIY--SIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 45/282 (15%)
Query: 677 LGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
LG G+ GSV +L GS Q A+K M K + + + + E + DHP V
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVK-MLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 734 LYA-SFQTKTHVCL-----ITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVV 782
L S +++ L I + G+L FLL+ R +P + + VRF ++
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF-MIDIAS 124
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+EYL + I+RDL N +L N V + DF LS KK
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS----------------KK------ 162
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGK 901
++ + R + +++A E +A +T+ D WA G+ ++E M G TP+ G
Sbjct: 163 ---IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
Query: 902 TRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + ++ + LK P ++ +LM + +PK R
Sbjct: 220 ENSEIYNYLIKGNRLKQPPDCLEDVY--ELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 727
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 728 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
H + Y + + + + +Y PGG + L + L E+ R Y +++ +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH I++RD+K N+L G+V L DF S KR
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS-----------------KRIQT----- 158
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ M+ S GT +++PE+I+G G+ D W++ + EML P+
Sbjct: 159 ICMSGT--GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-11
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 3/101 (2%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
++ D D I++A+ + +L YS EE++G++ L PE ++ +
Sbjct: 5 VIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGE 61
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
VT+++ K G W L L P+RD+ GEV +GV D
Sbjct: 62 PVTLEVRLRRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRD 102
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 74/293 (25%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALY 735
+GSG G V+ + +G A+K M + N+ + R + +++ D P++ Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 736 ASFQTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYL-HCQGI 792
F T + V I L LL R P + ED + +V AL YL G+
Sbjct: 81 GYFITDSDV-FICMELMSTCLDKLLKRIQGP---IPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
I+RD+KP N+LL +G+V L DF +S + +
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGISG---------------------------RLVDSK 169
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSA----VDWWALGILLYEMLYGYTPFRG-KTRQKTF 907
+ S G Y+APE I D W+LGI L E+ G P++ KT +
Sbjct: 170 AKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228
Query: 908 ANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
IL ++ P + S + L +D + R E+ +HPF +
Sbjct: 229 TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR----PKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 59/308 (19%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+R +K +GSG G+V +G A+K + + + RA E +L + H
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHEN 75
Query: 731 VPALYASFQTKTHVCLITDY---CP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
V L F + D+ P G +L L+ + L ED ++F +++ L+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLVYQMLKGLK 132
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+H GII+RDLKP N+ + + + + DF L+ R +
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQTDSE-- 171
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+V T Y APE+I H T VD W++G ++ EML G F+G
Sbjct: 172 ---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964
I+ + TP+ ++ +L S + N +KK P F+ ++
Sbjct: 223 DQLMEIMKV-----TGTPS-------------KEFVQKLQSEDAKNYVKKLPRFRKKDFR 264
Query: 965 -LVRCMNP 971
L+ NP
Sbjct: 265 SLLPNANP 272
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 58/245 (23%), Positives = 109/245 (44%), Gaps = 43/245 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI 722
Q + + +G G G V +L G++ A+K + ++G+ L+ R A
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLRH 57
Query: 723 LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
L+ +HP V L+ + +T + L+ ++ +L LD+ P + + ++
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--------------- 161
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897
F A S V T Y APE++ + + + VD W++G + EM
Sbjct: 162 ---------FQM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208
Query: 898 FRGKT 902
FRG +
Sbjct: 209 FRGSS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-11
Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 54/250 (21%)
Query: 727 DHPFVPALYASFQTKTHVC-----------LITDYCPGGELFLLLDRQPTKVLKE----- 770
D P A F+ +T +C L + P G LF + + P + L+E
Sbjct: 14 DAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAAD 73
Query: 771 ------DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLT 821
+ R +V+ AL H QGI++RDLKP+N+++ G H + DF +
Sbjct: 74 GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT-- 130
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881
LLP + + + +GT Y APE + G T D
Sbjct: 131 ------LLPGVRDADVAT------------LTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 882 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAK---QLMYRLLHR 937
+A G++ E L G +G + A IL++ L S P + Q++ + L++
Sbjct: 173 YAWGLIFLECLTGQRVVQG----ASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
Query: 938 DPKSRLGSHE 947
DP+ R S
Sbjct: 229 DPRQRAASAP 238
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-11
Identities = 67/286 (23%), Positives = 107/286 (37%), Gaps = 53/286 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ IK L G G V + G +K KG L E +L ++HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V + + + C++ + +L+ L ++ + + A+ ++ L YLH Q
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ-ILEGLRYLHAQ 176
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
II+RD+K EN+ + V + D + Q PV
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAA------------------------QFPV--VA 210
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK-TRQKTFA 908
P GT E APE++A + S D W+ GI+L+EML Y T F + + +
Sbjct: 211 PAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
Query: 909 NILHKDL------------KFPSSTPTSLHAKQLMYRLLHRDPKSR 942
H L +FP + L + Y L R P +R
Sbjct: 269 KSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTR 314
|
Length = 357 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 73/274 (26%), Positives = 114/274 (41%), Gaps = 59/274 (21%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH----RACAEREILDML-DH 728
I+ +G G G V V +G A+K +D +H AE IL L DH
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDP--------IHDIDEEIEAEYNILKALSDH 74
Query: 729 PFVPALYASFQTKT-----HVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVV 781
P V Y + K + L+ + C GG + L+ + + ++E + + E +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ L++LH I+RD+K N+LL G V L DF +S QL T+ + RR
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA------QL----TSTRLRR--- 181
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 896
N+ VGT ++APE+IA + + + D W+LGI E+ G
Sbjct: 182 --------------NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
Query: 897 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 930
P + K P + P +LH +L
Sbjct: 228 PLADLHPMRAL-------FKIPRNPPPTLHQPEL 254
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 78/335 (23%), Positives = 133/335 (39%), Gaps = 94/335 (28%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ PIKP+G G G V + + + A+K + NR R E ++L LDH
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN-AFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 731 V--------PALYASFQTKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFY 776
V P +F V ++ + L+D + ++ L +D +++
Sbjct: 66 VIAIKDIMPPPHREAFND---VYIVYE---------LMDTDLHQIIRSSQTLSDDHCQYF 113
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
+++ L+Y+H +++RDLKP N+LL N + + DF L+ TS K
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD---------- 163
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE-IIAGAGHTSAVDWWALGILLYEMLYGY 895
FM E +V T Y APE ++ + +T+A+D W++G + E+L
Sbjct: 164 ----------FMTE-------YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
Query: 896 TPFRGK---TRQKTFANIL----HKDL-------------------------KFPSSTPT 923
F GK + K +L +DL FP + P
Sbjct: 207 PLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPL 266
Query: 924 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
++ L+ ++L DP R+ E HP+
Sbjct: 267 AI---DLLEKMLVFDPSKRITVEEALA----HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 52/224 (23%), Positives = 81/224 (36%), Gaps = 77/224 (34%)
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ YLH +++RDLKP N+L+ G G V + D L+ L + + L
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA---------- 170
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPF 898
+PV V T Y APE++ GA H T A+D WA+G + E+L F
Sbjct: 171 --DLDPV------------VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
Query: 899 RGKTRQKTFANILHKD-----------------------------------LKFPSS--- 920
+G+ + +N +D +PS+
Sbjct: 217 KGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLA 276
Query: 921 ------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L+ +LL DP R+ + E HP+F
Sbjct: 277 KWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE----HPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 65/275 (23%), Positives = 112/275 (40%), Gaps = 65/275 (23%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A E +L L H + L+ TK + L+ +Y +L +D L VR
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRL 107
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA----------------- 150
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894
R K + P + ++ V T Y P+++ G+ +++++D W +G + YEM G
Sbjct: 151 --RAK--------SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
Query: 895 YTPFRGKT----------------RQKTFANILH----KDLKFPSSTPTSL--------- 925
F G T ++T+ + K FP P L
Sbjct: 201 RPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDR 260
Query: 926 --HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
H ++L + L +PK R+ + E KHP+F
Sbjct: 261 IPHGEELALKFLQYEPKKRISAAEAM----KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 38/276 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F ++ +G G G+V+ + + A+K M + K E L L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ + L+ +YC G LL + ++P + ++ AV A + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLHS 133
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+I+RD+K N+LL G V L DF A
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFG-------------------------------SA 162
Query: 850 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
M +N FVGT ++APE+I + VD W+LGI E+ P
Sbjct: 163 SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+I + S S + + + L + P+ R
Sbjct: 223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELC------GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
++ + I+ LG G G V L C G+G+ A+K + + + + + ++EI
Sbjct: 4 RYLKKIRVLGEGHFGKVSL--YCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEI 57
Query: 723 --LDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
L L H + S Q + LI +Y P G L D P L + +A
Sbjct: 58 NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL---RDYLPKHKLNLAQLLLFAQ 114
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ + YLH Q I+RDL NVLL + V + DF L+ +P +E R
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHEYYRV 166
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ +PVF + A E + + A D W+ G+ LYE+L
Sbjct: 167 REDGDSPVF----------------WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 45/245 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++PLG G G V + A+K K V+ + V A E +I+ LDH
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 731 VPALY-------------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
+ +Y T+ + I +L +L++ P L E+ R +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEHARLFM 120
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKK 836
+++ L+Y+H +++RDLKP NV + V + DF L+ + +
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV------------DPH 168
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGY 895
HKG +++E + T+ Y +P ++ + T A+D WA G + EML G
Sbjct: 169 YSHKG-----YLSEGLV-------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
Query: 896 TPFRG 900
F G
Sbjct: 217 PLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 38/280 (13%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 724
IN +K LGSG G VHL + Q A+KA+++G M + + A +++
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKW--RAQIKVAIKAINEGAMSEEDFIEEA----KVMM 54
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + LY + + ++T++ G L L RQ L +D + +V +
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGM 113
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL I+RDL N L+ G V ++DF ++ + +L +++ G +
Sbjct: 114 EYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT-------RYVL---DDEYTSSSGAKF 163
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903
PV ++ PE+ + ++S D W+ G+L++E+ G PF K+
Sbjct: 164 PV----------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207
Query: 904 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ I L P +++ ++MY H P+ R
Sbjct: 208 YEVVEMISRGFRLYRPKLASMTVY--EVMYSCWHEKPEGR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 39/230 (16%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E + L L H + +L+A V +IT+ G L L +VL ++ A
Sbjct: 52 EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+V + YL Q I+RDL N+L+ + + DF L+ L
Sbjct: 112 QVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI----------------- 154
Query: 839 HKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
+ V+++ P + + APE + ++ D W+ GILLYEM Y
Sbjct: 155 ----KEDVYLSSDKKIPYK----------WTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200
Query: 894 GYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G P+ G + + I + P+ P ++ ++M +P+ R
Sbjct: 201 GQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY--KIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 80/319 (25%), Positives = 122/319 (38%), Gaps = 72/319 (22%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K +GSG GSV +G+ A+K + + + RA E +L + H V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIG 78
Query: 734 LYASFQTKTHVCLITD-YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
L F + D Y + L + L ED V++ +++ L+Y+H GI
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
I+RDLKP N+ + + + + DF L+ RH +
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLA-------------------RHADAE--------- 170
Query: 853 RASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 911
+V T Y APE+I H VD W++G ++ EML G T F+GK IL
Sbjct: 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228
Query: 912 ------------------------------HKDLK--FPSSTPTSLHAKQLMYRLLHRDP 939
KD FP ++P A L+ ++L D
Sbjct: 229 KVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP---QAVDLLEKMLELDV 285
Query: 940 KSRLGSHEGANEIKKHPFF 958
RL A E +HP+F
Sbjct: 286 DKRL----TATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 58/241 (24%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+H + I+ LG G+ GSV ELC +G+ A+K + + R E E
Sbjct: 4 RHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIE 57
Query: 722 ILDMLDHPFVPALYASFQTKTHVC---------LITDYCPGGELFLLLDRQPTKVLKEDA 772
IL L H + Y VC L+ +Y P G L L + ++ D
Sbjct: 58 ILKSLQHDNI-VKYKG------VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DH 107
Query: 773 VRF--YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830
+ YA+++ +EYL + ++RDL N+L++ V + DF L+ +LP
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT--------KVLP 159
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
E + + ++P+F + APE + + + A D W+ G++LYE
Sbjct: 160 QDKEYYKVREPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 891 M 891
+
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 76/277 (27%), Positives = 111/277 (40%), Gaps = 42/277 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPF 730
K +G+G+ G V L G+ A+K + G K R +E I+ DHP
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPN 66
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLL---DRQPTKVLKEDAVRFYAAEVVVALEYL 787
+ L V ++T+Y G L L D Q T + +R A+ ++YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIAS----GMKYL 122
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
G ++RDL N+L+ N ++DF LS + P+ T K
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI----------- 171
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQKT 906
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 172 ---PIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218
Query: 907 FANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
I L P P +LH QLM +D R
Sbjct: 219 IKAIEEGYRLPAPMDCPAALH--QLMLDCWQKDRNER 253
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 9e-11
Identities = 65/248 (26%), Positives = 110/248 (44%), Gaps = 56/248 (22%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-- 725
L+ ++ +KP+GSG G V +GQ A+K + + +N H A RE++ M
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKL 71
Query: 726 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKEDAV 773
++H F P S + V L+ + L+D +V L + +
Sbjct: 72 VNHKNIIGLLNVFTPQ--KSLEEFQDVYLVME---------LMDANLCQVIQMDLDHERM 120
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+ +++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------- 165
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
R G FM P +V T Y APE+I G G+ VD W++G ++ EM+
Sbjct: 166 ----RTAGTS---FMMTP------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
Query: 894 GYTPFRGK 901
G F G
Sbjct: 213 GTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 75/336 (22%), Positives = 116/336 (34%), Gaps = 87/336 (25%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDH 728
+ + +G G G V + Q A+K K +M N + A RE IL +L H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIKILQLLKH 70
Query: 729 PFVPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
V L +T K L+ ++C + +L V+F +E+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFC---------EHDLAGLLSNKNVKFTLSEI 121
Query: 781 -------VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+ L Y+H I++RD+K N+L+ +G + L DF L+ S N
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS-------KN 174
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 892
K R+ + V T Y PE++ G +D W G ++ EM
Sbjct: 175 SKPNRYTNR----------------VVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218
Query: 893 YGYTPFRGKTRQKTFANI-------------------LHKDLKFPSSTP----------- 922
+G T Q I L K ++ P
Sbjct: 219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV 278
Query: 923 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
HA L+ +LL DP R+ + N H FF
Sbjct: 279 KDPHALDLIDKLLVLDPAKRIDADTALN----HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 69/272 (25%), Positives = 113/272 (41%), Gaps = 38/272 (13%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+K LG+G G V + A+K++ +G M AE ++ L HP +
Sbjct: 11 VKKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVR 65
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LYA T+ + +IT+Y G L L L + + AA++ + ++ + I
Sbjct: 66 LYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RDL+ N+L+ + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIE---------DNEYTAR-EGAKFPI------- 167
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 912
++ APE I T D W+ GILL E++ YG P+ G T + N L
Sbjct: 168 ---------KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LE 217
Query: 913 KDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + P + P L+ +LM P+ R
Sbjct: 218 RGYRMPRPDNCPEELY--ELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 67/229 (29%)
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
L + +F+ +++ AL+Y+H + +RDLKP+N+L + + + DF L+ +
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-----RVAF 154
Query: 828 L-LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWAL 884
PT +F + +V T Y APE+ + +T A+D W++
Sbjct: 155 NDTPTA-------------IFWTD-------YVATRWYRAPELCGSFFSKYTPAIDIWSI 194
Query: 885 GILLYEMLYGYTPFRGKT--------------------------RQKTFANILHKDL--- 915
G + E+L G F GK + + + + + K
Sbjct: 195 GCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVP 254
Query: 916 ---KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
KFP++ P +L +L+ RLL DPK R A E P+FKG+
Sbjct: 255 FSQKFPNADPLAL---RLLERLLAFDPKDR----PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 38/272 (13%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
IK LG+G G V + G+ + A+K + G M + + A +I+ L H +
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEA----QIMKKLRHDKLVQ 65
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
LYA ++ + ++T+Y G L L + LK + AA+V + Y+ I
Sbjct: 66 LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 794 YRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
+RDL+ N+L+ G+G V + DF L+ L NE R +G + P+
Sbjct: 125 HRDLRSANILV-GDGLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI------ 167
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 911
++ APE T D W+ GILL E++ G P+ G ++ +
Sbjct: 168 ----------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
Query: 912 HK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ P P SLH +LM + +DP+ R
Sbjct: 218 RGYRMPCPQDCPISLH--ELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 32/231 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ ++ LG G +V+ + +G+ A+K + + A E +L L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHAN 64
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ TK + L+ +Y +L +D+ P L + V+ + +++ L Y+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQR 122
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV--------------------------- 155
Query: 851 PMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRG 900
P ++ V T Y P+++ G+ +++ +D W +G + EM+ G F G
Sbjct: 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 66/281 (23%), Positives = 105/281 (37%), Gaps = 38/281 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F + +G G G+V+ + + A+K M K E + L L HP
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ + L+ +YC G LL + ++P + ++ A+ A + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHS 139
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+I+RD+K N+LL G V L DF + +S
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------------------------- 172
Query: 850 EPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+NSFVGT ++APE+I + VD W+LGI E+ P
Sbjct: 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
+I D S + + + L + P+ R S E
Sbjct: 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAE 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 70/286 (24%), Positives = 113/286 (39%), Gaps = 59/286 (20%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G G V E SG A+K + + + E I+ LDH +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK--EAAIMHSLDHENL 58
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF--------YAAEVVVA 783
LY T + ++T+ P G L LDR L++DA+ YA ++
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSL---LDR-----LRKDALGHFLISTLCDYAVQIANG 109
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ YL + I+RDL N+LL + V + DF L + + +
Sbjct: 110 MRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM-----------------RALPQNED 152
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
+ V M E ++ + + APE + + A D W G+ L+EM YG P+ G +
Sbjct: 153 HYV-MEEHLKVPFA------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205
Query: 903 RQKTFANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ IL K L+ P + P ++ +M + +P R
Sbjct: 206 G----SQILKKIDKEGERLERPEACPQDIY--NVMLQCWAHNPADR 245
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 47/274 (17%)
Query: 684 SVHLVELCGSGQY-------------FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
S+ L G+GQ+ A+K + G M E +I+ L H
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ LYA + + ++T+Y G L L K L+ + AA++ + YL +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I+RDL N+L+ N + DF L+ L +E R G + P+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIE---------DDEYTARE-GAKFPI---- 168
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 909
++ APE T D W+ GILL E++ YG P+ G T ++
Sbjct: 169 ------------KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ 216
Query: 910 I-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + P + P L+ LM + +DP+ R
Sbjct: 217 VERGYRMPRPPNCPEELY--DLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 73/280 (26%), Positives = 115/280 (41%), Gaps = 50/280 (17%)
Query: 677 LGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPA 733
+G+G+ G V L G + A+K + G + + +E I+ DHP +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69
Query: 734 LYASFQTKTHVCLITDYCPGGEL--FLLL-DRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
L V +IT++ G L FL D Q T + +R AA ++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAA----GMKYLSEM 125
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL N+L+ N ++DF LS + +P + +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLS-----------------RFLEDDTSDPTYTSS 168
Query: 851 -----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTRQ 904
P+R + APE IA TSA D W+ GI+++E M YG P+ + Q
Sbjct: 169 LGGKIPIR----------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 905 KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSR 942
N + +D + P PT+LH QLM +D +R
Sbjct: 219 DVI-NAIEQDYRLPPPMDCPTALH--QLMLDCWQKDRNAR 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 59/291 (20%)
Query: 675 KPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
K LG G+ GSV +L GS A+K M K + +++ +E + DHP V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 732 PALY------ASFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEV 780
L +S Q +I + G+L FLL R P K+ + ++F ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-MVDI 122
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK---- 836
+ +EYL + I+RDL N +L+ + V + DF LS KK
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS----------------KKIYSG 166
Query: 837 ---RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
R+ + + PV ++IA E +A +TS D WA G+ ++E+
Sbjct: 167 DYYRQGRIAKMPV----------------KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
Query: 893 YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G TP+ G + + + H + LK P L+ LMY DPK R
Sbjct: 211 RGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYD--LMYSCWRADPKDR 259
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 34/240 (14%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+I + + +K LG+G G V + S + A+K + G M V E ++
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMK 56
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVA 783
L H + LYA + + +IT+Y G L L KVL + F +A++
Sbjct: 57 TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEG 115
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ Y+ + I+RDL+ NVL+ + + DF L+ + NE R +G +
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE---------DNEYTAR-EGAK 165
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
P+ ++ APE I T D W+ GILLYE++ YG P+ G +
Sbjct: 166 FPI----------------KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 44/230 (19%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMK-----AMDKGVMLNRNKVHRACAEREI--L 723
++ ++ +G G G V+ +G+ A+K D+GV + A REI L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV--------PSTAIREISLL 52
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
L+HP + L ++ + L+ ++ +L +D P L ++ Y +++
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ Y H +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA-------------------RAFGV- 151
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEML 892
P+R V T Y APEI+ G+ S VD W++G + EM+
Sbjct: 152 -------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 50/183 (27%), Positives = 76/183 (41%), Gaps = 41/183 (22%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLI-----TD-YCPGGELFLLLDRQPTKVLKEDA 772
E IL ++HP + L +F CLI TD YC L ++ + A
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC------YLAAKRNIAICDILA 186
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ V+ A++YLH II+RD+K EN+ + G V L DF +C P
Sbjct: 187 IE---RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC---------FPVD 234
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ + + GT APE++A + AVD W+ GI+L+EM
Sbjct: 235 INANKYY-----------------GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277
Query: 893 YGY 895
+
Sbjct: 278 TCH 280
|
Length = 391 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 76/279 (27%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE----- 770
A E +L L H + L+ T+ + L+ +Y LD+ + L +
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY---------LDKDLKQYLDDCGNSI 101
Query: 771 --DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
V+ + +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 102 NMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI----- 156
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGIL 887
P + ++ V T Y P+I+ G+ +++ +D W +G +
Sbjct: 157 ----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCI 194
Query: 888 LYEMLYGYTPFRGKT---------------RQKTFANILH----KDLKFPSSTPTSLHAK 928
YEM G F G T ++T+ IL K +P LH
Sbjct: 195 FYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNH 254
Query: 929 ---------QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
+L+ +LL + + R+ A E KHP+F
Sbjct: 255 APRLDSDGAELLSKLLQFEGRKRI----SAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-10
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPG--GELFLLLDRQPTKVLKEDAVRFY 776
E +L L HP V AL CL+ P +L+ L + + L V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARL-RPLGLAQVTAV 265
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
A +++ A++Y+H +GII+RD+K ENVL+ G + L DF +C
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA--------------- 310
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
P GT + APE++AG +T +VD W+ G++++E
Sbjct: 311 --RGSWSTPFHYG--------IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM--DKGVMLNRNKVHRACAEREILDMLD 727
++R K LG G G V+L +G+ A+K + D +V+ E ++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 728 HPFVPALYASFQ--TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
H + Y + + + + ++ PGG + L + L E+ R Y +++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH I++RD+K N+L G+V L DF S K Q
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS---------------------KRLQTI 159
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
M+ S GT +++PE+I+G G+ D W++G + EML P+
Sbjct: 160 CLSGTGMK---SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 67/300 (22%), Positives = 114/300 (38%), Gaps = 52/300 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLN-RNKVHRACA 718
+I L R ++ LG G G V+ EL G S A+K + + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 764
E E++ L HP + L + C++ +Y G+L FL+ D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
L A ++ +EYL ++RDL N L+ V ++DF LS
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---- 173
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
++ A+ R + + ++ PE I T+ D W+
Sbjct: 174 ---------------------IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 885 GILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G++L+E+ YG P+ G + Q+ I + L P P ++A LM + P R
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYA--LMIECWNEIPARR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 73/331 (22%), Positives = 119/331 (35%), Gaps = 61/331 (18%)
Query: 669 QHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRA----CA 718
+ + LG G G V +G+ A+K + V +R V
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 719 EREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRF 775
RE+ M + H + L + + L+ D +L ++DR K+ L E V+
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR---KIRLTESQVKC 123
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+++ L LH ++RDL P N+ + G + DF L+ P T ++
Sbjct: 124 ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP--YSDTLSKD 181
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 894
+ + S V T Y APE++ GA + AVD W++G + E+L G
Sbjct: 182 ET-----------MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
Query: 895 YTPFRGKTRQKTFANILH-----------KDLKFPSSTPTSLHAKQ-------------- 929
F G+ I + K P T + +
Sbjct: 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI 290
Query: 930 -LMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L+ LL +P R+ A E KH +FK
Sbjct: 291 DLLQSLLKLNPLERI----SAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 48/235 (20%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731
+ L G G V + G Q +KA+ G R E +IL + H +
Sbjct: 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR--------EIDILKTISHRAI 148
Query: 732 PALYASFQTKTHVCLITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
L +++ K+ VC++ C +LF +DR L++ ++ AL YLH
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQ--AITIQRRLLEALAYLHG 203
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSC-LTSC--KPQLLLPTTNEKKRRHKGQQNPV 846
+GII+RD+K EN+ L + L DF +C L + PQ
Sbjct: 204 RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ-------------------- 243
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ GT E +PE++A + + D W+ G++L+EM GK
Sbjct: 244 --------CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290
|
Length = 392 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 76/324 (23%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--L 723
+ I+ +G G G V+ +GQ AMK + ++GV + A REI L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV--------PSTAIREISLL 53
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVV 782
L HP + L ++ + LI ++ +L LD P + + + V+ Y +++
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ + H + +++RDLKP+N+L+ G + L DF L+ R G
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA-------------------RAFGI 153
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYEMLYGYTPFRGK 901
P+R V T Y APE++ G+ S VD W++G + EM F G
Sbjct: 154 --------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
Query: 902 TRQKTFANILH----------------KDLK--FPSSTPTSLHAK---------QLMYRL 934
+ I D K FP SL + L+ ++
Sbjct: 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKM 265
Query: 935 LHRDPKSRLGSHEGANEIKKHPFF 958
L DP R+ A + HP+F
Sbjct: 266 LIYDPAKRI----SAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 76/327 (23%), Positives = 126/327 (38%), Gaps = 87/327 (26%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAM----DKGVMLNRNKVHRACAEREILDMLDHP 729
++ LG G +V+ +GQ A+K + ++GV A E +L L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT------AIREASLLKGLKHA 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ L+ TK + + +Y +L + + P L VR + +++ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGG-LHPYNVRLFMFQLLRGLAYIHG 121
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
Q I++RDLKP+N+L+ G + L DF L+ R K +
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLA-------------------RAK--------S 154
Query: 850 EPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
P + +S V T Y P+++ GA ++SA+D W G + EML G F G +
Sbjct: 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG------VS 208
Query: 909 NILHKDLK--------------------------FPSSTPTSLH-----------AKQLM 931
++ + K F P L A+ L
Sbjct: 209 DVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLA 268
Query: 932 YRLLHRDPKSRLGSHEGANEIKKHPFF 958
++L PK R+ A + HP+F
Sbjct: 269 SQMLMMFPKDRI----SAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 716 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 767
AC E +L L HP V AL F + V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQ 104
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 823
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 882
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD 232
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 36/279 (12%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILD 724
I+ + +K LG+G G V + GQY A+K + +G M + A +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKW--RGQYDVAIKMIKEGSMSEDEFIEEA----KVMM 54
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H + LY + + ++T+Y G L L R+ K + + +V +
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGM 113
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL + I+RDL N L+ G V ++DF LS + +L +++ G +
Sbjct: 114 AYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS-------RYVL---DDEYTSSVGSKF 163
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV + PE++ + +S D WA G+L++E+ G P+
Sbjct: 164 PV----------------RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207
Query: 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+T + + L+ S +MY H + R
Sbjct: 208 SETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEER 245
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 62/243 (25%), Positives = 103/243 (42%), Gaps = 50/243 (20%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH--RACAEREILDML 726
+ ++ + P+GSG GSV Q A+K + + ++ +H R E +L +
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF---QSLIHARRTYRELRLLKHM 71
Query: 727 DHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
H F PA S + V L+T+ G +L ++ Q L ++ V+F
Sbjct: 72 KHENVIGLLDVFTPA--TSIENFNEVYLVTNLM-GADLNNIVKCQK---LSDEHVQFLIY 125
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ L+Y+H GII+RDLKP NV + + + + DF L+
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---------------- 169
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897
+ M +V T Y APEI+ H VD W++G ++ E+L G
Sbjct: 170 -----------DEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
Query: 898 FRG 900
F G
Sbjct: 216 FPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 74/319 (23%), Positives = 127/319 (39%), Gaps = 74/319 (23%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDK--GVMLNRNKVHRACAEREILDMLDHPFV 731
++P+G G G V +GQ A+K + K + + +R E ++L L H +
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---ELKLLKHLRHENI 71
Query: 732 PALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+L F + +T+ G +L LL +P L++ ++++ +++ L+Y+H
Sbjct: 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP---LEKQFIQYFLYQILRGLKYVHSA 127
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
G+++RDLKP N+L+ N + + DF L+ + PQ+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQD--PQM----------------------- 162
Query: 851 PMRASNSFVGTEEYIAPEI-IAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+V T Y APEI + + VD W+ G + EML G F GK F+
Sbjct: 163 -----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217
Query: 910 IL----------------HKDLKFPSSTP-------------TSLHAKQLMYRLLHRDPK 940
I L+F S P A L+ ++L DP+
Sbjct: 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ 277
Query: 941 SRLGSHEGANEIKKHPFFK 959
R+ + E HP+
Sbjct: 278 KRISAAEAL----AHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 56/207 (27%), Positives = 79/207 (38%), Gaps = 50/207 (24%)
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
V+ E+ + A V AL YL + II+RD+KP N+LL NG++ L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS------ 155
Query: 825 PQLLLPTTNEKKRRHKGQ-QNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVD 880
GQ + + A G Y+APE I G+ D
Sbjct: 156 ----------------GQLVDSI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSD 192
Query: 881 WWALGILLYEMLYGYTPFRG------KTRQ--KTFANILHKDLKFPSSTPTSLHAKQLMY 932
W+LGI LYE+ G P+ + Q K IL + S +
Sbjct: 193 VWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF----VNFIN 248
Query: 933 RLLHRDPKSRLGSHEGANEIKKHPFFK 959
L +D R E+ +HPF K
Sbjct: 249 LCLIKDESKR----PKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|238075 cd00130, PAS, PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-09
Identities = 27/94 (28%), Positives = 55/94 (58%), Gaps = 8/94 (8%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN----GQSYCGRLLN 269
I+YA+ ++ GY+ +E++G++ L PED ++RE L+N G+ +
Sbjct: 14 ILYANPAAEQLLGYSPEELIGKSLLDL----IHPEDREELRERLENLLSGGEPVTLEVRL 69
Query: 270 YKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
+KDG+ W L+++ PI+D+ G+V+ +G+ ++
Sbjct: 70 RRKDGSVIWVLVSLTPIRDEGGEVIGLLGVVRDI 103
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. Length = 103 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 37/234 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
IN + + +G G+ G V L + GQ A+K + + AE ++
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKD----DSTAAQAFLAEASVMTT 56
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L HP + L + ++T+Y G L L + V+ +A +V +E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL + ++RDL NVL+ + ++DF L+ E + + P
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA--------------KEASQGQDSGKLP 162
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
V ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 163 V----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 716 ACAEREILDMLDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPTKV------ 767
AC E +L L HP V +L F V L+ DY ++ + +K
Sbjct: 45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 104
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTSC 823
L V+ +++ + YLH +++RDLKP N+L+ G G V + D + L +
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 163
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWW 882
+P+ +P+ + V T Y APE++ GA H T A+D W
Sbjct: 164 --------------------SPL---KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914
A+G + E+L F + +N H D
Sbjct: 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 232
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 36/268 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V + G+ + A+K + G M + A +++ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEA----QVMKKLRHEKLVQLYA 68
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
++ + ++T+Y G L L + K L+ + AA++ + Y+ ++RD
Sbjct: 69 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK-D 914
++ APE T D W+ GILL E+ G P+ G ++ +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221
Query: 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ P P SLH LM + ++P+ R
Sbjct: 222 MPCPPECPESLH--DLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 62/283 (21%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAEREI 722
I+ ++ +GSG G V L G A+K + +G M + + A ++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWL----GYWLEKRKVAIKTIREGAMSEEDFIEEA----QV 52
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ L HP + LY ++ +CL+ ++ G L L Q K +E + +V
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE-TLLGMCLDVCE 111
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ YL +I+RDL N L+ N V ++DF ++ + +L +++ G
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMT-------RFVL---DDQYTSSTGT 161
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901
+ PV ++ +PE+ + + ++S D W+ G+L++E+ G TP+ +
Sbjct: 162 KFPV----------------KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205
Query: 902 TRQKTFANIL--HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + I + K P S++ +LM P+ R
Sbjct: 206 SNSEVVETINAGFRLYK-PRLASQSVY--ELMQHCWKERPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 60/275 (21%), Positives = 108/275 (39%), Gaps = 62/275 (22%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A E +L L H + L+ T + L+ +Y +L +D ++ V+
Sbjct: 51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMD-DCGNIMSMHNVKI 108
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L Y H + +++RDLKP+N+L+ G + L DF L+ S
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV------------ 156
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 894
P + ++ V T Y P+++ G+ +++ +D W +G + +EM G
Sbjct: 157 ---------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
Query: 895 YTPFRGKTRQKTFANILH-------------------KDLKFPSSTPTSL--HAK----- 928
F G T + I K+ FP P L HA
Sbjct: 202 RPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTE 261
Query: 929 --QLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
+L+ + L + K R+ A E KH +F+ +
Sbjct: 262 GIELLTKFLQYESKKRI----SAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 22/96 (22%), Positives = 42/96 (43%), Gaps = 2/96 (2%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 555
I++ + +F E+ YS EE++GRN L E +I ++ + + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 556 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591
G + W + P+R G +G+ D +E +
Sbjct: 85 DGSEIWVEVSVSPIRTN-GGELGVVGIVRDITERKQ 119
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 29/90 (32%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ-----NGQSYCGRLL 268
I+Y S F ++ GYT +E+ +L PED ++R LQ G+ Y G
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDL--VHPEDRERVRRALQEFSLKKGEPYSGEYR 58
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
+KDG W PI+D+ GK ++ IG
Sbjct: 59 IRRKDGEYRWVEARGRPIRDENGKPVRVIG 88
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 62/272 (22%)
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A E +L L H + L+ T+ + L+ +Y +L LD ++ V+
Sbjct: 50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLD-NCGNLMSMHNVKI 107
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L Y H + I++RDLKP+N+L+ G + L DF L+ S
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV------------ 155
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYG 894
P + ++ V T Y P+++ G+ +++ +D W +G +LYEM G
Sbjct: 156 ---------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
Query: 895 YTPFRGKTRQKTF-------------------ANILHKDLKFPSSTPTSL--HAKQ---- 929
F G T ++ +N + FP L HA +
Sbjct: 201 RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTD 260
Query: 930 ---LMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L+ LL + KSR+ + +H +F
Sbjct: 261 GIDLLSSLLLYETKSRISAEAAL----RHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 42/189 (22%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
+E IL DHP + L + + ++ + PGG+ L ++ ++ + V+F A
Sbjct: 41 SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF-A 99
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+ + YL + I+RDL N L+ N + ++DF +S
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS------------------- 140
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ + + ++ + ++ ++ APE + ++S D W+ GILL+E G
Sbjct: 141 --RQEDDGIYSSSGLKQI-----PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVC 193
Query: 897 PFRGKTRQK 905
P+ G T Q+
Sbjct: 194 PYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 70/321 (21%), Positives = 125/321 (38%), Gaps = 77/321 (23%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAM-----DKGVMLNRNKVHRACAEREI--LDML 726
++ +G G G+V + + + A+K + D+GV + A REI L L
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--------ALREICLLKEL 56
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
H + LY + + L+ +YC +L D + + V+ + +++ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDI-DPEIVKSFMFQLLKGLAF 114
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
H +++RDLKP+N+L+ NG + L DF L+ R G
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLA-------------------RAFGI---- 151
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP-FRGKTRQ 904
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 152 ----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207
Query: 905 KTFANI-----------------LHKDLKFPSSTPTSLHA----------KQLMYRLLHR 937
I L +P T+ + L+ LL
Sbjct: 208 DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVC 267
Query: 938 DPKSRLGSHEGANEIKKHPFF 958
+P R+ A E +HP+F
Sbjct: 268 NPVQRI----SAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 36/268 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V + G+ + A+K + G M+ + A +I+ L H + LYA
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEA----QIMKKLRHDKLVPLYA 68
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
++ + ++T++ G L L K LK + AA++ + Y+ I+RD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
L+ N+L+ N + DF L+ L NE R +G + P+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE---------DNEYTAR-QGAKFPI---------- 167
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK-D 914
++ APE T D W+ GILL E++ G P+ G ++ +
Sbjct: 168 ------KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR 221
Query: 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ P P SLH +LM +DP R
Sbjct: 222 MPCPQGCPESLH--ELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 63/286 (22%), Positives = 104/286 (36%), Gaps = 48/286 (16%)
Query: 675 KPLGSGDTGSVHLVE---LCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ LG G G V L E LC A+K + R HR E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 730 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKEDAVRFYAA 778
+ Y + ++ +Y G+L L+ + L + + A
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF----------------------- 164
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
G V+ + R + ++ PE I T+ D W+LG++L+E+ YG P
Sbjct: 165 --GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
Query: 898 FRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + + I + L+ P + P ++ LM R+P R
Sbjct: 223 WYQLSNNEVIECITQGRVLQRPRTCPKEVY--DLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 63/293 (21%), Positives = 114/293 (38%), Gaps = 55/293 (18%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM---LNRNKVHRACAE-REILDM 725
+ + I LG G+ G V L + G + + V+ L + K +E R LDM
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 726 ---LDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR--------QPTKVLKEDA 772
L H V L + +I +Y G+L FL + P ++ A
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ ++ + +++L ++RDL N L+ V + S L+ K
Sbjct: 122 L---CTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV-----SLLSLSK-------D 166
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+K + + P+R ++APE + ++ D W+ G+L++E+
Sbjct: 167 VYNSEYYKLRNALI----PLR----------WLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 893 -YGYTPFRGKTRQKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 942
G PF G + ++ + L+ P P+ L+ +LM R +PK R
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY--KLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 55/248 (22%), Positives = 93/248 (37%), Gaps = 53/248 (21%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 773
E ++ DHP + L +CL+ +Y G+L L Q + +
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 774 RFY---------------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
R A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
+N ++ A+ +AS + ++ PE I +T+
Sbjct: 178 ------------------------RN-IYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 879 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRL 934
D WA G++L+E+ YG P+ G ++ + +D L P + P L+ LM
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCPDNCPLELYN--LMRLC 268
Query: 935 LHRDPKSR 942
+ P R
Sbjct: 269 WSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 32/227 (14%)
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E I+ DHP + L T+ V ++ + P GEL L L ++ Y+
Sbjct: 56 QEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYS 113
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ AL YL + ++RD+ NVL+ V L DF LS + L + K
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS-------RYLEDESYYKAS 166
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ K P++ ++APE I TSA D W G+ ++E+L G
Sbjct: 167 KGK---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
Query: 897 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
PF+G I + + L P + P +L++ LM + DP R
Sbjct: 208 PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS--LMTKCWAYDPSKR 252
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 42/233 (18%)
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
E I+ DHP + L V +IT+Y G L L K V
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-L 112
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+ ++YL ++RDL N+L+ N ++DF LS
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS------------------- 153
Query: 838 RHKGQQNPVFMAE----PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-ML 892
R + + P+R + APE IA TSA D W+ GI+++E M
Sbjct: 154 RRLEDSEATYTTKGGKIPIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
Query: 893 YGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
YG P+ + Q + +D L P P++L+ QLM +D R
Sbjct: 204 YGERPYWDMSNQDVIKAV--EDGYRLPPPMDCPSALY--QLMLDCWQKDRNER 252
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 65/281 (23%), Positives = 111/281 (39%), Gaps = 44/281 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+N++ + ++ +G G+ G V L G Y K K + N AE ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDVML------GDYRGNKVAVKCIK-NDATAQAFLAEASVMTQ 55
Query: 726 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H V L + K + ++T+Y G L L + VL D + ++ +V A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL ++RDL NVL+ + ++DF L T E +
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL--------------TKEASSTQDTGKL 161
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV ++ APE + ++ D W+ GILL+E+ +G P+ +
Sbjct: 162 PV----------------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-RIP 204
Query: 904 QKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSR 942
K + K K P P ++ +M + H D +R
Sbjct: 205 LKDVVPRVEKGYKMDAPDGCPPVVY--DVMKQCWHLDAATR 243
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 44/280 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-----CAEREILDML-DH 728
K LG+G G V VE G + M V + + H + +E +I+ L +H
Sbjct: 41 KTLGAGAFGKV--VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+ L + + +IT+YC G+L L R+ L + + ++ +V + +L
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 789 CQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
+ I+RDL NVLL +G + + DF L+ R N V
Sbjct: 159 SKNCIHRDLAARNVLLT-HGKIVKICDFGLA------------------RDIMNDSNYVV 199
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 906
N+ + +++APE I +T D W+ GILL+E+ G P+ G
Sbjct: 200 ------KGNARLPV-KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK 252
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHR----DPKSR 942
F ++ + + + P HA +Y ++ DP R
Sbjct: 253 FYKLIKEGYRM--AQPE--HAPAEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-07
Identities = 16/42 (38%), Positives = 22/42 (52%)
Query: 547 TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
TV+ K G W L P+RD+ GEV+ +GV D +E
Sbjct: 1 TVEYRLRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDITE 42
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 69/315 (21%), Positives = 114/315 (36%), Gaps = 68/315 (21%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK---AMDKGVML-----------NRNKVH 714
H + LG G G VHL E+ ++ + KG L N+N +
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FL----LLDRQ----- 763
E +IL L P + L + +C+IT+Y G+L FL L D++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 764 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817
+ ++ A ++ ++YL ++RDL N L+ N + + DF
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADF-- 182
Query: 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
G ++ + R V ++A E I T+
Sbjct: 183 -----------------------GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219
Query: 878 AVDWWALGILLYEMLY--GYTPFRGKTRQKTFANI--LHKD------LKFPSSTPTSLHA 927
A D WA G+ L+E+L P+ T ++ N +D L P P L+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY- 278
Query: 928 KQLMYRLLHRDPKSR 942
+LM + RD + R
Sbjct: 279 -ELMLQCWSRDCRER 292
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 41/294 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDML 726
R +K LGSG G+VH G + K + R + L
Sbjct: 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 727 DHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
DH ++ L AS Q L+T P G L + RQ L + + ++
Sbjct: 67 DHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIA 119
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ YL +++R+L N+LL+ + V + DF ++ LL P ++KK +
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA-------DLLYP--DDKKYFYSE 170
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
+ P+ +++A E I +T D W+ G+ ++EM+ YG P+ G
Sbjct: 171 HKTPI----------------KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
R ++L K + ++ +M + D R E ANE +
Sbjct: 215 -MRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 50/207 (24%), Positives = 77/207 (37%), Gaps = 62/207 (29%)
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ +LH I++RDLK N+LL G + + DF L+ R +
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLA------------------REY--- 156
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 901
P++ V T Y APE++ GA ++A+D W++G + E+L F GK
Sbjct: 157 ------GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210
Query: 902 ----TRQKTF--------------ANILH-KDLKFPSSTPTSLHAK-----------QLM 931
K F + + K F L K L+
Sbjct: 211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLL 270
Query: 932 YRLLHRDPKSRLGSHEGANEIKKHPFF 958
RLL DP R+ + + KHP+F
Sbjct: 271 NRLLTYDPAKRISAEDAL----KHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 46/225 (20%), Positives = 84/225 (37%), Gaps = 59/225 (26%)
Query: 762 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCL 820
R P + L ++ + +++ + + H G+++RDLKP+N+L+ + + D L
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAV 879
S P+++ + T Y APE++ G+ H ++ V
Sbjct: 161 FSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPV 193
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH-------------KDLK----FPSSTP 922
D W++G + EM F G + + +I L+ FP P
Sbjct: 194 DIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKP 253
Query: 923 TSL---------HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
L L+ ++L DP R+ A HP+F
Sbjct: 254 QDLSRAVPDLSPEGLDLLQKMLRYDPAKRI----SAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 44/283 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LG G+ GSV +L A+K M K + R+++ +E + DHP V
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 733 ALYA-SFQTKTH-----VCLITDYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVV 781
L QT +I + G+L FLL R P + + V+F ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTDIA 122
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+EYL + I+RDL N +L N +V + DF LS + R+ +
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI---------YNGDYYRQGRI 173
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM-LYGYTPFRG 900
+ PV ++IA E +A +T+ D W+ G+ ++E+ G TP+ G
Sbjct: 174 AKMPV----------------KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
Query: 901 KTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + + + LK P L++ LM +PK R
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCLDGLYS--LMSSCWLLNPKDR 258
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 26/114 (22%)
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+++ A+EY+H + +I+RD+K EN+ L +G + L DF + +P E++
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA----------MPFEKEREAF 324
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
G +VGT +PEI+AG G+ D W+ G++L +ML
Sbjct: 325 DYG----------------WVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 67/290 (23%), Positives = 119/290 (41%), Gaps = 37/290 (12%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE----REILDML 726
+ +K LGSG G+V+ G+ + K +LN +A E I+ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASM 66
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
DHP + L + T + L+T P G L + + + + + ++ + Y
Sbjct: 67 DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMY 124
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L + +++RDL NVL++ HV +TDF L+ L +EK+ G + P+
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE---------GDEKEYNADGGKMPI 175
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRG-KTRQ 904
+++A E I T D W+ G+ ++E M +G P+ G TR+
Sbjct: 176 ----------------KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
++L K + P ++ +M + D SR E A E +
Sbjct: 220 --IPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|131984 TIGR02938, nifL_nitrog, nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-07
Identities = 26/92 (28%), Positives = 51/92 (55%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
I++A+D+F +T Y++EEI+G+N L T P + + ++ Q +L+N K
Sbjct: 26 ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNRRKD 85
Query: 557 GKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
G+ + + P+ ++ GE +F+G+ D +E
Sbjct: 86 GELYLAELTVAPVLNEAGETTHFLGMHRDITE 117
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes [Central intermediary metabolism, Nitrogen fixation, Regulatory functions, Protein interactions]. Length = 494 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 52.5 bits (124), Expect = 3e-07
Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPAT 532
L LE + D D I++A+ + EL YS EE LGR L PE +
Sbjct: 113 RLRALLEASPDGIWVLDE---DGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERR 169
Query: 533 VRK--IRAAIDNQTDVTVQLINYTKSGKK-FWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ A + ++ K G++ W L + P+RD GE+ +G+ D +E
Sbjct: 170 ELELARALAEGRGGPLEIEYRVRRKDGERVRWILSRISPVRDD-GEIVGVVGIARDITE 227
|
Length = 232 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 48/241 (19%), Positives = 90/241 (37%), Gaps = 44/241 (18%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKV--------- 767
E ++ L HP + L + VC++ +Y G+L FL++ + V
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 768 ----LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
L A ++ +EYL +++DL N+L+ HV ++D LS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS----- 171
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
++ A+ R + ++ PE I +S D W+
Sbjct: 172 --------------------REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 884 LGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKS 941
G++L+E+ +G P+ G + Q+ + + L P +++ LM P
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS--LMTECWQEGPSR 269
Query: 942 R 942
R
Sbjct: 270 R 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 67/290 (23%), Positives = 113/290 (38%), Gaps = 48/290 (16%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY---FAMKAMDKGVMLNRNKVHRACAERE 721
+I+ H K +G+G+ G V L G+ A+K + G + +E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEAS 58
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
I+ H + L +IT+Y G L K L++ F + ++V
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL--------DKYLRDHDGEFSSYQLV 110
Query: 782 -------VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 111 GMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLY 893
K P+R + APE IA TSA D W+ GI+++E M +
Sbjct: 171 KI--------------PIR----------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSF 206
Query: 894 GYTPFRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G P+ + + I L P P++++ QLM + +D R
Sbjct: 207 GERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY--QLMLQCWQQDRARR 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 46/275 (16%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
K LG+G G V + A+K M G M V AE ++ L H + L
Sbjct: 12 KKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL 66
Query: 735 YASFQTKTHVCLITDYCPGGELFLLL-----DRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+A TK + +IT++ G L L +QP L + ++A++ + ++
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAFIEQ 120
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+ I+RDL+ N+L+ + + DF L+ + NE R +G + P+
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE---------DNEYTAR-EGAKFPI--- 167
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFA 908
++ APE I T D W+ GILL E++ YG P+ G + +
Sbjct: 168 -------------KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
Query: 909 NILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + P + P L+ +M R P+ R
Sbjct: 215 ALERGYRMPRPENCPEELY--NIMMRCWKNRPEER 247
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 68/293 (23%), Positives = 109/293 (37%), Gaps = 55/293 (18%)
Query: 674 IKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 726
I+ LG G G V ELC +G+ A+K++ N + E EIL L
Sbjct: 9 IRDLGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL 63
Query: 727 DHPFVPALYASFQTK---THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
H + Y T+ + LI ++ P G L L R K+ + ++ YA ++
Sbjct: 64 YHENI-VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKG 121
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKEYYTVKDDLD 173
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY----GYTPF- 898
+PVF + APE + + A D W+ G+ LYE+L +P
Sbjct: 174 SPVF----------------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217
Query: 899 ---------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G+ +L + + P QLM + P R
Sbjct: 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKR 270
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 58/239 (24%), Positives = 90/239 (37%), Gaps = 48/239 (20%)
Query: 677 LGSGDTGSVHLVELCGSGQY----FAMKAMDKGVMLNRNKVHRACA----------EREI 722
LG G G VHL E G ++ F++ +L K+ R A E +I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAV------- 773
+ L P + L A T +C+IT+Y G+L FL K D V
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
F A ++ ++YL ++RDL N L+ N + + DF
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADF------------------ 174
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
G ++ + R V +++ E I T+A D WA G+ L+E+L
Sbjct: 175 -------GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 61/259 (23%), Positives = 110/259 (42%), Gaps = 40/259 (15%)
Query: 677 LGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRAC-----AEREILDMLDHPF 730
LGSG+ G V G Y K +D + + +N+ ++ E EI+ LD+P+
Sbjct: 3 LGSGNFGCVK------KGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ + + + + L+ + GG L L + ++ + V +V + ++YL +
Sbjct: 57 IVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH-QVSMGMKYLEGK 114
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVLL + ++DF LS + L + K R G+
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLS-------KALGADDSYYKARSAGKW------- 160
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 909
P++ + APE I +S D W+ GI ++E YG P++ + +
Sbjct: 161 PLK----------WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF 210
Query: 910 ILH-KDLKFPSSTPTSLHA 927
I K L P+ P ++A
Sbjct: 211 IEQGKRLDCPAECPPEMYA 229
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 64/279 (22%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM----- 725
+ +K LGSG G+V+ G+ + K +L N +A +EILD
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIK--VLRENTSPKA--NKEILDEAYVMA 64
Query: 726 -LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ P+V L T T V L+T P G L + ++ +D + + ++ +
Sbjct: 65 GVGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGM 122
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL +++RDL NVL++ HV +TDF L+ L +E + G +
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD---------IDETEYHADGGKV 173
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE-MLYGYTPFRGKTR 903
P+ +++A E I T D W+ G+ ++E M +G P+ G
Sbjct: 174 PI----------------KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IP 216
Query: 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ ++L K + P ++ +M + D + R
Sbjct: 217 AREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECR 255
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 50/246 (20%), Positives = 91/246 (36%), Gaps = 47/246 (19%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA---MDKGVML---------NRNKVHRA 716
Q R + LG G G VHL E G ++ A + V++ + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 717 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP--TKVLKEDAVR 774
E +I+ L +P + L + +C+IT+Y G+L L ++ + + +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 775 --------FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
+ A ++ ++YL ++RDL N L+ + + + DF
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADF----------- 173
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
G ++ + R V ++A E I T+A D WA G+
Sbjct: 174 --------------GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 887 LLYEML 892
L+EM
Sbjct: 220 TLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 23/87 (26%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 272
I+Y +A ++ G + +EV+G++ L D E +R+ L G+ G ++++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGM 299
DG P + +P++D G+V F+G+
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGV 109
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 58/286 (20%), Positives = 109/286 (38%), Gaps = 46/286 (16%)
Query: 674 IKPLGSGDTGSVH--LVELCGSGQYF---AMKAM-DKGVMLNRNKVHRACAEREILDMLD 727
I+ LG G G V+ L + G+ A+K + + M R + E ++ +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF---LNEASVMKEFN 67
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFY--AAE 779
V L T ++ + G+L L + +F AAE
Sbjct: 68 CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ + YL + ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 128 IADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT--------RDIYETDYYRKGG 179
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
KG P+R ++APE + T+ D W+ G++L+EM P+
Sbjct: 180 KG-------LLPVR----------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
Query: 899 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 943
+G + ++ ++ L P + P L +LM +PK R
Sbjct: 223 QGLSNEEVLKFVIDGGHLDLPENCPDKLL--ELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 60/295 (20%), Positives = 108/295 (36%), Gaps = 61/295 (20%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-------- 726
KPLG G G V E + ++ + + E+++ D++
Sbjct: 18 KPLGEGAFGQVVKAE------AVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 727 --DHPFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKE 770
H + L + + ++ +Y G L FL R P + L +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV-SLTDFDLSCLTSCKPQLLL 829
+ +A +V +E+L + I+RDL NVL+ HV + DF L+
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHH------ 184
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
+ R+ + PV +++APE + +T D W+ G+LL+
Sbjct: 185 ---IDYYRKTTNGRLPV----------------KWMAPEALFDRVYTHQSDVWSFGVLLW 225
Query: 890 E-MLYGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
E G +P+ G ++ F + ++ P + L+ LM H P R
Sbjct: 226 EIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYH--LMRDCWHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|225112 COG2202, AtoS, FOG: PAS/PAC domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 49.1 bits (115), Expect = 3e-06
Identities = 19/97 (19%), Positives = 41/97 (42%), Gaps = 2/97 (2%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ--NGQSYCGRL 267
D I+YA+ ++ GY+ +E +GR L + ++ L G
Sbjct: 130 EDGRILYANPAAEELLGYSPEEELGRGLSDLIHPEDEERRELELARALAEGRGGPLEIEY 189
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+KDG +L+ D+G+++ +G+ +++
Sbjct: 190 RVRRKDGERVRWILSRISPVRDDGEIVGVVGIARDIT 226
|
Length = 232 |
| >gnl|CDD|216228 pfam00989, PAS, PAS fold | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 23/90 (25%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY-TK 555
I++ + + EL SREE++G++ L + D +R A+ + +++
Sbjct: 23 ILYVNAAAEELLGLSREEVIGKSLLDLIPEDDDAEVAELLRQALLQGEESRGFEVSFRVP 82
Query: 556 SGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
G+ P+RD GEV+ F+GV D
Sbjct: 83 DGRPRHVEVRASPVRDAGGEVRGFLGVLRD 112
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 113 |
| >gnl|CDD|232884 TIGR00229, sensory_box, PAS domain S-box | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 4e-06
Identities = 22/94 (23%), Positives = 46/94 (48%), Gaps = 2/94 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK-K 272
I+Y + F ++ GY+++E++GRN L E +I L+ + + K
Sbjct: 25 ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERRLEGEREPVSEERRVRRK 84
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
DG+ W ++++PI G L +G+ ++++
Sbjct: 85 DGSEIWVEVSVSPI-RTNGGELGVVGIVRDITER 117
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator [Regulatory functions, Small molecule interactions]. Length = 124 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 236
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894
R + P+ +++APE I +T D W+ G+LL+E+ G
Sbjct: 237 --RKGDARLPL----------------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 278
Query: 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+P+ G + F L + + + T+ Q M H +P R
Sbjct: 279 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 67/308 (21%), Positives = 120/308 (38%), Gaps = 56/308 (18%)
Query: 675 KPLGSGDTGSV---HLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
K LG G+ G V L G Y A+K + + + +++ +E +L ++HP
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHP 63
Query: 730 FVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQ------------PTKVLKEDAVRF 775
V LY + + LI +Y G L FL R+ + L R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 776 YAAEVVVALEYLHCQGIIY--------RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
+++ + +G+ Y RDL NVL+ + ++DF LS +
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
+ +R KG+ PV +++A E + +T+ D W+ G+L
Sbjct: 184 V--------KRSKGRI-PV----------------KWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 888 LYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 946
L+E++ G P+ G ++ F N+L + S LM ++P R
Sbjct: 219 LWEIVTLGGNPYPGIAPERLF-NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA 277
Query: 947 EGANEIKK 954
+ + E++K
Sbjct: 278 DISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 40/288 (13%)
Query: 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 720
D GE L + IK +G+G G V LV+ + ++F KA+ + R K + E
Sbjct: 6 DDGES-RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEV 63
Query: 721 EILDMLDHPFVPALYASFQTKTH--VCLITDYCPGGELFLLLDRQPTKVLK------EDA 772
++ L H + F K + + ++ ++C G+ L R K K E A
Sbjct: 64 NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD----LSRNIQKCYKMFGKIEEHA 119
Query: 773 VRFYAAEVVVALEYLH-------CQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCK 824
+ +++ AL Y H + +++RDLKP+N+ L G H+ + L +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG-R 178
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII--AGAGHTSAVDWW 882
P + K E M ++S VGT Y +PE++ + D W
Sbjct: 179 PIAKIGDFGLSKN---------IGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMW 227
Query: 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 930
ALG ++YE+ G TPF + F+ ++ +LK P +K+L
Sbjct: 228 ALGCIIYELCSGKTPFH---KANNFSQLI-SELKRGPDLPIKGKSKEL 271
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 231
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894
R + P+ +++APE I +T+ D W+ G+LL+E+ G
Sbjct: 232 --RKGSARLPL----------------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+P+ G + F L + + + ++M DPK R
Sbjct: 274 ASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 51/294 (17%)
Query: 675 KPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQHE 67
Query: 730 FVPALYASFQTKTHVCLITDYCPGGEL-----------FLLLDRQPTKVLKE---DAVRF 775
+ Y + ++ +Y G+L +L+D QP + E +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
A+++ + YL Q ++RDL N L+ N V + DF
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF-------------------- 167
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894
G V+ + R + ++ PE I T+ D W+ G++L+E+ YG
Sbjct: 168 -----GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG 222
Query: 895 YTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
P+ + + I + L+ P P ++ +M R+P+ RL E
Sbjct: 223 KQPWFQLSNTEVIECITQGRVLERPRVCPKEVY--DIMLGCWQREPQQRLNIKE 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|219844 pfam08447, PAS_3, PAS fold | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-05
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRKI--RAAIDNQTDVTVQLIN 552
II+ S F E+ Y+ EE+ +L PE D VR+ ++ + +
Sbjct: 1 IIYWSPRFEEILGYTPEELKSSYEGWLDLVHPE-DRERVRRALQEFSLKKGEPYSGEYRI 59
Query: 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
K G+ W +P+RD+ G+ IGV
Sbjct: 60 RRKDGEYRWVEARGRPIRDENGKPVRVIGV 89
|
The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs. The PAS fold appears in archaea, eubacteria and eukarya. Length = 90 |
| >gnl|CDD|197509 smart00086, PAC, Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain) | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-05
Identities = 11/36 (30%), Positives = 25/36 (69%)
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+KDG+ W L++ +PI+D++G+V +G+ +++
Sbjct: 6 LRRKDGSYIWVLVSASPIRDEDGEVEGILGVVRDIT 41
|
PAC motif occurs C-terminal to a subset of all known PAS motifs. It is proposed to contribute to the PAS domain fold. Length = 43 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 52/300 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAM-DKGVMLNRNKVHRACA 718
+INL R ++ LG G V+ L G+ Q A+K + DK R +
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLL------------DRQP 764
R L HP + L + + +I YC +L FL++ D+
Sbjct: 61 MRS---RLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 765 TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
L+ ++ +E+L ++++DL NVL+ +V ++D L
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF------ 171
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
V+ A+ + + + +++PE I + D W+
Sbjct: 172 -------------------REVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 885 GILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G++L+E+ YG P+ G + Q I ++ L P P ++ LM + P R
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT--LMLECWNEFPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 30/226 (13%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E IL HP + L K + ++ + GG+ L + ++ ++ ++
Sbjct: 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VE 101
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+EYL + I+RDL N L+ + ++DF +S + + +T K
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS---REEEDGVYASTGGMK-- 156
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
Q PV ++ APE + ++S D W+ GILL+E G P
Sbjct: 157 ----QIPV----------------KWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP 196
Query: 898 FRGKTRQKTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + Q+T I L P P +++ +LM R DP R
Sbjct: 197 YANLSNQQTREAIEQGVRLPCPELCPDAVY--RLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 62/293 (21%), Positives = 113/293 (38%), Gaps = 46/293 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+NLQ + +G G+ G+V E +GQ A+K + V E ++
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT-----AQAFLEETAVMTK 55
Query: 726 LDHP-FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H V L ++ + + G L L + ++ + ++ +V +
Sbjct: 56 LHHKNLVRLLGVILHNGLYI--VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + +++RDL N+L+ +G ++DF L+
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA-------------------------- 147
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
M NS + + + APE + +S D W+ G+LL+E+ YG P+ K
Sbjct: 148 ---RVGSMGVDNSKLPVK-WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMS 202
Query: 904 QKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
K + K + P P ++ LM +PK R H+ +++K
Sbjct: 203 LKEVKECVEKGYRMEPPEGCPADVYV--LMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 29/122 (23%)
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPT 831
++ Y +++ + Y H +++RDLKP+N+L+ + + L DF L+
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------------- 150
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-VDWWALGILLYE 890
R G P+R V T Y APEI+ G+ H S VD W++G + E
Sbjct: 151 ------RAFGI--------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAE 196
Query: 891 ML 892
M+
Sbjct: 197 MV 198
|
Length = 294 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 43/235 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREIL------DML 726
LGSG+ G+V + MK +K V + +N + + E+L L
Sbjct: 1 GELGSGNFGTV-------KKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL 53
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
D+P++ + + ++ + L+ + G L L Q K + E + +V + ++Y
Sbjct: 54 DNPYIVRMIGICEAESWM-LVMELAELGPLNKFL--QKNKHVTEKNITELVHQVSMGMKY 110
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
L ++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLS-------KALGADENYYKAKTHGKW--- 160
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
P++ + APE + +S D W+ G+L++E YG P++G
Sbjct: 161 ----PVK----------WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 31/123 (25%), Positives = 54/123 (43%), Gaps = 27/123 (21%)
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
ED ++ + +++ L Y H + ++RD+K N+LL G + L DF L+ L
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--------- 165
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILL 888
+ +E R + V T Y PE++ G + A+D W+ G +L
Sbjct: 166 -----------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
Query: 889 YEM 891
E+
Sbjct: 209 GEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 8e-05
Identities = 62/290 (21%), Positives = 100/290 (34%), Gaps = 50/290 (17%)
Query: 674 IKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDML 726
+ LG G G V L E + A+K + K N R R E E+L
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER---EAELLTNF 65
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGEL------------FLLLDRQPTKVLKEDAVR 774
H + Y ++ +Y G+L FL P L +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
A ++ + YL Q ++RDL N L+ + V + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS---------------- 169
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
V+ + R + ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 170 ---------RDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL 943
G P+ G + ++ I L T S +M RDP+ R+
Sbjct: 221 GKQPWYGLSNEEVIECITQGRLLQRPRTCPS-EVYDIMLGCWKRDPQQRI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 49/208 (23%)
Query: 714 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 51 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 108
Query: 772 ----------------AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
+ +AA+V ++YL + I+RDL N+L+ N + DF
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 168
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
LS +GQ+ V++ + M ++A E + + +
Sbjct: 169 GLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSVY 200
Query: 876 TSAVDWWALGILLYEML-YGYTPFRGKT 902
T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 201 TTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 53/244 (21%), Positives = 97/244 (39%), Gaps = 33/244 (13%)
Query: 684 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL--DMLDHPFVPALYASFQTK 741
SV+L +G ++ D + N + H + E++ HP + + F T
Sbjct: 15 SVYLARHTPTGTLVTVRITD---LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801
+ + +I+ + G LL + + E + + L YLH G I+R++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 802 VLLQGNGHVSLTDFD-LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 860
+L+ G+G VSL+ L L GQ+ V P
Sbjct: 132 ILISGDGLVSLSGLSHLYSLV-----------------RNGQKAKVVYDFP----QFSTS 170
Query: 861 TEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP 918
+++PE++ G+ D +++GI E+ G PF+ R + +L + LK P
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGP 226
Query: 919 SSTP 922
+P
Sbjct: 227 PYSP 230
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 15/149 (10%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFV 731
IK L G T V+L+ + +K R E IL +L V
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLK--INPSREKGADRER---EVAILQLLARKGLPV 55
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
P + AS ++ L+ ++ G L + + + + ++ AE++ L L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLV 109
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
+ + DL P N+L+ + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 26/168 (15%)
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y+ +V +E+L + I+RDL N+LL N V + DF L+ P +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------- 230
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YG 894
R + P+ +++APE I +T+ D W+ G+LL+E+ G
Sbjct: 231 --RKGDARLPL----------------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 272
Query: 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+P+ G + F L + + + + +M H +P+ R
Sbjct: 273 ASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 51/209 (24%)
Query: 714 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
HR A E E+L L HP + L + + + ++ + +Y P G L L + ++VL+ D
Sbjct: 46 HRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRK--SRVLETD 103
Query: 772 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
++F A++V ++YL + I+RDL NVL+ N + D
Sbjct: 104 PAFAKEHGTASTLTSQQLLQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD 162
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F LS +G++ V++ + M ++A E + +
Sbjct: 163 FGLS---------------------RGEE--VYVKKTMGRL-----PVRWMAIESLNYSV 194
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKT 902
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 195 YTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 46/213 (21%)
Query: 735 YASFQTKTHVCLITDYCP----GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
YA ++ + Y P L++ P L + ++ +V +E+L +
Sbjct: 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESP--ALSYMDLVGFSYQVANGMEFLASK 258
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVL+ V + DF L+ +
Sbjct: 259 NCVHRDLAARNVLICEGKLVKICDFGLA------------------------------RD 288
Query: 851 PMRASN-----SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
MR SN S +++APE I +T+ D W+ GILL+E+ G TP+
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHR 937
+ F N + + + + P HA +Y ++ +
Sbjct: 349 EQFYNAIKRGYRM--AKPA--HASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 47/224 (20%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 678 GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737
G D +V+L +G+Y ++ ++ N V E + + +HP + A+
Sbjct: 9 GFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRAT 67
Query: 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797
F + ++T + G L+ + E A+ + V+ AL+Y+H G ++R +
Sbjct: 68 FIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSV 127
Query: 798 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNS 857
K ++L+ +G V L+ +N H GQ+ V P +
Sbjct: 128 KASHILISVDGKVYLSGL---------------RSNLSMINH-GQRLRVVHDFPKYS--- 168
Query: 858 FVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFR 899
V +++PE++ G+ + D +++GI E+ G+ PF+
Sbjct: 169 -VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 51/209 (24%)
Query: 714 HRACA-EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
HR A E E+L L HP + L + + + ++ L +Y P G L L + ++VL+ D
Sbjct: 39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK--SRVLETD 96
Query: 772 A-----------------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
+ F AA+V ++YL + I+RDL N+L+ N + D
Sbjct: 97 PAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F LS +GQ+ V++ + M ++A E + +
Sbjct: 156 FGLS---------------------RGQE--VYVKKTMGRL-----PVRWMAIESLNYSV 187
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKT 902
+T+ D W+ G+LL+E++ G TP+ G T
Sbjct: 188 YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-04
Identities = 44/192 (22%), Positives = 78/192 (40%), Gaps = 26/192 (13%)
Query: 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811
E+ LL ++ L + + +V +E+L + ++RDL NVLL V
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVK 277
Query: 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 871
+ DF L+ ++ KG F+ P++ ++APE I
Sbjct: 278 ICDFGLA----------RDIMHDSNYVSKGS---TFL--PVK----------WMAPESIF 312
Query: 872 GAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL 930
+T+ D W+ GILL+E+ G TP+ G TF N + + + +
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDI 372
Query: 931 MYRLLHRDPKSR 942
M + + +P+ R
Sbjct: 373 MVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 9e-04
Identities = 66/320 (20%), Positives = 109/320 (34%), Gaps = 78/320 (24%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY----------------FAMKAMDKGVML 708
+ Q ++ LG G G VHL E G + A+K +
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-- 58
Query: 709 NRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQP 764
+ R +E IL L P + L +C+I +Y G+L FL
Sbjct: 59 --SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAE 116
Query: 765 TKVLKEDA-------VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817
T L ++ + + A ++ + YL ++RDL N L+ N + + DF +
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 818 SCLTSCKPQLLLPTTNE--KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
S ++ Q P+R ++A E +
Sbjct: 177 S--------------RNLYSSDYYRVQGRAPL---PIR----------WMAWESVLLGKF 209
Query: 876 TSAVDWWALGILLYEMLYGYT-----PFRGKTRQKTFANILHKD--------LKFPSSTP 922
T+ D WA G+ L+E+ T P+ T Q+ N H L P + P
Sbjct: 210 TTKSDVWAFGVTLWEI---LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCP 266
Query: 923 TSLHAKQLMYRLLHRDPKSR 942
++ +LM RD + R
Sbjct: 267 KDIY--ELMLECWRRDEEDR 284
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 48/295 (16%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 719
++ ++ LG G G V+ G A+K + + + E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLME 59
Query: 720 REILDMLDHP-FVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDA 772
I+ +H V + SF+ L+ + GG+L FL +R +P+ + +D
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPRFILL-ELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVS-LTDFDLSCLTSCKPQLLL 829
+ F A +V +YL I+RD+ N LL +G G V+ + DF
Sbjct: 119 L-FCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF-------------- 163
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
G ++ A R + +++ PE TS D W+ G+LL+
Sbjct: 164 -----------GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLW 212
Query: 890 EML-YGYTPFRGKTRQKTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
E+ GY P+ G+T Q+ + L P P ++ ++M P+ R
Sbjct: 213 EIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY--RIMTDCWQHTPEDR 265
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 50/184 (27%), Positives = 73/184 (39%), Gaps = 67/184 (36%)
Query: 782 VALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
VAL+Y H + +++ DLKPEN+L++ S T D P TN R
Sbjct: 242 VALDYFHTELHLMHTDLKPENILME----TSDTVVD-------------PVTN----RA- 279
Query: 841 GQQNPVFMAEPMR--------------ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
+P R + + V T Y +PE++ G G + D W++G
Sbjct: 280 ------LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK---SRL 943
++YE+ YT GK T N+ H LH LM + L R P R
Sbjct: 334 IIYEL---YT---GKLLYDTHDNLEH------------LH---LMEKTLGRLPSEWAGRC 372
Query: 944 GSHE 947
G+ E
Sbjct: 373 GTEE 376
|
Length = 467 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 17/37 (45%), Positives = 26/37 (70%)
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
+V+ L LH GI++RD+KPEN+L+ +G V + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 52/287 (18%)
Query: 677 LGSGDTGSVHLVELCGS------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
LG G G V L E C + A+KA+ + R R E E+L +L H
Sbjct: 13 LGEGAFGKVFLAE-CHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQH 68
Query: 731 VPALYASFQTKTHVCLITDYCPGGEL--FL--------LLDR---QPTKVLKEDAVRFYA 777
+ Y + ++ +Y G+L FL +L L + A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ + YL ++RDL N L+ V + DF
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDF---------------------- 166
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
G ++ + R + ++ PE I T+ D W+ G++L+E+ YG
Sbjct: 167 ---GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
Query: 897 PFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
P+ + + I ++L+ P + P ++A +M R+P+ R
Sbjct: 224 PWYQLSNTEAIECITQGRELERPRTCPPEVYA--IMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 46/254 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACA----EREILDML-DH 728
KPLG G G V + E G + +A+ V ML + + + E E++ M+ H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----------- 775
+ L + + +I +Y G L +L R P D R
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 776 -YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+V +EYL Q I+RDL NVL+ N + + DF L+ + +
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RDVNNIDY 192
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
K+ G+ PV +++APE + +T D W+ G+L++E+
Sbjct: 193 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 894 GYTPFRGKTRQKTF 907
G +P+ G ++ F
Sbjct: 236 GGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 47/285 (16%)
Query: 677 LGSGDTGSVH---LVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
LGSG G V+ ++ G G A+K + KG K E ++ +HP
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLL-----DRQPTKVLKEDAVRFYAAEVVVALE 785
+ L +I + GG+L L +R +L + +V
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 786 YLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
YL I+RDL N L+ G+ V + DF L+ + ++ ++ +
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--------RDIYKSDYYRKEGE 172
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 899
G P+R ++APE + T+ D W+ G+L++E+L G P+
Sbjct: 173 GLL-------PVR----------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 900 GKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 943
Q+ ++ L+ P + P ++ QLM +DP R
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIY--QLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 726 LDHPFVPALYA--SFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
+DH +P Y SF+ + L E+F + + K++K +
Sbjct: 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK-----D 134
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
++ LEY+H GI + D+KPEN+++ GN + D+
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170
|
Length = 294 |
| >gnl|CDD|214512 smart00091, PAS, PAS domain | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.002
Identities = 15/49 (30%), Positives = 28/49 (57%), Gaps = 4/49 (8%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS 262
I+YA+ ++ GY+ +E++G++ L PED +++E LQ S
Sbjct: 23 ILYANPAAEELLGYSPEELIGKSLLEL----IHPEDRERVQEALQRLLS 67
|
PAS motifs appear in archaea, eubacteria and eukarya. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. Length = 67 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 46/254 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHR----ACAEREILDML-DH 728
KPLG G G V + E G + K + V ML + + +E E++ M+ H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQP-------TKVLKEDAVRFY--- 776
+ L + + ++ +Y G L +L R P T L E+ + F
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 777 --AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
A +V +EYL Q I+RDL NVL+ + + + DF L+ + +
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA--------RDVHNIDY 189
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
K+ G+ PV +++APE + +T D W+ G+LL+E+
Sbjct: 190 YKKTTNGRL-PV----------------KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232
Query: 894 GYTPFRGKTRQKTF 907
G +P+ G ++ F
Sbjct: 233 GGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 33/145 (22%), Positives = 60/145 (41%), Gaps = 45/145 (31%)
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS----- 818
P + + V A ++ + YLH +G+I++D+ N ++ V +TD LS
Sbjct: 111 PQALSTQQLVHM-AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 819 ----CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
CL NE + P++ ++A E +
Sbjct: 170 MDYHCLGD----------NENR--------------PVK----------WMALESLVNKE 195
Query: 875 HTSAVDWWALGILLYEML-YGYTPF 898
++SA D W+ G+LL+E++ G TP+
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1002 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK13560 | 807 | hypothetical protein; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| PF13426 | 104 | PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_ | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.49 | |
| PF08448 | 110 | PAS_4: PAS fold; InterPro: IPR013656 The PAS fold | 99.49 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.48 | |
| PRK09776 | 1092 | putative diguanylate cyclase; Provisional | 99.47 | |
| PF00989 | 113 | PAS: PAS fold; InterPro: IPR013767 PAS domains are | 99.46 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.42 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.41 | |
| PRK13557 | 540 | histidine kinase; Provisional | 99.4 | |
| PRK13559 | 361 | hypothetical protein; Provisional | 99.39 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.38 | |
| PRK11091 | 779 | aerobic respiration control sensor protein ArcB; P | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| PRK13558 | 665 | bacterio-opsin activator; Provisional | 99.18 | |
| TIGR02040 | 442 | PpsR-CrtJ transcriptional regulator PpsR. This mod | 99.17 | |
| PRK10060 | 663 | RNase II stability modulator; Provisional | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.12 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.12 | |
| TIGR02938 | 494 | nifL_nitrog nitrogen fixation negative regulator N | 99.11 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 99.09 | |
| PRK11359 | 799 | cyclic-di-GMP phosphodiesterase; Provisional | 99.05 | |
| TIGR00229 | 124 | sensory_box PAS domain S-box. The PAS domain was p | 99.03 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| PF08447 | 91 | PAS_3: PAS fold; InterPro: IPR013655 The PAS fold | 98.95 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| COG3829 | 560 | RocR Transcriptional regulator containing PAS, AAA | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.82 | |
| cd00130 | 103 | PAS PAS domain; PAS motifs appear in archaea, euba | 98.77 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.77 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.75 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.73 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.72 | |
| PRK11073 | 348 | glnL nitrogen regulation protein NR(II); Provision | 98.72 | |
| PRK11360 | 607 | sensory histidine kinase AtoS; Provisional | 98.71 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.68 | |
| TIGR02966 | 333 | phoR_proteo phosphate regulon sensor kinase PhoR. | 98.66 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.62 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.59 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| KOG0501 | 971 | consensus K+-channel KCNQ [Inorganic ion transport | 98.53 | |
| PF12860 | 115 | PAS_7: PAS fold | 98.52 | |
| PF13596 | 106 | PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D. | 98.5 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=462.37 Aligned_cols=336 Identities=54% Similarity=0.968 Sum_probs=293.1
Q ss_pred CCCCCCCCCchhHHHhhc-ccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH
Q 001865 643 PKPHRKDSPPWKAIQKIL-DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721 (1002)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~-~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~ 721 (1002)
.+||.....-|.....+. .....+..++|++++.||.|.-|+||+|+...++..+|+|++.+..+.......+...|.+
T Consensus 50 ~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~e 129 (459)
T KOG0610|consen 50 NKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTERE 129 (459)
T ss_pred CCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHH
Confidence 446666666777776665 4667788999999999999999999999999999999999999998888888999999999
Q ss_pred HHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 722 il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
||..++||.++.||..|+.+.+.|+|||||+||+|..++++++.+.+++..+++|+..++.||+|||-.|||.|||||+|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcc----------------------h-hhhhc---ccC--CCCCccccccc-
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT----------------------N-EKKRR---HKG--QQNPVFMAEPM- 852 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~----------------------~-~~~~~---~~~--~~~~~~~~~~~- 852 (1002)
|||.++|++.|+||.++......+....... . ..++. ... ...+..+..+.
T Consensus 210 ILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 210 ILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred eEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 9999999999999999976543332221100 0 00000 000 00112223333
Q ss_pred ccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Q 001865 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 932 (1002)
Q Consensus 853 ~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~ 932 (1002)
..+.+++||-.|+|||++.|..++.++|+|.||+++|||++|..||.|.+..+.+.+|+.....+|..+..+..+++||+
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr 369 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIR 369 (459)
T ss_pred ccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHH
Confidence 34678999999999999999999999999999999999999999999999999999999999999999889999999999
Q ss_pred HccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 933 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 933 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
++|.+||.+|+.+...|.||.+||||++++|+++++..||+++.|.
T Consensus 370 ~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~ 415 (459)
T KOG0610|consen 370 KLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV 415 (459)
T ss_pred HHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence 9999999999999999999999999999999999999999987664
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=468.84 Aligned_cols=319 Identities=42% Similarity=0.707 Sum_probs=269.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|+++++||+|+||.||+|+-+.||.+||+|++++..+.....+..+..|..+|...++|+||++|..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999999999999999999999888899999999999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
||||||++||++..+|.+. ..|++..+++|+.+++.|+..||+.|+|||||||+|+||+..|++||+|||++.-+...
T Consensus 217 YLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999999874 56999999999999999999999999999999999999999999999999999654432
Q ss_pred CCCCCCcch--hhhhcc--cCCCCC----------------cccccccccccccccCCcccccccccCCCCCChhhHHHH
Q 001865 825 PQLLLPTTN--EKKRRH--KGQQNP----------------VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884 (1002)
Q Consensus 825 ~~~~~~~~~--~~~~~~--~~~~~~----------------~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSl 884 (1002)
......... ...... .....+ .+.........+.+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 221100000 000000 000000 000112233456799999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 885 GILLYEMLYGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 885 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
|||+||||.|.+||.+.+..+.+++|+... +.+|....++.++++||.+||+ ||++|+. ...++||.+||||++++
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCC
Confidence 999999999999999999999999999765 7888888899999999999999 9999998 56799999999999999
Q ss_pred hhhhhccCCCCCCCCCC----CCcccccccc
Q 001865 963 WALVRCMNPPELDAPLF----ATDTEKEYKV 989 (1002)
Q Consensus 963 ~~~~~~~~~~~~~~p~~----~~~~~~~~~~ 989 (1002)
|+.++.+.+| .+|.+ .|..+++|.+
T Consensus 453 W~~l~~~~ap--fvP~v~~~~DT~yFddF~e 481 (550)
T KOG0605|consen 453 WDHLREMPAP--FVPQVNSELDTQYFDDFPE 481 (550)
T ss_pred cchhhcCCCC--CCCCCCCcccccccccCcc
Confidence 9999998887 55754 4444445544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=451.26 Aligned_cols=283 Identities=45% Similarity=0.771 Sum_probs=256.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++++.||.|+||+||.|+.+.+++.||+|+++|..+...........|..||..++||+||.++..|++...+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45679999999999999999999999999999999999988888878889999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+|+||+.||.|+..|+++ +.+++..++.|+..|+.||.|||++|||||||||+|||++.+|+++|+|||+++..-.
T Consensus 102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-- 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-- 177 (357)
T ss_pred EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--
Confidence 999999999999999875 5699999999999999999999999999999999999999999999999999964211
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
......++|||+.|||||++.+.+|+..+|+||||+++|+|++|.+||.+.+..+
T Consensus 178 -------------------------~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 178 -------------------------DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred -------------------------CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 1123456899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
.+.+|+++....+.. ..+.++++||+++|..||++|......+.+|.+||||++++|+.+.....+.+..|.
T Consensus 233 ~~~~I~~~k~~~~p~-~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~ 304 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPG-YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPN 304 (357)
T ss_pred HHHHHhcCcCCCCCc-cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecC
Confidence 999999987443322 268899999999999999999875566999999999999999999777666666674
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=425.77 Aligned_cols=289 Identities=44% Similarity=0.806 Sum_probs=261.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
...++|+.++.||.|+||.|.+++++.+|.+||+|++.+..+....+.+...+|..+|+.+.||+++++++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45679999999999999999999999999999999999988878888888999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
|||||++||.|+.++++. +.+++..+++|+.||+.||+|||+++|++|||||+|||++++|++||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999874 569999999999999999999999999999999999999999999999999996543
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
....+.||||.|+|||++...+|+.++|.|+|||++|||+.|.+||...+...
T Consensus 196 ---------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 196 ---------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ---------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 12346899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhh--hccCCCCCCCC----C
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALV--RCMNPPELDAP----L 978 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~--~~~~~~~~~~p----~ 978 (1002)
++.+|+.+...+|.. .++.+++||.++|+.|-.+|.... ...++|.+||||++++|..+ +.+++|..+ | .
T Consensus 249 iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p-p~~~~~ 325 (355)
T KOG0616|consen 249 IYEKILEGKVKFPSY--FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP-PNIHGP 325 (355)
T ss_pred HHHHHHhCcccCCcc--cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC-ccccCC
Confidence 999999999999875 688999999999999999996654 47899999999999999999 455555432 2 2
Q ss_pred CCCcccccccc
Q 001865 979 FATDTEKEYKV 989 (1002)
Q Consensus 979 ~~~~~~~~~~~ 989 (1002)
..++..++|..
T Consensus 326 gdtsnfd~y~e 336 (355)
T KOG0616|consen 326 GDTSNFDDYEE 336 (355)
T ss_pred ccccccccccc
Confidence 44555555555
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=457.04 Aligned_cols=288 Identities=39% Similarity=0.668 Sum_probs=259.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 744 (1002)
....+|...+.||+|+|++|++|+++.+++.||||++.+..+....+...+..|..+|.+| +||.|++||..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457999999999999999999999999999999999988777777788889999999999 899999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+|+||+++|+|.+++++. +.|++.-++.|+.||+.||+|||++|||||||||+|||++.||+++|+|||.|..+...
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999885 66999999999999999999999999999999999999999999999999999887654
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
....- .+...........+++||..|.+||+|.....++.+|||+||||||+|+.|.+||.+.+..
T Consensus 228 ~~~~~--------------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 228 QKSQE--------------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred hcccc--------------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 33211 0111111111236799999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELD 975 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~ 975 (1002)
.++++|+.-...||.. .++.+.+||.++|..||..|+| +++|.+||||.+++|..++...||.+.
T Consensus 294 liFqkI~~l~y~fp~~--fp~~a~dLv~KLLv~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 294 LIFQKIQALDYEFPEG--FPEDARDLIKKLLVRDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKLQ 358 (604)
T ss_pred HHHHHHHHhcccCCCC--CCHHHHHHHHHHHccCcccccc----HHHHhhCcccccCChhhhhhcCCCccc
Confidence 9999999988888765 5689999999999999999999 999999999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=454.61 Aligned_cols=257 Identities=33% Similarity=0.575 Sum_probs=241.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.+|+..+.||+|||+.||.+++..+|..||+|++.+..+......+.+.+|++|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|+|..++|..+++++ +.+++.+++.+++||+.||.|||+++|||||||..|||++.+.+|||+|||+|.....+
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~---- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD---- 171 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc----
Confidence 999999999999864 67999999999999999999999999999999999999999999999999999765422
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.....+.||||+|+|||++....++..+||||+||++|.||+|++||...+..+.+.
T Consensus 172 -----------------------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~ 228 (592)
T KOG0575|consen 172 -----------------------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN 228 (592)
T ss_pred -----------------------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence 123457899999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+|......+|. .++.++++||.+||+.||.+||| ++++|.|+||+.
T Consensus 229 ~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rps----l~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 229 KIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERPS----LDEVLDHPFFKS 274 (592)
T ss_pred HHHhcCccccc--ccCHHHHHHHHHHhcCCcccCCC----HHHHhcCHhhhC
Confidence 99999888887 57999999999999999999999 999999999943
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=438.42 Aligned_cols=261 Identities=33% Similarity=0.508 Sum_probs=229.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChH----HHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN----KVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
.+.|.+.+.||+|+||.|-+|..+.||+.||||++++....... ....+.+|++||++|+|||||+++++|+..++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 57899999999999999999999999999999999987554422 34456799999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC---CcEEEEeccCCcc
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCL 820 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~---g~vkL~DFG~a~~ 820 (1002)
.|||||||+||+|++.+-.+ +.+.+...+.+++||+.||.|||++||+||||||+|||++.+ -.+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999875 558999999999999999999999999999999999999876 5799999999976
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC---CChhhHHHHHHHHHHHHcCCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~---~~~sDIwSlGvil~elltG~~P 897 (1002)
... .....++||||.|.|||++.+..+ ..++|||||||+||-+++|.+|
T Consensus 329 ~g~----------------------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SGE----------------------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred ccc----------------------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 431 122357899999999999977653 3478999999999999999999
Q ss_pred CCCCChHH-HHHHHHhCCCCC--CCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 898 FRGKTRQK-TFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 898 f~~~~~~~-~~~~i~~~~~~~--~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
|.+..... ..++|.++...+ +.+..++.++.+||.+||..||++||| +.++|+||||+...
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 98876555 788888887655 355678999999999999999999999 99999999999754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-50 Score=427.03 Aligned_cols=263 Identities=28% Similarity=0.463 Sum_probs=234.6
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT- 742 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~- 742 (1002)
..+...+.+.++.||+|+.|+||+|+|+.|++.||+|++.. ..+....+++.+|+++++..+|||||.+|+.|..++
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 34566789999999999999999999999999999999953 346777889999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
.++|+||||++|+|.+++... +.+++..+..++.++++||.|||. ++||||||||+|||+++.|.|||||||.|..+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 599999999999999999875 559999999999999999999996 89999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
..+ ...+++||..|||||.+.+..|+.++||||||++++|+++|++||...
T Consensus 230 vnS-----------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 230 VNS-----------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred hhh-----------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 311 456789999999999999999999999999999999999999999874
Q ss_pred -----ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCCh
Q 001865 902 -----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963 (1002)
Q Consensus 902 -----~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 963 (1002)
...+.+..|..+..+-.....+|+++.+||..||++||.+|++ +.||++|||++....
T Consensus 281 ~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s----~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 281 NPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPS----AKQLLQHPFIKKFED 343 (364)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCHHHhhccc
Confidence 5677778888765443333358999999999999999999999 999999999997543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=445.15 Aligned_cols=289 Identities=40% Similarity=0.753 Sum_probs=262.5
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 742 (1002)
..+..++|+++++||+|+||+|+++..+.++++||||+++|..+.....+...+.|..|+... +||+++.++.+|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 367889999999999999999999999999999999999999999999999999999999888 5999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
++|+||||+.||++....+ ...+++..++.|+..|+.||.|||++|||+||||.+|||++.+|++||+|||+++..-
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999999544433 3569999999999999999999999999999999999999999999999999995421
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
.......++||||.|||||++.+..|+.++|.|||||+||+||.|..||.|.+
T Consensus 520 ---------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd 572 (694)
T KOG0694|consen 520 ---------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD 572 (694)
T ss_pred ---------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 01124578999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCC
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 981 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~ 981 (1002)
..+.+..|+.....+|.. +|.++.++|+++|++||++|+.+- ..+++|.+||||+.++|.++..++.+....|....
T Consensus 573 Eee~FdsI~~d~~~yP~~--ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~ 650 (694)
T KOG0694|consen 573 EEEVFDSIVNDEVRYPRF--LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKG 650 (694)
T ss_pred HHHHHHHHhcCCCCCCCc--ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCC
Confidence 999999999999888876 688999999999999999999963 34789999999999999999888877778887665
Q ss_pred ccc
Q 001865 982 DTE 984 (1002)
Q Consensus 982 ~~~ 984 (1002)
...
T Consensus 651 ~~D 653 (694)
T KOG0694|consen 651 PED 653 (694)
T ss_pred hhh
Confidence 543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=401.52 Aligned_cols=258 Identities=28% Similarity=0.498 Sum_probs=229.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|.+.+.||+|+||+||+++++.++..||||.+.+..+ .+...+.+..|+.||+.++|||||.+++++...+++|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 5799999999999999999999999999999999987644 556677788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC------CcEEEEeccCCccc
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN------GHVSLTDFDLSCLT 821 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~------g~vkL~DFG~a~~~ 821 (1002)
||||.||+|.+|+.+. +.+++..++.++.||+.||++||+++||||||||+|||++.+ -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999885 469999999999999999999999999999999999999865 35899999999775
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
.. .....+.||+|.|||||++....|+.|+|+||+|+|+|++++|+.||...
T Consensus 166 ~~----------------------------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QP----------------------------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cc----------------------------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 42 23455789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCC-CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 902 TRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 902 ~~~~~~~~i~~~~~~~~~~-~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+..+....+.++.-..+.. ...+....+|+...|+.+|..|.+ ..+-+.|+++..
T Consensus 218 t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~----~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 218 TPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS----FEDFFDHPFLAA 273 (429)
T ss_pred CHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc----hHHhhhhhhccc
Confidence 9999988777665443332 224555679999999999999999 788889998876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=389.67 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=222.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
+.|+.+..+|+|+||+||+|+++.||+.||||.+... ..++.-.+-..+|+.+|++++|||+|.++++|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 5799999999999999999999999999999998754 334555566689999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||| .-++.+-+.+.+.+ ++...++.|+.|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+.+..
T Consensus 81 E~~-dhTvL~eLe~~p~G-~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~----- 153 (396)
T KOG0593|consen 81 EYC-DHTVLHELERYPNG-VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA----- 153 (396)
T ss_pred eec-chHHHHHHHhccCC-CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-----
Confidence 999 55666666665543 89999999999999999999999999999999999999999999999999987642
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
+....+.++.|.+|+|||.+.+ ..|+..+|||++||++.||++|.+.|+|.++.+.+
T Consensus 154 ----------------------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL 211 (396)
T KOG0593|consen 154 ----------------------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL 211 (396)
T ss_pred ----------------------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH
Confidence 1223345688999999999988 68999999999999999999999999999998887
Q ss_pred HHHHhC-------------------CCCCCC----------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHK-------------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~-------------------~~~~~~----------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..|... .+.+|. .+..+.-+.+|+++||..||++|++ .+|+|.||||
T Consensus 212 y~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yF 287 (396)
T KOG0593|consen 212 YLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYF 287 (396)
T ss_pred HHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHH
Confidence 776542 112222 1334556789999999999999999 9999999999
Q ss_pred CCC
Q 001865 959 KGV 961 (1002)
Q Consensus 959 ~~~ 961 (1002)
.++
T Consensus 288 d~~ 290 (396)
T KOG0593|consen 288 DGF 290 (396)
T ss_pred HHH
Confidence 764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=417.14 Aligned_cols=264 Identities=31% Similarity=0.548 Sum_probs=240.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.+.|++.+.||.|+.|.|-+|++..||+..|||++.+...........+.+||-||+.+.||||+++|++++++.++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 46899999999999999999999999999999999887555566678899999999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
.||++||.|++++-+. +.+++..+..++.||+.||.|||..+|+||||||+|+|++..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~----- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV----- 163 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-----
Confidence 9999999999999774 569999999999999999999999999999999999999999999999999995532
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~-~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
+...-.+.||+|.|.|||++.|.+|. .++||||.|||||.||+|++||.+++....
T Consensus 164 -----------------------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~L 220 (786)
T KOG0588|consen 164 -----------------------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVL 220 (786)
T ss_pred -----------------------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHH
Confidence 11233467999999999999998874 599999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhh
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 967 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 967 (1002)
+.++.++.+..|. .++.++++||.+||..||+.|+| .++|++|||+.++.-....
T Consensus 221 LlKV~~G~f~MPs--~Is~eaQdLLr~ml~VDp~~RiT----~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 221 LLKVQRGVFEMPS--NISSEAQDLLRRMLDVDPSTRIT----TEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred HHHHHcCcccCCC--cCCHHHHHHHHHHhccCcccccc----HHHHhhCchhhcCCCCChh
Confidence 9999999888884 47999999999999999999999 9999999999997665554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=409.02 Aligned_cols=255 Identities=33% Similarity=0.545 Sum_probs=234.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|.+...||+|+||+||+++.+.+.+.||+|.+.+... .....+.+.+|++|++.++||||+.++++|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 579999999999999999999999999999999987532 3445678899999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||.| +|+.++... +.++++.++.++.|++.||.|||+++|+|||+||.|||+..+|++|+||||+|+.+....
T Consensus 81 e~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--- 154 (808)
T ss_pred hhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc---
Confidence 99955 999999875 559999999999999999999999999999999999999999999999999998765322
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
....+..|||.|||||++.+.+|+..+|+|||||++||+++|++||...+....++
T Consensus 155 ------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~ 210 (808)
T KOG0597|consen 155 ------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVK 210 (808)
T ss_pred ------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHH
Confidence 22345679999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
.|......+|. ..+..+++||+.+|.+||.+|++ +.+++.|||.++
T Consensus 211 ~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rlt----W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 211 SILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRLT----WTDLLGHPFWKG 256 (808)
T ss_pred HHhcCCCCCcc--cccHHHHHHHHHHhhcChhhccc----HHHHhcChHHhh
Confidence 99999888887 47889999999999999999999 999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=382.24 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=224.0
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEE-EEeeCCe-E
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-SFQTKTH-V 744 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~~~-~ 744 (1002)
...+|++++.||.|+||.||+|.+..+|+.+|.|.+.-+ ..+......+..|+.+|++|+|||||++++ .|..++. +
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 456899999999999999999999999999999999855 346667788899999999999999999998 5555555 8
Q ss_pred EEEEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH--cC--cccCCCCCCcEEEecCCcEEEEeccCC
Q 001865 745 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC--QG--IIYRDLKPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~--~g--IiHrDLKP~NILl~~~g~vkL~DFG~a 818 (1002)
+||||||.+|+|..++++ ...+.+++..++.++.|++.||.++|+ .. |+||||||.||+++.+|.+||+|||++
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence 999999999999999984 456789999999999999999999999 45 999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
+.+..+ .....+++|||.||+||.+.+.+|+.+||||||||++|||+.-++||
T Consensus 176 r~l~s~---------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 176 RFLSSK---------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred hHhcch---------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 876532 12345789999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 899 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
.|.+-.+..++|.++..+.-.....|..+..||..|+..||+.||+..+.+.+
T Consensus 229 ~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 229 YGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred ccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 99999999999998865522223478889999999999999999984333333
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=376.16 Aligned_cols=261 Identities=30% Similarity=0.487 Sum_probs=233.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
...+.|.+...||+|.|+.||++.+..+|+.||+|++....+... ..+.+.+|+.|.+.|+||||+++++.+...++.|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345789999999999999999999999999999999876544333 6688899999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec---CCcEEEEeccCCcccC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~---~g~vkL~DFG~a~~~~ 822 (1002)
+|+|+|.|++|..-+-.+ ..+++..+-.+++||+.+|.|+|.+||||||+||.|+++.+ ..-+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999997665443 45899999999999999999999999999999999999964 3359999999996654
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
. ......++|||+|||||++...+|+..+|||+.||+||-|+.|++||.+.+
T Consensus 165 ~----------------------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 165 D----------------------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 216 (355)
T ss_pred C----------------------------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc
Confidence 1 123446789999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 903 RQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~--~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
....++.|+.+..+++ .++.+++++++|+++||..||.+|+| +.|+|+|||+...
T Consensus 217 ~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 217 QHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT----ADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc----HHHHhCCchhcch
Confidence 9999999999877665 46788999999999999999999999 9999999999873
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=408.98 Aligned_cols=262 Identities=34% Similarity=0.614 Sum_probs=234.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh--HHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLD-HPFVPALYASFQTKT 742 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~--~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~ 742 (1002)
...+.|.+.+.||+|+||+|+.+.+..++..||+|++.+...... .....+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 346799999999999999999999999999999998876533211 23456678999999998 999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCccc
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 821 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~-g~vkL~DFG~a~~~ 821 (1002)
.+|+|||||.||+|++++.. .+.+.+..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999988 3569999999999999999999999999999999999999999 99999999999664
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CC-ChhhHHHHHHHHHHHHcCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HT-SAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~-~~sDIwSlGvil~elltG~~Pf~ 899 (1002)
. .......+.|||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.
T Consensus 172 ~---------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 172 P---------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred C---------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 2 0112345789999999999999877 75 69999999999999999999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
..+....+..|..+...+|.... +.++..|+.+||..||.+|++ +.+|++||||+..
T Consensus 225 d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t----~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 225 DSNVPNLYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRIT----LLEILEHPWFQKE 281 (370)
T ss_pred CccHHHHHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCC----HHHHhhChhhccC
Confidence 99999999999999999888755 999999999999999999999 9999999999973
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=400.29 Aligned_cols=263 Identities=28% Similarity=0.470 Sum_probs=227.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCC-e
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKT-H 743 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~-~ 743 (1002)
+..++|.++++||.|+||.||+|+.+.++..||||.+++... .-+.+- -.+|+.-|++|+ ||||+++++++.+++ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 346799999999999999999999999999999999987643 222222 357999999998 999999999999888 9
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+|+||||| ..+|+++++.+ .+.+++..++.|+.||++||+|+|++|+.||||||+|||+..+..+||+|||+|+....
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 99999999 89999999987 78899999999999999999999999999999999999999889999999999987653
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
++ ..+.++.|.+|+|||+|.. ..|+.+.|+|++|||++|+++-++.|+|.+
T Consensus 163 kp----------------------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 163 KP----------------------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred CC----------------------------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 32 2345688999999999754 568899999999999999999999999999
Q ss_pred hHHHHHHHHh--C-----------------CCCCCCC---------CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 903 RQKTFANILH--K-----------------DLKFPSS---------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 903 ~~~~~~~i~~--~-----------------~~~~~~~---------~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
..+.+.+|.. + .+.+|.. +..+.++.+||.+||.+||.+||| |.|+|+
T Consensus 215 E~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~ 290 (538)
T KOG0661|consen 215 EIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQ 290 (538)
T ss_pred HHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhc
Confidence 9888877754 1 2233322 336788999999999999999999 999999
Q ss_pred CCCcCCCChh
Q 001865 955 HPFFKGVNWA 964 (1002)
Q Consensus 955 Hp~f~~~~~~ 964 (1002)
||||+.....
T Consensus 291 ~pffq~~~~~ 300 (538)
T KOG0661|consen 291 HPFFQVGRAS 300 (538)
T ss_pred Cccccccccc
Confidence 9999975433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=394.85 Aligned_cols=266 Identities=34% Similarity=0.563 Sum_probs=228.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC-----------hHHHHHHHHHHHHHHhCCCCCccee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----------RNKVHRACAEREILDMLDHPFVPAL 734 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~l 734 (1002)
...++|++.+.||+|.||.|-+|++..+++.||||++.+..... ....+.+.+||.||+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34679999999999999999999999999999999998643211 1124678899999999999999999
Q ss_pred EEEEee--CCeEEEEEeccCCCchhHHHhhCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001865 735 YASFQT--KTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (1002)
Q Consensus 735 ~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~-l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vk 811 (1002)
+++..+ .+.+|||+|||..|.+...-.. +. +++.+++.|+++++.||+|||.+|||||||||+|+|++++|++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 999975 5689999999988877654333 33 99999999999999999999999999999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHHH
Q 001865 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGIL 887 (1002)
Q Consensus 812 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDIwSlGvi 887 (1002)
|+|||.+........ .+........+|||.|+|||.+.+.. .+.+.||||+||+
T Consensus 251 IsDFGVs~~~~~~~~----------------------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSD----------------------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred eeccceeeecccCCc----------------------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 999999965532210 00001112368999999999987732 3458999999999
Q ss_pred HHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 888 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 888 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
||.|+.|+.||.+....+.+.+|....+.+|..+.+...+++||.+||++||++|++ +.+|..|||...
T Consensus 309 LYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 309 LYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTR 377 (576)
T ss_pred HHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee----hhhheecceecc
Confidence 999999999999999999999999999999999888999999999999999999999 999999999886
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=376.21 Aligned_cols=283 Identities=40% Similarity=0.731 Sum_probs=257.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+.+++|..++.||.|.||.|-+|+.+.+++.||+|++++..+..+..+..-..|-.+|+...||++..+...|+.++.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 45678999999999999999999999999999999999999888888888888999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||..||.|+-.+.+. ..+++...+.+-..|+.||.|||+++||.||||.+|+|++.+|++||.|||+++..-.
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence 9999999999999999774 5699999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
......++||||.|+|||++....|+.++|.|.+||++|||++|++||...+..
T Consensus 321 --------------------------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 321 --------------------------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred --------------------------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 112346799999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
..+..|+-..+.+|.. ++++++.||..+|.+||.+|+..- +.|.+|.+|+||.+++|+..-.+..+....|.
T Consensus 375 kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPq 447 (516)
T KOG0690|consen 375 KLFELILMEDLKFPRT--LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQ 447 (516)
T ss_pred HHHHHHHhhhccCCcc--CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCC
Confidence 9999999999999875 689999999999999999999863 56999999999999999998655544446665
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=364.45 Aligned_cols=261 Identities=26% Similarity=0.460 Sum_probs=225.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.+|..++.||+|.||+||+|++..+|+.||||.++.....+.- .....+|+++|+.++|+||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4799999999999999999999999999999999876433222 235678999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||| ..+|...++.. ...++..+++.++.++++||+|||++.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-- 156 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-- 156 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence 999 78999998765 46799999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.....+-|..|+|||.++|. .|+..+|+||.|||+.||+-|.+.|+|.++.+.+
T Consensus 157 -------------------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL 211 (318)
T KOG0659|consen 157 -------------------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL 211 (318)
T ss_pred -------------------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH
Confidence 22233789999999999886 5889999999999999999999999999999998
Q ss_pred HHHHhC--C---CCCCC---------------------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 908 ANILHK--D---LKFPS---------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 908 ~~i~~~--~---~~~~~---------------------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
..|.+- . -.||. .+..+.++.+|+.+||.+||.+|++ +.|+|+|+||+..
T Consensus 212 ~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 212 SKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSL 287 (318)
T ss_pred HHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcC
Confidence 888762 1 11221 1234667789999999999999999 9999999999974
Q ss_pred Ch
Q 001865 962 NW 963 (1002)
Q Consensus 962 ~~ 963 (1002)
..
T Consensus 288 P~ 289 (318)
T KOG0659|consen 288 PL 289 (318)
T ss_pred CC
Confidence 33
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=365.76 Aligned_cols=260 Identities=35% Similarity=0.595 Sum_probs=242.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
...++|.+.+.||.|.||.||+|+.+.++..+|+|++.+..+......+++.+|++|...|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 45679999999999999999999999999999999999887777777788999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+++||..+|+|+..|..+....+++.....|+.|++.||.|+|.++||||||||+|+|++..|.+||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~----- 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH----- 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee-----
Confidence 999999999999999977778899999999999999999999999999999999999999999999999999833
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
.++....+.|||..|.+||...+..++..+|+|++|++.|+++.|.+||...+..+
T Consensus 174 ------------------------~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 174 ------------------------APSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred ------------------------cCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 23445668899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
.++.|.+..+.+| ..++..+.+||.+||.++|.+|.. ..|++.|||+..
T Consensus 230 tYkrI~k~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~----l~~v~~hpwI~a 278 (281)
T KOG0580|consen 230 TYKRIRKVDLKFP--STISGGAADLISRLLVKNPIERLA----LTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHccccCC--cccChhHHHHHHHHhccCcccccc----HHHHhhhHHHHh
Confidence 9999999888888 457899999999999999999999 999999999875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=396.39 Aligned_cols=281 Identities=39% Similarity=0.693 Sum_probs=243.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 37999999999999999999999999999999997653333445567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~ 208 (291)
T cd05612 154 -------------------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE 208 (291)
T ss_pred -------------------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1123469999999999999889999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCC-hhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCCcc
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDT 983 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~~ 983 (1002)
.+..+...++.. .+..+++||.+||+.||.+|++. ...++++++||||+.++|..+....-.....|.++.+.
T Consensus 209 ~i~~~~~~~~~~--~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 282 (291)
T cd05612 209 KILAGKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDG 282 (291)
T ss_pred HHHhCCcCCCcc--CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCcc
Confidence 888887766654 57889999999999999999953 23499999999999999998876554544566655444
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=394.84 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=224.6
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--Ce
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--TH 743 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~ 743 (1002)
...+.|+.+.+||+|.||.||+|++..+|+.||+|.++.+.. +.....-..+||.||++|+||||++|.+..... +.
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 345789999999999999999999999999999999987632 344455667899999999999999999998765 78
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+|||+||| .-+|.-++.. +...|++.+++.|++||+.||+|||++||+|||||.+||||+.+|.+||+|||+|+.+..
T Consensus 193 iYlVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 193 IYLVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 99999999 6788888764 345699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
+... ..++.+-|++|+|||.|.|. .|+.++|+||.||||.||+.|++.|.|.+
T Consensus 271 ~~~~--------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 271 SGSA--------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred CCCc--------------------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 3321 23456889999999999885 68999999999999999999999999999
Q ss_pred hHHHHHHHHhC--CC--------CCCC-----------------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 903 RQKTFANILHK--DL--------KFPS-----------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 903 ~~~~~~~i~~~--~~--------~~~~-----------------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
..+.+..|.+- .. .+|. ....+..+.+|+..||..||.+|.| |.++|+|
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~s 400 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQS 400 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcC
Confidence 99999988752 10 1110 1124566789999999999999999 9999999
Q ss_pred CCcCC
Q 001865 956 PFFKG 960 (1002)
Q Consensus 956 p~f~~ 960 (1002)
+||+.
T Consensus 401 eyF~t 405 (560)
T KOG0600|consen 401 EYFTT 405 (560)
T ss_pred ccccc
Confidence 99964
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=403.75 Aligned_cols=285 Identities=35% Similarity=0.677 Sum_probs=244.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCC-eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 356779999999999999999999976654 6899999976544444556678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999764 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 184 ------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 184 ------------------------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred ------------------------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 01235799999999999998899999999999999999999999999988
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCC-hhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCCc
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATD 982 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 982 (1002)
...+..+..+...+|.. .+..+.+||.+||+.||.+|++. .+.++++++||||++++|..+.....+....|.+...
T Consensus 234 ~~~~~~i~~~~~~~p~~--~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 311 (340)
T PTZ00426 234 LLIYQKILEGIIYFPKF--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNV 311 (340)
T ss_pred HHHHHHHhcCCCCCCCC--CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCC
Confidence 88888888877666543 67889999999999999999732 2339999999999999999887555555566765444
Q ss_pred c
Q 001865 983 T 983 (1002)
Q Consensus 983 ~ 983 (1002)
.
T Consensus 312 ~ 312 (340)
T PTZ00426 312 F 312 (340)
T ss_pred c
Confidence 3
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=400.60 Aligned_cols=268 Identities=40% Similarity=0.770 Sum_probs=237.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 45799999999999999999999999999999999986544444556678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred EEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC---
Confidence 99999999999999764 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....
T Consensus 171 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 171 ---------------------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred ---------------------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 11235799999999999999899999999999999999999999999888888
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCC-hhcHHHHHcCCCcCCCChhhhhc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
+..+..+...+|.. .+..+++||.+||+.||.+||+. .+.+++|++||||++.+|..+..
T Consensus 224 ~~~i~~~~~~~p~~--~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~ 284 (329)
T PTZ00263 224 YEKILAGRLKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYA 284 (329)
T ss_pred HHHHhcCCcCCCCC--CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 88888877666543 67889999999999999999974 24589999999999999998754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=399.07 Aligned_cols=265 Identities=42% Similarity=0.768 Sum_probs=230.3
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 754 (1002)
+.||+|+||.||+|.+..+|+.||+|++++...........+.+|+.+++.++||||+++++++..++.+|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998764444555667788999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001865 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (1002)
Q Consensus 755 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 834 (1002)
+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---------- 148 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----------
Confidence 999998764 45899999999999999999999999999999999999999999999999998532110
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001865 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914 (1002)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 914 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211 (323)
T ss_pred -----------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 011234579999999999999999999999999999999999999999988888877777776
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCChh-cHHHHHcCCCcCCCChhhhhccC
Q 001865 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCMN 970 (1002)
Q Consensus 915 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~~~ 970 (1002)
..++. ..+..+.+||.+||..||++||+... .+.+|++||||++++|..+....
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~ 266 (323)
T cd05571 212 IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKK 266 (323)
T ss_pred CCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 66654 46889999999999999999993211 29999999999999999996433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=427.99 Aligned_cols=287 Identities=38% Similarity=0.683 Sum_probs=256.9
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|.+++.||+|+||.|.+|+++.+++.||+|++.+-.+.......-|..|..||..-+++-|+.++..|+++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 35678999999999999999999999999999999999886555566667788899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+|||||+||+|..++.+.. .+++..+++|+..|+.||.-||+.|.|||||||+|||++.+|++||+|||.+-.+..+
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 99999999999999998753 6999999999999999999999999999999999999999999999999988655422
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDIwSlGvil~elltG~~Pf~ 899 (1002)
....+..-+|||.|+|||+|.. +.|+..+|+||+||++|||++|..||+
T Consensus 229 --------------------------G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 229 --------------------------GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred --------------------------CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 2234556799999999999943 468889999999999999999999999
Q ss_pred CCChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCC
Q 001865 900 GKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
..+..+.|-+|+.- .+.||....+|.++++||.++++ +|+.|++ ...++++..||||.+++|..++...|| .+|
T Consensus 283 adslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP--~vP 358 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPP--VVP 358 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCC--CCC
Confidence 99999999999864 78888777799999999999996 8899987 556999999999999999999999999 557
Q ss_pred CCCCcc
Q 001865 978 LFATDT 983 (1002)
Q Consensus 978 ~~~~~~ 983 (1002)
.++-|.
T Consensus 359 evssd~ 364 (1317)
T KOG0612|consen 359 EVSSDD 364 (1317)
T ss_pred cCCCCC
Confidence 765444
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=381.58 Aligned_cols=273 Identities=26% Similarity=0.401 Sum_probs=237.8
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 662 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
.++.++.+.|++...||.|..++||+|+...++.+||||++..+.. ......+.+|+..|+.++||||+.++..|..+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc--~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC--NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh--hhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 3456778999999999999999999999999999999999986543 33478899999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|+||.||.+|++.+++...-...+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 99999999999999999998754455999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccc-cccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRAS-NSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~Gt~~Y~aPE~l~~--~~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
.... ...... .+++||+.|||||++.. ..|+.|+||||||++..||.+|..||
T Consensus 177 ~~~G------------------------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 177 FDSG------------------------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred cccC------------------------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 4321 011112 67899999999999754 46888999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCC--------CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChh
Q 001865 899 RGKTRQKTFANILHKDLKFPSS--------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~~~~~--------~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 964 (1002)
....+.+++..-+++.++.+.. ...+..+..++..||++||.+||| |.++|+|+||+...-.
T Consensus 233 ~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT----ASKLLKHAFFKKAKSK 302 (516)
T ss_pred ccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC----HHHHhccHHHhhccch
Confidence 9999999888888877654432 224567889999999999999999 9999999999986543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=399.21 Aligned_cols=266 Identities=27% Similarity=0.462 Sum_probs=235.1
Q ss_pred HHhhcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeE
Q 001865 656 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY 735 (1002)
Q Consensus 656 ~~~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~ 735 (1002)
++.+...+... ..|.....||+|+.|.||.|....+++.||+|.+.... .....-+.+|+.+|+..+|+|||.++
T Consensus 262 l~~v~~~~dP~--~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl 336 (550)
T KOG0578|consen 262 LKRVVSQGDPR--SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFL 336 (550)
T ss_pred hheeccCCChh--hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHH
Confidence 34444555543 48999999999999999999999999999999997653 33446688999999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEec
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (1002)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DF 815 (1002)
+.|...+.+|+|||||+||+|.+.+.. ..+++.++..|++.++.||+|||.+||||||||.+|||++.+|.+||+||
T Consensus 337 ~Sylv~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 337 DSYLVGDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred HHhcccceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeee
Confidence 999999999999999999999999976 34999999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCC
Q 001865 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~ 895 (1002)
|++..+.... ....+.+|||+|||||++....|++++||||||+++.||+-|+
T Consensus 414 GFcaqi~~~~---------------------------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGE 466 (550)
T KOG0578|consen 414 GFCAQISEEQ---------------------------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGE 466 (550)
T ss_pred eeeecccccc---------------------------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCC
Confidence 9996654221 1345779999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 896 TPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+||...+....+..|.. +...+.....+|+.+++||.+||+.|+.+|++ |.+||+||||+-
T Consensus 467 PPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras----A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 467 PPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS----AKELLEHPFLKM 528 (550)
T ss_pred CCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC----HHHHhcChhhhh
Confidence 99998888777777764 55666777779999999999999999999999 999999999964
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=388.57 Aligned_cols=280 Identities=33% Similarity=0.551 Sum_probs=231.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++++..++..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47889999999999999999999999999999876544333444567789999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 999999998886544456899999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 156 -----------------------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred -----------------------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 011234689999999999999999999999999999999999999987654322222
Q ss_pred HHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh-cHHHHHcCCCcCCCChhhhhccCCCCCCCC
Q 001865 910 ILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 910 i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
+... ..........+..+.+||.+||+.||.+||+..+ .++++++||||.+++|..+.....+....|
T Consensus 213 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred HHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCC
Confidence 2111 1112222346889999999999999999997542 389999999999999999987755544545
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=399.64 Aligned_cols=295 Identities=36% Similarity=0.636 Sum_probs=235.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||+||+|.+..+++.||+|++++...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 37999999999999999999999999999999998754444455567888999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999999764 459999999999999999999999999999999999999999999999999986543211100
Q ss_pred CCcchh-h--hhcccCCC-----CCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 829 LPTTNE-K--KRRHKGQQ-----NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 829 ~~~~~~-~--~~~~~~~~-----~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
...... . ........ ...............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 000000 0 00000000 000000001112356899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCC---CCChhcHHHHHcCCCcCCCChhhhhccC
Q 001865 901 KTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSR---LGSHEGANEIKKHPFFKGVNWALVRCMN 970 (1002)
Q Consensus 901 ~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R---pt~~~~a~elL~Hp~f~~~~~~~~~~~~ 970 (1002)
.+..+.+..+... ...+|.....+..+++||.+|+. +|.+| |+ +++|++||||++++|..+....
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~----~~ei~~hp~f~~~~~~~~~~~~ 308 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPG----VEEIKTNPFFEGVDWEHIRERP 308 (363)
T ss_pred CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCC----HHHHhCCCCCCCCCHHHHHhCC
Confidence 8888888888763 45566656688999999999775 55555 66 9999999999999999996644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=365.07 Aligned_cols=270 Identities=31% Similarity=0.532 Sum_probs=235.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC-----hHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDML-DHPFVPALYASFQTK 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 741 (1002)
...|.-.+.||.|..++|-+|.++.+|..+|+|++....... ....+.-.+|+.||+++ +||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 457888899999999999999999999999999986432211 12234456799999998 899999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+++|+|.|+.|.|++++... ..+++...+.|++||+.|++|||.++||||||||+|||++++.++||+|||+|+.+
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999874 56999999999999999999999999999999999999999999999999999775
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC------CCCCChhhHHHHHHHHHHHHcCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~------~~~~~~sDIwSlGvil~elltG~ 895 (1002)
.... .-...||||+|+|||.+.. ..|+..+|+|++|+|+|.|+.|+
T Consensus 174 ~~Ge----------------------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 EPGE----------------------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred CCch----------------------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 4221 1235799999999999854 46788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCC
Q 001865 896 TPFRGKTRQKTFANILHKDLKF--PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNP 971 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~ 971 (1002)
+||......-+++.|+.+...+ |.+..++...++||.+||+.||.+|+| ++|+|.||||..+.....+.+.|
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit----ake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT----AKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc----HHHHhcChHHHHHHHhcccccCC
Confidence 9999998889999999987765 456678889999999999999999999 99999999998876666665554
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=403.42 Aligned_cols=303 Identities=36% Similarity=0.683 Sum_probs=239.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+++++.++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 37999999999999999999999999999999997654434455667888999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999996432111000
Q ss_pred C-----Ccchhhhh---cccCCCCC------------cccccccccccccccCCcccccccccCCCCCChhhHHHHHHHH
Q 001865 829 L-----PTTNEKKR---RHKGQQNP------------VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (1002)
Q Consensus 829 ~-----~~~~~~~~---~~~~~~~~------------~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil 888 (1002)
. ........ ........ .+...........+||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 0 00000000 00000000 0000000011246799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCCHHHHHHHHHccccCcCCCC---CChhcHHHHHcCCCcCCCCh
Q 001865 889 YEMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL---GSHEGANEIKKHPFFKGVNW 963 (1002)
Q Consensus 889 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rp---t~~~~a~elL~Hp~f~~~~~ 963 (1002)
|+|++|..||.+.+..+.+..+.. ..+.++.....+..+.+||.+||. +|.+|+ + +.++++||||++++|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~----~~~~l~hp~~~~~~~ 313 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG----AHEIKSHPFFRGVDW 313 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC----HHHHhcCCCcCCCCH
Confidence 999999999998888777777765 344556555678899999999997 788765 6 999999999999999
Q ss_pred hhhhccCCCCCCCCCCC
Q 001865 964 ALVRCMNPPELDAPLFA 980 (1002)
Q Consensus 964 ~~~~~~~~~~~~~p~~~ 980 (1002)
+.++...+|-+ |.+.
T Consensus 314 ~~~~~~~~~~~--~~~~ 328 (377)
T cd05629 314 DTIRQIRAPFI--PQLK 328 (377)
T ss_pred HHHccCCCCcc--cCCC
Confidence 99987766644 5443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=394.91 Aligned_cols=277 Identities=37% Similarity=0.643 Sum_probs=238.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998764444455667889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999854321
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 154 -------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~ 208 (333)
T cd05600 154 -------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208 (333)
T ss_pred -------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH
Confidence 1234579999999999999999999999999999999999999999988877777
Q ss_pred HHHhCC--CCCCCCC----CCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCCc
Q 001865 909 NILHKD--LKFPSST----PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATD 982 (1002)
Q Consensus 909 ~i~~~~--~~~~~~~----~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 982 (1002)
.+.... ...+... ..+.++.+||.+||..+|.+||+ +.++++||||+.++|+.+....+| .+|.+..+
T Consensus 209 ~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~--~~~~~~~~ 282 (333)
T cd05600 209 NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPP--FVPELESE 282 (333)
T ss_pred HHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCC--CCCCCCCc
Confidence 665432 2222221 45889999999999999999999 999999999999999998866665 34654443
Q ss_pred c
Q 001865 983 T 983 (1002)
Q Consensus 983 ~ 983 (1002)
.
T Consensus 283 ~ 283 (333)
T cd05600 283 I 283 (333)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=368.21 Aligned_cols=264 Identities=23% Similarity=0.354 Sum_probs=224.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHV 744 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 744 (1002)
..+.|+.+..|++|+||.||+|+++.|++.||+|.++-..- .....-.-.+||.+|.+.+|||||.+-++... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 45689999999999999999999999999999999986532 11222345789999999999999999998763 4679
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
||||||| .-+|..++...+ ..+...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 153 y~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 153 YIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999 779999998764 56999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
....+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++.|+|.+.
T Consensus 231 ---------------------------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 231 ---------------------------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred ---------------------------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 1233456889999999999886 589999999999999999999999999999
Q ss_pred HHHHHHHHhC-----C--------------CCCCCC-----------CCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 904 QKTFANILHK-----D--------------LKFPSS-----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 904 ~~~~~~i~~~-----~--------------~~~~~~-----------~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
...+.+|.+- . +.++.. ...+....+|+..+|.+||.+|+| |.+.|
T Consensus 284 ~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L 359 (419)
T KOG0663|consen 284 IDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGL 359 (419)
T ss_pred HHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhh
Confidence 9888888651 0 111111 114567889999999999999999 99999
Q ss_pred cCCCcCCCChh
Q 001865 954 KHPFFKGVNWA 964 (1002)
Q Consensus 954 ~Hp~f~~~~~~ 964 (1002)
+|+||.....+
T Consensus 360 ~h~~F~e~P~p 370 (419)
T KOG0663|consen 360 KHEYFRETPLP 370 (419)
T ss_pred cccccccCCCC
Confidence 99999985444
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=383.66 Aligned_cols=261 Identities=32% Similarity=0.479 Sum_probs=218.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC--eEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVCL 746 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~l 746 (1002)
..|...+.||+|+||+||++.+..+|..+|+|.+... .....+.+.+|+.+|.+++|||||++++...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~---~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE---DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecc---cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 4688899999999999999999999999999998754 2222677899999999999999999999755444 6899
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-~g~vkL~DFG~a~~~~~~~ 825 (1002)
+|||+++|+|.+++....+ .+++..++.+.+||++||+|||++|||||||||+|||++. +|.+||+|||++......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~- 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK- 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc-
Confidence 9999999999999998765 7999999999999999999999999999999999999999 799999999998654320
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCC-CCh
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG-KTR 903 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~-~~~ 903 (1002)
...........||+.|||||++... ...+++|||||||++.||+||+.||.. ...
T Consensus 172 -----------------------~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 172 -----------------------GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred -----------------------cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 0011223457899999999999853 334599999999999999999999987 344
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
...+-.+........-+..++.++++||.+||.+||++||| |.++|+|||.+..
T Consensus 229 ~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt----a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 229 AEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPT----AEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcC----HHHHhhChhhhcc
Confidence 44444454444222334458899999999999999999999 9999999999874
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=399.06 Aligned_cols=301 Identities=38% Similarity=0.696 Sum_probs=240.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||.|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||++++++|..++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998654444455667788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999999764 459999999999999999999999999999999999999999999999999986543211100
Q ss_pred C-Ccchhhhhc----------ccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC
Q 001865 829 L-PTTNEKKRR----------HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 829 ~-~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~P 897 (1002)
. ......... ........+...........+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 0 000000000 00000000000000112245799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCC
Q 001865 898 FRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 973 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~ 973 (1002)
|.+.+....+..+.... ..++.....+..+.+||.+||. +|.+|++. ..+.++|+||||++++|..+....+|.
T Consensus 239 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~ 314 (364)
T cd05599 239 FCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPI 314 (364)
T ss_pred CCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCC
Confidence 99988888877776543 4455555678999999999997 99999974 359999999999999999887766553
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=391.50 Aligned_cols=264 Identities=44% Similarity=0.793 Sum_probs=228.9
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 754 (1002)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765444556677889999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001865 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (1002)
Q Consensus 755 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 834 (1002)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999988764 45899999999999999999999999999999999999999999999999998542110
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001865 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914 (1002)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 914 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 211 (328)
T cd05593 149 -----------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211 (328)
T ss_pred -----------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC
Confidence 011224579999999999998889999999999999999999999999888877777777666
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhcc
Q 001865 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCM 969 (1002)
Q Consensus 915 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~ 969 (1002)
..+|. ..+..+.+||.+||..||.+|++.. +.+.++++||||.+++|..+...
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~ 265 (328)
T cd05593 212 IKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDK 265 (328)
T ss_pred ccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 66554 4688999999999999999998321 12999999999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=387.73 Aligned_cols=262 Identities=42% Similarity=0.743 Sum_probs=228.7
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||+|+||.||+|.+..+++.||+|++++...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865444455567788899999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001865 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (1002)
Q Consensus 757 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 836 (1002)
.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9999764 45899999999999999999999999999999999999999999999999998542110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001865 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916 (1002)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 916 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 147 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~ 211 (312)
T cd05585 147 ---------------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211 (312)
T ss_pred ---------------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC
Confidence 01123457999999999999999999999999999999999999999998888888888877666
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccC
Q 001865 917 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMN 970 (1002)
Q Consensus 917 ~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~ 970 (1002)
++. ..+..+.+||.+||..||.+||++. .+.++|+||||+..+|..+....
T Consensus 212 ~~~--~~~~~~~~li~~~L~~dp~~R~~~~-~~~e~l~hp~~~~~~~~~~~~~~ 262 (312)
T cd05585 212 FPD--GFDRDAKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKG 262 (312)
T ss_pred CCC--cCCHHHHHHHHHHcCCCHHHcCCCC-CHHHHHcCCCcCCCCHHHHHhCC
Confidence 654 4678999999999999999998642 28999999999999998775433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=397.75 Aligned_cols=285 Identities=34% Similarity=0.603 Sum_probs=238.8
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567999999999999999999999999999999999765433444455677899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+|||||+||+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998653 4889999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC----CCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~----~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
. .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred C--------------------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 0 0112345799999999998654 377899999999999999999999999
Q ss_pred CChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCC--CCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCC
Q 001865 901 KTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 976 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~ 976 (1002)
.+....+..+.... +.++.....+..+.+||.+||+.+|.+ |++ ++++++||||+..+|............+
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~ 325 (370)
T cd05596 250 DSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVV 325 (370)
T ss_pred CCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCcc
Confidence 88888888887643 456666668999999999999999987 999 9999999999998887553333333345
Q ss_pred CCCCCc
Q 001865 977 PLFATD 982 (1002)
Q Consensus 977 p~~~~~ 982 (1002)
|.++.+
T Consensus 326 p~~~~~ 331 (370)
T cd05596 326 PELSSD 331 (370)
T ss_pred CcCCCc
Confidence 554443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=388.43 Aligned_cols=263 Identities=41% Similarity=0.777 Sum_probs=228.4
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 754 (1002)
+.||+|+||.||++.+..+|+.||+|++++...........+.+|+.+++.++||||++++++|...+.+|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998764444555667788999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001865 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (1002)
Q Consensus 755 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 834 (1002)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------
Confidence 999988764 45899999999999999999999999999999999999999999999999988532110
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001865 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914 (1002)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 914 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 149 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05595 149 -----------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211 (323)
T ss_pred -----------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 011123579999999999999899999999999999999999999999888888888877776
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhc
Q 001865 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 915 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
..++. ..+..+.+||.+||..||.+|++.. ..+.++++||||.+++|..+..
T Consensus 212 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 264 (323)
T cd05595 212 IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 264 (323)
T ss_pred CCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 66654 4688999999999999999998321 1399999999999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=395.87 Aligned_cols=296 Identities=36% Similarity=0.581 Sum_probs=233.4
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987654455566778899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999999764 4589999999999999999999999999999999999999999999999999854321110000
Q ss_pred CcchhhhhcccCC--------------------CCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001865 830 PTTNEKKRRHKGQ--------------------QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (1002)
Q Consensus 830 ~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ 889 (1002)
............. ................+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence 0000000000000 00000000111223568999999999999988999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCCHHHHHHHHHccc--cCcCCCCCChhcHHHHHcCCCcCCCChhh
Q 001865 890 EMLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLH--RDPKSRLGSHEGANEIKKHPFFKGVNWAL 965 (1002)
Q Consensus 890 elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~Ll~~~L~--~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 965 (1002)
+|++|..||...+.......+.. .....+....++.++.+||.+||. .+|..|++ +.++++||||+.++|..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~----~~~~l~hp~f~~~~~~~ 315 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNG----ADDIKAHPFFSEVDFSS 315 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCC----HHHHhcCcccCCCChhH
Confidence 99999999998887776666654 334555555688999999999654 45556999 99999999999999987
Q ss_pred hhccCC
Q 001865 966 VRCMNP 971 (1002)
Q Consensus 966 ~~~~~~ 971 (1002)
.....+
T Consensus 316 ~~~~~~ 321 (381)
T cd05626 316 DIRTQP 321 (381)
T ss_pred HhhcCC
Confidence 644433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=372.91 Aligned_cols=255 Identities=30% Similarity=0.555 Sum_probs=234.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
..+|++.+.||.|.||.|-+|++...|+.||||.++++.+.+..+.-.+.+||+||..|+||||+++|++|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||..+|.|++|+... +.|++..++.+++||+.|+.|+|+++++|||||.+|||++.|+++||.|||++..+..+
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--- 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--- 206 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc---
Confidence 9999999999999875 56999999999999999999999999999999999999999999999999999665422
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
..-.++||+|.|.+||.+.+.+| ++.+|.||||++||.|+.|..||.|.+....
T Consensus 207 -------------------------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l 261 (668)
T KOG0611|consen 207 -------------------------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL 261 (668)
T ss_pred -------------------------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH
Confidence 12357899999999999999887 5689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
+++|..+...-|.. +..+..||+.||..||+.|.| +++|-.|=|+.
T Consensus 262 vrQIs~GaYrEP~~---PSdA~gLIRwmLmVNP~RRAT----ieDiAsHWWvN 307 (668)
T KOG0611|consen 262 VRQISRGAYREPET---PSDASGLIRWMLMVNPERRAT----IEDIASHWWVN 307 (668)
T ss_pred HHHhhcccccCCCC---CchHHHHHHHHHhcCcccchh----HHHHhhhheee
Confidence 99999887655543 345778999999999999999 99999998864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=394.64 Aligned_cols=299 Identities=37% Similarity=0.683 Sum_probs=238.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444555677888999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..........
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999986543211000
Q ss_pred C------CcchhhhhcccCC--CCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 829 L------PTTNEKKRRHKGQ--QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 829 ~------~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
. ............. ....+...........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 0 0000000000000 0000000011122356899999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCC
Q 001865 901 KTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNP 971 (1002)
Q Consensus 901 ~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~ 971 (1002)
.+....+..+... ...+|.....+..+++||.+|+. ||.+|++.. .++++++||||++++|..+.....
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~-~~~ei~~hp~f~~~~~~~~~~~~~ 309 (360)
T cd05627 239 ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSN-GVEEIKSHPFFEGVDWGHIRERPA 309 (360)
T ss_pred CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCC-CHHHHhcCCCCCCCCHHHHhcCCC
Confidence 8888888777753 34555555678999999999874 999999632 389999999999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=387.25 Aligned_cols=273 Identities=37% Similarity=0.704 Sum_probs=231.5
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|+++.+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999865443444556777888888876 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999998532110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 211 (320)
T cd05590 150 ------------------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211 (320)
T ss_pred ------------------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 01123457999999999999988999999999999999999999999999888888888877
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh--cHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~--~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
...++. ..+..+.+||.+||+.||.+||++.+ ..+++++||||+.++|..+.....+....|.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 276 (320)
T cd05590 212 EVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPR 276 (320)
T ss_pred CCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 666554 36889999999999999999999432 2389999999999999988654433333343
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=386.67 Aligned_cols=278 Identities=35% Similarity=0.666 Sum_probs=236.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC-CCcceeEEEEeeCCeEEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~lV~ 748 (1002)
+|++++.||+|+||.||+|.+..+++.||||++++...........+..|+.++..+.| ++|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999987644444556677889999999976 46889999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC----
Confidence 999999999998764 45899999999999999999999999999999999999999999999999988432100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (324)
T cd05587 155 -----------------------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ 211 (324)
T ss_pred -----------------------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011224579999999999999999999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
.+......++. ..+..+.+|+.+||..||.+|++.. ...+++++||||+.++|..+.....+....|.
T Consensus 212 ~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~ 280 (324)
T cd05587 212 SIMEHNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPK 280 (324)
T ss_pred HHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCc
Confidence 88877666554 4688899999999999999999853 34589999999999999988655443333443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=391.71 Aligned_cols=273 Identities=38% Similarity=0.673 Sum_probs=236.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|.+.+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998764444455667888999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 9999999999997652 4599999999999999999999999999999999999999999999999999865431110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA------GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
.......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 158 ------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred ------------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 0112346899999999986 4567789999999999999999999999888
Q ss_pred hHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCC
Q 001865 903 RQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 973 (1002)
Q Consensus 903 ~~~~~~~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~ 973 (1002)
....+..+... ...++.....+..+.+||.+||+ +|.+||+ ++++++||||+.++|..+....+|.
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~ 281 (330)
T cd05601 214 SAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPF 281 (330)
T ss_pred HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCc
Confidence 88887777654 24456656678999999999998 9999999 9999999999999999998766653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=395.59 Aligned_cols=294 Identities=38% Similarity=0.633 Sum_probs=233.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||++++++|..++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999986544445556778899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
||++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999999764 4589999999999999999999999999999999999999999999999999854321111000
Q ss_pred Ccchhhhhc-------ccCCC-------------CCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001865 830 PTTNEKKRR-------HKGQQ-------------NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (1002)
Q Consensus 830 ~~~~~~~~~-------~~~~~-------------~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ 889 (1002)
.......+. ..+.. ...............+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 000000000 00000 0000000111223568999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhh
Q 001865 890 EMLYGYTPFRGKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 967 (1002)
Q Consensus 890 elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 967 (1002)
+|++|+.||.+.+..+....+... ....|.....++++.+||.+|+ .+|.+|++ ...+.++++||||+.++|....
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~-~~~~~ei~~hp~f~~~~~~~~~ 317 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG-KNGADEIKAHPFFKTIDFSSDL 317 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC-CCCHHHHhcCCCcCCcChHHHH
Confidence 999999999998887777777653 3445555567899999999987 59999997 3348999999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=368.64 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=222.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee-----CC
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-----KT 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~ 742 (1002)
...|..++.||.|+||.|+.|.++.+|+.||||.+... +......++..+|+.+|+.++|+||+.+++++.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 35677789999999999999999999999999998754 4566778889999999999999999999999865 45
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+|+|+|+| +.+|...++.+ ..+++.++..++.||+.||+|+|+.||+||||||+|+|++.+..+||+|||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 799999999 99999999875 449999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-CCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
..+ .....+..+.|..|+|||.+. ...|+...||||+|||+.||++|++.|+|.
T Consensus 177 ~~~-------------------------~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 177 KFF-------------------------EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred ccC-------------------------cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 220 011224568899999999974 467899999999999999999999999998
Q ss_pred ChHHHHHHHHhC-----------------------CCCCC------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 902 TRQKTFANILHK-----------------------DLKFP------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 902 ~~~~~~~~i~~~-----------------------~~~~~------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
+....+..|+.- ....| ..+..++.+.+||.+||..||.+|+| ++|+
T Consensus 232 d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eA 307 (359)
T KOG0660|consen 232 DYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEA 307 (359)
T ss_pred chHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHH
Confidence 777766665431 11111 12446788999999999999999999 9999
Q ss_pred HcCCCcCCC
Q 001865 953 KKHPFFKGV 961 (1002)
Q Consensus 953 L~Hp~f~~~ 961 (1002)
|+||||...
T Consensus 308 L~hPYl~~~ 316 (359)
T KOG0660|consen 308 LAHPYLAPY 316 (359)
T ss_pred hcChhhhhh
Confidence 999999984
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=395.96 Aligned_cols=292 Identities=38% Similarity=0.639 Sum_probs=231.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.|..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 37999999999999999999999999999999997654333445567788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..+.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999985432111000
Q ss_pred CCcchhhhhccc--------CCC----CC----cccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH
Q 001865 829 LPTTNEKKRRHK--------GQQ----NP----VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (1002)
Q Consensus 829 ~~~~~~~~~~~~--------~~~----~~----~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ell 892 (1002)
........+... ... .+ .............+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000000000000 000 00 00000111223568999999999999999999999999999999999
Q ss_pred cCCCCCCCCChHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCC---CChhcHHHHHcCCCcCCCChhhhh
Q 001865 893 YGYTPFRGKTRQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRL---GSHEGANEIKKHPFFKGVNWALVR 967 (1002)
Q Consensus 893 tG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rp---t~~~~a~elL~Hp~f~~~~~~~~~ 967 (1002)
+|+.||.+.+..+....+... ....+....++..+.+||.+|+ .+|.+|+ + +.++++||||+.++|..+.
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t----~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNG----ADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC----HHHHhCCCCcCCCCHHHHh
Confidence 999999998877766666543 2334444567889999999987 5999999 6 9999999999999999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=394.57 Aligned_cols=285 Identities=34% Similarity=0.629 Sum_probs=234.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999999999999999997654434444556788999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+|||||++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999653 48999999999999999999999999999999999999999999999999986532110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
.......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus 197 --------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred --------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 01123457999999999997643 678999999999999999999999998
Q ss_pred ChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCC--CCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCC
Q 001865 902 TRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 902 ~~~~~~~~i~~~~--~~~~~~~~~s~~~~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
+....+..+.... +.++.....+..+++|+.+||..++.. |++ +.++++||||+...|........+....|
T Consensus 251 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p 326 (370)
T cd05621 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVP 326 (370)
T ss_pred CHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCC
Confidence 8888888887643 455665567899999999999855543 778 99999999999866654332222223445
Q ss_pred CCCCcc
Q 001865 978 LFATDT 983 (1002)
Q Consensus 978 ~~~~~~ 983 (1002)
.++.+.
T Consensus 327 ~~~~~~ 332 (370)
T cd05621 327 ELSSDI 332 (370)
T ss_pred CCCCcc
Confidence 544443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=387.55 Aligned_cols=259 Identities=33% Similarity=0.559 Sum_probs=236.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 746 (1002)
...|.+.+.||.|.||.||+|.++.+|+.||+|++.+...........+.+|+.||+++. |||||.++++|++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 568999999999999999999999999999999999887666666788999999999998 9999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC----CcEEEEeccCCcccC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDFDLSCLTS 822 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~----g~vkL~DFG~a~~~~ 822 (1002)
|||+|.||.|++.+... .+++..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999999876 39999999999999999999999999999999999999743 579999999996643
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
. .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+
T Consensus 191 ~----------------------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 191 P----------------------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred C----------------------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 2 123346799999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 903 RQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~--~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.......+..+.+.++ .+..++..+++||.+||..||.+|++ +.++|+|||+++.
T Consensus 243 ~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 243 EFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred hhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC----HHHHhcCccccCC
Confidence 9999999999877655 45667999999999999999999999 9999999999874
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=385.54 Aligned_cols=273 Identities=39% Similarity=0.724 Sum_probs=233.3
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999876444445556677888998866 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--------- 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998532110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~ 211 (321)
T cd05591 150 ------------------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211 (321)
T ss_pred ------------------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999989999999999999999999999999999988888888887
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh---cHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE---GANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~---~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
...+|. ..+.++.+||.+||..||++||+..+ .++++++||||..++|..+..........|.
T Consensus 212 ~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T cd05591 212 DVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPK 277 (321)
T ss_pred CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCC
Confidence 666554 36889999999999999999994433 3999999999999999998665544444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=377.98 Aligned_cols=296 Identities=34% Similarity=0.564 Sum_probs=250.9
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
.++..+.|+.-++||.||||.||-|.-..||+.||+|.+.+..+..+.......+|..||.++++++||.+-..|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34667889999999999999999999999999999999987666555666677899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+|+||..|.||+|.-.+-......+++..+++|+.+|+.||++||+.+||.|||||+|||+|+.|+|+|+|+|+|..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999888776666799999999999999999999999999999999999999999999999999976542
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
.. .....+||.+|||||++.+..|+...|.|||||+||+|+.|+.||.....
T Consensus 340 g~----------------------------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 340 GK----------------------------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred CC----------------------------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 21 12234899999999999999999999999999999999999999975432
Q ss_pred ----HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 904 ----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 904 ----~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
.++-+.++.....++ ...|+++++|...+|++||.+|+..+ +.++++.+||||+.+||..++.-.-+...+|.
T Consensus 392 Kvk~eEvdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd 469 (591)
T KOG0986|consen 392 KVKREEVDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD 469 (591)
T ss_pred hhhHHHHHHHHhcchhhcc--cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC
Confidence 344445555555665 45799999999999999999999998 78999999999999999999543333335665
Q ss_pred CCCcccccccc
Q 001865 979 FATDTEKEYKV 989 (1002)
Q Consensus 979 ~~~~~~~~~~~ 989 (1002)
-.+-.++|..+
T Consensus 470 p~aVyakDv~D 480 (591)
T KOG0986|consen 470 PGAVYAKDVLD 480 (591)
T ss_pred ccccchhhhhh
Confidence 44433444333
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=393.16 Aligned_cols=305 Identities=41% Similarity=0.716 Sum_probs=245.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|.+++.||+|+||.||+|.+..+++.||+|++++...........+..|+.++..++||||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998764444455667888999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999999875 569999999999999999999999999999999999999999999999999987654322100
Q ss_pred CCcchhhhhcc--cCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 829 LPTTNEKKRRH--KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 829 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
........... ....................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 00000000000 0000000000011123356799999999999999999999999999999999999999999888888
Q ss_pred HHHHHh--CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCC
Q 001865 907 FANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 981 (1002)
Q Consensus 907 ~~~i~~--~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~ 981 (1002)
+..+.. ....++....++..+.+||.+||. ||.+|++. +.++++||||++++|.......+|. .|.++.
T Consensus 239 ~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~--~~~~~~ 309 (350)
T cd05573 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPF--VPELSS 309 (350)
T ss_pred HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC---HHHHhcCCCcCCCCHHHHhhCCCCc--CCCCCC
Confidence 888876 555666665678999999999997 99999984 7899999999999999888555553 354443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=385.22 Aligned_cols=267 Identities=40% Similarity=0.768 Sum_probs=229.6
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHH---HhCCCCCcceeEEEEeeCCeEEEE
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---DMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il---~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
|++++.||+|+||.||+|.+..+++.||||++++...........+.+|+.++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999865433344455666776665 456899999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+.+++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~--- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF--- 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC---
Confidence 999999999988754 35999999999999999999999999999999999999999999999999987432100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......+|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 155 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~ 210 (324)
T cd05589 155 ------------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210 (324)
T ss_pred ------------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 01123467999999999999998999999999999999999999999999888888
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh-cHHHHHcCCCcCCCChhhhhcc
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCM 969 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~~ 969 (1002)
..+......++. .++..+.+||.+||+.||.+||+..+ .+.++++||||+.++|......
T Consensus 211 ~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~ 271 (324)
T cd05589 211 DSIVNDEVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLAR 271 (324)
T ss_pred HHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhC
Confidence 888877666554 36888999999999999999996543 4999999999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=384.45 Aligned_cols=278 Identities=35% Similarity=0.665 Sum_probs=238.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
+|.+++.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ .|++|+.+++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876443444455667788888877 5899999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999998764 45899999999999999999999999999999999999999999999999998532110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 211 (323)
T cd05616 155 -----------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 211 (323)
T ss_pred -----------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011234579999999999999999999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
.+......+|. ..+.++.+|+.+||+.||.+|++.. +...++++||||+.++|..+.....+....|.
T Consensus 212 ~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05616 212 SIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPK 280 (323)
T ss_pred HHHhCCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 88887766654 4688999999999999999999853 34689999999999999999765544444444
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=384.94 Aligned_cols=264 Identities=41% Similarity=0.744 Sum_probs=227.2
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654433344455556655 46788999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--------- 149 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 211 (323)
T cd05575 150 ------------------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK 211 (323)
T ss_pred ------------------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999999999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhcc
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 969 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~ 969 (1002)
....+. ..+..+.+||.+||+.||.+||+..+.+.++++||||..++|..+...
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~ 265 (323)
T cd05575 212 PLRLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNK 265 (323)
T ss_pred CCCCCC--CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhc
Confidence 655443 468899999999999999999998777899999999999999988543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=379.50 Aligned_cols=311 Identities=59% Similarity=1.016 Sum_probs=256.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+++++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765444456677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+.+++|.+++.......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999987656679999999999999999999999999999999999999999999999999986543221111
Q ss_pred CCcchhhhhcc--cCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 829 LPTTNEKKRRH--KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 829 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
........... ....................|+..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000000011111223456799999999999998899999999999999999999999999888888
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCC
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF 979 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~ 979 (1002)
+..+......++.....+..+.+||.+||..||++||+....++++|+||||++++|..++-..+|.++.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (316)
T cd05574 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDD 313 (316)
T ss_pred HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCccc
Confidence 8888777777766655788999999999999999999999999999999999999999999988888866544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=386.42 Aligned_cols=264 Identities=42% Similarity=0.780 Sum_probs=227.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 754 (1002)
+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.+++.++||||+++++++..++.+|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765444555667788999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 755 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
+|..++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999988764 458999999999999999999997 79999999999999999999999999998532110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~ 211 (325)
T cd05594 150 ------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211 (325)
T ss_pred ------------------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC
Confidence 01112457999999999999988999999999999999999999999998888777777776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhcc
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCM 969 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~ 969 (1002)
...++. ..+..+.+||.+||++||.+|++.. +.+.++++||||+++.|......
T Consensus 212 ~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~ 266 (325)
T cd05594 212 EIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEK 266 (325)
T ss_pred CCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 666654 3688999999999999999998321 12999999999999999977543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=381.32 Aligned_cols=269 Identities=37% Similarity=0.740 Sum_probs=226.0
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++..............|..++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999875432333445566788888764 999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999999764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 211 (316)
T cd05619 150 ------------------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211 (316)
T ss_pred ------------------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 01122457999999999999988999999999999999999999999998888777777665
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHH-HHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN-EIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~-elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
...++. ..+..+.+||.+||+.||++||+ +. ++++||||+.++|..+.....+....|.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05619 212 NPCYPR--WLTREAKDILVKLFVREPERRLG----VKGDIRQHPFFREIDWSALEEREIEPPFKPK 271 (316)
T ss_pred CCCCCc--cCCHHHHHHHHHHhccCHhhcCC----ChHHHHcCcccCCCCHHHHHhCCCCCCcCCC
Confidence 544443 36788999999999999999999 64 8999999999999988655443333443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=381.51 Aligned_cols=278 Identities=35% Similarity=0.666 Sum_probs=236.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
+|...+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788899999999999999999999999999998754434445566778888988885 578889999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--- 155 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC---
Confidence 999999999998764 459999999999999999999999999999999999999999999999999985321100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+.
T Consensus 156 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~ 211 (323)
T cd05615 156 ------------------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ 211 (323)
T ss_pred ------------------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01224569999999999999889999999999999999999999999998888888
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
.+......+|. ..+..+.+|+.+||..+|.+|++.. +..+++++||||+.++|..+.....+....|.
T Consensus 212 ~i~~~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05615 212 SIMEHNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPK 280 (323)
T ss_pred HHHhCCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCc
Confidence 88887766654 3678899999999999999999864 34789999999999999988655433333343
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=383.40 Aligned_cols=267 Identities=38% Similarity=0.740 Sum_probs=224.9
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||++++++|...+.+|+|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876554555667788899999988 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 9999988764 4599999999999999999999999999999999999999999999999999843110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------ChH
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK---------TRQ 904 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~---------~~~ 904 (1002)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...
T Consensus 149 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05588 149 -----------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED 211 (329)
T ss_pred -----------------CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH
Confidence 001123457999999999999999999999999999999999999999631 112
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh--hcHHHHHcCCCcCCCChhhhhccCCC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCMNPP 972 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~~~~~ 972 (1002)
.....+.......|. .++..+.+||.+||+.||.+|++.. ..++++++||||+.++|..+...+..
T Consensus 212 ~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~ 279 (329)
T cd05588 212 YLFQVILEKQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVL 279 (329)
T ss_pred HHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCC
Confidence 234445555555543 4688899999999999999999853 23789999999999999988655443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=380.62 Aligned_cols=270 Identities=40% Similarity=0.787 Sum_probs=228.1
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++..............|..++..+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999875443444455666777777654 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999998764 45999999999999999999999999999999999999999999999999998542110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 150 ------------------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999988999999999999999999999999998888887777665
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
...++. .++..+.+||.+||..||.+||+. ..++++||||+.++|..+.....+....|.
T Consensus 212 ~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~---~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05592 212 RPHFPR--WISKEAKDCLSKLFERDPTKRLGV---DGDIRQHPFFRGIDWERLEKREIPPPFKPK 271 (316)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---hHHHHcCcccCCCCHHHHHhCCCCCCcCCC
Confidence 544443 368889999999999999999983 358899999999999988765555444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=381.04 Aligned_cols=273 Identities=39% Similarity=0.731 Sum_probs=231.3
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++...........+..|+.+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999876544455566778899999888 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--------- 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999988432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~ 211 (318)
T cd05570 150 ------------------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211 (318)
T ss_pred ------------------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 01122457999999999999999999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
...++. ..+..+.+||.+||..||.+||+.. ..+.++++||||+.++|.............|.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (318)
T cd05570 212 EVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275 (318)
T ss_pred CCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 665554 3688999999999999999999931 12299999999999999887654444333343
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=372.08 Aligned_cols=272 Identities=32% Similarity=0.555 Sum_probs=225.4
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||+|+||.||++.++.+|+.||+|.+.............+..|+++++.++||||+++++++..+.++|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999764433333344556799999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001865 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (1002)
Q Consensus 757 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 836 (1002)
.+++.......++...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 988876555568999999999999999999999999999999999999999999999999985432110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh----HHHHHHHHh
Q 001865 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR----QKTFANILH 912 (1002)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~ 912 (1002)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... .........
T Consensus 150 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 150 -----------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred -----------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 11224689999999999988899999999999999999999999976432 233333333
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCC
Q 001865 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 913 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
.....+ ....+.++.+||.+||++||++||++.+..++++.||||+.++|..++....|..++|
T Consensus 213 ~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 213 DEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred cccccc-cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 333332 2346888999999999999999999877779999999999999999976555544443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=379.49 Aligned_cols=270 Identities=39% Similarity=0.736 Sum_probs=226.2
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++..............|..++..+ +||||+++++++...+++|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4689999999999999999999999999875433333455667788888754 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999988432100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (316)
T cd05620 150 ------------------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211 (316)
T ss_pred ------------------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 01123457999999999999999999999999999999999999999998888777777666
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
...++. ..+.++.+||.+||..||++||+. .+++++||||+.++|..+.....+....|.
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~---~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~ 271 (316)
T cd05620 212 TPHYPR--WITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKRELDPPFKPK 271 (316)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---hHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 555544 368899999999999999999992 358999999999999987544433333343
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=387.23 Aligned_cols=268 Identities=36% Similarity=0.660 Sum_probs=227.9
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++++
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999764333444455677899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+|||||++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999998753 4899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
. .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+
T Consensus 196 ~--------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 196 G--------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred C--------------------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 0 01123457999999999997543 77899999999999999999999999
Q ss_pred CChHHHHHHHHhCC--CCCCCCCCCCHHHHHHHHHccccCcCC---CCCChhcHHHHHcCCCcCCCChhhh
Q 001865 901 KTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKS---RLGSHEGANEIKKHPFFKGVNWALV 966 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~--~~~~~~~~~s~~~~~Ll~~~L~~dP~~---Rpt~~~~a~elL~Hp~f~~~~~~~~ 966 (1002)
.+....+..+.... +.++.....+..+++||.+||. +|.. |++ ++++++||||++..|...
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~----~~ei~~h~~~~~~~~~~~ 315 (371)
T cd05622 250 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNG----VEEIKRHLFFKNDQWAWE 315 (371)
T ss_pred CCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCC----HHHHhcCcccCCCChhHH
Confidence 88888888887643 4566666689999999999998 5554 556 999999999999666443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=382.04 Aligned_cols=267 Identities=42% Similarity=0.739 Sum_probs=228.5
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654333344455556655 46778999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--------- 149 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--------- 149 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---------
Confidence 9999988764 45899999999999999999999999999999999999999999999999998532100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 150 ------------------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred ------------------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 01123457999999999999999999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCC
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 972 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~ 972 (1002)
....+. ..+..+.++|.+||..+|.+||+..+.+.++++||||+.++|..+.....|
T Consensus 212 ~~~~~~--~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~ 268 (325)
T cd05604 212 PLVLRP--GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIP 268 (325)
T ss_pred CccCCC--CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCC
Confidence 554433 468889999999999999999998888899999999999999988654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=371.35 Aligned_cols=272 Identities=32% Similarity=0.588 Sum_probs=223.5
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||+|+||+||++.+..+++.||+|.+.+...........+..|+.+++.++|+||+++++++...+.+|+|||||++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999765443444456678899999999999999999999999999999999999999
Q ss_pred hHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001865 757 FLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (1002)
Q Consensus 757 ~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 834 (1002)
..++.. .....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 888743 223468999999999999999999999999999999999999999999999999985432110
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH----HHHHHH
Q 001865 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ----KTFANI 910 (1002)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~----~~~~~i 910 (1002)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+
T Consensus 152 ------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 152 ------------------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred ------------------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 0112357899999999999999999999999999999999999999765432 222333
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh-cHHHHHcCCCcCCCChhhhhccCCCCCCCC
Q 001865 911 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 911 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
......++ ...+..+.+|+.+||+.||++||++.+ .++++++||||+.++|..+.....|....|
T Consensus 214 ~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 214 LNDSVTYP--DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred cccCCCCc--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 33322222 346889999999999999999996543 499999999999999998866555444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=380.54 Aligned_cols=305 Identities=37% Similarity=0.635 Sum_probs=251.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
++..-|..++.||=|+||.|.+|+-..|...||+|.+++..+..++.+..+..|..||..-+++-||+||..|++.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 56678999999999999999999999999999999999887888888888999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||+|++||++-.+|.+. +.+.+..+++|+..+.+|++++|+.|+|||||||+|||||.+|++||+|||++.-+....
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999999885 569999999999999999999999999999999999999999999999999986443221
Q ss_pred CCCCCcchhhhhcccCCCCCccc---------------ccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFM---------------AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~e 890 (1002)
...+....+..|.......+.+. ..........+||+.|+|||++....|+..||.||.|||||+
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 11111111111111000000000 011123346799999999999999999999999999999999
Q ss_pred HHcCCCCCCCCChHHHHHHHHh--CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhc
Q 001865 891 MLYGYTPFRGKTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 891 lltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
|+.|++||...+..+...+++. ..+.++....++.++.+||+++++ +++.|+. +..++++..||||++++|..++.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLG-kng~d~vKaHpfFkgIDfsslRk 941 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLG-KNGADQVKAHPFFKGIDFSSLRK 941 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhc-ccchhhhhcCccccccchHhhhh
Confidence 9999999998887776666653 345667777789999999998774 8899998 55688999999999999999988
Q ss_pred cCCCCC
Q 001865 969 MNPPEL 974 (1002)
Q Consensus 969 ~~~~~~ 974 (1002)
..-|=+
T Consensus 942 q~ApYI 947 (1034)
T KOG0608|consen 942 QRAPYI 947 (1034)
T ss_pred ccCCcC
Confidence 776633
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=370.70 Aligned_cols=262 Identities=31% Similarity=0.487 Sum_probs=235.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
-+-|.+.+.||+|-|++|-+|++..||..||||++.+..+.+ .....+.+|+.+|+.++|||||++|++...+..+|+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 367999999999999999999999999999999999876543 4456788899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-ecCCcEEEEeccCCcccCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl-~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
+|+-++|+|++|+.+.. ..+++..++.|+.||+.|+.|+|+..+|||||||+|+.| .+-|-|||.|||++..+.+
T Consensus 96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--- 171 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--- 171 (864)
T ss_pred EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC---
Confidence 99999999999998764 449999999999999999999999999999999999876 4678999999999854321
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~-~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
...-.+.||++.|-|||+|.+..|+ +++||||||||||-|++|++||...++.+
T Consensus 172 -------------------------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 172 -------------------------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred -------------------------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 1234578999999999999999886 48999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhh
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 965 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 965 (1002)
.+..|+......|.. .+.++++||++||..||.+|.+ +++|..|+|++.++-.+
T Consensus 227 TLTmImDCKYtvPsh--vS~eCrdLI~sMLvRdPkkRAs----lEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 227 TLTMIMDCKYTVPSH--VSKECRDLIQSMLVRDPKKRAS----LEEIVSTSWLQAGDRGL 280 (864)
T ss_pred hhhhhhcccccCchh--hhHHHHHHHHHHHhcCchhhcc----HHHHhccccccCCCCCc
Confidence 999999988777765 6899999999999999999999 99999999999976543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=371.95 Aligned_cols=280 Identities=33% Similarity=0.563 Sum_probs=229.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999976544333344566789999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 999999998886654456999999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
......+|++.|+|||++.+..++.++||||+||++|+|++|..||.+.........
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 156 -----------------------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred -----------------------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 011234689999999999988899999999999999999999999988665433322
Q ss_pred HHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCC
Q 001865 910 ILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 910 i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
+... ..........+..+.+||.+||..||.+||++. +.+.++++||||...+|..+.....+....|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 213 VERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred HHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCC
Confidence 2211 111112234678899999999999999999322 1289999999999999999966555444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=379.77 Aligned_cols=265 Identities=38% Similarity=0.739 Sum_probs=222.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555555666788899888776 899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--------- 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---------
Confidence 9999888764 45999999999999999999999999999999999999999999999999998532100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC---------CChH
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG---------KTRQ 904 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~---------~~~~ 904 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.. ....
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~ 211 (329)
T cd05618 150 ------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 211 (329)
T ss_pred ------------------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHH
Confidence 0112345799999999999999999999999999999999999999952 1122
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh--hcHHHHHcCCCcCCCChhhhhccC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCMN 970 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~~~ 970 (1002)
.....+......+|. ..+..+.+||.+||..||.+||++. ..+.++++||||+.++|......+
T Consensus 212 ~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~ 277 (329)
T cd05618 212 YLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQ 277 (329)
T ss_pred HHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCC
Confidence 334445555555554 4678899999999999999999853 236899999999999998885543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=379.17 Aligned_cols=277 Identities=37% Similarity=0.689 Sum_probs=230.2
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++++...........+.+|+.++.++ +||||+.+++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554555667788899999888 699999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------- 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--------- 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---------
Confidence 9999988764 45999999999999999999999999999999999999999999999999988532100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-------ChHHH
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-------TRQKT 906 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~-------~~~~~ 906 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||... .....
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~ 211 (327)
T cd05617 150 ------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211 (327)
T ss_pred ------------------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH
Confidence 01123467999999999999999999999999999999999999999532 22234
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh--hcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCCc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH--EGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATD 982 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~--~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 982 (1002)
...+......+|. ..+..+.++|.+||..||.+|++.. ..++++++||||+.++|..+.....+....|....+
T Consensus 212 ~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 287 (327)
T cd05617 212 FQVILEKPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDD 287 (327)
T ss_pred HHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCC
Confidence 4444454444443 3678899999999999999999843 236899999999999999997766665555554333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=360.12 Aligned_cols=261 Identities=26% Similarity=0.453 Sum_probs=222.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-cceeEEEEeeCC----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKT---- 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~---- 742 (1002)
...|..+++||+|+||+||+|+.+.+|+.||+|.++-.... ........+|+.+|+.|+|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45788999999999999999999999999999999865321 123345678999999999999 999999998877
Q ss_pred --eEEEEEeccCCCchhHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001865 743 --HVCLITDYCPGGELFLLLDRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 743 --~~~lV~E~~~ggsL~~~l~~~~~--~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a 818 (1002)
.+++||||+ .-+|..++..... ..++...++.++.||+.||+|||+++|+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 8899999987543 35788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~P 897 (1002)
+... .+....+..++|..|+|||++.+. .|+...||||+|||++||+++++.
T Consensus 168 ra~~---------------------------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFS---------------------------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhc---------------------------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 7543 122335567899999999999987 788999999999999999999999
Q ss_pred CCCCChHHHHHHHHhC-----CCCC-------------CCC----------CCCCHHHHHHHHHccccCcCCCCCChhcH
Q 001865 898 FRGKTRQKTFANILHK-----DLKF-------------PSS----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~-----~~~~-------------~~~----------~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a 949 (1002)
|+|.+.......|.+- ...| +.. +..+....+|+.+||+++|.+|.| +
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a 296 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----A 296 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----H
Confidence 9999998888888651 1111 111 112347889999999999999999 9
Q ss_pred HHHHcCCCcCCC
Q 001865 950 NEIKKHPFFKGV 961 (1002)
Q Consensus 950 ~elL~Hp~f~~~ 961 (1002)
+.+|.||||...
T Consensus 297 ~~al~h~yf~~~ 308 (323)
T KOG0594|consen 297 KGALTHPYFSEL 308 (323)
T ss_pred HHHhcChhhccc
Confidence 999999999985
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=377.90 Aligned_cols=265 Identities=45% Similarity=0.794 Sum_probs=225.2
Q ss_pred cccccccCcEEEEEEEEc---CCCeEEEEEEeeccccc-ChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 674 IKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~---~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
++.||+|+||.||+|++. .+++.||+|++++.... .......+.+|+.+|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 46889999999864322 22334566789999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999999764 45889999999999999999999999999999999999999999999999998532110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..
T Consensus 154 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~ 211 (323)
T cd05584 154 ----------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211 (323)
T ss_pred ----------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 0112235799999999999998899999999999999999999999999888888888
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhcc
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCM 969 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~ 969 (1002)
+..+...++. ..+..+.+||.+||+.+|++||+.. ..++++++||||+..+|..+...
T Consensus 212 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~ 270 (323)
T cd05584 212 ILKGKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270 (323)
T ss_pred HHcCCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcC
Confidence 8877665554 4678899999999999999999321 12999999999999999888543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=383.14 Aligned_cols=273 Identities=40% Similarity=0.718 Sum_probs=229.6
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
||+|+||+||+|.+..+++.||+|++.+..............|..++..+ +||||+.+++++...+.+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443334445556677777655 799999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--------- 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--------- 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---------
Confidence 9999998764 45899999999999999999999999999999999999999999999999998542111
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 912 (1002)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~ 211 (330)
T cd05586 150 ------------------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211 (330)
T ss_pred ------------------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc
Confidence 0112345799999999998764 478899999999999999999999999888888888877
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCC
Q 001865 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF 979 (1002)
Q Consensus 913 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~ 979 (1002)
+...++.. ..+..+.+||.+||..||.+||+..+.+.++++||||+.++|..+.....+....|..
T Consensus 212 ~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~ 277 (330)
T cd05586 212 GKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIV 277 (330)
T ss_pred CCCCCCCc-cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCC
Confidence 76666543 3678899999999999999999877779999999999999999886554443344443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=378.71 Aligned_cols=264 Identities=39% Similarity=0.707 Sum_probs=225.3
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHH-HHHHhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-EILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999865332223333444444 456788999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--------- 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--------- 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---------
Confidence 9999999764 45889999999999999999999999999999999999999999999999998532110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 150 ------------------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred ------------------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 01123457999999999999999999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhcc
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 969 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~ 969 (1002)
...++ ...+..+.+||.+||+.||.+|++..+.+.++++|+||..++|..+...
T Consensus 212 ~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~ 265 (325)
T cd05602 212 PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINK 265 (325)
T ss_pred CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhC
Confidence 55443 3468899999999999999999998888899999999999999988543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=377.22 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=227.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|..+..||+|+||.||++.+..+++.||+|++.... .......+.+|+.+|..++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 46888899999999999999999999999999998543 3456778899999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||.||++.++++.. ..+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++..+..
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~----- 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN----- 163 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-----
Confidence 999999999999763 4468999999999999999999999999999999999999999999999999854321
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
......+++|||.|||||++.+..|+.++||||||++.|||++|.+||....+...+.
T Consensus 164 ----------------------~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf 221 (467)
T KOG0201|consen 164 ----------------------TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF 221 (467)
T ss_pred ----------------------hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence 1122367899999999999999899999999999999999999999999888765555
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
.|-+...+.... ..++.+++|+..||.+||+.||+ |.+||+|+|++...
T Consensus 222 lIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~Rps----A~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 222 LIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRPS----AKELLKHKFIKRAK 270 (467)
T ss_pred eccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCcC----HHHHhhhHHHHhcC
Confidence 554444433333 67888999999999999999999 99999999999843
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.21 Aligned_cols=273 Identities=38% Similarity=0.678 Sum_probs=228.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+.+|+.++..++|+||+.+++++..++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998643334445566788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+.+++|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence 999999999999753 34589999999999999999999999999999999999999999999999999854321100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~ 213 (331)
T cd05597 158 ------------------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ------------------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH
Confidence 01123469999999999863 4567899999999999999999999998887
Q ss_pred HHHHHHHHhCC--CCCCCC-CCCCHHHHHHHHHccccCcCC--CCCChhcHHHHHcCCCcCCCChhhhhccCCC
Q 001865 904 QKTFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPP 972 (1002)
Q Consensus 904 ~~~~~~i~~~~--~~~~~~-~~~s~~~~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~ 972 (1002)
.+.+..+.... ..++.. ...+..+++||++||..++.. |++ ++++++||||++++|..+....+|
T Consensus 214 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~ 283 (331)
T cd05597 214 VETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAP 283 (331)
T ss_pred HHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCC
Confidence 77777776543 223222 346889999999998754333 667 999999999999999999876665
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=375.09 Aligned_cols=259 Identities=28% Similarity=0.433 Sum_probs=221.4
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeE-EEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 663 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~-~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
.+.++.....+...||.|+||+||++.+ .|.. +|+|++......... ...+.+|+.+|.+++|||||++++++...
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3456667778888899999999999999 4445 999999876443333 77899999999999999999999999988
Q ss_pred C-eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-cccCCCCCCcEEEecCC-cEEEEeccCC
Q 001865 742 T-HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNG-HVSLTDFDLS 818 (1002)
Q Consensus 742 ~-~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g-IiHrDLKP~NILl~~~g-~vkL~DFG~a 818 (1002)
. ..++|||||++|+|.+++.......++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 7 7999999999999999998744567999999999999999999999999 99999999999999998 9999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc--CCCCCChhhHHHHHHHHHHHHcCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGHTSAVDWWALGILLYEMLYGYT 896 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--~~~~~~~sDIwSlGvil~elltG~~ 896 (1002)
+...... .......||+.|||||++. ...|+.++||||||+++|||++|+.
T Consensus 192 r~~~~~~---------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 192 REKVISK---------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred eeecccc---------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 6643211 1123367999999999999 5689999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 897 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
||.+.........+..+....+....+++.+..|+.+||..||..||++.+.+..
T Consensus 245 Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~ 299 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSR 299 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence 9999988777777766555554444588899999999999999999998765443
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=376.39 Aligned_cols=263 Identities=43% Similarity=0.756 Sum_probs=225.2
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHH-HHHhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE-ILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+|+|||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999998654333333445555554 67889999999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--------- 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---------
Confidence 9999888764 45899999999999999999999999999999999999999999999999988532100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 150 ------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 150 ------------------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred ------------------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence 01123457999999999999988999999999999999999999999998888888888776
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhc
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
...++. ..+..+.++|.+||+.||.+|++....+.++++||||..++|..+..
T Consensus 212 ~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T cd05603 212 PLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYH 264 (321)
T ss_pred CCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhc
Confidence 655543 46788999999999999999999777788999999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=376.79 Aligned_cols=295 Identities=37% Similarity=0.631 Sum_probs=261.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
++...+++++..||-|+||.|-++........+|+|++++..+.+......+..|.+||...++|+||++|..|.++.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45567899999999999999999998777667999999998888888888899999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|++||-|-||.|+..+..+ +.+.+...++|+..+++|++|||++|||.|||||+|+|++.+|.+||.|||+|+.+...
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999999875 56999999999999999999999999999999999999999999999999999765422
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
....++||||.|.|||++.+..++.++|.||||+++|||++|.+||.+.++.
T Consensus 574 ----------------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm 625 (732)
T KOG0614|consen 574 ----------------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM 625 (732)
T ss_pred ----------------------------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence 2345799999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCC-hhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCCcc
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDT 983 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~~ 983 (1002)
..+..|+++--.+.-+..+...+.+||+++++.+|.+|+.. ...+.+|.+|.||.+++|..++..+-|.+..|.++-+.
T Consensus 626 ktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~pt 705 (732)
T KOG0614|consen 626 KTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPT 705 (732)
T ss_pred HHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcc
Confidence 99999998743322224467889999999999999999985 45699999999999999999977666666678877766
Q ss_pred cccccc
Q 001865 984 EKEYKV 989 (1002)
Q Consensus 984 ~~~~~~ 989 (1002)
.-.|+.
T Consensus 706 D~s~Fd 711 (732)
T KOG0614|consen 706 DVSNFD 711 (732)
T ss_pred cchhcc
Confidence 555543
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=368.57 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=212.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976422 2334566788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||++++.|..+... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 155 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-- 155 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc--
Confidence 99988766655433 24589999999999999999999999999999999999999999999999999865321110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||++.+..++.++|||||||++|+|++|++||.+.+......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~ 211 (287)
T cd07848 156 ------------------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211 (287)
T ss_pred ------------------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 11123568999999999998889999999999999999999999998876655443
Q ss_pred HHHhCC-------------------CCCCCC-----------CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 909 NILHKD-------------------LKFPSS-----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 909 ~i~~~~-------------------~~~~~~-----------~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+.... ..++.. ...+..+.+||++||++||++||| ++++|+||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 212 TIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred HHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 332210 011110 125678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=375.88 Aligned_cols=279 Identities=43% Similarity=0.754 Sum_probs=224.7
Q ss_pred CccccccccccCcEEEEEEEEc---CCCeEEEEEEeecccccC-hHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 744 (1002)
+|++++.||+|+||.||+|++. .+++.||+|++.+..... ......+..|+.+++.+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 468999999997643222 23345677899999999 599999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999998764 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCC--
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK-- 901 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~-- 901 (1002)
. .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 159 ~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 159 E--------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred C--------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 0 0112245799999999999875 4788999999999999999999999643
Q ss_pred --ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCC
Q 001865 902 --TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978 (1002)
Q Consensus 902 --~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~ 978 (1002)
........+......++ ...+..+.+||.+||..||++||+.. +.++++++||||+..+|..+.....+....|.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~ 290 (332)
T cd05614 213 RNTQSEVSRRILKCDPPFP--SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290 (332)
T ss_pred CCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 22333444444443333 34688999999999999999999432 23899999999999999888654333333343
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=377.11 Aligned_cols=277 Identities=37% Similarity=0.662 Sum_probs=230.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++|+||+++++++...++.|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997643333444556778999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 9999999999997642 4589999999999999999999999999999999999999999999999999855321100
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 158 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 158 ------------------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred ------------------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 01123579999999999875 4577899999999999999999999999888
Q ss_pred HHHHHHHHhCC--CCCCCC-CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCC
Q 001865 904 QKTFANILHKD--LKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 974 (1002)
Q Consensus 904 ~~~~~~i~~~~--~~~~~~-~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~ 974 (1002)
.+.+..+.... +.++.. ...+..+.+||.+||+.++. |+. ...++++++||||+.++|..+....+|..
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~-~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~ 285 (331)
T cd05624 214 VETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRER-RLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYI 285 (331)
T ss_pred HHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchh-hcC-CCCHHHHhcCCCcCCCCHHHHhhCCCCcc
Confidence 88777776643 333332 33688999999999986554 432 12299999999999999999988776644
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=382.27 Aligned_cols=253 Identities=29% Similarity=0.498 Sum_probs=219.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-C-----CCcceeEEEEeeCCe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-H-----PFVPALYASFQTKTH 743 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----pnIv~l~~~~~~~~~ 743 (1002)
+|.+++.||+|+||+|.+|.+..|++.||||+++.. +....+...|+.+|..|+ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999999864 556677788999999996 4 399999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC--cEEEEeccCCccc
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--HVSLTDFDLSCLT 821 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g--~vkL~DFG~a~~~ 821 (1002)
.|||+|++ +.+|.++++.+....++...++.|+.||+.||.+||++||||+||||+|||+..-+ .|||+|||.|+..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 99999999998888899999999999999999999999999999999999998543 6999999999764
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... .-+++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|+|.
T Consensus 342 ~q~------------------------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 SQR------------------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred CCc------------------------------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 311 11567899999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhC--------------------C-C-------------------------------CCC-CC-------C
Q 001865 902 TRQKTFANILHK--------------------D-L-------------------------------KFP-SS-------T 921 (1002)
Q Consensus 902 ~~~~~~~~i~~~--------------------~-~-------------------------------~~~-~~-------~ 921 (1002)
+..+.+..|++- . . ..| .. .
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 988888777541 0 0 001 00 0
Q ss_pred -CCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 922 -PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 922 -~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.....+.+||.+||.+||.+|+| ..++|+||||+..
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~t----p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERIT----PAQALNHPFLTGT 508 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCC----HHHHhcCcccccc
Confidence 11235789999999999999999 9999999999964
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=375.78 Aligned_cols=275 Identities=36% Similarity=0.642 Sum_probs=229.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 37999999999999999999999999999999997643333344455778999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+.+|+|.+++.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC---
Confidence 999999999999764 2458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
.......+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.
T Consensus 157 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 157 -----------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred -----------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 01112357999999999986 34578899999999999999999999999888
Q ss_pred HHHHHHHHhCCC--CCCCC-CCCCHHHHHHHHHccccCcCC--CCCChhcHHHHHcCCCcCCCChhhhhccCCCCC
Q 001865 904 QKTFANILHKDL--KFPSS-TPTSLHAKQLMYRLLHRDPKS--RLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 974 (1002)
Q Consensus 904 ~~~~~~i~~~~~--~~~~~-~~~s~~~~~Ll~~~L~~dP~~--Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~ 974 (1002)
.+.+..+..... .++.. ..++..+++||.+||..++.. |++ ++++++||||.+++|..+.....|.+
T Consensus 214 ~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~ 285 (332)
T cd05623 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYI 285 (332)
T ss_pred HHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCcc
Confidence 888888876543 23332 346889999999999765544 567 99999999999999999977665544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=376.36 Aligned_cols=266 Identities=43% Similarity=0.768 Sum_probs=228.1
Q ss_pred cccccccCcEEEEEEEE---cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 674 IKPLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
++.||+|+||.||++++ ..+|+.||+|++.+... .......+.+|++++++++||||+++++++..++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999987 35789999999986532 222345567899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----- 152 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE----- 152 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-----
Confidence 9999999999764 458999999999999999999999999999999999999999999999999985432110
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i 910 (1002)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+
T Consensus 153 ----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 153 ----------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred ----------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 1122457999999999999888899999999999999999999999998888888888
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh-cHHHHHcCCCcCCCChhhhhccCC
Q 001865 911 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRCMNP 971 (1002)
Q Consensus 911 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~~~~ 971 (1002)
......++. ..+..+.+||.+||+.||++||++.+ .++++++||||..++|..+.....
T Consensus 211 ~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (318)
T cd05582 211 LKAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREI 270 (318)
T ss_pred HcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCC
Confidence 777665554 36788999999999999999999654 478899999999999998865443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.11 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=213.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++++.||.|+||.||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4689999999999999999999999999999999875421 22234567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||++ ++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 99995 5899888654 345899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~ 212 (288)
T cd07871 157 ------------------------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE 212 (288)
T ss_pred ------------------------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011223468999999999875 5688899999999999999999999998877666
Q ss_pred HHHHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~-------------------~~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..+.... ..++. ....+.++++||.+||++||.+||| ++|+|+||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 213 LHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred HHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 65554311 00111 1235778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=370.77 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=210.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875421 22234567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 82 ~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 82 FEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--- 156 (303)
T ss_pred EECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC---
Confidence 9999 57888887654 245899999999999999999999999999999999999999999999999998542211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 905 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~-~ 905 (1002)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .
T Consensus 157 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 212 (303)
T cd07869 157 ------------------------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212 (303)
T ss_pred ------------------------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 011223468999999999865 45788999999999999999999999875432 2
Q ss_pred HHHHHHhC--CC---CCC-------------------------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 906 TFANILHK--DL---KFP-------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 906 ~~~~i~~~--~~---~~~-------------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
.+..+... .. .++ .....+..+.+||.+||++||.+||| +.++|+|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h 288 (303)
T cd07869 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSH 288 (303)
T ss_pred HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcC
Confidence 23222210 00 000 00113457889999999999999999 9999999
Q ss_pred CCcCCCCh
Q 001865 956 PFFKGVNW 963 (1002)
Q Consensus 956 p~f~~~~~ 963 (1002)
|||+.+++
T Consensus 289 ~~f~~~~~ 296 (303)
T cd07869 289 EYFSDLPP 296 (303)
T ss_pred cccccCCh
Confidence 99998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.64 Aligned_cols=289 Identities=35% Similarity=0.654 Sum_probs=256.1
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 742 (1002)
..+...+|..+..||.|+||.|.++..+.+...||||+++++.+....+.+--..|-.+|... +-|.+++++.+|+.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 356678999999999999999999999999999999999998887777777777888888877 5689999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+|+||||+.||+|--.+++- +.+.+..+..|+..|+-||-+||++|||.||||.+|||++.+|++||+|||++..--
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999998888764 558999999999999999999999999999999999999999999999999985421
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
. ......++||||.|+|||.+...+|+.++|.||+||+||||+.|++||.|.+
T Consensus 502 ~---------------------------~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 502 F---------------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred c---------------------------CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 1 1123457899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCC
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 981 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~ 981 (1002)
..+.++.|......+|.. .|.++.++...+|.+.|.+|+..- +.-++|..||||+.++|+.++....+....|..++
T Consensus 555 E~elF~aI~ehnvsyPKs--lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~ 632 (683)
T KOG0696|consen 555 EDELFQAIMEHNVSYPKS--LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKC 632 (683)
T ss_pred HHHHHHHHHHccCcCccc--ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcccc
Confidence 999999999999888876 689999999999999999999875 34568999999999999999766655556677654
Q ss_pred cc
Q 001865 982 DT 983 (1002)
Q Consensus 982 ~~ 983 (1002)
..
T Consensus 633 ~r 634 (683)
T KOG0696|consen 633 GR 634 (683)
T ss_pred CC
Confidence 43
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.38 Aligned_cols=262 Identities=24% Similarity=0.390 Sum_probs=218.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++++.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++|+.++||||+++++++..++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 44679999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999999999764 4589999999999999999999986 6999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 158 -----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 158 -----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred -----------------------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 112346899999999999988999999999999999999999999766544
Q ss_pred HHHHHHH----------------------------------------------hCCCCCCCCCCCCHHHHHHHHHccccC
Q 001865 905 KTFANIL----------------------------------------------HKDLKFPSSTPTSLHAKQLMYRLLHRD 938 (1002)
Q Consensus 905 ~~~~~i~----------------------------------------------~~~~~~~~~~~~s~~~~~Ll~~~L~~d 938 (1002)
+....+. ....+.......+.++++||.+||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC
Confidence 3322111 000011111235778999999999999
Q ss_pred cCCCCCChhcHHHHHcCCCcCCCChh
Q 001865 939 PKSRLGSHEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 939 P~~Rpt~~~~a~elL~Hp~f~~~~~~ 964 (1002)
|++||| +++|++||||+.....
T Consensus 289 P~~Rpt----~~ell~h~~~~~~~~~ 310 (331)
T cd06649 289 PAERAD----LKMLMNHTFIKRSEVE 310 (331)
T ss_pred cccCCC----HHHHhcChHHhhcccc
Confidence 999999 9999999999875443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=372.73 Aligned_cols=262 Identities=25% Similarity=0.451 Sum_probs=236.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe-EEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH-VCL 746 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~l 746 (1002)
++.|.+++++|.|+||.+++++++..++.||+|.+.-.....+.. ....+|..+++++.|||||.+.+.|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r-~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER-RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh-HHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 568999999999999999999999999999999998765544443 366789999999999999999999998887 999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||+||+||+|.+.+.++.+..++++.+..++.||+.||.|||+++|+|||||+.|||++.++.|+|+|||+|+.+..+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 9999999999999998877889999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
....+.+|||.||+||.+.+.+|+.++|||||||++|||++-+.+|.+.+-...
T Consensus 161 --------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 161 --------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred --------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 134578999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
+.+|.+.. -.|.+...+.+++.||..||+.+|..||+ +.+||.+|.+...-
T Consensus 215 i~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPs----a~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 215 ILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPS----ALELLRRPHLLRYL 265 (426)
T ss_pred HHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCC----HHHHhhChhhhhHH
Confidence 99998876 34445557889999999999999999999 99999999988543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=360.36 Aligned_cols=280 Identities=33% Similarity=0.560 Sum_probs=230.6
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|+..+.||.|+||+||++.+..+++.||+|.+.+...........+.+|+.+++.++|+||+.+++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47788999999999999999999999999999976544333444567789999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998887654456999999999999999999999999999999999999999999999999988543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........
T Consensus 156 -----------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 156 -----------------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred -----------------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011234689999999999988899999999999999999999999988765444333
Q ss_pred HHhCC--CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc-HHHHHcCCCcCCCChhhhhccCCCCCCCC
Q 001865 910 ILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG-ANEIKKHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 910 i~~~~--~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~-a~elL~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
+.... .........+..+.+|+.+||+.||.+||++.+. +.++++|+||+.++|..+....-....+|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05632 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVP 283 (285)
T ss_pred HHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCC
Confidence 33211 1112223467789999999999999999997644 88999999999999998755444433333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=359.98 Aligned_cols=278 Identities=43% Similarity=0.770 Sum_probs=240.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||++.+..+++.+|+|++.+...........+.+|++++++++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 37999999999999999999999999999999998654444555677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999999775 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+......
T Consensus 155 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 208 (290)
T cd05580 155 --------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE 208 (290)
T ss_pred --------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 123468999999999988888899999999999999999999999888777777
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCC-hhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFA 980 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~ 980 (1002)
.+..+...++.. .+..++++|.+||..||.+|++. .+.++++++||||+.++|..+....-+....|...
T Consensus 209 ~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (290)
T cd05580 209 KILEGKVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVK 279 (290)
T ss_pred HHhcCCccCCcc--CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCC
Confidence 777666555543 57889999999999999999932 23499999999999999999976555555555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=369.87 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=221.1
Q ss_pred ccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 661 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
...+.+....+++++.||+|.||.||++.+.. ...+|+|.++...+ ....+.+|+++|++|+|++||++++++..
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 44567888899999999999999999999933 33799999987533 23567799999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
+..+|||||||+.|+|.++|+...+..+...+...++.||++|++||+++++|||||...||||++++.|||+|||+|+.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 88999999999999999999986677899999999999999999999999999999999999999999999999999984
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~ 899 (1002)
...+.. ......--...|.|||++....++.+||||||||+||||+| |+.||.
T Consensus 353 ~~d~~Y--------------------------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 353 IGDDEY--------------------------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred cCCCce--------------------------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 332111 01111123557999999999999999999999999999997 999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
+.+..+.+..+.++ ..+|.+..++.++.+++..||..+|++|||+..
T Consensus 407 ~msn~ev~~~le~G-yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 407 GMSNEEVLELLERG-YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred CCCHHHHHHHHhcc-CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 99999999887765 456666678999999999999999999999653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.59 Aligned_cols=270 Identities=35% Similarity=0.619 Sum_probs=224.2
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++|++|+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47788999999999999999999999999999876544444444567789999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 999999999987654456999999999999999999999999999999999999999999999999988543210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH---HH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ---KT 906 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~---~~ 906 (1002)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.... ..
T Consensus 156 -----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 156 -----------------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred -----------------------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 0112346899999999999988999999999999999999999999875432 22
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
...+... .........+..+.+|+.+||+.||++|||+. ..++++++||||+.++|..++.
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~ 274 (285)
T cd05630 213 VERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEA 274 (285)
T ss_pred HHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhc
Confidence 2222221 11112234678899999999999999999843 1378999999999999998866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=370.70 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=211.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----CeE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----THV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 744 (1002)
+|++.+.||+|+||.||+|.+..++..||||.+.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 2233445788999999999999999999987543 358
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 67899988764 35899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
.. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 157 ~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 157 TP------------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cC------------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 00 0011234579999999999876 578889999999999999999999998766
Q ss_pred hHHHHHHHHh--------------------------CCCCCC---CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 903 RQKTFANILH--------------------------KDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 903 ~~~~~~~i~~--------------------------~~~~~~---~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
.......+.. .....+ ..+..+..+.+||.+||+.||++||+ +.++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l 288 (338)
T cd07859 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEAL 288 (338)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHh
Confidence 4433221111 000000 11235677899999999999999999 99999
Q ss_pred cCCCcCCCChh
Q 001865 954 KHPFFKGVNWA 964 (1002)
Q Consensus 954 ~Hp~f~~~~~~ 964 (1002)
+||||+++...
T Consensus 289 ~hp~f~~~~~~ 299 (338)
T cd07859 289 ADPYFKGLAKV 299 (338)
T ss_pred cCchhhhcCcc
Confidence 99999986654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=360.34 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=209.9
Q ss_pred CCccccccccccCcEEEEEEEEcC-CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceeEEEEe-----
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQ----- 739 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~----- 739 (1002)
++|++++.||+|+||.||+|.+.. +++.||+|.++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 4788999998754322 22233455677777665 6999999999875
Q ss_pred eCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
....+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 345789999999 5799999987655668999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~ 899 (1002)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 159 ~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSFQ----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccCC----------------------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 43211 11234568999999999988889999999999999999999999999
Q ss_pred CCChHHHHHHHHhCCC-----CCCC--------------------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 900 GKTRQKTFANILHKDL-----KFPS--------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~-----~~~~--------------------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
+.+..+.+..+..... .++. .+..+..+.+||.+||+.||++||| +.++|+
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~ 286 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALS 286 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhc
Confidence 9888777777654211 0100 1235677899999999999999999 999999
Q ss_pred CCCc
Q 001865 955 HPFF 958 (1002)
Q Consensus 955 Hp~f 958 (1002)
||||
T Consensus 287 hp~f 290 (290)
T cd07862 287 HPYF 290 (290)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=371.16 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=227.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.+.|.++..||.|+||.||+|..+.++...|-|++.. ........+.-||+||..++||+||++++.|..++.++|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 3578899999999999999999999999999998863 3466778889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
.|||.||-...++-.- +..|++.++.-+++|++.||.|||+++|||||||..|||++-+|.++|+|||++....
T Consensus 108 iEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~----- 181 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK----- 181 (1187)
T ss_pred EeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-----
Confidence 9999888887776543 4569999999999999999999999999999999999999999999999999984311
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
.......+++|||+|||||+.. ..+|++++||||||++|.+|..+.+|-..-+
T Consensus 182 ----------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 182 ----------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred ----------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 0112346789999999999974 4689999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 903 RQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
...++-+|.+...+ +..+...+..+.+||.+||.+||..||+ +.+||+||||++++
T Consensus 240 pMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~----aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 240 PMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP----AAQLLKHPFVQNAP 296 (1187)
T ss_pred hHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC----HHHHhhCcccccCC
Confidence 98888888876544 3344456788999999999999999999 99999999999754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.19 Aligned_cols=266 Identities=27% Similarity=0.459 Sum_probs=216.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--C---eE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T---HV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~---~~ 744 (1002)
.|...+.+|+|+||.||.+...++++.+|||.+-.+. ..--+|+++|+.++|||||++..+|... . +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 6888999999999999999999999999999876442 1224699999999999999999888632 2 45
Q ss_pred EEEEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCccc
Q 001865 745 CLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 821 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~-g~vkL~DFG~a~~~ 821 (1002)
.+||||| .-+|.++++. ..+..++.-.++.++.||++||+|||+.||+||||||+|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 6899999 7799998874 123558999999999999999999999999999999999999965 99999999999765
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
... ....++..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|+|
T Consensus 177 ~~~----------------------------epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 VKG----------------------------EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred ccC----------------------------CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 422 123466789999999999885 688999999999999999999999999
Q ss_pred CChHHHHHHHHhC-----------------CCCCC----------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 901 KTRQKTFANILHK-----------------DLKFP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 901 ~~~~~~~~~i~~~-----------------~~~~~----------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
.+...++..|.+- ...+| .....++++.+|+.++|+++|.+|.+ +.|++
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l 304 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEAL 304 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHh
Confidence 9888777766541 11111 12335788999999999999999999 99999
Q ss_pred cCCCcCCCChhhhhccCCCCCCCC
Q 001865 954 KHPFFKGVNWALVRCMNPPELDAP 977 (1002)
Q Consensus 954 ~Hp~f~~~~~~~~~~~~~~~~~~p 977 (1002)
.||||...--. ..+.|-..++|
T Consensus 305 ~h~fFdelr~~--~~~l~~g~~lp 326 (364)
T KOG0658|consen 305 AHPFFDELRDP--NTKLPNGRPLP 326 (364)
T ss_pred cchhhHHhhCc--CccCcCCCcCC
Confidence 99999874333 33334444444
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=374.95 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=207.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.++||||++++++|..+...|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 456789999999999999999999999999999996532 34678999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+|||++ +++|..++... ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999999 67898888664 458999999999999999999999999999999999999999999999999985421100
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--- 902 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~--- 902 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 237 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~ 290 (391)
T PHA03212 237 --------------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290 (391)
T ss_pred --------------------------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccc
Confidence 011224579999999999999999999999999999999999998875432
Q ss_pred ----hHHHHHHHHhC--------------------------CCCCCC-------CCCCCHHHHHHHHHccccCcCCCCCC
Q 001865 903 ----RQKTFANILHK--------------------------DLKFPS-------STPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 903 ----~~~~~~~i~~~--------------------------~~~~~~-------~~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
....+..+... ....+. ....+.++.+||.+||++||.+|||
T Consensus 291 ~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt- 369 (391)
T PHA03212 291 GDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS- 369 (391)
T ss_pred ccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC-
Confidence 11111111110 000000 0123557889999999999999999
Q ss_pred hhcHHHHHcCCCcCCC
Q 001865 946 HEGANEIKKHPFFKGV 961 (1002)
Q Consensus 946 ~~~a~elL~Hp~f~~~ 961 (1002)
+.|+|+||||+.+
T Consensus 370 ---a~elL~hp~f~~~ 382 (391)
T PHA03212 370 ---AEALLDFAAFQDI 382 (391)
T ss_pred ---HHHHhcChhhccC
Confidence 9999999999874
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=363.25 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=213.0
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 743 (1002)
.++...|+++++||+||.+.||+|.... ...||+|.+... ..+......+.+|+.+|.+| +|.+|+++++|-..+++
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4677899999999999999999999844 445666554332 34677788999999999999 79999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+||||||- ..+|..+|++.. ..++...++.|..||+.|+.++|+.||||.||||.|+|+. .|.+||+|||.|..+..
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred EEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 99999988 899999998754 3355569999999999999999999999999999999998 78999999999976543
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-----------CCChhhHHHHHHHHHHHH
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEML 892 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-----------~~~~sDIwSlGvil~ell 892 (1002)
+... -...+.+||+.||+||++.... .+.++||||||||||+|+
T Consensus 512 DTTs-------------------------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 512 DTTS-------------------------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred cccc-------------------------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 3222 2345679999999999995433 456899999999999999
Q ss_pred cCCCCCCCCC-hHHHHHHHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 893 YGYTPFRGKT-RQKTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 893 tG~~Pf~~~~-~~~~~~~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
.|+.||.... ....+..|..- .+.||..+. ..+++++++.||.+||.+||+ +.+||+|||+..
T Consensus 567 YgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~ 632 (677)
T KOG0596|consen 567 YGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWS----IPELLQHPFLQI 632 (677)
T ss_pred hcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCC----cHHHhcCccccc
Confidence 9999997643 23333334332 345665543 234999999999999999999 999999999997
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=368.34 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=209.9
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.....+|+.++.||+|+||.||+|.+..+++.||||++.... .......+.+|+++++.++|+||+++++++..++.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 344678999999999999999999999999999999986542 334456788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+|||||.+++|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999999998653 23567888999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDIwSlGvil~elltG~~Pf~ 899 (1002)
........||+.|+|||++.. ...+.++|||||||++|+|++|+.||.
T Consensus 222 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 222 ---------------------------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ---------------------------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 011223579999999999743 234568999999999999999999997
Q ss_pred CCChH---HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 900 GKTRQ---KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 900 ~~~~~---~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
..... .....+.. .........++..+.+||.+||..||++||+ +.++|+||||...
T Consensus 275 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 275 VGRQGDWASLMCAICM-SQPPEAPATASREFRHFISCCLQREPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred CCCCccHHHHHHHHhc-cCCCCCCCccCHHHHHHHHHHccCChhhCcC----HHHHhcCcccccC
Confidence 43322 22222221 1222223456889999999999999999999 9999999999985
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=363.60 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=215.8
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++.+.||.|+||.||++.+..++..+|+|++.... .......+.+|+++++.++||||++++++|..++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45679999999999999999999999999999999987542 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
+||||+.+++|.+++... ..+++..+..++.||+.||.|||++ +|+|+||||+|||++.+|.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999999764 4589999999999999999999985 7999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 158 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 158 -----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred -----------------------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 112346899999999999888999999999999999999999999765443
Q ss_pred HHHHHH--------------------------------------------HhCCCCCCCCCCCCHHHHHHHHHccccCcC
Q 001865 905 KTFANI--------------------------------------------LHKDLKFPSSTPTSLHAKQLMYRLLHRDPK 940 (1002)
Q Consensus 905 ~~~~~i--------------------------------------------~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~ 940 (1002)
.....+ .....+.......+.++++||.+||++||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 288 (333)
T cd06650 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPA 288 (333)
T ss_pred HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcc
Confidence 322111 111101111112467889999999999999
Q ss_pred CCCCChhcHHHHHcCCCcCCC
Q 001865 941 SRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 941 ~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
+||| +.++++||||+..
T Consensus 289 ~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 289 ERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred cCcC----HHHHhhCHHHhcC
Confidence 9999 9999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.29 Aligned_cols=256 Identities=26% Similarity=0.427 Sum_probs=224.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
-|.++.+||+|+||.||+|.++++|..+|+|.+... .+...+..|+.||+++++|+||++|+.|.....+|+|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 488999999999999999999999999999987643 467889999999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
||..|+..+.+..+ .+.|++..+..+++..++||+|||...-||||||..|||++.+|++||.|||.|..+
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL-------- 179 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL-------- 179 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh--------
Confidence 99999999999754 577999999999999999999999999999999999999999999999999998432
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.+.....+++.|||.|||||++....|+.++||||||++..+|..|++||....+...+-.
T Consensus 180 -------------------TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 180 -------------------TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred -------------------hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 2233445678999999999999999999999999999999999999999988776554433
Q ss_pred HHhCC-CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 910 ILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 910 i~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
|-... ..+..+...|.++.+|+++||.++|++|-| |-+|++|||+++..
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T----A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT----ALRLCEHTFIKNAP 290 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH----HHHHhhhhhhcCCC
Confidence 33222 223344446788999999999999999999 99999999999854
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=368.49 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=214.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----eE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 744 (1002)
+|++.+.||+|+||.||++.+..+++.||+|.+... .........+.+|+.+++.++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478899999999999999999999999999998653 223345567889999999999999999999998776 89
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELM-QSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeecc-ccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999999 56888877553 45999999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
.. .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 157 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 157 ES--------------------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred cc--------------------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 10 111234689999999999874 478899999999999999999999988776
Q ss_pred HHHHHHHHh-----------------------CCCCCC-------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 904 QKTFANILH-----------------------KDLKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 904 ~~~~~~i~~-----------------------~~~~~~-------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
...+..+.. .....+ .....+.++.+||.+||+.||.+||| +.++|
T Consensus 211 ~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l 286 (372)
T cd07853 211 IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADAL 286 (372)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHh
Confidence 655544432 111111 11234778999999999999999999 99999
Q ss_pred cCCCcCCCChh
Q 001865 954 KHPFFKGVNWA 964 (1002)
Q Consensus 954 ~Hp~f~~~~~~ 964 (1002)
+||||++..+.
T Consensus 287 ~hp~~~~~~~~ 297 (372)
T cd07853 287 AHPYLDEGRLR 297 (372)
T ss_pred cCHhhCCCcch
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=377.97 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=207.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee-------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 740 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------- 740 (1002)
..+|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||++++++|..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999886431 223469999999999999999988743
Q ss_pred -CCeEEEEEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEecc
Q 001865 741 -KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFD 816 (1002)
Q Consensus 741 -~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g-~vkL~DFG 816 (1002)
..++++||||++ ++|.+++.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 235789999995 577777653 2345699999999999999999999999999999999999999665 79999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCC
Q 001865 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~ 895 (1002)
+|...... ......+||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 217 la~~~~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 217 SAKNLLAG----------------------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred cchhccCC----------------------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99643211 011235789999999998764 6899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhC-----------------CCCCCC----------CCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 896 TPFRGKTRQKTFANILHK-----------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~-----------------~~~~~~----------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
+||.+.+..+.+..+... .+.++. ....+.++.+||.+||++||.+|||
T Consensus 269 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t---- 344 (440)
T PTZ00036 269 PIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN---- 344 (440)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----
Confidence 999998777666655431 111111 1124678999999999999999999
Q ss_pred HHHHHcCCCcCCCCh
Q 001865 949 ANEIKKHPFFKGVNW 963 (1002)
Q Consensus 949 a~elL~Hp~f~~~~~ 963 (1002)
+.++|+||||..+..
T Consensus 345 a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 PIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhCChhHHhhhc
Confidence 999999999987543
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=367.18 Aligned_cols=255 Identities=25% Similarity=0.483 Sum_probs=208.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|++++.||+|+||.||++.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 579999999999999999999999999999999997642 2344556778899999999999999999998644
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|+||||+. ++|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 35799999994 567666643 3889999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 174 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 174 CTN----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccC----------------------------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 210 0112347899999999999999999999999999999999999999877
Q ss_pred ChHHHHHHHHh----------------------CCCCCC--------------C----CCCCCHHHHHHHHHccccCcCC
Q 001865 902 TRQKTFANILH----------------------KDLKFP--------------S----STPTSLHAKQLMYRLLHRDPKS 941 (1002)
Q Consensus 902 ~~~~~~~~i~~----------------------~~~~~~--------------~----~~~~s~~~~~Ll~~~L~~dP~~ 941 (1002)
+....+..+.. ....++ . ....+..+.+||.+||+.||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 65443332221 111110 0 0113567899999999999999
Q ss_pred CCCChhcHHHHHcCCCcCC
Q 001865 942 RLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 942 Rpt~~~~a~elL~Hp~f~~ 960 (1002)
||| +.|+|+||||..
T Consensus 306 R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 306 RIS----VDEALRHPYITV 320 (359)
T ss_pred CCC----HHHHhcCchhhh
Confidence 999 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=367.19 Aligned_cols=255 Identities=25% Similarity=0.461 Sum_probs=211.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 579999999999999999999999999999999987642 2334456778899999999999999999987543
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|+||||+ +++|.+++.. .++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELM-DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCC-CCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 4679999999 5577777753 3889999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 177 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 177 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCC----------------------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 211 0112356899999999999999999999999999999999999999988
Q ss_pred ChHHHHHHHHhCCC----------------------C--------------CCC----CCCCCHHHHHHHHHccccCcCC
Q 001865 902 TRQKTFANILHKDL----------------------K--------------FPS----STPTSLHAKQLMYRLLHRDPKS 941 (1002)
Q Consensus 902 ~~~~~~~~i~~~~~----------------------~--------------~~~----~~~~s~~~~~Ll~~~L~~dP~~ 941 (1002)
+....+..++.... . ++. ....+..+.+||.+||+.||.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 308 (364)
T cd07875 229 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 308 (364)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCccc
Confidence 77666655543100 0 000 0112456889999999999999
Q ss_pred CCCChhcHHHHHcCCCcCC
Q 001865 942 RLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 942 Rpt~~~~a~elL~Hp~f~~ 960 (1002)
||| +.++|+||||..
T Consensus 309 R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 309 RIS----VDEALQHPYINV 323 (364)
T ss_pred CCC----HHHHhcCccccc
Confidence 999 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=353.49 Aligned_cols=302 Identities=38% Similarity=0.676 Sum_probs=242.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||++.+..+++.|++|.+.+...........+.+|+++++.++||||+++++.+..++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 37999999999999999999999999999999987654434445567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||++|++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999764 458999999999999999999999999999999999999999999999999985421110000
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.... . ..............|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 159 ~~~~---------~---~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~ 226 (305)
T cd05609 159 LYEG---------H---IEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226 (305)
T ss_pred cccc---------c---cccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0000 0 000000011123568899999999988889999999999999999999999999988888777
Q ss_pred HHHhCCCCCCCCC-CCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCCcccccc
Q 001865 909 NILHKDLKFPSST-PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEY 987 (1002)
Q Consensus 909 ~i~~~~~~~~~~~-~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 987 (1002)
.+.......+... ..+..+.+||.+||..+|++||++. .+.++|+||||...+|+....... -.+|.+..--..+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~-~~~~ll~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 303 (305)
T cd05609 227 QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQHRFFLGLDWNGLLRQKA--EFIPQLESEDDTSY 303 (305)
T ss_pred HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCcc-CHHHHHhCccccCCCHHHHhhcCC--CCCCCCCCcccccc
Confidence 7776655544432 4688899999999999999999853 378999999999999998754332 34566643333433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=338.14 Aligned_cols=290 Identities=36% Similarity=0.694 Sum_probs=251.2
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEee
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 740 (1002)
Q Consensus 662 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 740 (1002)
..+.+.+++|.+++.||+|+|+.|.++++++|.+.||+|++++..+.+.+++.=+..|..+..+- +||++|-++.+|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 34567789999999999999999999999999999999999999888888888888888887766 79999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
+..+++|.||++||+|--.++++ ..+++++++.+...|..||.|||++|||.||||.+|+|++..|++||+|+|+++.
T Consensus 323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999999888876 4599999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC-
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR- 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~- 899 (1002)
.- .+....+++||||+|+|||.+.+..|+..+|.|+||+++++|+.|+.||.
T Consensus 401 ~l---------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GL---------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CC---------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 21 12234568999999999999999999999999999999999999999994
Q ss_pred -------CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh--cHHHHHcCCCcCCCChhhhhccC
Q 001865 900 -------GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVRCMN 970 (1002)
Q Consensus 900 -------~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~--~a~elL~Hp~f~~~~~~~~~~~~ 970 (1002)
..+....++-|+...+..|.. .|-.+..+|+..|.+||.+|+.... ...++..|+||+.++|..++-++
T Consensus 454 vgm~n~d~ntedylfqvilekqiriprs--lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~ 531 (593)
T KOG0695|consen 454 VGMDNPDMNTEDYLFQVILEKQIRIPRS--LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQ 531 (593)
T ss_pred ecCCCcccchhHHHHHHHhhhcccccce--eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcc
Confidence 123344556677777777765 4556778999999999999998763 57899999999999999998776
Q ss_pred CCCCCCCCCCCc
Q 001865 971 PPELDAPLFATD 982 (1002)
Q Consensus 971 ~~~~~~p~~~~~ 982 (1002)
.-....|....|
T Consensus 532 v~ppf~p~i~~d 543 (593)
T KOG0695|consen 532 VLPPFQPQITDD 543 (593)
T ss_pred cCCCCCCccccc
Confidence 555555654433
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=363.35 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=232.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|.-++.||.|+||.||-|++..+...||||.+........+....+..|+..|+++.|||++.+.++|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 47888999999999999999999999999999987766677888999999999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|| -|+-.+++.-. .+++-+-.+..|+.+.+.||+|||+.+.||||||..|||++..|.|||+|||.|....
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------- 177 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-------
Confidence 99 77888888754 4679999999999999999999999999999999999999999999999999985532
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
..++++|||+|||||++. .+.|+-++||||||++..+|...++|+...+....
T Consensus 178 ------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA 233 (948)
T KOG0577|consen 178 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 233 (948)
T ss_pred ------------------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH
Confidence 356789999999999984 46788999999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+.-|.+...+.......|..+.+|+.+||++-|.+||| .+++|.|+|+..
T Consensus 234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPT----SEELLKHRFVLR 283 (948)
T ss_pred HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCc----HHHHhhcchhcc
Confidence 98898887766666678999999999999999999999 999999999875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=365.02 Aligned_cols=256 Identities=25% Similarity=0.466 Sum_probs=209.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|++++.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 579999999999999999999999999999999987642 2334456778899999999999999999988643
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|+||||+ +++|.+.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~~~lv~e~~-~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELM-DANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhh-cccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 3579999999 4567777653 3889999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 170 ~~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 170 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred CCc----------------------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 211 0112357899999999999999999999999999999999999999887
Q ss_pred ChHHHHHHHHhC----------------------CCC-----CC-------------CCCCCCHHHHHHHHHccccCcCC
Q 001865 902 TRQKTFANILHK----------------------DLK-----FP-------------SSTPTSLHAKQLMYRLLHRDPKS 941 (1002)
Q Consensus 902 ~~~~~~~~i~~~----------------------~~~-----~~-------------~~~~~s~~~~~Ll~~~L~~dP~~ 941 (1002)
+....+..+... ... ++ .....+..+.+||.+||..||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence 655444333221 000 00 00112456789999999999999
Q ss_pred CCCChhcHHHHHcCCCcCCC
Q 001865 942 RLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 942 Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
||| +.|+|+||||...
T Consensus 302 Rps----~~ell~hp~~~~~ 317 (355)
T cd07874 302 RIS----VDEALQHPYINVW 317 (355)
T ss_pred cCC----HHHHhcCcchhcc
Confidence 999 9999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=357.42 Aligned_cols=259 Identities=23% Similarity=0.410 Sum_probs=213.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|.+++.||+|+||.||++.+..+++.+|+|.++.... ......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4689999999999999999999999999999999875422 22234567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||++ ++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 99995 5888887654 3458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 159 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 159 -------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred -------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 11123467899999999865 4578899999999999999999999988776655
Q ss_pred HHHHHhCC-------------------CCCC---------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKD-------------------LKFP---------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~-------------------~~~~---------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
...+.... ..++ ....++.++.+||.+||+.||.+||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~ 289 (309)
T cd07872 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYF 289 (309)
T ss_pred HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhh
Confidence 54443210 1111 11235778999999999999999999 9999999999
Q ss_pred CCC
Q 001865 959 KGV 961 (1002)
Q Consensus 959 ~~~ 961 (1002)
+.+
T Consensus 290 ~~~ 292 (309)
T cd07872 290 RSL 292 (309)
T ss_pred hhc
Confidence 975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.54 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=207.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceeEEEEee-----C
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT-----K 741 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~-----~ 741 (1002)
+|++++.||+|+||.||+|.+..+++.||+|.++..... ........+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999998754221 12223445677766655 79999999998864 3
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999995 68988887655556899999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 159 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SCQ----------------------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cCc----------------------------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 211 0112346899999999999888999999999999999999999999887
Q ss_pred ChHHHHHHHHhCC-----CCCC--------------------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCC
Q 001865 902 TRQKTFANILHKD-----LKFP--------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956 (1002)
Q Consensus 902 ~~~~~~~~i~~~~-----~~~~--------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 956 (1002)
.....+..+.... ..++ .....+..+.+||.+||++||.+||| +.+++.||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp 286 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHP 286 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCC
Confidence 7766555554310 0000 01235667899999999999999999 99999999
Q ss_pred Cc
Q 001865 957 FF 958 (1002)
Q Consensus 957 ~f 958 (1002)
||
T Consensus 287 ~f 288 (288)
T cd07863 287 FF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=377.63 Aligned_cols=269 Identities=28% Similarity=0.408 Sum_probs=227.0
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC---
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--- 742 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--- 742 (1002)
...++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345799999999999999999999999999999999976533 3445567888999999999999999988775432
Q ss_pred -----eEEEEEeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEec
Q 001865 743 -----HVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (1002)
Q Consensus 743 -----~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DF 815 (1002)
.+++||||+++|+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 478999999999999998643 2346899999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCC
Q 001865 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~ 895 (1002)
|+++.+..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 188 Gls~~~~~~~~-------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~ 242 (496)
T PTZ00283 188 GFSKMYAATVS-------------------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242 (496)
T ss_pred ccCeecccccc-------------------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99865431100 01123467999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhh
Q 001865 896 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWAL 965 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~ 965 (1002)
.||.+.+..+.+..+..+... +....++..+.+|+.+||..||.+||+ +.++++|||++...-..
T Consensus 243 ~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs----~~ell~~p~~~~~~~~~ 307 (496)
T PTZ00283 243 RPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPS----SSKLLNMPICKLFISGL 307 (496)
T ss_pred CCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHhCHHHHHhhhhH
Confidence 999998888877777765443 233457889999999999999999999 99999999998754333
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=335.62 Aligned_cols=265 Identities=30% Similarity=0.483 Sum_probs=223.1
Q ss_pred cccc-ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEE
Q 001865 671 FRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 671 y~i~-~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
|++. ..||+|+|+.|-.|....+|..||||++.+. ......++.+|++++.+. +|+||++++++|+++..+|+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4443 4689999999999999999999999999875 445667889999999988 7999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---cEEEEeccCCcccCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g---~vkL~DFG~a~~~~~~~ 825 (1002)
|.|.||+|...+.++ +.+++..+..+.++|+.||.|||.+||.||||||+|||..+.. -+|||||.+..-+.-..
T Consensus 156 EKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred ecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 999999999999875 5599999999999999999999999999999999999998655 48999999974321110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
. .. ......-.+.+|+..|||||+.. ...|+.++|.||||+|||.|++|.+||.|
T Consensus 234 ~-------------------~s-pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 234 D-------------------CS-PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred C-------------------CC-CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 0 00 01111234678999999999862 34688999999999999999999999976
Q ss_pred C---------------ChHHHHHHHHhCCCCCCC--CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCCh
Q 001865 901 K---------------TRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963 (1002)
Q Consensus 901 ~---------------~~~~~~~~i~~~~~~~~~--~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 963 (1002)
. .....+..|..+...+|+ +..+|.++++|+..+|..++.+|.+ +.++++|||+..+..
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAP 369 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccch
Confidence 4 234677788888888885 4557899999999999999999999 999999999998755
Q ss_pred h
Q 001865 964 A 964 (1002)
Q Consensus 964 ~ 964 (1002)
+
T Consensus 370 e 370 (463)
T KOG0607|consen 370 E 370 (463)
T ss_pred h
Confidence 4
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=375.95 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=203.6
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC------CCcceeEEEEee
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQT 740 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~~ 740 (1002)
..++|++++.||+|+||+||+|.+..+++.||||+++.. .........|+.+++.+.| .+++.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 457899999999999999999999999999999998642 1223345567777776644 458889998875
Q ss_pred C-CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCC----------
Q 001865 741 K-THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNG---------- 808 (1002)
Q Consensus 741 ~-~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g---------- 808 (1002)
+ +++|+||+++ |++|.+++.+. ..+++..++.|+.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5789999999 88999888764 459999999999999999999998 5999999999999998765
Q ss_pred ------cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001865 809 ------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (1002)
Q Consensus 809 ------~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIw 882 (1002)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 329 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------cccccccCCccccCcHHhhcCCCCcHHHHH
Confidence 49999999874311 112346799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCC------------------------C----------------CCC
Q 001865 883 ALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFP------------------------S----------------STP 922 (1002)
Q Consensus 883 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------------~----------------~~~ 922 (1002)
||||++|+|++|++||.+.+..+.+..+......+| . ...
T Consensus 330 SlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (467)
T PTZ00284 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409 (467)
T ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence 999999999999999988776554443322110000 0 001
Q ss_pred CCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 923 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 923 ~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.+..+.+||.+||++||.+||| ++|+|+||||...
T Consensus 410 ~~~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 410 RDDLLCDLIYGLLHYDRQKRLN----ARQMTTHPYVLKY 444 (467)
T ss_pred chHHHHHHHHHhCCcChhhCCC----HHHHhcCcccccc
Confidence 1345779999999999999999 9999999999873
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=375.45 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=223.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCC-CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
...|.+.+.||+|+||.||+|....+ +..+|+|.+... .......+.+|+.+|+.++||||+++++++..++..|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999999877 788999976533 34445567789999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 747 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
||||++||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999999887542 2346899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 223 ~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 VS-------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred cc-------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 00 01223567999999999999999999999999999999999999999998888
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
..+..+..+... +....++..+.+||.+||..||++||+ +.+++.|||++.+
T Consensus 278 ~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 278 EIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcC----HHHHHhCHHHHHH
Confidence 888877766543 223457889999999999999999999 9999999999754
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=342.45 Aligned_cols=260 Identities=26% Similarity=0.381 Sum_probs=220.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC--hHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN--RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
+.|.+.+.||+|++|.||+|.+..+++.||+|.+....... ......+.+|++++++++||||+++++++..++.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46899999999999999999999999999999987543221 2234578889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999998764 4589999999999999999999999999999999999999999999999999854321100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.........|+..|+|||++.+..++.++||||||+++|+|++|+.||...+....
T Consensus 160 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 160 ------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred ------------------------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 00011234688999999999998899999999999999999999999988777666
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..+.............+..+.+||.+||..+|.+||+ +.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPS----AEELLRHFFV 263 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCC----HHHHhhCCCC
Confidence 66665554444444457889999999999999999999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.71 Aligned_cols=264 Identities=34% Similarity=0.601 Sum_probs=219.1
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||+|+||+||+|.+..+|+.||+|++.+...........+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765443334455667899999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001865 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (1002)
Q Consensus 757 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 836 (1002)
.+++.......+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99997755456999999999999999999999999999999999999999999999999988543210
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCC-
Q 001865 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDL- 915 (1002)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~- 915 (1002)
.......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 149 ----------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 149 ----------------KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ----------------CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 011233578899999999888889999999999999999999999977544222222222111
Q ss_pred -CCCCCCCCCHHHHHHHHHccccCcCCCCCChh-cHHHHHcCCCcCCCChhhhhc
Q 001865 916 -KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 916 -~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~-~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
........+..+.+||.+||+.||.+||++.+ .+.++++||||+.++|..+..
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~ 267 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEA 267 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhc
Confidence 12222346889999999999999999997766 699999999999999988843
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=362.92 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=210.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|++++.||.|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 468999999999999999999999999999999987542 2233445677899999999999999999987533
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...|++|+++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999999 8899888764 34999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 169 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CC------------------------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 21 1123478999999999877 5678899999999999999999999988
Q ss_pred CChHHHHHHHHhCCC-----------------------CCCC------CCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 901 KTRQKTFANILHKDL-----------------------KFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~-----------------------~~~~------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
.+....+..+..... ..+. ....++.+.+||.+||..||.+||| +.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~e 294 (343)
T cd07878 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASE 294 (343)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHH
Confidence 766555544432100 0000 0124566889999999999999999 999
Q ss_pred HHcCCCcCCC
Q 001865 952 IKKHPFFKGV 961 (1002)
Q Consensus 952 lL~Hp~f~~~ 961 (1002)
+|+||||...
T Consensus 295 ll~hp~~~~~ 304 (343)
T cd07878 295 ALAHPYFSQY 304 (343)
T ss_pred HhcCcchhcc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=359.99 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=205.2
Q ss_pred cccccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEE
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 737 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 737 (1002)
+++..++|++.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.++..+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 3566789999999999999999999852 345689999987542 233456788999999999 89999999998
Q ss_pred Eee-CCeEEEEEeccCCCchhHHHhhCC----------------------------------------------------
Q 001865 738 FQT-KTHVCLITDYCPGGELFLLLDRQP---------------------------------------------------- 764 (1002)
Q Consensus 738 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 764 (1002)
+.. ++.+|+||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 775 456899999999999999987531
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001865 765 --------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (1002)
Q Consensus 765 --------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 836 (1002)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~---------- 229 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---------- 229 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc----------
Confidence 12478889999999999999999999999999999999999999999999999865321110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCC
Q 001865 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDL 915 (1002)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~ 915 (1002)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+......+...+....
T Consensus 230 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 230 ---------------YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred ---------------hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 001123356788999999999889999999999999999996 9999988654444444443333
Q ss_pred CCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 916 KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 916 ~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
........+..+.+|+.+||..||.+|||+.+
T Consensus 295 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 326 (338)
T cd05102 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSA 326 (338)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 33333456888999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.39 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=214.0
Q ss_pred cCCcccc-ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHH-hCCCCCcceeEEEEee----C
Q 001865 668 LQHFRPI-KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-MLDHPFVPALYASFQT----K 741 (1002)
Q Consensus 668 ~~~y~i~-~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~----~ 741 (1002)
.++|.+- ++||-|-.|.|-.|.++.|+.++|+|++.-. ....+|+++-- .-.|||||.++++|++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3566654 4699999999999999999999999987532 34456776643 3479999999999864 3
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec---CCcEEEEeccCC
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 818 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~---~g~vkL~DFG~a 818 (1002)
..+.+|||.|+||.|++.++.+....+++.++..|++||..||.|||+.+|.||||||+|+|++. |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 56789999999999999999988888999999999999999999999999999999999999975 457999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
+.... ...-.+.|-||.|.|||++-...|+..+|+||+||++|-|++|.+||
T Consensus 212 K~t~~----------------------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPF 263 (400)
T KOG0604|consen 212 KETQE----------------------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263 (400)
T ss_pred cccCC----------------------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcc
Confidence 65321 11224568899999999999999999999999999999999999999
Q ss_pred CCCCh----HHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 899 RGKTR----QKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 899 ~~~~~----~~~~~~i~~~~~~~~--~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+.... ..+..+|..+...|| .+...|..++++|+++|..+|.+|+| +.+++.|||+.+
T Consensus 264 YS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~ 327 (400)
T KOG0604|consen 264 YSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQ 327 (400)
T ss_pred cccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee----HHHhhcCchhcc
Confidence 86543 344456666666665 45668999999999999999999999 999999999997
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=325.48 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=222.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 744 (1002)
.+.++.+.+..||+|+.|+|++++.+.+|...|||.+.+. .+.+..+++...+.++.+- ++|+||+++++|..+..+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 3456778889999999999999999999999999999875 3566777888888877665 599999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
++.||.| +.++..++++. .+++++..+-.+..-++.||.||..+ ||||||+||+|||++..|++||||||.+..+..
T Consensus 167 ~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999 77777777654 45699999999999999999999865 899999999999999999999999999865432
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
+ ...+...|.+.|||||.+. ...|+.++||||||++++||.||..||.+
T Consensus 245 S----------------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 245 S----------------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred c----------------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 2 2334457999999999985 34688899999999999999999999988
Q ss_pred -CChHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 901 -KTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 901 -~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.++.+++.+++....+ ++.....|+.+.+|+..||++|+.+||. +.+||+|||+...
T Consensus 297 c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~----Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 297 CKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK----YNKLLEHPFIKRY 355 (391)
T ss_pred CCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc----hHHHhcCcceeec
Confidence 4667888888875443 4444558999999999999999999999 9999999999864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.36 Aligned_cols=264 Identities=26% Similarity=0.447 Sum_probs=222.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.+.|++++.||.|+||.||++.+..+++.+++|++... .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46799999999999999999999999999999998754 345567788899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+++++|..++.... ..+++..++.++.||+.+|.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999999988875432 45899999999999999999999999999999999999999999999999987432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
........+++.|+|||++. ...++.++|||||||++|+|++|..||...+
T Consensus 164 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 164 ------------------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred ------------------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 01122346889999999985 3446779999999999999999999998877
Q ss_pred hHHHHHHHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhh
Q 001865 903 RQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966 (1002)
Q Consensus 903 ~~~~~~~i~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 966 (1002)
....+..+..... ........+..+.+||.+||..+|++||+ ++++++||||..++++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 220 PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS----AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccccchh
Confidence 6666655554332 22233446788999999999999999999 999999999999888764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=341.32 Aligned_cols=258 Identities=41% Similarity=0.749 Sum_probs=221.3
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||.|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++.+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999988999999999876544455567889999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001865 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (1002)
Q Consensus 757 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 836 (1002)
.+++.+. ..++...+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------
Confidence 9999764 348999999999999999999999999999999999999999999999999985532110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--hHHHHHHHHhCC
Q 001865 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--RQKTFANILHKD 914 (1002)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~ 914 (1002)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||.... ....+..+..+.
T Consensus 148 -----------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 210 (262)
T cd05572 148 -----------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN 210 (262)
T ss_pred -----------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC
Confidence 1123468899999999988888999999999999999999999998776 666666666433
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCC-hhcHHHHHcCCCcCCCChh
Q 001865 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 915 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~-~~~a~elL~Hp~f~~~~~~ 964 (1002)
.........+..+.+||.+||..+|++||++ ...++|+++||||++.+|+
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 3333333347889999999999999999984 3458999999999999886
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=354.09 Aligned_cols=265 Identities=21% Similarity=0.352 Sum_probs=210.2
Q ss_pred cccccccc--CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 673 PIKPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 673 i~~~LG~G--~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
+++.||+| +|++||++.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999875432 233445677899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~-- 158 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL-- 158 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc--
Confidence 999999999976544568999999999999999999999999999999999999999999999998653321100000
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
...........++..|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 159 ------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 159 ------------------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred ------------------cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 000001122357788999999976 458899999999999999999999998765544433
Q ss_pred HHHhCCCCC--------------------------------------------CCCCCCCHHHHHHHHHccccCcCCCCC
Q 001865 909 NILHKDLKF--------------------------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLG 944 (1002)
Q Consensus 909 ~i~~~~~~~--------------------------------------------~~~~~~s~~~~~Ll~~~L~~dP~~Rpt 944 (1002)
.......+. +.....++.+.+||.+||++||++|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 333221110 001123567899999999999999999
Q ss_pred ChhcHHHHHcCCCcCCCC
Q 001865 945 SHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 945 ~~~~a~elL~Hp~f~~~~ 962 (1002)
++++++||||+.+.
T Consensus 301 ----~~ell~~p~f~~~~ 314 (327)
T cd08227 301 ----ASTLLNHSFFKQIK 314 (327)
T ss_pred ----HHHHhcChhhhhcc
Confidence 99999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=348.51 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=214.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++++.||.|+||.||++.+..+++.||+|.++.... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 5689999999999999999999999999999999875422 22234567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 99995 6898888654 3458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.
T Consensus 159 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 159 -------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 111234578999999998654 477899999999999999999999998776655
Q ss_pred HHHHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~-------------------~~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..+.... ..++. ....+..+.+||.+||+.||.+||| +.++|+||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f 289 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYF 289 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccc
Confidence 54443210 01111 1235778899999999999999999 9999999999
Q ss_pred CCCC
Q 001865 959 KGVN 962 (1002)
Q Consensus 959 ~~~~ 962 (1002)
+.+.
T Consensus 290 ~~~~ 293 (301)
T cd07873 290 HCLG 293 (301)
T ss_pred cccc
Confidence 9865
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=337.05 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=218.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee-CCeEEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLIT 748 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~lV~ 748 (1002)
+|++++.||.|++|.||++.+..+++.||+|.+..... .......+.+|+++++.++|+|++++++.+.. .+.+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999875422 33445667889999999999999999998864 45789999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++.......+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999999987555668999999999999999999999999999999999999999999999999985542110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 157 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 157 ------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 11224568999999999999889999999999999999999999998877766666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+..+.... .....+..+.+|+.+||+.+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKLPP-MPKDYSPELGELIATMLSKRPEKRPS----VKSILRQPYI 257 (257)
T ss_pred HHHhcCCCC-CccccCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 665554322 22346789999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.67 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=222.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 47888999999999999999999999999999875432 34456678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+++++|.+++.......++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 9999999999987655679999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......
T Consensus 156 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 156 -----------------------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred -----------------------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 111234688999999999988889999999999999999999999998887777777
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..+...... ...+..+.++|.+||+.+|++||+ +.++++|||+
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVFPPVS-QMYSQQLAQLIDQCLTKDYRQRPD----TFQLLRNPSL 256 (256)
T ss_pred HHcCCCCCCc-cccCHHHHHHHHHHccCCcccCcC----HHHHhhCCCC
Confidence 7665433222 256788999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.03 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=213.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEee------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT------ 740 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~------ 740 (1002)
.+.|++.+.||.|+||.||++.+..+++.+|+|++.... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 357999999999999999999999999999999987532 2235677899999988 79999999999875
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
...+|+||||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 34689999999999999999875556789999999999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~ 895 (1002)
.... ........|++.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 161 ~~~~---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~ 213 (272)
T cd06637 161 LDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213 (272)
T ss_pred cccc---------------------------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 3211 01123457899999999986 345778999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 896 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.||...........+............++..+.+||.+||..+|.+||| +.++++||||
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 214 PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred CCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 9998766555554444433333333456789999999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=362.50 Aligned_cols=262 Identities=25% Similarity=0.408 Sum_probs=212.4
Q ss_pred ccCCccccccccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
...+|.+++.||.|+||.||+|... .+++.+|+|.+... ....+|+.+|+.++||||+++++++...+.+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3468999999999999999999764 34678999988643 2345799999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 162 ~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999 6788888854 356999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR- 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~- 903 (1002)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 239 ~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 239 PD-------------------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred cc-------------------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 10 0112245799999999999999999999999999999999999999976532
Q ss_pred --HHHHHHHHhC----CCCCC-------------------------C---CCCCCHHHHHHHHHccccCcCCCCCChhcH
Q 001865 904 --QKTFANILHK----DLKFP-------------------------S---STPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949 (1002)
Q Consensus 904 --~~~~~~i~~~----~~~~~-------------------------~---~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a 949 (1002)
...+..+.+. ...++ . ....+..+.+||.+||+.||++||+ +
T Consensus 294 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a 369 (392)
T PHA03207 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----A 369 (392)
T ss_pred CcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----H
Confidence 1222222210 00000 0 0123567889999999999999999 9
Q ss_pred HHHHcCCCcCCCChhhhhc
Q 001865 950 NEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 950 ~elL~Hp~f~~~~~~~~~~ 968 (1002)
.++|.||||+...|+.++-
T Consensus 370 ~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 370 QDILSLPLFTKEPINLLNI 388 (392)
T ss_pred HHHhhCchhhccchhhhcC
Confidence 9999999999988887643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.27 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=210.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987542 2334467889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|..+. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 79 EFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred ecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999999986542 3788999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-----
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR----- 903 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~----- 903 (1002)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....
T Consensus 149 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 203 (279)
T cd06619 149 -------------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203 (279)
T ss_pred -------------------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence 11235789999999999998899999999999999999999999965321
Q ss_pred --HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 904 --QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 904 --~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
......+.............+..+.+|+.+||+.+|.+||+ ++++++||||...
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~eil~~~~~~~~ 259 (279)
T cd06619 204 MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA----PENLMDHPFIVQY 259 (279)
T ss_pred chHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCC----HHHHhcCcccccc
Confidence 12222222222222122336778999999999999999999 9999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=379.74 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=217.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--CCe
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTH 743 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ 743 (1002)
...++|++++.||.|+||+||+|.+..++..+|+|++..... .......+..|+.+|+.|+||||++++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 346799999999999999999999999999999999876533 33445678899999999999999999998854 467
Q ss_pred EEEEEeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-------CcccCCCCCCcEEEec--------
Q 001865 744 VCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-------GIIYRDLKPENVLLQG-------- 806 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~-------gIiHrDLKP~NILl~~-------- 806 (1002)
+||||||+++++|.+++... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 99999999999999998752 234699999999999999999999985 4999999999999964
Q ss_pred ---------CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCC
Q 001865 807 ---------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGH 875 (1002)
Q Consensus 807 ---------~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~ 875 (1002)
.+.+||+|||++..+... ......+||+.|+|||++.+ ..+
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~----------------------------s~~~s~vGTp~YmAPEvL~ge~~~~ 220 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE----------------------------SMAHSCVGTPYYWSPELLLHETKSY 220 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc----------------------------ccccccCCCccccCHHHHhccCCCC
Confidence 235899999998543211 01123579999999999865 457
Q ss_pred CChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 876 ~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
+.++||||||||||+|++|..||........+...+.....++. ...+..+.+||..||..+|.+||+ +.++|.|
T Consensus 221 s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h 295 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGY 295 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhcc
Confidence 88999999999999999999999876665555455444433332 336788999999999999999999 9999999
Q ss_pred CCcCCCCh
Q 001865 956 PFFKGVNW 963 (1002)
Q Consensus 956 p~f~~~~~ 963 (1002)
|||+.+..
T Consensus 296 ~~ik~i~~ 303 (1021)
T PTZ00266 296 QIIKNVGP 303 (1021)
T ss_pred HHHhhcCC
Confidence 99987644
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=340.90 Aligned_cols=261 Identities=36% Similarity=0.645 Sum_probs=206.6
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHH---hCCCCCcceeEEEEeeCCeEEEEEeccC
Q 001865 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD---MLDHPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~---~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 752 (1002)
.||+|+||.||++.+..+++.+|+|++.+.............++..+++ ..+||||+.+++++..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654332222233344544443 3479999999999999999999999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcc
Q 001865 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (1002)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 832 (1002)
+++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999998764 45999999999999999999999999999999999999999999999999998543210
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCccccccccc-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--HHHHHH
Q 001865 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--QKTFAN 909 (1002)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~--~~~~~~ 909 (1002)
......|++.|+|||.+. +..++.++|||||||++|+|++|..||..... ......
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 209 (279)
T cd05633 151 ---------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (279)
T ss_pred ---------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH
Confidence 011236899999999986 45678899999999999999999999975432 122222
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhc
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
... ..........+..+.+||.+||..||.+|++.. ..+.++++||||++++|.....
T Consensus 210 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~ 268 (279)
T cd05633 210 MTL-TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268 (279)
T ss_pred Hhh-cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhc
Confidence 111 112222234688999999999999999999321 2289999999999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=342.99 Aligned_cols=254 Identities=38% Similarity=0.629 Sum_probs=211.1
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
|++++.||+|+||+||++.+..+++.||+|++..... .........+|+.+++.++||||+++++++......|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI-EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH-HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc-cccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 7899999999999999999999999999999987632 122223345699999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+++++|.+++... ..++...+..++.||+.||++||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9888999999843 4589999999999999999999999999999999999999999999999999854210
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCccccccccc-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---hHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKT---RQKT 906 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDIwSlGvil~elltG~~Pf~~~~---~~~~ 906 (1002)
.........+++.|+|||++. +..++.++||||||+++|+|++|..||.... ....
T Consensus 151 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~ 210 (260)
T PF00069_consen 151 --------------------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI 210 (260)
T ss_dssp --------------------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH
T ss_pred --------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 111233457899999999998 7888999999999999999999999999873 3333
Q ss_pred HHHHHhCCCCCC--CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~~~~~--~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+........... .....+..+.+||.+||+.||++||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 211 IEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp HHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT----HHHHHTSGGG
T ss_pred hhhcccccccccccccchhHHHHHHHHHHHccCChhHCcC----HHHHhcCCCC
Confidence 333333221111 11112378999999999999999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.76 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=209.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++++.||+|++|.||+|.+..++..||+|.++.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999999999999999999999999875422 22334567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 750 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~-~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|+. ++|.+++.... ...+++..++.++.||+.||+|||++||+|+||||+||+++.+|.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 995 68888886533 256899999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
........+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.....
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 155 -----------------------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred -----------------------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0112234678999999998654 4688999999999999999999999887654444
Q ss_pred HHHHhCCC------------------CC---------CCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKDL------------------KF---------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~~------------------~~---------~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+..... .+ ......+.++.+||.+||..||.+||| +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 33321100 00 011236788899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.62 Aligned_cols=256 Identities=43% Similarity=0.758 Sum_probs=215.9
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHH-HhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
+.||.|+||.||+|.+..+++.||+|++++...........+..|..++ ...+|+|++++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998765332333334445555544 445899999999999999999999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999999764 4589999999999999999999999999999999999999999999999998743210
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhC
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+....+..+...
T Consensus 150 ---------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (260)
T cd05611 150 ---------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR 208 (260)
T ss_pred ---------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 12346888999999998888889999999999999999999999988888777777666
Q ss_pred CCCCCCC--CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChh
Q 001865 914 DLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 914 ~~~~~~~--~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 964 (1002)
...++.. ..++..+.+++.+||..+|++||++.. ++|++.||||+.++|.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~-~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANG-YQEIKSHPFFKSINWD 260 (260)
T ss_pred ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCc-HHHHHcChHhhcCCCC
Confidence 5544432 246889999999999999999997322 6899999999999984
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.56 Aligned_cols=265 Identities=45% Similarity=0.827 Sum_probs=225.8
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||.|+||.||++.+..+++.+++|++.............+.+|++++++++||||+++++.+..++..|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999765444445667888999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001865 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (1002)
Q Consensus 757 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 836 (1002)
.+++.... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 99997643 589999999999999999999999999999999999999999999999999854322111000
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001865 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916 (1002)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 916 (1002)
...........++..|+|||.+....++.++|+||||+++|+|++|..||...........+..+...
T Consensus 152 ------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (265)
T cd05579 152 ------------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIE 219 (265)
T ss_pred ------------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcC
Confidence 00011223456888999999998888889999999999999999999999988888888888776666
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCCh
Q 001865 917 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963 (1002)
Q Consensus 917 ~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 963 (1002)
++.....+..+.+|+.+||+.+|.+|||+.. +.++|+||||+.++|
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~-~~~~l~~~~~~~~~~ 265 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKS-IEEIKNHPFFKGIDW 265 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCcc-HHHHhcCccccCCCC
Confidence 6665556889999999999999999999322 389999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=341.67 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=221.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++++.||.|+||.||++.+..++..+|+|+++.. .......+.+|+++++.++||||+++++++..++..|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998643 445567788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+++++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--- 156 (280)
T cd06611 81 IEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--- 156 (280)
T ss_pred eeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc---
Confidence 9999999999998764 245999999999999999999999999999999999999999999999999987542211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
........|++.|+|||++. ...++.++|||||||++|+|++|+.||...+
T Consensus 157 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 157 ------------------------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred ------------------------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 01122356899999999985 3446779999999999999999999998887
Q ss_pred hHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 903 RQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
....+..+.....+ +......+..+.+||.+||+.+|.+||+ +.++++||||+...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~~ 269 (280)
T cd06611 213 PMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT----AAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC----HHHHhcChhhcccc
Confidence 77766666654332 2233446788999999999999999999 99999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=362.82 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=205.4
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++++|+||+++++++..++..|+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35689999999999999999999999999999996432 235689999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
|||++ .++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 238 v~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 238 VLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 99999 678988886542 3599999999999999999999999999999999999999999999999999865421100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT---- 902 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~---- 902 (1002)
........||+.|+|||++.+..++.++|||||||++|+|++|..|+....
T Consensus 316 -------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 316 -------------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred -------------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 011124579999999999999999999999999999999999876653321
Q ss_pred ----hHHHHHHHHhCCCC---C-----------------------------CCCCCCCHHHHHHHHHccccCcCCCCCCh
Q 001865 903 ----RQKTFANILHKDLK---F-----------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSH 946 (1002)
Q Consensus 903 ----~~~~~~~i~~~~~~---~-----------------------------~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~ 946 (1002)
.......+...... + ......+..+.+||.+||+.||.+|||
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs-- 448 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS-- 448 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC--
Confidence 12222222211110 1 111123457889999999999999999
Q ss_pred hcHHHHHcCCCcCC
Q 001865 947 EGANEIKKHPFFKG 960 (1002)
Q Consensus 947 ~~a~elL~Hp~f~~ 960 (1002)
+.|+|+||||+.
T Consensus 449 --a~elL~hp~f~~ 460 (461)
T PHA03211 449 --AAELLRLPLFQS 460 (461)
T ss_pred --HHHHhhCcccCC
Confidence 999999999975
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=339.03 Aligned_cols=257 Identities=30% Similarity=0.471 Sum_probs=221.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++..+..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999987542 2344567789999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++... .+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999998764 58999999999999999999999999999999999999999999999999986543210
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||...+......
T Consensus 153 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~ 208 (274)
T cd06609 153 ------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF 208 (274)
T ss_pred ------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 11223468899999999998889999999999999999999999998877666655
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.+.....+.......+..+.++|.+||..+|++||+ ++++++||||+..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt----~~~il~~~~~~~~ 257 (274)
T cd06609 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS----AKELLKHKFIKKA 257 (274)
T ss_pred HhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcC----HHHHhhChhhcCC
Confidence 555443332222226788999999999999999999 9999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=356.58 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=201.5
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
...+|++++.||+|+||.||+|.+..+++.||+|+..+. ....|+.++++++||||+++++++...+..|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 345899999999999999999999999999999986543 23468999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
|||++ .++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 135 VLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 99999 67888888654 346899999999999999999999999999999999999999999999999998532110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCh--
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-RGKTR-- 903 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf-~~~~~-- 903 (1002)
.......||+.|+|||++.+..++.++|||||||++|+|+++..|+ .....
T Consensus 211 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~ 264 (357)
T PHA03209 211 --------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264 (357)
T ss_pred --------------------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcH
Confidence 0112356999999999999999999999999999999999754444 32111
Q ss_pred -------HHHHHHHHhC----CCCCC----------------------------CCCCCCHHHHHHHHHccccCcCCCCC
Q 001865 904 -------QKTFANILHK----DLKFP----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLG 944 (1002)
Q Consensus 904 -------~~~~~~i~~~----~~~~~----------------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt 944 (1002)
...+..+... ...++ .....+..+.+||.+||+.||.+|||
T Consensus 265 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt 344 (357)
T PHA03209 265 EEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS 344 (357)
T ss_pred HHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC
Confidence 0111111110 00011 01123456678999999999999999
Q ss_pred ChhcHHHHHcCCCcCCC
Q 001865 945 SHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 945 ~~~~a~elL~Hp~f~~~ 961 (1002)
+.|+|+||||+.+
T Consensus 345 ----a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 ----AEEILNYPMFAQL 357 (357)
T ss_pred ----HHHHhcCchhccC
Confidence 9999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=341.70 Aligned_cols=246 Identities=18% Similarity=0.200 Sum_probs=208.1
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee----CCeEEEEEec
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KTHVCLITDY 750 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~~~~lV~E~ 750 (1002)
..||+|+++.||++.. +|+.||+|.+++...........+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999998 789999999987544344445778899999999999999999999876 4578999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
+++|+|.+++... ..++......++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----
Confidence 9999999999764 4588999999999999999999984 9999999999999999999999999998543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 177 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 177 -------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred -------------------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 112468899999999976 67899999999999999999999999998888887
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
..+......++....++..+.+|+.+||+.||++|||+.+++..+-+
T Consensus 232 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 232 DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 77766655555444578899999999999999999995554444433
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=339.03 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=217.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
-|++++.||.|+||.||++.+..++..+++|.+... .......+.+|+++++.++||||+++++++...+..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 378899999999999999999999999999998653 34456678889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+++++|..++... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~----- 156 (282)
T cd06643 83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----- 156 (282)
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-----
Confidence 99999999887653 245899999999999999999999999999999999999999999999999998543210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
........|++.|+|||++. +..++.++|||||||++|+|++|..||...+..
T Consensus 157 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~ 214 (282)
T cd06643 157 ----------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214 (282)
T ss_pred ----------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH
Confidence 01122346899999999984 345677999999999999999999999888776
Q ss_pred HHHHHHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 905 KTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 905 ~~~~~i~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
..+..+..... ........+..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 268 (282)
T cd06643 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT----TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCCCEecc
Confidence 66666655432 22233446788999999999999999999 9999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.07 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=213.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE---PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 45899999999999999999999999999999998754 233445677899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999999998764 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
........|++.|+|||++. ...++.++|+|||||++|+|++|..||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 160 ------------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 01112346899999999974 455788999999999999999999999766554
Q ss_pred HHHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCC
Q 001865 905 KTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 957 (1002)
.............+. ....+..+.+||.+||..+|++||+ +.++++|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC----HHHHhcCCC
Confidence 444443333332222 2235678999999999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=344.31 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=213.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999987532 2344567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
||+++++|.+++... ..+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999999764 458999999999999999999997 5999999999999999999999999998743211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 153 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 153 -------------------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred -------------------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 0112357899999999998888899999999999999999999999765543332
Q ss_pred HHHHhCC------------------------------------CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 908 ANILHKD------------------------------------LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 908 ~~i~~~~------------------------------------~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
..+.... .+.......+.++.+|+.+||..+|++||+ +.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ 283 (308)
T cd06615 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD----LKE 283 (308)
T ss_pred HhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC----HHH
Confidence 2221100 000001125678999999999999999999 999
Q ss_pred HHcCCCcCC
Q 001865 952 IKKHPFFKG 960 (1002)
Q Consensus 952 lL~Hp~f~~ 960 (1002)
+++||||.+
T Consensus 284 ll~~~~~~~ 292 (308)
T cd06615 284 LTKHPFIKR 292 (308)
T ss_pred HhcChhhhh
Confidence 999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=299.95 Aligned_cols=259 Identities=24% Similarity=0.438 Sum_probs=219.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|.-.++||+|.||+||++++..+++.||+|.++.+.. +........+|+.+|+.++|.|||+++++...+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467888999999999999999999999999999986532 3333456788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||| ..+|..+...- .+.+....++.++.|++.||.++|++++.||||||.|+||+.||.+||.|||+|+.++.
T Consensus 81 e~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi----- 153 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI----- 153 (292)
T ss_pred HHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC-----
Confidence 999 77898888754 35599999999999999999999999999999999999999999999999999976542
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHH-cCCCCCCCCChHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEML-YGYTPFRGKTRQKT 906 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDIwSlGvil~ell-tG~~Pf~~~~~~~~ 906 (1002)
+.+..+..+-|..|.+|.++.+.. |+...|+||.|||+.|+. .|++.|+|.+..+.
T Consensus 154 ----------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 154 ----------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred ----------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 223345567899999999998864 788999999999999999 59999999998888
Q ss_pred HHHHHhC-----CCCCCCC----------------------CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 907 FANILHK-----DLKFPSS----------------------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 907 ~~~i~~~-----~~~~~~~----------------------~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
.++|... .-.||.. +..+...++|++++|..+|.+|++ ++.+++||||.
T Consensus 212 lkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~ 287 (292)
T KOG0662|consen 212 LKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFS 287 (292)
T ss_pred HHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccc
Confidence 8888652 1112211 112234579999999999999999 99999999998
Q ss_pred CC
Q 001865 960 GV 961 (1002)
Q Consensus 960 ~~ 961 (1002)
..
T Consensus 288 d~ 289 (292)
T KOG0662|consen 288 DF 289 (292)
T ss_pred cc
Confidence 63
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=338.04 Aligned_cols=260 Identities=35% Similarity=0.641 Sum_probs=210.5
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHH---HHHHhCCCCCcceeEEEEeeCCeEEEEEeccC
Q 001865 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER---EILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 752 (1002)
.||+|+||.||+|.+..+++.||+|++.+..............|. .+++...||+|+.+++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999999999999998765433222222233343 34455689999999999999999999999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcc
Q 001865 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (1002)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 832 (1002)
|++|..++... ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999988754 45999999999999999999999999999999999999999999999999998543210
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCC---ChHHHHH
Q 001865 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK---TRQKTFA 908 (1002)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~---~~~~~~~ 908 (1002)
......|+..|+|||++.+. .++.++||||+||++|+|++|+.||... .......
T Consensus 151 ---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~ 209 (278)
T cd05606 151 ---------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209 (278)
T ss_pred ---------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH
Confidence 11234689999999998754 6788999999999999999999999875 2233222
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCC-----CChhcHHHHHcCCCcCCCChhhhhccCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-----GSHEGANEIKKHPFFKGVNWALVRCMNPP 972 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rp-----t~~~~a~elL~Hp~f~~~~~~~~~~~~~~ 972 (1002)
.+......++. ..+..+.+++.+||..+|.+|| + +.++++||||+.++|..+.....|
T Consensus 210 ~~~~~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~----~~~ll~~~~~~~~~~~~~~~~~~~ 272 (278)
T cd05606 210 MTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRG----AQEVKEHPFFRSLDWQMVFLQKYP 272 (278)
T ss_pred HhhccCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCC----HHHHHhCccccCCCchHhhhcccC
Confidence 33222333332 3588999999999999999999 7 999999999999999999655554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=339.60 Aligned_cols=271 Identities=18% Similarity=0.262 Sum_probs=219.1
Q ss_pred ccccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 739 (1002)
.+..++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567899999999999999999997642 35589999876432 2233456778999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (1002)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vk 811 (1002)
..+..|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997532 13356778899999999999999999999999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHH
Q 001865 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (1002)
Q Consensus 812 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~el 891 (1002)
|+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|
T Consensus 160 L~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred ECcCCcccccccccc-------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 999999864321100 0111223457789999999988899999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc--CCCcCCCCh
Q 001865 892 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKGVNW 963 (1002)
Q Consensus 892 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~--Hp~f~~~~~ 963 (1002)
++ |..||.+....+....+..+... +.....+..+.+|+.+||+.+|++||++.++++.+.+ ||||.+++|
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 98 89999888777766666544322 2223457889999999999999999996665555555 999999988
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=334.37 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=217.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh------HHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR------NKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+........ .....+.+|+.+++.++||||+++++++...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47888999999999999999988999999999876433221 223567889999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999764 4589999999999999999999999999999999999999999999999999865431
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
.... ...........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 159 ~~~~---------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 159 NSLS---------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred cccc---------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 1100 0001112235688999999999988889999999999999999999999988776
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
...+..+..... .......+..+.+||.+||+.||.+||+ +.++++||||
T Consensus 218 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 218 LQAIFKIGENAS-PEIPSNISSEAIDFLEKTFEIDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred HHHHHHHhccCC-CcCCcccCHHHHHHHHHHccCCchhCcC----HHHHhhCCCC
Confidence 665555544211 1222346788999999999999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.79 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=213.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEe------e
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ------T 740 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~------~ 740 (1002)
.+.|++.+.||.|+||.||++.+..+++.+|+|++... ......+..|+.+++++ +|+||+++++++. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 46899999999999999999999999999999998653 23345677899999888 7999999999985 3
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
.+.+|++|||+.+++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 56889999999999999999876556689999999999999999999999999999999999999999999999998854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG~ 895 (1002)
.... ........|++.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 171 ~~~~---------------------------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~ 223 (282)
T cd06636 171 LDRT---------------------------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223 (282)
T ss_pred hhcc---------------------------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC
Confidence 3210 01112356899999999986 345778999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 896 TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.||........+..+.............+..+.+||.+||..||.+||+ +.+|++||||
T Consensus 224 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 224 PPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred CCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 9998766555554444433222233346789999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=345.92 Aligned_cols=251 Identities=26% Similarity=0.435 Sum_probs=193.3
Q ss_pred cccccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeEEEEEe
Q 001865 674 IKPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCLITD 749 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lV~E 749 (1002)
.++||+|+||.||+|.++ .+++.||+|.+.... ....+.+|+.+|+.++||||+++++++.. +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 367999999999999975 467899999986532 12346789999999999999999999853 567899999
Q ss_pred ccCCCchhHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----ecCCcEEEEeccCC
Q 001865 750 YCPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLS 818 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~-------~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl----~~~g~vkL~DFG~a 818 (1002)
|+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 66888887532 12358999999999999999999999999999999999999 45678999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~P 897 (1002)
........ .........||+.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 160 ~~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCCc------------------------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 65432110 01112345789999999999774 578899999999999999999999
Q ss_pred CCCCCh---------HHHHHHHHhC-C------------C-------------CCC----------CCCCCCHHHHHHHH
Q 001865 898 FRGKTR---------QKTFANILHK-D------------L-------------KFP----------SSTPTSLHAKQLMY 932 (1002)
Q Consensus 898 f~~~~~---------~~~~~~i~~~-~------------~-------------~~~----------~~~~~s~~~~~Ll~ 932 (1002)
|.+... ...+..+... . + ... .....+..+.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 965332 1111111110 0 0 000 00113456889999
Q ss_pred HccccCcCCCCCChhcHHHHHcCCCc
Q 001865 933 RLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 933 ~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+||++||.+||| ++|+|+||||
T Consensus 296 ~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC----HHHHhcCCCC
Confidence 999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.52 Aligned_cols=256 Identities=28% Similarity=0.477 Sum_probs=223.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++++.||.|+||.||.+++..++..+++|.+..... .......+.+|+.++++++|+||+++++++...+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875432 33445678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999987655668999999999999999999999999999999999999999999999999985432111
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....
T Consensus 156 -----------------------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 156 -----------------------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred -----------------------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 012235689999999999888888999999999999999999999998888887777
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..+.... .....+..+.++|.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s----~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPT----ADEVLDQPLL 256 (256)
T ss_pred HHcCCCCC-CccccCHHHHHHHHHHcccCcccCCC----HHHHhhCcCC
Confidence 77655433 22456889999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=341.61 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=217.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.+|++++.||+|+||.||++.+..+++.|++|.+.... ......+.+|+.+++.++|+||+++++.+..+...|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 58999999999999999999999999999999987543 233466788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++.. ..++..++..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 170 (296)
T cd06654 97 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (296)
T ss_pred cccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc---
Confidence 99999999999865 348899999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 171 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 171 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred ------------------------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 01123468899999999988888999999999999999999999998877654444
Q ss_pred HHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 909 NILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 909 ~i~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.+.... ...+.....+..+.+|+.+||..+|++||+ +.++++||||...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 276 (296)
T cd06654 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS----AKELLQHQFLKIA 276 (296)
T ss_pred HHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC----HHHHhhChhhhcc
Confidence 333322 222233446778999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=342.71 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=216.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.+|++++.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++..++..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999987542 233456788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 99999999999865 348999999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+......
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred ------------------------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 01123468899999999998888999999999999999999999998766544333
Q ss_pred HHHhC-CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 909 NILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 909 ~i~~~-~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.+... ..........+..+.+|+.+||..+|++||+ +.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 226 LIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS----AKELLQHPFLKLA 275 (297)
T ss_pred eeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCchhccc
Confidence 23222 2222223346778899999999999999999 9999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=333.98 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=220.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|+||+||+|.+..++..+++|++..... ......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc--chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 479999999999999999999988999999999875432 225677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~-~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|++++++|.+++..... ..+++..++.++.||+.||+|||++||+|+||+|+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999976422 46899999999999999999999999999999999999999999999999998654322110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.........|++.|+|||++... .++.++|+|||||++|+|++|+.||...+..+.
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 159 -----------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred -----------------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 00112345689999999998776 788899999999999999999999988877766
Q ss_pred HHHHHhCCCC-CCCC---CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKDLK-FPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~~~-~~~~---~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+......... ++.. ...+..+.+|+.+||..||++||+ +.+|++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC----HHHHhhCCCC
Confidence 6666554322 1111 245778999999999999999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=331.78 Aligned_cols=256 Identities=25% Similarity=0.471 Sum_probs=221.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++++.||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875422 23344678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence 9999999999976544568999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.+..
T Consensus 156 -----------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 156 -----------------------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred -----------------------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 011124588899999999988888999999999999999999999998888777777
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..+.... .....+..+.++|.+||+.+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSYPP-VSSHYSYDLRNLVSQLFKRNPRDRPS----VNSILEKNFI 256 (256)
T ss_pred HhcCCCCC-CcccCCHHHHHHHHHHhhCChhhCcC----HHHHhhCcCC
Confidence 76654432 23346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=340.09 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=219.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.+|++.+.||.|+||.||++.+..+++.|++|.+.... ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 47999999999999999999999999999999986532 233567788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+.+++|..++... .+++.++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999999998653 48999999999999999999999999999999999999999999999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 170 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~ 225 (296)
T cd06655 170 ------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (296)
T ss_pred ------------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 01123468899999999998888999999999999999999999999887766555
Q ss_pred HHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 909 NILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 909 ~i~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
.+..... .+.....++..+.+||.+||..||.+||+ +.++++||||+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~il~~~~~~~~~ 276 (296)
T cd06655 226 LIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS----AKELLQHPFLKLAK 276 (296)
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhhcc
Confidence 5543322 22233456788999999999999999999 99999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=335.30 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=211.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 468999999999999999999999999999999987542 23345677899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--- 159 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc---
Confidence 9999999999998754 45899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
........|++.|+|||.+. ...++.++|+|||||++|+|++|..||......
T Consensus 160 ------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 160 ------------------------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred ------------------------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 01112346889999999984 344678999999999999999999999766544
Q ss_pred HHHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCC
Q 001865 905 KTFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 957 (1002)
.....+....+..+. ....+..+.+||++||..+|++||+ ++++|+|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 216 RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC----HHHHhcCCC
Confidence 443333333332222 2345788999999999999999999 999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=351.78 Aligned_cols=263 Identities=29% Similarity=0.494 Sum_probs=234.7
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 663 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 742 (1002)
..+...+.|.+.+.||.|.|+.|.++++..++..||||++.+..... .....+.+|+++|+.|+|||||+++.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34456789999999999999999999999999999999999876544 44455899999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+|+||||+.+|.+++++.+. ..+.+..++.++.|++.|++|||+++|||||||++|||++.+.++||+|||++..+.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999999999886 447889999999999999999999999999999999999999999999999996654
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC-CChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
. .....++||++.|.|||++.+..| ++.+|+||+|++||.|+.|.+||.+.
T Consensus 207 ~----------------------------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 207 Y----------------------------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred c----------------------------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 2 223457899999999999999876 56999999999999999999999999
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 902 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 902 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
+..+.-...+.+.+..|.. ++.++.+||+++|..+|.+|++ ++++.+|.|.....
T Consensus 259 ~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl~Pskr~~----~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 259 NLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVLNPSKRGP----CDQIMKDRWRNDLL 313 (596)
T ss_pred ccccccchheeeeecccce--eechhHHHHHHhhccCccccCC----HHHhhhhcccchhh
Confidence 8888888888887776654 5667899999999999999999 99999999988643
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.51 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=212.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVC 745 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~ 745 (1002)
.|++.+.||+|+||.||+|.+..++..|++|.+...... .......+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 699999999999999999999999999999998754321 22345678889999999999999999998875 46789
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
++|||+++++|.+++... ..++...++.++.||+.||+|||+++|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999999764 348999999999999999999999999999999999999999999999999985432100
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
. .........|+..|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 161 ~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 161 M------------------------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred c------------------------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 0 0001123458899999999998888999999999999999999999998776666
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
.+..+.............+..+.+|+ +||..+|++||+ ++++++||||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 217 AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcC----HHHHhcCcccc
Confidence 55554433222222233577788888 577789999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.51 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=210.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875421 2223345678999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|..++... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 999888888776543 3589999999999999999999999999999999999999999999999999865421110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
......++..|+|||++.+ ..++.++||||||+++|+|++|++||.+.+..+..
T Consensus 156 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~ 210 (286)
T cd07847 156 -------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210 (286)
T ss_pred -------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 1123457889999999876 45788999999999999999999999987765544
Q ss_pred HHHHhCC-------------------CCCCC----------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKD-------------------LKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~-------------------~~~~~----------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+.... ...+. ....+..+.+||.+||+.+|++||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 211 YLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred HHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 4432210 00111 1234677899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.42 Aligned_cols=255 Identities=38% Similarity=0.725 Sum_probs=217.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|++++++++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999998999999999987654444567788999999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|..++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999999765 468999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--HHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--QKTF 907 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~--~~~~ 907 (1002)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ...+
T Consensus 155 ------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (258)
T cd05578 155 ------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210 (258)
T ss_pred ------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 11234688899999999888889999999999999999999999987663 2222
Q ss_pred HHHHh-CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~-~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..... .....+ ...+..+.++|.+||..||.+||++. +.++++||||
T Consensus 211 ~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 211 RAKQETADVLYP--ATWSTEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred HHHhccccccCc--ccCcHHHHHHHHHHccCChhHcCCcc--HHHHhcCCCC
Confidence 22222 222222 34678899999999999999999932 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=340.26 Aligned_cols=255 Identities=23% Similarity=0.417 Sum_probs=206.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++++.||.|+||.||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999875422 22233556789999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+. ++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---- 153 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---- 153 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC----
Confidence 995 6888877653 2458999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC-CCCChHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF-RGKTRQKTF 907 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf-~~~~~~~~~ 907 (1002)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~ 210 (284)
T cd07839 154 -----------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210 (284)
T ss_pred -----------------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence 111234578899999998764 4688999999999999999988885 444444444
Q ss_pred HHHHhCC--------------CC---CC----------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKD--------------LK---FP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~--------------~~---~~----------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+.... .. ++ .....+..+.+||.+||+.||.+||| ++++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 211 KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 3332210 00 00 01235778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=371.65 Aligned_cols=151 Identities=39% Similarity=0.653 Sum_probs=139.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++++.||+|+||.||+|.+..+++.||||++++...........+..|+.+++.++||||+++++++...+++|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999876555556667888999999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
|||+.|++|.+++... ..+++..++.|+.||+.||.|||.+|||||||||+|||++.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999999764 4589999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.92 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=215.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc---ChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
+|++.+.||.|+||.||++.+ .+++.+|+|.+...... .......+.+|+++++.++|+||+++++++...+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 57889999988753211 22344668889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||++++++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999764 3589999999999999999999999999999999999999999999999998854321100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.. ..........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 158 ~~---------------------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~ 216 (265)
T cd06631 158 HG---------------------THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216 (265)
T ss_pred cc---------------------cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence 00 001112335689999999999988889999999999999999999999987766555
Q ss_pred HHHHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
...+.... ...+.....+..+.+||++||..+|.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 217 MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS----ALQLLRHDFL 265 (265)
T ss_pred HHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 54444332 222233457888999999999999999999 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.85 Aligned_cols=257 Identities=30% Similarity=0.490 Sum_probs=214.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999876532 23345678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 999999987543 5699999999999999999999999999999999999999999999999999865432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+.
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 155 -----------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred -----------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 112234689999999998654 45889999999999999999999998877766655
Q ss_pred HHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 909 NILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 909 ~i~~~~-------------------~~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
.+.... ..++. ....+..+.+||++||..+|++||+ ++++++||||.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 212 IVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred HHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 554311 01111 1234678899999999999999999 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=337.34 Aligned_cols=262 Identities=24% Similarity=0.421 Sum_probs=215.4
Q ss_pred cccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--C----Ccce
Q 001865 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--P----FVPA 733 (1002)
Q Consensus 660 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----nIv~ 733 (1002)
+..+..+ .++|.+++.+|+|.||.|-.|.+..++..+|||+++.- ....+...-|+++|.++.+ | -+|+
T Consensus 81 ~~~gD~l-~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 81 YQVGDIL-TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEecccc-ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 3344433 68999999999999999999999999999999998742 2233455678999999932 2 5789
Q ss_pred eEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC------
Q 001865 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN------ 807 (1002)
Q Consensus 734 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~------ 807 (1002)
+.++|+..+++|||+|.+ |.|+++++..+...+++..+++.|+.||+.+|+|||+++++|.||||+|||+.+.
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 999999999999999999 9999999999888999999999999999999999999999999999999999532
Q ss_pred --------------CcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC
Q 001865 808 --------------GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873 (1002)
Q Consensus 808 --------------g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 873 (1002)
-.++|+|||.|..-. ....+.+.|..|+|||++.+-
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~------------------------------e~hs~iVsTRHYRAPEViLgL 284 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDH------------------------------EHHSTIVSTRHYRAPEVILGL 284 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceec------------------------------cCcceeeeccccCCchheecc
Confidence 248999999885422 123567899999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHh------------------CCCCCCCC------------
Q 001865 874 GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK---TFANILH------------------KDLKFPSS------------ 920 (1002)
Q Consensus 874 ~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~------------------~~~~~~~~------------ 920 (1002)
+++.++||||+||||+||++|...|+..++.+ +++.|+. +.+.|+..
T Consensus 285 GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ 364 (415)
T KOG0671|consen 285 GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEP 364 (415)
T ss_pred CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcC
Confidence 99999999999999999999999999877665 3333322 12222211
Q ss_pred -----------CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 921 -----------TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 921 -----------~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
......+.+||++||.+||.+|+| +.|+|.||||+..
T Consensus 365 ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT----l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 365 CKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT----LREALSHPFFARL 412 (415)
T ss_pred CccHHHHhccCcHHHhHHHHHHHHHHccCcccccc----HHHHhcCHHhhcC
Confidence 001225789999999999999999 9999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.48 Aligned_cols=258 Identities=29% Similarity=0.475 Sum_probs=221.2
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
.+.||+|.||+||-+.++.+|+.||||++.+-.+..+. ...+.+|+.||+++.||.||.+--.|+..+.+++|||.+ .
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 36799999999999999999999999999987654443 378899999999999999999999999999999999999 5
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC---CcEEEEeccCCcccCCCCCCCCC
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~---g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
|++.+++-....+.|++...++++.||+.||.|||-+||+|+||||+|||+.+. -++||||||+|+.+..+.
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks----- 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS----- 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh-----
Confidence 555555555556789999999999999999999999999999999999999754 369999999998875332
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i 910 (1002)
...+++|||.|+|||++....|+..-|+||.|+|+|--++|.+||..+. ++-.+|
T Consensus 722 -----------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQI 776 (888)
T KOG4236|consen 722 -----------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQI 776 (888)
T ss_pred -----------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHh
Confidence 1236799999999999999999999999999999999999999997653 344455
Q ss_pred HhCCCCCCC--CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC-Chhhhh
Q 001865 911 LHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV-NWALVR 967 (1002)
Q Consensus 911 ~~~~~~~~~--~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~-~~~~~~ 967 (1002)
....+-+|. +..++.++++||..+|+..-.+|.+ +++.|.|||+++. .|-+++
T Consensus 777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys----vdk~lsh~Wlq~yq~w~DLR 832 (888)
T KOG4236|consen 777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS----VDKSLSHPWLQDYQTWLDLR 832 (888)
T ss_pred hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc----hHhhccchhhhcchHHHHHH
Confidence 555554443 3457899999999999999999999 9999999999984 466664
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.47 Aligned_cols=255 Identities=28% Similarity=0.476 Sum_probs=219.3
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58899999999999999999999999999999976533 33446778899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCcccCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~-g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|+++++|.+++.......+++..+..++.|++.+|+|||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999987555568999999999999999999999999999999999999855 46899999998553211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 156 ------------------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred ------------------------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 01123468899999999998888899999999999999999999998887777666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+...... +.....+..+.+|+.+||..+|++||| +.++++||||
T Consensus 212 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQ----LSQIMAQPIC 256 (256)
T ss_pred HHHhcCCC-CCCCCcCHHHHHHHHHHccCChhhCCC----HHHHhhCCCC
Confidence 66554332 223346888999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.70 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=214.3
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 663 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 742 (1002)
.|+|.+....-+..||+|+-|.||+++. .++.||||.++. .-..+|+-|++|+||||+.+.+++....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCc
Confidence 4556666777788999999999999998 677899997752 2235788899999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+|||||||..|.|..+|+.. ..++......+.++|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++...
T Consensus 186 cyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999999999864 568899999999999999999999999999999999999999999999999886654
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
... ..-+++||..|||||++...+.+.++|||||||+|||||||..||..-+
T Consensus 264 ~~S----------------------------TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 264 DKS----------------------------TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred hhh----------------------------hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 221 2236899999999999999999999999999999999999999998766
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCC
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 956 (1002)
...++--+-...+.+|-+..++..++=||+.||.-.|.+||+ ..+||.|=
T Consensus 316 ssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPS----Frqil~Hl 365 (904)
T KOG4721|consen 316 SSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPS----FRQILLHL 365 (904)
T ss_pred hheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCcc----HHHHHHHH
Confidence 555444444445666777778889999999999999999999 77888774
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.30 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=211.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|++++.||.|++|.||+|.+..++..||||.++.... .......+.+|++++++++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999999999999998875422 22334567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+ .++|..++.......+++..++.++.||+.||+|||++|++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~-~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred cc-ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 99 5689998876655678999999999999999999999999999999999999999999999999985432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+......
T Consensus 155 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 155 -----------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred -----------------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 0112335788999999987644 5789999999999999999999998876655444
Q ss_pred HHHhCCC------------------CCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 909 NILHKDL------------------KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 909 ~i~~~~~------------------~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+..... .++. ....+..+.+||.+||+.||.+||| ++++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 4332100 0010 1235678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=330.15 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=213.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHV 744 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 744 (1002)
..|++.+.||+|+||.||++.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 479999999999999999999999999999998864321 123445678889999999999999999999876 3578
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998764 34889999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
.. .........|+..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 160 CL------------------------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred cc------------------------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 00 001122346899999999998888899999999999999999999999877666
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
..+..+.............+..+.++|.+||. +|.+||+ ++++++|||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 216 AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCC----HHHHhcCcccC
Confidence 65555543332222233456788999999995 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=347.16 Aligned_cols=255 Identities=26% Similarity=0.491 Sum_probs=209.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|++++.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.++++++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 478999999999999999999999999999999987542 2334456677899999999999999999988643
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...|+||||+ +++|.+.+... ++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 3579999999 56888887643 899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 169 ~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 169 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCC----------------------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 211 0112346889999999999999999999999999999999999999877
Q ss_pred ChHHHHHHHHhCC----------------------C--------------CCCC-----CCCCCHHHHHHHHHccccCcC
Q 001865 902 TRQKTFANILHKD----------------------L--------------KFPS-----STPTSLHAKQLMYRLLHRDPK 940 (1002)
Q Consensus 902 ~~~~~~~~i~~~~----------------------~--------------~~~~-----~~~~s~~~~~Ll~~~L~~dP~ 940 (1002)
+....+..+.... . .++. ....+..+.+||.+||+.||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 300 (353)
T cd07850 221 DHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300 (353)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh
Confidence 6555444432210 0 0000 012345688999999999999
Q ss_pred CCCCChhcHHHHHcCCCcCC
Q 001865 941 SRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 941 ~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+||| +.++|+||||+.
T Consensus 301 ~R~t----~~eiL~~~~~~~ 316 (353)
T cd07850 301 KRIS----VDDALQHPYINV 316 (353)
T ss_pred hCcC----HHHHhcChhHhh
Confidence 9999 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=351.71 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=208.7
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 738 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 738 (1002)
.+..++|++.+.||+|+||.||+|.+...+ ..||+|+++... .......+.+|+.+++.+ +|+||+++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 345668999999999999999999875443 579999997542 233456788999999999 899999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHhhCC------------------------------------------------------
Q 001865 739 QTKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 764 (1002)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 764 (1002)
...+.+|+|||||.+|+|.+++....
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999999986421
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 765 --------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 765 --------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~---- 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---- 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----
Confidence 12478889999999999999999999999999999999999999999999999854321100
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 909 (1002)
........+++.|+|||++.+..++.++|||||||++|+|++ |+.||........+..
T Consensus 268 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~ 326 (374)
T cd05106 268 ---------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326 (374)
T ss_pred ---------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH
Confidence 001122345678999999998889999999999999999997 9999988765555555
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
+.............+.++.+|+.+||+.||.+||++.++
T Consensus 327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l 365 (374)
T cd05106 327 MVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365 (374)
T ss_pred HHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 555544444444467899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.63 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=210.3
Q ss_pred cccCCccccccccccCcEEEEEEEEc---CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 742 (1002)
++..+|++.+.||+|+||.||++.+. ..+..+|+|.++... .......+.+|+.+++.++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 44568999999999999999999875 346689999987542 2334467889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999997643 458999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~ 901 (1002)
... ........++..|+|||++.+..++.++|||||||++|++++ |..||.+.
T Consensus 159 ~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 159 SEA--------------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ccc--------------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 100 001112345678999999999999999999999999999775 99999988
Q ss_pred ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 902 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 902 ~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
+....+..+..+ ...+....++..+.+++.+||+.+|.+||+ +++|+
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~RP~----~~~i~ 259 (266)
T cd05064 213 SGQDVIKAVEDG-FRLPAPRNCPNLLHQLMLDCWQKERGERPR----FSQIH 259 (266)
T ss_pred CHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCCchhCCC----HHHHH
Confidence 877777666544 333444557888999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.29 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=216.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|+||.||+|.+..+++.+++|++... .......+.+|+.+++.++||||+++++++...+.+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC---chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5899999999999999999999999999999999754 2335677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+.+++|.+++... ...+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 999999999998764 245899999999999999999999999999999999999999999999999998543210
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
........|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+...
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 155 -----------------------IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred -----------------------hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0111235688899999999776 78889999999999999999999999877666
Q ss_pred HHHHHHhCCCCCCC---CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCC
Q 001865 906 TFANILHKDLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 957 (1002)
....+....+..+. ....+..+.+||.+||..+|..||+ +.+++.|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC----HHHHhcCCC
Confidence 65555554333222 2234678899999999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=334.32 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=214.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCC-----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSG-----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
+..++|++++.||+|+||.||++.+...+ ..+|+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34568999999999999999999986655 689999987542 34445678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPT--------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~--------------~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~ 806 (1002)
.+..|++|||+++++|.+++..... ..++...++.++.||+.||.|||++||+|+||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999975321 45888999999999999999999999999999999999999
Q ss_pred CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHH
Q 001865 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886 (1002)
Q Consensus 807 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGv 886 (1002)
++.++|+|||++........ ........+++.|+|||.+.+..++.++|||||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-------------------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred CCcEEECCCcceeecccccc-------------------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 99999999999864321110 01122345788999999998888999999999999
Q ss_pred HHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 887 LLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 887 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
++|+|++ |..||.+.+..+....+..+.. .+....++..+.+|+.+||+.||.+||+ +.+++++
T Consensus 215 il~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 215 VLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPCPEDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCcccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 9999997 9999999888777766655433 2334457889999999999999999999 6676653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.04 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=215.6
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|+||.||++.+..+++.|++|.+.... ....+.+|+.+++.++||||+++++++......|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 58999999999999999999998889999999987542 2678889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+.+++|.+++... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--- 153 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--- 153 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc---
Confidence 999999999998653 3468999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 154 ------------------------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred ------------------------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 01123457889999999998889999999999999999999999998776655444
Q ss_pred HHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 909 NILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 909 ~i~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+..... .+......+..+.+||.+||+.||++||+ +.++|+||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS----AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC----HHHHhcCCCC
Confidence 4333221 12222345778999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=349.69 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=208.7
Q ss_pred ccccCCccccccccccCcEEEEEEEE-----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 738 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 738 (1002)
.+..++|++.+.||+|+||.||+|.+ ..++..||+|+++... .......+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34566899999999999999999974 3457789999987542 233446788999999999 899999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHhhCC------------------------------------------------------
Q 001865 739 QTKTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 764 (1002)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 764 (1002)
...+..|+|||||++|+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986421
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 765 -------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 765 -------------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 1247888999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
. ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 269 ~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~ 323 (375)
T cd05104 269 N-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323 (375)
T ss_pred c-------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence 0 001112345678999999999999999999999999999997 99999876654
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
..+...+............+.++.+||.+||+.||++||+ +.++++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~ 369 (375)
T cd05104 324 SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPT----FKQIVQ 369 (375)
T ss_pred HHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcC----HHHHHH
Confidence 4444454443333333345788999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.07 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=216.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
+.|.....||.|+||.||++.+..++..||||.+... .......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 3566678899999999999999999999999998643 2344566889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---- 171 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---- 171 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc----
Confidence 99999999998854 34899999999999999999999999999999999999999999999999988543211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||........+.
T Consensus 172 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 228 (292)
T cd06658 172 -----------------------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228 (292)
T ss_pred -----------------------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011123568999999999988889999999999999999999999998877766555
Q ss_pred HHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 909 NILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 909 ~i~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
.+.... ...+.....+..+.+||.+||..||.+||| ++++++||||..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~~~ 277 (292)
T cd06658 229 RIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT----AQELLQHPFLKL 277 (292)
T ss_pred HHHhcCCCccccccccCHHHHHHHHHHccCChhHCcC----HHHHhhChhhhc
Confidence 544321 222333346788999999999999999999 999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=338.74 Aligned_cols=264 Identities=28% Similarity=0.390 Sum_probs=214.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 744 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 744 (1002)
..++|++.+.||.|+||.||+|.+..+|..||+|.++.... .......+.+|+.++++++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 45789999999999999999999999999999999875422 112223456799999999999999999998754 578
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYC-EQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecC-CCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999999 568888887542 55899999999999999999999999999999999999999999999999998654311
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 162 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 162 A---------------------------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred c---------------------------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 01112245788999999865 4578899999999999999999999998888
Q ss_pred HHHHHHHHhCC-------------------CCCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 904 QKTFANILHKD-------------------LKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 904 ~~~~~~i~~~~-------------------~~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
...+..+.... ...+. ....+..+.+||.+||+.||++||| +.+++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h 290 (309)
T cd07845 215 IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALES 290 (309)
T ss_pred HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcC
Confidence 77776665421 00110 0124678899999999999999999 9999999
Q ss_pred CCcCCCChh
Q 001865 956 PFFKGVNWA 964 (1002)
Q Consensus 956 p~f~~~~~~ 964 (1002)
|||+.....
T Consensus 291 ~~f~~~~~~ 299 (309)
T cd07845 291 SYFKEKPLP 299 (309)
T ss_pred hhhccCCCC
Confidence 999974333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=349.60 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=210.3
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCc
Q 001865 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 755 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggs 755 (1002)
+||.|.||+||.++|..|...+|||.+... +......+..||.+-++|+|.|||++++++..++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 499999999999999999999999988643 45566778899999999999999999999999999999999999999
Q ss_pred hhHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-cCCcEEEEeccCCcccCCCCCCCCCcc
Q 001865 756 LFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (1002)
Q Consensus 756 L~~~l~~~~~~~l--~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~-~~g~vkL~DFG~a~~~~~~~~~~~~~~ 832 (1002)
|.+++.... +++ ++..+..|.+||++||+|||.+.|||||||-+|+|++ -.|.+||+|||-++.+..
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--------- 728 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--------- 728 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc---------
Confidence 999998764 346 8899999999999999999999999999999999997 578999999998855421
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH-HHH
Q 001865 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT-FAN 909 (1002)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~-~~~ 909 (1002)
-.....++.||+.|||||++..+ .|+.++|||||||++.||.||++||........ +-+
T Consensus 729 ------------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 729 ------------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred ------------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 12234578899999999999765 478899999999999999999999976433222 211
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+---..-.|.+..++.+++.||.+|+.++|..||+ |.++|..||++.
T Consensus 791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~s----A~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPS----AKDLLQDPFLQH 837 (1226)
T ss_pred hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCcc----HHHhccCccccc
Confidence 11111222333346889999999999999999999 999999999986
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.33 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=212.0
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+...+|.+.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++.++||||+++++++...+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4566899999999999999999999999999999998753 233567888999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||||+++++|.+++.......++...++.++.|++.||+|||++|++|+||||+||++++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
. .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 159 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 Y--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred e--------------------------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 0 00112234678999999998889999999999999999998 99999988777
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
+....+... ...+.....+..+.+|+.+||..||++||++.+
T Consensus 213 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 213 QVYELLEKG-YRMERPEGCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred HHHHHHHCC-CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 666665543 333344457889999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=336.96 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=205.0
Q ss_pred ccCCccccccccccCcEEEEEEEEcC----------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn 730 (1002)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35689999999999999999998632 34579999987542 3444567889999999999999
Q ss_pred cceeEEEEeeCCeEEEEEeccCCCchhHHHhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Q 001865 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQP-----------------TKVLKEDAVRFYAAEVVVALEYLHCQGII 793 (1002)
Q Consensus 731 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~~l~~~~i~~i~~qil~aL~~LH~~gIi 793 (1002)
|+++++++...+..|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986531 12467788999999999999999999999
Q ss_pred cCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC
Q 001865 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873 (1002)
Q Consensus 794 HrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 873 (1002)
||||||+|||++.++.+||+|||++....... .........++..|+|||++.+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------YYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCc-------------------------eeEecCcCCCCccccCHHHHhcC
Confidence 99999999999999999999999985432110 00112234567899999999888
Q ss_pred CCCChhhHHHHHHHHHHHHc--CCCCCCCCChHHHHHHHHh---C---CCCCCCCCCCCHHHHHHHHHccccCcCCCCCC
Q 001865 874 GHTSAVDWWALGILLYEMLY--GYTPFRGKTRQKTFANILH---K---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 874 ~~~~~sDIwSlGvil~ellt--G~~Pf~~~~~~~~~~~i~~---~---~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
.++.++|||||||++|+|++ |..||.+.+....+..+.. . .........++..+.+|+.+||..||.+|||
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs- 294 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS- 294 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC-
Confidence 89999999999999999986 6788887766655544322 1 1112223456788999999999999999999
Q ss_pred hhcHHHH
Q 001865 946 HEGANEI 952 (1002)
Q Consensus 946 ~~~a~el 952 (1002)
+.+|
T Consensus 295 ---~~~i 298 (304)
T cd05096 295 ---FSDI 298 (304)
T ss_pred ---HHHH
Confidence 6666
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.94 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=215.1
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 662 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
..|.|..+...+...||+|.||+||++++-. .||||++... ...++..+.|.+|+.++++-+|.||+-+.|++...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~-~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVD-DPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecC-CCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4566777889999999999999999999955 4999999876 34566889999999999999999999999999998
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
+. .||+.+|+|.+|+.++.... ..|...+.+.|++||++|+.|||.++|||||||..|||+.++++|||+|||++..-
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 87 99999999999999997653 56999999999999999999999999999999999999999999999999998432
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC---CCCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
. .+ .+ ........|...|||||++.. .+|++.+||||||+++|||++|.+||
T Consensus 539 ~-------------~w--~g----------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 539 T-------------RW--SG----------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred e-------------ee--cc----------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 1 00 00 011223458899999999864 47889999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCC---CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCC
Q 001865 899 RGKTRQKTFANILHKDLK---FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~---~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 956 (1002)
.......++-.+-++... ......++.++++|+..||.+++++||.+.++...|+.++
T Consensus 594 si~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred CCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 954444443333333211 1122346778999999999999999999777666555444
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=315.93 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=215.4
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe-----
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----- 739 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 739 (1002)
.|+..+|++.+.||+|||+-||+++...+++.||+|.+.... .+..+...+|++..++++||||++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 467899999999999999999999999999999999998653 566778899999999999999999988753
Q ss_pred eCCeEEEEEeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEecCCcEEEEec
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDF 815 (1002)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~g--IiHrDLKP~NILl~~~g~vkL~DF 815 (1002)
.....|+++.|+..|+|.+.++.. ++..+++.++..|+.+|++||++||+.. .+||||||.|||++..+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 334699999999999999999853 3457999999999999999999999998 999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHH
Q 001865 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEML 892 (1002)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~~~~~sDIwSlGvil~ell 892 (1002)
|.++.....-. ...+ ............|..|+|||.+.-. ..+.++|||||||+||.|+
T Consensus 174 GS~~~a~i~i~----~~~~--------------a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m 235 (302)
T KOG2345|consen 174 GSATQAPIQIE----GSRQ--------------ALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM 235 (302)
T ss_pred cCccccceEee----chHH--------------HHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH
Confidence 99865321100 0000 0001112334679999999998544 4567999999999999999
Q ss_pred cCCCCCCCCC--hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 893 YGYTPFRGKT--RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 893 tG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
+|..||.... .....-.+....+.+|...+.|..+.+||++||+.||.+||+ +.+++.+
T Consensus 236 f~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 236 FGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred HcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 9999995321 111222334457788988889999999999999999999999 7777653
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=331.40 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=212.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT---- 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~---- 742 (1002)
.++|++.+.||.|+||.||+|.+..+++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 468999999999999999999999899999999987542 2346788999999998 7999999999997544
Q ss_pred --eEEEEEeccCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001865 743 --HVCLITDYCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 743 --~~~lV~E~~~ggsL~~~l~~~~--~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a 818 (1002)
.+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999987533 456899999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHc
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLY 893 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDIwSlGvil~ellt 893 (1002)
...... ........|++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 161 ~~~~~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~ 213 (275)
T cd06608 161 AQLDST---------------------------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD 213 (275)
T ss_pred eecccc---------------------------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh
Confidence 543211 011123468999999999854 345678999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 894 GYTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
|..||...........+...... .......+..+.+||.+||..||++||| +.++++|||+
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 214 GKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred CCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 99999877666666666554322 2222235678999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.69 Aligned_cols=257 Identities=30% Similarity=0.457 Sum_probs=213.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..++..||+|.++.. ........+.+|+.++++++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 3789999999999999999999989999999988753 13444577889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 749 DYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~-~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||+++++|..++.... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999999887531 2368999999999999999999997 59999999999999999999999999988543210
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC------CCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
......|++.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 157 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 157 ---------------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ---------------------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 112345888999999985543 47799999999999999999999976
Q ss_pred CChHHHHHH---HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 901 KTRQKTFAN---ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 901 ~~~~~~~~~---i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
......... +.... ........+..+.+||.+||..+|++||+ +.++++||||...
T Consensus 210 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 210 ETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred cchhhHHHHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCC----HHHHhcChhhhhc
Confidence 554443332 22222 22222347889999999999999999999 9999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.58 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=215.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|+||.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||+++++++...+..|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 46889999999999999999999999999999987653 2345567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
||+.+++|.+++.... ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999997643 568999999999999999999999 99999999999999999999999999988443210
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----C
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-----T 902 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~-----~ 902 (1002)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||... .
T Consensus 155 --------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 208 (265)
T cd06605 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208 (265)
T ss_pred --------------------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence 001156888999999999989999999999999999999999999754 2
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
.......+.............+..+.+||.+||..||++||+ +.+++.||||+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~~~ 262 (265)
T cd06605 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPS----YKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcC----HHHHhhCchhhc
Confidence 233344444332211111126788999999999999999999 999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.04 Aligned_cols=252 Identities=26% Similarity=0.476 Sum_probs=216.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||.|+||.||++.+..+++.||+|.++... .......+.+|+.+++.++|+||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999987532 23455677889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999999987655566899999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 154 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 154 ----------------------GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ----------------------ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 0112235689999999999988899999999999999999999999998877777666
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
+..+.... .....+..+.+||.+||..||++||+ +.+++.-
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~ 252 (255)
T cd08219 212 VCQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPS----ATTILSR 252 (255)
T ss_pred HhcCCCCC-CCcccCHHHHHHHHHHHhCCcccCCC----HHHHhhc
Confidence 66554332 22346788999999999999999999 7777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.90 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=215.3
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
..++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+++++.++||||+++++++...+.+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999987542 23445678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
||||+++++|.+++... +.++...++.++.+++.+|.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 99999999999998764 458999999999999999999997 59999999999999999999999999987432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH-
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ- 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~- 904 (1002)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 158 ----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~ 209 (284)
T cd06620 158 ----------------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209 (284)
T ss_pred ----------------------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhh
Confidence 012346899999999998888899999999999999999999999865432
Q ss_pred ----------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 905 ----------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 905 ----------~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
..+..+.............+..+.+|+.+||..||++||+ +.++++||||..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 210 DGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccc
Confidence 2233333322221112225678999999999999999999 999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.00 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=209.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHH-HHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
++|++++.||+|+||.||++.+..+|+.||+|.++.... ......+..|+.+ ++.++||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876532 1223345556654 6677999999999999999999999
Q ss_pred EeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 748 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|||+ .++|.+++... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999 57888877642 235689999999999999999999997 9999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC----CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~----~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
.......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 158 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 ----------------------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ----------------------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 01122458889999999865 4467899999999999999999999965
Q ss_pred C-ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChh
Q 001865 901 K-TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 901 ~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 964 (1002)
. ...+.+..+............++..+.+||.+||..+|.+||+ ++++++||||......
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~~ 270 (283)
T cd06617 210 WKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPN----YPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCchhhhcccc
Confidence 3 3334444444432221122246788999999999999999999 9999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=361.31 Aligned_cols=259 Identities=28% Similarity=0.396 Sum_probs=214.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEE-Ee---
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS-FQ--- 739 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~-~~--- 739 (1002)
.+...+++|.+.|.+|||+.||+|.+...|..||+|.+-. .+....+.+.+|+++|++| +|+|||.+++. ..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 3556788999999999999999999988889999998753 3778889999999999999 59999999993 22
Q ss_pred e---CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEecCCcEEEEe
Q 001865 740 T---KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTD 814 (1002)
Q Consensus 740 ~---~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g--IiHrDLKP~NILl~~~g~vkL~D 814 (1002)
. .-.++|+||||.||.|-+++..+....|++.+++.|+.|+++||++||... |||||||-+||||+.+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 1 135789999999999999999765566999999999999999999999997 99999999999999999999999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccc---cCCCCCChhhHHHHHHHHHHH
Q 001865 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEM 891 (1002)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l---~~~~~~~~sDIwSlGvil~el 891 (1002)
||.|+..-.... ...+. .-........-|+.|+|||++ .+.+.+.|+|||+|||+||-|
T Consensus 190 FGSatt~~~~~~----~~~e~--------------~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 190 FGSATTKILSPT----SAQEV--------------NYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred ccccccccCCCc----cHHHH--------------HHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 999854221110 00000 000111233569999999997 567889999999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 892 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 892 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
++...||.+.-. -.|+.+.+.+|..+.++..+++||..||+.||.+||+.-++
T Consensus 252 Cy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv 304 (738)
T KOG1989|consen 252 CYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQV 304 (738)
T ss_pred HHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHH
Confidence 999999987532 35678889999998999999999999999999999995443
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.30 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=210.7
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|++++.||+|+||.||++.+. ++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 456789999999999999999999974 56679999876532 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+++++|.+++.......++...+..++.||+.||+|||+++++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 99999999999999998765567899999999999999999999999999999999999999999999999998653211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
.. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 157 ~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 157 EY--------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred ce--------------------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 00 01112345678999999988888999999999999999998 9999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCC
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
......+... ...+.....+..+.+|+.+||..+|++||++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 251 (261)
T cd05072 211 SDVMSALQRG-YRMPRMENCPDELYDIMKTCWKEKAEERPTF 251 (261)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCCcccCcCH
Confidence 7766666543 3444445578899999999999999999993
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=328.95 Aligned_cols=261 Identities=23% Similarity=0.386 Sum_probs=212.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC---hHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
+|+..+.||+|+||.||++.+..+++.+|+|++....... ......+.+|+.+++.++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987543211 2245678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g-~vkL~DFG~a~~~~~~~ 825 (1002)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999764 4589999999999999999999999999999999999998776 59999999985543110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
. ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.......
T Consensus 159 ~-----------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 159 T-----------------------GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred c-----------------------cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 0 00011233568999999999988888999999999999999999999997544322
Q ss_pred HHH---HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 906 TFA---NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 906 ~~~---~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
... .+.............+..+.+++.+||..+|.+||+ +.++++||||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcC----HHHHhcCcccC
Confidence 222 222222222222346788999999999999999999 99999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=330.56 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=216.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
.|...+.||+|++|.||++.+..+++.+++|.+... .......+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 466668899999999999999889999999988643 23344567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|.+++.. ..++...+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999999876 34899999999999999999999999999999999999999999999999987432210
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
........|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+....+..
T Consensus 169 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~ 226 (285)
T cd06648 169 ----------------------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR 226 (285)
T ss_pred ----------------------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence 0111234689999999999888899999999999999999999999988877766666
Q ss_pred HHhCCCCCC-CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 910 ILHKDLKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 910 i~~~~~~~~-~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
+........ .....+..+.+|+.+||..+|++||+ +.++++||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~~ 275 (285)
T cd06648 227 IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT----AAELLNHPFLAKA 275 (285)
T ss_pred HHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC----HHHHccCcccccC
Confidence 655432222 22236788999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=333.34 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=212.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999865422 2233456778999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
||+ +++|.+++.......+++..++.++.||+.||+|||++||+|+||+|+||+++. ++.+||+|||++.......
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 81 EYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred ecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 999 568888886655555789999999999999999999999999999999999985 5679999999985432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.......|++.|+|||++.+. .++.++|||||||++|+|++|+.||...+....
T Consensus 158 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 158 -------------------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred -------------------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 111234578899999998664 578899999999999999999999988776666
Q ss_pred HHHHHhCCC---------------------CCC------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 907 FANILHKDL---------------------KFP------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 907 ~~~i~~~~~---------------------~~~------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
+..+..... .++ .....+..+.+|+.+||+.+|++||+ +.++++||||+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~ 288 (294)
T PLN00009 213 LFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFK 288 (294)
T ss_pred HHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHh
Confidence 555432100 000 01235778899999999999999999 99999999999
Q ss_pred CC
Q 001865 960 GV 961 (1002)
Q Consensus 960 ~~ 961 (1002)
.+
T Consensus 289 ~~ 290 (294)
T PLN00009 289 DL 290 (294)
T ss_pred HH
Confidence 75
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=341.79 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=208.7
Q ss_pred cccccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEE
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS 737 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~ 737 (1002)
|++..++|++++.||+|+||.||+|.+.. +++.||+|+++... .......+..|+.+++++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 44566799999999999999999997543 45789999987532 233445678899999999 89999999998
Q ss_pred Eee-CCeEEEEEeccCCCchhHHHhhCCC---------------------------------------------------
Q 001865 738 FQT-KTHVCLITDYCPGGELFLLLDRQPT--------------------------------------------------- 765 (1002)
Q Consensus 738 ~~~-~~~~~lV~E~~~ggsL~~~l~~~~~--------------------------------------------------- 765 (1002)
+.. +..++++|||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 5678999999999999999864321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhh
Q 001865 766 --------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837 (1002)
Q Consensus 766 --------~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~ 837 (1002)
..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---------- 229 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 229 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch----------
Confidence 25789999999999999999999999999999999999999999999999998654211100
Q ss_pred cccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCC
Q 001865 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLK 916 (1002)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~ 916 (1002)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+...+.....
T Consensus 230 ---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 294 (337)
T cd05054 230 ---------------VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294 (337)
T ss_pred ---------------hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence 01123356778999999999999999999999999999997 99999876554444444444333
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 917 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 917 ~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
.......+..+.+++.+||+.+|++||+ +.++++|
T Consensus 295 ~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~ell~~ 329 (337)
T cd05054 295 MRAPEYATPEIYSIMLDCWHNNPEDRPT----FSELVEI 329 (337)
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 3333456788999999999999999999 6666653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=331.05 Aligned_cols=257 Identities=28% Similarity=0.388 Sum_probs=211.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeC-----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK----- 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~----- 741 (1002)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 578999999999999999999999999999999986531 2235567889999988 899999999998753
Q ss_pred CeEEEEEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 742 THVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
+..|+||||+++++|.+++.. .....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 468999999999999998863 223568999999999999999999999999999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-----CCCChhhHHHHHHHHHHHHcC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYG 894 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----~~~~~sDIwSlGvil~elltG 894 (1002)
...... .......|+..|+|||++... .++.++|||||||++|+|++|
T Consensus 177 ~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 177 QLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred hccccc---------------------------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 432110 011234688999999998543 257899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 895 YTPFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
+.||........+..+...... .......+..+.+||.+||+.+|++||+ +.+|++||||+
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 9999887766666555544222 2222335678999999999999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.83 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=210.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..+++.||+|.+.+... .......+.+|+++++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 378999999999999999999998999999999875432 2234456788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|..+.... ..+++..++.++.||+.||+|||+.||+|+||+|+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999988888776543 348999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......++..|+|||++.+ ..++.++||||||+++|+|++|++||.+....+..
T Consensus 155 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~ 210 (286)
T cd07846 155 ------------------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL 210 (286)
T ss_pred ------------------------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 11123468899999999875 34678999999999999999999999876655444
Q ss_pred HHHHhC-------------------CCCCCC----------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHK-------------------DLKFPS----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~-------------------~~~~~~----------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+... ....+. .+.++..+.+|+.+||..+|++||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 211 YHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred HHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 433321 011111 1245778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=327.81 Aligned_cols=258 Identities=27% Similarity=0.428 Sum_probs=212.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC-------hHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-------RNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~-------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 742 (1002)
+|.+.+.||.|+||.||++.+..+++.+|+|.++...... ......+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5888999999999999999998899999999886432111 112356778999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+++||||+++++|.+++... ..++...++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999999765 458999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC--CCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
.... ........|+..|+|||++.... ++.++|+||||+++|++++|..||..
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 160 DIYD-------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred cccc-------------------------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 1100 00122346889999999987654 78899999999999999999999976
Q ss_pred CChHHHHHHHHhCC--CCCCC--CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 901 KTRQKTFANILHKD--LKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~--~~~~~--~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.........+.... ..++. ...++..+.+||.+||..+|++||+ ++++|+||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 215 EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred cchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 66555444433222 12222 1245788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.52 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=214.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ........+.+|+.+++.++|+||+++++++......|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999988999999999875422 1234556788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+++++|.+++... ..+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999999764 358999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
......|++.|++||.+.... ++.++|+|||||++|+|++|..||........
T Consensus 157 --------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~ 210 (258)
T cd06632 157 --------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA 210 (258)
T ss_pred --------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH
Confidence 112356889999999987766 88899999999999999999999987765555
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
...+.............+..+.+|+.+||..+|++||+ +.+++.|||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 211 VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT----AAELLEHPFV 258 (258)
T ss_pred HHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcC----HHHHhcCCCC
Confidence 54444322222223346788999999999999999999 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=333.90 Aligned_cols=256 Identities=27% Similarity=0.384 Sum_probs=215.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|.+.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46999999999999999999999899999999987554444555677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+. ++|.+++... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9995 6777776543 24589999999999999999999999999999999999999999999999998854221
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
.....|++.|+|||++. ...++.++||||||+++|+|++|..||.+.+...
T Consensus 168 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~ 221 (307)
T cd06607 168 --------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (307)
T ss_pred --------------------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH
Confidence 11346788999999984 3557889999999999999999999998877766
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
....+.............+..+.+||.+||..+|++||+ +.+++.||||...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~ 273 (307)
T cd06607 222 ALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS----SEELLKHRFVLRE 273 (307)
T ss_pred HHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhccc
Confidence 655554433222222335778999999999999999999 9999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=328.97 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=217.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|+.++.||.|+||.||+|.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999987542 2345577889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++.. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 99999999999865 348899999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 156 ------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06640 156 ------------------------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211 (277)
T ss_pred ------------------------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence 01123468889999999988889999999999999999999999998877666555
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
.+..... .......+..+.+|+.+||..+|++||+ +.++++||||....
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~ 260 (277)
T cd06640 212 LIPKNNP-PTLTGEFSKPFKEFIDACLNKDPSFRPT----AKELLKHKFIVKNA 260 (277)
T ss_pred hhhcCCC-CCCchhhhHHHHHHHHHHcccCcccCcC----HHHHHhChHhhhcc
Confidence 4433321 1122235678899999999999999999 99999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.91 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=216.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|+.++.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 46888999999999999999998999999999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc---
Confidence 99999999999864 358999999999999999999999999999999999999999999999999985432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|+..|+|||++.+..++.++|+|||||++|+|++|..||..........
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06642 156 ------------------------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211 (277)
T ss_pred ------------------------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence 01123468899999999998888999999999999999999999998766555444
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
.+...... ......+..+.+||.+||+.+|++||+ +.++++||||..+.
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~~~~~ 260 (277)
T cd06642 212 LIPKNSPP-TLEGQYSKPFKEFVEACLNKDPRFRPT----AKELLKHKFITRYT 260 (277)
T ss_pred hhhcCCCC-CCCcccCHHHHHHHHHHccCCcccCcC----HHHHHHhHHHHHHh
Confidence 43333221 112235778999999999999999999 99999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.08 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=209.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEe-----e
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----T 740 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~ 740 (1002)
..++|++++.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3579999999999999999999999999999999876431 1234577899999999 7999999999873 4
Q ss_pred CCeEEEEEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001865 741 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a 818 (1002)
++.+|+||||+++++|.+++.. .....+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 5679999999999999998753 22346899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----CCCCChhhHHHHHHHHHHHHc
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLY 893 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~~~~~sDIwSlGvil~ellt 893 (1002)
....... .......|++.|+|||++.. ..++.++|||||||++|+|++
T Consensus 172 ~~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 172 AQLTSTR---------------------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred eecccCC---------------------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 5432110 01123468999999999853 446789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 894 GYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
|+.||........+..+.... .........+..+.+||.+||+.||++||+ +.++++|+||
T Consensus 225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 225 GDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred CCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 999998776555444433322 112222335678999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=363.20 Aligned_cols=270 Identities=25% Similarity=0.336 Sum_probs=210.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++++.||+|+||.||+|.+..+++.||+|+++...........++.+|+.+++.++||||+++++++..++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999998654444455667889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 749 DYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~---------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999986421 1235667788999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~ 899 (1002)
............ .. ................+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 162 ~i~~~~~~~~~l-------~~--~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 162 FKKLEEEDLLDI-------DV--DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred eccccccccccc-------cc--ccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 652211100000 00 000000111122234679999999999999999999999999999999999999998
Q ss_pred CCChHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 900 GKTRQKTFANI-LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 900 ~~~~~~~~~~i-~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
........... .............+..+.+++.+||..||++|++..+
T Consensus 233 ~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 233 RKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred CcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 76544333221 1111112222346788999999999999999998543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=333.83 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=213.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
+|++.+.||.|+||.||+|.+..+++.||+|.++..... .......+..|+.+++.++|+||+++++++...+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999865432 122334567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 999999997643 369999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+....
T Consensus 157 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~ 211 (298)
T cd07841 157 -------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211 (298)
T ss_pred -------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH
Confidence 01122356888999999865 4578899999999999999999988988776665
Q ss_pred HHHHHhCCCC-----CC---------------------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 907 FANILHKDLK-----FP---------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 907 ~~~i~~~~~~-----~~---------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+..+...... ++ .....+..+.+||.+||.++|++||| +.++++||||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~ 287 (298)
T cd07841 212 LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSN 287 (298)
T ss_pred HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccC
Confidence 5554331000 00 01224667889999999999999999 999999999997
Q ss_pred C
Q 001865 961 V 961 (1002)
Q Consensus 961 ~ 961 (1002)
.
T Consensus 288 ~ 288 (298)
T cd07841 288 D 288 (298)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=347.07 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=215.7
Q ss_pred cccccccccCcEEEEEEEEcCCCeEEEEEEeecc-cccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC--eEEEEE
Q 001865 672 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT--HVCLIT 748 (1002)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~-~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--~~~lV~ 748 (1002)
+....||+|+|-+||+|.|..+|..||--.++-. ....+....++..|+.+|+.|+||||+++|+++.+.. .+-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4556799999999999999999988875544322 2345667789999999999999999999999998654 588999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--CcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~--gIiHrDLKP~NILl~~-~g~vkL~DFG~a~~~~~~~ 825 (1002)
|+|..|+|..|+++. +.++...++.|++||++||.|||++ -|||||||.+||||+. .|.|||+|+|+|..+..+
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999999885 5599999999999999999999998 4999999999999984 589999999999765422
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~-~~~~ 904 (1002)
.....+|||.|||||++. ..|+..+||||||++++||+|+.+||.. .+..
T Consensus 200 ----------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 200 ----------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred ----------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 123478999999999987 6699999999999999999999999976 5667
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.+|+++..+..+-.-..-..+++++||.+||.. ...|+| +.|||+||||..-
T Consensus 251 QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLS----AKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccC----HHHHhhChhhccc
Confidence 888888777544333333578999999999998 899999 9999999999984
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=325.22 Aligned_cols=258 Identities=29% Similarity=0.480 Sum_probs=219.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... ......+.+|+.++..++|+|++++++++...+..|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 368999999999999999999999999999999876532 245677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
||+++++|.+++... ..+++..+..++.||+.||.|||+ +|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 999999999999764 558999999999999999999999 9999999999999999999999999999855421110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---ChH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK---TRQ 904 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~---~~~ 904 (1002)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||... ...
T Consensus 156 --------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~ 209 (264)
T cd06623 156 --------------------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF 209 (264)
T ss_pred --------------------------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence 112346889999999999888899999999999999999999999776 334
Q ss_pred HHHHHHHhCCCCCCCCCC-CCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 905 KTFANILHKDLKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
.....+..... ...... .+..+.++|.+||..+|++||+ +.++++||||+.++
T Consensus 210 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 210 ELMQAICDGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHhcCCC-CCCCcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCHHHHhcc
Confidence 44444443322 222233 6788999999999999999999 99999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.09 Aligned_cols=269 Identities=44% Similarity=0.768 Sum_probs=218.5
Q ss_pred CccccccccccCcEEEEEEEEc---CCCeEEEEEEeecccccC-hHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 744 (1002)
.|++.+.||.|+||.||+|.+. .+|..||+|+++...... ......+.+|+.+++.+ +|+||+.+++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999984 478999999997643222 23345677899999999 699999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999999764 45899999999999999999999999999999999999999999999999998553211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
. ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 159 E--------------------------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred c--------------------------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 0 0111235689999999998753 46779999999999999999999996432
Q ss_pred ----hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhc
Q 001865 903 ----RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRC 968 (1002)
Q Consensus 903 ----~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~ 968 (1002)
.......+......++ ...+..+.+|+.+||..||++||+.. ..+.+++.||||..++|+.+..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 281 (290)
T cd05613 213 EKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAA 281 (290)
T ss_pred ccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhh
Confidence 2333333333333333 34678899999999999999998432 3499999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=362.05 Aligned_cols=268 Identities=24% Similarity=0.325 Sum_probs=200.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCC-eEEEEE--------------EeecccccChHHHHHHHHHHHHHHhCCCCCcc
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSG-QYFAMK--------------AMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~-~~~avK--------------~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv 732 (1002)
.++|++++.||+|+||.||+|..+... ...+.| .+.+...........+.+|+.+|++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 478999999999999999998764332 122222 11111111223445678999999999999999
Q ss_pred eeEEEEeeCCeEEEEEeccCCCchhHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001865 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (1002)
Q Consensus 733 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~ 809 (1002)
++++++...+..|+||+++ +++|..++.... ........++.++.||+.||.|||++|||||||||+|||++.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 677877765421 122446778889999999999999999999999999999999999
Q ss_pred EEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001865 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (1002)
Q Consensus 810 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ 889 (1002)
+||+|||++..+..... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 306 vkL~DFGla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 359 (501)
T PHA03210 306 IVLGDFGTAMPFEKERE--------------------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359 (501)
T ss_pred EEEEeCCCceecCcccc--------------------------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHH
Confidence 99999999965431110 1122457999999999999999999999999999999
Q ss_pred HHHcCCCCCCCC---ChHHHHHHHHhCC----CCCC--------------------------CCCCCCHHHHHHHHHccc
Q 001865 890 EMLYGYTPFRGK---TRQKTFANILHKD----LKFP--------------------------SSTPTSLHAKQLMYRLLH 936 (1002)
Q Consensus 890 elltG~~Pf~~~---~~~~~~~~i~~~~----~~~~--------------------------~~~~~s~~~~~Ll~~~L~ 936 (1002)
+|++|..++.+. .....+..++... ..++ .....+..+.++|.+||+
T Consensus 360 ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~ 439 (501)
T PHA03210 360 DMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLT 439 (501)
T ss_pred HHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhc
Confidence 999987654322 2222222222210 0011 011234567788999999
Q ss_pred cCcCCCCCChhcHHHHHcCCCcCCCChhhh
Q 001865 937 RDPKSRLGSHEGANEIKKHPFFKGVNWALV 966 (1002)
Q Consensus 937 ~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 966 (1002)
+||.+||| +.|+|.||||.......+
T Consensus 440 ~DP~~Rps----a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 440 FDWHLRPG----AAELLALPLFSAEEEEEI 465 (501)
T ss_pred cCcccCcC----HHHHhhChhhhcCCchHH
Confidence 99999999 999999999998765554
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=331.83 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=205.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.+.|++.+.||+|++|.||++.+..+++.||+|.+...... .....+.+|+++++.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 46899999999999999999999989999999998754221 1223456899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+|.+||+|||++.......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 99995 58999887643 358999999999999999999999999999999999999999999999999885321100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC-hHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQK 905 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~-~~~ 905 (1002)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ..+
T Consensus 158 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 158 -------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred -------------------------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH
Confidence 01122356889999999876 457889999999999999999999997665 223
Q ss_pred HHHHHHhC-------------------CCCCC---------CCCCCC--HHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 906 TFANILHK-------------------DLKFP---------SSTPTS--LHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 906 ~~~~i~~~-------------------~~~~~---------~~~~~s--~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
....+... ....+ .....+ ..+.+||.+||+.+|.+||| +.++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~ 288 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKH 288 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcC
Confidence 22222110 00000 001223 67889999999999999999 9999999
Q ss_pred CCc
Q 001865 956 PFF 958 (1002)
Q Consensus 956 p~f 958 (1002)
|||
T Consensus 289 ~~f 291 (291)
T cd07844 289 PYF 291 (291)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=340.71 Aligned_cols=289 Identities=25% Similarity=0.386 Sum_probs=222.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----Ce
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----TH 743 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~ 743 (1002)
.+|++.+.||.|+||.||++.+..+++.||||.+.... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 58999999999999999999999999999999987542 2333455677899999999999999999988644 35
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888764 4599999999999999999999999999999999999999999999999999854321
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
.. .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 161 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 161 KG---------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred Cc---------------------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 10 01123467889999999865 458889999999999999999999998765
Q ss_pred hHHHHHHHHhC-----------------------CCCC------CCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 903 RQKTFANILHK-----------------------DLKF------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 903 ~~~~~~~i~~~-----------------------~~~~------~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
....+..+... .... ......+..+.+||.+||+.+|++||| +++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell 289 (337)
T cd07858 214 YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEAL 289 (337)
T ss_pred hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHH
Confidence 44333322210 0000 011346788899999999999999999 99999
Q ss_pred cCCCcCCCChhhhhccCCCCCCCCCCCCccccccccCCchhHhhhhhc
Q 001865 954 KHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQNV 1001 (1002)
Q Consensus 954 ~Hp~f~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1002)
+||||+.+.-.. ..|.-.+.+.-+++...=+..|+-+++
T Consensus 290 ~h~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (337)
T cd07858 290 AHPYLASLHDPS---------DEPVCQTPFSFDFEEDALTEEDIKELI 328 (337)
T ss_pred cCcchhhhcCcc---------cCccCCCccchhhhhhhcCHHHHHHHH
Confidence 999998752221 122233444444555444444555543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=335.38 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=191.4
Q ss_pred ccccccCcEEEEEEEEcC--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe--eCCeEEEEEec
Q 001865 675 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVCLITDY 750 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV~E~ 750 (1002)
..||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++. .+..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999754 56899999886532 2235678999999999999999999885 45688999999
Q ss_pred cCCCchhHHHhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE----ecCCcEEEEeccCCc
Q 001865 751 CPGGELFLLLDRQ-------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL----QGNGHVSLTDFDLSC 819 (1002)
Q Consensus 751 ~~ggsL~~~l~~~-------~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl----~~~g~vkL~DFG~a~ 819 (1002)
+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9 56888877521 12358899999999999999999999999999999999999 456789999999996
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
....... .........||+.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 161 ~~~~~~~------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPLK------------------------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCcc------------------------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 5432110 01112345789999999998764 5788999999999999999999999
Q ss_pred CCCChH---------HHHHHHHhC--------------CCCC----------------------CCCCCCCHHHHHHHHH
Q 001865 899 RGKTRQ---------KTFANILHK--------------DLKF----------------------PSSTPTSLHAKQLMYR 933 (1002)
Q Consensus 899 ~~~~~~---------~~~~~i~~~--------------~~~~----------------------~~~~~~s~~~~~Ll~~ 933 (1002)
...... ..+..+... ...+ ......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 753221 111111100 0000 0011234567899999
Q ss_pred ccccCcCCCCCChhcHHHHHcCCCc
Q 001865 934 LLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 934 ~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
||+.||.+||| +.|+|+||||
T Consensus 297 ~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 297 LLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred HhccCcccccC----HHHHhcCCCC
Confidence 99999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.85 Aligned_cols=259 Identities=29% Similarity=0.536 Sum_probs=215.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||+|+||.||++.+..+++.|++|.++.... .......+.+|+.+++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999988999999999986532 24567888999999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~- 156 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM- 156 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-
Confidence 99999999999764 448899999999999999999999999999999999999999999999999986543221100
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC---CCChhhHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 905 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---~~~~sDIwSlGvil~elltG~~Pf~~~~~~-~ 905 (1002)
........+++.|+|||++.+.. ++.++||||||+++|++++|+.||...... .
T Consensus 157 ----------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~ 214 (264)
T cd06626 157 ----------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214 (264)
T ss_pred ----------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH
Confidence 00012356889999999998766 788999999999999999999999765332 2
Q ss_pred HHHHHHh-CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 906 TFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 906 ~~~~i~~-~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
....+.. ....++.....+..+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 215 IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT----ASELLQHPFV 264 (264)
T ss_pred HHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 2222222 22334444445888999999999999999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=324.12 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=217.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|.+.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+.+++.++|+||+++++.+...+..|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999876432 22334567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc-EEEEeccCCcccCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-VSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~-vkL~DFG~a~~~~~~~~~~ 828 (1002)
|+++++|.+++.......+++..+..++.||+.||.|||+++++|+||||+||+++.++. ++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 999999999998765556899999999999999999999999999999999999998864 6999999885432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+.
T Consensus 157 ------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 157 ------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 01122358899999999988888999999999999999999999998877777666
Q ss_pred HHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 909 NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 909 ~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+...... +.....+..+.++|.+||..+|++||| +.++++||||
T Consensus 213 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt----~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPS----ITSILKRPFL 257 (257)
T ss_pred HHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcC----HHHHhhCCCC
Confidence 66554332 223346778999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=328.74 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=212.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.++... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35689999999999999999998743 36789999987542 233456888999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001865 742 THVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~ 809 (1002)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997532 235788999999999999999999999999999999999999999
Q ss_pred EEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001865 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (1002)
Q Consensus 810 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ 889 (1002)
++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCcc-------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 99999999854321100 01112334678899999999999999999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 890 EMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 890 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
+|++ |..||.+.+.......+..+....+ ....+..+.+|+.+||..||++||+ +.+++
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil 275 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQR-PRTCPSEVYDIMLGCWKRDPQQRIN----IKDIH 275 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCCC-CCCCCHHHHHHHHHHcCCCcccCCC----HHHHH
Confidence 9998 9999998888877777776544332 2347889999999999999999999 56654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=331.29 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=208.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCe----
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH---- 743 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~---- 743 (1002)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999999875421 222335677899999999 46999999999887665
Q ss_pred -EEEEEeccCCCchhHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCC
Q 001865 744 -VCLITDYCPGGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLS 818 (1002)
Q Consensus 744 -~~lV~E~~~ggsL~~~l~~~~---~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-~g~vkL~DFG~a 818 (1002)
.|+||||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 899999996 48888876532 245899999999999999999999999999999999999998 889999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~P 897 (1002)
....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 159 ~~~~~~~---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSIPV---------------------------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCCCc---------------------------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 5432110 01122357889999998865 4568899999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCC-----C------------CCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 898 FRGKTRQKTFANILHKDL-----K------------FPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~-----~------------~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
|.+.+.......+..... . .+. ....+..+.+||.+||.+||.+||+ +.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~e 287 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKA 287 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHH
Confidence 998877666555443100 0 000 1235778999999999999999999 999
Q ss_pred HHcCCCcC
Q 001865 952 IKKHPFFK 959 (1002)
Q Consensus 952 lL~Hp~f~ 959 (1002)
++.||||+
T Consensus 288 il~~~~~~ 295 (295)
T cd07837 288 ALTHPYFD 295 (295)
T ss_pred HhcCCCcC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.76 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=210.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||+|.+..+++.||+|.++............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999887644445556667889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 749 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||+++++|.+++... ....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999999888642 23458999999999999999999999999999999999999999999999999885532110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 904 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~--~ 904 (1002)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... .
T Consensus 161 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 214 (267)
T cd08228 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF 214 (267)
T ss_pred --------------------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH
Confidence 011234688999999999888889999999999999999999999975432 3
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
.....+.....+.......+..+.+||.+||..+|++||+ +.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~vl~ 260 (267)
T cd08228 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPD----IGYVHQ 260 (267)
T ss_pred HHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcC----HHHHHH
Confidence 3333333322221112235678999999999999999999 666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=328.79 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=213.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCcceeEEEEeeCCeEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~~~~~l 746 (1002)
.|++++.||.|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.+. |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987542 2344567788999999986 9999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||||+++++|.+++... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999999998653 58999999999999999999999999999999999999999999999999985543111
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
.......|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.....
T Consensus 156 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 156 --------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred --------------------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 11223468999999999865 446889999999999999999999998876655
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
....+.....+.......+..+.+|+.+||..||++||+ +.++++||||+..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~il~~~~~~~~ 261 (277)
T cd06917 210 AMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLS----AEELLKSKWIKAH 261 (277)
T ss_pred hhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcC----HHHHhhChHhhcc
Confidence 544333322111111126778999999999999999999 9999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=339.78 Aligned_cols=255 Identities=28% Similarity=0.435 Sum_probs=211.2
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 742 (1002)
.++|++++.||+|+||.||++.+..++..||+|.+.+. .........+.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccc-ccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46899999999999999999999999999999998653 223334456789999999999999999999987543
Q ss_pred -eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899888864 35899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
.. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+
T Consensus 169 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 169 DS------------------------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cc------------------------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 0123457889999999876 4578899999999999999999999988
Q ss_pred CChHHHHHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 901 KTRQKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~-----------------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
.+....+..+.......+ .....+..+.++|.+||+.||.+||| +.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~ 294 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAE 294 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHH
Confidence 776555554433211100 01245677899999999999999999 999
Q ss_pred HHcCCCcCCC
Q 001865 952 IKKHPFFKGV 961 (1002)
Q Consensus 952 lL~Hp~f~~~ 961 (1002)
++.||||+.+
T Consensus 295 ~l~~~~~~~~ 304 (343)
T cd07880 295 ALAHPYFEEF 304 (343)
T ss_pred HhcCccHhhh
Confidence 9999999974
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=329.44 Aligned_cols=279 Identities=37% Similarity=0.639 Sum_probs=227.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV 747 (1002)
++|.+.+.||.|+||.||++.+..++..||+|++.+...........+.+|+.+++++. ||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 37999999999999999999999999999999998754444455677888999999998 99999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+.+++|.+++... ..++...++.++.||+.||.|||++|++|+||+|+||+++.+|.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999999875 35999999999999999999999999999999999999999999999999998654322211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
....... . .................|+..|+|||++.+..++.++|+||||++++++++|..||........+
T Consensus 159 ~~~~~~~-~------~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 159 ESNKGDA-T------NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred ccCCCCC-c------cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 0000000 0 00000011112334567899999999998888899999999999999999999999988777777
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+......++. ..+..+.+||.+||+.+|.+||++....+++|+||||
T Consensus 232 ~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 232 QKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 776655444443 4578899999999999999999943333999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.92 Aligned_cols=256 Identities=25% Similarity=0.474 Sum_probs=216.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe--eCCeEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ--TKTHVCLI 747 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~lV 747 (1002)
+|++++.||.|+||.||+|.+..++..+|+|.+..... .......+..|+.+++.++||||+++++++. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999875432 3445567888999999999999999999775 45678999
Q ss_pred EeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----HcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 748 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH-----~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
|||+++++|.+++... ....+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999998753 2356899999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
..... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..
T Consensus 160 ~~~~~---------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGHDS---------------------------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccCCc---------------------------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 43111 001234689999999999888889999999999999999999999998
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+.......+..+... ......+..+.+|+.+||..+|++||+ +.++++|||+
T Consensus 213 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCCcccCCC----HHHHhhCCCC
Confidence 8766666666554332 222346788999999999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=333.36 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=217.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|.....||+|+||.||++.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 45666778999999999999999899999999986542 223456788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+++++|..++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---- 170 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---- 170 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc----
Confidence 99999999998754 34899999999999999999999999999999999999999999999999988543211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
........|++.|+|||++.+..++.++|||||||++|+|++|+.||........+.
T Consensus 171 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 227 (297)
T cd06659 171 -----------------------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 227 (297)
T ss_pred -----------------------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 011123568999999999998889999999999999999999999998877766665
Q ss_pred HHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 909 NILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 909 ~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
.+...... +......+..+.++|.+||+.+|.+||+ +.++++||||....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps----~~~ll~~~~~~~~~ 278 (297)
T cd06659 228 RLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT----AQELLDHPFLLQTG 278 (297)
T ss_pred HHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC----HHHHhhChhhccCC
Confidence 55443222 2223346778999999999999999999 99999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=330.55 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=217.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
-|...+.||+|+||.||+|.+..++..|++|.+.............+.+|+.+++.++|||++++++++......|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 47778889999999999999999999999999976544445556678889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+ .++|.+++... ...+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cC-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 99 56788877653 3458999999999999999999999999999999999999999999999999873211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
......|+..|+|||++. ...++.++|||||||++|+|++|..||...+....
T Consensus 173 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~ 228 (313)
T cd06633 173 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228 (313)
T ss_pred ------------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 112346889999999984 35678899999999999999999999988877666
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCCh
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~ 963 (1002)
...+.............+..+.+|+.+||+++|.+||+ +.+++.||||+..+-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~----~~~~l~~~~~~~~~~ 281 (313)
T cd06633 229 LYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA----SAELLRHDFVRRDRP 281 (313)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCcccCCCch
Confidence 66665544433333446678999999999999999999 999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=344.09 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=210.2
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEE
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYA 736 (1002)
Q Consensus 663 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~ 736 (1002)
.+.+..++|++++.||+|+||.||+|.+... +..||||+++... .......+.+|+.++++++ ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 3455678999999999999999999987433 3479999987542 2334567889999999996 999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHhhCC----------------------------------------------------
Q 001865 737 SFQTKTHVCLITDYCPGGELFLLLDRQP---------------------------------------------------- 764 (1002)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 764 (1002)
++...+.+|+|||||++|+|.+++..+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999886431
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001865 765 ------------------------------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (1002)
Q Consensus 765 ------------------------------------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NI 802 (1002)
...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12478888999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001865 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (1002)
Q Consensus 803 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIw 882 (1002)
|++.++.+||+|||++........ ........+++.|+|||++.+..++.++|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN-------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc-------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 999999999999999865321110 0112234578899999999988899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcH
Q 001865 883 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949 (1002)
Q Consensus 883 SlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a 949 (1002)
||||++|+|++ |..||........+..........+....++..+.+|+.+||..||++||++.+++
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 99999999996 99999876544444444444444444456788999999999999999999955533
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=326.63 Aligned_cols=248 Identities=31% Similarity=0.485 Sum_probs=201.0
Q ss_pred CCccccccc--cccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEE
Q 001865 669 QHFRPIKPL--GSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 669 ~~y~i~~~L--G~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 745 (1002)
+.|.+.+.+ |+|+||.||++.++.++..+|+|.+....... .|+.+...+ +||||++++++|..++..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 466776766 99999999999999999999999987542211 122233323 7999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g-~vkL~DFG~a~~~~~~ 824 (1002)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999999765 3699999999999999999999999999999999999999988 999999998854321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 163 ------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 163 ------------------------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred ------------------------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 11235889999999999888999999999999999999999999865433
Q ss_pred HHH-HHHHhC-CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 905 KTF-ANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 905 ~~~-~~i~~~-~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
... ..+... ....+.....+..+.+||.+||+.+|.+||+. ++++|+||||+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~---~~~~l~h~~~~~ 267 (267)
T PHA03390 213 ELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTN---YNEIIKHPFLKI 267 (267)
T ss_pred hhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCch---HHHHhcCCcccC
Confidence 221 111111 11222233578899999999999999999961 599999999974
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.54 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=211.8
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--CCeEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 746 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 746 (1002)
++|...+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|++++++++||||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 47889999999999999999999999999999987542 23455778899999999999999999998864 447899
Q ss_pred EEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 747 ITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
||||+++++|.+++.. .....++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988754 22355899999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK--- 901 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~--- 901 (1002)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 159 -----------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 159 -----------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred -----------------------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 011245788999999999888999999999999999999999999765
Q ss_pred --ChHHHHHHHHhCCC-CCCCC----CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 902 --TRQKTFANILHKDL-KFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 902 --~~~~~~~~i~~~~~-~~~~~----~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
...+....+..... ..+.. ...+..+.+||.+||..+|++||| +.|+++||||+..
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 272 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQ 272 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC----HHHHHhCcccccc
Confidence 22333333333211 11111 123567899999999999999999 9999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=333.42 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=216.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|.+++.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999999889999999998643 223346778899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
+||+++++|.+++... .++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-- 169 (293)
T cd06647 95 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 169 (293)
T ss_pred EecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--
Confidence 9999999999998753 47899999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......|++.|+|||.+.+..++.++|+|||||++|++++|+.||...+....+
T Consensus 170 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~ 224 (293)
T cd06647 170 -------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (293)
T ss_pred -------------------------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe
Confidence 0112346889999999998888899999999999999999999999876654443
Q ss_pred HHHHhC-CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 908 ANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 908 ~~i~~~-~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
..+... ...+......+..+.+|+.+||..+|++||+ +.+++.||||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~h~~~~~~ 275 (293)
T cd06647 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS----AKELLQHPFLKIA 275 (293)
T ss_pred eehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcC----HHHHhcCHHHhcC
Confidence 333322 2223333345678999999999999999999 9999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.16 Aligned_cols=257 Identities=18% Similarity=0.232 Sum_probs=209.6
Q ss_pred cccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
+..++|++.+.||+|+||.||++.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998742 35689999886432 22344568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEE
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL 812 (1002)
+...++||||+++++|.+++.... ...++...+..++.|++.||.|||++|++|+||||+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999987532 123677889999999999999999999999999999999999999999
Q ss_pred EeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH
Q 001865 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (1002)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ell 892 (1002)
+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99999854321100 00111234678899999999888999999999999999999
Q ss_pred c-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 893 Y-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 893 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
+ |..||.+.+.......+...... +....++..+.+|+.+||+.||++||+ +.++++
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps----~~e~l~ 273 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPS----FLEIIS 273 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 8 79999988877777666654432 223346788999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.72 Aligned_cols=272 Identities=42% Similarity=0.737 Sum_probs=219.8
Q ss_pred CccccccccccCcEEEEEEEEc---CCCeEEEEEEeecccccC-hHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML-DHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~---~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~ 744 (1002)
+|++.+.||.|+||.||++.+. .++..||+|++++..... ......+.+|+.++.++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4888999999999999999864 457899999987543222 23345677899999999 699999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+.+++|.+++... ..+++..++.++.|++.+|.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999998754 45899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
. ........|++.|+|||.+.+.. .+.++||||||+++|+|++|..||....
T Consensus 159 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 E--------------------------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred c--------------------------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 0 01112346899999999987654 6789999999999999999999996432
Q ss_pred ----hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhccCCC
Q 001865 903 ----RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPP 972 (1002)
Q Consensus 903 ----~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~ 972 (1002)
..+....+....... ....+..+.+||.+||+.+|++|||+.+ +.++|+||||+.+.|+.+...+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~t~~~-~~~~l~~~~~~~~~~~~~~~~~~~ 283 (288)
T cd05583 213 EQNSQSEISRRILKSKPPF--PKTMSAEARDFIQKLLEKDPKKRLGANG-ADEIKNHPFFQGIDWDDLAAKRIP 283 (288)
T ss_pred ccchHHHHHHHHHccCCCC--CcccCHHHHHHHHHHhcCCHhhccCcch-HHHHhcCcccccCCHHHHhhhccC
Confidence 223333333333332 3346788999999999999999999543 678999999999999888665554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=328.58 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=203.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|++++.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999875422 12223567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+ +++|.+++.... ..++...++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 82 FEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred Eecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 9999 577777765443 347888999999999999999999999999999999999999999999999985422110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChH-H
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 905 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~-~ 905 (1002)
.......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.... +
T Consensus 158 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~ 212 (291)
T cd07870 158 -------------------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212 (291)
T ss_pred -------------------------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH
Confidence 111233578999999998764 4788999999999999999999999765432 2
Q ss_pred HHHHHHhC-C-------------CC-----C----C-------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 906 TFANILHK-D-------------LK-----F----P-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 906 ~~~~i~~~-~-------------~~-----~----~-------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
.+..+... . .. + + .....+..+.+|+.+||..||.+||| +.+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h 288 (291)
T cd07870 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLH 288 (291)
T ss_pred HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcC
Confidence 22222110 0 00 0 0 00113567889999999999999999 9999999
Q ss_pred CCc
Q 001865 956 PFF 958 (1002)
Q Consensus 956 p~f 958 (1002)
|||
T Consensus 289 ~~~ 291 (291)
T cd07870 289 PYF 291 (291)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.48 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=208.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
+.++|++.+.||+|+||.||++.++. +..+|+|.+.... .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 34679999999999999999998854 5679999876542 123567889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||.+.......
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE- 154 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-
Confidence 999999999999987543 358999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~ 905 (1002)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~ 209 (256)
T cd05114 155 -------------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209 (256)
T ss_pred -------------------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 001112235678999999988889999999999999999999 999999888887
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
.+..+..+... ......+..+.+|+.+||..+|++||+ +.++++
T Consensus 210 ~~~~i~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rps----~~~l~~ 253 (256)
T cd05114 210 VVEMISRGFRL-YRPKLASMTVYEVMYSCWHEKPEGRPT----FAELLR 253 (256)
T ss_pred HHHHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 77777665322 223345778999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.15 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=210.5
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
|++.+.||.|++|.||++.+..+|..||+|++..... .......+.+|+.+++.++|||++++++++..++..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875422 222335677899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+ +++|.+++.......+++..+..++.||+.||+|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----- 153 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----- 153 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-----
Confidence 9 5799999877654568999999999999999999999999999999999999999999999999985432110
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......+++.|+|||++.+. .++.++||||||+++|+|++|++||...+.......
T Consensus 154 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 154 ----------------------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ----------------------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011223568899999988664 468899999999999999999999988776555444
Q ss_pred HHhCCC------------------CCC---------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 910 ILHKDL------------------KFP---------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 910 i~~~~~------------------~~~---------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+.+... .++ .....+..+.+||.+||+.+|.+||+ +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 433100 000 11335678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=324.81 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=213.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
..+|++++.||.|+||.||+|.+.. +..+++|++... .......+..|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc---chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4579999999999999999999977 889999998754 233456788899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+++++|.+++.......++...++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 999999999999987656678999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~ 906 (1002)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+.
T Consensus 159 -------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~ 213 (261)
T cd05148 159 -------------------------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213 (261)
T ss_pred -------------------------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 00112346778999999988889999999999999999998 8999998887777
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHH
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~ 950 (1002)
+..+... ...+....++..+.+++.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 214 YDQITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHhC-CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7766643 344445567889999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.84 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=209.0
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||.|+||.||++.+..+++.+|||.+.............+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999887644444455677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 749 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||+++++|.+++... ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988642 23468999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--H
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR--Q 904 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~--~ 904 (1002)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+... .
T Consensus 161 --------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08229 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred --------------------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH
Confidence 011234688999999999888899999999999999999999999976533 2
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
.....+.............+..+.+|+.+||..||++|||+.++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 258 (267)
T cd08229 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258 (267)
T ss_pred HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHH
Confidence 33333333222222223467889999999999999999995443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.32 Aligned_cols=251 Identities=27% Similarity=0.468 Sum_probs=203.5
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeC--CeEEEE
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THVCLI 747 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~lV 747 (1002)
|++++.||+|+||.||++.+..+++.||+|.+++... .... ....+|+.++.++ +|+||+++++++.++ +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999876422 2222 2345788888888 599999999999987 899999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+. ++|.+.+.... ..+++..++.++.||+.||+|||++||+|+||||+||+++. +.+||+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 99995 68888876542 45899999999999999999999999999999999999999 999999999985432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~ 906 (1002)
......+++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 154 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 154 --------------------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred --------------------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 1122457889999998654 4568899999999999999999999988776655
Q ss_pred HHHHHhC------------------CCCCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHK------------------DLKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~------------------~~~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..+... ...++. ....+..+.+||.+||.++|++||+ +.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 208 IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 5444321 111111 1235788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=334.07 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=205.4
Q ss_pred CccccccccccCcEEEEEEEEcC--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 745 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 745 (1002)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... +.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58899999999999999999988 8999999999874322333446678899999999999999999999988 8899
Q ss_pred EEEeccCCCchhHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec----CCcEEEEeccCC
Q 001865 746 LITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG----NGHVSLTDFDLS 818 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~---~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~----~g~vkL~DFG~a 818 (1002)
+||||++ ++|.+++... ....+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 5777766532 1236899999999999999999999999999999999999999 899999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~P 897 (1002)
......... ........+++.|+|||++.+. .++.++|||||||++|+|++|++|
T Consensus 160 ~~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPLKP------------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCccc------------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 654321110 1112345689999999988764 578899999999999999999999
Q ss_pred CCCCChHH---------HHHHHHh--------------------------CCCCCCC---------CCCCCHHHHHHHHH
Q 001865 898 FRGKTRQK---------TFANILH--------------------------KDLKFPS---------STPTSLHAKQLMYR 933 (1002)
Q Consensus 898 f~~~~~~~---------~~~~i~~--------------------------~~~~~~~---------~~~~s~~~~~Ll~~ 933 (1002)
|.+..... .+..+.. ....++. ....+..+.++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 97654321 1111110 0001110 01356678899999
Q ss_pred ccccCcCCCCCChhcHHHHHcCCCc
Q 001865 934 LLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 934 ~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
||+.||++||| +.++++||||
T Consensus 296 ~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC----HHHHhcCCCC
Confidence 99999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.86 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=209.5
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++.+.||+|++|.||++.+. +++.||+|.++.... ....+.+|+.++++++||||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999974 457899999875422 2456788999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||||+.+++|.+++.......++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999987655568999999999999999999999999999999999999999999999999986543110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 158 ~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 158 Y--------------------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred c--------------------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0 00111223468999999998889999999999999999998 99999988877
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
.....+... ...+.....+..+.+|+.+||+.+|.+||++.+
T Consensus 212 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 253 (261)
T cd05068 212 EVLQQVDQG-YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFET 253 (261)
T ss_pred HHHHHHHcC-CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 777666543 333444557889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=327.44 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=210.5
Q ss_pred cccCCccccccccccCcEEEEEEEE-----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
|+.++|.+.+.||+|+||.||++.+ ..++..+|+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 4567899999999999999999986 234567999988653 34456678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQP-----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~ 809 (1002)
.+.+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999987432 124899999999999999999999999999999999999999999
Q ss_pred EEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHH
Q 001865 810 VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889 (1002)
Q Consensus 810 vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ 889 (1002)
++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|
T Consensus 159 ~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~ 213 (288)
T cd05093 159 VKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213 (288)
T ss_pred EEeccCCccccccCCce-------------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHH
Confidence 99999999864321100 01112234678899999999888999999999999999
Q ss_pred HHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 890 EMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 890 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
+|++ |..||...........+..+.... .....+..+.+|+.+||+.||.+|||+.+
T Consensus 214 ~l~t~g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 271 (288)
T cd05093 214 EIFTYGKQPWYQLSNNEVIECITQGRVLQ-RPRTCPKEVYDLMLGCWQREPHMRLNIKE 271 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 9998 999999888877777777654322 22346788999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.53 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=211.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ........+.+|+++++.++|+||+++++++..++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 37999999999999999999999999999999987542 23344567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||++++.|..+.... ..++...+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999877666655443 4489999999999999999999999999999999999999999999999999855432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||.+.......
T Consensus 156 ------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 156 ------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred ------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 012235688999999999888 7889999999999999999999999877655444
Q ss_pred HHHHhC-------------------CCCCCC-----------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCC
Q 001865 908 ANILHK-------------------DLKFPS-----------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957 (1002)
Q Consensus 908 ~~i~~~-------------------~~~~~~-----------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 957 (1002)
..+... ...++. ...++..+.+||++||..+|++||+ ++++++|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~ 287 (288)
T cd07833 212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPY 287 (288)
T ss_pred HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCC
Confidence 333210 000000 1123678999999999999999999 999999999
Q ss_pred c
Q 001865 958 F 958 (1002)
Q Consensus 958 f 958 (1002)
|
T Consensus 288 f 288 (288)
T cd07833 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.77 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=210.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVC 745 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~ 745 (1002)
.++|++.+.||.|+||.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 45899999999999999999999999999999999754322 22334567899999999999999999998877 8999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999995 69999887643 358999999999999999999999999999999999999999999999999886543110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..
T Consensus 161 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 161 ---------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred ---------------------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1112345788999999987643 578999999999999999999999887766
Q ss_pred HHHHHHHhCCC-------------------CC---------CCCCC--CCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 905 KTFANILHKDL-------------------KF---------PSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 905 ~~~~~i~~~~~-------------------~~---------~~~~~--~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
..+..+..... .+ ..... .+..+.+||++||+.+|++||| +.|+|+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~ 289 (293)
T cd07843 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALK 289 (293)
T ss_pred HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhc
Confidence 65554432100 00 00111 3777899999999999999999 999999
Q ss_pred CCCc
Q 001865 955 HPFF 958 (1002)
Q Consensus 955 Hp~f 958 (1002)
||||
T Consensus 290 ~~~f 293 (293)
T cd07843 290 HPYF 293 (293)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=330.52 Aligned_cols=262 Identities=24% Similarity=0.357 Sum_probs=209.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~l 746 (1002)
.++|...+.||+|+||.||++.+..++..+|+|.+..... ......+.+|+.++.++. |+||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3578888999999999999999999999999999875432 244567788999999985 9999999999999999999
Q ss_pred EEeccCCCchhHHHh---hCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 747 ITDYCPGGELFLLLD---RQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~---~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
+|||+ +++|.++.. ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99999 556655432 22335699999999999999999999975 99999999999999999999999999985432
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHHcCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~~~~~sDIwSlGvil~elltG~~Pf~ 899 (1002)
.. .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 160 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 DS----------------------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cC----------------------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 11 011233588899999999776 68889999999999999999999997
Q ss_pred CCCh-HHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChh
Q 001865 900 GKTR-QKTFANILHKDL-KFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 900 ~~~~-~~~~~~i~~~~~-~~~--~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~ 964 (1002)
.... .+.+..+..... ..+ .....+..+.+||.+||..+|++||| ++++++||||+...+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 212 KWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK----YKELLEHPFIKDYEER 276 (288)
T ss_pred hcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhchhhc
Confidence 6542 222223322221 111 12246788999999999999999999 9999999999875433
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.03 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=226.8
Q ss_pred ccccccccCCccccccccccCcEEEEEEEEcCCCe---E-EEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEE
Q 001865 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---Y-FAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736 (1002)
Q Consensus 661 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~-~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~ 736 (1002)
...|++..++-.+.+.||+|+||.||++..+..+. . ||+|..+............+.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45577888888889999999999999999865422 3 8999988655556788899999999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001865 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (1002)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG 816 (1002)
+......+|+|||+|.||+|.++|++.+. .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999999998753 69999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCccccccccccc-ccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-C
Q 001865 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN-SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-G 894 (1002)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G 894 (1002)
+++..... .... ..--...|+|||.+....|+.++|||||||++||+++ |
T Consensus 308 Ls~~~~~~----------------------------~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g 359 (474)
T KOG0194|consen 308 LSRAGSQY----------------------------VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENG 359 (474)
T ss_pred cccCCcce----------------------------eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccC
Confidence 98553200 0000 1124568999999999999999999999999999997 8
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
..||.+....+....+.......+.+...+..+..++.+|+..+|+.||++.++++.
T Consensus 360 ~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 360 AEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred CCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHH
Confidence 999999999999999977777666666778889999999999999999998765443
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=319.33 Aligned_cols=256 Identities=31% Similarity=0.538 Sum_probs=221.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||.|+||.||++.+..++..|++|++..... .......+.+|+++++.++|||++++++.+...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999988999999999876432 34556678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 750 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~--~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|+++++|.+++.... ...++...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999997643 3669999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 158 -------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 158 -------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred -------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 1122346899999999998888899999999999999999999999888777766
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+....... .....+..+.+++.+||..+|++||+ +.++|+||||
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQYPP-IPSQYSSELRNLVSSLLQKDPEERPS----IAQILQSPFI 258 (258)
T ss_pred HHHhcCCCCC-CCCCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCCCC
Confidence 6666544322 22356788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=337.83 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=208.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----C
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~ 742 (1002)
.++|++.+.||+|+||.||++.+..+|+.||+|+++.. ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 36899999999999999999999999999999998642 2233456678899999999999999999887643 3
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 589999999 5688887754 358999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
.... .........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 158 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 158 PEHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred cccc------------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1110 0011123578999999998754 46788999999999999999999999876
Q ss_pred ChHHHHHHHHhC----------------------CCCCC-------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 902 TRQKTFANILHK----------------------DLKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 902 ~~~~~~~~i~~~----------------------~~~~~-------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
+.......+... ..... .....+..+.+||.+||+.+|++||| +.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~ 289 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEA 289 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHH
Confidence 544333322110 00000 01234667899999999999999999 9999
Q ss_pred HcCCCcCCC
Q 001865 953 KKHPFFKGV 961 (1002)
Q Consensus 953 L~Hp~f~~~ 961 (1002)
++||||+.+
T Consensus 290 l~hp~~~~~ 298 (336)
T cd07849 290 LAHPYLEQY 298 (336)
T ss_pred hcCcccccc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.89 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=209.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++++.||.|++|.||+|.+..+|..||+|+++.... ......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 48899999999999999999999999999999976432 2233556789999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 750 YCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~-~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|+. ++|.+++.... ...+++..+..++.||+.||.|||++|++|+||||+||++++++.++|+|||++......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 996 58888876532 245899999999999999999999999999999999999999999999999998543211
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
........+++.|++||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 154 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 154 -----------------------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred -----------------------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 0111234578899999998664 4688999999999999999999999987766665
Q ss_pred HHHHhCCC------------------CCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKDL------------------KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~~------------------~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+..... ..+. .+..+..+.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 55432100 0000 0134667889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.08 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=207.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
+...+|++.+.||+|+||.||+|.+..++. .||+|+++.. ........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 345689999999999999999999866655 4899998643 2334456788999999999999999999988764
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..++|++|+.+|+|.+++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999997643 35889999999999999999999999999999999999999999999999999654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~ 900 (1002)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEKE-------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCcc-------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 321110 01112235678999999999999999999999999999997 9999988
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHH
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~ 950 (1002)
....+. ..+......++....++..+.+++.+||..+|++||++.+++.
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 215 IPASEI-SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred CCHHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 766554 3455554555555567888999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=329.96 Aligned_cols=255 Identities=26% Similarity=0.389 Sum_probs=218.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|...+.||+|+||.||++.+..++..+|+|.+.............+.+|+.+++.++|||++++++++..++..|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 35899999999999999999999999999999987654444455667889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||+. |+|.+++... ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 105 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred eCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 9995 5787777543 34589999999999999999999999999999999999999999999999998743221
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
.....|++.|+|||++. ...++.++|||||||++|+|++|+.||.......
T Consensus 178 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~ 231 (317)
T cd06635 178 --------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231 (317)
T ss_pred --------------------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 12346888999999974 3567889999999999999999999998887777
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
....+.............+..+.+||.+||+.+|.+||+ +.++++|+|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 232 ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPT----SEELLKHMFVLR 282 (317)
T ss_pred HHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcC----HHHHHhChhhhc
Confidence 777776655444444456788999999999999999999 999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=325.06 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=216.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
-|++++.||.|+||.||++.+..++..+|+|++.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 5888999999999999999998899999999886432 23345678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+++++|..++.. ..++...+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch----
Confidence 9999999999864 348999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........
T Consensus 156 -----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (277)
T cd06641 156 -----------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212 (277)
T ss_pred -----------------------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence 011234688899999999888888999999999999999999999988776666555
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+.....+ ......+..+.+++.+||+.+|.+||+ +.++++||||..
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~l~~~~~~~ 258 (277)
T cd06641 213 IPKNNPP-TLEGNYSKPLKEFVEACLNKEPSFRPT----AKELLKHKFIVR 258 (277)
T ss_pred HhcCCCC-CCCcccCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHhh
Confidence 5443222 122346788999999999999999999 999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=330.58 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=205.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 742 (1002)
.++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4689999999999999999999999999999999865422 1222334567999999999999999999886543
Q ss_pred ---eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 743 ---HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 743 ---~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
..|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus 90 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFC-EHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCC-CcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 469999999 568888876542 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
.+...... .........++..|+|||.+.+. .++.++||||||+++|+|++|+.||
T Consensus 168 ~~~~~~~~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 168 AFSLSKNS-----------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred cccCCccc-----------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 54321110 00112234678999999998764 3678999999999999999999999
Q ss_pred CCCChHHHHHHHHh--CCC-----------------CCCC-----------CCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 899 RGKTRQKTFANILH--KDL-----------------KFPS-----------STPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~--~~~-----------------~~~~-----------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
.+.+.......+.. +.+ ..+. ....+..+.+||.+||..||.+|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t---- 300 (310)
T cd07865 225 QGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID---- 300 (310)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----
Confidence 88766544333322 100 0010 0112456789999999999999999
Q ss_pred HHHHHcCCCc
Q 001865 949 ANEIKKHPFF 958 (1002)
Q Consensus 949 a~elL~Hp~f 958 (1002)
++++|+||||
T Consensus 301 ~~e~l~h~~f 310 (310)
T cd07865 301 ADTALNHDFF 310 (310)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=325.15 Aligned_cols=258 Identities=19% Similarity=0.248 Sum_probs=212.0
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 739 (1002)
.+..++|++.+.||+|+||.||++.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45677999999999999999999998644 3789999986542 2334456788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQP--------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (1002)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~--------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vk 811 (1002)
.....|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999987532 12478889999999999999999999999999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHH
Q 001865 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (1002)
Q Consensus 812 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~el 891 (1002)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 160 IGDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred ECCcccchhhccCcc-------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 999999864321110 0111234567899999999888899999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 892 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 892 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
++ |..||.+.+.......+.... ..+.....+..+.+|+.+||+.+|++||| +.++++
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVIDGG-HLDLPENCPDKLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 98 999999888777766665332 23333446889999999999999999999 666553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.50 Aligned_cols=248 Identities=23% Similarity=0.353 Sum_probs=205.6
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.++.... ....+.+|+.+++.++||||+++++.+.. +..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 4567899999999999999999998665 4599999875321 23567889999999999999999998754 5689
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||||+.+++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999986545568999999999999999999999999999999999999999999999999986543111
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 157 ~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 157 Y--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred c--------------------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 0 01112346778999999988889999999999999999999 89999888777
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH 946 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~ 946 (1002)
..+..+... ...+.....+..+.+|+.+||+.+|++||++.
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 211 EVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred HHHHHHhcC-CCCCCccccCHHHHHHHHHHccCCcccCCCHH
Confidence 766665543 23344445788899999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.22 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=206.9
Q ss_pred cccccc--CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccC
Q 001865 675 KPLGSG--DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 675 ~~LG~G--~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 752 (1002)
..||.| +||+||++.+..+|+.||+|++..... .......+.+|+.+++.++||||++++++|..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999875432 23445778889999999999999999999999999999999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcc
Q 001865 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (1002)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~ 832 (1002)
+++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~----- 157 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK----- 157 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc-----
Confidence 999999998754456899999999999999999999999999999999999999999999999865332110000
Q ss_pred hhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001865 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (1002)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i 910 (1002)
... .........++..|+|||++.+. .++.++|||||||++|+|++|..||.+......+...
T Consensus 158 -----------~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 158 -----------AKV----VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred -----------ccc----cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 000 00001112356779999999764 4678999999999999999999999877655544443
Q ss_pred HhCCCC---------------------------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCC
Q 001865 911 LHKDLK---------------------------------------------FPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 911 ~~~~~~---------------------------------------------~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
+..... .+.....+..+.+||.+||++||++|||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 322111 1111224567899999999999999999
Q ss_pred hhcHHHHHcCCCcCCC
Q 001865 946 HEGANEIKKHPFFKGV 961 (1002)
Q Consensus 946 ~~~a~elL~Hp~f~~~ 961 (1002)
+.++|+||||+.+
T Consensus 302 ---a~e~l~~~~~~~~ 314 (328)
T cd08226 302 ---ASSLLSHAFFKQV 314 (328)
T ss_pred ---HHHHhhCHHHHHH
Confidence 9999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.62 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=220.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.+.|++.+.||+|++|.||++.+..++..+++|++..... ....+.+|+++++.++|+||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4579999999999999999999988899999999975421 456788899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
+||+++++|.+++.... ..++...+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999998753 369999999999999999999999999999999999999999999999999874432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......+++.|+|||++.+..++.++|+||||+++|+|++|..||.........
T Consensus 171 -------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 171 -------------------------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred -------------------------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112345788999999998888899999999999999999999999887766655
Q ss_pred HHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 908 ANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 908 ~~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
..+...... ......++..+.+||.+||+.+|.+||+ +.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~il~~~~~~~~ 276 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS----AEELLQHPFLKKA 276 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC----HHHHhhChHhhcc
Confidence 555443332 2222336788999999999999999999 9999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=320.24 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=215.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeeccc--ccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV--MLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THV 744 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~--~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~ 744 (1002)
..|++.+.||+|+||.||++.+..+++.||+|.+.... .........+.+|++++++++|+||+++++++... +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 37999999999999999999999999999999875421 12234556788999999999999999999998753 568
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999998764 34889999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
.. .........|+..|+|||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 160 ~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 215 (264)
T cd06653 160 CM------------------------SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215 (264)
T ss_pred cc------------------------cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH
Confidence 00 000112356899999999999888899999999999999999999999887766
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+.++.............+..+.++|.+||. +|..||+ +.+++.|||.
T Consensus 216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCcc----HHHHhcCCCC
Confidence 66666554433333334577889999999999 5799999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=321.73 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=208.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|++++.||+|+||.||+|.+. .+..+|+|.++.... ....+.+|+.++++++|+|++++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~ 75 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI 75 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence 355678999999999999999999875 556799999876432 2356889999999999999999999875 4568
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|++|||+.+++|.+++.......+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999999999997655556899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
. ........++..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 156 E--------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred c--------------------------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 0 001112245678999999988889999999999999999998 9999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
.+....+... ...+.....+..+.+|+.+||..+|++||| +.+++
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~ 254 (260)
T cd05070 210 REVLEQVERG-YRMPCPQDCPISLHELMLQCWKKDPEERPT----FEYLQ 254 (260)
T ss_pred HHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccCcccCcC----HHHHH
Confidence 7777666543 333334456788999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=325.80 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=209.7
Q ss_pred ccCCccccccccccCcEEEEEEEEc----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 742 (1002)
...+|++.+.||+|+||.||+|.+. .++..+++|.+... ........+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3568999999999999999999863 35678999998753 23445567889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC
Q 001865 743 HVCLITDYCPGGELFLLLDRQP---------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~---------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~ 807 (1002)
..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+|+||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985321 1247889999999999999999999999999999999999999
Q ss_pred CcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHH
Q 001865 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (1002)
Q Consensus 808 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvi 887 (1002)
+.+||+|||++........ ........++..|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCcc-------------------------eecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 9999999999865321110 011223346778999999988889999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 888 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 888 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
+|+|++ |..||.+.........+.... ..+....++..+.+++.+||+.||.+||+ +.+|++
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 278 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LLPCSEDCPPRMYSLMTECWQEGPSRRPR----FKDIHT 278 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHH
Confidence 999998 999998877666555554433 33344457889999999999999999999 666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=335.97 Aligned_cols=260 Identities=25% Similarity=0.391 Sum_probs=215.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----eE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 744 (1002)
+|++.+.||.|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++|+||+++++++...+ .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999998889999999987642 22445567888999999999999999999988765 88
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999995 6898888764 36999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
... ........+++.|+|||++.+. .++.++|+||||+++|+|++|..||.+.+.
T Consensus 157 ~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 157 EDE------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccc------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 100 0112234688999999999887 788999999999999999999999998887
Q ss_pred HHHHHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 904 QKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~-----------------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
.+.+..+.......+ .....+..+.+||.+||+++|.+||+ +.++++
T Consensus 213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~ 288 (330)
T cd07834 213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALA 288 (330)
T ss_pred HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHh
Confidence 766665544211000 01225678899999999999999999 999999
Q ss_pred CCCcCCC
Q 001865 955 HPFFKGV 961 (1002)
Q Consensus 955 Hp~f~~~ 961 (1002)
||||+++
T Consensus 289 ~~~~~~~ 295 (330)
T cd07834 289 HPYLAQL 295 (330)
T ss_pred CccHHhh
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=314.58 Aligned_cols=264 Identities=28% Similarity=0.462 Sum_probs=210.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee-CC
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KT 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 742 (1002)
...|+++..||+|.||.||+|..+.++ +.||||.++.....+ ......++|+.+++.++||||+.+..+|-. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 458999999999999999999765553 279999987653322 223456899999999999999999998876 78
Q ss_pred eEEEEEeccCCCchhHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC----CcEEEEec
Q 001865 743 HVCLITDYCPGGELFLLLDRQ---PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN----GHVSLTDF 815 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~---~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~----g~vkL~DF 815 (1002)
.+++++||. .-+|++.++.. ..+.++...++.|+.||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999999 67899888742 23579999999999999999999999999999999999999977 89999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcC
Q 001865 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG 894 (1002)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG 894 (1002)
|+++.+... ..+....+.++-|..|+|||.+.|. .|+++.|||+.|||+.||++-
T Consensus 181 GlaR~~~~p------------------------lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 181 GLARLFNNP------------------------LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cHHHHhhcc------------------------ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999876422 2233445667899999999999886 578899999999999999999
Q ss_pred CCCCCCCC---------hHHHHHHHHh--C---CCCCCC------------------------------CCCCCHHHHHH
Q 001865 895 YTPFRGKT---------RQKTFANILH--K---DLKFPS------------------------------STPTSLHAKQL 930 (1002)
Q Consensus 895 ~~Pf~~~~---------~~~~~~~i~~--~---~~~~~~------------------------------~~~~s~~~~~L 930 (1002)
.+.|.+.. ....+.+|+. + .-.||. ...-++.+.+|
T Consensus 237 ~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~L 316 (438)
T KOG0666|consen 237 EPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDL 316 (438)
T ss_pred CccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHH
Confidence 99997632 1233334432 1 011111 01123346799
Q ss_pred HHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 931 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 931 l~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
|.+||++||.+|+| ++++|+|+||+.-
T Consensus 317 L~klL~yDP~kRIt----a~qAleh~yF~~d 343 (438)
T KOG0666|consen 317 LQKLLTYDPIKRIT----AEQALEHPYFTED 343 (438)
T ss_pred HHHHhccCchhhcc----HHHHhcccccccC
Confidence 99999999999999 9999999999973
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=328.81 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=211.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASF 738 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~ 738 (1002)
.+..++|.+.+.||+|+||.||++.+. .++..+|+|.++... .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 355678999999999999999999863 345689999987542 233456788999999999 799999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001865 739 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 739 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a 818 (1002)
...+..|+||||+.+++|.+++.......+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997654445899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~P 897 (1002)
........ ........+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 189 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 189 RDIMNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred ccccCCCc-------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 54321110 001122346788999999999889999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 898 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
|.+......+................+..+.+|+.+||..+|++||++.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 244 YPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred cCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 988766555555555444444444567899999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.99 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=209.9
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|++++.||+|+||.||+|.. .+++.||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 75 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI 75 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence 45678999999999999999999987 4567899999875432 3457888999999999999999999874 4678
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+.+++|.+++.......++..++..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999999999987765567899999999999999999999999999999999999999999999999998543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
. ........++..|+|||++....++.++||||||+++|+|++ |++||.+.+.
T Consensus 156 ~--------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 156 E--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred C--------------------------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 0 001122346778999999998889999999999999999998 9999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
......+... ...+.....+..+.+|+.+||..+|++||+ +++++
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~l~ 254 (260)
T cd05067 210 PEVIQNLERG-YRMPRPDNCPEELYELMRLCWKEKPEERPT----FEYLR 254 (260)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHH
Confidence 7766655443 333444556789999999999999999999 66654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=320.61 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=204.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
+.+.....||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444456799999999999999999999999988654 3345567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVL--KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l--~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-~g~vkL~DFG~a~~~~~~~ 825 (1002)
||+++++|.+++.... ..+ +...+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 85 EQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred ecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999987542 234 88889999999999999999999999999999999976 6799999999885432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
.......|++.|+|||++.+.. ++.++|+||||+++|+|++|..||.....
T Consensus 164 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 164 ---------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred ---------------------------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 0111235789999999986643 77899999999999999999999976433
Q ss_pred HHHH-HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 904 QKTF-ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 904 ~~~~-~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.... ................+..+.+|+.+||..+|.+||| +.+++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 217 PQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred hhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCC----HHHHHhCCCC
Confidence 2211 1111111111122346788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=336.83 Aligned_cols=263 Identities=26% Similarity=0.434 Sum_probs=211.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe----eCCeE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----TKTHV 744 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~~ 744 (1002)
++|.+.+.||.|+||.||++.+..+++.||+|.+..... .......+.+|+.+|+.++||||+++++++. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875422 2334566778999999999999999999876 34578
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 57898888654 44999999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
... .........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 161 ~~~-----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 161 PTE-----------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred CcC-----------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 100 0011223478999999999866 4578899999999999999999999987665
Q ss_pred HHHHHHHHhC----------------------CCC----CC---CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 904 QKTFANILHK----------------------DLK----FP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 904 ~~~~~~i~~~----------------------~~~----~~---~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
...+..+... ... .+ .....+..+.+||.+||+.+|.+||+ +.+++.
T Consensus 218 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~ 293 (334)
T cd07855 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQ 293 (334)
T ss_pred HHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHh
Confidence 4433322210 000 00 01235778999999999999999999 999999
Q ss_pred CCCcCCCC
Q 001865 955 HPFFKGVN 962 (1002)
Q Consensus 955 Hp~f~~~~ 962 (1002)
||||.+..
T Consensus 294 ~~~~~~~~ 301 (334)
T cd07855 294 HPFLAQYH 301 (334)
T ss_pred Chhhhhcc
Confidence 99999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.45 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=207.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
..+|++.+.||+|+||.||++.+. ++..+|+|++.+... ....+.+|+++++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457999999999999999999885 466899999875422 234577899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~- 155 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY- 155 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence 99999999999997643 3589999999999999999999999999999999999999999999999998854321100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~ 906 (1002)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+.
T Consensus 156 -------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05059 156 -------------------------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV 210 (256)
T ss_pred -------------------------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH
Confidence 00111224567999999998889999999999999999998 8999988877776
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
...+... ...+.....+..+.+|+.+||..+|++||| +.++++
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~~~l~ 253 (256)
T cd05059 211 VESVSAG-YRLYRPKLAPTEVYTIMYSCWHEKPEDRPA----FKKLLS 253 (256)
T ss_pred HHHHHcC-CcCCCCCCCCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 6666543 333334457889999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=327.39 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=214.2
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeE
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (1002)
Q Consensus 662 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 735 (1002)
+...+..++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++ +|+||++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 44567778999999999999999999998644 3789999987542 233456688999999999 899999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
+++..++.+|++|||+++++|..++... ....+++..+..++.||+.||.|||++||+|+||||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 9999999999999999999999998642 24568999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
|+++.++.+||+|||++........ ........++..|+|||++.+..++.++||
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 217 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217 (293)
T ss_pred EEEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCcccce
Confidence 9999999999999999865431100 001112235678999999988889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 882 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
|||||++|+|++ |..||.+....+....+.... ........+..+.+|+.+||..||++||| +.++++
T Consensus 218 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~ 286 (293)
T cd05053 218 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY-RMEKPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVE 286 (293)
T ss_pred eehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHH
Confidence 999999999997 999999887777666555442 33334456788999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.64 Aligned_cols=252 Identities=22% Similarity=0.331 Sum_probs=209.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
+..+|++++.||+|+||.||++.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 34679999999999999999998744 44699998875422 23567889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus 77 v~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 77 VTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 999999999999997643 358999999999999999999999999999999999999999999999999885432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~ 905 (1002)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+...
T Consensus 155 -------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~ 209 (256)
T cd05113 155 -------------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209 (256)
T ss_pred -------------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 001112345678999999988889999999999999999998 999998887777
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
....+...... +.....+..+.+++.+||..+|.+||+ +.+|+.+
T Consensus 210 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~ll~~ 254 (256)
T cd05113 210 TVEKVSQGLRL-YRPHLASEKVYAIMYSCWHEKAEERPT----FQQLLSS 254 (256)
T ss_pred HHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHHh
Confidence 77777655333 223346788999999999999999999 7777753
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=329.56 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=206.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeE--EEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 742 (1002)
+..++|++.+.||+|+||.||+|.+..++.. +++|.++.. ........+.+|+.++.++ +||||+++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3456899999999999999999999777754 577766532 2334456788899999999 8999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC
Q 001865 743 HVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g 808 (1002)
.+|+||||+++++|.+++.... ...++...++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999997532 23588999999999999999999999999999999999999999
Q ss_pred cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHH
Q 001865 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888 (1002)
Q Consensus 809 ~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil 888 (1002)
.+||+|||++...... .......++..|+|||++.+..++.++|||||||++
T Consensus 162 ~~kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 213 (303)
T cd05088 162 VAKIADFGLSRGQEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 213 (303)
T ss_pred cEEeCccccCcccchh----------------------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHH
Confidence 9999999988421100 001112346679999999888889999999999999
Q ss_pred HHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 889 YEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 889 ~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
|+|++ |..||.+.+..+....+... .........+..+.+|+.+||+.+|++||+ +.+++++
T Consensus 214 ~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 214 WEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred HHHHhcCCCCcccCChHHHHHHHhcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99998 99999887776666555433 222333346788999999999999999999 6666554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=319.16 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=208.4
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++|++.+.||+|+||.||+|.+..+|+.||+|.++............+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999899999999987644444555678889999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 749 DYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||+++++|..++... ....++...++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999999998642 23458999999999999999999999999999999999999999999999999985432110
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--hH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT--RQ 904 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~--~~ 904 (1002)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.... ..
T Consensus 161 --------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred --------------------------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 01123468889999999998889999999999999999999999996543 22
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
.....+..+..........+..+.++|.+||..+|++||++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 3333333332221112246778999999999999999999443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=322.82 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=210.1
Q ss_pred ccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
..+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45689999999999999999999977 77899999886432 233445688899999999999999999999998
Q ss_pred CeEEEEEeccCCCchhHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---cEEEE
Q 001865 742 THVCLITDYCPGGELFLLLDRQPT-----KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLT 813 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~-----~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g---~vkL~ 813 (1002)
+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||+++++|+||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999999875421 2589999999999999999999999999999999999998765 59999
Q ss_pred eccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc
Q 001865 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893 (1002)
Q Consensus 814 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt 893 (1002)
|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 162 dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 216 (277)
T cd05036 162 DFGMARDIYRASY-------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216 (277)
T ss_pred cCccccccCCccc-------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc
Confidence 9999865421100 000112234568999999998889999999999999999996
Q ss_pred -CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 894 -GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 894 -G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
|..||.+.+..+....+... ........++..+.+|+.+||+.+|++||+ +.++++|
T Consensus 217 ~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 217 LGYMPYPGRTNQEVMEFVTGG-GRLDPPKGCPGPVYRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred CCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999988777766555443 222333456788999999999999999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=319.67 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=210.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.++|++.+.||+|+||.||+|.+..+ ...+|+|.++... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998644 4589999887542 334456788899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+++++|.+++.... ..++...+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999997643 36899999999999999999999999999999999999999999999999998664311
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 160 ~~~-------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 160 EAT-------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred ccc-------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 100 00112235678999999998889999999999999999997 9999988877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
......+... ...+.....+..+.+|+.+||+.+|++||+ +.++++
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~----~~ei~~ 260 (266)
T cd05033 215 QDVIKAVEDG-YRLPPPMDCPSALYQLMLDCWQKDRNERPT----FSQIVS 260 (266)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 7776666543 233334457889999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=319.17 Aligned_cols=247 Identities=22% Similarity=0.386 Sum_probs=206.4
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEE-eeCCe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF-QTKTH 743 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~ 743 (1002)
.++..+|++.+.||+|+||.||++.. .+..+|+|.++.. .....+.+|+.++++++|+|++++++++ ..++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 2 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred CccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 46678999999999999999999987 4778999988643 2345688899999999999999999875 45678
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
.|+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999999999999876555689999999999999999999999999999999999999999999999998854221
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~ 902 (1002)
. .....++..|+|||++.+..++.++|||||||++|+|++ |+.||....
T Consensus 155 ~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 155 T------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred c------------------------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 112234568999999988889999999999999999997 999998877
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
.......+..+ ........++..+.+|+.+||+.+|++||| +.+++
T Consensus 205 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~l~ 250 (256)
T cd05082 205 LKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHLDAATRPS----FLQLR 250 (256)
T ss_pred HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhcCChhhCcC----HHHHH
Confidence 76666655443 222333456889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.25 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=201.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 754 (1002)
+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||+++++++...+..|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999886432 3344567889999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001865 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (1002)
Q Consensus 755 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 834 (1002)
+|.+++... ...+++..++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 999998654 24589999999999999999999999999999999999999999999999999854321000
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001865 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (1002)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 150 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~ 212 (252)
T cd05084 150 -----------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212 (252)
T ss_pred -----------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 000011123567999999988889999999999999999997 99999877666555544432
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
...+.....+..+.+|+.+||+.+|++||+ +.+++
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 247 (252)
T cd05084 213 -VRLPCPELCPDAVYRLMERCWEYDPGQRPS----FSTVH 247 (252)
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 233334456789999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=333.50 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=207.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999986542 24456678899999999999999999876543
Q ss_pred --------CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEE
Q 001865 742 --------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSL 812 (1002)
Q Consensus 742 --------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-~g~vkL 812 (1002)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 36899999995 689888864 34899999999999999999999999999999999999974 567899
Q ss_pred EeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHH
Q 001865 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEM 891 (1002)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~el 891 (1002)
+|||++........ .........|+..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 157 ~dfg~~~~~~~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 157 GDFGLARIVDPHYS------------------------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred CCcccceecCCccc------------------------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 99999854321100 0001122357889999998754 4577899999999999999
Q ss_pred HcCCCCCCCCChHHHHHHHHhCCCC----------------------CC------CCCCCCHHHHHHHHHccccCcCCCC
Q 001865 892 LYGYTPFRGKTRQKTFANILHKDLK----------------------FP------SSTPTSLHAKQLMYRLLHRDPKSRL 943 (1002)
Q Consensus 892 ltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~------~~~~~s~~~~~Ll~~~L~~dP~~Rp 943 (1002)
++|+.||.+.+.......+...... .+ .....+.++.+||.+||+.||.+||
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 213 LTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 9999999887766555544432100 00 0123567889999999999999999
Q ss_pred CChhcHHHHHcCCCcCCC
Q 001865 944 GSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 944 t~~~~a~elL~Hp~f~~~ 961 (1002)
| +.++++||||+.+
T Consensus 293 t----~~ell~h~~~~~~ 306 (342)
T cd07854 293 T----AEEALMHPYMSCY 306 (342)
T ss_pred C----HHHHhCCCccccc
Confidence 9 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=335.18 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=212.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH---- 743 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~---- 743 (1002)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 468999999999999999999999999999999987542 233445667889999999999999999988866554
Q ss_pred --EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 744 --VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 744 --~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
.|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899999875 35899999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 169 ~~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 169 DDE------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred ccc------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 210 123357889999999865 3577899999999999999999999988
Q ss_pred CChHHHHHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 901 KTRQKTFANILHKDLKFP-----------------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~-----------------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
......+..+.......+ .....+..+.+||.+||..+|++||| +.+
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~e 294 (343)
T cd07851 219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAE 294 (343)
T ss_pred CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHH
Confidence 777666655543211000 01234778999999999999999999 999
Q ss_pred HHcCCCcCCC
Q 001865 952 IKKHPFFKGV 961 (1002)
Q Consensus 952 lL~Hp~f~~~ 961 (1002)
|++||||...
T Consensus 295 ll~h~~~~~~ 304 (343)
T cd07851 295 ALAHPYLAEY 304 (343)
T ss_pred HhcCCCcccc
Confidence 9999999973
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=316.47 Aligned_cols=250 Identities=48% Similarity=0.864 Sum_probs=216.8
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||.|+||.||++.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+..++.+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999877555555677888999999999999999999999999999999999999999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhh
Q 001865 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836 (1002)
Q Consensus 757 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~ 836 (1002)
.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9999765 358999999999999999999999999999999999999999999999999985532110
Q ss_pred hcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCC
Q 001865 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK 916 (1002)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 916 (1002)
.......|+..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+......
T Consensus 148 ----------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 211 (250)
T cd05123 148 ----------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR 211 (250)
T ss_pred ----------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 1123456889999999998888889999999999999999999999888777777777664444
Q ss_pred CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 917 FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 917 ~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
++. ..+..+.+||++||..||++||+..+ +.++++||||
T Consensus 212 ~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~-~~~l~~~~~f 250 (250)
T cd05123 212 FPE--FLSPEARDLISGLLQKDPTKRLGSGG-AEEIKAHPFF 250 (250)
T ss_pred CCC--CCCHHHHHHHHHHhcCCHhhCCCccc-HHHHHhCCCC
Confidence 433 35788999999999999999999433 4999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=324.33 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=211.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
++..+|++++.||.|+||.||++.+..+ +..+|+|+++... .......+.+|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456899999999999999999987543 5789999987542 23344668889999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~--------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~ 806 (1002)
.+..++++||+.+++|.+++... ....++...+..++.|++.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 99999999999999999998532 1234788899999999999999999999999999999999999
Q ss_pred CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHH
Q 001865 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886 (1002)
Q Consensus 807 ~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGv 886 (1002)
++.+||+|||++....... .........+++.|+|||++.+..++.++|||||||
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 214 (283)
T cd05091 160 KLNVKISDLGLFREVYAAD-------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGV 214 (283)
T ss_pred CCceEecccccccccccch-------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHHHH
Confidence 9999999999986532110 001112335678999999998888999999999999
Q ss_pred HHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 887 LLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 887 il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
++|+|++ |..||.+......+..+...... +....++..+.+|+.+||+.+|.+||+ +++|+.
T Consensus 215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 9999998 88999988887777776665432 223457888999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=329.53 Aligned_cols=256 Identities=24% Similarity=0.346 Sum_probs=201.9
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCchhHHH
Q 001865 681 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 760 (1002)
Q Consensus 681 ~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 760 (1002)
+++.||.++...+++.||+|++.... ........+.+|+.+++.++|+||+++++++...+..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 44566666676799999999997652 24456678999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhccc
Q 001865 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840 (1002)
Q Consensus 761 ~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 840 (1002)
.......+++..+..++.||+.||+|||++||+|+||||+||+++.+|.+||+|||.+..........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------------ 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------------ 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc------------
Confidence 86545568999999999999999999999999999999999999999999999999885442111000
Q ss_pred CCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCC-
Q 001865 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKF- 917 (1002)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~- 917 (1002)
...........++..|+|||++.+. .++.++|||||||++|+|++|..||..............+....
T Consensus 159 --------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (314)
T cd08216 159 --------RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230 (314)
T ss_pred --------cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence 0001112345678899999998763 57889999999999999999999998765544332222211100
Q ss_pred -------------------------------CCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 918 -------------------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 918 -------------------------------~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
......+..+.+|+.+||.+||++||| ++++|+||||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~ 301 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQC 301 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhh
Confidence 000112356789999999999999999 9999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=317.87 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=212.3
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|.+.+.||+|+||.||++.+. .++.+|+|.+.... .....+.+|+.+++.++|+||+++++++......
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356789999999999999999999975 45779999987542 2345688899999999999999999999998999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+++++|.+++.......++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999998765567999999999999999999999999999999999999999999999999998553210
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
. ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+.
T Consensus 157 ~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 157 E--------------------------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred h--------------------------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0 000112234678999999998889999999999999999998 9999998887
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
...+..+... ...+.....+..+.+++.+||+.+|++||+ +++++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~l~ 255 (261)
T cd05034 211 REVLEQVERG-YRMPRPPNCPEELYDLMLQCWDKDPEERPT----FEYLQ 255 (261)
T ss_pred HHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHH
Confidence 7777766553 333444446788999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=326.52 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=216.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
...|...+.||.|+||.||++.+..++..+|+|.+.............+.+|+++++.++|+|++++++++...+..|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34688899999999999999999999999999998754333444556788899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+. ++|.+++... ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 99995 6887777543 24589999999999999999999999999999999999999999999999998854321
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 168 ---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 220 (308)
T cd06634 168 ---------------------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (308)
T ss_pred ---------------------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH
Confidence 12346888999999975 345678999999999999999999999887666
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.....+.............+..+.+||.+||..+|++||+ +.++++|||+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~----~~~ll~~~~~~~~ 273 (308)
T cd06634 221 SALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCC----HHHHhhCcccccc
Confidence 6655555554444334457788999999999999999999 9999999999973
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=324.43 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=213.8
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
|.....||+|+||.||++.+..++..+|+|.+... .......+.+|+.+++.++|+||+++++++...++.|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 44457799999999999999999999999987533 233456688899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+++++|.+++.. ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----- 170 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 170 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-----
Confidence 999999998754 348999999999999999999999999999999999999999999999999875432110
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i 910 (1002)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.........+
T Consensus 171 ----------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 171 ----------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred ----------------------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1122346889999999998888899999999999999999999999887766555544
Q ss_pred HhCC-CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 911 LHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 911 ~~~~-~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.... ..+......+..+.+++.+||..+|.+||+ +.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~----~~~ll~~~~~~~~ 276 (292)
T cd06657 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT----AAELLKHPFLAKA 276 (292)
T ss_pred HhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcC----HHHHhcChHHhcc
Confidence 3322 122233446788999999999999999999 9999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.53 Aligned_cols=257 Identities=30% Similarity=0.437 Sum_probs=216.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLI 747 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV 747 (1002)
+|++.+.||+|++|.||++.+..+++.+++|++..... .......+.+|+.++++++||||+++++.+... +.+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 47888999999999999999998999999999876532 235567888999999999999999999999988 899999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+.+++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999998753 6999999999999999999999999999999999999999999999999998654321100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-hHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~-~~~~ 906 (1002)
.......++..|+|||.+.+...+.++||||||+++|+|++|..||.... ....
T Consensus 158 -------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (260)
T cd06606 158 -------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA 212 (260)
T ss_pred -------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 01223568899999999988888999999999999999999999998765 2233
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
...+.............+..+.+||.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT----ADELLQHPFL 260 (260)
T ss_pred HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCC----HHHHhhCCCC
Confidence 33333212222223345788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=324.56 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=209.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCC----------------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSG----------------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----------------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn 730 (1002)
..++|++++.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+++++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999886543 568999987643 2345677889999999999999
Q ss_pred cceeEEEEeeCCeEEEEEeccCCCchhHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQP---------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 731 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
|+++++++..++..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997643 1258999999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
|+++.++.++|+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-------------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-------------------------eeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 9999999999999999854321100 011223456789999999988889999999
Q ss_pred HHHHHHHHHHHc--CCCCCCCCChHHHHHHHHhC------CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 882 WALGILLYEMLY--GYTPFRGKTRQKTFANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 882 wSlGvil~ellt--G~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
|||||++|+|++ |..||...+....+..+... ....+.....+.++.+|+.+||+.||++||| +.+|+
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~ 291 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIH 291 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHH
Confidence 999999999997 78899877766666655432 1122233345788999999999999999999 66664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=317.92 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=206.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|.+...||+|+||.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|+|++++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 4456899999999999999999998555 469999876542 22356788999999999999999998875 45689
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||||+.+++|.+++.......++...+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999999999976555568999999999999999999999999999999999999999999999999985532110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
........++..|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 157 --------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 210 (260)
T cd05069 157 --------------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210 (260)
T ss_pred --------------------------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 001112346778999999988889999999999999999999 99999988777
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
.....+... ...+.....+..+.+|+.+||..||++||+ +++++
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~i~ 254 (260)
T cd05069 211 EVLEQVERG-YRMPCPQGCPESLHELMKLCWKKDPDERPT----FEYIQ 254 (260)
T ss_pred HHHHHHHcC-CCCCCCcccCHHHHHHHHHHccCCcccCcC----HHHHH
Confidence 766665543 333333456788999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=319.00 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=205.8
Q ss_pred ccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 742 (1002)
|++.+.||+|+||.||+|.+..+ +..||+|.++... ........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999997653 4789999987542 23445567889999999999999999999876544
Q ss_pred -eEEEEEeccCCCchhHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001865 743 -HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~ 817 (1002)
..++||||+++++|..++... ....+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 379999999999999998542 223689999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 896 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~ 896 (1002)
+........ ........++..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 865432110 001112235678999999988889999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 897 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
||.+....+.+..+..+. ........+..+.+++.+||..||++||+ +.++++
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~e~~~ 267 (273)
T cd05035 215 PYPGVENHEIYDYLRHGN-RLKQPEDCLDELYDLMYSCWRADPKDRPT----FTKLRE 267 (273)
T ss_pred CCCCCCHHHHHHHHHcCC-CCCCCcCCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 998888777776665543 33334457889999999999999999999 555544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.86 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=201.8
Q ss_pred cccccCcEEEEEEEE--cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 676 PLGSGDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
.||+|+||.||+|.+ ..++..+|+|+++.. .........+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 456789999998754 2334456778899999999999999999998764 567999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------ 151 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY------ 151 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe------
Confidence 9999999764 45899999999999999999999999999999999999999999999999998654321110
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 912 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 912 (1002)
........+++.|+|||.+....++.++|||||||++|+|++ |..||...........+..
T Consensus 152 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~ 213 (257)
T cd05116 152 ------------------YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213 (257)
T ss_pred ------------------eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 000112235678999999988888999999999999999997 9999988777776666654
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 913 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
+. ..+....++..+.+||.+||+.||++||++..++..|
T Consensus 214 ~~-~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 214 GE-RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHH
Confidence 43 2333345788999999999999999999965544433
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=321.71 Aligned_cols=254 Identities=24% Similarity=0.435 Sum_probs=208.7
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC---CCCCcceeEEEEeeCCe----
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQTKTH---- 743 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~~~~~---- 743 (1002)
|++.+.||.|+||.||++.+..+++.||+|.++.... .......+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7788999999999999999988899999999975432 222334566787777666 69999999999988776
Q ss_pred -EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 744 -VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 744 -~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
+|++|||+. ++|.+++.......+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999995 589998877544569999999999999999999999999999999999999999999999999985542
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
... ......++..|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus 159 ~~~----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 FEM----------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred CCc----------------------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 110 0112357889999999998889999999999999999999999999888
Q ss_pred hHHHHHHHHhCCC-----CCC-----------C---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCC
Q 001865 903 RQKTFANILHKDL-----KFP-----------S---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957 (1002)
Q Consensus 903 ~~~~~~~i~~~~~-----~~~-----------~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 957 (1002)
..+.+.++..... .++ . ....+..+.+||.+||+.||.+||+ +.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~ 286 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPY 286 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcC
Confidence 7777766654210 000 0 0123467789999999999999999 999999999
Q ss_pred c
Q 001865 958 F 958 (1002)
Q Consensus 958 f 958 (1002)
|
T Consensus 287 ~ 287 (287)
T cd07838 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=336.18 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=211.4
Q ss_pred cccccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEE
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYAS 737 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~ 737 (1002)
+.+..++|.+.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+|.++. ||||++++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566778999999999999999999963 345689999997542 2233456889999999997 9999999999
Q ss_pred EeeCCeEEEEEeccCCCchhHHHhhCCC----------------------------------------------------
Q 001865 738 FQTKTHVCLITDYCPGGELFLLLDRQPT---------------------------------------------------- 765 (1002)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------------------------------------------------- 765 (1002)
+...+.+|+|||||.+|+|.+++.+...
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 9999999999999999999999865321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 766 --------------------------------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 766 --------------------------------------------~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
..++...+..++.||+.||+|||+++|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 246777889999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
||++.++.+||+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSN-------------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccc-------------------------cccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 9999999999999999864321100 001123457889999999998889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 882 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
|||||++|+|++ |..||......+.....+......+....++..+.+|+.+||..+|.+||+ +.+|++
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~ 394 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVH 394 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 999999999997 899998766655555555544444444457889999999999999999999 555543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.01 Aligned_cols=252 Identities=31% Similarity=0.513 Sum_probs=214.6
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|.+.+.||+|++|.||++.+..++..+++|++..... .....+.+|+.+++.++|+||+++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48889999999999999999988999999999976432 355778899999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999987643 468999999999999999999999999999999999999999999999999885432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 153 ------------------------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred ------------------------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 02245688999999999888888999999999999999999999987755444444
Q ss_pred HHhCCC-CCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCC
Q 001865 910 ILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957 (1002)
Q Consensus 910 i~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~ 957 (1002)
+..... ..+.....+..+.++|.+||+.||++||| +.++++|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~~~l~~~~ 253 (253)
T cd05122 209 IATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT----AEQLLKHPF 253 (253)
T ss_pred HHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC----HHHHhcCCC
Confidence 433222 22222223788999999999999999999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=320.95 Aligned_cols=253 Identities=20% Similarity=0.299 Sum_probs=208.9
Q ss_pred cccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
++..+|++.+.||+|+||.||++... .++..+|+|.+... .......+.+|+++++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 34568999999999999999999753 34678999987643 34455678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~-------------~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~ 807 (1002)
.+..|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+|+||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 9999999999999999999875421 348899999999999999999999999999999999999999
Q ss_pred CcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHH
Q 001865 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (1002)
Q Consensus 808 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvi 887 (1002)
+.+||+|||++........ ........+++.|+|||++.+..++.++|||||||+
T Consensus 159 ~~~kL~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDY-------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVV 213 (280)
T ss_pred CCEEECCCCceeEcCCCce-------------------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHH
Confidence 9999999999864321100 011123346788999999998889999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 888 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 888 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
+|+|++ |.+||...........+..+.. ......++..+.+||.+||+.||.+||++.+
T Consensus 214 l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 214 LWEIFTYGKQPWYQLSNTEAIECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHHHHcCCCCCCccCCHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 999998 9999988777777666655432 2333457888999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=347.53 Aligned_cols=256 Identities=24% Similarity=0.364 Sum_probs=222.8
Q ss_pred ccccCCccccccccccCcEEEEEEEEc-----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 739 (1002)
.+...+.+..+.||+|+||+||+++.. .....||||.++... +.....+|.+|++++..++|||||+++|++.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 355678888999999999999999863 234579999998653 3446788999999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQP------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~ 807 (1002)
.++..|||+|||..|+|.++|.... ...|+..+.+.|+.||+.|+.||-++.+|||||-..|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 9999999999999999999998421 1238999999999999999999999999999999999999999
Q ss_pred CcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHH
Q 001865 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (1002)
Q Consensus 808 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvi 887 (1002)
-.|||+|||+++..... ++++ ......-...|||||.+....|+.+|||||+||+
T Consensus 640 l~VKIsDfGLsRdiYss---------DYYk----------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVv 694 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSS---------DYYK----------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVV 694 (774)
T ss_pred eEEEecccccchhhhhh---------hhhc----------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhh
Confidence 99999999999765422 1111 1112345678999999999999999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 888 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 888 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
|||+++ |+.||.+.++.+++..+..+.. ++.+..++.++.+||..||+.+|.+||+++++
T Consensus 695 LWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 695 LWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred hhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 999995 9999999999999999999888 88888899999999999999999999997664
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.98 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=211.4
Q ss_pred ccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEecc
Q 001865 675 KPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 751 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 751 (1002)
+.||+|+||.||+|.+... +..|++|.++.... ......+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999766 88999999986532 224678889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 752 PGGELFLLLDRQP-------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 752 ~ggsL~~~l~~~~-------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
++++|.+++.... ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999998641 356999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
.. ........+++.|+|||.+....++.++|||||||++|+|++ |..||.....
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 11 111234467889999999988888999999999999999998 6999999887
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
......+... ...+.....+..+.+++.+||..+|.+||+ +.++++|
T Consensus 214 ~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~l~~~ 260 (262)
T cd00192 214 EEVLEYLRKG-YRLPKPEYCPDELYELMLSCWQLDPEDRPT----FSELVER 260 (262)
T ss_pred HHHHHHHHcC-CCCCCCccCChHHHHHHHHHccCCcccCcC----HHHHHHh
Confidence 7777766653 233334456889999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.21 Aligned_cols=254 Identities=27% Similarity=0.462 Sum_probs=217.9
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|++++++++|||++++++++...+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999998999999999986533 23456788999999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+.+++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999999765 4589999999999999999999999999999999999999999999999999865432110
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
......|+..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 155 ------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (254)
T cd06627 155 ------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210 (254)
T ss_pred ------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 01234688899999999888888899999999999999999999987766555555
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+...... +.....+..+.+++.+||..+|++||+ +.+++.||||
T Consensus 211 ~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~~ 254 (254)
T cd06627 211 IVQDDHP-PLPEGISPELKDFLMQCFQKDPNLRPT----AKQLLKHPWI 254 (254)
T ss_pred HhccCCC-CCCCCCCHHHHHHHHHHHhCChhhCcC----HHHHhcCCCC
Confidence 5433222 223346788999999999999999999 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=325.72 Aligned_cols=260 Identities=21% Similarity=0.300 Sum_probs=208.8
Q ss_pred cccccCCccccccccccCcEEEEEEEEcCC-------CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeE
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 735 (1002)
+.+..++|.+.+.||+|+||.||++.+... ...+|+|.++... .......+.+|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 345567899999999999999999987432 3479999987542 233456788899999999 799999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
+++...+..|+||||+.+++|.+++.... ...++...++.++.||+.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997542 1348889999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
|+++.++.+||+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 225 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225 (307)
T ss_pred eEEcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHH
Confidence 9999999999999999854321100 000111234578999999998889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 882 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
|||||++|+|++ |..||.+....+....+... ...+.....+..+.+|+.+||..+|++||++.++++.
T Consensus 226 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 226 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999999999998 89999887766555554433 3333344568899999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=322.74 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=210.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
...+|.+.+.||+|+||.||+|.+.. ++..+++|.+... .......+.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 35679999999999999999998643 4567899988643 233446688999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC
Q 001865 742 THVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~ 807 (1002)
+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997532 2348999999999999999999999999999999999999999
Q ss_pred CcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHH
Q 001865 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (1002)
Q Consensus 808 g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvi 887 (1002)
+.++|+|||++........ ........|++.|+|||++.+..++.++|||||||+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY-------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCce-------------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence 9999999999854321110 011123457889999999998889999999999999
Q ss_pred HHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 888 LYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 888 l~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
+|+|++ |..||...+....+..+..+.... .....+..+.+|+.+||+.+|++||++.++++.+
T Consensus 215 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 215 LWEIFTYGKQPWFQLSNTEVIECITQGRVLE-RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhCCCCCC-CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 999998 999998888777776665544332 2234678899999999999999999965544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.34 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=207.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee-CCeEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCL 746 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l 746 (1002)
.++|++++.||.|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.++||||++++++|.. ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 568999999999999999999999999999999887542 223344667789999999999999999999865 568899
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
||||+ +++|..++.. ..++...+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--- 160 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--- 160 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---
Confidence 99999 7789888864 3478899999999999999999999999999999999999999999999998853211
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....
T Consensus 161 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 161 ---------------------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred ---------------------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0123457889999999866 568889999999999999999999998766533
Q ss_pred HHHHHHhC--------------------------CCCCC---CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCC
Q 001865 906 TFANILHK--------------------------DLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956 (1002)
Q Consensus 906 ~~~~i~~~--------------------------~~~~~---~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 956 (1002)
....+... ....+ .....+..+.++|++||+.+|++||+ +.+++.||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~ 289 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHP 289 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCC
Confidence 22221110 00111 01235678999999999999999999 99999999
Q ss_pred CcCC
Q 001865 957 FFKG 960 (1002)
Q Consensus 957 ~f~~ 960 (1002)
||..
T Consensus 290 ~~~~ 293 (328)
T cd07856 290 YLAP 293 (328)
T ss_pred cccc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=332.99 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=209.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3689999999999999999999999999999999876422 222345678899999999999999999998754
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...|+||||+ ..+|..++. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYM-QTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ceEEEEeccc-ccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 3469999999 457776653 34899999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 168 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 168 DA------------------------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CC------------------------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 1123467889999999876 4578899999999999999999999998
Q ss_pred CChHHHHHHHHhCC-----------------------CCCCC------CCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 901 KTRQKTFANILHKD-----------------------LKFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~-----------------------~~~~~------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
.+....+..+.... ...+. .+..+..+.+||.+||+.||.+||+ +.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e 293 (342)
T cd07879 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATE 293 (342)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHH
Confidence 77655554443210 00000 1235677899999999999999999 999
Q ss_pred HHcCCCcCCCChh
Q 001865 952 IKKHPFFKGVNWA 964 (1002)
Q Consensus 952 lL~Hp~f~~~~~~ 964 (1002)
++.||||+.+...
T Consensus 294 ~l~h~~f~~~~~~ 306 (342)
T cd07879 294 ALEHPYFDSFRDA 306 (342)
T ss_pred HhcCcchhhcccc
Confidence 9999999997654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.08 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=208.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
...+|++.+.||+|+||.||+|.+..++ ..+|+|.++... .......+.+|+.+++.++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3468999999999999999999986544 379999987542 23345678889999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+|+||||+++++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999997653 4589999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~ 902 (1002)
..... .......++..|+|||++.+..++.++|+|||||++|++++ |..||.+..
T Consensus 159 ~~~~~------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 159 DPEAA------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred cccee------------------------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC
Confidence 11000 00111234568999999998889999999999999999886 999998877
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
.......+... ...+.....+..+.+|+.+||+.+|.+||++.++
T Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 215 NQDVIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred HHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 76666666544 3444445578889999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.14 Aligned_cols=245 Identities=22% Similarity=0.339 Sum_probs=207.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++.+.||.|+||.||+|.. .++.+|+|.++... .....+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 4567899999999999999999987 47899999987542 14567889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999999999998765456999999999999999999999999999999999999999999999999998543210
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
.....++..|+|||++....++.++||||||+++|+|++ |..||......
T Consensus 156 -----------------------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 156 -----------------------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred -----------------------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 001234567999999988888999999999999999997 99999888766
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
.....+... .........+..+.+||.+||..+|++||++.+
T Consensus 207 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 248 (256)
T cd05039 207 DVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248 (256)
T ss_pred HHHHHHhcC-CCCCCccCCCHHHHHHHHHHhccChhhCcCHHH
Confidence 665555443 222333446789999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=332.31 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=208.4
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|.+.+.||+|+||.||++.+..+++.||+|++.+.. ........+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 478999999999999999999999999999999987642 2233345677899999999999999999988643
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...|++++++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 4578999988 8899888764 34899999999999999999999999999999999999999999999999998542
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
.. ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 171 ~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 171 DD------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cc------------------------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11 1123467889999999866 4678899999999999999999999987
Q ss_pred CChHHHHHHHHhCCC-----------------------CCCC------CCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 901 KTRQKTFANILHKDL-----------------------KFPS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~-----------------------~~~~------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
.+....+..+..... ..+. ....+..+.+||.+||+.||.+||+ +.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e 296 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQ 296 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHH
Confidence 665554444332110 0000 1124678899999999999999999 999
Q ss_pred HHcCCCcCC
Q 001865 952 IKKHPFFKG 960 (1002)
Q Consensus 952 lL~Hp~f~~ 960 (1002)
++.||||+.
T Consensus 297 ~l~h~~f~~ 305 (345)
T cd07877 297 ALAHAYFAQ 305 (345)
T ss_pred HhcChhhhh
Confidence 999999996
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.47 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=204.1
Q ss_pred ccccccccccCcEEEEEEEEcCCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee------CC
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KT 742 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~ 742 (1002)
|.+.+.||+|+||.||++.+..++. .+|+|.++.. .........+..|+.+++.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4567889999999999999877765 6999988754 2344556778899999999999999999987642 23
Q ss_pred eEEEEEeccCCCchhHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001865 743 HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a 818 (1002)
..+++|||+.+++|.+++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999887421 2235899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~P 897 (1002)
..+..... ........+++.|++||++.+..++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 65431100 001122346778999999999889999999999999999998 8999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 898 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
|.+.........+..+.. .+.....+..+.++|.+||..||++||| +.+|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~l~~ 266 (272)
T cd05075 215 YPGVENSEIYDYLRQGNR-LKQPPDCLDGLYSLMSSCWLLNPKDRPS----FETLRC 266 (272)
T ss_pred CCCCCHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 998877777666655432 2333456788999999999999999999 566553
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.64 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=218.0
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
+|++.+.||.|+||.||++.+..++..+|+|.+..... .......+.+|+.+++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58899999999999999999999999999999876533 23445677889999999999999999999999999999999
Q ss_pred ccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 750 YCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|+++++|..++... ....+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999998652 2346899999999999999999999999999999999999999999999999998554211
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.....
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 111235788999999999988899999999999999999999999988877666
Q ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+....... .....+..+.+++.+||..+|++||+ +.++++||++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGKYPP-IPPIYSQDLQNFIRSMLQVKPKLRPN----CDKILASPAV 256 (256)
T ss_pred HHHhcCCCCC-CchhhCHHHHHHHHHHcCCCcccCCC----HHHHhcCCCC
Confidence 6665544332 22356788999999999999999999 9999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=331.23 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=204.7
Q ss_pred cccCCccccccccccCcEEEEEEEE-----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEe
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVEL-----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ 739 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~-----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 739 (1002)
+..++|++.+.||.|+||.||+|.+ ..+++.||||.++... .......+.+|+.++..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 4567899999999999999999985 3457899999997542 233456788899999999 6899999999876
Q ss_pred e-CCeEEEEEeccCCCchhHHHhhCC------------------------------------------------------
Q 001865 740 T-KTHVCLITDYCPGGELFLLLDRQP------------------------------------------------------ 764 (1002)
Q Consensus 740 ~-~~~~~lV~E~~~ggsL~~~l~~~~------------------------------------------------------ 764 (1002)
. +..+|+|||||++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 457899999999999999986421
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 765 -----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 765 -----------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------ 235 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------ 235 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence 123678888999999999999999999999999999999999999999999998553211100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 912 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 912 (1002)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..........+.
T Consensus 236 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 296 (343)
T cd05103 236 -------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296 (343)
T ss_pred -------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh
Confidence 01112345678999999988889999999999999999996 9999987654333333333
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 913 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
.....+.....+..+.+++..||+.||++||+ +.+|++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps----~~eil~~ 335 (343)
T cd05103 297 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 335 (343)
T ss_pred ccCCCCCCCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 33333333346778999999999999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.91 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=207.1
Q ss_pred ccccccCcEEEEEEEEcC-CC--eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEecc
Q 001865 675 KPLGSGDTGSVHLVELCG-SG--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 751 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~-~~--~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 751 (1002)
+.||+|++|.||++.+.. .+ ..+|+|.+...... .....+.+|+.++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 33 36999999876432 556788899999999999999999999988 8999999999
Q ss_pred CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCc
Q 001865 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831 (1002)
Q Consensus 752 ~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~ 831 (1002)
++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---- 153 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---- 153 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc----
Confidence 9999999997754356899999999999999999999999999999999999999999999999998654321100
Q ss_pred chhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001865 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 910 (1002)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 910 (1002)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 154 --------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 154 --------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred --------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 011113457788999999998889999999999999999998 99999888887777777
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 911 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 911 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
......++.....+..+.+|+.+||..+|++||+ +.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~~ 252 (257)
T cd05040 214 DKEGERLERPEACPQDIYNVMLQCWAHNPADRPT----FAALR 252 (257)
T ss_pred HhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCC----HHHHH
Confidence 6544444444456788999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.29 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=207.1
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
+...+|++++.||.|+||+||+|.+..++. .||+|+++... .......+.+|+.+++.++||||+.+++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456789999999999999999999877765 48999987542 34445678889999999999999999998875
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...+++|+|+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 45789999999999999987542 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~ 900 (1002)
...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 160 DIDETE-------------------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred ccccce-------------------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 321110 00112235678999999998889999999999999999998 9999987
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
.........+.. ....+.....+..+.+++.+||..||++||+ +.+++
T Consensus 215 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~l~ 262 (279)
T cd05109 215 IPAREIPDLLEK-GERLPQPPICTIDVYMIMVKCWMIDSECRPR----FRELV 262 (279)
T ss_pred CCHHHHHHHHHC-CCcCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 766555544433 3333444557889999999999999999999 55555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=314.66 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=208.0
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..++|++.+.||+|+||.||++.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 456789999999999999999999864 4567999988653 2245678889999999999999999999887 778
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|++|||+++++|.+++.......++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.+......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998765566899999999999999999999999999999999999999999999999988543211
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
.. .......++..|+|||++....++.++|+|||||++|++++ |..||.+.+.
T Consensus 156 ~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 156 EY--------------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred Cc--------------------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 00 01112245678999999988888999999999999999998 9999998877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
......+... ...+.....+..+.+++.+||+.+|++||+..+
T Consensus 210 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 252 (260)
T cd05073 210 PEVIRALERG-YRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 252 (260)
T ss_pred HHHHHHHhCC-CCCCCcccCCHHHHHHHHHHcccCcccCcCHHH
Confidence 6666555443 334444557889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.22 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=210.6
Q ss_pred cccccCCccccccccccCcEEEEEEEEc-------CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeE
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELC-------GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 735 (1002)
+.+..++|.+.+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 3456789999999999999999999752 234579999987532 234456788999999999 899999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
+++...+.+|+||||+.+++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999997532 2347888899999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
|+++.++.+||+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222 (304)
T ss_pred EEEcCCCcEEECCCccceecccccc-------------------------cccccCCCCCceeeCchhhccCCCCchhhH
Confidence 9999999999999999865421110 001122346778999999998889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHH
Q 001865 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950 (1002)
Q Consensus 882 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~ 950 (1002)
||||+++|+|++ |..||.+.+..+....+.... .......++..+.+|+.+||..+|.+||++.+++.
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 999999999998 889998887777766665443 22333457889999999999999999999444433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=321.77 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=204.3
Q ss_pred CCccccccccccCcEEEEEEEEcCCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 745 (1002)
++|++.+.||.|+||.||+|.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877764 4688877632 2334456788899999999 7999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001865 746 LITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vk 811 (1002)
+||||+++++|.+++.... ...++...++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 13488999999999999999999999999999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHH
Q 001865 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (1002)
Q Consensus 812 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~el 891 (1002)
|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|
T Consensus 160 l~dfg~~~~~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccce----------------------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 9999988421100 000111235579999999988899999999999999999
Q ss_pred Hc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 892 LY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 892 lt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
++ |..||.+.+.......+..+ ...+....++..+.+|+.+||..+|.+||++.++
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQG-YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 97 99999988877777666554 2233334578899999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.33 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=204.1
Q ss_pred ccCCccccccccccCcEEEEEEEEcCC--------------CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcc
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGS--------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~--------------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv 732 (1002)
..++|++.+.||+|+||.||+|.+..+ ...||+|.++... .......+.+|++++++++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 346899999999999999999987543 2358999987542 234456788999999999999999
Q ss_pred eeEEEEeeCCeEEEEEeccCCCchhHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001865 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP----------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (1002)
Q Consensus 733 ~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NI 802 (1002)
++++++...+.+|+||||+.+++|.+++.... ...++...+..++.||+.||+|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986431 12368889999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001865 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (1002)
Q Consensus 803 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIw 882 (1002)
+++.++.+||+|||++....... .........+++.|+|||++.+..++.++|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 215 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVW 215 (295)
T ss_pred EEcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHH
Confidence 99999999999999985432110 00111233467889999999888899999999
Q ss_pred HHHHHHHHHHc--CCCCCCCCChHHHHHHHHh------CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 883 ALGILLYEMLY--GYTPFRGKTRQKTFANILH------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 883 SlGvil~ellt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
||||++|+|++ |..||...+....+..+.. ...........+..+.+|+.+||..+|++||++.+
T Consensus 216 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 216 AFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred HHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 99999999987 7789988776666554432 11112223346788999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.01 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=214.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCC-----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
...+|++++.||.|+||.||+|..+.+ .+.+++|.+.... .......+.+|++++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 346899999999999999999997543 4679999876432 223456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEe
Q 001865 742 THVCLITDYCPGGELFLLLDRQPT-------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~-------~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~D 814 (1002)
+..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999999976531 1589999999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-
Q 001865 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY- 893 (1002)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt- 893 (1002)
||++...... .........+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 161 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~ 214 (275)
T cd05046 161 LSLSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ 214 (275)
T ss_pred cccccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9987532110 0011223356788999999988888899999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
|..||........+..+..+...++.....+..+.+++.+||+.+|.+||+ +.+++.
T Consensus 215 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~----~~~~l~ 271 (275)
T cd05046 215 GELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPS----FSELVS 271 (275)
T ss_pred CCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 889998877777777777666666666667889999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.37 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=211.9
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 741 (1002)
Q Consensus 663 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 741 (1002)
...+..++|++.+.||+|+||.||+|.+..+++.||+|.+++.. .......+..|+.++..+ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 34566789999999999999999999998889999999997542 223345566677766666 599999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
...|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||++..
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999999 567877776532 368999999999999999999997 5999999999999999999999999999854
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC----CCChhhHHHHHHHHHHHHcCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYT 896 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----~~~~sDIwSlGvil~elltG~~ 896 (1002)
+.... ......+++.|+|||++.+.. ++.++||||||+++|+|++|+.
T Consensus 165 ~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 165 LVDSK----------------------------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred ccCCC----------------------------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 32110 011234788999999987553 7789999999999999999999
Q ss_pred CCCCCCh-HHHHHHHHhCCC-CCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 897 PFRGKTR-QKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 897 Pf~~~~~-~~~~~~i~~~~~-~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
||..... .+.+..+..... ..+....++..+.+|+.+||..||.+||+ ++++++||||..
T Consensus 217 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~il~~~~~~~ 278 (296)
T cd06618 217 PYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK----YRELLQHPFIRR 278 (296)
T ss_pred CCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHhcChhhhc
Confidence 9976433 344445554432 23333346788999999999999999999 999999999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=325.20 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=206.4
Q ss_pred CccccccccccCcEEEEEEEEcCC--CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEee----CC
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT----KT 742 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~----~~ 742 (1002)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ........+.+|+.+++++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8899999987532 2233345677899999999 69999999987532 25
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
.+|++|+|+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 689999999 57899888653 458999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
..... .........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 157 ~~~~~-----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 157 ENPGE-----------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ccccc-----------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 11100 0011234578999999998765 46788999999999999999999999876
Q ss_pred ChHHHHHHHHhCC----------------------------CCCC-CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 902 TRQKTFANILHKD----------------------------LKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 902 ~~~~~~~~i~~~~----------------------------~~~~-~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
+....+..++... ..+. .....+..+.+|+.+||+.||.+||| +.++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~l 289 (332)
T cd07857 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEA 289 (332)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHH
Confidence 6544433322210 0000 11234678999999999999999999 9999
Q ss_pred HcCCCcCC
Q 001865 953 KKHPFFKG 960 (1002)
Q Consensus 953 L~Hp~f~~ 960 (1002)
+.||||+.
T Consensus 290 l~~~~~~~ 297 (332)
T cd07857 290 LEHPYLAI 297 (332)
T ss_pred hcChhhhh
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=326.90 Aligned_cols=273 Identities=25% Similarity=0.336 Sum_probs=212.9
Q ss_pred CCccc-cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChH-----------HHHHHHHHHHHHHhCCCCCcceeEE
Q 001865 669 QHFRP-IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------KVHRACAEREILDMLDHPFVPALYA 736 (1002)
Q Consensus 669 ~~y~i-~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~-----------~~~~~~~E~~il~~l~hpnIv~l~~ 736 (1002)
++|.. .+.||.|+||.||+|.+..+++.||+|+++........ ....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 56764 57799999999999999999999999998754322110 0124678999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001865 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (1002)
Q Consensus 737 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG 816 (1002)
++...+..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999994 7899998753 458999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCC
Q 001865 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~ 895 (1002)
++.....+........ .. ............+++.|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus 165 ~~~~~~~~~~~~~~~~---------~~----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 231 (335)
T PTZ00024 165 LARRYGYPPYSDTLSK---------DE----TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231 (335)
T ss_pred ceeecccccccccccc---------cc----cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9866542211100000 00 00001112234578899999998764 4688999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCC--C---CCCC---------------------CCCCCHHHHHHHHHccccCcCCCCCChhcH
Q 001865 896 TPFRGKTRQKTFANILHKD--L---KFPS---------------------STPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~--~---~~~~---------------------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a 949 (1002)
+||.+.+....+..+.... . .++. ....+..+.+||.+||..+|++||+ +
T Consensus 232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~ 307 (335)
T PTZ00024 232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----A 307 (335)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----H
Confidence 9999888776665554310 0 0100 1224677899999999999999999 9
Q ss_pred HHHHcCCCcCCC
Q 001865 950 NEIKKHPFFKGV 961 (1002)
Q Consensus 950 ~elL~Hp~f~~~ 961 (1002)
+++|.||||+..
T Consensus 308 ~~~l~~~~~~~~ 319 (335)
T PTZ00024 308 KEALKHEYFKSD 319 (335)
T ss_pred HHHhcCcccCCC
Confidence 999999999975
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.87 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=205.0
Q ss_pred CccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47889999999999999998753 23578999887542 234456788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001865 745 CLITDYCPGGELFLLLDRQ----------------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~----------------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NI 802 (1002)
|+||||+.+++|.+++... ....++...+..++.|++.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 123478999999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001865 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (1002)
Q Consensus 803 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIw 882 (1002)
|++.++.+||+|||++........ ........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDS-------------------------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCccc-------------------------hhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 999999999999999864321110 0011223456789999999888899999999
Q ss_pred HHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 883 ALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 883 SlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
|||+++|+|++ |..||.+.........+. .....+.....+..+.+|+.+||+.+|++||++.++
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 99999999998 999998887766555443 333444445578899999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.39 Aligned_cols=268 Identities=26% Similarity=0.377 Sum_probs=208.6
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+....... .....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 579999999999999999999999999999999987543222 1223557899999999999999999887533
Q ss_pred --CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 742 --THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 742 --~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
..+|+||||+ +++|...+... ...+++..++.++.||+.||.|||++||+|+||||+||++++++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~-~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecC-CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 3579999999 55677766543 3469999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
.......... ..............|++.|+|||++.+. .++.++|||||||++|+|++|++||
T Consensus 164 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPNPK----------------GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcccc----------------cCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 5432211000 0000011123445789999999988654 5788999999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCC-----C------C---------C--------CCCCCHHHHHHHHHccccCcCCCCCChhcHH
Q 001865 899 RGKTRQKTFANILHKDLK-----F------P---------S--------STPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~-----~------~---------~--------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~ 950 (1002)
.+.+.......+...... + + . ....+..+.+||.+||..||.+||| +.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ 303 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----AS 303 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HH
Confidence 988776655554431000 0 0 0 0123456789999999999999999 99
Q ss_pred HHHcCCCc
Q 001865 951 EIKKHPFF 958 (1002)
Q Consensus 951 elL~Hp~f 958 (1002)
+++.||||
T Consensus 304 ell~~~~f 311 (311)
T cd07866 304 DALEHPYF 311 (311)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.83 Aligned_cols=253 Identities=20% Similarity=0.294 Sum_probs=202.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
+..++|++++.||.|+||.||+|.+..++. .+++|.+... ........+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 345689999999999999999999977776 4677766432 123344567788889999999999999998754
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...++++||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 56789999999999999997643 45899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~ 900 (1002)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 160 YPDDKK-------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCCCcc-------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 211100 01123457788999999988889999999999999999998 9999988
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
.........+ ......+....++..+.+++.+||..||++|||+.++
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 215 MRPHEVPDLL-EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred CCHHHHHHHH-HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 7665544444 3333333333467788999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.15 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=208.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcC-----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
..++|++++.||+|+||.||+|.+.. ++..+|+|+++... .......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999999743 57899999987542 234456788899999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 742 THVCLITDYCPGGELFLLLDRQP--------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~--------------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
+..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997431 1247888999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
|+++.++.++|+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-------------------------YKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCcc-------------------------ccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 9999999999999998854321100 011112235677999999998889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 882 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
|||||++|+|++ |..||.+.+..+....+..+... +.....+..+.+||.+||+.+|++||++.+
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 999999999997 88999888877777766655432 223346788999999999999999999444
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.49 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=209.6
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--CeEEEEE
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--THVCLIT 748 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~~~~lV~ 748 (1002)
|++++.||.|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|+|++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999999999999998653 2333445678899999999999999999999987 8999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
||++ ++|..++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9995 58988886542 4689999999999999999999999999999999999999999999999999865432110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+....+
T Consensus 156 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 156 ------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred ------------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 01122356888999998765 45788999999999999999999999887766655
Q ss_pred HHHHhCCC-----CCCCC-----------------------CC-CCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 908 ANILHKDL-----KFPSS-----------------------TP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 908 ~~i~~~~~-----~~~~~-----------------------~~-~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
..+..... .++.. .. ++..+.+++.+||..+|.+||+ +.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 55543110 00000 01 2778899999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.03 Aligned_cols=248 Identities=22% Similarity=0.324 Sum_probs=201.1
Q ss_pred ccccccCcEEEEEEEEcCCC---eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEecc
Q 001865 675 KPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYC 751 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~ 751 (1002)
+.||+|+||.||+|.+..++ ..+|+|.+...... .....+.+|+.+++.++||||+++++++. .+.+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999875554 78999998765432 34567888999999999999999999876 45689999999
Q ss_pred CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCc
Q 001865 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831 (1002)
Q Consensus 752 ~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~ 831 (1002)
++++|.+++.... .+++..+..++.|++.||+|||.+|++|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---- 151 (257)
T cd05060 78 PLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---- 151 (257)
T ss_pred CCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc----
Confidence 9999999998753 5899999999999999999999999999999999999999999999999998654311100
Q ss_pred chhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHH
Q 001865 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANI 910 (1002)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i 910 (1002)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 152 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 152 --------------------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred --------------------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 001111234568999999998889999999999999999997 99999887776666555
Q ss_pred HhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 911 LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 911 ~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
.... ..+....++..+.+||.+||..+|++||++.++++.+
T Consensus 212 ~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 212 ESGE-RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred HcCC-cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 4432 3344445778899999999999999999955443333
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=314.65 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=209.2
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
..+.|+..+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+++++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34578999999999999999999876654 79999886542 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+|+||||+++++|.+++.... ..++...+..++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999987643 4589999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~ 902 (1002)
..... ........++.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 160 ~~~~~------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEGT------------------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred ccccc------------------------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 11100 00111223567999999988888999999999999999997 999998887
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
..+....+... ...+.....+..+.+|+.+||..+|++||++.++
T Consensus 216 ~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 216 NHEVMKAINDG-FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred HHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 77776666543 3445555578889999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=328.14 Aligned_cols=263 Identities=28% Similarity=0.417 Sum_probs=211.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeC--CeE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--THV 744 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~ 744 (1002)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.+.. ........+.+|+.+++++ +||||+++++++... ...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 468999999999999999999998899999999886532 2333445677899999999 999999999998653 468
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+||||+. ++|..++... .+++..++.++.||+.||+|||++||+|+||||+||+++.+|.+||+|||++......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999995 6999888653 5888999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
.... .........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus 161 ~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EENP----------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred cccc----------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 1100 0011223568999999998865 4577899999999999999999999987665
Q ss_pred HHHHHHHHhCCCC-----------------------------CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 904 QKTFANILHKDLK-----------------------------FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 904 ~~~~~~i~~~~~~-----------------------------~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
......+...... .......+..+.+||.+||+.+|++||| +.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~ 294 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALE 294 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhh
Confidence 5544433221100 0011225778999999999999999999 999999
Q ss_pred CCCcCCC
Q 001865 955 HPFFKGV 961 (1002)
Q Consensus 955 Hp~f~~~ 961 (1002)
||||+.+
T Consensus 295 ~~~~~~~ 301 (337)
T cd07852 295 HPYVAQF 301 (337)
T ss_pred Chhhhhh
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=322.48 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=207.6
Q ss_pred cccccCCccccccccccCcEEEEEEEEcC-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeE
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~ 735 (1002)
+.+..++|.+.+.||+|+||.||+|.+.. ....+|+|.++... .......+.+|+.+++.+ +||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34556789999999999999999998632 34579999987532 234456788899999999 699999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCc
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 736 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~N 801 (1002)
+++...+.+|+||||+++++|.+++.... ...++...+..++.||+.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 99999999999999999999999997532 2358889999999999999999999999999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhH
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
||++.++.+||+|||++........ ........+++.|+|||++.+..++.++||
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDY-------------------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EEEcCCCcEEEcccccccccccccc-------------------------ccccccCCCCccccCHHHHccCCcCccchh
Confidence 9999999999999999865321100 000111234568999999998889999999
Q ss_pred HHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 882 WALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 882 wSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
|||||++|+|++ |..||.+......+..+.... .......++..+.+|+.+||..+|++||++.+
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 999999999998 999998887777666665543 22223456788999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.43 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=204.9
Q ss_pred cCCccccccccccCcEEEEEEEEcC----------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCG----------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~----------------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI 731 (1002)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.++... .......+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999986532 34579999987542 33445678899999999999999
Q ss_pred ceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcE
Q 001865 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802 (1002)
Q Consensus 732 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~---------~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NI 802 (1002)
+++++++...+..|+||||+.+++|.+++..... ..++...+..++.||+.||+|||++||+|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999999875321 2477789999999999999999999999999999999
Q ss_pred EEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHH
Q 001865 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882 (1002)
Q Consensus 803 Ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIw 882 (1002)
|++.++.++|+|||++..+..... ........+++.|++||++.+..++.++|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-------------------------eeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 999999999999999864321100 0111223456789999998888899999999
Q ss_pred HHHHHHHHHHc--CCCCCCCCChHHHHHHHHh------CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHH
Q 001865 883 ALGILLYEMLY--GYTPFRGKTRQKTFANILH------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950 (1002)
Q Consensus 883 SlGvil~ellt--G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~ 950 (1002)
||||++|+|++ |..||...+..+.+..... .....+....++..+.+|+.+||+.||.+||++.++++
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999997 7899987766665544321 11223344456788999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=317.04 Aligned_cols=250 Identities=30% Similarity=0.445 Sum_probs=203.2
Q ss_pred cccccccccCcEEEEEEEEc----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 672 RPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.+.+.||.|.||.||+|.+. ..+..|+||.++.. ........+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 35678999999999999997 34678999999542 2344578899999999999999999999999988889999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
||||++|+|.+++.......++...+..++.||+.||.|||+++|+|+||+|+||++++++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999886456699999999999999999999999999999999999999999999999999865421100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~ 906 (1002)
........+...|+|||.+....++.++||||||+++|||++ |+.||...+..+.
T Consensus 159 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 159 ------------------------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ------------------------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ------------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 011223457788999999988889999999999999999999 7899999888887
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
...+... ...+....++..+.++|..||..+|++||+ +.+|+
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~~li~~C~~~~p~~RPs----~~~i~ 256 (259)
T PF07714_consen 215 IEKLKQG-QRLPIPDNCPKDIYSLIQQCWSHDPEKRPS----FQEIL 256 (259)
T ss_dssp HHHHHTT-EETTSBTTSBHHHHHHHHHHT-SSGGGS------HHHHH
T ss_pred ccccccc-ccceeccchhHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 7777444 333444457889999999999999999999 55554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.95 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=208.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC----
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT---- 742 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~---- 742 (1002)
..++|++.+.||+|+||.||++.++.+++.||+|.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35789999999999999999999999999999999875422 2223346678999999999999999999887654
Q ss_pred ------eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001865 743 ------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (1002)
Q Consensus 743 ------~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG 816 (1002)
.+|+||||+++ +|..++... ...+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999955 777777654 3458999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCC
Q 001865 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~ 895 (1002)
++........ .......++..|+|||++.+. .++.++|||||||++|+|++|+
T Consensus 162 ~~~~~~~~~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSEES--------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCCcc--------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9865432110 011123467889999988653 5688999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhC---CC--CCC-----------------------CCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 896 TPFRGKTRQKTFANILHK---DL--KFP-----------------------SSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~---~~--~~~-----------------------~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
+||...+....+..+... .. .++ .....+..+.+||.+||..+|.+||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~--- 292 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT--- 292 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC---
Confidence 999877766555544431 00 000 11235778999999999999999999
Q ss_pred cHHHHHcCCCc
Q 001865 948 GANEIKKHPFF 958 (1002)
Q Consensus 948 ~a~elL~Hp~f 958 (1002)
+.+++.||||
T Consensus 293 -~~~il~~~~~ 302 (302)
T cd07864 293 -AEEALNSPWL 302 (302)
T ss_pred -HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.64 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=211.1
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++..++.+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999998999999999876532 223456778899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+. ++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 95 58888886643 468999999999999999999999999999999999999999999999999885543211
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..
T Consensus 153 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 210 (283)
T cd05118 153 ----------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210 (283)
T ss_pred ----------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 011223578899999998776 688899999999999999999999988877665555
Q ss_pred HHhCCC-------------------CCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 910 ILHKDL-------------------KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 910 i~~~~~-------------------~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+..... .++. ....+..+.+||.+||..||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 211 IFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred HHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 432100 0000 1225678899999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=314.92 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=210.7
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+.|++.+.||+|+||.||+|.+..+++ .||+|+++... .......+..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999877664 69999987542 344567789999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
++||||+.+++|.+++.... ..++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999987643 45899999999999999999999999999999999999999999999999998654221
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~ 903 (1002)
.... .........++..|+|||++.+..++.++|||||||++|++++ |..||...+.
T Consensus 160 ~~~~----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 160 TSDP----------------------TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred cccc----------------------ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 1000 0000011123467999999998889999999999999999886 9999988877
Q ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
......+.. ....+....++..+.+++.+||..+|.+||+ +++++.
T Consensus 218 ~~~~~~i~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~i~~ 263 (269)
T cd05065 218 QDVINAIEQ-DYRLPPPMDCPTALHQLMLDCWQKDRNARPK----FGQIVS 263 (269)
T ss_pred HHHHHHHHc-CCcCCCcccCCHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 776666543 3444444557888999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=325.59 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=211.6
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCC-------CeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcce
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGS-------GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733 (1002)
Q Consensus 662 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~ 733 (1002)
+.+.+...+|++++.||+|+||.||+|.+... +..+|+|.++.. ........+.+|+.+++++ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34556677899999999999999999986432 236899988743 2334456788999999999 8999999
Q ss_pred eEEEEeeCCeEEEEEeccCCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCC
Q 001865 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKP 799 (1002)
Q Consensus 734 l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP 799 (1002)
+++++...+.+|++|||+.+++|.+++.... ...++...+..++.||+.||+|||++||+||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999987532 23478888999999999999999999999999999
Q ss_pred CcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChh
Q 001865 800 ENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879 (1002)
Q Consensus 800 ~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~s 879 (1002)
+|||++.++.+||+|||+++....... ........++..|+|||++.+..++.++
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 217 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDY-------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQS 217 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccc-------------------------cccccCCCcCceEcCHHHhccCCcCchh
Confidence 999999999999999999865321100 0011122345789999999998899999
Q ss_pred hHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 880 DWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 880 DIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
|||||||++|+|++ |..||.+.+..+....+... ...+.....+..+.+|+.+||..+|++||++.+++..+
T Consensus 218 Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 99999999999998 89999988777776666543 23333345678899999999999999999954444433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.74 Aligned_cols=267 Identities=28% Similarity=0.468 Sum_probs=222.5
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC----hHHHHHHHHHHHHHHhCCCCCcceeEEEEe-eCC
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLDHPFVPALYASFQ-TKT 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~ 742 (1002)
.++|-++..||+|||+.||+|.|....+++|||+-.....-. .+..+..++|..|-+.|+||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 578999999999999999999999999999999875432211 222345678999999999999999999997 567
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--CcccCCCCCCcEEEec---CCcEEEEeccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLLQG---NGHVSLTDFDL 817 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~--gIiHrDLKP~NILl~~---~g~vkL~DFG~ 817 (1002)
.+|-|+|||+|.+|..||+.. +.+++..++.|+.||+.||.||... .|||-||||.|||+.+ -|.+||+|||+
T Consensus 542 sFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 899999999999999999875 6799999999999999999999976 6999999999999974 36799999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC----CCCChhhHHHHHHHHHHHHc
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----GHTSAVDWWALGILLYEMLY 893 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~----~~~~~sDIwSlGvil~ellt 893 (1002)
+.++..++... ...........||.+|++||.+.-+ ..+.++||||+|||+|.++.
T Consensus 620 SKIMdddSy~~--------------------vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 620 SKIMDDDSYNS--------------------VDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred hhhccCCccCc--------------------ccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 99987554321 2233455667899999999998543 35679999999999999999
Q ss_pred CCCCCCCCChH-HHHH--HHH-hCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 894 GYTPFRGKTRQ-KTFA--NIL-HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 894 G~~Pf~~~~~~-~~~~--~i~-~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
|+-||...... +++. .|+ .....||.-+..+.++++||++||.+.-+.|+. +.+|-.||||..
T Consensus 680 GrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred cCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 99999765332 2221 222 345678888889999999999999999999999 999999999986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.95 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=212.5
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc--ChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML--NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
+|.+.+.||+|+||.||++.+..++..+++|+++..... .......+..|+.+++.++||||+++++++......|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999999888777888877653322 122344566789999999999999999999999999999
Q ss_pred EeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 748 TDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
|||+++++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 23456999999999999999999999999999999999999974 679999999885432110
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~ 905 (1002)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 160 ---------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 160 ---------------------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred ---------------------------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 11223468889999999988888889999999999999999999998877766
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
....+..+..+. .....+..+.++|.+||..+|++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGPTPS-LPETYSRQLNSIMQSMLNKDPSLRPS----AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCCCCC-CcchhcHHHHHHHHHHhcCChhhCcC----HHHHhhCCCC
Confidence 666665543222 22346788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=315.98 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=196.0
Q ss_pred CCc-cccccccccCcEEEEEEE----EcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--C
Q 001865 669 QHF-RPIKPLGSGDTGSVHLVE----LCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 741 (1002)
Q Consensus 669 ~~y-~i~~~LG~G~~g~Vy~a~----~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 741 (1002)
++| ++++.||+|+||+||++. ...++..+|+|+++... .......+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 999999999999998865 33567899999987542 22345667889999999999999999998765 4
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|+||||+.+++|.+++... .+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999999763 4899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
...... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 158 ~~~~~~------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 158 PEGHEY------------------------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CCcchh------------------------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 311100 00111234567799999998888899999999999999999999998643
Q ss_pred ChH--------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 902 TRQ--------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 902 ~~~--------------~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
... .............+....++..+.+|+.+||..+|++||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~ 273 (283)
T cd05080 214 PKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRS 273 (283)
T ss_pred cchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHH
Confidence 211 0111111122223334456789999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=332.11 Aligned_cols=244 Identities=34% Similarity=0.520 Sum_probs=207.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 745 (1002)
....|.+...+|.|+||.|-.+.+..+++.+++|++.+.. ....+|+.++... +||||+++++.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 3678999999999999999999999999999999998652 2334566565554 8999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEE-ecCCcEEEEeccCCcccCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl-~~~g~vkL~DFG~a~~~~~~ 824 (1002)
+|||++.|+-|.+.+...+. +. ..+..|+.+|+.+|.|||.+|||||||||+|||+ ++.|+++|+|||.++....+
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999999999888876432 33 6777899999999999999999999999999999 58999999999998654321
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
..+.|-|..|.|||++....|+.+|||||||++||+|++|+.||......
T Consensus 470 ------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 470 ------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred ------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 22446789999999999999999999999999999999999999876555
Q ss_pred -HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 905 -KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 905 -~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
++...+....+. ..+|..+++||++||+.||.+|++ +.+++.||||
T Consensus 520 ~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 520 IEIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLG----ADEIGAHPWF 566 (612)
T ss_pred HHHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcC----hhhhccCcch
Confidence 444444333222 458999999999999999999999 9999999999
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.77 Aligned_cols=243 Identities=21% Similarity=0.351 Sum_probs=203.0
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
+..++|++.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++|||++++++++..+ ..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 3456899999999999999999875 78889999986532 235678899999999999999999998765 479
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
+||||+.+++|.+++.......++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 9999999999999998765556899999999999999999999999999999999999999999999999988532100
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..
T Consensus 154 -----------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 204 (254)
T cd05083 154 -----------------------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK 204 (254)
T ss_pred -----------------------------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 011234567999999988889999999999999999997 99999988777
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
+....+..+ ...+.....+..+.+|+.+||..+|++||++.+
T Consensus 205 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 205 EVKECVEKG-YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred HHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 666655543 333333456889999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=349.30 Aligned_cols=273 Identities=27% Similarity=0.414 Sum_probs=210.4
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC-----
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK----- 741 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~----- 741 (1002)
...+|+.+..||+||||.||+|+++-+|+.||||.+.... .......+.+|+.+|.+|+|||||++|..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3568999999999999999999999999999999987653 556678899999999999999999998432000
Q ss_pred --------------------------------------------------------------------------------
Q 001865 742 -------------------------------------------------------------------------------- 741 (1002)
Q Consensus 742 -------------------------------------------------------------------------------- 741 (1002)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH
Q 001865 742 ----------------------------------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787 (1002)
Q Consensus 742 ----------------------------------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~L 787 (1002)
..+||-||||+..+|.+++.++.... .....+.+++||++||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence 12799999999999998888754321 4678899999999999999
Q ss_pred HHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccc
Q 001865 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 867 (1002)
Q Consensus 788 H~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 867 (1002)
|++|||||||||.||++++++.|||+|||+|+......... + ........-...+....++.+||..|+||
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~----d-----~~~~~~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESI----D-----QDLSFSTNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhH----h-----hccCccccccCCCCcccccccceeeeecH
Confidence 99999999999999999999999999999996521000000 0 00000000011222345678999999999
Q ss_pred ccccCCC---CCChhhHHHHHHHHHHHHcCCCCCCCC-ChHHHHHHHHhCCCCCC---CCCCCCHHHHHHHHHccccCcC
Q 001865 868 EIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGK-TRQKTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPK 940 (1002)
Q Consensus 868 E~l~~~~---~~~~sDIwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~---~~~~~s~~~~~Ll~~~L~~dP~ 940 (1002)
|++.+.. |+.++|+||||++++||+. ||... ....++.++..+.++.+ ... .-+.-..+|+.||+.||+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~-~~~~e~slI~~Ll~hdP~ 860 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDP-EHPEEASLIRWLLSHDPS 860 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccc-cchHHHHHHHHHhcCCCc
Confidence 9997654 8999999999999999997 56543 34455555555555555 222 223456899999999999
Q ss_pred CCCCChhcHHHHHcCCCcC
Q 001865 941 SRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 941 ~Rpt~~~~a~elL~Hp~f~ 959 (1002)
+||| |.|||++.||-
T Consensus 861 kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 861 KRPT----ATELLNSELLP 875 (1351)
T ss_pred cCCC----HHHHhhccCCC
Confidence 9999 99999999987
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=316.68 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=202.4
Q ss_pred CCccccccccccCcEEEEEEEE----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC--C
Q 001865 669 QHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK--T 742 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~--~ 742 (1002)
.-|++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4689999999999999999984 4568899999987542 334456788999999999999999999998765 6
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
..++||||++|++|.+++.... ..++...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999987642 358999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
..... ........|+..|+|||++.+..++.++|||||||++|+|++++.|+....
T Consensus 161 ~~~~~------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 161 TDKEY------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred cCccc------------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 11100 011123457778999999988889999999999999999999877653211
Q ss_pred --------------hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 903 --------------RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 903 --------------~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
...............+....++..+.+|+.+||+.+|++||+ +.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 278 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT----FQNLIE 278 (284)
T ss_pred chhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcC----HHHHHH
Confidence 111111222233334444557889999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=360.96 Aligned_cols=261 Identities=28% Similarity=0.480 Sum_probs=219.2
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
-+|.....||.|.||.||.|.+..+|...|+|.++-... .......+.+|..++..++|||+|++|++-.+.+.++|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~-~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS-DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc-ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 467777889999999999999999999999998875432 2445567788999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||.+|+|.+++... ...++...+.+..|++.|++|||+.|||||||||.||+++.+|.+|++|||.|......-...
T Consensus 1314 EyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999999999874 558888899999999999999999999999999999999999999999999996654221000
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCh-H
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFRGKTR-Q 904 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~~~~~sDIwSlGvil~elltG~~Pf~~~~~-~ 904 (1002)
...-....||+.|||||++.+. +...+.|||||||+..||+||+.||...+. .
T Consensus 1392 -----------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1392 -----------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred -----------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 0122356899999999999664 456699999999999999999999987544 4
Q ss_pred HHHHHHHhC-CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 905 KTFANILHK-DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 905 ~~~~~i~~~-~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.++..+-.+ .+++|.. ++.+..+||..||..||..|.+ +.|||+|.|-+..
T Consensus 1449 aIMy~V~~gh~Pq~P~~--ls~~g~dFle~Cl~~dP~~Rw~----~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPER--LSSEGRDFLEHCLEQDPKMRWT----ASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHhHHhccCCCCCchh--hhHhHHHHHHHHHhcCchhhhH----HHHHHHhhccccc
Confidence 444444444 3344444 8999999999999999999999 8899999998764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=309.17 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=198.5
Q ss_pred cccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCC
Q 001865 676 PLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~g 753 (1002)
.||+|+||.||++.+. .++..+|+|++.... .......+.+|+.++++++||||+++++++.. +..|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 4899999999999774 445679999987542 33445678899999999999999999998764 578999999999
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
++|.+++... ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++..........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~----- 152 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY----- 152 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce-----
Confidence 9999998753 2458999999999999999999999999999999999999999999999999986432111100
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHh
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILH 912 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~ 912 (1002)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 153 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 153 -------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred -------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 00111234678999999988889999999999999999996 9999998887776665554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHH
Q 001865 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950 (1002)
Q Consensus 913 ~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~ 950 (1002)
+. ..+.....+.++.+||.+||..+|++||++.++++
T Consensus 214 ~~-~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 214 GK-RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 43 22333456889999999999999999999555433
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=315.79 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=210.7
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
|++.+.||+|++|.||+|.+..+++.||+|++.... ........+..|+.+++.++|+|++++++++...+..|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998653 2233345677899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+. ++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 152 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----- 152 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-----
Confidence 95 69999997653 359999999999999999999999999999999999999999999999999885532110
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 909 (1002)
.......++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.+....+..
T Consensus 153 ----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~ 210 (282)
T cd07829 153 ----------------------RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK 210 (282)
T ss_pred ----------------------cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 011233567889999998776 788899999999999999999999988876665555
Q ss_pred HHhC------------------CCCCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 910 ILHK------------------DLKFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 910 i~~~------------------~~~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+... ...++. .+..+..+.++|.+||..+|++||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 211 IFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred HHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 4321 001111 1123668999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=309.54 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=207.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
..+|++.+.||.|+||.||++.+. .+..+|+|.++.... ....+.+|+++++.++|||++++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457999999999999999999885 467899999875432 234678899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
|||+.+++|.+++.... ..+++..++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 99999999999987543 358899999999999999999999999999999999999999999999999885432110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~ 906 (1002)
........++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 155 ------------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 155 ------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred ------------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 001112335678999999988889999999999999999998 9999988877777
Q ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
...+..+... ......+..+.+|+.+||..+|++||+ +.++++
T Consensus 211 ~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~----~~~~l~ 253 (256)
T cd05112 211 VETINAGFRL-YKPRLASQSVYELMQHCWKERPEDRPS----FSLLLH 253 (256)
T ss_pred HHHHhCCCCC-CCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHH
Confidence 7666544222 222336788999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=312.49 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=209.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
+...+|++.+.||+|+||.||+|.++.+|. .+|+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999876654 68999887543 24455678899999999999999999999887
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 78999999999999999997653 34899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~ 900 (1002)
....... ......++..|+|||.+....++.++|||||||++|++++ |..||.+
T Consensus 160 ~~~~~~~-------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 160 DVDEKEY-------------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cCcccce-------------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 3111100 0011224678999999988888999999999999999998 9999998
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
....+....+..+ ..++.....+..+.+++.+||..+|+.||++.+..+.
T Consensus 215 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~ 264 (279)
T cd05057 215 IPAVEIPDLLEKG-ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINE 264 (279)
T ss_pred CCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8777666555543 3344444567889999999999999999995544333
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=313.55 Aligned_cols=254 Identities=22% Similarity=0.376 Sum_probs=200.4
Q ss_pred cCCccccccccccCcEEEEEEEE----cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--C
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVEL----CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~----~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 741 (1002)
..+|++++.||+|+||.||++.. ..++..||+|.+... .......+.+|+++++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 45899999999999999999974 456889999998754 34455678899999999999999999998653 4
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 57899999999999999997542 35899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
...... ........++..|+|||++.+..++.++|||||||++|+|++|..|+...
T Consensus 159 ~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 159 PQDKEY------------------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred cCCCcc------------------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 321100 00011123455699999999888999999999999999999988776432
Q ss_pred ChH---------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 902 TRQ---------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 902 ~~~---------------~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
... ..+..++.....++....++..+.+|+.+||..+|++||| +.+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~ 277 (284)
T cd05081 215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS----FSELA 277 (284)
T ss_pred chhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC----HHHHH
Confidence 211 0111223333344444557789999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=315.01 Aligned_cols=253 Identities=30% Similarity=0.479 Sum_probs=207.2
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEEe
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
|++.+.||+|++|.||+|.+..+++.+++|.+..... . .......+|+..++++. |+||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-c-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999988999999999875422 1 12234457889999998 9999999999999999999999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
|+ +++|.+++.......+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~----- 152 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----- 152 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-----
Confidence 99 889999987764456899999999999999999999999999999999999999999999999998543211
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHH
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~ 908 (1002)
.......|+..|+|||++.+ ..++.++|+||||+++|+|++|++||...+....+.
T Consensus 153 -----------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 153 -----------------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred -----------------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 01123467889999998854 457889999999999999999999998877665554
Q ss_pred HHHhCC-----------------C--CCCC---------CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 909 NILHKD-----------------L--KFPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 909 ~i~~~~-----------------~--~~~~---------~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
.+...- + .++. ....+..+.+||.+||+.+|++||+ +.|++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 443210 0 0000 0122567899999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.82 Aligned_cols=246 Identities=23% Similarity=0.352 Sum_probs=200.8
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 754 (1002)
+.||+|+||.||++.. .++..+|+|.++... .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 3689999999999986 467899999987542 2333456888999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001865 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (1002)
Q Consensus 755 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 834 (1002)
+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--------- 147 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI--------- 147 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc---------
Confidence 9999987543 458899999999999999999999999999999999999999999999999985422100
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001865 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (1002)
........+++.|+|||++.+..++.++||||||+++|++++ |..||.+.........+...
T Consensus 148 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 148 -----------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred -----------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 000111234678999999988888999999999999999998 99999988777666665543
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
. ........+..+.+|+.+||..+|++||++.+++++
T Consensus 211 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 211 Y-RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred C-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 2 223334467899999999999999999994444333
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=307.13 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=210.5
Q ss_pred ccccccccccCcEEEEEEEEcCCC----eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
+++.+.||.|+||.||++.+...+ ..+|+|.++... .......+..|+.+++.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 899999987542 22256678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
+|||+++++|.+++.......+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999999765433389999999999999999999999999999999999999999999999999865432100
Q ss_pred CCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHH
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~ 905 (1002)
. ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+...
T Consensus 159 ~--------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 Y--------------------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred c--------------------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0 0001226789999999988888999999999999999998 899998887777
Q ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
....+...... +.....+..+.+++.+||..+|++||| +.++++
T Consensus 213 ~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt----~~~ll~ 256 (258)
T smart00219 213 VLEYLKKGYRL-PKPENCPPEIYKLMLQCWAEDPEDRPT----FSELVE 256 (258)
T ss_pred HHHHHhcCCCC-CCCCcCCHHHHHHHHHHCcCChhhCcC----HHHHHh
Confidence 77776655432 233347889999999999999999999 777765
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.17 Aligned_cols=255 Identities=19% Similarity=0.213 Sum_probs=208.6
Q ss_pred cccCCccccccccccCcEEEEEEEEcC----CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee-
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT- 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~----~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 740 (1002)
+..++|++.+.||+|+||.||+|.+.. ++..+++|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999866 3578999988643 244556778899999999999999999998665
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCC------CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEe
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPT------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~------~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~D 814 (1002)
+...+++++|+.+++|.+++..... ..+++..+..++.||+.||+|||+++++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5788999999999999999875322 4589999999999999999999999999999999999999999999999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-
Q 001865 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY- 893 (1002)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt- 893 (1002)
||+++.+...... .......++..|+|||++.+..++.++|||||||++|++++
T Consensus 161 ~g~~~~~~~~~~~-------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDYH-------------------------CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCceE-------------------------EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 9998654321110 00112345778999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
|+.||...+.......+.. ...++....++..+.+++.+||..+|++|||+.++
T Consensus 216 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 269 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKD-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269 (280)
T ss_pred CCCCcCcCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 9999988776665544443 33444444567889999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=347.53 Aligned_cols=258 Identities=21% Similarity=0.342 Sum_probs=219.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe-----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
++....++.+.||+|+||.||.+....... .||+|.+++. .+......|.+|..+|+.++|||||++++++-.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 345677888999999999999998754432 4899988764 467788999999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEec
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~-----~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DF 815 (1002)
....+|++|||+||+|..+|+.. ....++...+..++.||++|+.||+++++|||||...|+|++....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999864 1346999999999999999999999999999999999999999999999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-C
Q 001865 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-G 894 (1002)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G 894 (1002)
|+|+.+..... ++ .. ..-.-...|||||.+....++.++|||||||+|||+++ |
T Consensus 847 GlArDiy~~~y---------yr-~~---------------~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDY---------YR-KH---------------GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchh---------ee-cc---------------CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 99985432211 11 10 01123467999999999999999999999999999997 9
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
..||.+.++.+++...+.+. .++.+..++..+.++|..||+.+|++||++...+++
T Consensus 902 ~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q 957 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ 957 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence 99999999999998777765 666666788889999999999999999997665554
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.74 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=202.8
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCC
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~gg 754 (1002)
+.||.|+||.||++.+.. ++.||+|.+..... ......+.+|++++++++|+||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999977 99999999876532 235567889999999999999999999999999999999999999
Q ss_pred chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchh
Q 001865 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834 (1002)
Q Consensus 755 sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~ 834 (1002)
+|.+++.... ..++...+..++.+++.+|+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~------- 149 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT------- 149 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-------
Confidence 9999986542 35889999999999999999999999999999999999999999999999998543210000
Q ss_pred hhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHhC
Q 001865 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHK 913 (1002)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~ 913 (1002)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+...
T Consensus 150 ------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~ 211 (251)
T cd05041 150 ------------------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG 211 (251)
T ss_pred ------------------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC
Confidence 00011234567999999988889999999999999999998 89999887766655554432
Q ss_pred CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 914 ~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
...+.....+..+.+|+.+||..+|.+||+ +.++++
T Consensus 212 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~ell~ 247 (251)
T cd05041 212 -YRMPAPQLCPEEIYRLMLQCWAYDPENRPS----FSEIYN 247 (251)
T ss_pred -CCCCCCccCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 333334456789999999999999999999 777664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.90 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=204.8
Q ss_pred ccCCccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
...+|.+.+.||.|+||.||+|.+... ...+++|...... .......+.+|+.+++.++||||+++++++.. +.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 456799999999999999999987544 4578999886542 24455678899999999999999999998875 55
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
.|+||||+++++|.+++.... ..++...++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999997643 3589999999999999999999999999999999999999999999999999855321
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~ 902 (1002)
... .......+++.|+|||.+....++.++||||||+++|++++ |..||.+.+
T Consensus 160 ~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESY--------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred ccc--------------------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 100 00112235678999999988889999999999999999985 999999888
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
..+....+..+. ..+....++..+.+|+.+||..+|.+|||+.+
T Consensus 214 ~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 257 (270)
T cd05056 214 NNDVIGRIENGE-RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTE 257 (270)
T ss_pred HHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 777666655432 23334457889999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.13 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=198.0
Q ss_pred ccccccCcEEEEEEEEcCCCe--EEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEEEecc
Q 001865 675 KPLGSGDTGSVHLVELCGSGQ--YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYC 751 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~--~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV~E~~ 751 (1002)
+.||+|+||.||++.+..++. .+++|.++.. ........+.+|+.++.++ +||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 358999999999999988775 4688887642 2334456788899999999 8999999999999999999999999
Q ss_pred CCCchhHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001865 752 PGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 752 ~ggsL~~~l~~~~--------------~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~ 817 (1002)
++++|.+++.... ...++...++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999987532 12478999999999999999999999999999999999999999999999998
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 896 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~ 896 (1002)
+...... ........++.|+|||++....++.++|||||||++|+|++ |..
T Consensus 159 ~~~~~~~----------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~ 210 (270)
T cd05047 159 SRGQEVY----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 210 (270)
T ss_pred ccccchh----------------------------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 7421100 00011234567999999988889999999999999999996 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcH
Q 001865 897 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949 (1002)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a 949 (1002)
||.+.+....+..+... ...+.....+..+.+|+.+||..||.+||++.+++
T Consensus 211 pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (270)
T cd05047 211 PYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 262 (270)
T ss_pred CccccCHHHHHHHHhCC-CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 99887776666665443 22223334678899999999999999999944433
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.38 Aligned_cols=238 Identities=20% Similarity=0.307 Sum_probs=191.5
Q ss_pred ccccccCcEEEEEEEEcCCCe-------EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 675 KPLGSGDTGSVHLVELCGSGQ-------YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~-------~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
+.||.|+||.||+|.+...+. .+++|.+... .......+..|..+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999865543 4888877543 234456778899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc--------EEEEeccCCc
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--------VSLTDFDLSC 819 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~--------vkL~DFG~a~ 819 (1002)
|||+++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999997653 35899999999999999999999999999999999999987765 6999999874
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcC-CCC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYG-YTP 897 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG-~~P 897 (1002)
... ......+++.|+|||++.+. .++.++|||||||++|+|++| ..|
T Consensus 157 ~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~ 205 (258)
T cd05078 157 TVL-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205 (258)
T ss_pred ccC-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 321 01234578899999999764 578899999999999999998 466
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 898 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
|...+..... .+......++. ..+..+.+||.+||+.||++||| +++|++
T Consensus 206 ~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps----~~~il~ 255 (258)
T cd05078 206 LSALDSQKKL-QFYEDRHQLPA--PKWTELANLINQCMDYEPDFRPS----FRAIIR 255 (258)
T ss_pred hhhccHHHHH-HHHHccccCCC--CCcHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 6655544433 23333333333 35678999999999999999999 777664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.56 Aligned_cols=233 Identities=32% Similarity=0.476 Sum_probs=190.5
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCchhHH
Q 001865 680 GDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759 (1002)
Q Consensus 680 G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~ 759 (1002)
|.+|.||+|.+..+++.||+|.+++.. ...+|...+....||||+++++++...+.+|+||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997642 223344455556799999999999999999999999999999999
Q ss_pred HhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcc
Q 001865 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839 (1002)
Q Consensus 760 l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~ 839 (1002)
+... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+......
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------------- 138 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------------- 138 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------------
Confidence 8764 34899999999999999999999999999999999999999999999999987433210
Q ss_pred cCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCC
Q 001865 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919 (1002)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 919 (1002)
.....++..|+|||++.+..++.++|+||+|+++|+|++|..||...... ......+..
T Consensus 139 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~ 197 (237)
T cd05576 139 ---------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNI 197 (237)
T ss_pred ---------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCC
Confidence 11234567899999998888899999999999999999999887643211 111111112
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCc
Q 001865 920 STPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFF 958 (1002)
Q Consensus 920 ~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f 958 (1002)
....+..+.+||.+||+.||++||+.. ..++++++||||
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 233678899999999999999999953 236999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=323.13 Aligned_cols=253 Identities=26% Similarity=0.312 Sum_probs=198.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-eEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-HVCL 746 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-~~~l 746 (1002)
.+.|.-...||+|+||.||++.... |..+|||.+....... ..+|.+|+.++.+++|||+|+++|||.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 3688888999999999999999844 4899999877543211 455999999999999999999999999988 5999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g---IiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
|+|||++|+|.+.+.......+++.....|+.+++.||+|||... ||||||||+|||+|++..+||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 999999999999998754327899999999999999999999853 99999999999999999999999999954321
Q ss_pred -CCCCCCCcchhhhhcccCCCCCccccccccccccc-ccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 824 -KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF-VGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 824 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
.. ..... .||.+|+|||++.....+.++||||||++|.||++|+.+....
T Consensus 230 ~~~----------------------------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 230 GDT----------------------------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred ccc----------------------------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 10 00111 7999999999999888999999999999999999999887643
Q ss_pred C------hHHHHHHHHhC-CC----CCCCC-CCCC--H---HHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 902 T------RQKTFANILHK-DL----KFPSS-TPTS--L---HAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 902 ~------~~~~~~~i~~~-~~----~~~~~-~~~s--~---~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
. ..+-....+.. .+ +.... .... . .+..+..+|++.+|..||++.+++..+
T Consensus 282 ~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 282 RPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 2 11111112211 11 11100 1112 2 245677899999999999977765555
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.27 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=199.1
Q ss_pred ccccccCcEEEEEEEEcCCC------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 675 KPLGSGDTGSVHLVELCGSG------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
+.||+|+||.||++.+.... ..+|+|.+.+.. .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 789999886542 2234567888999999999999999999999999999999
Q ss_pred eccCCCchhHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-----cEEEEeccCC
Q 001865 749 DYCPGGELFLLLDRQ-----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-----HVSLTDFDLS 818 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~-----~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g-----~vkL~DFG~a 818 (1002)
||+++++|.+++... ....+++..+..++.||+.||.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999753 223478899999999999999999999999999999999999887 8999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~P 897 (1002)
........ ........++..|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 54321100 001122346788999999998889999999999999999997 9999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 898 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
|...+.......+..+. .+......+..+.+||.+||..+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 214 YPALNNQEVLQHVTAGG-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred CcccCHHHHHHHHhcCC-ccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 98877766665554332 22333446788999999999999999999443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=306.53 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=207.5
Q ss_pred CccccccccccCcEEEEEEEEcC-CCeEEEEEEeecccc-------cChHHHHHHHHHHHHHHh-CCCCCcceeEEEEee
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM-------LNRNKVHRACAEREILDM-LDHPFVPALYASFQT 740 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~-~~~~~avK~~~~~~~-------~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~ 740 (1002)
.|++.+.||+|+||.||++.+.. +++.+|+|.+..... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999977 678999998864321 122344567788888865 799999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecCCcEEEEeccC
Q 001865 741 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~g~vkL~DFG~ 817 (1002)
++..|+||||+++++|.+++.. .....+++..++.++.|++.||.|||+ .||+|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998753 223568999999999999999999996 6899999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~P 897 (1002)
+....... ......|+..|+|||++.+..++.++|+||||+++|+|++|+.|
T Consensus 161 ~~~~~~~~----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQPES----------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccccc----------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 85432110 11234688999999999988889999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcH
Q 001865 898 FRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a 949 (1002)
|...........+.............+..+.+||.+||+.||++||++.+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~ 264 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264 (269)
T ss_pred ccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHH
Confidence 9887776666666555443323335678999999999999999999944443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.72 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=205.4
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
+...+|+..+.||+|+||.||++.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345689999999999999999999877775 57888876432 233344678899999999999999999988754
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..++++||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+|+||||+||+++.++.+||+|||++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4689999999999999987642 35889999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~ 900 (1002)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 160 ~~~~~~-------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEKE-------------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcccc-------------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 311100 01112346778999999998889999999999999999997 9999987
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
....... .+......++....++..+.+++.+||..+|++||++.+++..
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 215 IPTREIP-DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCHHHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6654443 3444444444445567889999999999999999995554443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=306.08 Aligned_cols=245 Identities=21% Similarity=0.315 Sum_probs=190.9
Q ss_pred ccccccCcEEEEEEEEcC--CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccC
Q 001865 675 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~--~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 752 (1002)
+.||+|+||.||++.... ....+|+|.+.... .......+.+|+.+++.++||||+++++++...+..|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997533 34578888776432 23344567889999999999999999999999999999999999
Q ss_pred CCchhHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 753 GGELFLLLDRQPT---KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 753 ggsL~~~l~~~~~---~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
+++|.+++..... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999999976432 2356788899999999999999999999999999999999999999999999854221100
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~~~~~sDIwSlGvil~ellt-G~~Pf~~~ 901 (1002)
........+++.|+|||++.. ..++.++|||||||++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 156 ----------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ----------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 001123346778999999743 356779999999999999998 88999888
Q ss_pred ChHHHHHHHHhC-CCCCCC---CCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 902 TRQKTFANILHK-DLKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 902 ~~~~~~~~i~~~-~~~~~~---~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
...+....+... ...++. ....+..+.+++..|+ .||++||++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence 776666655443 222222 2246777888999998 59999999433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=303.23 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=196.1
Q ss_pred ccccccCcEEEEEEEEcC---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe-eCCeEEEEEec
Q 001865 675 KPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ-TKTHVCLITDY 750 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lV~E~ 750 (1002)
+.||+|+||.||+|.+.. .+..+|+|.+... ........+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998743 3467999987542 23445677888999999999999999999765 56678999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+.+++|.+++.... ..++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 99999999997643 34677888899999999999999999999999999999999999999999998643211100
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChHHHHHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 909 (1002)
.........+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+.......
T Consensus 155 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 214 (262)
T cd05058 155 --------------------SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY 214 (262)
T ss_pred --------------------eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 0011122346778999999988889999999999999999999 5677877776666655
Q ss_pred HHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 910 i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
+..+. ..+.....+..+.+++.+||..+|++||+ +.+++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~il 253 (262)
T cd05058 215 LLQGR-RLLQPEYCPDPLYEVMLSCWHPKPEMRPT----FSELV 253 (262)
T ss_pred HhcCC-CCCCCCcCCHHHHHHHHHHcCCChhhCCC----HHHHH
Confidence 55442 22223345778999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=308.27 Aligned_cols=257 Identities=23% Similarity=0.339 Sum_probs=205.7
Q ss_pred cCCccccccccccCcEEEEEEEEc----CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee--C
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELC----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--K 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~ 741 (1002)
...|++.+.||+|+||.||++... .++..+|+|+++..... .....+.+|+.+++.+.|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 457899999999999999999864 34789999999765321 356778999999999999999999999877 5
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
...|+||||+++++|.+++.... ..++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 68999999999999999997653 35899999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
...... ........++..|++||.+.+..++.++|||||||++|+|++|..||...
T Consensus 160 ~~~~~~------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 160 PEDKDY------------------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccCCcc------------------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 311100 00011123556799999998888999999999999999999999998654
Q ss_pred ChH--------------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 902 TRQ--------------KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 902 ~~~--------------~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
... ......+......+....++..+.+|+.+||..+|.+||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05038 216 PAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279 (284)
T ss_pred cchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 221 12223334444455455567889999999999999999995444433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=304.95 Aligned_cols=239 Identities=21% Similarity=0.299 Sum_probs=189.8
Q ss_pred ccccccCcEEEEEEEEcC------------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC
Q 001865 675 KPLGSGDTGSVHLVELCG------------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~------------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 742 (1002)
+.||+|+||.||++.... ....+++|++... .......+..|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998532 2336888887643 2334456788899999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc-------EEEEec
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH-------VSLTDF 815 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~-------vkL~DF 815 (1002)
..++||||+++++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999888654 245899999999999999999999999999999999999987664 899999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-CCCCCChhhHHHHHHHHHHHH-c
Q 001865 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEML-Y 893 (1002)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~~~~~sDIwSlGvil~ell-t 893 (1002)
|++..... .....|+..|+|||++. +..++.++|||||||++|+|+ .
T Consensus 157 g~~~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 157 GIPITVLS-------------------------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CCCccccC-------------------------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 98844211 11235788999999986 466888999999999999998 5
Q ss_pred CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 894 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
|..||......+.. .+...... ...+.+.++.+||.+||+.||.+||+ +.+|+++
T Consensus 206 ~~~p~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 206 GEIPLKDKTLAEKE-RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred CCCCCCCcchhHHH-HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcC----HHHHHHh
Confidence 89998776544332 22332222 22234578899999999999999999 6676653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=304.76 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=192.1
Q ss_pred ccccccCcEEEEEEEEc--CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccC
Q 001865 675 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 752 (1002)
+.||+|+||.||++... .++..+|+|.++... .......+.+|+.+++.++||||+++++++.....+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 345689999887542 22333567889999999999999999999999999999999999
Q ss_pred CCchhHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCC
Q 001865 753 GGELFLLLDRQP---TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829 (1002)
Q Consensus 753 ggsL~~~l~~~~---~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 829 (1002)
+++|.+++.... ....+...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999999987532 22466778889999999999999999999999999999999999999999999853221100
Q ss_pred CcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-------CCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 001865 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (1002)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-------~~~~~sDIwSlGvil~ellt-G~~Pf~~~ 901 (1002)
........|++.|+|||++.+. .++.++||||||+++|+|++ |..||...
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 156 ----------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ----------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 0112234678899999998642 35779999999999999996 99999877
Q ss_pred ChHHHHHHHHh-CCCCCCCC---CCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 902 TRQKTFANILH-KDLKFPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 902 ~~~~~~~~i~~-~~~~~~~~---~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
...+....... .....+.. ...+..+.+++.+|+ .+|++||| +++|+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt----~~~l~ 264 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPS----AEEVH 264 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCC----HHHHH
Confidence 66555443332 22222221 235678899999998 68999999 55554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=284.56 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=209.1
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeC--Ce
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK--TH 743 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~ 743 (1002)
+.++|++++.+|+|.||.||.+....++.+++||++++ ...+.+.+|+.||+.| +||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 35799999999999999999999999999999999874 4567899999999999 599999999998754 56
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-~g~vkL~DFG~a~~~~ 822 (1002)
..+|+||+.+.+...+... ++...++.++.+|+.||.|+|++||+|||+||.|+|++. ...++|+|+|+|..+.
T Consensus 110 paLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred chhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 7899999999998888754 889999999999999999999999999999999999995 4579999999997653
Q ss_pred CCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCCCCC-C
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFR-G 900 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~Pf~-~ 900 (1002)
+. ...+..+.+..|--||.+.. ..|+.+-|+|||||++..|++.+.||. |
T Consensus 185 p~----------------------------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG 236 (338)
T KOG0668|consen 185 PG----------------------------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 236 (338)
T ss_pred CC----------------------------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence 21 12233467788999999865 457889999999999999999888875 4
Q ss_pred CChHHHHHHHHh-------------CCCC----------------CC-----CC-CCCCHHHHHHHHHccccCcCCCCCC
Q 001865 901 KTRQKTFANILH-------------KDLK----------------FP-----SS-TPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 901 ~~~~~~~~~i~~-------------~~~~----------------~~-----~~-~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
.++.+.+-+|.+ -.+. |. .. .-.++++.+||.++|.+|..+|+|
T Consensus 237 ~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT- 315 (338)
T KOG0668|consen 237 HDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT- 315 (338)
T ss_pred CCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc-
Confidence 455544444422 0111 11 11 124689999999999999999999
Q ss_pred hhcHHHHHcCCCcCCCChh
Q 001865 946 HEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 946 ~~~a~elL~Hp~f~~~~~~ 964 (1002)
|.|++.||||..+--+
T Consensus 316 ---akEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 316 ---AKEAMAHPYFAPVREA 331 (338)
T ss_pred ---hHHHhcCchHHHHHHH
Confidence 9999999999975433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=297.30 Aligned_cols=263 Identities=24% Similarity=0.365 Sum_probs=215.3
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHH-HHhCCCCCcceeEEEEeeCCe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-LDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~~~~ 743 (1002)
.+..++.+-+..||.|+||+|++..++.+|+..|||.++.... .....++..|.+. ++.-++||||++|+....++.
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 3556677888899999999999999999999999999987533 3344566677765 555689999999999999999
Q ss_pred EEEEEeccCCCchhHHHhh---CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 744 VCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~---~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
-||.||+| ..+|..+.+. .....+++..+-.|..-.+.||.||-.. +|||||+||+|||++..|.+||||||.+.
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 99999999 7888766553 2235699999999999999999999865 89999999999999999999999999985
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC--CCCCChhhHHHHHHHHHHHHcCCCC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~~~~~sDIwSlGvil~elltG~~P 897 (1002)
.+.. +...+...|...|||||.+.. ..|+.+||+||||++|||+.||.+|
T Consensus 217 qLv~----------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP 268 (361)
T KOG1006|consen 217 QLVD----------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP 268 (361)
T ss_pred hHHH----------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence 4321 112234578899999999843 4588899999999999999999999
Q ss_pred CCCCC-hHHHHHHHHhCCCCCCCC----CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 898 FRGKT-RQKTFANILHKDLKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 898 f~~~~-~~~~~~~i~~~~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
|.+-+ ..+.+..+..+..+.... ...+..+..||.-||.+|-+.||. +.+|+++||++-..
T Consensus 269 yr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 269 YRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK----YDDLKKFPFYRMYA 334 (361)
T ss_pred cchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc----hhhhhcCchhhhhh
Confidence 98854 456667777776553322 236788999999999999999999 99999999998743
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=305.64 Aligned_cols=238 Identities=19% Similarity=0.295 Sum_probs=188.8
Q ss_pred cccccCcEEEEEEEEcCC------------------------CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCc
Q 001865 676 PLGSGDTGSVHLVELCGS------------------------GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFV 731 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~------------------------~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI 731 (1002)
.||+|+||.||++....+ ...+++|++... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 689999999999975322 235888987643 22334567888999999999999
Q ss_pred ceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---
Q 001865 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG--- 808 (1002)
Q Consensus 732 v~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g--- 808 (1002)
+++++++..++..|+||||+++++|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999988653 34589999999999999999999999999999999999998644
Q ss_pred ----cEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHH
Q 001865 809 ----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWA 883 (1002)
Q Consensus 809 ----~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwS 883 (1002)
.+||+|||++..... .....++..|+|||.+.+ ..++.++||||
T Consensus 158 ~~~~~~kl~d~g~~~~~~~-------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~s 206 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS-------------------------------REERVERIPWIAPECVPGGNSLSTAADKWS 206 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------ccccccCCcccCchhhcCCCCCCcHHHHHH
Confidence 489999998743210 011246788999999865 56788999999
Q ss_pred HHHHHHHHH-cCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 884 LGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 884 lGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
|||++|+|+ +|..||.+....+... ........+. ..+..+.+||.+||+.+|++||+ +.++|++
T Consensus 207 lG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERTPSEKER-FYEKKHRLPE--PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred HHHHHHHHHhCCCCCccccChHHHHH-HHHhccCCCC--CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 999999985 7999998766544332 2333223332 24567899999999999999999 6777653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=304.26 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=201.7
Q ss_pred ccccccccccCcEEEEEEEEc---CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----
Q 001865 671 FRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~---~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 742 (1002)
|++.+.||+|+||.||+|.+. .++..+|||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 357899999997643 33445677889999999999999999999886432
Q ss_pred -eEEEEEeccCCCchhHHHhhC----CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001865 743 -HVCLITDYCPGGELFLLLDRQ----PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 743 -~~~lV~E~~~ggsL~~~l~~~----~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~ 817 (1002)
..+++++|+.+++|.+++... ....++...++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 357899999999998887432 112578999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYT 896 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~ 896 (1002)
+........ ........+++.|++||.+....++.++|||||||++|+|++ |++
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCcc-------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 865421110 001112345678999999988888999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 897 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
||.+.+.......+.... ........+..+.+|+.+||..+|++||+ +.+++
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rps----~~~~~ 266 (273)
T cd05074 215 PYAGVENSEIYNYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPS----FQHLR 266 (273)
T ss_pred CCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHH
Confidence 998877766665555432 22223346788999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=298.99 Aligned_cols=264 Identities=25% Similarity=0.469 Sum_probs=216.9
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------ 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------ 741 (1002)
..+|.-++.+|.|+- .|..|.|.-.++.+|+|.+... ........+..+|..++..+.|+||++++.+|...
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 458999999999998 7888999899999999998776 44455567788999999999999999999999643
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|+|||+| ..+|...+.- .+....+..++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+.-
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 4689999999 8889888863 2888999999999999999999999999999999999999999999999999543
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... -.-+.++.|..|.|||++.+..+...+||||+||++.||+.|+..|.|.
T Consensus 169 ~~~----------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 169 DTD----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred Ccc----------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 211 1223467899999999999999999999999999999999999999987
Q ss_pred ChHHHHHHHHhCC---------------------------C----CCCC---------CCCCCHHHHHHHHHccccCcCC
Q 001865 902 TRQKTFANILHKD---------------------------L----KFPS---------STPTSLHAKQLMYRLLHRDPKS 941 (1002)
Q Consensus 902 ~~~~~~~~i~~~~---------------------------~----~~~~---------~~~~s~~~~~Ll~~~L~~dP~~ 941 (1002)
+....+.++...- . .+|+ .......+.+|+.+||..||++
T Consensus 221 d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 221 DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhh
Confidence 7766665554310 0 0111 1122346789999999999999
Q ss_pred CCCChhcHHHHHcCCCcCCCChhhhhccCCC
Q 001865 942 RLGSHEGANEIKKHPFFKGVNWALVRCMNPP 972 (1002)
Q Consensus 942 Rpt~~~~a~elL~Hp~f~~~~~~~~~~~~~~ 972 (1002)
|++ ++++|+||||+ -|-.-...+.|
T Consensus 301 Ris----v~daL~HPY~~--vw~~~~ev~ap 325 (369)
T KOG0665|consen 301 RIS----VDDALRHPYIK--VWYDPDEVEAP 325 (369)
T ss_pred ccc----HHHHhcCCeee--eecccccccCC
Confidence 999 99999999999 35433443444
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.15 Aligned_cols=142 Identities=29% Similarity=0.435 Sum_probs=125.4
Q ss_pred hcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-----C---CC
Q 001865 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----H---PF 730 (1002)
Q Consensus 659 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---pn 730 (1002)
.+..|..++.++|.+.++||+|-|++||+|+|..+.++||+|+++.. ....+....||.+|+++. | .+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 34567778889999999999999999999999999999999999864 334456678999999882 2 48
Q ss_pred cceeEEEEe----eCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEe
Q 001865 731 VPALYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQ 805 (1002)
Q Consensus 731 Iv~l~~~~~----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~ 805 (1002)
||+|++.|. .+.++|||+|++ |.+|..++.....+-++...++.|++|||.||.|||.. ||||.||||+|||+.
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999997 456999999999 99999999988778899999999999999999999975 999999999999994
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=326.51 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=223.1
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEe-----eC
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQ-----TK 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-----~~ 741 (1002)
.+.|++...||.|.+|.||+++.+.+++..|+|+...... .-..+..|.+||+.+ +|||++.+|++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 4678999999999999999999999999999999876532 224667788999888 7999999999986 35
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
+.+|||||||.||+..++++.-.+..+.+..+..|++.++.||.+||.+.+||||||-.|||++.+|.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 78999999999999999998766788999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-----CCCChhhHHHHHHHHHHHHcCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYGYT 896 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----~~~~~sDIwSlGvil~elltG~~ 896 (1002)
. ......++.+|||.|||||++... .|+..+|+||||++..||.-|.+
T Consensus 174 d---------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~P 226 (953)
T KOG0587|consen 174 D---------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAP 226 (953)
T ss_pred e---------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCC
Confidence 3 223445678999999999999543 46679999999999999999999
Q ss_pred CCCCCChHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 897 PFRGKTRQKTFANILHKDLK-FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~~~-~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
|+....+...+-.|-+...+ +..+...+.++.+||..||.+|-.+||+ ..++|+|||++.-
T Consensus 227 Pl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 227 PLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS----TEELLKHPFITEQ 288 (953)
T ss_pred CccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc----hhhhccCCccccc
Confidence 99988887766666554332 2234456788999999999999999999 9999999999953
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=307.53 Aligned_cols=259 Identities=16% Similarity=0.171 Sum_probs=191.3
Q ss_pred cccCCccccccccccCcEEEEEEEEcCC---CeEEEEEEeecccccChHH--------HHHHHHHHHHHHhCCCCCccee
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNK--------VHRACAEREILDMLDHPFVPAL 734 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~~avK~~~~~~~~~~~~--------~~~~~~E~~il~~l~hpnIv~l 734 (1002)
+..++|++.+.||+|+||.||+|.+..+ +..+|+|+........... ......+...+..++|++++.+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4457899999999999999999999777 6778888654321110000 0111223344556789999999
Q ss_pred EEEEeeCC----eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcE
Q 001865 735 YASFQTKT----HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 810 (1002)
Q Consensus 735 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~v 810 (1002)
++++.... +.+++++++ ..++.+++... ...++..++.++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred EEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 98765443 457899988 56777777653 336788899999999999999999999999999999999999999
Q ss_pred EEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHH
Q 001865 811 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890 (1002)
Q Consensus 811 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~e 890 (1002)
+|+|||+|.......... ...........||+.|+|||++.+..++.++|||||||++|+
T Consensus 166 ~l~DFGla~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHI--------------------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred EEEEcCCceeeccCCccc--------------------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999996653211100 000111233579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCh-HHH--------HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 891 MLYGYTPFRGKTR-QKT--------FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 891 lltG~~Pf~~~~~-~~~--------~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
|++|..||.+... ... +..+..+.... ..++..+.+++..|+..+|++||+ +++|++
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 9999999987632 221 12222222222 235678999999999999999999 666653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=301.58 Aligned_cols=236 Identities=19% Similarity=0.260 Sum_probs=190.1
Q ss_pred ccccccCcEEEEEEEEcCCC----------eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 675 KPLGSGDTGSVHLVELCGSG----------QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~----------~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
+.||+|+||.||++.+..++ ..+++|.+.... .....+.+|+.+++.++||||+++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998776 357888776432 115678889999999999999999999888 778
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-------cEEEEeccC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-------HVSLTDFDL 817 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g-------~vkL~DFG~ 817 (1002)
|+||||+++++|.+++..... .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999999986532 589999999999999999999999999999999999999887 799999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC--CCCChhhHHHHHHHHHHHHc-C
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLY-G 894 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~~~~sDIwSlGvil~ellt-G 894 (1002)
+..... .....++..|+|||++.+. .++.++|||||||++|+|++ |
T Consensus 155 a~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~ 203 (259)
T cd05037 155 PITVLS-------------------------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203 (259)
T ss_pred cccccc-------------------------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence 854321 1123467789999999876 78889999999999999998 6
Q ss_pred CCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHc
Q 001865 895 YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~ 954 (1002)
..||...+......... .....+. .....+.+||.+||..+|.+||+ +.++++
T Consensus 204 ~~p~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 204 EEPLSTLSSSEKERFYQ-DQHRLPM--PDCAELANLINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred CCCcccCCchhHHHHHh-cCCCCCC--CCchHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 88887765433332222 2211221 22368899999999999999999 666553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.34 Aligned_cols=257 Identities=27% Similarity=0.402 Sum_probs=212.7
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC------CCcceeEEEEe
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH------PFVPALYASFQ 739 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h------pnIv~l~~~~~ 739 (1002)
+..++|.+....|.|-||+|..|.+...|..||||+++... ...+.-+.|++||++|+. -|++.++..|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 44689999999999999999999999999999999998642 233445679999999953 48999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccC
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDL 817 (1002)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~-~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~-g~vkL~DFG~ 817 (1002)
..+++|||+|-+ .-+|.++|++- ....|....++.|+.||..||..|-..||+|.||||+|||++.+ ..+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 999999999999 88999999863 23458889999999999999999999999999999999999965 4699999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~P 897 (1002)
|...+.. ..+.+..+..|.|||++.|.+|++..|+||+||+||||+||+..
T Consensus 584 A~~~~en-----------------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASEN-----------------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ccccccc-----------------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 8543321 11234556789999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHHhCCCCCCC---------------------------------------------------CCCC---
Q 001865 898 FRGKTRQKTFANILHKDLKFPS---------------------------------------------------STPT--- 923 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~~~~~---------------------------------------------------~~~~--- 923 (1002)
|+|.++..+++..+.-.-++|. ...+
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 9999888877755442111110 0001
Q ss_pred ----CHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 924 ----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 924 ----s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
-..+.+||.+||..||++|+| ++|+|+||||+.
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCC----HHHHhcCCcccC
Confidence 124678999999999999999 999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=293.21 Aligned_cols=265 Identities=25% Similarity=0.367 Sum_probs=214.1
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe------
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ------ 739 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------ 739 (1002)
...+.|.-+..||+|.||.||+|+.+.+|+.||+|.+--... .........+|+.+|..|+|+|++.+++.+.
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 346789999999999999999999999999999986532111 1122345578999999999999999988764
Q ss_pred --eCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001865 740 --TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 740 --~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~ 817 (1002)
+...+|+||.+| ..+|..++... ...++..+++.++.++..||.|+|.+.|+|||+||.|+||+.+|.+||+|||+
T Consensus 93 ~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 93 NRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 234699999999 67888888653 35699999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYT 896 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~ 896 (1002)
++.++......-+ ..+..+.|+.|++||.+.+. .|+++.|||..|||+.+|.++.+
T Consensus 171 ar~fs~~~n~~kp-----------------------rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 171 ARAFSTSKNVVKP-----------------------RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred ccceecccccCCC-----------------------CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 9776544332211 12345779999999999875 58899999999999999999999
Q ss_pred CCCCCChHHHHHHHHh--CCCC---CCCC----------------------------CCCCHHHHHHHHHccccCcCCCC
Q 001865 897 PFRGKTRQKTFANILH--KDLK---FPSS----------------------------TPTSLHAKQLMYRLLHRDPKSRL 943 (1002)
Q Consensus 897 Pf~~~~~~~~~~~i~~--~~~~---~~~~----------------------------~~~s~~~~~Ll~~~L~~dP~~Rp 943 (1002)
-|.+.+....+..|.. +.+. ||.. -.-++++.+|+.+||.+||.+|+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 9999988877776643 2111 1110 01234677999999999999999
Q ss_pred CChhcHHHHHcCCCcCC
Q 001865 944 GSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 944 t~~~~a~elL~Hp~f~~ 960 (1002)
+ +.++|+|.||..
T Consensus 308 ~----ad~alnh~~F~k 320 (376)
T KOG0669|consen 308 D----ADQALNHDFFWK 320 (376)
T ss_pred c----hHhhhchhhhhc
Confidence 9 999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=310.17 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=222.5
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 662 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 741 (1002)
..|.+...+.....+||.|.||.||.+.++...-.+|||.++.+. -.++.|..|+.+|+.++|||+|+++++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 456677788889999999999999999999989999999998653 3578899999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCccc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~ 821 (1002)
..+|||+|||..|+|.+||.......++.-.+..++.||..|+.||..+++|||||...|+|+..+..||+.|||+++.+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999999766666888888899999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~ 900 (1002)
..+.. ..+..---...|.|||.|.-..++.++|||+|||+|||+.| |-.||+|
T Consensus 416 tgDTY--------------------------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 416 TGDTY--------------------------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cCCce--------------------------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 53321 11111123567999999999999999999999999999996 9999999
Q ss_pred CChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
.+...++. ++...+.......|++...+|+..||+++|..||++.+
T Consensus 470 idlSqVY~-LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFae 515 (1157)
T KOG4278|consen 470 IDLSQVYG-LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAE 515 (1157)
T ss_pred ccHHHHHH-HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHH
Confidence 98777664 55555666666778999999999999999999999765
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=298.95 Aligned_cols=247 Identities=18% Similarity=0.301 Sum_probs=191.9
Q ss_pred ccccccCcEEEEEEEEcCC--CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccC
Q 001865 675 KPLGSGDTGSVHLVELCGS--GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~--~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ 752 (1002)
+.||+|+||.||++..... ...+++|.++... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3589999999999976433 3356677765432 23345678899999999999999999999999999999999999
Q ss_pred CCchhHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 753 GGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 753 ggsL~~~l~~~~--~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+++|.+++.... ...++...++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999999997532 23467778889999999999999999999999999999999999999999998743211100
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccccC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-------AGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~ 902 (1002)
.......+|++.|+|||++.. ..++.++|||||||++|+|++ |..||...+
T Consensus 155 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 155 ---------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred ---------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 011123568899999999853 235678999999999999996 678998877
Q ss_pred hHHHHHHHHhCC-CCCCC---CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 903 RQKTFANILHKD-LKFPS---STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 903 ~~~~~~~i~~~~-~~~~~---~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
..+.+..+..+. ...+. ....+..+.+++..|| .+|++||+ +.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~----~~~i~ 263 (268)
T cd05086 214 DREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRAT----AEEVH 263 (268)
T ss_pred HHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCC----HHHHH
Confidence 777666655432 22211 2346778899999999 68999999 66654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=314.50 Aligned_cols=259 Identities=21% Similarity=0.290 Sum_probs=221.1
Q ss_pred ccCCccccccccccCcEEEEEEEEcCC-C--eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGS-G--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-~--~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
.....++.+.||+|.||+|+++.|... | ..||||+++...... ....|.+|+.+|-+|+|+|+++||++..+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 345677889999999999999998544 3 368999998765432 67889999999999999999999999887 67
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
+.||||+++.|+|.+.|.+.....|....+..|+.||+.|+.||.+++.|||||...|||+-.-..|||+|||+.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 88999999999999999986677899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~ 902 (1002)
..... ......--...|+|||.|....++.++|+|++||+||||++ |..||.|-.
T Consensus 265 ned~Y------------------------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 265 NEDMY------------------------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred CCcce------------------------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 33211 11112234567999999999999999999999999999996 999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHH
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL 953 (1002)
...++++|- ..-.++....|+..+.+++..||..+|..||||..+.++.+
T Consensus 321 g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 321 GIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred HHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 999888887 55567777789999999999999999999999765544443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=318.72 Aligned_cols=245 Identities=31% Similarity=0.446 Sum_probs=196.5
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeC------C
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK------T 742 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~ 742 (1002)
.-|...+.||.|+||.||+++++.+|+.+|||.+++.. .....+...+|+++|++++|+|||+++++-++. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 45677788999999999999999999999999998754 455667889999999999999999999886543 3
Q ss_pred eEEEEEeccCCCchhHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec--CC--cEEEEeccC
Q 001865 743 HVCLITDYCPGGELFLLLDRQP-TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NG--HVSLTDFDL 817 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~-~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~--~g--~vkL~DFG~ 817 (1002)
...+|||||.||+|..+++.-. ...|++..++.++..+..||.|||++|||||||||.||++-. +| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 5789999999999999998521 235999999999999999999999999999999999999863 34 379999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-CCCCChhhHHHHHHHHHHHHcCCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYT 896 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~~~~sDIwSlGvil~elltG~~ 896 (1002)
|+..+.. ....+++||+.|.+||++.. ..|+..+|.|||||++|+++||..
T Consensus 171 Arel~d~----------------------------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l 222 (732)
T KOG4250|consen 171 ARELDDN----------------------------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL 222 (732)
T ss_pred cccCCCC----------------------------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence 9776532 13457899999999999984 788889999999999999999999
Q ss_pred CCCCCC----hHHHHHHHHhC---------------CC----CCCCCCCCCHH----HHHHHHHccccCcCCCC
Q 001865 897 PFRGKT----RQKTFANILHK---------------DL----KFPSSTPTSLH----AKQLMYRLLHRDPKSRL 943 (1002)
Q Consensus 897 Pf~~~~----~~~~~~~i~~~---------------~~----~~~~~~~~s~~----~~~Ll~~~L~~dP~~Rp 943 (1002)
||-..- ..++...+..+ .+ .+|.+...+.. +-..|..+|..+|.+|-
T Consensus 223 PF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 223 PFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 995422 22233333221 11 12222223332 34678899999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=328.82 Aligned_cols=263 Identities=17% Similarity=0.216 Sum_probs=182.0
Q ss_pred cccCCccccccccccCcEEEEEEEEcCC----CeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEE----
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGS----GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS---- 737 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~----~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~---- 737 (1002)
+..++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... .......+ .++...+.+++.+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3467999999999999999999999888 8999999876421 11111111 1222222222222211
Q ss_pred --EeeCCeEEEEEeccCCCchhHHHhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHHcCcccCCC
Q 001865 738 --FQTKTHVCLITDYCPGGELFLLLDRQPTK------------------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797 (1002)
Q Consensus 738 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~------------------~l~~~~i~~i~~qil~aL~~LH~~gIiHrDL 797 (1002)
.......++||||+.+++|.+++...... ......+..++.||+.||+|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24567899999999999999998753211 1123456789999999999999999999999
Q ss_pred CCCcEEEec-CCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC--
Q 001865 798 KPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-- 874 (1002)
Q Consensus 798 KP~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-- 874 (1002)
||+|||++. ++.+||+|||+|..+.... .......+||+.|+|||.+....
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~--------------------------~~~~~~~~~t~~Y~APE~~~~~~~~ 335 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI--------------------------NYIPKEFLLDPRYAAPEQYIMSTQT 335 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc--------------------------ccCCcccccCCCccChHHhhccCCC
Confidence 999999985 6899999999996532110 01123467899999999764322
Q ss_pred --------------------CCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHh-CCCCC----------------
Q 001865 875 --------------------HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH-KDLKF---------------- 917 (1002)
Q Consensus 875 --------------------~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~-~~~~~---------------- 917 (1002)
++.++|||||||++|+|+++..|+.. ....+...+. ....+
T Consensus 336 ~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 413 (566)
T PLN03225 336 PSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLR 413 (566)
T ss_pred CCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhh
Confidence 23456999999999999997766532 2222222211 11100
Q ss_pred ---CCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhh
Q 001865 918 ---PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 967 (1002)
Q Consensus 918 ---~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 967 (1002)
.........+++||.+||++||.+||| +.++|+||||++..+..+.
T Consensus 414 ~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t----a~e~L~Hpff~~~~~~~~~ 462 (566)
T PLN03225 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRIS----AKAALAHPYFDREGLLGLS 462 (566)
T ss_pred hhhhhccccchHHHHHHHHHccCCcccCCC----HHHHhCCcCcCCCCccccc
Confidence 000112334568999999999999999 9999999999997776443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=306.88 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=213.5
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCC--C--eEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEee
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGS--G--QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~--~--~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 740 (1002)
.+......+.+.||.|.||.||++....- | --||||.-+.+. ++...+.|..|..+|++++||||++++|++.+
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34455667778899999999999986332 2 358888877653 45567899999999999999999999999987
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
. .+|||||+++-|.|..|++.+. ..++...+..|+.||..||+|||+.+.|||||...|||+.+..-|||+|||+++.
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 4 5899999999999999998874 5699999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~ 899 (1002)
+..+.. ...+...-...|||||.+.-..++.+||||.|||++||+++ |.-||.
T Consensus 541 ~ed~~y--------------------------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 541 LEDDAY--------------------------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred ccccch--------------------------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 753321 11122234668999999999999999999999999999985 999999
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
+-.+.+++-.+.++ -.+|.++.|++.+..|+.+||.++|.+||.+.+.
T Consensus 595 gvkNsDVI~~iEnG-eRlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 595 GVKNSDVIGHIENG-ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred cccccceEEEecCC-CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 98887777666554 3566677789999999999999999999998753
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=303.89 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=211.6
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 744 (1002)
.+..+...++++||+|.||.|.+|.. ..+.+||+|.++... .......|..|+++|.+|+||||+.+++++..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 35567889999999999999999997 336899999998764 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+|||||++|+|.+++.......+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++.+...
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999999998764444455666779999999999999999999999999999999999999999999754422
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH--cCCCCCCCCC
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML--YGYTPFRGKT 902 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ell--tG~~Pf~~~~ 902 (1002)
+. .+.....+-...|||+|.+..+.++.+||+|+||+++||++ +..-||...+
T Consensus 691 ~y-------------------------y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt 745 (807)
T KOG1094|consen 691 DY-------------------------YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT 745 (807)
T ss_pred Cc-------------------------eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence 11 11223446678999999999999999999999999999987 5788999888
Q ss_pred hHHHHHHHHhC---C---CCCCCCCCCCHHHHHHHHHccccCcCCCCCC
Q 001865 903 RQKTFANILHK---D---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 903 ~~~~~~~i~~~---~---~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
+...+.+.-.- . .-++.+.-++..+.+||.+||.++-.+||++
T Consensus 746 ~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF 794 (807)
T KOG1094|consen 746 DEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSF 794 (807)
T ss_pred HHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence 88777665321 1 1123344578889999999999999999994
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=288.00 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=213.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCC-----eE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT-----HV 744 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~ 744 (1002)
+.+-.+.||.|+||+||.+.|..+|+.||+|.+..- +..-...+++.+|+.+|...+|.||+..+++.+..+ .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 455668899999999999999999999999988542 445566788999999999999999999998876543 57
Q ss_pred EEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCC
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 745 ~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~ 824 (1002)
|+++|+| ..+|...+-. ...++.++++-++.||+.||+|||+.||.||||||.|+|+++|..+||||||+++....+
T Consensus 133 YV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8999999 7788877744 345999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCh
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~ 903 (1002)
... ..+..+-|-+|+|||.+.|. .|+.+.||||.|||+.||+..+..|...++
T Consensus 210 ~~~--------------------------hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 210 DRL--------------------------NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hhh--------------------------hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 211 12334678899999999886 578899999999999999999999988776
Q ss_pred HHHHHHHHh-----------------------CCCCCCCCC---------CCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 904 QKTFANILH-----------------------KDLKFPSST---------PTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 904 ~~~~~~i~~-----------------------~~~~~~~~~---------~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
.+.+..|.. +....|... ....+...++.+||..||++|++ ..+
T Consensus 264 iqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~ 339 (449)
T KOG0664|consen 264 IEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEE 339 (449)
T ss_pred HHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhh
Confidence 655554422 222222221 12335678999999999999999 999
Q ss_pred HHcCCCcCCCChhhh
Q 001865 952 IKKHPFFKGVNWALV 966 (1002)
Q Consensus 952 lL~Hp~f~~~~~~~~ 966 (1002)
++.|+|+...-+.-+
T Consensus 340 A~~~~~~~e~R~r~~ 354 (449)
T KOG0664|consen 340 ALQHRYLEEGRLRFH 354 (449)
T ss_pred hcccccccccceeee
Confidence 999999987555444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=309.98 Aligned_cols=266 Identities=18% Similarity=0.203 Sum_probs=192.4
Q ss_pred ccccCCccccccccccCcEEEEEEEEc----------------CCCeEEEEEEeecccccChH-----------HHHHHH
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELC----------------GSGQYFAMKAMDKGVMLNRN-----------KVHRAC 717 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~----------------~~~~~~avK~~~~~~~~~~~-----------~~~~~~ 717 (1002)
.+..++|.+.++||+|+||+||++.+. ..++.||||.+......... ..+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 356789999999999999999999752 23567999998643211000 011233
Q ss_pred HHHHHHHhCCCCC-----cceeEEEEee--------CCeEEEEEeccCCCchhHHHhhCC--------------------
Q 001865 718 AEREILDMLDHPF-----VPALYASFQT--------KTHVCLITDYCPGGELFLLLDRQP-------------------- 764 (1002)
Q Consensus 718 ~E~~il~~l~hpn-----Iv~l~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~-------------------- 764 (1002)
.|+.++.++.|.+ ++.++++|.. .+..|+||||+.+++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 4666777776654 3666666642 356899999999999999886421
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCC
Q 001865 765 --TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842 (1002)
Q Consensus 765 --~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~ 842 (1002)
...++...++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++........
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---------------- 364 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---------------- 364 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc----------------
Confidence 11245678899999999999999999999999999999999999999999999854321100
Q ss_pred CCCcccccccccccccccCCcccccccccCCCC--------------------C--ChhhHHHHHHHHHHHHcCCC-CCC
Q 001865 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH--------------------T--SAVDWWALGILLYEMLYGYT-PFR 899 (1002)
Q Consensus 843 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~--------------------~--~~sDIwSlGvil~elltG~~-Pf~ 899 (1002)
.......+|+.|+|||.+..... + .+.||||+||++|+|++|.+ ||.
T Consensus 365 ----------~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 365 ----------FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred ----------cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 00112245889999999854321 1 24699999999999999886 775
Q ss_pred CCC-----------hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCc---CCCCCChhcHHHHHcCCCcCC
Q 001865 900 GKT-----------RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDP---KSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 900 ~~~-----------~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP---~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
+.. ....++.+......++.....+..+++|+.+||..+| .+|+| +.|+|+||||..
T Consensus 435 ~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~~ 505 (507)
T PLN03224 435 NIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLS----VGQALSHRFFLP 505 (507)
T ss_pred chhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcCC
Confidence 421 1112222333445566566678899999999999876 68999 999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-31 Score=282.70 Aligned_cols=242 Identities=43% Similarity=0.719 Sum_probs=203.9
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCchhHHH
Q 001865 681 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 760 (1002)
Q Consensus 681 ~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l 760 (1002)
+||.||++.+..+++.+|+|++........ ...+.+|+.++++++|+||+++++++......+++|||+.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999988899999999976532221 578889999999999999999999999999999999999888999998
Q ss_pred hhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhccc
Q 001865 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840 (1002)
Q Consensus 761 ~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~ 840 (1002)
..... ++...+..++.+++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred HhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 76432 8999999999999999999999999999999999999999999999999986543211
Q ss_pred CCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CChHHHHHHHHhCCCCCCC
Q 001865 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANILHKDLKFPS 919 (1002)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~ 919 (1002)
......++..|++||.+.+..++.++||||||+++|+|++|..||.. .........+.........
T Consensus 142 -------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 208 (244)
T smart00220 142 -------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 208 (244)
T ss_pred -------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc
Confidence 12234688899999999888889999999999999999999999987 4444444444433333322
Q ss_pred CCC-CCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 920 STP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 920 ~~~-~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
... .+..+.+++.+||..+|++||+ +.++++||||
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~~~~~~~ 244 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLT----AEEALQHPFF 244 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccC----HHHHhhCCCC
Confidence 222 6788999999999999999999 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=312.62 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=224.4
Q ss_pred ccccccccCCccccccccccCcEEEEEEEEcCCCe---EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEE
Q 001865 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYAS 737 (1002)
Q Consensus 661 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~ 737 (1002)
.....|+....++.+.||.|.||.||.++.+..|+ .||||.++... .......|+.|+.||-+.+||||++|.++
T Consensus 621 eFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 621 EFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred HhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEE
Confidence 33445777788999999999999999999977764 69999998763 34456789999999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccC
Q 001865 738 FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 738 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~ 817 (1002)
......++||+|||++|+|..+|+.+. +.++..++-.+++.|+.|++||-++|.|||||...|||++++-.||++|||+
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999999998875 4489999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH-cCCC
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ell-tG~~ 896 (1002)
++.+..++...+.+ ..---...|.|||++...+++.+|||||+|++|||.+ +|..
T Consensus 778 SRvledd~~~~ytt------------------------~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGER 833 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTT------------------------LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 833 (996)
T ss_pred eeecccCCCccccc------------------------cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCC
Confidence 98775544211110 0111246799999999999999999999999999988 5999
Q ss_pred CCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhc
Q 001865 897 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 897 Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~ 948 (1002)
||...++.++++.|.++ ..+|.+..++..+.+|+..||++|-.+||.+.++
T Consensus 834 PYWdmSNQdVIkaIe~g-yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qi 884 (996)
T KOG0196|consen 834 PYWDMSNQDVIKAIEQG-YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQI 884 (996)
T ss_pred cccccchHHHHHHHHhc-cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence 99999999999888765 5666667789999999999999999999997654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=289.70 Aligned_cols=280 Identities=25% Similarity=0.375 Sum_probs=206.7
Q ss_pred cCCccccccccccCcEEEEEEEEcC---CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCe
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCG---SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH 743 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~ 743 (1002)
...|+++.+||+|.|++||++.+.. ..++||+|.+... +...++.+|+++|..+ .+.||+.+.+++..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4689999999999999999999977 7889999988754 3456789999999988 79999999999999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe-cCCcEEEEeccCCcccC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ-GNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~-~~g~vkL~DFG~a~~~~ 822 (1002)
+++||||++.....+++.. ++...++.+++.++.||.++|.+|||||||||+|+|++ ..+.-.|+|||+|....
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999999999999865 78899999999999999999999999999999999998 46788999999996311
Q ss_pred CCCCCC----------CC-cchh-hhhcccCCCCCc-cc----ccccccccccccCCcccccccccCC-CCCChhhHHHH
Q 001865 823 CKPQLL----------LP-TTNE-KKRRHKGQQNPV-FM----AEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWAL 884 (1002)
Q Consensus 823 ~~~~~~----------~~-~~~~-~~~~~~~~~~~~-~~----~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSl 884 (1002)
...... .+ .... ......+...|. .. ...........||++|.|||++... ..++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 100000 00 0000 000000000000 00 1111223456899999999999765 46889999999
Q ss_pred HHHHHHHHcCCCCCCCCCh-HHHHHHH--------------HhCC---------------------C----CCC------
Q 001865 885 GILLYEMLYGYTPFRGKTR-QKTFANI--------------LHKD---------------------L----KFP------ 918 (1002)
Q Consensus 885 Gvil~elltG~~Pf~~~~~-~~~~~~i--------------~~~~---------------------~----~~~------ 918 (1002)
|+|+..+++++.||..... ...+..+ +.+. + ..+
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999954211 1111000 0011 0 000
Q ss_pred ----CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 919 ----SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 919 ----~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.....+..+.+|+.+||..||.+|+| |+++|+||||...
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~~ 387 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDEA 387 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcch
Confidence 00112447889999999999999999 9999999999964
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=258.55 Aligned_cols=224 Identities=26% Similarity=0.403 Sum_probs=185.0
Q ss_pred cccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHh-CCCCCcceeEEEEee
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQT 740 (1002)
Q Consensus 662 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~ 740 (1002)
.+-.+.-+....+..||+|++|.|-+.++..+|...|+|.++... .....+++.+|+.+..+ ..+|++|.+|+.+..
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 334455667778889999999999999999999999999997642 34445677788887655 489999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccC
Q 001865 741 KTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~--~~~~~l~~~~i~~i~~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~ 817 (1002)
.+.+++.||.| ..||..+.++ ..+..+++..+-.|+..++.||.|||++ .|||||+||+|||++.+|++|+||||.
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999999 8888777654 2456799999999999999999999986 999999999999999999999999999
Q ss_pred CcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC----CCCCChhhHHHHHHHHHHHHc
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLY 893 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~----~~~~~~sDIwSlGvil~ellt 893 (1002)
+..+..+ ...+...|.-.|||||.+.. ..|+.++||||||+++.||.+
T Consensus 196 sG~L~dS----------------------------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 196 SGYLVDS----------------------------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred ceeehhh----------------------------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 8654321 11122457888999999843 368889999999999999999
Q ss_pred CCCCCCC-CChHHHHHHHHhCCCC
Q 001865 894 GYTPFRG-KTRQKTFANILHKDLK 916 (1002)
Q Consensus 894 G~~Pf~~-~~~~~~~~~i~~~~~~ 916 (1002)
++.||.. .++.+.++++.....+
T Consensus 248 lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 248 LRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred ccccccccCCHHHHHHHHhcCCCC
Confidence 9999975 5677778887776443
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=319.67 Aligned_cols=411 Identities=12% Similarity=0.090 Sum_probs=301.5
Q ss_pred ccccccccccccccccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCCh
Q 001865 168 VRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDP 247 (1002)
Q Consensus 168 ~~~~~dit~~~~~e~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~ 247 (1002)
.....|||++++++++|+++++.|+.++++++++++++|. +|+|+++|+++++++||+.+|++|+++..+.++....
T Consensus 183 ~g~~~DIT~rk~ae~~l~~~~~~l~~l~e~~~~~i~~~d~---~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~ 259 (807)
T PRK13560 183 DGFAEDITERKRAEERIDEALHFLQQLLDNIADPAFWKDE---DAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPAD 259 (807)
T ss_pred EEEEEccchHHHHHHHHHHHHHHHHHHHhhCCCeEEEEcC---CCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhH
Confidence 3445899999999999999999999999999999999998 7889999999999999999999999998887766544
Q ss_pred HHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEe--eeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhh
Q 001865 248 EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTI--APIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLI 325 (1002)
Q Consensus 248 ~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~--~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~~l~ 325 (1002)
.........+..++....+.+.+++||+.+|+.+.+ .|+.|.+|.+.+++++++|||++|++|++|+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~~~~~DITerk~~e~~L~~se-------- 331 (807)
T PRK13560 260 DYQEADAAKFDADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLVGAITDISGRRAAERELLEKE-------- 331 (807)
T ss_pred HHHHHHHHHhccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEEEEEEechHHHHHHHHHHHHH--------
Confidence 443445555667777778888999999999776654 5667899999999999999999999999987421
Q ss_pred hHHHHHHHHhhhhHHHHHHHhc-CCCCcccCCCCCcc-cccCCCCchhhhcccccCCCCCCCCCCCCCC--------CCC
Q 001865 326 RYDARQKEMATSSVTELVQAMK-KPRSLSESTNRPPI-IRKSEGGVEEERAGALGRRKSENVPPPRRNS--------YGG 395 (1002)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~a~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~--------~~~ 395 (1002)
+....+..+.. .+...+.......+ +..+...+|++.+++.|+......|...... +..
T Consensus 332 -----------~~l~~l~~~~~~~i~~~d~~g~i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (807)
T PRK13560 332 -----------DMLRAIIEAAPIAAIGLDADGNICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPD 400 (807)
T ss_pred -----------HHHHHHHHhCcccEEEEcCCCCEEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCc
Confidence 11122222222 22334444444444 4456678999999999988765543211100 000
Q ss_pred Cc------------ccccccccccchhhccccCCcccccccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHH
Q 001865 396 GC------------RTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKV 463 (1002)
Q Consensus 396 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~ 463 (1002)
.. ................++|...|+...+.+..+.++....... ...|+|+|+.
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~-------------~~~DITerk~ 467 (807)
T PRK13560 401 GRPMAFDACPMAKTIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIA-------------LLVDITERKQ 467 (807)
T ss_pred CCcchhhhhhHHHHHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEE-------------EeehhhhHHH
Confidence 00 0111122223444556677777887777777776665443333 3679999999
Q ss_pred HHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCC--CccccCCCCChHHHHHHHHHHh
Q 001865 464 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAID 541 (1002)
Q Consensus 464 ~e~~l~~~~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~--~~~l~~~d~~~~~~~~l~~~l~ 541 (1002)
.|++++. .+.++++++++++.++..+ +..+.+|.....++||+++|+++.. +..+++|++.......+...+.
T Consensus 468 ~E~~L~~---~~~~~e~~~~~i~~~~~~~--~~~~~~~~~~~~~~G~~~~e~~~~~~~~~~~~~p~d~~~~~~~~~~~~~ 542 (807)
T PRK13560 468 VEEQLLL---ANLIVENSPLVLFRWKAEE--GWPVELVSKNITQFGYEPDEFISGKRMFAAIIHPADLEQVAAEVAEFAA 542 (807)
T ss_pred HHHHHHH---HHHHHhcCCceEEEEecCC--CceEEEecchhhhcCCCHHHhhcccchHhhhcChhhHHHHHHHHHHHHh
Confidence 9999987 6789999999999888652 2255566666788999999998643 5567788888777777777666
Q ss_pred cC-CcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccccccccCCchhhHHHHHHHHHHHhhhhhhhh
Q 001865 542 NQ-TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAV 620 (1002)
Q Consensus 542 ~~-~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e~~~~~~~~~~e~~~~~k~~~~~v~~~~ 620 (1002)
.+ ..+..++++.++||..+|+.....|++|++|.+.+++|+++|||+||++|++++ ...++...++..++|.+++.+
T Consensus 543 ~g~~~~~~e~r~~~~dG~~~w~~~~~~~~~d~~G~~~~~~g~~~DITerK~aE~~L~--~a~~~~~~~l~~isHelrnpL 620 (807)
T PRK13560 543 QGVDRFEQEYRILGKGGAVCWIDDQSAAERDEEGQISHFEGIVIDISERKHAEEKIK--AALTEKEVLLKEIHHRVKNNL 620 (807)
T ss_pred cCCccceeEEEEEcCCCCEEEEEecceeeeCCCCCEEEEEEEEechHHHHHHHHHHH--HHHHHHHHHHHHhHHHHhChH
Confidence 55 457889999999999999999999999999999999999999999999654432 334445555555555555444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=303.84 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=199.2
Q ss_pred CccccccccccCcEE-EEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCCeEEEE
Q 001865 670 HFRPIKPLGSGDTGS-VHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~-Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lV 747 (1002)
-|.-.+.+|.|+.|+ ||++.. .|+.||||.+-.+ ...-..+|+.+|+.- .||||+++|+.-.+....||.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIA 581 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEE
Confidence 355567789999875 798887 7889999977432 345667899999887 799999999999999999999
Q ss_pred EeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec---CC--cEEEEeccCCcc
Q 001865 748 TDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NG--HVSLTDFDLSCL 820 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~---~g--~vkL~DFG~a~~ 820 (1002)
.|+| ..+|.+++... ..........+.++.|++.||++||+.+||||||||.||||+. ++ .++|+|||+++.
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 89999999863 1111222445778899999999999999999999999999986 34 689999999977
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~ 899 (1002)
+...... .....+..||-+|+|||++.....+.++|||||||++|+.++ |..||.
T Consensus 661 l~~~~sS------------------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 661 LAGGKSS------------------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred cCCCcch------------------------hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 6543221 112445679999999999999888889999999999999997 489997
Q ss_pred CCChHHHHHHHHhCCCCCCCCCC-CCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 900 GKTRQKTFANILHKDLKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
..... -.+|+.+...+-...+ ...++.+||.+||.++|..||+ |.++|.||||=.
T Consensus 717 d~~~R--~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs----a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 717 DSLER--QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS----ATDVLNHPLFWD 772 (903)
T ss_pred chHHh--hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC----HHHHhCCCccCC
Confidence 64333 2356666544322211 1128899999999999999999 999999999954
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=297.66 Aligned_cols=276 Identities=26% Similarity=0.409 Sum_probs=231.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.++|.++..+|+|.||.||+++++.+++..|+|+++.. ....+.-+.+|+-+++-.+|||||.+++.|...+..+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 46899999999999999999999999999999999854 345567778899999999999999999999999999999
Q ss_pred EeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
||||.||+|++...- ...+++.++..+++..++||+|||+.|-+|||||-.||++++.|.+||.|||.+..+..
T Consensus 91 MEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita---- 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA---- 164 (829)
T ss_pred EEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh----
Confidence 999999999998754 46799999999999999999999999999999999999999999999999999854321
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccc---cCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII---AGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l---~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~ 904 (1002)
......++.||++|||||+- ....|...+|||++|++..++-.-++|.......
T Consensus 165 -----------------------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 165 -----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred -----------------------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 11234568999999999996 4566888999999999999999888887776666
Q ss_pred HHHHHHHhCCCCCC---CCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC-----ChhhhhccCCCCCCC
Q 001865 905 KTFANILHKDLKFP---SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV-----NWALVRCMNPPELDA 976 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~---~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~-----~~~~~~~~~~~~~~~ 976 (1002)
.....+-+..++.| +....+..+-+|++.+|.++|.+||+ ++.+|.|||...- .-+++...+.|-..+
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt----aeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v 297 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT----AEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVV 297 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC----hhhheeceeeccchhhHHHHHHHHHccCCCCcc
Confidence 66655555555444 34456788899999999999999999 9999999999873 233445555565444
Q ss_pred CCC
Q 001865 977 PLF 979 (1002)
Q Consensus 977 p~~ 979 (1002)
..+
T Consensus 298 ~~~ 300 (829)
T KOG0576|consen 298 RYL 300 (829)
T ss_pred ccc
Confidence 433
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=291.47 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=213.7
Q ss_pred CccccccccccCcEEEEEEEEcCCCe----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
..+..++||+|+||+||++.+...|+ +||+|++... ........+..|+-+|.+|+|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 46677899999999999999866655 6889988754 34555678899999999999999999999998765 88
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
||++||+.|+|.++++.. ...+-....+.|+.||++||.|||.++++||||-..|+|+.+-.++||.|||+|+....+.
T Consensus 774 lvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999999999875 3558888999999999999999999999999999999999999999999999998765443
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCChH
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ellt-G~~Pf~~~~~~ 904 (1002)
... ......-.+.|||-|.+....|+.++|||||||++||++| |..||.+....
T Consensus 853 ~ey-------------------------~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~ 907 (1177)
T KOG1025|consen 853 KEY-------------------------SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE 907 (1177)
T ss_pred ccc-------------------------cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence 211 1111223567999999999999999999999999999996 99999998776
Q ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHH
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el 952 (1002)
++- ++++..-.++.++.++.++.-++.+||..|+..||++++.++++
T Consensus 908 eI~-dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 908 EIP-DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred Hhh-HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 654 55555555888888999999999999999999999988766654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=286.34 Aligned_cols=202 Identities=31% Similarity=0.499 Sum_probs=177.8
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHH-----HHHHHHHHHHHHhCC---CCCcceeEEEEe
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----VHRACAEREILDMLD---HPFVPALYASFQ 739 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~il~~l~---hpnIv~l~~~~~ 739 (1002)
..+|..++.||+|+||.|++|.++++...|+||.+.|..+..... ...+-.||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 457999999999999999999999999999999998765433222 233557999999997 999999999999
Q ss_pred eCCeEEEEEecc-CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCC
Q 001865 740 TKTHVCLITDYC-PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 740 ~~~~~~lV~E~~-~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a 818 (1002)
+++++||+||-. +|.+|++++... ..+++..++.|++|++.|+++||+.||||||||-+|+.++.+|-+||+|||.|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999987 467999999875 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC-CChhhHHHHHHHHHHHHcCCCC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-~~~sDIwSlGvil~elltG~~P 897 (1002)
.... +.....++||..|.|||++.|.+| +..-|||+||++||.++....|
T Consensus 718 a~~k-----------------------------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 718 AYTK-----------------------------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred hhhc-----------------------------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 5532 233467899999999999999876 5678999999999999999999
Q ss_pred CCC
Q 001865 898 FRG 900 (1002)
Q Consensus 898 f~~ 900 (1002)
|+.
T Consensus 769 yyn 771 (772)
T KOG1152|consen 769 YYN 771 (772)
T ss_pred CcC
Confidence 864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=298.11 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=215.7
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcC-------CCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCccee
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPAL 734 (1002)
Q Consensus 663 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~-------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l 734 (1002)
.+.+......+.+.||+|.||.|+++.... ....||||.++.... ......+..|+++|+.+ .|+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 445666667778899999999999997531 145799999986543 36678899999999999 69999999
Q ss_pred EEEEeeCCeEEEEEeccCCCchhHHHhhCC------------C--CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCC
Q 001865 735 YASFQTKTHVCLITDYCPGGELFLLLDRQP------------T--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPE 800 (1002)
Q Consensus 735 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------~--~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~ 800 (1002)
++++...+.+++|+||+..|+|..++.... . ..++...+..++.||+.|++||++.++|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998754 0 13889999999999999999999999999999999
Q ss_pred cEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccc--cCCcccccccccCCCCCCh
Q 001865 801 NVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFV--GTEEYIAPEIIAGAGHTSA 878 (1002)
Q Consensus 801 NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--Gt~~Y~aPE~l~~~~~~~~ 878 (1002)
|||+..+..+||+|||+|+....+.... ..... -...|||||.+....|+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~--------------------------~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYR--------------------------TKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceE--------------------------ecCCCCccceeecCHHHhccCccccc
Confidence 9999999999999999997543221110 00111 2345999999999999999
Q ss_pred hhHHHHHHHHHHHHc-CCCCCCCCC-hHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC
Q 001865 879 VDWWALGILLYEMLY-GYTPFRGKT-RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 879 sDIwSlGvil~ellt-G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H 955 (1002)
+||||+|++|||+++ |..||++.. ..+.+. .++.......+..++.++.++++.||+.+|++||++.+..+.+-.|
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 999999999999997 999999865 455544 5555445555556799999999999999999999988776666554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=320.03 Aligned_cols=239 Identities=20% Similarity=0.295 Sum_probs=184.7
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
..|...+.||+|+||.||+|.+..++..||+|.+..... ....|++++++++|||||++++++...+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 356777889999999999999988999999998864321 1124578899999999999999999999999999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH---CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH---~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~ 825 (1002)
|||++|+|.+++.. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||.+....
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 99999999999953 788999999999999999999 6699999999999999988887775 66542211
Q ss_pred CCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCh--
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR-- 903 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~-- 903 (1002)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 834 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~ 885 (968)
T PLN00113 834 ----------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885 (968)
T ss_pred ----------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC
Confidence 01123688999999999999999999999999999999999999854211
Q ss_pred ---HHHHHHHHhC-------CCCCCCC----CCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 904 ---QKTFANILHK-------DLKFPSS----TPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 904 ---~~~~~~i~~~-------~~~~~~~----~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
.+........ ....... .....++.+++.+||+.||++||++.++++.
T Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 1111110000 0000000 1112346789999999999999995554443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=265.90 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=189.6
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHh--CCCCCcceeEEEEeeCC--
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKT-- 742 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~-- 742 (1002)
+....+++..||+|.||.||+|.. +++.||||++.. .....+.+|.+|.+. +.|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 356778889999999999999998 668999999863 456778888888775 48999999998876544
Q ss_pred --eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---------CcccCCCCCCcEEEecCCcEE
Q 001865 743 --HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVS 811 (1002)
Q Consensus 743 --~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~---------gIiHrDLKP~NILl~~~g~vk 811 (1002)
.++||++|.+.|+|.+||+.+ .+++.....|+.-|+.||+|||+- .|+|||||..|||+.+|+++.
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 789999999999999999874 489999999999999999999973 599999999999999999999
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-CC-----ChhhHHHHH
Q 001865 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HT-----SAVDWWALG 885 (1002)
Q Consensus 812 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-~~-----~~sDIwSlG 885 (1002)
|+|||+|..+... .+.......+||..|||||+|.+.. +. .+.||||+|
T Consensus 357 IaDFGLAl~~~p~-------------------------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamg 411 (534)
T KOG3653|consen 357 IADFGLALRLEPG-------------------------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMG 411 (534)
T ss_pred eeccceeEEecCC-------------------------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHH
Confidence 9999999665411 1122334479999999999996642 11 378999999
Q ss_pred HHHHHHHcCCCC------------CC-----CCChHHHHHHHHh--CCCCCCCCCC---CCHHHHHHHHHccccCcCCCC
Q 001865 886 ILLYEMLYGYTP------------FR-----GKTRQKTFANILH--KDLKFPSSTP---TSLHAKQLMYRLLHRDPKSRL 943 (1002)
Q Consensus 886 vil~elltG~~P------------f~-----~~~~~~~~~~i~~--~~~~~~~~~~---~s~~~~~Ll~~~L~~dP~~Rp 943 (1002)
.+|||+++.... |. ..+..++...+++ .+..+|..-. .-..+.+.+..||..||+.|+
T Consensus 412 LVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARL 491 (534)
T KOG3653|consen 412 LVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARL 491 (534)
T ss_pred HHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhh
Confidence 999999974432 22 1222333333333 3344443211 223567899999999999999
Q ss_pred CCh
Q 001865 944 GSH 946 (1002)
Q Consensus 944 t~~ 946 (1002)
|+-
T Consensus 492 TA~ 494 (534)
T KOG3653|consen 492 TAG 494 (534)
T ss_pred hhH
Confidence 954
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=261.95 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=183.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHh--CCCCCcceeEEEEeeCC----
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKT---- 742 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~--l~hpnIv~l~~~~~~~~---- 742 (1002)
.+..+++.||+|.||.||++.+ .|..||||++... .-....+|.+|.+. |+|+||+.+++.-..++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4678899999999999999999 7889999999743 23456777777664 59999999988755332
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc--------CcccCCCCCCcEEEecCCcEEEEe
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTD 814 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~--------gIiHrDLKP~NILl~~~g~vkL~D 814 (1002)
.+|||++|.+.|||+|||.+. .++.+....++.-++.||+|||.. .|.|||||..|||+.++|.|-|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 689999999999999999884 489999999999999999999963 499999999999999999999999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCC------CChhhHHHHHHHH
Q 001865 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILL 888 (1002)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~------~~~sDIwSlGvil 888 (1002)
+|+|-......... ....+..+||-.|||||+|..... -..+||||||+++
T Consensus 360 LGLAv~h~~~t~~i-----------------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl 416 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTI-----------------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL 416 (513)
T ss_pred ceeeEEecccCCcc-----------------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence 99996543321110 112345689999999999965421 2379999999999
Q ss_pred HHHHc----------CCCCCCCC----ChHHHHHHHHh-C--CCCCCCCCCCCH---HHHHHHHHccccCcCCCCCC
Q 001865 889 YEMLY----------GYTPFRGK----TRQKTFANILH-K--DLKFPSSTPTSL---HAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 889 ~ellt----------G~~Pf~~~----~~~~~~~~i~~-~--~~~~~~~~~~s~---~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
||++. -++||.+- ...+.+.+++- . +...|..-...+ .+-+|++.||..||..|.|+
T Consensus 417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 99883 24677642 22333333321 2 222332222223 34578999999999999993
|
|
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=313.61 Aligned_cols=380 Identities=15% Similarity=0.136 Sum_probs=278.1
Q ss_pred ccccccccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHH
Q 001865 176 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRE 255 (1002)
Q Consensus 176 ~~~~~e~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~ 255 (1002)
..+..++.++++++.++.++++++++|+++|. +|+|+++|+++++++||+.+|++|+++..+.++++.......+..
T Consensus 270 ~~r~~~~~l~~~e~r~~~l~e~~~~~i~~~d~---dG~i~~~N~~~~~l~G~~~~el~g~~~~~~~~~~d~~~~~~~~~~ 346 (1092)
T PRK09776 270 AFRAERKHISESETRFRNAMEYSAIGMALVGT---EGQWLQVNKALCQFLGYSQEELRGLTFQQLTWPEDLNKDLQQVEK 346 (1092)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCHHHHccCCceeccCcchhHhHHHHHHH
Confidence 34445667888999999999999999999998 888999999999999999999999998887777765555555555
Q ss_pred HHHcC-CcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHH
Q 001865 256 TLQNG-QSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEM 334 (1002)
Q Consensus 256 ~l~~g-~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~ 334 (1002)
.+..+ ..+..+.+..++||+.+|+..+..++++.+|.+.+++++++|||++|++|++++...
T Consensus 347 ~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~g~~~~~i~~~~DITerk~~e~~l~~~~----------------- 409 (1092)
T PRK09776 347 LLSGEINSYSMEKRYYRRDGEVVWALLAVSLVRDTDGTPLYFIAQIEDINELKRTEQVNERLM----------------- 409 (1092)
T ss_pred HHcCCccceeeeeEEEcCCCCEEEEEEEEEEEECCCCCEeeehhhHHhhHHHHHHHHHHHHHH-----------------
Confidence 44433 346778889999999999999999999999999999999999999999998877311
Q ss_pred hhhhHHHHHHHh-cCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCC---cccccccccccchh
Q 001865 335 ATSSVTELVQAM-KKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG---CRTSMQRISEVPEK 410 (1002)
Q Consensus 335 ~~~~~~~~~~a~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 410 (1002)
+....+.++. ......+.......+|......+|++.++..+...-..+-++........ ...........+.+
T Consensus 410 --~~~~~~~~~~~~~i~~~d~~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~e~r 487 (1092)
T PRK09776 410 --ERITLANEAGGIGIWEWDLKPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPEDRQRVEKEIRDALQGRSPFKLEFR 487 (1092)
T ss_pred --HHHHHHHHhcCceEEEEecCCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhHHHHHHHHHHHHHhcCCCeeEEEE
Confidence 1111122221 12344455555666777766777777655332111111111111000000 00011123345666
Q ss_pred hccccCCcccccccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhc-ccHHHHHHhccccEEEEc
Q 001865 411 KKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLATTLERIEKNFVITD 489 (1002)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~l~~~-~~l~~i~e~~~~~I~i~D 489 (1002)
...++| ..|+...+....+.++.......+ ..|+|+|+..++++++. ..++.++++++++|+++|
T Consensus 488 ~~~~dG-~~w~~~~~~~~~d~~G~~~~~ig~-------------~~DITerk~~e~~L~~~~~~l~~~l~~~~~~i~~~D 553 (1092)
T PRK09776 488 IVVKDG-VRHIRALANRVLNKDGEVERLLGI-------------NMDMTEVRQLNEALFQEKERLHITLDSIGEAVVCTD 553 (1092)
T ss_pred EEcCCc-eEEEEEeeEEEECCCCCEEEEEee-------------eeehhHHHHHHHHHHHHHHHHHHHHhccccEEEEEC
Confidence 778888 888888877777766655443333 68999999999999766 679999999999999999
Q ss_pred CCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCC--CChHHHHHHHHHHhcCCc--EEEEEEEEecCCcEEEEEEE
Q 001865 490 PRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPE--TDPATVRKIRAAIDNQTD--VTVQLINYTKSGKKFWNLFH 565 (1002)
Q Consensus 490 ~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d--~~~~~~~~l~~~l~~~~~--~~~e~~~~~kdG~~~wv~~~ 565 (1002)
.+|. |+++|+++++++||+.+|++|+++..+.+.. ........+......... ...+....++||..+|+..+
T Consensus 554 ~~g~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~~ 630 (1092)
T PRK09776 554 MAMK---VTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTSRSAAYLEQDVVLHCRSGGSYDVHYS 630 (1092)
T ss_pred CCCe---EEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhcCCCccccceEEEEeCCCcEEEEEEE
Confidence 9888 9999999999999999999999976654322 222222334444444433 55677889999999999999
Q ss_pred EEeeecCCCCEEEEEEEEecCCccccccc
Q 001865 566 LQPMRDQKGEVQYFIGVQLDGSEHLEPLR 594 (1002)
Q Consensus 566 ~~pi~d~~G~v~~~vgi~~DITerk~~e~ 594 (1002)
..|+++.+|++.+++++++|||++|+.++
T Consensus 631 ~~pi~~~~g~~~g~v~~~~DITe~k~~e~ 659 (1092)
T PRK09776 631 ITPLSTLDGENIGSVLVIQDVTESRKMLR 659 (1092)
T ss_pred eeeeecCCCCEEEEEEEEEecchHHHHHH
Confidence 99999999999999999999999998543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-26 Score=238.33 Aligned_cols=213 Identities=39% Similarity=0.646 Sum_probs=185.0
Q ss_pred ccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCch
Q 001865 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL 756 (1002)
Q Consensus 677 LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL 756 (1002)
||+|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653211 346788999999999999999999999999999999999988999
Q ss_pred hHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-CCcEEEEeccCCcccCCCCCCCCCcchhh
Q 001865 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835 (1002)
Q Consensus 757 ~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-~g~vkL~DFG~a~~~~~~~~~~~~~~~~~ 835 (1002)
.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 35899999999999999999999999999999999999998 89999999999865432110
Q ss_pred hhcccCCCCCcccccccccccccccCCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCC
Q 001865 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD 914 (1002)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 914 (1002)
......+...|++||.+... .++.+.|+|+||+++++|
T Consensus 149 ------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------- 187 (215)
T cd00180 149 ------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------- 187 (215)
T ss_pred ------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------
Confidence 11234578899999999877 778899999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCC
Q 001865 915 LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956 (1002)
Q Consensus 915 ~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp 956 (1002)
..+.+++.+||..+|++||+ +.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~----~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPS----AKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcC----HHHHhhCC
Confidence 46889999999999999999 89999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=238.16 Aligned_cols=215 Identities=37% Similarity=0.603 Sum_probs=180.3
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
|.+.+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 66788999999999999999888999999999865322 2567888899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCC
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~ 830 (1002)
+++++|.+++..... .++...+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999976432 17899999999999999999999999999999999999999999999999886543211
Q ss_pred cchhhhhcccCCCCCcccccccccccccccCCcccccccc-cCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CChH-HHH
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-AGAGHTSAVDWWALGILLYEMLYGYTPFRG-KTRQ-KTF 907 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l-~~~~~~~~sDIwSlGvil~elltG~~Pf~~-~~~~-~~~ 907 (1002)
........++..|++||.+ ....++.++|+|+||+++|+|++|+.||.. .+.. .+.
T Consensus 153 ---------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~ 211 (225)
T smart00221 153 ---------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS 211 (225)
T ss_pred ---------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence 0011234678899999998 666778899999999999999999999987 4555 444
Q ss_pred HHHHhCC
Q 001865 908 ANILHKD 914 (1002)
Q Consensus 908 ~~i~~~~ 914 (1002)
..+..+.
T Consensus 212 ~~~~~~~ 218 (225)
T smart00221 212 DVWSFGV 218 (225)
T ss_pred HHHhcCC
Confidence 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.29 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=193.3
Q ss_pred cCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEE-EeeCCeEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS-FQTKTHVC 745 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~-~~~~~~~~ 745 (1002)
.+.|.+.+.||+|-||.+.+|+++.++..+|+|.+.+.. .....|.+|...--.| .|.||+..|+. |+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 368999999999999999999999999999999988753 3456777777654444 58999988774 77888899
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEe--cCCcEEEEeccCCcccCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~--~~g~vkL~DFG~a~~~~~ 823 (1002)
+++||++-|+|..-+... .+-+.-.+.++.|++.|+.|||++++||||||.+||||- +...+||||||+++..+.
T Consensus 99 F~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999999888653 378899999999999999999999999999999999995 344799999998854321
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-----CCCChhhHHHHHHHHHHHHcCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-----GHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----~~~~~sDIwSlGvil~elltG~~Pf 898 (1002)
- -....-+..|.+||.+... ...+.+|||.||+++|.+++|++||
T Consensus 176 t------------------------------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 176 T------------------------------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred e------------------------------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 0 0112245679999987432 2466899999999999999999999
Q ss_pred CCCC----hHHHHHHHHhC-CCCCCC-CCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 899 RGKT----RQKTFANILHK-DLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 899 ~~~~----~~~~~~~i~~~-~~~~~~-~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
.... ..-.+.+...+ .+..|. ..+.++.+..+.++-|..+|+.|....+ +....+.-|..
T Consensus 226 Qka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~-~kk~rk~~w~E 291 (378)
T KOG1345|consen 226 QKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWT-AKKMRKCLWKE 291 (378)
T ss_pred hhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHH-HHHHHHHHHHH
Confidence 7532 22223333333 334443 3457888999999999999999944222 33444444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=236.72 Aligned_cols=255 Identities=16% Similarity=0.161 Sum_probs=206.7
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCe-----EEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 739 (1002)
++...++++...+-+|.||.||.+.+.+... .+-+|.++... ..-+...+..|..++..+.|||+.++.++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3456678999999999999999997754433 34556554332 3445677888888899999999999998764
Q ss_pred -eCCeEEEEEeccCCCchhHHHhh------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEE
Q 001865 740 -TKTHVCLITDYCPGGELFLLLDR------QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812 (1002)
Q Consensus 740 -~~~~~~lV~E~~~ggsL~~~l~~------~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL 812 (1002)
+....++++.++.-|+|..++.. .....++..++-.++.|++.|++|||+.||||.||...|++|++.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 55678999999989999999982 12345778888899999999999999999999999999999999999999
Q ss_pred EeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHH
Q 001865 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892 (1002)
Q Consensus 813 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ell 892 (1002)
+|=.+++..-+. +-....++......||+||.+....|+.++|+||||++||||+
T Consensus 438 tDsaLSRDLFP~-------------------------DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELm 492 (563)
T KOG1024|consen 438 TDSALSRDLFPG-------------------------DYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELM 492 (563)
T ss_pred ccchhccccCcc-------------------------cccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHH
Confidence 999998653221 1122334445677899999999999999999999999999999
Q ss_pred c-CCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 893 Y-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 893 t-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
+ |+.||...++.++..-+..+ ..+-.+..+++++..++..||...|++||++.+
T Consensus 493 tlg~~PyaeIDPfEm~~ylkdG-yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q 547 (563)
T KOG1024|consen 493 TLGKLPYAEIDPFEMEHYLKDG-YRLAQPFNCPDELFTVMACCWALLPEERPSFSQ 547 (563)
T ss_pred hcCCCCccccCHHHHHHHHhcc-ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH
Confidence 7 99999999998887766654 444555568999999999999999999999443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-26 Score=288.15 Aligned_cols=221 Identities=19% Similarity=0.276 Sum_probs=155.4
Q ss_pred CCC-CCcceeEEEEe-------eCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCC
Q 001865 726 LDH-PFVPALYASFQ-------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797 (1002)
Q Consensus 726 l~h-pnIv~l~~~~~-------~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDL 797 (1002)
+.| +||+.++++|. ....++++|||+ +++|.+++... ...++..+++.++.||+.||+|||++||+||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 344 57777777762 334678899998 77999999753 355999999999999999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCC-------------cccccc-cccccccccCCc
Q 001865 798 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP-------------VFMAEP-MRASNSFVGTEE 863 (1002)
Q Consensus 798 KP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~-~~~~~~~~Gt~~ 863 (1002)
||+||||+..|.+|++|||++.............. .+|.... .....+ .......+||+.
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~------DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSR------EIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCccccc------ccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999998878888888877654322111100000 0000000 000000 011223578999
Q ss_pred ccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCC
Q 001865 864 YIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL 943 (1002)
Q Consensus 864 Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rp 943 (1002)
|||||++.+..++.++|||||||+||||++|.+||.... ..+..+.....+ +......+...+++.+||+++|.+||
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~~P~~Rp 257 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLP-PQILLNWPKEASFCLWLLHPEPSCRP 257 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcC-hhhhhcCHHHHHHHHHhCCCChhhCc
Confidence 999999999999999999999999999999988875432 222222222111 11112345667899999999999999
Q ss_pred CChhcHHHHHcCCCcCCC
Q 001865 944 GSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 944 t~~~~a~elL~Hp~f~~~ 961 (1002)
+ +.++|+||||...
T Consensus 258 s----~~eil~h~~~~~~ 271 (793)
T PLN00181 258 S----MSELLQSEFINEP 271 (793)
T ss_pred C----hHHHhhchhhhhh
Confidence 9 9999999999863
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=264.79 Aligned_cols=363 Identities=13% Similarity=0.032 Sum_probs=227.2
Q ss_pred HHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCC-cEEEEEEEEecC
Q 001865 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRLLNYKKD 273 (1002)
Q Consensus 195 le~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~~~~~kd 273 (1002)
+++++|+++++|. +|+|++||.+++.++||+.+|++|+++..+++++........+...+..+. .+..+..+..++
T Consensus 2 ~~~~~d~~~~~d~---~g~i~~~n~~~~~~~g~~~~el~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 78 (442)
T TIGR02040 2 LATAADVTLLLDA---EGVVREVAANPHHPSFEQLSEWEGRRWEEIVTAESVEKFELRLSEALRTGRGAVRVELNHIDPS 78 (442)
T ss_pred CcccCcEEEEECC---CCcEEEEEECCCcccccccccCCCCcHhHhhCcchHHHHHHHHHHHhccCCCcceEeeccCCCC
Confidence 5788999999999 778999999999999999999999999888777665554555555566654 455666666677
Q ss_pred CcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHHHHHHhc-CCCCc
Q 001865 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK-KPRSL 352 (1002)
Q Consensus 274 G~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~a~~-~~~~~ 352 (1002)
|..+|+.++..++.+ + .+++++.+|||++++.+.+|......+ +.+.........+...+..... .+..+
T Consensus 79 g~~~~~~~~~~~~~~--~--~~~~~i~rDi~~~~~~~~~l~~~~~~~-----e~~~~~l~~~e~r~~~l~e~~~~~i~~~ 149 (442)
T TIGR02040 79 SFELPMRFILVRLGA--D--RGVLALGRDLRAVAELQQQLVAAQQAM-----ERDYWTLREMETRYRVVLEVSSDAVLLV 149 (442)
T ss_pred CCccCeEEEEEEeCC--C--CeEEEEecccHHHHHHHHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHhhCCceEEEE
Confidence 777777777777644 2 256789999999888766552110000 0000011112223333333332 23334
Q ss_pred cc-CCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccccccccccccC
Q 001865 353 SE-STNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQST 431 (1002)
Q Consensus 353 ~~-~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (1002)
+. ......+|..+...+||+.+++.|++..+.++.............................+...| .+.+.....
T Consensus 150 d~~~g~i~~~N~a~~~l~G~~~~el~g~~~~~~~~~~~~~~~~~~l~~~~~~g~~~~~~~~~~~~~~~~-~~~~~~~~~- 227 (442)
T TIGR02040 150 DMSTGRIVEANSAAAALLGGVGQSLVGRAFPQEFEGRRREELMLTLRNVRATGSAAPVRILLRRSQKRL-LVVVSVFRQ- 227 (442)
T ss_pred ECCCCEEEEEcHHHHHHhCcCHHHHcCCCHHHhCCHHHHHHHHHHHHHHHhcCCCcceEEEEcCCCeEE-EEEEEEEEe-
Confidence 43 345667888899999999999999988877654221100000000000000001111111111111 111111111
Q ss_pred CCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCC
Q 001865 432 DDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYS 511 (1002)
Q Consensus 432 ~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys 511 (1002)
++...++ ....|+++++..++++++ .|+.++++++++|+++|.+|. |+++|++|++++||+
T Consensus 228 ~~~~~~l--------------~~~~dit~~~~~e~~~~~--~~~~l~e~~~d~I~v~D~~G~---I~~~N~a~~~l~G~~ 288 (442)
T TIGR02040 228 DGESLFL--------------CQLSPAGATQPVGDELSE--NLARLYHEAPDAIVFSDADGT---IRGANEAFLELTDSS 288 (442)
T ss_pred CCceEEE--------------EEEcccchhhhhhHHHHH--HHHHHHHhCCceEEEEcCCCc---EEehhHHHHHHhCCC
Confidence 1111111 123456676665555432 499999999999999999888 999999999999997
Q ss_pred -hhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccc
Q 001865 512 -REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590 (1002)
Q Consensus 512 -~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk 590 (1002)
.++++|+++..++++.... ....+......+.....+..++++||+.+|+++++.|+.+..+ ..++++++|||+||
T Consensus 289 ~~~~l~G~~~~~~~~~~~~~-~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDITeR~ 365 (442)
T TIGR02040 289 SLEAVRGRTLDRWLGRGGVD-LRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGER--PLIVLVIRDISRRL 365 (442)
T ss_pred ChHHHcCCCHHHHhCCCccc-HHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCc--eEEEEEEecchhhc
Confidence 5789999976665543222 1222223333444455677889999999999999999976544 46788999999999
Q ss_pred ccc
Q 001865 591 EPL 593 (1002)
Q Consensus 591 ~~e 593 (1002)
+++
T Consensus 366 ~~~ 368 (442)
T TIGR02040 366 TMR 368 (442)
T ss_pred cCC
Confidence 863
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-27 Score=264.29 Aligned_cols=264 Identities=41% Similarity=0.697 Sum_probs=225.8
Q ss_pred cccccCcEEEEEEEE---cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEEecc
Q 001865 676 PLGSGDTGSVHLVEL---CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLITDYC 751 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~E~~ 751 (1002)
.+|.|+||.|++++- ...+..||+|++++......... ....|..++...+ ||++|+++..|+.+...|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999999875 34477899999988765544444 5567888888886 999999999999999999999999
Q ss_pred CCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCc
Q 001865 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831 (1002)
Q Consensus 752 ~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~ 831 (1002)
.||.|+..+... ..+.+..++.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++....
T Consensus 80 rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~-------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK-------- 149 (612)
T ss_pred ccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh--------
Confidence 999999888764 4588899999999999999999999999999999999999999999999999865321
Q ss_pred chhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHH
Q 001865 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL 911 (1002)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 911 (1002)
....|||..|||||++. .+..++|.||||+++++|++|..||.+ ++...|+
T Consensus 150 -----------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 150 -----------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred -----------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 11228999999999998 567889999999999999999999988 7777888
Q ss_pred hCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCCh-hcHHHHHcCCCcCCCChhhhhccCCCCCCCCCCCC
Q 001865 912 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPPELDAPLFAT 981 (1002)
Q Consensus 912 ~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~-~~a~elL~Hp~f~~~~~~~~~~~~~~~~~~p~~~~ 981 (1002)
+.....|.. .+..+++++..++..+|.+|.... ..+.++++|+||..++|..+....++....|-..+
T Consensus 201 ~~~~~~p~~--l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~ 269 (612)
T KOG0603|consen 201 KAELEMPRE--LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSIT 269 (612)
T ss_pred hhccCCchh--hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccc
Confidence 766666554 678899999999999999999875 57899999999999999999888888777775433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=218.68 Aligned_cols=274 Identities=20% Similarity=0.258 Sum_probs=212.5
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCe
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH 743 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~ 743 (1002)
.+..+.|+++++||+|+||.+|++....+|..||||+-+... ....+.-|..+.+.|. ...|+.+..++.+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 456789999999999999999999999999999999876542 2235667888888885 4788888888999999
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC---CcEEEEeccCCcc
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN---GHVSLTDFDLSCL 820 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~---g~vkL~DFG~a~~ 820 (1002)
-.+||+++ |.+|.++++-. ...++..+++.++-|++.-++|+|.++.|||||||+|+|+.-+ ..+.|+|||+|+.
T Consensus 86 nvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence 99999999 99999998754 3559999999999999999999999999999999999999743 4689999999976
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
+.+.... ...+.+......||..|.+-.++.+...+.+.|+-|+|.+|.++.-|.+||.+
T Consensus 164 y~d~~t~--------------------~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 164 YRDIRTR--------------------QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred hcccccc--------------------ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 5432111 12345566678899999999999999899999999999999999999999988
Q ss_pred C---ChHHHHHHHHhCCCCCCCC---CCCCHHHHHHHHHccccCcCCCCCChhcHHHH-------HcCCCcCCCChhhh
Q 001865 901 K---TRQKTFANILHKDLKFPSS---TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI-------KKHPFFKGVNWALV 966 (1002)
Q Consensus 901 ~---~~~~~~~~i~~~~~~~~~~---~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~el-------L~Hp~f~~~~~~~~ 966 (1002)
. +....+++|.+..+..+.. ...+.++.-.|.-|=...=++-|...- +.++ |+|.+=--.+|.-+
T Consensus 224 lka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y-lrqlFriLfr~ln~~~d~iyDW~~l 301 (341)
T KOG1163|consen 224 LKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY-LRQLFRILFRTLNHQYDYIYDWTML 301 (341)
T ss_pred cchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH-HHHHHHHHHhhccccCCeEeeHHHH
Confidence 5 4455666777766655532 335667777777664443344444211 2333 34444334677766
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=222.26 Aligned_cols=223 Identities=24% Similarity=0.342 Sum_probs=189.5
Q ss_pred ccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeC
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 741 (1002)
Q Consensus 663 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~ 741 (1002)
+..+..-.|++.++||+|+||.+|.+.+.-++.+||||.-... ...-++..|....+.| ..+.|+.+|.+..++
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 3345667999999999999999999999999999999976532 2345677788888887 679999999999999
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-----cEEEEecc
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-----HVSLTDFD 816 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g-----~vkL~DFG 816 (1002)
-+..||+|++ |.+|.+++.-. +..++..++..++.|++.-++|+|++++|.|||||+|+||..-+ .+-|+|||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 9999999999 99999999866 35699999999999999999999999999999999999997433 48899999
Q ss_pred CCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCC
Q 001865 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896 (1002)
Q Consensus 817 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~ 896 (1002)
+|+.+....... ..+.+...+..||..||+-..+.+...+.+.|+-|||-+++++|-|.+
T Consensus 175 mAK~YrDp~Tkq--------------------HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsL 234 (449)
T KOG1165|consen 175 MAKEYRDPKTKQ--------------------HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 234 (449)
T ss_pred chhhhcCccccc--------------------cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCC
Confidence 998765432221 345677788899999999999999999999999999999999999999
Q ss_pred CCCC---CChHHHHHHHHh
Q 001865 897 PFRG---KTRQKTFANILH 912 (1002)
Q Consensus 897 Pf~~---~~~~~~~~~i~~ 912 (1002)
||.| .+..+.+++|-.
T Consensus 235 PWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 235 PWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred ccccccCcchHHHHHHhcc
Confidence 9987 455566666643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-23 Score=232.69 Aligned_cols=252 Identities=22% Similarity=0.214 Sum_probs=195.0
Q ss_pred CccccccccccCcEEEEEEEEcCCC-eEEEEEEeecccccChHHHHHHHHHHHHHHhCC----CCCcceeEEEE-eeCCe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSG-QYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----HPFVPALYASF-QTKTH 743 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~-~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~----hpnIv~l~~~~-~~~~~ 743 (1002)
+|++.+.||+|+||.||+|.+..++ ..+|+|+........ ...+..|..++..+. ..++..+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997774 689999887542111 115677888888886 36999999999 58889
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-----CcEEEEeccCC
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-----GHVSLTDFDLS 818 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~-----g~vkL~DFG~a 818 (1002)
.|+||+.+ |.+|.++....+...++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999877666789999999999999999999999999999999999999865 36999999999
Q ss_pred cc--cCCCCCCCCCcchhhhhcccCCCCCccccccccc-ccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCC
Q 001865 819 CL--TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA-SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 819 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~ 895 (1002)
+. +....... ..+.+. ...+.||..|+++.++.+...+.+.|+||+++++.+|+.|.
T Consensus 175 r~~~~~~~~~~~--------------------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 175 RRFKYVGDSGGN--------------------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred ccccccCCCCcc--------------------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 73 22111100 000111 23567999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhCCC--CCC-CCCCCCHHHHHHHHHccccCcCCCCCC
Q 001865 896 TPFRGKTRQKTFANILHKDL--KFP-SSTPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 896 ~Pf~~~~~~~~~~~i~~~~~--~~~-~~~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
+||.+.........+..... ... .....+..+..++..+-..+...+|..
T Consensus 235 LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 235 LPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred CCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCH
Confidence 99977654333333222111 111 122245567777777777888999983
|
|
| >PRK13560 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=265.49 Aligned_cols=380 Identities=10% Similarity=0.045 Sum_probs=265.4
Q ss_pred cccccccccccchHHHH-HHHHHhcCCcEEEEeCCCCCCcE--EEechHHHHHcCCChhHHcCCC--CCcccCCCCChHH
Q 001865 175 SDEGGKEKGLPRVSDIV-KDALSTFQQTFVVSDATKPDYPI--MYASAGFFKMTGYTSKEVVGRN--CRFLQGAGTDPED 249 (1002)
Q Consensus 175 t~~~~~e~~L~~~~~~l-~~ile~~~d~i~i~D~~~~dG~I--~~vN~a~~~l~Gys~eEllG~~--~~~l~~~~~~~~~ 249 (1002)
+.++.++.+|.++++.+ +.+++++|+++++.+..+ +|.+ .+++.++.+++||...++++.. +..+++|++....
T Consensus 53 ~~r~~~~~~l~~~~e~~~r~l~~~~p~~i~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~p~d~~~~ 131 (807)
T PRK13560 53 DARAIAEAEAQDCREQCERNLKANIPGGMFLFALDG-DGTFSFPSLLDANGELAAIAKHDLMADKGLLAMLIGGDDGDFF 131 (807)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHhcCCceEEEEEEcC-ccccccceeeccchhHHHhcCcccCCccchhhhhcCCCcchhh
Confidence 34566778888888888 999999999999988632 3443 3488888888998888877543 3345666654433
Q ss_pred H-------HHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCch
Q 001865 250 V-------AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPE 322 (1002)
Q Consensus 250 ~-------~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~ 322 (1002)
. +.+..++..+.....+++.+++||+ |+.....|.++.+|.+ .+.|+++|||++|++|++|+..
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~e~r~~~~dg~--~~~~~~~~~~~~~g~~-~~~g~~~DIT~rk~ae~~l~~~------ 202 (807)
T PRK13560 132 FANPFRSAETIAMALQSDDWQEEEGHFRCGDGR--FIDCCLRFERHAHADD-QVDGFAEDITERKRAEERIDEA------ 202 (807)
T ss_pred hhChhhHHHHHHHHhccCcccceEEEEEeCCcc--EEEEEeeeeecCCCce-EEEEEEEccchHHHHHHHHHHH------
Confidence 3 2333344445556678888999996 7777888999888876 6899999999999999987731
Q ss_pred hhhhHHHHHHHHhhhhHHHHHHHhc-CCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCC--ccc
Q 001865 323 SLIRYDARQKEMATSSVTELVQAMK-KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGG--CRT 399 (1002)
Q Consensus 323 ~l~~~~~~~~~~~~~~~~~~~~a~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~--~~~ 399 (1002)
.+....+..... .+...+.....+++|..+...+||+.++++|+...++.|.......... ...
T Consensus 203 -------------~~~l~~l~e~~~~~i~~~d~~g~i~~~N~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~ 269 (807)
T PRK13560 203 -------------LHFLQQLLDNIADPAFWKDEDAKVFGCNDAACLACGFRREEIIGMSIHDFAPAQPADDYQEADAAKF 269 (807)
T ss_pred -------------HHHHHHHHhhCCCeEEEEcCCCCEEEEhHHHHHHhCCCHHHHcCCcchhcCCcchhHHHHHHHHHHh
Confidence 111122222222 2344566677888999999999999999999999888766332211000 000
Q ss_pred ccccccccchhhccccCCccccccccc--ccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhc-ccHHH
Q 001865 400 SMQRISEVPEKKKQKSGRRSFMGLIGR--KSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKG-IDLAT 476 (1002)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~l~~~-~~l~~ 476 (1002)
.......++.....++|+..|+.+..+ ...+.++...... ....|+|+|+..++++++. ..|+.
T Consensus 270 ~~~~~~~~e~~~~~~dG~~~~~~~~~~~~~~~~~~g~~~g~~-------------~~~~DITerk~~e~~L~~se~~l~~ 336 (807)
T PRK13560 270 DADGSQIIEAEFQNKDGRTRPVDVIFNHAEFDDKENHCAGLV-------------GAITDISGRRAAERELLEKEDMLRA 336 (807)
T ss_pred ccCCceEEEEEEEcCCCCEEEEEEEecceEEEcCCCCEEEEE-------------EEEEechHHHHHHHHHHHHHHHHHH
Confidence 011122344455677787775544432 2223333222222 2367999999999999876 66999
Q ss_pred HHHhccccEEEEcCCCCCCCEEec-cHHHHHHcCCChhhhcCCCCccccCCCCChH---------------H--HHHHHH
Q 001865 477 TLERIEKNFVITDPRLPDNPIIFA-SDSFLELTEYSREEILGRNCRFLQGPETDPA---------------T--VRKIRA 538 (1002)
Q Consensus 477 i~e~~~~~I~i~D~~g~~~~Iv~v-N~a~~~l~Gys~eEliG~~~~~l~~~d~~~~---------------~--~~~l~~ 538 (1002)
++++++++|+++|.+|. ++++ |+++++++||+.+|++|+++..+.+...... . ...+..
T Consensus 337 l~~~~~~~i~~~d~~g~---i~~~nn~~~~~~~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (807)
T PRK13560 337 IIEAAPIAAIGLDADGN---ICFVNNNAAERMLGWSAAEVMGKPLPGMDPELNEEFWCGDFQEWYPDGRPMAFDACPMAK 413 (807)
T ss_pred HHHhCcccEEEEcCCCC---EEEecCHHHHHHhCCCHHHHcCCCccccChhhhhhhhhchhhhcCCcCCcchhhhhhHHH
Confidence 99999999999999888 9987 6788889999999999998654433221110 0 011233
Q ss_pred HHhcCCcEE-EEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCcccccc
Q 001865 539 AIDNQTDVT-VQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (1002)
Q Consensus 539 ~l~~~~~~~-~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e 593 (1002)
.+..+..+. .++++.+++|..+|+.....|++|.+|.+++++++++|||++|+++
T Consensus 414 ~~~~~~~~~~~e~~~~~~~g~~~~~~~~~~p~~d~~g~~~~~~~~~~DITerk~~E 469 (807)
T PRK13560 414 TIKGGKIFDGQEVLIEREDDGPADCSAYAEPLHDADGNIIGAIALLVDITERKQVE 469 (807)
T ss_pred HHhcCCcccCceEEEEcCCCCeEEEEEEEeeeECCCCCEEEEEEEeehhhhHHHHH
Confidence 355555543 4788889999999999999999999999999999999999999853
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-24 Score=217.57 Aligned_cols=161 Identities=25% Similarity=0.262 Sum_probs=128.4
Q ss_pred CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcch
Q 001865 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833 (1002)
Q Consensus 754 gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~ 833 (1002)
|+|.+++... ...+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899999754 345999999999999999999999998 999999999999999 998854321
Q ss_pred hhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHh
Q 001865 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILH 912 (1002)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~-~~~~~i~~ 912 (1002)
....||+.|||||++.+..++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 62 ----------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 119 (176)
T smart00750 62 ----------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119 (176)
T ss_pred ----------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH
Confidence 1125899999999999999999999999999999999999999765432 33333333
Q ss_pred CCCCC-C----CCCCCCH--HHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 913 KDLKF-P----SSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 913 ~~~~~-~----~~~~~s~--~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
..... + .....+. .+.+||.+||..+|.+||+ +.++++|+|+.
T Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA----ANHYLAHCRAL 169 (176)
T ss_pred HhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC----HHHHHHHHHHH
Confidence 22111 0 1111222 5899999999999999999 99999999876
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-24 Score=252.05 Aligned_cols=242 Identities=39% Similarity=0.651 Sum_probs=186.1
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.+|..++.|..|+||.||.++++.+.+.+|+|+=+.. .+.+ +|+....+|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---------lilR--nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---------LILR--NILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc---------hhhh--ccccccCCccee----------------
Confidence 5899999999999999999999999999999643221 1111 144444566555
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCC-
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL- 827 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~- 827 (1002)
|+-..+++.. +.++.. ++.+++|||+-||+|||+||+|++|+.-|++|+.|||++....-....
T Consensus 136 -----gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 3333334332 234432 378899999999999999999999999999999999998653211110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.+..+.++..+. -....+||||.|+|||++....|+..+|+|++|+|+|+++.|+.||.+++.++.+
T Consensus 201 l~eg~I~k~t~E-------------f~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 201 LKEGHIEKDTHE-------------FQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhcchHHHHHH-------------hhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 000000110000 1234579999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC-CCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhh
Q 001865 908 ANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966 (1002)
Q Consensus 908 ~~i~~~~~~~~~~-~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~ 966 (1002)
..++...+.|++. ....+++++++.++|+.+|..|..- ..+-++.+|+||+.++|.-+
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt-~ga~evk~h~ff~~LDw~~l 326 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT-GGALEVKQHGFFQLLDWKSL 326 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhccc-chhhhhhhccceeecccchh
Confidence 9999988888865 3467899999999999999999874 36889999999999999955
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=259.58 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=201.6
Q ss_pred cccccccccCcEEEEEEEEcCCCeEEEEEEeec---ccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 672 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK---GVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~---~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.....+|.|++|.|+.+......+.++.|.++. ...........+..|..+-..+.|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456779999999999888877777677776542 11112222233667888888899999988887777766666669
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
|||++ +|+.++... ..++...+..+++||+.||+|||+.||.||||||+|++++.+|.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~--- 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW--- 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc---
Confidence 99988 999999874 358999999999999999999999999999999999999999999999999985542111
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCC-hhhHHHHHHHHHHHHcCCCCCCCCChHHHH
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~-~sDIwSlGvil~elltG~~Pf~~~~~~~~~ 907 (1002)
.........++|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||......+..
T Consensus 475 --------------------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 475 --------------------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred --------------------chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 11123456789999999999999998877 799999999999999999999765443321
Q ss_pred -HHHHh-CCCC-----CCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCC
Q 001865 908 -ANILH-KDLK-----FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 908 -~~i~~-~~~~-----~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~ 962 (1002)
..... .... ......++...+.+|.+||+.||.+|+| +++|++.+||+.+.
T Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t----i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 535 FKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT----IEQILNDEWIRSIE 592 (601)
T ss_pred hhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec----HHHHhhChHhhhcc
Confidence 11111 1111 1111224556789999999999999999 99999999999863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=218.47 Aligned_cols=262 Identities=36% Similarity=0.555 Sum_probs=207.1
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCC-CcceeEEEEeeCCeEEEEEe
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP-FVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~~~~~~lV~E 749 (1002)
|.+.+.||.|+|+.||++.+. ..+++|.+.............+.+|+.++..+.|+ +++.+++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999996 78999999876544434567889999999999988 79999999988888899999
Q ss_pred ccCCCchhHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCCCCCC
Q 001865 750 YCPGGELFLLLDRQPT-KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~-~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g-~vkL~DFG~a~~~~~~~~~ 827 (1002)
++.+++|.+++..... ..++...+..++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765421 2699999999999999999999999999999999999999988 7999999998643211110
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTR- 903 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~~~~sDIwSlGvil~elltG~~Pf~~~~~- 903 (1002)
.. ........+||..|++||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 159 ~~---------------------~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 SS---------------------IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred cc---------------------ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 00 0012356789999999999987 5778899999999999999999999887663
Q ss_pred ---HHHHHHHHhCCCC-CCCCCCCC------HHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 904 ---QKTFANILHKDLK-FPSSTPTS------LHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 904 ---~~~~~~i~~~~~~-~~~~~~~s------~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
......+...... ........ ..+.+++.+|+..+|..|.+ ......++|...
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC----HHHHhhchHhhC
Confidence 3444444443322 22221111 46889999999999999999 666666655554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=228.91 Aligned_cols=177 Identities=21% Similarity=0.189 Sum_probs=132.9
Q ss_pred cccccCCccccccccccCcEEEEEEEEcC-CCeEEEEEEeecccc--cChHHHHHHHHHHHHHHhCCCCCcce-eEEEEe
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCG-SGQYFAMKAMDKGVM--LNRNKVHRACAEREILDMLDHPFVPA-LYASFQ 739 (1002)
Q Consensus 664 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~-l~~~~~ 739 (1002)
.....++|.+.+.||+|+||+||+|.+.. ++..+|||.+..... ........+.+|+++|+.++|+|++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34456899999999999999999999876 678889998753311 12334566889999999999999985 4432
Q ss_pred eCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCC-CCCcEEEecCCcEEEEeccCC
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLS 818 (1002)
Q Consensus 740 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDL-KP~NILl~~~g~vkL~DFG~a 818 (1002)
+..|+|||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999632 11 11 1467889999999999999999999 999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 872 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~ 872 (1002)
..+...... ... .....-.+..+++.|+|||++..
T Consensus 160 ~~~~~~~~~----------------~~~---~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGAL----------------YRI---AAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcch----------------hhh---hhhhhhhhhhccCccCCcccCCh
Confidence 765422100 000 00011135678999999999854
|
|
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-20 Score=234.48 Aligned_cols=241 Identities=20% Similarity=0.309 Sum_probs=197.7
Q ss_pred chHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCC----
Q 001865 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ---- 261 (1002)
Q Consensus 186 ~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~---- 261 (1002)
.....+..+++.++++++++|. +|+|++||++|++++||+.+|++|+++..+.+++........+......+.
T Consensus 9 ~~~~~~~~~le~~~~~i~~~d~---~g~i~~~N~~~~~l~G~s~eeliG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (799)
T PRK11359 9 AADGIFFPALEQNMMGAVLINE---NDEVLFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVE 85 (799)
T ss_pred hhhhhHHHHHHhhcCcEEEEcC---CCeEEEEcHHHHHHhCCCHHHHcCCCHHHhcCccccccchHHHhhhhccCCcccc
Confidence 3445678899999999999998 778999999999999999999999998877777665444444444444433
Q ss_pred cEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHH
Q 001865 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTE 341 (1002)
Q Consensus 262 ~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 341 (1002)
.+..+++.+++||+.+|+.++..++. .+|. .+++++.+|||++++.+++++.
T Consensus 86 ~~~~e~~~~~~dG~~~~v~~~~~~~~-~~g~-~~~~~~~~DiT~~~~~~~~~~~-------------------------- 137 (799)
T PRK11359 86 GMSRELQLEKKDGSKIWTRFALSKVS-AEGK-VYYLALVRDASVEMAQKEQTRQ-------------------------- 137 (799)
T ss_pred ccceeeEEecCCcCEEEEEEEeeeec-cCCc-eEEEEEEeeccchhhhHHHHHH--------------------------
Confidence 24457888999999999999998874 4454 5678999999987766544331
Q ss_pred HHHHhcCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccc
Q 001865 342 LVQAMKKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFM 421 (1002)
Q Consensus 342 ~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (1002)
T Consensus 138 -------------------------------------------------------------------------------- 137 (799)
T PRK11359 138 -------------------------------------------------------------------------------- 137 (799)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEecc
Q 001865 422 GLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFAS 501 (1002)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN 501 (1002)
+..++++++++++++|.+|. ++++|
T Consensus 138 ----------------------------------------------------~~~~~~~~~~~i~~~d~~g~---i~~~N 162 (799)
T PRK11359 138 ----------------------------------------------------LIIAVDHLDRPVIVLDPERR---IVQCN 162 (799)
T ss_pred ----------------------------------------------------HHHHHhcCCCcEEEEcCCCc---EEEEC
Confidence 45678899999999999888 99999
Q ss_pred HHHHHHcCCChhhhcCCCCcccc-CCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEE
Q 001865 502 DSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 580 (1002)
Q Consensus 502 ~a~~~l~Gys~eEliG~~~~~l~-~~d~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~v 580 (1002)
+++++++||+.++++|++...+. +++........+...+..+..+..+++..+++|..+|+..+..|+.+.+|.+.+++
T Consensus 163 ~~~~~l~G~~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~ 242 (799)
T PRK11359 163 RAFTEMFGYCISEASGMQPDTLLNIPEFPADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLV 242 (799)
T ss_pred hhhHhhhCCCHHHHCCCChHHhcCCCCCcHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEE
Confidence 99999999999999999876554 35555556666777777777788899999999999999999999999999999999
Q ss_pred EEEecCCccccc
Q 001865 581 GVQLDGSEHLEP 592 (1002)
Q Consensus 581 gi~~DITerk~~ 592 (1002)
++.+|||++|+.
T Consensus 243 ~~~~DITerk~~ 254 (799)
T PRK11359 243 MTFSDITEERQI 254 (799)
T ss_pred EEeehhhhHHHH
Confidence 999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-22 Score=235.44 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=194.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeeccc-ccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
.|...+.||++.|=+|.+|++.+ | .+++|++-+.. ...-....+...|++ ...+++||++.+.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68899999999999999999833 4 49999987643 222333444455555 56679999999988888888899999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 828 (1002)
+|+ ..+|+|.+..++. +..-+.+.|+.||+.||..+|..||+|+|||.+||||++-+.+.|+||..-+...-...
T Consensus 101 qyv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD-- 175 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED-- 175 (1431)
T ss_pred HHH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC--
Confidence 999 8899999987644 88889999999999999999999999999999999999999999999996543221110
Q ss_pred CCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC----------C-CCChhhHHHHHHHHHHHHc-CCC
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----------G-HTSAVDWWALGILLYEMLY-GYT 896 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~----------~-~~~~sDIwSlGvil~ellt-G~~ 896 (1002)
+|..+ ..-.++...-..|+|||.+... + .+++.||||+||++.||++ |++
T Consensus 176 ---------------NPadf---~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P 237 (1431)
T KOG1240|consen 176 ---------------NPADF---TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP 237 (1431)
T ss_pred ---------------Ccccc---eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence 01000 0011222334579999988542 1 4678999999999999996 899
Q ss_pred CCCCCCh-------HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcC-------CCcCCCC
Q 001865 897 PFRGKTR-------QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH-------PFFKGVN 962 (1002)
Q Consensus 897 Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~H-------p~f~~~~ 962 (1002)
||.-... .......+++ -.+..+++||..|++.||.+|++ |++.|+- .||-.+-
T Consensus 238 lF~LSQL~aYr~~~~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlS----AedyL~~yrG~~FP~yFy~FL 305 (1431)
T KOG1240|consen 238 LFTLSQLLAYRSGNADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLS----AEDYLQKYRGLVFPEYFYSFL 305 (1431)
T ss_pred cccHHHHHhHhccCccCHHHHHHh--------CcCccHHHHHHHHHccCchhccC----HHHHHHhhhccccHHHHHHHH
Confidence 9842100 1111111111 01235789999999999999999 8888876 4555566
Q ss_pred hhhhhccCCCC
Q 001865 963 WALVRCMNPPE 973 (1002)
Q Consensus 963 ~~~~~~~~~~~ 973 (1002)
+.-+.++.++.
T Consensus 306 ~~Y~~~~~~~~ 316 (1431)
T KOG1240|consen 306 YDYLDRFVPLT 316 (1431)
T ss_pred HHHHHhcCCcc
Confidence 66667777766
|
|
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.4e-21 Score=228.83 Aligned_cols=245 Identities=20% Similarity=0.301 Sum_probs=192.3
Q ss_pred HHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEE
Q 001865 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267 (1002)
Q Consensus 188 ~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (1002)
.+.|+.++++++++++++|. +|+++++|++|++++||+.++++|++...+.++.........+.+.+..+..+..++
T Consensus 3 ~~~~~~i~~~~~~~i~~~d~---~g~~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (494)
T TIGR02938 3 PEAYRQTVDQAPLAISITDL---KANILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKL 79 (494)
T ss_pred hHHHHHHHHhCCceEEEECC---CCcEEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCccccee
Confidence 46789999999999999998 777999999999999999999999987766666666666777778888888888888
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHHHHHHhc
Q 001865 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMK 347 (1002)
Q Consensus 268 ~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~a~~ 347 (1002)
..++++|..+|+...+.|+++.+|.+.+++++++|||++|+++++|+..
T Consensus 80 ~~~~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~e~~l~~~------------------------------- 128 (494)
T TIGR02938 80 LNRRKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRLEQVVANQ------------------------------- 128 (494)
T ss_pred eccCCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHHHHHHHHH-------------------------------
Confidence 8889999999999999999999999999999999999999998776520
Q ss_pred CCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccccccccc
Q 001865 348 KPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRK 427 (1002)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (1002)
T Consensus 129 -------------------------------------------------------------------------------- 128 (494)
T TIGR02938 129 -------------------------------------------------------------------------------- 128 (494)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHH
Q 001865 428 SQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLEL 507 (1002)
Q Consensus 428 ~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l 507 (1002)
+ ..++.++++++++|+++|.+|. ++++|++|+++
T Consensus 129 --------------------------------------~-----~~~~~~~~~~~~~i~~~d~~~~---i~~~N~~~~~~ 162 (494)
T TIGR02938 129 --------------------------------------K-----LLIESVVDAAPVAFVLLDPTGR---VILDNQEYKKL 162 (494)
T ss_pred --------------------------------------H-----HHHHHHHhcccceEEEEcCCCC---EEEechhHHHh
Confidence 0 0178899999999999999888 99999999999
Q ss_pred cCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEE-EEEEEEecCCc-EEEEEEEEEeeecCCCCE---------
Q 001865 508 TEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVT-VQLINYTKSGK-KFWNLFHLQPMRDQKGEV--------- 576 (1002)
Q Consensus 508 ~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~-~e~~~~~kdG~-~~wv~~~~~pi~d~~G~v--------- 576 (1002)
+|+...+..+..+....+++..... ......+..+. .+......+|. .+|+.....++.+..|.+
T Consensus 163 ~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (494)
T TIGR02938 163 ATDLRVKEPAHTVLDLLREAWREAL----AENWPQQLAFSNREARFDRGGGRPARWLSCTGSVIGMESDCADSFFCAAEQ 238 (494)
T ss_pred hchhhhhHHHHHHHHHhhHHhhhhh----hhcchhhhccccceeeeccCCCceeeEEEecCceEEeecchhhheeccCCC
Confidence 9999888877654444443322221 11111122222 24444555555 789999988887766654
Q ss_pred EEEEEEEecCCccccccccC
Q 001865 577 QYFIGVQLDGSEHLEPLRNS 596 (1002)
Q Consensus 577 ~~~vgi~~DITerk~~e~~~ 596 (1002)
.+++++++|||++|++++++
T Consensus 239 ~~~~~~~~DITe~k~~ee~l 258 (494)
T TIGR02938 239 PYLLLTIADISNLREEQERA 258 (494)
T ss_pred chheehHHHHHHHHHHHHHH
Confidence 34567889999999865543
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.3e-21 Score=198.71 Aligned_cols=176 Identities=16% Similarity=0.140 Sum_probs=135.9
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHH------HHHHHHHHHhCCCCCcceeEEEEe
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR------ACAEREILDMLDHPFVPALYASFQ 739 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~ 739 (1002)
+..++|++++.||.|+||.||++.+ ++..+|+|+++............ +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4568999999999999999999766 46689999998664434433333 578999999999999999998866
Q ss_pred eC--------CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEE
Q 001865 740 TK--------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811 (1002)
Q Consensus 740 ~~--------~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vk 811 (1002)
.. +..++||||++|.+|.++.. +++ ..+.+++.+|..||+.|++|||+||+||+++.+| ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 33 35899999999999988732 333 2456999999999999999999999999999988 99
Q ss_pred EEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHH
Q 001865 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891 (1002)
Q Consensus 812 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~el 891 (1002)
|+|||.......+.. ..-++....++.++|+||||+++..+
T Consensus 175 liDfg~~~~~~e~~a---------------------------------------~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 175 IIDLSGKRCTAQRKA---------------------------------------KDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEECCCcccccchhh---------------------------------------HHHHHHHhHhcccccccceeEeehHH
Confidence 999998744321100 00023334466789999999999876
Q ss_pred Hc
Q 001865 892 LY 893 (1002)
Q Consensus 892 lt 893 (1002)
..
T Consensus 216 ~~ 217 (232)
T PRK10359 216 KK 217 (232)
T ss_pred HH
Confidence 43
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=191.68 Aligned_cols=141 Identities=16% Similarity=0.173 Sum_probs=109.7
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHH-----------------------HHHHHHHHHHHHhCCCCC
Q 001865 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-----------------------VHRACAEREILDMLDHPF 730 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~-----------------------~~~~~~E~~il~~l~hpn 730 (1002)
...||+|+||.||+|.+. +|+.||+|+++......... .....+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999996 89999999998653211110 112245899999998887
Q ss_pred cceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCcccCCCCCCcEEEecCCc
Q 001865 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPENVLLQGNGH 809 (1002)
Q Consensus 731 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~L-H~~gIiHrDLKP~NILl~~~g~ 809 (1002)
+.....+... . .++||||++|++|....... ..++...+..++.||+.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 7544433222 2 38999999887776553322 4589999999999999999999 799999999999999998 588
Q ss_pred EEEEeccCCcc
Q 001865 810 VSLTDFDLSCL 820 (1002)
Q Consensus 810 vkL~DFG~a~~ 820 (1002)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-20 Score=202.02 Aligned_cols=236 Identities=23% Similarity=0.282 Sum_probs=153.1
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC----------CCCcceeEEEEe
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD----------HPFVPALYASFQ 739 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~----------hpnIv~l~~~~~ 739 (1002)
.+.....||.|+++.||.|.+..||+.+|+|++..........++.+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4677888999999999999999999999999997665444556666666654443322 223333334332
Q ss_pred ---------eC---C-----eEEEEEeccCCCchhHHHhh---CCCC--CCCHHHHHHHHHHHHHHHHHHHHcCcccCCC
Q 001865 740 ---------TK---T-----HVCLITDYCPGGELFLLLDR---QPTK--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDL 797 (1002)
Q Consensus 740 ---------~~---~-----~~~lV~E~~~ggsL~~~l~~---~~~~--~l~~~~i~~i~~qil~aL~~LH~~gIiHrDL 797 (1002)
.. . ..+++|+-+ .++|.+++.. .... .+.......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 236788888 8899888652 1111 1222333445589999999999999999999
Q ss_pred CCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC-----
Q 001865 798 KPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----- 872 (1002)
Q Consensus 798 KP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~----- 872 (1002)
+|+|++++.+|.++|+||+.....+.. .. ....+..|.+||....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~-----------------------------~~-~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR-----------------------------YR-CSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE-----------------------------EE-GGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce-----------------------------ee-ccCCCcccCChhhhhhhcccC
Confidence 999999999999999999976432210 00 0124577999998743
Q ss_pred ---CCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCC
Q 001865 873 ---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942 (1002)
Q Consensus 873 ---~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~R 942 (1002)
..++.+.|.|+||+++|.|.+|..||........... .+......+..++.||..||++||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 2467799999999999999999999986543221110 233333567789999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.6e-20 Score=187.17 Aligned_cols=245 Identities=19% Similarity=0.298 Sum_probs=202.2
Q ss_pred cccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEE
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 745 (1002)
++.....++.+|.+...|..|++++ .|.-++.|++..... .......|..|.-.|+-..||||+.+++.+.....+.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 5567888889999999999999999 556778888764322 2233356667777888889999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccCCCCCCcEEEecCCcEEEE--eccCCccc
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLT--DFDLSCLT 821 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g--IiHrDLKP~NILl~~~g~vkL~--DFG~a~~~ 821 (1002)
++..||+-|+|+.++..+........++..++.+|+.|++|||+.. |..--|....++++++-+++|. |--++...
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999999888888899999999999999999999984 4445688889999998877663 33333110
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCC---ChhhHHHHHHHHHHHHcCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT---SAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~---~~sDIwSlGvil~elltG~~Pf 898 (1002)
....-.|.||+||.+...+.+ .++|+|||.+++|||.|...||
T Consensus 344 ----------------------------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf 389 (448)
T KOG0195|consen 344 ----------------------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF 389 (448)
T ss_pred ----------------------------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence 112347889999999887654 3899999999999999999999
Q ss_pred CCCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChh
Q 001865 899 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~ 947 (1002)
..-++.+.-.+|.-..+....++.++...-.|+.-|+..||.+||.+..
T Consensus 390 adlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdm 438 (448)
T KOG0195|consen 390 ADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDM 438 (448)
T ss_pred ccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcce
Confidence 9999988888887777777777788999999999999999999999643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.2e-19 Score=182.97 Aligned_cols=143 Identities=18% Similarity=0.160 Sum_probs=112.3
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChH-----------------------HHHHHHHHHHHHHhCCCC
Q 001865 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-----------------------KVHRACAEREILDMLDHP 729 (1002)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~-----------------------~~~~~~~E~~il~~l~hp 729 (1002)
+...||+|+||.||+|.+. +|+.||||+++........ ....+..|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 8999999999875211000 012235788999999999
Q ss_pred CcceeEEEEeeCCeEEEEEeccCCCchhHH-HhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecC
Q 001865 730 FVPALYASFQTKTHVCLITDYCPGGELFLL-LDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 730 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~-l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~ 807 (1002)
++.....+.... .|+||||++|+++... +.. ..++...+..++.|++.+|.+||+ +||+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence 885554443332 4899999988755433 332 347888999999999999999999 9999999999999999 8
Q ss_pred CcEEEEeccCCcccC
Q 001865 808 GHVSLTDFDLSCLTS 822 (1002)
Q Consensus 808 g~vkL~DFG~a~~~~ 822 (1002)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.8e-19 Score=179.48 Aligned_cols=203 Identities=20% Similarity=0.191 Sum_probs=141.5
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh-HHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEEEEE
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-NKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
+-+...|++|+||+||.+.. .+.+++.+.+........ -....+.+|+++|++|+ |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999998776 677888776654321111 11225788999999995 5889999886 4469999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCC-CCCcEEEecCCcEEEEeccCCcccCCCCCC
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDL-KPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDL-KP~NILl~~~g~vkL~DFG~a~~~~~~~~~ 827 (1002)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999998754321 1 1347789999999999999999999 799999999999999999999643321100
Q ss_pred CCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCC-CCC-ChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHT-SAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~~-~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
. ..-. +.+. ... ...-...++.|++|+...-. ..+ ...+.++.|+.+|.++|+..|+.++.
T Consensus 149 ~--r~L~--~rDl---------~~l-lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 M--RLLA--REDL---------RHL-LKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred H--HHHH--HHHH---------HHH-HHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0000 0000 000 00012367788888764322 223 47899999999999999999987654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.8e-19 Score=215.17 Aligned_cols=198 Identities=25% Similarity=0.361 Sum_probs=161.7
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCC---CCCcceeEEEEeeC
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD---HPFVPALYASFQTK 741 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~~~ 741 (1002)
++....|.|-+.||+|+||+||+|.+.. |+.+|||+-+....- .++--.+++.+|+ -+.|..+..++...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W------EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW------EFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce------eeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4567789999999999999999999966 999999998765432 3333334555555 24555666666677
Q ss_pred CeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-------CCcEEEEe
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTD 814 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-------~g~vkL~D 814 (1002)
+.-++|+||.+.|+|.++++. .+.+++..+..+..||+..|++||..+|||+||||+|+|+.. +-.++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 778999999999999999984 467999999999999999999999999999999999999952 33599999
Q ss_pred ccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcC
Q 001865 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG 894 (1002)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG 894 (1002)
||.|..+.--+ +.......++|-.|-++|+..|.++++..|.|.|..+++.||+|
T Consensus 845 fG~siDm~lfp-------------------------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG 899 (974)
T KOG1166|consen 845 FGRSIDMKLFP-------------------------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFG 899 (974)
T ss_pred cccceeeeEcC-------------------------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHH
Confidence 99986543111 11234567899999999999999999999999999999999999
Q ss_pred CC
Q 001865 895 YT 896 (1002)
Q Consensus 895 ~~ 896 (1002)
++
T Consensus 900 ~y 901 (974)
T KOG1166|consen 900 KY 901 (974)
T ss_pred HH
Confidence 64
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.7e-18 Score=176.47 Aligned_cols=136 Identities=22% Similarity=0.224 Sum_probs=107.4
Q ss_pred cccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-----CCCCcceeEEEEeeCC---e
Q 001865 672 RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-----DHPFVPALYASFQTKT---H 743 (1002)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~---~ 743 (1002)
.-...||+|+||.||. ++.++.. +||++.... ......+.+|+.+++.+ +||||++++++++++. .
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 3456799999999995 7777666 699886542 22346789999999999 6799999999999863 5
Q ss_pred EE-EEEec--cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCcccCCCCCCcEEEec----CCcEEEEec
Q 001865 744 VC-LITDY--CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL-EYLHCQGIIYRDLKPENVLLQG----NGHVSLTDF 815 (1002)
Q Consensus 744 ~~-lV~E~--~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL-~~LH~~gIiHrDLKP~NILl~~----~g~vkL~DF 815 (1002)
++ +|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 44 78999 4579999999653 25555 35678888888 9999999999999999999974 337999994
Q ss_pred cCC
Q 001865 816 DLS 818 (1002)
Q Consensus 816 G~a 818 (1002)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=177.74 Aligned_cols=205 Identities=23% Similarity=0.335 Sum_probs=145.7
Q ss_pred CCCCcceeEEEEee---------------------------CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHH
Q 001865 727 DHPFVPALYASFQT---------------------------KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779 (1002)
Q Consensus 727 ~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~q 779 (1002)
.|||||.++.+|.+ +..+|+||..+ ..+|..|+..+. .+....+.++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999887632 23689999999 889999998753 677888889999
Q ss_pred HHHHHHHHHHcCcccCCCCCCcEEEe--cCC--cEEEEeccCCcccCCCCC-CCCCcchhhhhcccCCCCCccccccccc
Q 001865 780 VVVALEYLHCQGIIYRDLKPENVLLQ--GNG--HVSLTDFDLSCLTSCKPQ-LLLPTTNEKKRRHKGQQNPVFMAEPMRA 854 (1002)
Q Consensus 780 il~aL~~LH~~gIiHrDLKP~NILl~--~~g--~vkL~DFG~a~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (1002)
+++|+.|||++||.|||||.+|||+. +|+ .+.|.|||++-. ++.. ...+.. ..
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLA--d~~hGlqlpy~--------------------S~ 407 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLA--DDNHGLQLPYE--------------------SD 407 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeee--ccccccccccc--------------------cc
Confidence 99999999999999999999999995 333 589999997632 2211 111110 01
Q ss_pred ccccccCCcccccccccCCCC------CChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCHHHH
Q 001865 855 SNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAK 928 (1002)
Q Consensus 855 ~~~~~Gt~~Y~aPE~l~~~~~------~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~ 928 (1002)
.-..-|...-||||+....+- ..++|.|+.|.+.||++....||++.-....-..-.+..-..+-+..+++.++
T Consensus 408 ~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~r 487 (598)
T KOG4158|consen 408 EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVAR 487 (598)
T ss_pred cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHH
Confidence 112347778999999854321 23899999999999999999999873322111111222212223345788999
Q ss_pred HHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 929 QLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 929 ~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
+|+..+|+.||++|++.+ ++..+|+-.-+
T Consensus 488 qlV~~lL~r~pskRvsp~-iAANvl~LsLw 516 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPN-IAANVLNLSLW 516 (598)
T ss_pred HHHHHHhcCCccccCCcc-HHHhHHHHHHh
Confidence 999999999999999954 34455544333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-18 Score=191.58 Aligned_cols=185 Identities=26% Similarity=0.385 Sum_probs=137.7
Q ss_pred CeEEEEEeccCCCchhHHHhh-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 742 THVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 742 ~~~~lV~E~~~ggsL~~~l~~-~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
.++||.|++|...+|.+++.+ ......+....+.++.|++.|++| +|.+|+|+||.||++..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 468999999999999999974 344557788899999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~ 900 (1002)
....+. ........+...||..||+||.+.+..|+.++||||||++|+||+. +|..
T Consensus 406 ~~~~~~---------------------~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T 461 (516)
T KOG1033|consen 406 QDKDET---------------------VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFST 461 (516)
T ss_pred cccCCc---------------------ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---Hhcc
Confidence 543321 0111223455689999999999999999999999999999999997 2222
Q ss_pred CCh-HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCc
Q 001865 901 KTR-QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 901 ~~~-~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f 958 (1002)
... ......+-.+.++ |......+.-..|+++||...|.+||+ +.+.--|+|.
T Consensus 462 ~~er~~t~~d~r~g~ip-~~~~~d~p~e~~ll~~lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 462 QFERIATLTDIRDGIIP-PEFLQDYPEEYTLLQQLLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred HHHHHHhhhhhhcCCCC-hHHhhcCcHHHHHHHHhcCCCcccCch----HHHHhhhhhc
Confidence 111 1122222223222 222222344568999999999999997 5555555553
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-17 Score=174.70 Aligned_cols=145 Identities=20% Similarity=0.150 Sum_probs=113.8
Q ss_pred CccccccccccCcEEEEEEE-EcCCCeEEEEEEeecccccC-------------------hH--HHHHHHHHHHHHHhCC
Q 001865 670 HFRPIKPLGSGDTGSVHLVE-LCGSGQYFAMKAMDKGVMLN-------------------RN--KVHRACAEREILDMLD 727 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~-~~~~~~~~avK~~~~~~~~~-------------------~~--~~~~~~~E~~il~~l~ 727 (1002)
.|.+.+.||.|+||.||+|. +..+|+.||+|+++...... .. ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999999 66789999999998542110 00 1123567999999997
Q ss_pred CC--CcceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-cccCCCCCCcEEE
Q 001865 728 HP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLL 804 (1002)
Q Consensus 728 hp--nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~g-IiHrDLKP~NILl 804 (1002)
+. .+++++++ . ..|+||||++|++|....... ..+....+..++.||+.+|.+||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34455543 2 348999999888887664332 34666778899999999999999999 9999999999999
Q ss_pred ecCCcEEEEeccCCccc
Q 001865 805 QGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 805 ~~~g~vkL~DFG~a~~~ 821 (1002)
+ ++.++|+|||.+...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999998543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-17 Score=197.62 Aligned_cols=298 Identities=33% Similarity=0.536 Sum_probs=229.9
Q ss_pred ccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEE
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 746 (1002)
..+.+.+.+.+-+|.++.++.+.-..+|-..+.|+..+........+.....+-.++-...+|.++...-.+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45678888899999999999999888887777777665433333344444455555544566777766666667788999
Q ss_pred EEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCC
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~ 826 (1002)
|++|+.+++|...+...+ ..+.+-.+.++..+..+++|||...+.|+|++|.|++...+|+.++.|||.......-+.
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999999999987653 477778888999999999999999999999999999999999999999995432221110
Q ss_pred CCCC----cchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 001865 827 LLLP----TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 827 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~ 902 (1002)
..-. ......+.......+.......+......||+.|.+||.+.+......+|+|++|+++++.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0000 000000111122222222334455667899999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCC-CCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCCChhhhh
Q 001865 903 RQKTFANILHKDLKFPSSTP-TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 967 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~-~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~ 967 (1002)
...++.+|..+.+.|+.... .+.++++++..+|..+|.+|..++ ++.+...||||+.++|+.+.
T Consensus 1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~-~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK-GAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc-cccccccCCccCCCCccccc
Confidence 99999999999999987643 578899999999999999999943 24588999999999999884
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-16 Score=164.54 Aligned_cols=138 Identities=21% Similarity=0.237 Sum_probs=115.2
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh-----HHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEE
Q 001865 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~ 748 (1002)
++.||+|++|.||++.+ .+..+++|+......... .....+.+|+.++..+.|++++....++...+..++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36799999999999987 677899998664332221 12245778999999999999887777777778889999
Q ss_pred eccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 749 E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
||++|++|.+++... .. ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999998653 12 7888999999999999999999999999999999 88999999998854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.9e-16 Score=161.92 Aligned_cols=133 Identities=18% Similarity=0.213 Sum_probs=107.7
Q ss_pred cccccCcEEEEEEEEcCCCeEEEEEEeecccccC-----hHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEec
Q 001865 676 PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-----RNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 676 ~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
.||+|+||.||++.. ++..+++|+........ ......+.+|+++++.+.|+++....-++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999995 67889999865432211 11235677899999999888766555555666777999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~-----~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH-----H----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999875421 0 7789999999999999999999999999999 89999999998854
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.1e-16 Score=160.83 Aligned_cols=139 Identities=21% Similarity=0.152 Sum_probs=108.8
Q ss_pred CccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh-------------------HHHHHHHHHHHHHHhCCCC-
Q 001865 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-------------------NKVHRACAEREILDMLDHP- 729 (1002)
Q Consensus 670 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~-------------------~~~~~~~~E~~il~~l~hp- 729 (1002)
.|.+.+.||.|+||.||++.+. +|+.+|||++........ ........|+.++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999884 799999999765321000 0112356788889888777
Q ss_pred -CcceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC
Q 001865 730 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808 (1002)
Q Consensus 730 -nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g 808 (1002)
.++.+++ ....++||||++|++|..+... .....++.+|+.++.++|+.||+|+||||+||+++.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 4445443 2455899999999998765431 34567889999999999999999999999999999999
Q ss_pred cEEEEeccCCccc
Q 001865 809 HVSLTDFDLSCLT 821 (1002)
Q Consensus 809 ~vkL~DFG~a~~~ 821 (1002)
.++|+|||++...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 9999999998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-17 Score=198.28 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=206.0
Q ss_pred cCCccccccccccCcEEEEEEEEcCC-CeEEEEEEeecccccChHHHHHHHHHHHHHHhCC-CCCcceeEEEEeeCCeEE
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~ 745 (1002)
...|.+.+.||+|+|+.|-.+....+ ...+|+|.+.... ...........|..+-+.+. |.|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 45788999999999999988887443 4467777665432 23334455556777777776 999999999999999999
Q ss_pred EEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEEecCC-cEEEEeccCCcccCC
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTSC 823 (1002)
Q Consensus 746 lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH-~~gIiHrDLKP~NILl~~~g-~vkL~DFG~a~~~~~ 823 (1002)
++++|..|++++..+........+......++.|+..++.|+| ..++.|+||||+|.+++.++ .+++.|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999999884222225778888999999999999999 99999999999999999999 999999999966542
Q ss_pred CCCCCCCcchhhhhcccCCCCCccccccccccccccc-CCcccccccccCC-CCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG-TEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G-t~~Y~aPE~l~~~-~~~~~sDIwSlGvil~elltG~~Pf~~~ 901 (1002)
... ........+| ++.|+|||.+.+. ...+..|+||.|+++.-+++|..|+...
T Consensus 178 ~~g------------------------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 178 KNG------------------------AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred cCC------------------------cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 111 1122334577 9999999999884 5567899999999999999999999765
Q ss_pred ChHHHHH-HHHhC--CCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCC
Q 001865 902 TRQKTFA-NILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 902 ~~~~~~~-~i~~~--~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~ 960 (1002)
....... ..... ......+...+....+++.+++..+|..|.+ ++++..+||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccccccceeecccccccccCccccCChhhhhcccccccCCchhccc----cccccccccccc
Confidence 4433221 11111 1123344456778889999999999999999 999999999998
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.8e-15 Score=136.71 Aligned_cols=104 Identities=26% Similarity=0.564 Sum_probs=96.2
Q ss_pred CCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCcEEE
Q 001865 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 278 (1002)
Q Consensus 199 ~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 278 (1002)
|+|++++|. +|+|+++|++|++++||+.++++|+++..++++.........+.+.+..+..+..++..++++|+.+|
T Consensus 1 p~~i~i~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDP---DGRILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEET---TSBEEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECC---cCcEEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999 78899999999999999999999999998888888888889999999999999999999999999999
Q ss_pred EEEEeeeeecCCCCEEEEEEEEecchh
Q 001865 279 NLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (1002)
Q Consensus 279 ~~~~~~pi~d~~G~v~~~v~i~~DITe 305 (1002)
+.++++|+.+++|++.+++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-15 Score=180.97 Aligned_cols=139 Identities=21% Similarity=0.226 Sum_probs=111.9
Q ss_pred CCccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc-----ChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCe
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-----NRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 743 (1002)
..|...+.||+|+||.||++.+... .+++|+....... .......+.+|+++++.++|++++....++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3557789999999999999987443 3444433221111 11234567889999999999999988777777777
Q ss_pred EEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 744 ~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
.++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999875 346788999999999999999999999999999 578999999999965
|
|
| >PF13426 PAS_9: PAS domain; PDB: 3ULF_B 3UE6_E 2Z6D_B 2Z6C_B 3P7N_B 1LL8_A 3MJQ_A 3BWL_A 4EET_B 4EEP_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.1e-15 Score=136.52 Aligned_cols=104 Identities=28% Similarity=0.460 Sum_probs=96.4
Q ss_pred cccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEE
Q 001865 482 EKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (1002)
Q Consensus 482 ~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~w 561 (1002)
|+||+++|.+|. |+++|++|++++||++++++|+++..+.+++......+.+.+.+..+..+..+..+++++|+.+|
T Consensus 1 p~~i~i~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~g~~~~ 77 (104)
T PF13426_consen 1 PDGIFILDPDGR---ILYVNPAFERLFGYSREELIGKSISDFFPEEDRPEFEEQIERALEEGGSWSGEVRLRRKDGETFW 77 (104)
T ss_dssp -SEEEEEETTSB---EEEE-HHHHHHHTS-HHHHTTSBGGGGCSTTSCHHHHHHHHHHHHHTSSEEEEEEEEETTSEEEE
T ss_pred CEEEEEECCcCc---EEehhHHHHHHHCcCHHHHcCCCcccccCcccchhhHHHHHHHHhcCCceeEEEEEEcCCCCEEE
Confidence 689999999888 99999999999999999999999999988888888889999999999999999999999999999
Q ss_pred EEEEEEeeecCCCCEEEEEEEEecCCc
Q 001865 562 NLFHLQPMRDQKGEVQYFIGVQLDGSE 588 (1002)
Q Consensus 562 v~~~~~pi~d~~G~v~~~vgi~~DITe 588 (1002)
+++++.|+++++|++.+++++++||||
T Consensus 78 ~~~~~~~i~~~~g~~~~~i~~~~DiTe 104 (104)
T PF13426_consen 78 VEVSASPIRDEDGEITGIIGIFRDITE 104 (104)
T ss_dssp EEEEEEEEEETTSSEEEEEEEEEEEHH
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCC
Confidence 999999999999999999999999996
|
... |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.8e-15 Score=152.75 Aligned_cols=140 Identities=20% Similarity=0.213 Sum_probs=100.3
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHH---------------------HHHHHHHHHhCCCC--
Q 001865 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR---------------------ACAEREILDMLDHP-- 729 (1002)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~---------------------~~~E~~il~~l~hp-- 729 (1002)
+.+.||+|+||+||+|.+. +++.||||+++............ ...|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999986 78999999987642211111111 13456666666443
Q ss_pred CcceeEEEEeeCCeEEEEEeccCCCchhH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccCCCCCCcEEEecC
Q 001865 730 FVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 730 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~-~gIiHrDLKP~NILl~~~ 807 (1002)
.+++++++ ...++||||++++.+.. .+.... . ...++.++.+++.++.++|. .||+|+||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 34555543 23589999998854432 121110 1 16678899999999999999 9999999999999999 9
Q ss_pred CcEEEEeccCCcccC
Q 001865 808 GHVSLTDFDLSCLTS 822 (1002)
Q Consensus 808 g~vkL~DFG~a~~~~ 822 (1002)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=166.94 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=152.5
Q ss_pred HHhCCCCCcceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-ccCCCCCCc
Q 001865 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-IYRDLKPEN 801 (1002)
Q Consensus 723 l~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gI-iHrDLKP~N 801 (1002)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... ...++..-...++++|+.||+|||...| .|+.|++.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45689999999999999999999999999999999999763 3458888888999999999999998865 999999999
Q ss_pred EEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCC-------
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------- 874 (1002)
Q Consensus 802 ILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------- 874 (1002)
++++....+||.|||+......... ........-...|.|||.+.+..
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~-------------------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~ 134 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAE-------------------------PEAHHPIRKALLWTAPELLRGALSQSLESA 134 (484)
T ss_pred ceeeeeEEEEechhhhccccccccc-------------------------ccccchhHHHHhccCHHHhccccccccccc
Confidence 9999999999999999865421000 00111122455799999997641
Q ss_pred CCChhhHHHHHHHHHHHHcCCCCCCCC----ChHHHHHHHHhCCCC--CCC---CCCCCHHHHHHHHHccccCcCCCCCC
Q 001865 875 HTSAVDWWALGILLYEMLYGYTPFRGK----TRQKTFANILHKDLK--FPS---STPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 875 ~~~~sDIwSlGvil~elltG~~Pf~~~----~~~~~~~~i~~~~~~--~~~---~~~~s~~~~~Ll~~~L~~dP~~Rpt~ 945 (1002)
.+.+.||||+|+++||+++...||... ...+++..+..+... .|. .....+.+..++..||..+|..||++
T Consensus 135 ~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 135 LTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred ccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 355799999999999999999999762 223455555441211 111 11234468899999999999999995
Q ss_pred hh
Q 001865 946 HE 947 (1002)
Q Consensus 946 ~~ 947 (1002)
..
T Consensus 215 ~~ 216 (484)
T KOG1023|consen 215 EQ 216 (484)
T ss_pred HH
Confidence 43
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.9e-14 Score=153.09 Aligned_cols=137 Identities=23% Similarity=0.341 Sum_probs=105.0
Q ss_pred cccc-ccCcEEEEEEEEcCCCeEEEEEEeecccc-----c-----ChHHHHHHHHHHHHHHhCCCCCc--ceeEEEEeeC
Q 001865 675 KPLG-SGDTGSVHLVELCGSGQYFAMKAMDKGVM-----L-----NRNKVHRACAEREILDMLDHPFV--PALYASFQTK 741 (1002)
Q Consensus 675 ~~LG-~G~~g~Vy~a~~~~~~~~~avK~~~~~~~-----~-----~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~~~ 741 (1002)
..|| .||.|+||.+.. .+..++||.+....+ . .......+.+|+.++..|.|++| +.++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3466 888889999887 477899998864321 0 11233567889999999988775 6777664432
Q ss_pred -C---eEEEEEeccCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEecc
Q 001865 742 -T---HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816 (1002)
Q Consensus 742 -~---~~~lV~E~~~g-gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG 816 (1002)
. ..++|||+++| .+|.+++... .++... +.||+.+|.+||++||+|+||||.|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999987 6898888652 355543 5689999999999999999999999999999999999999
Q ss_pred CCcc
Q 001865 817 LSCL 820 (1002)
Q Consensus 817 ~a~~ 820 (1002)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.7e-14 Score=138.33 Aligned_cols=132 Identities=23% Similarity=0.245 Sum_probs=112.1
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCcceeEEEEeeCCeEEEEEec
Q 001865 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~~~~~lV~E~ 750 (1002)
+++.||.|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.+ .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999843 7899999865421 4567889999999976 5899999988888899999999
Q ss_pred cCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHc---CcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ---GIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 751 ~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~---gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
+.|+.+..+ +......++.+++.+|++||.. +++|+||+|+||++++++.++++|||.+..
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988777554 4566677889999999999985 799999999999999989999999999854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-13 Score=127.24 Aligned_cols=110 Identities=24% Similarity=0.365 Sum_probs=99.1
Q ss_pred HHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCC
Q 001865 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDG 274 (1002)
Q Consensus 195 le~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG 274 (1002)
|++++++++++|. +|+|+++|+++++++|++.++++|+++..++++.........+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~---~~~i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDP---DGRIVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEET---TSBEEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECC---CCEEEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6899999999999 8889999999999999999999999999888887777788888899998887776665544 99
Q ss_pred cEEEEEEEeeeeecCCCCEEEEEEEEecchhhhH
Q 001865 275 TPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308 (1002)
Q Consensus 275 ~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~ 308 (1002)
..+|+.+++.|++|.+|++.|++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-14 Score=164.64 Aligned_cols=263 Identities=22% Similarity=0.221 Sum_probs=200.4
Q ss_pred cccCCccccccccc--cCcEEEEEEEE--cCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEee
Q 001865 666 INLQHFRPIKPLGS--GDTGSVHLVEL--CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT 740 (1002)
Q Consensus 666 i~~~~y~i~~~LG~--G~~g~Vy~a~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 740 (1002)
.....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.. ...+.....-.+|..-...+ .|++.++.+..+..
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence 34567888899999 99999999998 888999999975433 22223333445565555555 58999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCcccCCCCCCcEEEecC-CcEEEEec
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV----ALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDF 815 (1002)
Q Consensus 741 ~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~----aL~~LH~~gIiHrDLKP~NILl~~~-g~vkL~DF 815 (1002)
.+..|+-+|+| +.+|..+... ....++...++.+..+... ||.++|+.+|+|-|+||.||++..+ ..++++||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred CCcceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 99999999999 7888888754 3456899999999999999 9999999999999999999999999 88999999
Q ss_pred cCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCC
Q 001865 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895 (1002)
Q Consensus 816 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~ 895 (1002)
|+...+....... .........|...|++||.+.+. ++...|||+||.++.+..+|.
T Consensus 268 ~~v~~i~~~~~~~----------------------~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 268 GLVSKISDGNFSS----------------------VFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred ceeEEccCCcccc----------------------ceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhc
Confidence 9987665332111 11111233577889999998766 678999999999999988877
Q ss_pred CCCCCC--ChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcCCC
Q 001865 896 TPFRGK--TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 896 ~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~ 961 (1002)
.++... +.......+ .++.......+..+...+..|++.+|-.|++ ++.+++|+++..-
T Consensus 325 ~~~~~g~~~~W~~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 325 HLPSVGKNSSWSQLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred ccccCCCCCCccccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhH----HHHHhccccccch
Confidence 766543 322222221 1222222334556667899999999999999 9999999999863
|
|
| >PF08448 PAS_4: PAS fold; InterPro: IPR013656 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=127.82 Aligned_cols=110 Identities=25% Similarity=0.335 Sum_probs=99.5
Q ss_pred HHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCC
Q 001865 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 557 (1002)
Q Consensus 478 ~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG 557 (1002)
|++++++|+++|.+|+ |+++|+++++++|++.++++|+++..+.++.....+...+.+++.++.....+..... +|
T Consensus 1 l~~~p~~i~v~D~~~~---i~~~N~~~~~~~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 76 (110)
T PF08448_consen 1 LDSSPDGIFVIDPDGR---IVYANQAAAELFGVSPEELIGRSLFDLLPPEDREEFQAALRRALAGGEPVFFEEILLR-DG 76 (110)
T ss_dssp HHHCSSEEEEEETTSB---EEEE-HHHHHHHTSTHHHHTTSBHHHHSCCGCHHHHHHHHHHHHHHTSEEEEEEEECT-TS
T ss_pred CCCCCceeEEECCCCE---EEEEHHHHHHHhCCCHHHHhhccchhccccchhhhhHHHHHHhhccCceEEEEEEEee-cC
Confidence 6889999999999888 9999999999999999999999998888888778888888999888887776666555 99
Q ss_pred cEEEEEEEEEeeecCCCCEEEEEEEEecCCcccc
Q 001865 558 KKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (1002)
Q Consensus 558 ~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~ 591 (1002)
..+|+.+++.|++|.+|++.+++++++|||++|+
T Consensus 77 ~~~~~~~~~~Pi~~~~g~~~g~~~~~~DiT~~rr 110 (110)
T PF08448_consen 77 EERWFEVSISPIFDEDGEVVGVLVIIRDITERRR 110 (110)
T ss_dssp CEEEEEEEEEEEECTTTCEEEEEEEEEEECCHHH
T ss_pred CcEEEEEEEEEeEcCCCCEEEEEEEEEECchhhC
Confidence 9999999999999999999999999999999985
|
The PAS fold appears in archaea, eubacteria and eukarya. ; PDB: 3K3D_A 3K3C_B 3KX0_X 3FC7_B 3LUQ_D 3MXQ_A 3BWL_C 3FG8_A. |
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.4e-13 Score=126.45 Aligned_cols=112 Identities=21% Similarity=0.385 Sum_probs=95.5
Q ss_pred HHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE-EE
Q 001865 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG-RL 267 (1002)
Q Consensus 189 ~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~-e~ 267 (1002)
+.|++++++++++++++|. +|+|+++|++|++++||+.++++|+++..+++++........+.+.+..+..... +.
T Consensus 1 e~~~~i~~~~~~~i~~~d~---~g~I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (113)
T PF00989_consen 1 ERYRAILENSPDGIFVIDE---DGRILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEV 77 (113)
T ss_dssp HHHHHHHHCSSSEEEEEET---TSBEEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEE
T ss_pred CHHHHHHhcCCceEEEEeC---cCeEEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEE
Confidence 5789999999999999998 8889999999999999999999999999887776555577778888877776544 34
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecc
Q 001865 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303 (1002)
Q Consensus 268 ~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DI 303 (1002)
....++|+.+|+.+..+|+++.+|++.|++++++||
T Consensus 78 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 78 RFRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 344469999999999999999999999999999997
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK09776 putative diguanylate cyclase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.9e-14 Score=187.37 Aligned_cols=267 Identities=9% Similarity=-0.004 Sum_probs=195.2
Q ss_pred ccccccccccccccccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCC-CCcccCCCCC
Q 001865 168 VRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRN-CRFLQGAGTD 246 (1002)
Q Consensus 168 ~~~~~dit~~~~~e~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~-~~~l~~~~~~ 246 (1002)
+....|||++++++++++++++.++.+++..+++++.+|. +|+++++|+++++++||+.++..+.. +..+.++++.
T Consensus 389 i~~~~DITerk~~e~~l~~~~~~~~~~~~~~~~~i~~~d~---~~~~~~~n~~~~~l~G~~~~~~~~~~~~~~~~~p~d~ 465 (1092)
T PRK09776 389 IAQIEDINELKRTEQVNERLMERITLANEAGGIGIWEWDL---KPNIISWDKRMFELYEIPPHIKPTWQVWYACLHPEDR 465 (1092)
T ss_pred hhhHHhhHHHHHHHHHHHHHHHHHHHHHHhcCceEEEEec---CCCeEeeCHHHHHHhCCCcccCCCHHHHHHhcCHhHH
Confidence 3445899999999999999999999999999999999999 77799999999999999998844432 2234556666
Q ss_pred hHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhh
Q 001865 247 PEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIR 326 (1002)
Q Consensus 247 ~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~~l~~ 326 (1002)
......+...+..+..+..+++.+++|| .+|+.....+++|++|.+.+++++.+|||++|+++++|+...++
T Consensus 466 ~~~~~~~~~~~~~~~~~~~e~r~~~~dG-~~w~~~~~~~~~d~~G~~~~~ig~~~DITerk~~e~~L~~~~~~------- 537 (1092)
T PRK09776 466 QRVEKEIRDALQGRSPFKLEFRIVVKDG-VRHIRALANRVLNKDGEVERLLGINMDMTEVRQLNEALFQEKER------- 537 (1092)
T ss_pred HHHHHHHHHHHhcCCCeeEEEEEEcCCc-eEEEEEeeEEEECCCCCEEEEEeeeeehhHHHHHHHHHHHHHHH-------
Confidence 6666777888888888999999999999 99999999999999999999999999999999999888732111
Q ss_pred HHHHHHHHhhhhHHHHHHHh-cCCCCcccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCC-C-CCcccccc-
Q 001865 327 YDARQKEMATSSVTELVQAM-KKPRSLSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSY-G-GGCRTSMQ- 402 (1002)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~a~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~-~-~~~~~~~~- 402 (1002)
...+.... ..+...+......++|..+....|++.+++.|+...+.......... . ........
T Consensus 538 ------------l~~~l~~~~~~i~~~D~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (1092)
T PRK09776 538 ------------LHITLDSIGEAVVCTDMAMKVTFMNPVAEKMTGWTQEEALGVPLLTVLHITFGDNGPLMENIYSCLTS 605 (1092)
T ss_pred ------------HHHHHhccccEEEEECCCCeEEEEcHHHHHHhCCCHHHHcCCCHHHHcccccCCcchhhHHHHHHHhc
Confidence 11122222 22344555566778899999999999999999988776543211100 0 00000000
Q ss_pred ---cccccchhhccccCCcccccccccccccCCCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhh
Q 001865 403 ---RISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRK 470 (1002)
Q Consensus 403 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~l~~ 470 (1002)
...........++|...|+.....+..+.++.......+ .+|+|++++.+++++.
T Consensus 606 ~~~~~~~~~~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~-------------~~DITe~k~~e~~L~~ 663 (1092)
T PRK09776 606 RSAAYLEQDVVLHCRSGGSYDVHYSITPLSTLDGENIGSVLV-------------IQDVTESRKMLRQLSY 663 (1092)
T ss_pred CCCccccceEEEEeCCCcEEEEEEEeeeeecCCCCEEEEEEE-------------EEecchHHHHHHHHHh
Confidence 111223334567888888888877777766654433333 5789999998888754
|
|
| >PF00989 PAS: PAS fold; InterPro: IPR013767 PAS domains are involved in many signalling proteins where they are used as a signal sensor domain [] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.3e-13 Score=125.71 Aligned_cols=111 Identities=22% Similarity=0.328 Sum_probs=96.4
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEE-EEE
Q 001865 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTV-QLI 551 (1002)
Q Consensus 473 ~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~-e~~ 551 (1002)
.|++++++++++++++|.+|. |+++|++++++|||+.++++|+++..++++++.....+.+.+.+..+..... +..
T Consensus 2 ~~~~i~~~~~~~i~~~d~~g~---I~~~N~a~~~l~g~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T PF00989_consen 2 RYRAILENSPDGIFVIDEDGR---ILYVNQAAEELLGYSREELIGKSLFDLIHPEDRRELRERLRQALSQGESGESFEVR 78 (113)
T ss_dssp HHHHHHHCSSSEEEEEETTSB---EEEECHHHHHHHSS-HHHHTTSBGGGGCSGGGHHHHHHHHHHHHHHCCHECEEEEE
T ss_pred HHHHHHhcCCceEEEEeCcCe---EEEECHHHHHHHccCHHHHcCCcHHHhcCchhhHHHHHHHHHHHHcCCCceeEEEE
Confidence 389999999999999999888 9999999999999999999999999888887665677788888877766444 555
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecC
Q 001865 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 586 (1002)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DI 586 (1002)
...++|+.+|+.++..|+++.+|++.+++++++||
T Consensus 79 ~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~DI 113 (113)
T PF00989_consen 79 FRLRDGRPRWVEVRASPVRDEDGQIIGILVIFRDI 113 (113)
T ss_dssp EEETTSCEEEEEEEEEEEEETTEEEEEEEEEEEE-
T ss_pred EEecCCcEEEEEEEEEEEEeCCCCEEEEEEEEEeC
Confidence 55579999999999999999999999999999998
|
PAS domains appear in archaea, bacteria and eukaryotes. Several PAS-domain proteins are known to detect their signal by way of an associated cofactor. Haeme, flavin, and a 4-hydroxycinnamyl chromophore are used in different proteins. The PAS domain was named after three proteins that it occurs in: Per- period circadian protein Arnt- Ah receptor nuclear translocator protein Sim- single-minded protein. PAS domains are often associated with PAC domains IPR001610 from INTERPRO. It appears that these domains are directly linked, and that together they form the conserved 3D PAS fold. The division between the PAS and PAC domains is caused by major differences in sequences in the region connecting these two motifs []. In human PAS kinase, this region has been shown to be very flexible, and adopts different conformations depending on the bound ligand []. Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels [].; GO: 0006355 regulation of transcription, DNA-dependent; PDB: 2GJ3_A 4F3L_B 1XFN_A 1OTD_A 2PYR_A 1KOU_A 1XFQ_A 2ZOI_A 2ZOH_A 1OTA_A .... |
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.4e-12 Score=146.45 Aligned_cols=122 Identities=44% Similarity=0.808 Sum_probs=109.0
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEE
Q 001865 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (1002)
Q Consensus 472 ~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~ 551 (1002)
..|+.++++++++|+++|.++.+++|+++|++|++++||+.+|++|+++..+.+++........+...+..+..+..+..
T Consensus 43 ~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 122 (361)
T PRK13559 43 RLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVVELL 122 (361)
T ss_pred hHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEEEEE
Confidence 34888999999999999986656669999999999999999999999988777777666677777888888888888999
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCcccccc
Q 001865 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (1002)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e 593 (1002)
.+++||..+|+..+..|+++.+|.+.+++++++|||++|+.+
T Consensus 123 ~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e 164 (361)
T PRK13559 123 NYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVR 164 (361)
T ss_pred EEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhH
Confidence 999999999999999999999999999999999999999853
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.8e-12 Score=153.14 Aligned_cols=133 Identities=37% Similarity=0.735 Sum_probs=121.0
Q ss_pred ccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCC
Q 001865 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (1002)
Q Consensus 182 ~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (1002)
.........|+.+++.++++|+++|..+.+|+|+|+|++|++++||+.+|++|+++..+.+++........++..+..+.
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~ 102 (540)
T PRK13557 23 DVSDHRSDIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERR 102 (540)
T ss_pred hhhhhhhHHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCC
Confidence 33456678999999999999999998777899999999999999999999999999988887777777888888898888
Q ss_pred cEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhh
Q 001865 262 SYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (1002)
Q Consensus 262 ~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~ 314 (1002)
.+..+++.++++|+.+|+.+++.|+++.+|.+++++++.+|||+++++++++.
T Consensus 103 ~~~~~~~~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~ 155 (540)
T PRK13557 103 EIATEILNYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALR 155 (540)
T ss_pred CceEEEEEEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHH
Confidence 88888888999999999999999999999999999999999999999987765
|
|
| >PRK13557 histidine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.3e-12 Score=155.90 Aligned_cols=148 Identities=39% Similarity=0.698 Sum_probs=121.4
Q ss_pred ccHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEE
Q 001865 472 IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLI 551 (1002)
Q Consensus 472 ~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~ 551 (1002)
..|..++++++++|+++|.++.+++|+|+|++|++++||+.+|++|+++..+.+++........++..+..+..+..+++
T Consensus 30 ~~~~~~~~~~~~~i~v~d~~~~~g~i~~~N~a~~~~~G~~~~e~~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 109 (540)
T PRK13557 30 DIFFAAVETTRMPMIVTDPNQPDNPIVFANRAFLEMTGYAAEEIIGNNCRFLQGPETDRATVAEVRDAIAERREIATEIL 109 (540)
T ss_pred HHHHHHHHhCcCcEEEEcCCCCCCCEEEEcHHHHHHhCCCHHHhcCCChHhhcCCCCCHHHHHHHHHHHHcCCCceEEEE
Confidence 45899999999999999986556669999999999999999999999988888888877778888888888888888998
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccccccccCCchhhHHHHHHHHHHHhhhhhhh
Q 001865 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 619 (1002)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e~~~~~~~~~~e~~~~~k~~~~~v~~~ 619 (1002)
..+++|+.+|+..++.|+++.+|.+++++++.+|||++++.++..........+...+..+.|.++..
T Consensus 110 ~~~~~G~~~~~~~~~~~i~~~~g~~~~~~~~~~dit~~~~~e~~l~~~~~~~~l~~~~~~i~h~l~~p 177 (540)
T PRK13557 110 NYRKDGSSFWNALFVSPVYNDAGDLVYFFGSQLDVSRRRDAEDALRQAQKMEALGQLTGGIAHDFNNL 177 (540)
T ss_pred EEeCCCCEEEEEEEEEEeECCCCCEEEEEEEecChHHHHHHHHHHHHHHHHHHhhhhhhhhhHHhhhH
Confidence 89999999999999999999999999999999999999986544332222233333344444444433
|
|
| >PRK13559 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.9e-12 Score=142.98 Aligned_cols=129 Identities=40% Similarity=0.748 Sum_probs=114.2
Q ss_pred chHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEE
Q 001865 186 RVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG 265 (1002)
Q Consensus 186 ~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~ 265 (1002)
.+...|+.++++++++|+++|..+.+|+|+++|++|++++||+.+|++|+++..+.++.........+...+..+..+..
T Consensus 40 ~~~~~~~~~~e~~~~~i~i~D~~~~~g~i~~~N~a~~~l~G~~~~e~iG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (361)
T PRK13559 40 ASGRLFEQAMEQTRMAMCITDPHQPDLPIVLANQAFLDLTGYAAEEVVGRNCRFLQGAATDPIAVAKIRAAIAAEREIVV 119 (361)
T ss_pred hhhhHHHHHHHhCCCcEEEecCCCCCCcEEEEchHHHHHhCCCHHHHcCCChhhhcCCCCCHHHHHHHHHHhccCCceEE
Confidence 45667889999999999999986667889999999999999999999999988777666666666777888888888888
Q ss_pred EEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhh
Q 001865 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (1002)
Q Consensus 266 e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~ 314 (1002)
+...+++||..+|+.+++.|+++.+|.+.+++++++|||++|+++++++
T Consensus 120 e~~~~~~dG~~~~~~~~~~~i~d~~G~~~~~v~~~~DITerk~~e~~~~ 168 (361)
T PRK13559 120 ELLNYRKDGEPFWNALHLGPVYGEDGRLLYFFGSQWDVTDIRAVRALEA 168 (361)
T ss_pred EEEEEcCCCCEEEEEEEEEEEEcCCCCEEEeeeeeeehhcchhhHHHHH
Confidence 8888999999999999999999999999999999999999998875543
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.1e-12 Score=163.39 Aligned_cols=142 Identities=13% Similarity=0.120 Sum_probs=128.7
Q ss_pred cccccccccccccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHH
Q 001865 171 SGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDV 250 (1002)
Q Consensus 171 ~~dit~~~~~e~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~ 250 (1002)
..+++++++++.+++++++.++.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..+++++......
T Consensus 137 ~~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~---~g~i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~ 213 (779)
T PRK11091 137 KNEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNE---DGEFSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVI 213 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECC---CCcEEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHH
Confidence 3788899999999999999999999999999999998 7889999999999999999999999988887776555556
Q ss_pred HHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001865 251 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (1002)
Q Consensus 251 ~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~ 315 (1002)
......+..+..+..+.+..++||..+|+.++..|+++.+|.+.|++++++|||++|+++++++.
T Consensus 214 ~~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e~~l~~ 278 (779)
T PRK11091 214 ETDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQDALEK 278 (779)
T ss_pred HHHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHHHHHHH
Confidence 66667778888888899989999999999999999999999999999999999999999988763
|
|
| >PRK11091 aerobic respiration control sensor protein ArcB; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.2e-12 Score=160.76 Aligned_cols=135 Identities=14% Similarity=0.101 Sum_probs=119.7
Q ss_pred CCchhhHHHHHhhhhc-ccHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHH
Q 001865 456 PDSVDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR 534 (1002)
Q Consensus 456 ~~~~~~~~~e~~l~~~-~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~ 534 (1002)
.++.++...++++++. ..++.++++++++|+++|.+|+ |+++|+++++++||+.++++|+++..+.+++.......
T Consensus 138 ~~i~~r~~~~~~l~~~~~~l~~il~~~~~~i~~~D~~g~---i~~~N~a~~~l~G~~~~eliG~~~~~l~~~~~~~~~~~ 214 (779)
T PRK11091 138 NEIKEREETQIELEQQSSLLRSFLDASPDLVYYRNEDGE---FSGCNRAMELLTGKSEKQLIGLTPKDVYSPEAAEKVIE 214 (779)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhcCcceEEEECCCCc---EEeEcHHHHHHhCcCHHHHcCCChHHhCCHHHHHHHHH
Confidence 4566777777777655 5689999999999999999888 99999999999999999999999888888776666666
Q ss_pred HHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCcccccc
Q 001865 535 KIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (1002)
Q Consensus 535 ~l~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e 593 (1002)
.....+..+..+..+.+..++||..+|+.++..|+++.+|.+.+++++++|||++|+.+
T Consensus 215 ~~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~pi~~~~g~~~g~v~~~~DITe~k~~e 273 (779)
T PRK11091 215 TDEKVFRHNVSLTYEQWLDYPDGRKACFELRKVPFYDRVGKRHGLMGFGRDITERKRYQ 273 (779)
T ss_pred HHHHHHhcCCCeEEEEEEEcCCCCEEEEEEEeeeEEcCCCCEEEEEEEEeehhHHHHHH
Confidence 67777788888899999999999999999999999999999999999999999999854
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-12 Score=150.83 Aligned_cols=144 Identities=21% Similarity=0.242 Sum_probs=98.3
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChH---------------------------HH----H------HH
Q 001865 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN---------------------------KV----H------RA 716 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~---------------------------~~----~------~~ 716 (1002)
.+.||.|++|+||+|.. .+|+.||||+.++.....-. .. . .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999997 47899999998765211000 00 0 13
Q ss_pred HHHHHHHHhC-----CCCCcceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHH-HHHHHHHc
Q 001865 717 CAEREILDML-----DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV-ALEYLHCQ 790 (1002)
Q Consensus 717 ~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~-aL~~LH~~ 790 (1002)
.+|...+.++ ++++|.-..-+.......++||||++|++|.++....... .. ...++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHhC
Confidence 3444444444 2343322222223344578999999999998886532111 22 3445666665 47889999
Q ss_pred CcccCCCCCCcEEEecCCcEEEEeccCCcccC
Q 001865 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 791 gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~ 822 (1002)
|++|+|++|.||+++.+|.++|+|||++..+.
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.5e-13 Score=156.90 Aligned_cols=186 Identities=17% Similarity=0.207 Sum_probs=110.1
Q ss_pred CchhhhccCCcccCCCCCCCCCCchhHHHhhcccccccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeeccccc
Q 001865 629 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 708 (1002)
Q Consensus 629 ~p~~l~an~s~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~ 708 (1002)
=|+++...-+++....|+.........+..-+.....-....|.. +.||+|++|+||+|..+.+|+.||||+.++....
T Consensus 80 lP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~ 158 (537)
T PRK04750 80 FPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILP 158 (537)
T ss_pred CCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHH
Confidence 355565555555554443322212222222222111112456777 8999999999999999888999999999865211
Q ss_pred C---------------------------h----HHHHHH------HHHHHHHHhC----CCCCcceeEEEE-eeCCeEEE
Q 001865 709 N---------------------------R----NKVHRA------CAEREILDML----DHPFVPALYASF-QTKTHVCL 746 (1002)
Q Consensus 709 ~---------------------------~----~~~~~~------~~E~~il~~l----~hpnIv~l~~~~-~~~~~~~l 746 (1002)
. . +....+ .+|+..+.++ .+...+.+-.++ +.....++
T Consensus 159 ~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VL 238 (537)
T PRK04750 159 VIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVM 238 (537)
T ss_pred HHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceE
Confidence 0 0 011112 2333333333 233333332333 22456789
Q ss_pred EEeccCCCchhHHH--hhCCC--CCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC----cEEEEeccCC
Q 001865 747 ITDYCPGGELFLLL--DRQPT--KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLS 818 (1002)
Q Consensus 747 V~E~~~ggsL~~~l--~~~~~--~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g----~vkL~DFG~a 818 (1002)
||||+.|+.|.++. ..... ..+....+..++.| ++..|++|+|+||.||+++.+| .++++|||++
T Consensus 239 vmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGiv 311 (537)
T PRK04750 239 VMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIV 311 (537)
T ss_pred EEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceE
Confidence 99999999998753 22110 02333334444444 4468999999999999999888 9999999998
Q ss_pred cccC
Q 001865 819 CLTS 822 (1002)
Q Consensus 819 ~~~~ 822 (1002)
..++
T Consensus 312 g~l~ 315 (537)
T PRK04750 312 GSLN 315 (537)
T ss_pred EECC
Confidence 6654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.9e-12 Score=134.20 Aligned_cols=211 Identities=22% Similarity=0.262 Sum_probs=147.2
Q ss_pred HHHhCCCCCcceeEEEEeeC-----CeEEEEEeccCCCchhHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHc--Cc
Q 001865 722 ILDMLDHPFVPALYASFQTK-----THVCLITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQ--GI 792 (1002)
Q Consensus 722 il~~l~hpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~--~~~~l~~~~i~~i~~qil~aL~~LH~~--gI 792 (1002)
-|-++.|.|+|+++.|+.+. ..+.+++|||..|+|..+|++. -.+.+.....+.++-||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34456799999999998654 4588999999999999999852 235688999999999999999999998 59
Q ss_pred ccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccC
Q 001865 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 872 (1002)
Q Consensus 793 iHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~ 872 (1002)
+|+++..+-|++..+|-+|+.--.-... .+... .+. -.......|-++|.+||.=..
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~---h~s~~--~~~------------------~~Ek~~~~~~~g~~a~~sg~~ 256 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDST---HPSVN--STR------------------EAEKSVNTSLPGFSAPESGTT 256 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcccc---chhhh--hhh------------------HhhhhccccCCccccCCcCcc
Confidence 9999999999999998888753322110 00000 000 001122346788999997555
Q ss_pred CCCCChhhHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHH
Q 001865 873 AGHTSAVDWWALGILLYEMLYGYTPFRGKTR-QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 873 ~~~~~~sDIwSlGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~e 951 (1002)
...+.++|||+||....+|..|..--..... .+.-..+..-.+.+.. .--.+++++||...|..||+ +++
T Consensus 257 tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len-----~lqr~~i~kcl~~eP~~rp~----ar~ 327 (458)
T KOG1266|consen 257 TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLEN-----GLQRGSITKCLEGEPNGRPD----ARL 327 (458)
T ss_pred cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccC-----ccccCcCcccccCCCCCCcc----hhh
Confidence 5566789999999999999987764322211 1111112111111111 11246899999999999999 999
Q ss_pred HHcCCCcCCCChh
Q 001865 952 IKKHPFFKGVNWA 964 (1002)
Q Consensus 952 lL~Hp~f~~~~~~ 964 (1002)
+|.||-+-.+.-.
T Consensus 328 llfHpllfeVhsl 340 (458)
T KOG1266|consen 328 LLFHPLLFEVHSL 340 (458)
T ss_pred hhcCceeeecchH
Confidence 9999998776443
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.1e-11 Score=146.87 Aligned_cols=128 Identities=39% Similarity=0.741 Sum_probs=115.1
Q ss_pred HHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEE
Q 001865 188 SDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267 (1002)
Q Consensus 188 ~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (1002)
..+++.+++.+++++++.|..+.+|+|+|+|+++++++||+.++++|+++..+.++.........+...+..+..+..++
T Consensus 147 ~r~~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~ 226 (665)
T PRK13558 147 RRLKERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVEL 226 (665)
T ss_pred hHHHHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEE
Confidence 34567899999999999986666889999999999999999999999998877777766666677888888888889999
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001865 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (1002)
Q Consensus 268 ~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~ 315 (1002)
+.+++||..+|+.++..|+.+.+|.+.+++++++|||++|++|++++.
T Consensus 227 ~~~~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~~L~~ 274 (665)
T PRK13558 227 RNYRKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAELALQR 274 (665)
T ss_pred EEECCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999999998874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.8e-12 Score=145.23 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=186.2
Q ss_pred ccccCCccccccccccCcEEEEEEEEc-CCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEEEeeCC
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELC-GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKT 742 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 742 (1002)
.....+|..+..||.|.|+.|+.+.-. .++..|++|.+.........+... ..|.-+...+ .|.+++..+..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccccc
Confidence 345689999999999999999998755 678899999988775544444433 3344444444 6899999888888888
Q ss_pred eEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecC-CcEEEEeccCCccc
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLT 821 (1002)
Q Consensus 743 ~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~-g~vkL~DFG~a~~~ 821 (1002)
..|+-.|||+++++...... ...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||....+
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 88899999999988766532 2347888899999999999999999999999999999999976 78899999987432
Q ss_pred CCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccc--ccccccCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYI--APEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~--aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~ 899 (1002)
.... ....+...++ ++..+....+..+.|++|||..+++.++|.+.-.
T Consensus 418 ~~~~------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 418 AFSS------------------------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ceec------------------------------ccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 2111 1112333444 4444555677889999999999999999875433
Q ss_pred CCChHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCCCCCChhcHHHHHcCCCcC
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~Hp~f~ 959 (1002)
.... ...+..+. .+........+..+.+.++..++..|+. +.++..|.-|.
T Consensus 468 ~~~~---~~~i~~~~--~p~~~~~~~~~q~~~kv~~~~~~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 468 SGVQ---SLTIRSGD--TPNLPGLKLQLQVLLKVMINPDRKRRPS----AVELSLHSEFY 518 (524)
T ss_pred cccc---ceeeeccc--ccCCCchHHhhhhhhhhhcCCccccchh----hhhhcccchhh
Confidence 2221 22222332 2222333467888999999999999998 77777776554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.7e-11 Score=123.00 Aligned_cols=127 Identities=24% Similarity=0.291 Sum_probs=95.8
Q ss_pred cccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCC-cceeEEEEeeCCeEEEEEeccC
Q 001865 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~lV~E~~~ 752 (1002)
++.|+.|.++.||++.. .+..|++|+...... ....+..|+.+++.+.+.+ +++++.+... ..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence 46789999999999997 478899998765421 1224567888888885444 4566654432 3479999999
Q ss_pred CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCc-----ccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI-----IYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 753 ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gI-----iHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
|.++.... . ....++.+++.+|+.||..++ +|+|++|+||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98876430 1 113456799999999999985 9999999999999 7789999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.4e-10 Score=119.33 Aligned_cols=140 Identities=15% Similarity=0.127 Sum_probs=101.7
Q ss_pred cccccccCcEEEEEEEEcC------CCeEEEEEEeecccc--c--------C---------hHHHHHHH----HHHHHHH
Q 001865 674 IKPLGSGDTGSVHLVELCG------SGQYFAMKAMDKGVM--L--------N---------RNKVHRAC----AEREILD 724 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~------~~~~~avK~~~~~~~--~--------~---------~~~~~~~~----~E~~il~ 724 (1002)
...||.|.=+.||.|.... .+..+|||+.+.... . + .+....+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998643 357899998874211 0 0 11122333 7888898
Q ss_pred hCCC--CCcceeEEEEeeCCeEEEEEeccCCCchhH-HHhhCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCcccCCCCCC
Q 001865 725 MLDH--PFVPALYASFQTKTHVCLITDYCPGGELFL-LLDRQPTKVLKEDAVRFYAAEVVVALEYL-HCQGIIYRDLKPE 800 (1002)
Q Consensus 725 ~l~h--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~l~~~~i~~i~~qil~aL~~L-H~~gIiHrDLKP~ 800 (1002)
++.. -+++.++++ ..-++||||+.++.+.. .+.. ..++...+..++.+++.+|..| |+.||||+||+|.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 8843 567777764 44589999996554422 2222 2355667778889999999999 8999999999999
Q ss_pred cEEEecCCcEEEEeccCCccc
Q 001865 801 NVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 801 NILl~~~g~vkL~DFG~a~~~ 821 (1002)
|||+. ++.+.|+|||.|-..
T Consensus 155 NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE-CCcEEEEECCCceeC
Confidence 99997 578999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=1e-10 Score=144.59 Aligned_cols=153 Identities=14% Similarity=0.151 Sum_probs=117.1
Q ss_pred ccccccccccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCccc-CCCCChHHHHH
Q 001865 174 MSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQ-GAGTDPEDVAK 252 (1002)
Q Consensus 174 it~~~~~e~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~-~~~~~~~~~~~ 252 (1002)
+++.....+.+.....+++.+++.++++|+++|. +|+|+++|++|++++||+.+|++|+++..++ ++.........
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~v~~~~~~gI~i~D~---~g~I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~ 172 (663)
T PRK10060 96 WHDTPSVARDLSHGLSFAEQVVSEANSVIVILDS---RGNIQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRN 172 (663)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhCCceEEEEeC---CCCEEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHH
Confidence 3333444445666777889999999999999999 7789999999999999999999999976444 44444455566
Q ss_pred HHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCC-CEEEEEEEEecchhhhHHHHHhhcC-----CCCCchhhhh
Q 001865 253 IRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEG-KVLKFIGMQVEVSKHTEGAKDKMLR-----PNGLPESLIR 326 (1002)
Q Consensus 253 i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G-~v~~~v~i~~DITerk~~e~~L~~~-----~~~l~~~l~~ 326 (1002)
++..+..+..|.++.+..+++|..+|+.....+ .+..| ...+++++.+|||++|+++++++.. ++.|++|-..
T Consensus 173 ~~~~~~~~~~~~~e~~~~~~~G~~~~~~~~~~~-~~~~g~~~~~~i~~~~DITe~k~~e~~l~~~a~~D~LTGL~NR~~f 251 (663)
T PRK10060 173 IRGFFRSGNAYEVERWIKTRKGQRLFLFRNKFV-HSGSGKNEIFLICSGTDITEERRAQERLRILANTDSITGLPNRNAI 251 (663)
T ss_pred HHHHHhcCCceEEEEEEEeCCCCEEEEEeeeEE-EcCCCCceEEEEEEEEechHHHHHHHHHHHHhhcCccCCCcCHHHH
Confidence 777788888899999999999999998766544 44444 4567889999999999999887653 5556665444
Q ss_pred HHHH
Q 001865 327 YDAR 330 (1002)
Q Consensus 327 ~~~~ 330 (1002)
.+..
T Consensus 252 ~~~l 255 (663)
T PRK10060 252 QELI 255 (663)
T ss_pred HHHH
Confidence 4333
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.9e-10 Score=133.13 Aligned_cols=226 Identities=18% Similarity=0.177 Sum_probs=152.1
Q ss_pred EEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCC
Q 001865 687 LVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK 766 (1002)
Q Consensus 687 ~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~ 766 (1002)
.+..+.++.++.+.+++... ........+-++-|+.++||||+++++.++..+.+|+|+|.+ ..|..+++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~---- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE---- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH----
Confidence 34556678888888887542 244556677788899999999999999999999999999999 456667765
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-HcCcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCC
Q 001865 767 VLKEDAVRFYAAEVVVALEYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845 (1002)
Q Consensus 767 ~l~~~~i~~i~~qil~aL~~LH-~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (1002)
+....+..-+.||+.||.||| +.+++|++|.-+-|+|+..|.-||++|.++.....-..
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------------------- 160 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------------------- 160 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------------------
Confidence 346667777899999999998 56899999999999999999999999998744221100
Q ss_pred cccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHhCCCCCCCCCCCCH
Q 001865 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSL 925 (1002)
Q Consensus 846 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~ 925 (1002)
......---.|..|+.+.... ...|.|-|||++++++.|..+ ...... .. ..++.
T Consensus 161 --------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~~--~~~~~~-----------~~--~~ipk 215 (690)
T KOG1243|consen 161 --------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSLL--TKTDLS-----------NT--GKIPK 215 (690)
T ss_pred --------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcccC--cchhhh-----------cc--Cccch
Confidence 000111122356666543332 357999999999999999332 211110 00 01122
Q ss_pred HHHHHHHHccccCcCCCCCChhcHHHHHc-CCCcCCCChhhh
Q 001865 926 HAKQLMYRLLHRDPKSRLGSHEGANEIKK-HPFFKGVNWALV 966 (1002)
Q Consensus 926 ~~~~Ll~~~L~~dP~~Rpt~~~~a~elL~-Hp~f~~~~~~~~ 966 (1002)
....+..+-+.-.+..||.....+..++. |+||+..-...+
T Consensus 216 ~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n~fvd~~ 257 (690)
T KOG1243|consen 216 ALIELYCKKLGATELKRPNKLRFILECRLLGGFFRNDFVDTL 257 (690)
T ss_pred hHHHHHHHHhccccccccchhhHHHHHHhccccccchHHHHH
Confidence 33344444455566666663334555554 899887544433
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-10 Score=113.43 Aligned_cols=146 Identities=19% Similarity=0.201 Sum_probs=109.3
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEee-----cccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEE
Q 001865 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMD-----KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~-----~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV 747 (1002)
.+..|.+|+-+.|+++.+ .|+.++||.-. -..+...-...+..+|+.+|.++.--.|.-..=+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567789999999999998 78888888532 22233334456778899999887544444333345555666899
Q ss_pred EeccCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCC---cEEEEeccCCcc
Q 001865 748 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCL 820 (1002)
Q Consensus 748 ~E~~~g-gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g---~vkL~DFG~a~~ 820 (1002)
|||++| .++.+++...-...........++.+|-..+.-||.++|||+||..+||++.++| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999966 4888888764333344445578899999999999999999999999999998766 358999999843
|
|
| >PRK13558 bacterio-opsin activator; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.9e-10 Score=141.45 Aligned_cols=121 Identities=40% Similarity=0.759 Sum_probs=108.0
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEE
Q 001865 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (1002)
Q Consensus 474 l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~ 553 (1002)
++.+++.+++++++.|..+.++.|+|+|+++++++||+.++++|+++..+.+++........+...+..+..+..+++.+
T Consensus 150 ~~~~~~~~~~gi~~~d~~~~dg~i~~~N~~~~~l~G~~~eel~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 229 (665)
T PRK13558 150 KERALDEAPVGITIADATLPDEPLIYINDAFERITGYSPDEVLGRNCRFLQGEDTNEERVAELREAIDEERPTSVELRNY 229 (665)
T ss_pred HHHHHhcCCccEEEEcCCCCCCcEEEEcHHHHHHhCcCHHHHcCCCHHHhcCCCccHHHHHHHHHHHhcCCCeEEEEEEE
Confidence 57799999999999986544555999999999999999999999998888877777667777788888888889999999
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccccccc
Q 001865 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 594 (1002)
Q Consensus 554 ~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e~ 594 (1002)
++||..+|+..+..|+++..|.+.+++++++|||++|+.++
T Consensus 230 ~~dG~~~~~~~~~~pi~d~~G~~~~~vgi~~DITerk~~E~ 270 (665)
T PRK13558 230 RKDGSTFWNQVDIAPIRDEDGTVTHYVGFQTDVTERKEAEL 270 (665)
T ss_pred CCCCCEEEEEEEEEEEECCCCCEEEEEEEEEeCcHHHHHHH
Confidence 99999999999999999999999999999999999999543
|
|
| >TIGR02040 PpsR-CrtJ transcriptional regulator PpsR | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.6e-11 Score=138.33 Aligned_cols=132 Identities=17% Similarity=0.105 Sum_probs=98.9
Q ss_pred ccccccccccccccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCC-hhHHcCCCCCcccCCCCChH
Q 001865 170 SSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYT-SKEVVGRNCRFLQGAGTDPE 248 (1002)
Q Consensus 170 ~~~dit~~~~~e~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys-~eEllG~~~~~l~~~~~~~~ 248 (1002)
...||+.++..+.++ .+.|+.++++++++|+++|. +|+|+++|++|++++||+ .++++|+++..+.++... .
T Consensus 236 ~~~dit~~~~~e~~~---~~~~~~l~e~~~d~I~v~D~---~G~I~~~N~a~~~l~G~~~~~~l~G~~~~~~~~~~~~-~ 308 (442)
T TIGR02040 236 QLSPAGATQPVGDEL---SENLARLYHEAPDAIVFSDA---DGTIRGANEAFLELTDSSSLEAVRGRTLDRWLGRGGV-D 308 (442)
T ss_pred EEcccchhhhhhHHH---HHHHHHHHHhCCceEEEEcC---CCcEEehhHHHHHHhCCCChHHHcCCCHHHHhCCCcc-c
Confidence 346777776655433 24799999999999999998 788999999999999997 578999998755443222 1
Q ss_pred HHHHHHHHH-HcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHH
Q 001865 249 DVAKIRETL-QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (1002)
Q Consensus 249 ~~~~i~~~l-~~g~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~ 311 (1002)
...+...+ ..|.....+....++||+.+|++++++|+.+.++ ..++++++|||+|++.+.
T Consensus 309 -~~~~~~~~~~~g~~~~~~~~~~~~~G~~~~ve~s~~~i~~~~~--~~~~~v~rDITeR~~~~~ 369 (442)
T TIGR02040 309 -LRVLLSNVRRTGQVRLYATTLTGEFGAQTEVEISAAWVDQGER--PLIVLVIRDISRRLTMRD 369 (442)
T ss_pred -HHHHHHHHhhcCceEEEEEEEEcCCCCEEEEEEEEEEeccCCc--eEEEEEEecchhhccCCC
Confidence 22223333 3444444566778999999999999999976544 467889999999988753
|
This model represents the transcriptional regulator PpsR which is strictly associated with photosynthetic proteobacteria and found in photosynthetic operons. PpsR has been reported to be a repressor. These proteins contain a Helix-Turn_Helix motif of the "fis" type (pfam02954). |
| >PRK10060 RNase II stability modulator; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.2e-10 Score=137.64 Aligned_cols=115 Identities=17% Similarity=0.174 Sum_probs=95.6
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCcccc-CCCCChHHHHHHHHHHhcCCcEEEEEEE
Q 001865 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQLIN 552 (1002)
Q Consensus 474 l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~-~~d~~~~~~~~l~~~l~~~~~~~~e~~~ 552 (1002)
++.+++.++++|+++|.+|. |+++|++|++++||+.+|++|+++..+. ++++.......+...+..+..+..|.+.
T Consensus 113 ~~~v~~~~~~gI~i~D~~g~---I~~~N~a~~~l~Gy~~~eliG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 189 (663)
T PRK10060 113 AEQVVSEANSVIVILDSRGN---IQRFNRLCEEYTGLKEHDVIGQSVFKLFMSRREAAASRRNIRGFFRSGNAYEVERWI 189 (663)
T ss_pred HHHHHhhCCceEEEEeCCCC---EEEEcHHHHHHHCcCHHHHcCCCHHHHhCChhhHHHHHHHHHHHHhcCCceEEEEEE
Confidence 67899999999999999888 9999999999999999999999975544 5555555666777778888889999999
Q ss_pred EecCCcEEEEEEEEEeeecCCCC-EEEEEEEEecCCccccc
Q 001865 553 YTKSGKKFWNLFHLQPMRDQKGE-VQYFIGVQLDGSEHLEP 592 (1002)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~d~~G~-v~~~vgi~~DITerk~~ 592 (1002)
++++|..+|+.... ++.+..|. ..+++++.+|||++|+.
T Consensus 190 ~~~~G~~~~~~~~~-~~~~~~g~~~~~~i~~~~DITe~k~~ 229 (663)
T PRK10060 190 KTRKGQRLFLFRNK-FVHSGSGKNEIFLICSGTDITEERRA 229 (663)
T ss_pred EeCCCCEEEEEeee-EEEcCCCCceEEEEEEEEechHHHHH
Confidence 99999999987654 44444554 46788999999999984
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9e-10 Score=109.26 Aligned_cols=134 Identities=21% Similarity=0.205 Sum_probs=99.5
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccCh-----HHHHHHHHHHHHHHhCCCCCcceeEEEEeeCCeEEEEEe
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR-----NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITD 749 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lV~E 749 (1002)
..+++|+-+.+|.+.+ -|..+++|.=.+...-.+ -...+-.+|..++.++.--.|...+=++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999976 455577775443322222 223455678999988865444444444555566779999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcc
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~ 820 (1002)
|++|..|.+++... ...++..+-.-+.-||.+||||+||.++||++..+ .+.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 99999999998763 14567778888999999999999999999999854 499999999853
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.2e-10 Score=100.10 Aligned_cols=120 Identities=20% Similarity=0.408 Sum_probs=96.9
Q ss_pred HHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCC-cEEEEE
Q 001865 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ-SYCGRL 267 (1002)
Q Consensus 189 ~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~-~~~~e~ 267 (1002)
+.++.+++.++++++++|. +|+|+++|+++++++|++.++++|+.+..+.++.........+...+..+. ....+.
T Consensus 3 ~~~~~~~~~~~~~~~~~d~---~~~i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (124)
T TIGR00229 3 ERYRAIFESSPDAIIVIDL---EGNILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEER 79 (124)
T ss_pred hHHHHHHhhCCceEEEEcC---CCcEEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEe
Confidence 5678899999999999998 777999999999999999999999988776666555444455555555332 233445
Q ss_pred EEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHH
Q 001865 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKD 312 (1002)
Q Consensus 268 ~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~ 312 (1002)
....++|..+|+.....|+. .+|...++++++.|||++++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~~~~ 123 (124)
T TIGR00229 80 RVRRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQAEEA 123 (124)
T ss_pred eeEcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHHHhc
Confidence 55588999999999999998 788899999999999999988765
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >TIGR02938 nifL_nitrog nitrogen fixation negative regulator NifL | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-10 Score=137.51 Aligned_cols=116 Identities=26% Similarity=0.450 Sum_probs=105.8
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEE
Q 001865 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (1002)
Q Consensus 474 l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~ 553 (1002)
|+.++++++++++++|.+|+ ++++|+++++++||++++++|++...+.++.........+.+.+..+..+..+...+
T Consensus 6 ~~~i~~~~~~~i~~~d~~g~---~~~~N~~~~~~~G~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (494)
T TIGR02938 6 YRQTVDQAPLAISITDLKAN---ILYANDAFTRITGYTKEEIIGKNESVLSNHTTPPEVYQALWGSLAEQKPWAGKLLNR 82 (494)
T ss_pred HHHHHHhCCceEEEECCCCc---EEEEchhheeecCCCHHHHhCCCchhhcCCCCCHHHHHHHHHHHHhCCcccceeecc
Confidence 89999999999999999888 999999999999999999999987777766666667777778888888888888889
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccccc
Q 001865 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (1002)
Q Consensus 554 ~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~ 592 (1002)
+++|+.+|+..+..|+++.+|.+.+++++++|||++|++
T Consensus 83 ~~~g~~~~~~~~~~~~~~~~g~~~~~~~~~~DIt~~k~~ 121 (494)
T TIGR02938 83 RKDGELYLAELTVAPVLNEAGETTHFLGMHRDITELHRL 121 (494)
T ss_pred CCCccchhhheeeEEEECCCCCEEEEEEehhhhhHHHHH
Confidence 999999999999999999999999999999999999984
|
NifL is a modulator of the nitrogen fixation positive regulator protein NifA, and is therefore a negative regulator. It binds NifA. NifA and NifL are encoded by adjacent genes. |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.1e-10 Score=100.92 Aligned_cols=86 Identities=29% Similarity=0.408 Sum_probs=74.6
Q ss_pred EEeccHHHHHHcCCChhhhcCCC----CccccCCCCChHHHHHHHH-HHhcCCcEEEEEEEEecCCcEEEEEEEEEeeec
Q 001865 497 IIFASDSFLELTEYSREEILGRN----CRFLQGPETDPATVRKIRA-AIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRD 571 (1002)
Q Consensus 497 Iv~vN~a~~~l~Gys~eEliG~~----~~~l~~~d~~~~~~~~l~~-~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d 571 (1002)
|+|||+++++|+||+++++ +.. +..++||++...+.+.+.. .+..+..+..+++++++||+.+|++.++.+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 7778999999999999999 778888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 001865 572 QKGEVQYFIGVQ 583 (1002)
Q Consensus 572 ~~G~v~~~vgi~ 583 (1002)
++|+++.++|+.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999974
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >PRK11359 cyclic-di-GMP phosphodiesterase; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-09 Score=139.31 Aligned_cols=141 Identities=14% Similarity=0.183 Sum_probs=117.0
Q ss_pred cccccccccccccccccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCccc-CCCC
Q 001865 167 SVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQ-GAGT 245 (1002)
Q Consensus 167 ~~~~~~dit~~~~~e~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~-~~~~ 245 (1002)
.+....|||++++.++ ..+.+..++++++++++++|. +|+|+++|+++++++||+.++++|+.+..+. ++..
T Consensus 118 ~~~~~~DiT~~~~~~~----~~~~~~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~l~G~~~~e~~g~~~~~~~~~~~~ 190 (799)
T PRK11359 118 YLALVRDASVEMAQKE----QTRQLIIAVDHLDRPVIVLDP---ERRIVQCNRAFTEMFGYCISEASGMQPDTLLNIPEF 190 (799)
T ss_pred EEEEEeeccchhhhHH----HHHHHHHHHhcCCCcEEEEcC---CCcEEEEChhhHhhhCCCHHHHCCCChHHhcCCCCC
Confidence 4455689987665543 456677889999999999998 7789999999999999999999999977554 3444
Q ss_pred ChHHHHHHHHHHHcCCcEEEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhh
Q 001865 246 DPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (1002)
Q Consensus 246 ~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~ 314 (1002)
.......+...+..+..+..+++..+++|..+|+.++..|+.+.+|.+.+++++++|||++|++++..+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~e~~~~~~dG~~~~~~~~~~~v~d~~g~~~~~~~~~~DITerk~~e~~~~ 259 (799)
T PRK11359 191 PADNRIRLQQLLWKTARDQDEFLLLTRTGEKIWIKASISPVYDVLAHLQNLVMTFSDITEERQIRQLEG 259 (799)
T ss_pred cHHHHHHHHHhhccCCCCcceeEEeCCCCCEEEEEeeeeeeecCCCceeEEEEEeehhhhHHHHHHHHH
Confidence 555556667777777778888888999999999999999999999999999999999999998875543
|
|
| >TIGR00229 sensory_box PAS domain S-box | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-09 Score=97.47 Aligned_cols=115 Identities=22% Similarity=0.351 Sum_probs=95.7
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcC-CcEEEEEEE
Q 001865 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ-TDVTVQLIN 552 (1002)
Q Consensus 474 l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~-~~~~~e~~~ 552 (1002)
++.++++++++++++|.+|. ++++|+++++++|++.++++|+.+..+.++.........+...+..+ .....+..+
T Consensus 5 ~~~~~~~~~~~~~~~d~~~~---i~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (124)
T TIGR00229 5 YRAIFESSPDAIIVIDLEGN---ILYVNPAFEEIFGYSAEELIGRNVLELIPEEDREEVRERIERLLEGEREPVSEERRV 81 (124)
T ss_pred HHHHHhhCCceEEEEcCCCc---EEEEchHHHHHhCCChHHhcCcchhhhcChhhhHHHHHHHHHHHcCCCCCcceEeee
Confidence 78899999999999999888 99999999999999999999999777777666655555565655533 234455556
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccccc
Q 001865 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (1002)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~ 592 (1002)
..++|..+|+.....|+. .+|...+++++++|||++++.
T Consensus 82 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~dit~~~~~ 120 (124)
T TIGR00229 82 RRKDGSEIWVEVSVSPIR-TNGGELGVVGIVRDITERKQA 120 (124)
T ss_pred EcCCCCEEEEEEEEeehh-hCCCeeEEEEEeeehhHHHHH
Confidence 689999999999999998 788899999999999999874
|
The PAS domain was previously described. This sensory box, or S-box domain occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include heme in the oxygen sensor FixL, FAD in the redox potential sensor NifL, and a 4-hydroxycinnamyl chromophore in photoactive yellow protein. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.8e-09 Score=113.09 Aligned_cols=140 Identities=24% Similarity=0.320 Sum_probs=107.7
Q ss_pred ccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCC--CCcceeEEEEeeC---CeEEEEEe
Q 001865 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH--PFVPALYASFQTK---THVCLITD 749 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~~---~~~~lV~E 749 (1002)
+.|+.|.++.||++.... |+.|++|+....... .....+..|..+++.+.+ .++++++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998743 678999997654211 134567889999999965 4467777776653 36789999
Q ss_pred ccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 001865 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC---------------------------------------- 789 (1002)
Q Consensus 750 ~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~---------------------------------------- 789 (1002)
|++|.+|.+.+.. ..++......++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999988776532 236777777888888888888884
Q ss_pred ----------------cCcccCCCCCCcEEEec--CCcEEEEeccCCcc
Q 001865 790 ----------------QGIIYRDLKPENVLLQG--NGHVSLTDFDLSCL 820 (1002)
Q Consensus 790 ----------------~gIiHrDLKP~NILl~~--~g~vkL~DFG~a~~ 820 (1002)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56789999998843
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF08447 PAS_3: PAS fold; InterPro: IPR013655 The PAS fold corresponds to the structural domain that has previously been defined as PAS and PAC motifs [] | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.1e-09 Score=94.96 Aligned_cols=86 Identities=28% Similarity=0.453 Sum_probs=73.2
Q ss_pred EEEechHHHHHcCCChhHHcCCC----CCcccCCCCChHHHHHHHH-HHHcCCcEEEEEEEEecCCcEEEEEEEeeeeec
Q 001865 214 IMYASAGFFKMTGYTSKEVVGRN----CRFLQGAGTDPEDVAKIRE-TLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKD 288 (1002)
Q Consensus 214 I~~vN~a~~~l~Gys~eEllG~~----~~~l~~~~~~~~~~~~i~~-~l~~g~~~~~e~~~~~kdG~~~w~~~~~~pi~d 288 (1002)
|+|||+.+++++||+++++ |.. +..+++|++.......+.. .+..+..+..+++.+++||+.+|++.+..+++|
T Consensus 1 ~i~~s~~~~~i~G~~~~~~-~~~~~~~~~~~ihpdD~~~~~~~~~~~~~~~~~~~~~e~R~~~~~G~~~wi~~~~~~~~d 79 (91)
T PF08447_consen 1 IIYWSDNFYEIFGYSPEEI-GKPDFEEWLERIHPDDRERVRQAIQQAALQNGEPFEIEYRIRRKDGEYRWIEVRGRPIFD 79 (91)
T ss_dssp -EEE-THHHHHHTS-HHHH-TCBEHHHHHHHB-TTTHHHHHHHHHHHHHHTT-EEEEEEEEEGTTSTEEEEEEEEEEEET
T ss_pred CEEEeHHHHHHhCCCHHHh-ccCCHHHHHhhcCHHHHHHHHHHHHHHhhccCcceEEEEEEECCCCCEEEEEEEEEEEEC
Confidence 6899999999999999999 766 6677888888888888888 778888999999999999999999999999999
Q ss_pred CCCCEEEEEEEE
Q 001865 289 DEGKVLKFIGMQ 300 (1002)
Q Consensus 289 ~~G~v~~~v~i~ 300 (1002)
++|++++++|+.
T Consensus 80 ~~g~~~~~~Gv~ 91 (91)
T PF08447_consen 80 ENGKPIRIIGVI 91 (91)
T ss_dssp TTS-EEEEEEEE
T ss_pred CCCCEEEEEEEC
Confidence 999999999874
|
The PAS fold appears in archaea, eubacteria and eukarya. The PAS domain contains a sensory box, or S-box domain that occupies the central portion of the PAS domain but is more widely distributed. It is often tandemly repeated. Known prosthetic groups bound in the S-box domain include haem in the oxygen sensor FixL [], FAD in the redox potential sensor NifL [], and a 4-hydroxycinnamyl chromophore in photoactive yellow protein []. Proteins containing the domain often contain other regulatory domains such as response regulator or sensor histidine kinase domains. Other S-box proteins include phytochromes and the aryl hydrocarbon receptor nuclear translocator. This domain has been found in the gene product of the madA gene of the filamentous zygomycete fungus Phycomyces blakesleeanus. It has been shown that MadA encodes a blue-light photoreceptor for phototropism and other light responses. The gene is involved in the phototropic responses associated with sporangiophore growth; they exhibit phototropism by bending toward near-UV and blue wavelengths and away from far-UV wavelengths in a manner that is physiologically similar to plant phototropic responses [].; GO: 0005515 protein binding; PDB: 3NJA_D 3H9W_A 3GDI_B 3ICY_A 3EEH_A 3MR0_B. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.9e-08 Score=110.60 Aligned_cols=204 Identities=18% Similarity=0.234 Sum_probs=141.7
Q ss_pred cEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhCCCCCcceeEEEEe----eCCeEEEEEeccCC-Cch
Q 001865 682 TGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ----TKTHVCLITDYCPG-GEL 756 (1002)
Q Consensus 682 ~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----~~~~~~lV~E~~~g-gsL 756 (1002)
..+.|+|....+|..|++|.++........ ....-.++++++.|+|||++.++|. .+..+++|++|+++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 358899999999999999998543222222 2233467899999999999999987 34578999999975 577
Q ss_pred hHHHhhC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCcccCC
Q 001865 757 FLLLDRQ-------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 757 ~~~l~~~-------------~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~ 823 (1002)
.++.-.. .+...++..+|.|+.||..||.++|+.|+..+-|.|.+|+++.+.+++|.-.|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 6654321 123578899999999999999999999999999999999999888888887776533221
Q ss_pred CCCCCCCcchhhhhcccCCCCCcccccccccccccccCCcccccccccCCCCCChhhHHHHHHHHHHHHcCCCC-CCCCC
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP-FRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~elltG~~P-f~~~~ 902 (1002)
++ . +-+.+ -.+-|.=.||.+++.|.+|..- +....
T Consensus 446 d~---------------------------------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~ 481 (655)
T KOG3741|consen 446 DP---------------------------------------T--EPLES---QQQNDLRDLGLLLLALATGTENSNRTDS 481 (655)
T ss_pred CC---------------------------------------C--cchhH---HhhhhHHHHHHHHHHHhhcccccccccc
Confidence 11 0 11111 1367899999999999999654 11122
Q ss_pred hHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHccccCcCC
Q 001865 903 RQKT-FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 941 (1002)
Q Consensus 903 ~~~~-~~~i~~~~~~~~~~~~~s~~~~~Ll~~~L~~dP~~ 941 (1002)
..+. +..|.. ..+.++.++|.-+...++++
T Consensus 482 ~~~s~~~~I~~---------~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 482 TQSSHLTRITT---------TYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hHHHHHHHhhh---------hhhHHHHHHHHHHHhcCccc
Confidence 2222 111111 13555666666666666653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.7e-08 Score=107.14 Aligned_cols=134 Identities=19% Similarity=0.063 Sum_probs=94.2
Q ss_pred EEEEEEEcCCCeEEEEEEeeccccc----C----hHHHHHHHHHHHHHHhCCCCC--cceeEEEEee-----CCeEEEEE
Q 001865 684 SVHLVELCGSGQYFAMKAMDKGVML----N----RNKVHRACAEREILDMLDHPF--VPALYASFQT-----KTHVCLIT 748 (1002)
Q Consensus 684 ~Vy~a~~~~~~~~~avK~~~~~~~~----~----~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~~-----~~~~~lV~ 748 (1002)
.|+++.. .|+.|.||........ . ........+|...+..|..-+ ++.+..++.. ...-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3556655 6778999976432210 0 011113667888777773322 3344445532 23578999
Q ss_pred eccCCC-chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEec-------CCcEEEEeccCCc
Q 001865 749 DYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-------NGHVSLTDFDLSC 819 (1002)
Q Consensus 749 E~~~gg-sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~-------~g~vkL~DFG~a~ 819 (1002)
|++++. +|.+++........+......++.+++..+..||.+||+|+||+++|||++. ++.+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999875 8999986432334567788899999999999999999999999999999985 4679999999874
|
|
| >COG3829 RocR Transcriptional regulator containing PAS, AAA-type ATPase, and DNA-binding domains [Transcription / Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.4e-08 Score=113.78 Aligned_cols=221 Identities=17% Similarity=0.183 Sum_probs=153.5
Q ss_pred HHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEe
Q 001865 192 KDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYK 271 (1002)
Q Consensus 192 ~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~ 271 (1002)
+.+++.+.++++++|. ...|.++|..+..+++-....++|+++..+.+........ .+..+........
T Consensus 4 ~~~l~~~~~~~~vi~~---~~~~~~~~~~a~~~~~~~~~~~i~~~~~~i~~~~~~~~v~--------~~~~~~~~~~~~~ 72 (560)
T COG3829 4 EGILKSILDGPVVIDK---NTGIDVANALALAKRQKNAEAVIGRPLREILETLGMERVE--------QSRDKELTERLKL 72 (560)
T ss_pred hhhhhhcccceEEEEc---CCceeeechHHHHhhhcceEEEecccceeeccccCcceee--------ccCccceeeeeec
Confidence 4489999999999998 4459999999999999999999999888666554332211 2222222222223
Q ss_pred cCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhcCCCCCchhhhhHHHHHHHHhhhhHHHHHHHhcCCCC
Q 001865 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLPESLIRYDARQKEMATSSVTELVQAMKKPRS 351 (1002)
Q Consensus 272 kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~a~~~~~~ 351 (1002)
+ + .. ..+..-++.++.|+++|++.++.|+++....-++..
T Consensus 73 ~-~-~~-~~~~~~~~~~~~~~~~g~~~~~~~~~e~~~~~~~~l------------------------------------- 112 (560)
T COG3829 73 K-V-KR-IVVVGKTPVDEQGRVVGVLEVFLDISEALELIEENL------------------------------------- 112 (560)
T ss_pred c-c-ee-EEEcCCceeecCCceeeeehhhhhhHHHHHHHHHHH-------------------------------------
Confidence 3 3 22 233344456788999999999999998443322210
Q ss_pred cccCCCCCcccccCCCCchhhhcccccCCCCCCCCCCCCCCCCCCcccccccccccchhhccccCCcccccccccccccC
Q 001865 352 LSESTNRPPIIRKSEGGVEEERAGALGRRKSENVPPPRRNSYGGGCRTSMQRISEVPEKKKQKSGRRSFMGLIGRKSQST 431 (1002)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (1002)
T Consensus 113 -------------------------------------------------------------------------------- 112 (560)
T COG3829 113 -------------------------------------------------------------------------------- 112 (560)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CCCCCccccccccCCCCCCCCCCCCCchhhHHHHHhhhhcccHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCC
Q 001865 432 DDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYS 511 (1002)
Q Consensus 432 ~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~e~~l~~~~~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys 511 (1002)
.++. ..|+.+++.+.++++++|.+|. ++++|.++..++|++
T Consensus 113 -------------------------------~~~~-----~~l~~il~~~~~~l~vvD~~G~---~i~~N~~~~~~~gl~ 153 (560)
T COG3829 113 -------------------------------RQLR-----QRLEAILDSIDDGLLVVDEDGI---IIYYNKAYAKLLGLS 153 (560)
T ss_pred -------------------------------HHHH-----HHHHHHHhhccCceEEEcCCCc---EEEEcHHHHHHhCCC
Confidence 0000 1189999999999999999988 999999999999999
Q ss_pred hhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCcccc
Q 001865 512 REEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (1002)
Q Consensus 512 ~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~ 591 (1002)
.++++|+++.++...... ....+.+..+++..........++. ..+..|++ .+|.+.|.+++++|+++-+.
T Consensus 154 ~e~~~gk~~~~v~~~~~~----s~~l~vl~~~kp~~~~~~~~~~~~~----i~~~~pv~-~~g~l~G~v~~~~~~~~l~~ 224 (560)
T COG3829 154 PEEVLGKHLLDVVSAGED----STLLEVLRTGKPIRDVVQTYNGNKI----IVNVAPVY-ADGQLIGVVGISKDVSELER 224 (560)
T ss_pred HHHHcCCcHHHHHhccCC----ceehhhhhcCCcceeeeeeecCCce----eEeeccEe-cCCcEEEEEEeecchHHHHH
Confidence 999999997666511111 1234566777775555444333332 34556776 46799999999999998776
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-08 Score=102.86 Aligned_cols=127 Identities=24% Similarity=0.198 Sum_probs=82.3
Q ss_pred EEEEEEEcCCCeEEEEEEeecccccC-----------------------hHHHHHHHHHHHHHHhCCCC--CcceeEEEE
Q 001865 684 SVHLVELCGSGQYFAMKAMDKGVMLN-----------------------RNKVHRACAEREILDMLDHP--FVPALYASF 738 (1002)
Q Consensus 684 ~Vy~a~~~~~~~~~avK~~~~~~~~~-----------------------~~~~~~~~~E~~il~~l~hp--nIv~l~~~~ 738 (1002)
.||.|.. ..|..+|+|+.+.....- ........+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 567899999987531100 01123456799999999765 577777553
Q ss_pred eeCCeEEEEEeccC--CCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCcccCCCCCCcEEEecCCcEEEEec
Q 001865 739 QTKTHVCLITDYCP--GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY-LHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (1002)
Q Consensus 739 ~~~~~~~lV~E~~~--ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~-LH~~gIiHrDLKP~NILl~~~g~vkL~DF 815 (1002)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2369999997 55555443321 2244566777888885555 579999999999999999966 9999999
Q ss_pred cCCcc
Q 001865 816 DLSCL 820 (1002)
Q Consensus 816 G~a~~ 820 (1002)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98844
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.5e-08 Score=82.37 Aligned_cols=103 Identities=27% Similarity=0.422 Sum_probs=89.4
Q ss_pred ccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEEecCCcEE
Q 001865 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (1002)
Q Consensus 481 ~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~ 560 (1002)
++++++++|.+|. ++++|+++++++|++.++++|..+..+++++........+...+..+.....+..+...+|..+
T Consensus 1 ~~~~i~~~d~~~~---~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDLDGR---ILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECCCCc---EEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3678999999888 9999999999999999999999987777777776666666666666667778888888999999
Q ss_pred EEEEEEEeeecCCCCEEEEEEEEecC
Q 001865 561 WNLFHLQPMRDQKGEVQYFIGVQLDG 586 (1002)
Q Consensus 561 wv~~~~~pi~d~~G~v~~~vgi~~DI 586 (1002)
|+.....++.+..|...+++++.+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999999889999999999986
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >cd00130 PAS PAS domain; PAS motifs appear in archaea, eubacteria and eukarya | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-07 Score=80.52 Aligned_cols=103 Identities=24% Similarity=0.479 Sum_probs=86.5
Q ss_pred cCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEEecCCcEE
Q 001865 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (1002)
Q Consensus 198 ~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (1002)
++++++++|. +|.++++|+++++++|++.++++|+.+..++++.........+...+..+.....++.....+|...
T Consensus 1 ~~~~i~~~d~---~~~~~~~n~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (103)
T cd00130 1 LPDGVIVLDL---DGRILYANPAAEQLLGYSPEELIGKSLLDLIHPEDREELRERLENLLSGGEPVTLEVRLRRKDGSVI 77 (103)
T ss_pred CCceEEEECC---CCcEEEECHHHHHHhCCCHHHHcCccHHHhcCCccchHHHHHHHHHHhcCcCeEEEEEEEccCCCEE
Confidence 3578899998 7779999999999999999999999987677666665555666666666666777888888899999
Q ss_pred EEEEEeeeeecCCCCEEEEEEEEecc
Q 001865 278 WNLLTIAPIKDDEGKVLKFIGMQVEV 303 (1002)
Q Consensus 278 w~~~~~~pi~d~~G~v~~~v~i~~DI 303 (1002)
|+.+...++.+..|...+++++++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~di 103 (103)
T cd00130 78 WVLVSLTPIRDEGGEVIGLLGVVRDI 103 (103)
T ss_pred EEEEEEEEEecCCCCEEEEEEEEecC
Confidence 99999999999888999999999886
|
Probably the most surprising identification of a PAS domain was that in EAG-like K+-channels. PAS domains have been found to bind ligands, and to act as sensors for light and oxygen in signal transduction. |
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.8e-08 Score=113.38 Aligned_cols=113 Identities=12% Similarity=0.132 Sum_probs=88.9
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEE
Q 001865 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (1002)
Q Consensus 473 ~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~ 552 (1002)
.++++++++++|++++|.+|. |+++|+++++++||+.++++|+++..+.+... .....+...+..+..+..+...
T Consensus 8 ~~~~il~~~~~gi~~~d~~~~---i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 82 (348)
T PRK11073 8 DAGQILNSLINSILLLDDDLA---IHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDNEVT 82 (348)
T ss_pred hHHHHHhcCcCeEEEECCCCe---EeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCcccccceE
Confidence 389999999999999999888 99999999999999999999999877765432 2234455566666555544455
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCcccccccc
Q 001865 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRN 595 (1002)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e~~ 595 (1002)
..+||..+|+.++..|+. . .+++..++|||++++.+++
T Consensus 83 ~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~ 120 (348)
T PRK11073 83 LVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQE 120 (348)
T ss_pred EEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHH
Confidence 567999999999999997 2 2466778999999885433
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.2e-08 Score=117.58 Aligned_cols=140 Identities=16% Similarity=0.129 Sum_probs=105.0
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCc-EEEEEE
Q 001865 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD-VTVQLI 551 (1002)
Q Consensus 473 ~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~-~~~e~~ 551 (1002)
.++.++++++++++++|.+|. ++++|+++++++||+.++++|+++..+.+++. .....+.+.+..+.. ...+..
T Consensus 263 ~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 337 (607)
T PRK11360 263 LNELILESIADGVIAIDRQGK---ITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGTEHVDLEIS 337 (607)
T ss_pred HHHHHHHhccCeEEEEcCCCC---EEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCCCccceEEE
Confidence 378899999999999999888 99999999999999999999999887776542 233445555555444 345677
Q ss_pred EEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccccccccCCchhhHHHHHHHHHHHhhhhhh
Q 001865 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNE 618 (1002)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e~~~~~~~~~~e~~~~~k~~~~~v~~ 618 (1002)
..+++|..+ +.++..|+++.+|.+.+++++++|||++++.+++.........+.+.+..+.|.+..
T Consensus 338 ~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~~~~~~~l~~~~~~~~hel~~ 403 (607)
T PRK11360 338 FPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVARQERLAALGELVAGVAHEIRN 403 (607)
T ss_pred EEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 788888876 899999999999999999999999999998654443222222233333444444433
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.73 E-value=4.6e-08 Score=110.19 Aligned_cols=114 Identities=14% Similarity=0.114 Sum_probs=89.1
Q ss_pred cchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEE
Q 001865 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYC 264 (1002)
Q Consensus 185 ~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (1002)
....+.|+.++++++++|+++|. +|+|+++|++|++++||+.++++|+++..+..+ ..+...+..+.. .
T Consensus 2 ~~~~~~l~~~~~~~~~~i~~~d~---~g~i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~-------~~~~~~l~~~~~-~ 70 (333)
T TIGR02966 2 SALLSRFRAAAQALPDAVVVLDE---EGQIEWCNPAAERLLGLRWPDDLGQRITNLIRH-------PEFVEYLAAGRF-S 70 (333)
T ss_pred hhHHHHHHHHHHhCcCcEEEECC---CCcEEEEcHHHHHHhCCChHHHcCCcHHHHccC-------HHHHHHHHhccc-C
Confidence 35567899999999999999999 777999999999999999999999997766443 123334444332 2
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhh
Q 001865 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (1002)
Q Consensus 265 ~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~ 314 (1002)
.......++|..+|+.+.+.|+.+.. ++++++|||++++.++.+.
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~~~~~~~ 115 (333)
T TIGR02966 71 EPLELPSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRRLEQMRR 115 (333)
T ss_pred CCeEeecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHHHHHHHH
Confidence 23455568999999999999987642 6788999999998876644
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.7e-07 Score=101.30 Aligned_cols=236 Identities=19% Similarity=0.245 Sum_probs=154.5
Q ss_pred ccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHHHHHHHHHHHHhC-CCCCcceeEEE------EeeCC-eE
Q 001865 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYAS------FQTKT-HV 744 (1002)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~------~~~~~-~~ 744 (1002)
..+.||+|+-+.+|.+-... -.+-|++.+... .. ..+....|... .||-+..-+.+ .-..+ .+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Ppp---a~---~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPP---AA---QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCc---hH---HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45779999999999876433 367788875421 11 11223334433 56644331111 11222 36
Q ss_pred EEEEeccCCCc-hhHHHh----hCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcEEEEeccCCc
Q 001865 745 CLITDYCPGGE-LFLLLD----RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 745 ~lV~E~~~ggs-L~~~l~----~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~vkL~DFG~a~ 819 (1002)
.++|..+.|.. ...++. ++......+.-+...++.|+.+.+.||..|.+-+|+.++|+|+++++.|.|+|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78888886642 222222 3455678889999999999999999999999999999999999999999999866431
Q ss_pred ccCCCCCCCCCcchhhhhcccCCCCCcccccccccccccccCCccccccccc-----CCCCCChhhHHHHHHHHHHHHcC
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYG 894 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~~~~~sDIwSlGvil~elltG 894 (1002)
. ..+.......+|.+.|.+||.-. +..-+...|-|.||+++++|+.|
T Consensus 166 i----------------------------~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~g 217 (637)
T COG4248 166 I----------------------------NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFG 217 (637)
T ss_pred e----------------------------ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhc
Confidence 1 11112233457999999999864 23345579999999999999975
Q ss_pred -CCCCCCCC-------hHHHHHHHHhC-----------CCCCCCCC---CCCHHHHHHHHHcccc--CcCCCCCChh
Q 001865 895 -YTPFRGKT-------RQKTFANILHK-----------DLKFPSST---PTSLHAKQLMYRLLHR--DPKSRLGSHE 947 (1002)
Q Consensus 895 -~~Pf~~~~-------~~~~~~~i~~~-----------~~~~~~~~---~~s~~~~~Ll~~~L~~--dP~~Rpt~~~ 947 (1002)
+.||.|.. ..+ ..|..+ ..+.|... -+++.+..|..+|+.. ++.-|||.+.
T Consensus 218 grHPysGI~~~~~ap~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 218 GRHPYSGIPLISDAPNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CCCCCCcccccCCCCCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 99997631 111 122221 11222222 2466788999999865 4568999764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.7e-09 Score=120.96 Aligned_cols=169 Identities=20% Similarity=0.328 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHHc-CcccCCCCCCcEEEecCCcEEEEeccCCcccCCCCCCCCCcchhhhhcccCCCCCccccccccccc
Q 001865 778 AEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856 (1002)
Q Consensus 778 ~qil~aL~~LH~~-gIiHrDLKP~NILl~~~g~vkL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (1002)
.+.+.||.|+|.. ++||++|.|++|.++.+|..||+.|+++........ + .... .......
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~------p~~~----------yd~~lp~ 167 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--Y------PFSE----------YDPPLPL 167 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--c------cccc----------CCCCCCh
Confidence 4555999999975 999999999999999999999999998743321111 0 0000 0111111
Q ss_pred ccccCCcccccccccCCCCCChhhHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHhCCC---CCCCCCCCCHHHHHHHH
Q 001865 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDL---KFPSSTPTSLHAKQLMY 932 (1002)
Q Consensus 857 ~~~Gt~~Y~aPE~l~~~~~~~~sDIwSlGvil~ell-tG~~Pf~~~~~~~~~~~i~~~~~---~~~~~~~~s~~~~~Ll~ 932 (1002)
...-...|.|||++.+...+.++|+|||||++|.+. .|+.-+........+ ....... .+-....++.++.+=|.
T Consensus 168 ~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 168 LLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccccccccccCcHHHHHHHH
Confidence 223467899999999988889999999999999999 566665544332222 2222111 12223457789999999
Q ss_pred HccccCcCCCCCChhcHHHHHcCCCcCCCChhhhhcc
Q 001865 933 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCM 969 (1002)
Q Consensus 933 ~~L~~dP~~Rpt~~~~a~elL~Hp~f~~~~~~~~~~~ 969 (1002)
++|..++.-||+ +.+++..|||.+.-...++.+
T Consensus 247 k~l~~~~~~rp~----~~~l~~~~ff~D~~~~aLrfL 279 (700)
T KOG2137|consen 247 KLLNGDSAVRPT----LDLLLSIPFFSDPGLKALRFL 279 (700)
T ss_pred HHhcCCcccCcc----hhhhhcccccCCchhhhhhhc
Confidence 999999999998 999999999999766666543
|
|
| >PRK11073 glnL nitrogen regulation protein NR(II); Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.2e-07 Score=108.22 Aligned_cols=118 Identities=17% Similarity=0.212 Sum_probs=93.5
Q ss_pred hHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEE
Q 001865 187 VSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGR 266 (1002)
Q Consensus 187 ~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e 266 (1002)
+...+.++++++++|++++|. +|+|+++|+++++++||+.++++|+++..+.+... .....+...+..+..+...
T Consensus 5 ~~~~~~~il~~~~~gi~~~d~---~~~i~~~N~a~~~~~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 79 (348)
T PRK11073 5 TLPDAGQILNSLINSILLLDD---DLAIHYANPAAQQLLAQSSRKLFGTPLPELLSYFS--LNIELMRESLQAGQGFTDN 79 (348)
T ss_pred CcchHHHHHhcCcCeEEEECC---CCeEeeEcHHHHHHhCCCHHHHcCCCHHHHcCcch--hhHHHHHHHHHcCCccccc
Confidence 345679999999999999998 78899999999999999999999999887765432 2234455666666655544
Q ss_pred EEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhh
Q 001865 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKM 314 (1002)
Q Consensus 267 ~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~ 314 (1002)
...+.+||..+|+.++.+|+. . .+++..++|||++++.++++.
T Consensus 80 ~~~~~~~g~~~~~~~~~~~~~--~---~~~~~~~~dit~~~~~~~~~~ 122 (348)
T PRK11073 80 EVTLVIDGRSHILSLTAQRLP--E---GMILLEMAPMDNQRRLSQEQL 122 (348)
T ss_pred ceEEEECCceEEEEEEEEEcc--C---ceeEEEEechhHHHHHHHHHH
Confidence 455678999999999999986 2 246678999999998877654
|
|
| >PRK11360 sensory histidine kinase AtoS; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=2e-07 Score=114.24 Aligned_cols=128 Identities=13% Similarity=0.121 Sum_probs=105.1
Q ss_pred ccccchHHHHHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCC
Q 001865 182 KGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ 261 (1002)
Q Consensus 182 ~~L~~~~~~l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~ 261 (1002)
..+.+....++.++++++++++++|. +|+|+++|+++++++||+.++++|+++..++++.. .....+...+..+.
T Consensus 255 ~~l~~~~~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~g~~~~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 329 (607)
T PRK11360 255 QALRETRSLNELILESIADGVIAIDR---QGKITTMNPAAEVITGLQRHELVGKPYSELFPPNT--PFASPLLDTLEHGT 329 (607)
T ss_pred HHHHHHHHHHHHHHHhccCeEEEEcC---CCCEEEECHHHHHHhCCChHHhcCCcHHHHcCCch--hHHHHHHHHHhcCC
Confidence 34566677889999999999999998 77799999999999999999999999887776542 23344555565554
Q ss_pred cE-EEEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHHHhhc
Q 001865 262 SY-CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKML 315 (1002)
Q Consensus 262 ~~-~~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~~L~~ 315 (1002)
.. ..++...+++|..+ +.++..|+.|.+|.+.+++++++|||++++++++++.
T Consensus 330 ~~~~~~~~~~~~~~~~~-~~~~~~~i~~~~g~~~~~i~~~~Dite~~~~e~~l~~ 383 (607)
T PRK11360 330 EHVDLEISFPGRDRTIE-LSVSTSLLHNTHGEMIGALVIFSDLTERKRLQRRVAR 383 (607)
T ss_pred CccceEEEEEcCCCcEE-EEEEEeeEEcCCCCEEEEEEEEeechHHHHHHHHHHH
Confidence 43 34566678888876 8999999999999999999999999999999988763
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.6e-08 Score=88.97 Aligned_cols=106 Identities=15% Similarity=0.279 Sum_probs=74.8
Q ss_pred HHHHHHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCCcccCCCCChHHHHHHHHHHHcCCcEEEEEEEE
Q 001865 191 VKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNY 270 (1002)
Q Consensus 191 l~~ile~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~ 270 (1002)
++.++++++.+++++|. +++|.++|+++.++++... ..+|+++..+.++... .....+.+.+..++....+...
T Consensus 1 L~~il~s~~~~i~~vD~---~~~I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~~~-~~l~~~i~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDR---NLRIRYFNPAAARLFNLSP-SDIGRPLFDIHPPLSY-PNLKKIIEQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEET---TSBEEEE-SCGC-SS---G-GGTTSBCCCSS-HHHH-HHHHHHHHHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcC---CCeEEEeChhHhhhcCCCh-HHCCCCHHHcCCccch-HHHHHHHHHHHcCCCceEEEEe-
Confidence 46899999999999999 7779999999999999764 5689999988766333 3334445556666653333332
Q ss_pred ecCCcEEEEEEEeeeeecCCCCEEEEEEEEecch
Q 001865 271 KKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (1002)
Q Consensus 271 ~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DIT 304 (1002)
..+|. |+.+++.|++|++|...|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 35554 778999999999999999999999998
|
|
| >TIGR02966 phoR_proteo phosphate regulon sensor kinase PhoR | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.5e-08 Score=107.61 Aligned_cols=103 Identities=11% Similarity=0.026 Sum_probs=82.0
Q ss_pred cHHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEE
Q 001865 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552 (1002)
Q Consensus 473 ~l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~ 552 (1002)
.|+.+++++++||+++|.+|. |+++|++|++++||++++++|+++..+..++ . +.+.+..+.. ......
T Consensus 7 ~l~~~~~~~~~~i~~~d~~g~---i~~~N~~~~~~~g~~~~~~~g~~~~~~~~~~---~----~~~~l~~~~~-~~~~~~ 75 (333)
T TIGR02966 7 RFRAAAQALPDAVVVLDEEGQ---IEWCNPAAERLLGLRWPDDLGQRITNLIRHP---E----FVEYLAAGRF-SEPLEL 75 (333)
T ss_pred HHHHHHHhCcCcEEEECCCCc---EEEEcHHHHHHhCCChHHHcCCcHHHHccCH---H----HHHHHHhccc-CCCeEe
Confidence 389999999999999999888 9999999999999999999999977776542 2 2333333322 233555
Q ss_pred EecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCcccc
Q 001865 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591 (1002)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~ 591 (1002)
..++|..+|+..+..|+.+.. ++++++|||++++
T Consensus 76 ~~~~~~~~~~~~~~~p~~~~~-----~~~~~~dit~~~~ 109 (333)
T TIGR02966 76 PSPINSERVLEIRIAPYGEEQ-----KLLVARDVTRLRR 109 (333)
T ss_pred ecCCCCceEEEEEEEEcCCCc-----eEEEEeCchHHHH
Confidence 668999999999999997642 6788899999887
|
Members of this protein family are the regulatory histidine kinase PhoR associated with the phosphate ABC transporter in most Proteobacteria. Related proteins from Gram-positive organisms are not included in this model. The phoR gene usually is adjacent to the response regulator phoB gene (TIGR02154). |
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.9e-07 Score=103.21 Aligned_cols=119 Identities=27% Similarity=0.600 Sum_probs=105.4
Q ss_pred HHHHHHhcc---ccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCC--CccccCCCCChHHHHHHHHHHhcCCcEEE
Q 001865 474 LATTLERIE---KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRN--CRFLQGPETDPATVRKIRAAIDNQTDVTV 548 (1002)
Q Consensus 474 l~~i~e~~~---~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~--~~~l~~~d~~~~~~~~l~~~l~~~~~~~~ 548 (1002)
++.++..+. ..+++.+++-.|++|+|+|+.||++.||.+.|++.++ +.+++++-.+....+.+++.+.+.+.-.+
T Consensus 16 LENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~qf 95 (971)
T KOG0501|consen 16 LENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQF 95 (971)
T ss_pred HHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcce
Confidence 677775554 4555566666789999999999999999999999988 66778888888889999999999998899
Q ss_pred EEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCccccc
Q 001865 549 QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEP 592 (1002)
Q Consensus 549 e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~ 592 (1002)
|.-++.|+.+.+|..+.+.||+++...++.|+..+.|||.-||+
T Consensus 96 EillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQP 139 (971)
T KOG0501|consen 96 EILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQP 139 (971)
T ss_pred eeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCC
Confidence 99999999999999999999999999999999999999999996
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.3e-07 Score=96.44 Aligned_cols=138 Identities=22% Similarity=0.194 Sum_probs=102.4
Q ss_pred ccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccC------h-------------HHHHHHHHHHHHHHhCCCC--
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------R-------------NKVHRACAEREILDMLDHP-- 729 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~------~-------------~~~~~~~~E~~il~~l~hp-- 729 (1002)
+.+...||-|.-|.||.|.+. .|.++|||.-+.+...- . .......+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 455678999999999999984 68899999766431100 0 0112345788999998665
Q ss_pred CcceeEEEEeeCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc
Q 001865 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH 809 (1002)
Q Consensus 730 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~ 809 (1002)
.|+..+++ +.-++||||++|-.|...- ++......++..|+.-+..+-..||||+|+.+-||+++++|.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 77877765 4558999999887775442 234445556666676666666899999999999999999999
Q ss_pred EEEEeccCCcc
Q 001865 810 VSLTDFDLSCL 820 (1002)
Q Consensus 810 vkL~DFG~a~~ 820 (1002)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999997743
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.6e-07 Score=93.16 Aligned_cols=142 Identities=20% Similarity=0.244 Sum_probs=96.1
Q ss_pred ccccCCccccccccccCcEEEEEEEEcCCCeEEEEEEeecccccChHHHH------HHHHHHHHHHhC---CCCCcceeE
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH------RACAEREILDML---DHPFVPALY 735 (1002)
Q Consensus 665 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~avK~~~~~~~~~~~~~~------~~~~E~~il~~l---~hpnIv~l~ 735 (1002)
.+..+.|.+++.+-......|.+... +|+.|++|..+........... ...+.+..+..+ +.-....++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 35568899999999999998988887 7789999998754211111111 112233333333 333333333
Q ss_pred EEEe-----eCCeEEEEEeccCCCchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCcE
Q 001865 736 ASFQ-----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHV 810 (1002)
Q Consensus 736 ~~~~-----~~~~~~lV~E~~~ggsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~v 810 (1002)
.+.. .....++||||++|..|.++.. +++ .+...|..++..||+.|+.|+|..|+|++++. +.+
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i 173 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGI 173 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcE
Confidence 3222 2345578999999998877643 222 24456778899999999999999999999995 459
Q ss_pred EEEeccCCc
Q 001865 811 SLTDFDLSC 819 (1002)
Q Consensus 811 kL~DFG~a~ 819 (1002)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999999653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.9e-07 Score=88.39 Aligned_cols=105 Identities=20% Similarity=0.275 Sum_probs=75.1
Q ss_pred HHhcCCcEEEEeCCCCCCcEEEechHHHHHcCCChhHH-cCCCCCccc---------CCCCChHHHHHHHHHHHcCCcEE
Q 001865 195 LSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEV-VGRNCRFLQ---------GAGTDPEDVAKIRETLQNGQSYC 264 (1002)
Q Consensus 195 le~~~d~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEl-lG~~~~~l~---------~~~~~~~~~~~i~~~l~~g~~~~ 264 (1002)
|+++++||++.|. +|+++++|++|.+++|++.+.+ .|.++..+. .+.....................
T Consensus 1 Ld~l~~Gv~v~D~---~~rl~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDS---DGRLVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcC---CCeEEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4789999999999 7889999999999999999998 788865332 21222233333333344444433
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHHHH
Q 001865 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAK 311 (1002)
Q Consensus 265 ~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~e~ 311 (1002)
.+ ....||. |++++..|+. +| |+|.++.|||+++++|+
T Consensus 78 ~~--~~~~dgr--~l~~~~~~~~--~G---g~v~~~~DVT~~~~~E~ 115 (115)
T PF12860_consen 78 FE--LRLPDGR--WLEVRAQPLP--DG---GFVLTFTDVTERRRAEE 115 (115)
T ss_pred eE--EECCCCE--EEEEEeEECC--CC---CEEEEEEeCCHHHHhcC
Confidence 33 3467886 7888888884 45 57789999999999874
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.2e-07 Score=94.29 Aligned_cols=105 Identities=28% Similarity=0.291 Sum_probs=82.6
Q ss_pred HHHHHHHHHHHhCCC--CCcceeEEEEeeC----CeEEEEEeccCCC-chhHHHhhCCCCCCCHHHHHHHHHHHHHHHHH
Q 001865 714 HRACAEREILDMLDH--PFVPALYASFQTK----THVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786 (1002)
Q Consensus 714 ~~~~~E~~il~~l~h--pnIv~l~~~~~~~----~~~~lV~E~~~gg-sL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~ 786 (1002)
....+|...+..|.. =.++.++++.... ...++|||++++. +|.+++..... ++......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 456677777666632 2345666666542 2458999999874 79999876422 6777888999999999999
Q ss_pred HHHcCcccCCCCCCcEEEecCC---cEEEEeccCCcc
Q 001865 787 LHCQGIIYRDLKPENVLLQGNG---HVSLTDFDLSCL 820 (1002)
Q Consensus 787 LH~~gIiHrDLKP~NILl~~~g---~vkL~DFG~a~~ 820 (1002)
||.+||+|+|++|.|||++.++ .+.|+||+.+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.4e-07 Score=91.64 Aligned_cols=140 Identities=14% Similarity=0.145 Sum_probs=102.3
Q ss_pred cccCcEEEEEEEEcCCCeEEEEEEeeccc---ccChHHHHHHHHHHHHHHhCCCC--CcceeEEEEe-e----CCeEEEE
Q 001865 678 GSGDTGSVHLVELCGSGQYFAMKAMDKGV---MLNRNKVHRACAEREILDMLDHP--FVPALYASFQ-T----KTHVCLI 747 (1002)
Q Consensus 678 G~G~~g~Vy~a~~~~~~~~~avK~~~~~~---~~~~~~~~~~~~E~~il~~l~hp--nIv~l~~~~~-~----~~~~~lV 747 (1002)
|+||-|-|+.... .|+.|-+|.-.... ..-+.....+.+|...+..|..- .++++. ++. . .-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 7789999999876 44468888654111 11133456788898888887422 255555 232 1 2246799
Q ss_pred EeccCC-CchhHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHcCcccCCCCCCcEEEecCCc--EEEEeccCCcc
Q 001865 748 TDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCL 820 (1002)
Q Consensus 748 ~E~~~g-gsL~~~l~~~~~~~l~~~~i~~i~~qil~aL~~LH~~gIiHrDLKP~NILl~~~g~--vkL~DFG~a~~ 820 (1002)
+|-+.| .+|.+++....-...+......++.+++..+.-||+.|+.|+|+.+.||+++.+|. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998843 68888886644345677888899999999999999999999999999999987777 99999997743
|
|
| >KOG0501 consensus K+-channel KCNQ [Inorganic ion transport and metabolism] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.2e-07 Score=102.83 Aligned_cols=120 Identities=32% Similarity=0.639 Sum_probs=102.8
Q ss_pred HHHHHHHhcC--C-cEEEEeCCCCCCcEEEechHHHHHcCCChhHHcCCCCC--cccCCCCChHHHHHHHHHHHcCCcEE
Q 001865 190 IVKDALSTFQ--Q-TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSYC 264 (1002)
Q Consensus 190 ~l~~ile~~~--d-~i~i~D~~~~dG~I~~vN~a~~~l~Gys~eEllG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~~ 264 (1002)
.++.++..+. | .+++-++.-.|..|+|+|..||++.||.+.|+..+++. +++++..+....+.+++.++..+..+
T Consensus 15 FLENiiRRsn~~dtsFlL~NAQiVD~PiVY~NdgFcKlsGY~RAevMQKs~tc~FMyGEltdk~ti~k~~~t~eN~~~~q 94 (971)
T KOG0501|consen 15 FLENIIRRSNNADTSFLLANAQIVDWPIVYCNDGFCKLSGYHRAEVMQKSCTCSFMYGELTDKGTIEKVRQTLENYETNQ 94 (971)
T ss_pred HHHHHHhhccCCCcceeeccceeeccceEEecCcchhccCccHHHHhcccceeeeeeccccchhhHHHHHHHHHhhhhcc
Confidence 4444444433 3 34444555558889999999999999999999999855 78888889999999999999999989
Q ss_pred EEEEEEecCCcEEEEEEEeeeeecCCCCEEEEEEEEecchhhhHH
Q 001865 265 GRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEG 309 (1002)
Q Consensus 265 ~e~~~~~kdG~~~w~~~~~~pi~d~~G~v~~~v~i~~DITerk~~ 309 (1002)
.|+..++|+...+|+.+.+.||+++...++-|+++++|||..|+-
T Consensus 95 fEillyKKN~TPvW~~vqiAPIrNe~d~VVLfLctFkDIT~~KQP 139 (971)
T KOG0501|consen 95 FEILLYKKNRTPVWLLVQIAPIRNEKDKVVLFLCTFKDITALKQP 139 (971)
T ss_pred eeeEeeecCCCceEEEEEeecccCCCceEEEEEeecccchhhcCC
Confidence 999999999999999999999999999999999999999998874
|
|
| >PF12860 PAS_7: PAS fold | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.3e-07 Score=86.72 Aligned_cols=104 Identities=22% Similarity=0.284 Sum_probs=73.3
Q ss_pred HHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhh-cCCCCcccc---------CCCCChHHHHHHHHHHhcCCcEE
Q 001865 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEI-LGRNCRFLQ---------GPETDPATVRKIRAAIDNQTDVT 547 (1002)
Q Consensus 478 ~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEl-iG~~~~~l~---------~~d~~~~~~~~l~~~l~~~~~~~ 547 (1002)
++++++||++.|.+|+ ++++|++|.+++|++.+.+ .|.++..++ .+.............+.......
T Consensus 1 Ld~l~~Gv~v~D~~~r---l~~~N~~~~~l~~~~~~~~~~G~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (115)
T PF12860_consen 1 LDSLPQGVAVFDSDGR---LVFWNQRFRELFGLPPEMLRPGASFRDLLRRLAERGEFPPGDPEAWVRQRLARLRRRQPRS 77 (115)
T ss_pred CCCcCceEEEEcCCCe---EEeEcHHHHHHhCCCHHHhcCCCCHHHHHHHHHHcCCCCCCCHHHHHHHHHHHHhcCCCce
Confidence 4678999999999888 9999999999999999998 788854433 12222223333333333333333
Q ss_pred EEEEEEecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCCcccccc
Q 001865 548 VQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593 (1002)
Q Consensus 548 ~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DITerk~~e 593 (1002)
.+ ....||+ |+.++..|+ .+| |+|.++.|||+++++|
T Consensus 78 ~~--~~~~dgr--~l~~~~~~~--~~G---g~v~~~~DVT~~~~~E 114 (115)
T PF12860_consen 78 FE--LRLPDGR--WLEVRAQPL--PDG---GFVLTFTDVTERRRAE 114 (115)
T ss_pred eE--EECCCCE--EEEEEeEEC--CCC---CEEEEEEeCCHHHHhc
Confidence 33 4568887 667788888 456 5788899999999854
|
|
| >PF13596 PAS_10: PAS domain; PDB: 3CAX_A 2QKP_D | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.5e-07 Score=84.45 Aligned_cols=106 Identities=20% Similarity=0.316 Sum_probs=73.9
Q ss_pred HHHHHHhccccEEEEcCCCCCCCEEeccHHHHHHcCCChhhhcCCCCccccCCCCChHHHHHHHHHHhcCCcEEEEEEEE
Q 001865 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINY 553 (1002)
Q Consensus 474 l~~i~e~~~~~I~i~D~~g~~~~Iv~vN~a~~~l~Gys~eEliG~~~~~l~~~d~~~~~~~~l~~~l~~~~~~~~e~~~~ 553 (1002)
++.++++++.++.++|.++. |.+.|+++.++|+... ..+|+++..+.++.........+ +.+..++....+...
T Consensus 1 L~~il~s~~~~i~~vD~~~~---I~~~n~~a~~~f~~~~-~~iGr~l~~~~~~~~~~~l~~~i-~~~~~~~~~~~~~~~- 74 (106)
T PF13596_consen 1 LNNILDSMPIGIIFVDRNLR---IRYFNPAAARLFNLSP-SDIGRPLFDIHPPLSYPNLKKII-EQVRSGKEEEFEIVI- 74 (106)
T ss_dssp HHHHHHHSSSEEEEEETTSB---EEEE-SCGC-SS---G-GGTTSBCCCSS-HHHHHHHHHHH-HHHHTTSBSEEEEEE-
T ss_pred ChHHHhcCCCCEEEEcCCCe---EEEeChhHhhhcCCCh-HHCCCCHHHcCCccchHHHHHHH-HHHHcCCCceEEEEe-
Confidence 46789999999999999877 9999999999999764 66899988887664444444444 445555543333333
Q ss_pred ecCCcEEEEEEEEEeeecCCCCEEEEEEEEecCC
Q 001865 554 TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (1002)
Q Consensus 554 ~kdG~~~wv~~~~~pi~d~~G~v~~~vgi~~DIT 587 (1002)
..+|. |+..+..|++|++|+..|++.++.|||
T Consensus 75 ~~~~~--~~~~~~~P~~~~~g~~~G~v~~~~DIT 106 (106)
T PF13596_consen 75 PNGGR--WYLVRYRPYRDEDGEYAGAVITFQDIT 106 (106)
T ss_dssp EETTE--EEEEEEEEEE-TTS-EEEEEEEEEE-G
T ss_pred cCCCE--EEEEEEEEEECCCCCEEEEEEEEEecC
Confidence 35665 667889999999999999999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1002 | ||||
| 2v0u_A | 146 | N- And C-terminal Helices Of Oat Lov2 (404-546) Are | 2e-67 | ||
| 2v1a_A | 144 | N- And C-Terminal Helices Of Oat Lov2 (404-546) Are | 2e-67 | ||
| 2wkp_A | 332 | Structure Of A Photoactivatable Rac1 Containing Lov | 6e-67 | ||
| 2wkq_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 8e-66 | ||
| 2wkr_A | 332 | Structure Of A Photoactivatable Rac1 Containing The | 1e-65 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 2e-63 | ||
| 2z6c_A | 129 | Crystal Structure Of Lov1 Domain Of Phototropin1 Fr | 4e-25 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-55 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-55 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-55 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-55 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-55 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 7e-55 | ||
| 2z6d_A | 130 | Crystal Structure Of Lov1 Domain Of Phototropin2 Fr | 4e-26 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-55 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-55 | ||
| 4eep_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 1e-54 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-54 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-54 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-54 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-54 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-54 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-54 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-54 | ||
| 4eer_A | 115 | Crystal Structure Of Lov2 Domain Of Arabidopsis Tha | 9e-54 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-53 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-53 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-53 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-53 | ||
| 4ees_A | 115 | Crystal Structure Of Ilov Length = 115 | 6e-52 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-51 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-49 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-48 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-48 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-48 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-48 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-48 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-48 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-48 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-48 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-48 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-48 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-48 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-48 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-48 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-48 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-48 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-48 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-48 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-48 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-48 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-48 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-48 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-48 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-48 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-48 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-48 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-48 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-48 | ||
| 4eeu_A | 118 | Crystal Structure Of Philov2.1 Length = 118 | 8e-48 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-48 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-48 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-48 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-48 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-47 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-47 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-47 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-47 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-47 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-47 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-47 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-47 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-47 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-47 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-47 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-47 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-47 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-47 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-47 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-47 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-47 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-47 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-47 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-47 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-47 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-47 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-47 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-47 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-46 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-46 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-46 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-46 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-44 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-44 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-44 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-44 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-43 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-43 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-43 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-43 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-43 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-43 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-42 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-42 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-42 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-42 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-42 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-42 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-42 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-42 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-42 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-42 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-42 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-42 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-42 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-42 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-42 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-42 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-42 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-42 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-42 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-42 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-41 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-41 | ||
| 1g28_A | 104 | Structure Of A Flavin-Binding Domain, Lov2, From Th | 2e-40 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-39 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-38 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-38 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-37 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-37 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-36 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-36 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-35 | ||
| 1n9l_A | 109 | Crystal Structure Of The Phot-lov1 Domain From Chla | 2e-24 | ||
| 3ulf_A | 170 | The Light State Structure Of The Blue-light Photore | 1e-32 | ||
| 3ue6_A | 166 | The Dark Structure Of The Blue-light Photoreceptor | 2e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-31 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-31 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-31 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-31 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-30 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-30 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-30 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-30 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-30 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-30 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-30 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-30 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-30 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-30 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-30 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-30 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-30 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-29 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-29 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-29 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-29 | ||
| 3t50_A | 128 | X-Ray Structure Of The Lov Domain From The Lov-Hk S | 4e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-28 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-26 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-26 | ||
| 2pr5_A | 132 | Structural Basis For Light-dependent Signaling In T | 7e-26 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-25 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-25 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-25 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-24 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-24 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-24 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-24 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-24 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-24 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-24 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-24 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-24 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-23 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-23 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-23 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-23 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-23 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-23 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-23 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-23 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-23 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-23 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-23 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-23 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-23 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-23 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-23 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-23 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-23 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-23 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-23 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-23 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-23 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-23 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-23 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-22 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-22 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-22 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 5e-22 | ||
| 3p7n_A | 258 | Crystal Structure Of Light Activated Transcription | 6e-20 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-22 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-21 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-21 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-21 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-21 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-21 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-21 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-21 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-21 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-20 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-20 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-20 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-20 | ||
| 3hjk_A | 154 | 2.0 Angstrom Structure Of The Ile74val Variant Of V | 2e-20 | ||
| 3rh8_B | 148 | Crystal Structure Of The Light-State Dimer Of Funga | 2e-20 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-20 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-20 | ||
| 3hji_A | 154 | 1.8 Angstrom Crystal Structure Of The I74v:i85v Var | 3e-20 | ||
| 3is2_B | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-20 | ||
| 3is2_A | 154 | 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic | 3e-20 | ||
| 2pd8_A | 149 | 1.8 Angstrom Crystal Structure Of The Cys71ser Muta | 3e-20 | ||
| 2pd7_A | 149 | 2.0 Angstrom Crystal Structure Of The Fungal Blue-L | 3e-20 | ||
| 3d72_A | 149 | 1.65 Angstrom Crystal Structure Of The Cys71val Var | 4e-20 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-20 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-19 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-19 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-19 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-19 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-18 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-18 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-17 | ||
| 3sw1_A | 162 | Structure Of A Full-Length Bacterial Lov Protein Le | 2e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-13 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hj3_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-11 | ||
| 4hia_A | 176 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj6_A | 178 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 1e-10 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 3e-11 | ||
| 4hj4_A | 177 | Crystal Structure Of Rhodobacter Sphaeroides Lov Pr | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-09 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2l0w_A | 138 | Solution Nmr Structure Of The N-Terminal Pas Domain | 6e-08 | ||
| 2l4r_A | 135 | Nmr Solution Structure Of The N-Terminal Pas Domain | 6e-08 | ||
| 2l1m_A | 150 | Solution Structure Of The Eag Domain Of The Herg (K | 6e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 2gj3_A | 120 | Crystal Structure Of The Fad-Containing Pas Domain | 1e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-07 | ||
| 1byw_A | 110 | Structure Of The N-Terminal Domain Of The Human-Erg | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-07 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-07 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 1e-06 | ||
| 3ewk_A | 227 | Structure Of The Redox Sensor Domain Of Methylococc | 3e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-05 |
| >pdb|2V0U|A Chain A, N- And C-terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-induced Signal Transduction (cryo Dark Structure Of Lov2 (404-546)) Length = 146 | Back alignment and structure |
|
| >pdb|2V1A|A Chain A, N- And C-Terminal Helices Of Oat Lov2 (404-546) Are Involved In Light-Induced Signal Transduction (Room Temperature (293k) Dark Structure Of Lov2 (404-546)) Length = 144 | Back alignment and structure |
|
| >pdb|2WKP|A Chain A, Structure Of A Photoactivatable Rac1 Containing Lov2 Wildtype Length = 332 | Back alignment and structure |
|
| >pdb|2WKQ|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450a Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2WKR|A Chain A, Structure Of A Photoactivatable Rac1 Containing The Lov2 C450m Mutant Length = 332 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|2Z6C|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin1 From Arabidopsis Thaliana Length = 129 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|2Z6D|A Chain A, Crystal Structure Of Lov1 Domain Of Phototropin2 From Arabidopsis Thaliana Length = 130 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EEP|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 Length = 115 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EER|A Chain A, Crystal Structure Of Lov2 Domain Of Arabidopsis Thaliana Phototropin 2 C426a Mutant Length = 115 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EES|A Chain A, Crystal Structure Of Ilov Length = 115 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EEU|A Chain A, Crystal Structure Of Philov2.1 Length = 118 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1G28|A Chain A, Structure Of A Flavin-Binding Domain, Lov2, From The Chimeric PhytochromePHOTOTROPIN PHOTORECEPTOR PHY3 Length = 104 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|1N9L|A Chain A, Crystal Structure Of The Phot-lov1 Domain From Chlamydomonas Reinhardtii In The Dark State. Length = 109 | Back alignment and structure |
|
| >pdb|3ULF|A Chain A, The Light State Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 170 | Back alignment and structure |
|
| >pdb|3UE6|A Chain A, The Dark Structure Of The Blue-light Photoreceptor Aureochrome1 Lov Length = 166 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3T50|A Chain A, X-Ray Structure Of The Lov Domain From The Lov-Hk Sensory Protein From Brucella Abortus (Dark State). Length = 128 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PR5|A Chain A, Structural Basis For Light-dependent Signaling In The Dimeric Lov Photosensor Ytva (dark Structure) Length = 132 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|3P7N|A Chain A, Crystal Structure Of Light Activated Transcription Factor El222 From Erythrobacter Litoralis Length = 258 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HJK|A Chain A, 2.0 Angstrom Structure Of The Ile74val Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3RH8|B Chain B, Crystal Structure Of The Light-State Dimer Of Fungal Blue-Light Photoreceptor Vivid Length = 148 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3HJI|A Chain A, 1.8 Angstrom Crystal Structure Of The I74v:i85v Variant Of Vivid (Vvd). Length = 154 | Back alignment and structure |
|
| >pdb|3IS2|B Chain B, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|3IS2|A Chain A, 2.3 Angstrom Crystal Structure Of A Cys71 Sulfenic Acid Form Of Vivid Length = 154 | Back alignment and structure |
|
| >pdb|2PD8|A Chain A, 1.8 Angstrom Crystal Structure Of The Cys71ser Mutant Of Vivid Length = 149 | Back alignment and structure |
|
| >pdb|2PD7|A Chain A, 2.0 Angstrom Crystal Structure Of The Fungal Blue-Light Photoreceptor Vivid Length = 149 | Back alignment and structure |
|
| >pdb|3D72|A Chain A, 1.65 Angstrom Crystal Structure Of The Cys71val Variant In The Fungal Photoreceptor Vvd Length = 149 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3SW1|A Chain A, Structure Of A Full-Length Bacterial Lov Protein Length = 162 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HJ3|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|4HIA|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 176 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4HJ6|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 178 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|4HJ4|A Chain A, Crystal Structure Of Rhodobacter Sphaeroides Lov Protein Length = 177 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2L0W|A Chain A, Solution Nmr Structure Of The N-Terminal Pas Domain Of Herg Potassium Channel Length = 138 | Back alignment and structure |
|
| >pdb|2L4R|A Chain A, Nmr Solution Structure Of The N-Terminal Pas Domain Of Herg Length = 135 | Back alignment and structure |
|
| >pdb|2L1M|A Chain A, Solution Structure Of The Eag Domain Of The Herg (Kv11.1) K+ Channel Length = 150 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2GJ3|A Chain A, Crystal Structure Of The Fad-Containing Pas Domain Of The Protein Nifl From Azotobacter Vinelandii. Length = 120 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BYW|A Chain A, Structure Of The N-Terminal Domain Of The Human-Erg Potassium Channel Length = 110 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|3EWK|A Chain A, Structure Of The Redox Sensor Domain Of Methylococcus Capsulatus (Bath) Mmos Length = 227 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1002 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-119 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-113 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-112 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-112 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-112 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-112 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-112 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-110 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-109 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-109 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-108 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-108 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-108 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-106 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-106 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-106 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-105 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-105 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-104 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-103 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-103 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-99 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-86 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-85 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-73 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-71 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 9e-69 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-68 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-67 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-66 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 1e-65 | |
| 2wkq_A | 332 | NPH1-1, RAS-related C3 botulinum toxin substrate 1 | 3e-40 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 9e-65 | |
| 2v0u_A | 146 | NPH1-1, LOV2; kinase, transferase, ATP-binding, se | 4e-54 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 3e-62 | |
| 2z6d_A | 130 | Phototropin-2; PAS-fold, LOV-fold, alternative spl | 1e-56 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 2e-59 | |
| 4eet_B | 115 | Phototropin-2; LOV, blue light photoreceptor, sign | 9e-55 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 6e-59 | |
| 3ue6_A | 166 | Aureochrome1; PAS/LOV domain, FMN-binding blue-lig | 3e-54 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-59 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-58 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-58 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 5e-58 | |
| 1n9l_A | 109 | PHOT-LOV1, putative blue light receptor; phototrop | 1e-55 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 5e-58 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-57 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-57 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-57 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-57 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-57 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-57 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-57 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-57 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-56 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-56 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-56 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-56 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-56 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-56 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 4e-56 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-56 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-56 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-56 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-56 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 1e-55 | |
| 3p7n_A | 258 | Sensor histidine kinase; LOV domain, light-activat | 4e-54 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-55 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-55 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 4e-55 | |
| 3t50_A | 128 | Blue-light-activated histidine kinase; PAS superfa | 9e-53 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-55 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-55 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 6e-55 | |
| 2l0w_A | 138 | Potassium voltage-gated channel, subfamily H (EAG | 3e-52 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-55 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 7e-55 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 9e-55 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-54 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-54 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-54 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 5e-54 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 2e-53 | |
| 3sw1_A | 162 | Sensory box protein; light-oxygen-voltage, LOV, PA | 3e-53 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 2e-53 | |
| 1byw_A | 110 | Protein (human ERG potassium channel); PAS domain, | 1e-52 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 5e-53 | |
| 2pr5_A | 132 | Blue-light photoreceptor; light-oxygen-voltage, LO | 3e-50 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-53 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-52 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-52 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-52 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-52 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-52 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-52 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 7e-52 | |
| 3d72_A | 149 | Vivid PAS protein VVD; circadian, photoreceptor, b | 5e-49 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-52 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-50 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-50 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-50 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-50 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-50 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-50 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-49 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-49 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 7e-49 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-48 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-48 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-47 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-47 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-47 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-46 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-06 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-46 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 5e-44 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-43 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-41 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-41 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-36 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-35 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-35 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-35 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-35 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-35 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-34 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-34 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-34 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-34 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 9e-34 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-33 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-33 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 3e-33 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-33 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 8e-33 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-32 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-31 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-31 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-31 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-30 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-30 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-26 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-26 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-26 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-25 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-25 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-24 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-24 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 4e-23 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 4e-22 | |
| 3ewk_A | 227 | Sensor protein; PAS domain, alpha/beta fold, kinas | 3e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-23 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-23 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-22 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-22 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-22 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-22 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-22 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-22 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-22 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-21 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 3e-21 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-21 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 7e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 8e-21 | |
| 2gj3_A | 120 | Nitrogen fixation regulatory protein; PAS domain, | 5e-16 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-20 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-20 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-20 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-20 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 6e-20 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-20 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-19 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-19 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-19 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-19 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-19 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-19 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-19 | |
| 3lyx_A | 124 | Sensory BOX/ggdef domain protein; structural genom | 3e-17 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-19 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 4e-19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-19 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-19 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-19 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 9e-19 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-18 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-18 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-18 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-18 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-18 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 8e-18 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 8e-18 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 8e-18 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-17 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-17 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-17 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-17 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-17 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 7e-17 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-17 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-16 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-16 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 3e-16 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-16 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-16 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-16 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-16 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 8e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-15 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-15 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-15 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-14 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 2e-14 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-14 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-14 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-14 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-13 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-12 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 2e-12 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-12 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-12 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 4e-12 | |
| 3mqq_A | 120 | Transcriptional regulator, LUXR family; PAS domain | 6e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 8e-12 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-11 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-11 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-11 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 9e-11 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-10 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-10 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 8e-10 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-09 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 5e-08 | |
| 3luq_A | 114 | Sensor protein; PAS, histidine, kinase, PSI, MCSG, | 7e-05 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-08 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 1e-07 | |
| 3b33_A | 115 | Sensor protein; structural genomics, PAS domain, n | 5e-05 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 1e-07 | |
| 2r78_A | 117 | Sensor protein; sensory box sensor histidine kinas | 4e-07 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 5e-07 | |
| 2vlg_A | 111 | Sporulation kinase A; histidine kinase, two-compon | 3e-04 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 6e-07 | |
| 3bwl_A | 126 | Sensor protein; structural genomics, APC87707.1, P | 7e-07 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 5e-06 | |
| 3mjq_A | 126 | Uncharacterized protein; NESG, structural genomics | 2e-05 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 8e-06 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 1e-05 | |
| 3olo_A | 118 | Two-component sensor histidine kinase; structural | 4e-05 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 2e-05 | |
| 3fc7_A | 125 | HTR-like protein, sensor protein; APC87712.1, HTR- | 3e-04 | |
| 3eeh_A | 125 | Putative light and redox sensing histidine kinase; | 3e-05 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 3e-05 | |
| 3icy_A | 118 | Sensor protein; sensory box histidine kinase/respo | 2e-04 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-05 | |
| 3kx0_X | 185 | Uncharacterized protein RV1364C/MT1410; PAS domain | 9e-04 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 366 bits (943), Expect = e-119
Identities = 104/315 (33%), Positives = 155/315 (49%), Gaps = 31/315 (9%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
+ + F+ K LG G +V L + + +A+K ++K ++ NKV ER+++
Sbjct: 25 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 84
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
LDHPF LY +FQ + Y GEL + + E RFY AE+V A
Sbjct: 85 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSA 142
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
LEYLH +GII+RDLKPEN+LL + H+ +TDF K +L +++ R
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT-----AK---VLSPESKQAR------ 188
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR
Sbjct: 189 -----------ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237
Query: 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS--HEGANEIKKHPFFKGV 961
F I+ + FP A+ L+ +LL D RLG EG +K HPFF+ V
Sbjct: 238 YLIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 962 NWALVRCMNPPELDA 976
W + PP+L A
Sbjct: 296 TWENLHQQTPPKLTA 310
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-113
Identities = 118/322 (36%), Positives = 176/322 (54%), Gaps = 38/322 (11%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKV 713
+ + E+ + F +K LG G G V LV+ + Q +AMK + K + R++V
Sbjct: 12 HHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 714 HRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAV 773
ER+IL ++HPF+ L+ +FQT+ + LI D+ GG+LF L ++ + E+ V
Sbjct: 72 R-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDV 128
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+FY AE+ +AL++LH GIIYRDLKPEN+LL GH+ LTDF L K +
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-----SKESIDHEKK- 182
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
+ SF GT EY+APE++ GHT + DWW+ G+L++EML
Sbjct: 183 ---------------------AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEI 952
G PF+GK R++T IL L P S A+ L+ L R+P +RLG+ +G EI
Sbjct: 222 GTLPFQGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 953 KKHPFFKGVNWALV--RCMNPP 972
K+H FF ++W + R ++PP
Sbjct: 280 KRHSFFSTIDWNKLYRREIHPP 301
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-112
Identities = 123/323 (38%), Positives = 174/323 (53%), Gaps = 38/323 (11%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK- 712
+ E+I + F ++ LG G G V V +G+ FAMK + K +++ K
Sbjct: 5 TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD 64
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
AER IL+ + HPF+ L +FQT + LI +Y GGELF+ L+R+ + ED
Sbjct: 65 TAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDT 122
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
FY AE+ +AL +LH +GIIYRDLKPEN++L GHV LTDF L CK
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL-----CK-------- 169
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
+ + ++F GT EY+APEI+ +GH AVDWW+LG L+Y+ML
Sbjct: 170 -------------ESIHDGTVT-HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 893 YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANE 951
G PF G+ R+KT IL L P + A+ L+ +LL R+ SRLG+ A E
Sbjct: 216 TGAPPFTGENRKKTIDKILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGE 273
Query: 952 IKKHPFFKGVNWALV--RCMNPP 972
++ HPFF+ +NW + R + PP
Sbjct: 274 VQAHPFFRHINWEELLARKVEPP 296
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 348 bits (895), Expect = e-112
Identities = 120/349 (34%), Positives = 182/349 (52%), Gaps = 46/349 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+ +LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
++ HPF+ ++ +FQ + +I DY GGELF LL + + +FYAAEV +AL
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLAL 119
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYLH + IIYRDLKPEN+LL NGH+ +TDF K
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-----AK-------------------- 154
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF
Sbjct: 155 -----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 963
KT+ IL+ +L+FP + K L+ RL+ RD RLG+ G ++K HP+FK V W
Sbjct: 210 KTYEKILNAELRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267
Query: 964 ALV--RCMNPP--------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
+ R + P + D F E++ G +D ++F
Sbjct: 268 EKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQG-EDPYADLF 315
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-112
Identities = 113/329 (34%), Positives = 162/329 (49%), Gaps = 34/329 (10%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 706
P + I S F +K +G G G V L ++A+K + K
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKA 75
Query: 707 MLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+L + + +ER +L + HPF+ L+ SFQT + + DY GGELF L R+
Sbjct: 76 ILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-- 133
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
+ E RFYAAE+ AL YLH I+YRDLKPEN+LL GH+ LTDF L CK
Sbjct: 134 RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL-----CKE 188
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
+ +T +++F GT EY+APE++ + VDWW LG
Sbjct: 189 NIEHNST----------------------TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG 226
Query: 886 ILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945
+LYEMLYG PF + + + NIL+K L+ + + A+ L+ LL +D RLG+
Sbjct: 227 AVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGA 284
Query: 946 HEGANEIKKHPFFKGVNWALV--RCMNPP 972
+ EIK H FF +NW + + + PP
Sbjct: 285 KDDFMEIKSHVFFSLINWDDLINKKITPP 313
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 350 bits (901), Expect = e-112
Identities = 108/356 (30%), Positives = 167/356 (46%), Gaps = 49/356 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + + +K +G G G V LV + + +AMK + K M+ R+ ER+I+
Sbjct: 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ P+V L+ +FQ ++ ++ +Y PGG+L L+ + E RFY AEVV+AL
Sbjct: 125 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLAL 181
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+ +H G I+RD+KP+N+LL +GH+ L DF K +G
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC----------------MKMNKEGMVR 225
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG----HTSAVDWWALGILLYEMLYGYTPFRG 900
++ VGT +YI+PE++ G + DWW++G+ LYEML G TPF
Sbjct: 226 ----------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
Query: 901 KTRQKTFANILH--KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
+ T++ I++ L FP S AK L+ L D + RLG + G EIK+H FF
Sbjct: 276 DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRN-GVEEIKRHLFF 333
Query: 959 KGVNWA--LVRCMNPP-------ELDAPLF---ATDTEKEYKVVDPGMQDLQQNVF 1002
K WA +R P ++D F D +E P Q F
Sbjct: 334 KNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPF 389
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-112
Identities = 113/311 (36%), Positives = 170/311 (54%), Gaps = 34/311 (10%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
HPF+ AL +FQT +C + +Y GGELF L R+ +V E+ RFY AE+V AL
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYLH + ++YRD+K EN++L +GH+ +TDF L CK +
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL-----CKEGI----------------- 156
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +
Sbjct: 157 -----SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNW 963
+ F IL ++++FP + S AK L+ LL +DPK RLG A E+ +H FF +NW
Sbjct: 212 RLFELILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269
Query: 964 ALV--RCMNPP 972
V + + PP
Sbjct: 270 QDVVQKKLLPP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 347 bits (893), Expect = e-110
Identities = 102/318 (32%), Positives = 159/318 (50%), Gaps = 39/318 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ F +K +G G V +V++ +GQ +AMK M+K ML R +V ER++L
Sbjct: 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
D ++ L+ +FQ + ++ L+ +Y GG+L LL + + + + RFY AE+V+A+
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAI 175
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+ +H G ++RD+KP+N+LL GH+ L DF K R G
Sbjct: 176 DSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC----------------LKLRADGTVR 219
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-------HTSAVDWWALGILLYEMLYGYTP 897
S VGT +Y++PEI+ G + DWWALG+ YEM YG TP
Sbjct: 220 ----------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
Query: 898 FRGKTRQKTFANILHKD--LKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
F + +T+ I+H L P A+ + RLL P++RLG GA + +
Sbjct: 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRG-GAGDFRT 327
Query: 955 HPFFKGVNWALVRCMNPP 972
HPFF G++W +R PP
Sbjct: 328 HPFFFGLDWDGLRDSVPP 345
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-109
Identities = 101/315 (32%), Positives = 160/315 (50%), Gaps = 35/315 (11%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ +++ L F + LG G G V L E G+ + +A+K + K V++ + V E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 722 ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
+L + PF+ L++ FQT + + +Y GG+L + + KE FYAAE+
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEI 130
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L +L +GIIYRDLK +NV+L GH+ + DF + CK + T
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKENIWDGVT-------- 177
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ +F GT +YIAPEIIA + +VDWWA G+LLYEML G PF G
Sbjct: 178 --------------TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
Query: 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFK 959
+ + F +I+ ++ +P S S A + L+ + P RLG G +IK+H FF+
Sbjct: 224 EDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
Query: 960 GVNWALV--RCMNPP 972
++W + + + PP
Sbjct: 282 YIDWEKLERKEIQPP 296
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-109
Identities = 102/317 (32%), Positives = 165/317 (52%), Gaps = 37/317 (11%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
+++ + F +K +G G G V +V+L + + FAMK ++K ML R + ER++L
Sbjct: 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL 128
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
D ++ L+ +FQ ++ L+ DY GG+L LL + + L E+ RFY AE+V+A
Sbjct: 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIA 187
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++ +H ++RD+KP+N+L+ NGH+ L DF C
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS-----CLK------------------ 224
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPF 898
M + S+ VGT +YI+PEI+ + DWW+LG+ +YEMLYG TPF
Sbjct: 225 ---LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281
Query: 899 RGKTRQKTFANILHK--DLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955
++ +T+ I++ +FP+ S +AK L+ RL+ RLG + G + KKH
Sbjct: 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREH-RLGQN-GIEDFKKH 339
Query: 956 PFFKGVNWALVRCMNPP 972
PFF G++W +R P
Sbjct: 340 PFFSGIDWDNIRNCEAP 356
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-108
Identities = 107/316 (33%), Positives = 163/316 (51%), Gaps = 36/316 (11%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
S ++ + +F I+ LG G G V L + +G +A+K + K V+L + V E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 722 IL-DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
IL +HPF+ L+ FQT + + ++ GG+L + + + E RFYAAE+
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEI 133
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ AL +LH +GIIYRDLK +NVLL GH L DF + CK + T
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM-----CKEGICNGVT-------- 180
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ +F GT +YIAPEI+ + AVDWWA+G+LLYEML G+ PF
Sbjct: 181 --------------TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
Query: 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFF 958
+ F IL+ ++ +P+ A ++ + ++P RLGS G + I +HPFF
Sbjct: 227 ENEDDLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
Query: 959 KGVNWALV--RCMNPP 972
K ++WA + R + PP
Sbjct: 285 KEIDWAQLNHRQIEPP 300
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-108
Identities = 102/314 (32%), Positives = 168/314 (53%), Gaps = 37/314 (11%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
++ ++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 722 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
+L + +HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 127
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
++ L++LH +GI+YRDLK +N+LL +GH+ + DF + CK +L
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM-----CKENMLGDAK-------- 174
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G
Sbjct: 175 --------------TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ ++ F +I + +P AK L+ +L R+P+ RLG +I++HP F+
Sbjct: 221 QDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRG---DIRQHPLFRE 275
Query: 961 VNWALV--RCMNPP 972
+NW + + ++PP
Sbjct: 276 INWEELERKEIDPP 289
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-108
Identities = 111/351 (31%), Positives = 163/351 (46%), Gaps = 47/351 (13%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
S L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+
Sbjct: 34 SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
IL ++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ EYLH +IYRDLKPEN+L+ G++ +TDF K
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-----AK----------------- 189
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 --------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
Query: 902 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKG 960
+ + I+ ++FPS S K L+ LL D R G+ G N+IK H +F
Sbjct: 242 QPIQIYEKIVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
Query: 961 VNWALV--RCMNPP-------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
+W + R + P D F E+E + + + F
Sbjct: 300 TDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEE---IRVSINEKCGKEF 347
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-106
Identities = 123/366 (33%), Positives = 184/366 (50%), Gaps = 36/366 (9%)
Query: 611 QTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQH 670
+T E E + + A P +S + + ++ +
Sbjct: 91 ETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSP-SDNSGAEEMEVSLAKPKHRVTMNE 149
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
F +K LG G G V LV+ +G+Y+AMK + K V++ +++V E +L HPF
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ AL SFQT +C + +Y GGELF L R+ +V ED RFY AE+V AL+YLH +
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE 267
Query: 791 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
++YRDLK EN++L +GH+ +TDF L CK + T
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGL-----CKEGIKDGAT----------------- 305
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + +K F
Sbjct: 306 -----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV-- 966
IL ++++FP + AK L+ LL +DPK RLG A EI +H FF G+ W V
Sbjct: 361 ILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYE 418
Query: 967 RCMNPP 972
+ ++PP
Sbjct: 419 KKLSPP 424
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-106
Identities = 110/325 (33%), Positives = 174/325 (53%), Gaps = 45/325 (13%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + + LQ F ++ +G G V LV L + + +AMK + K ++ + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 722 ILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
+ + +HPF+ L++ FQT++ + + +Y GG+L + RQ + L E+ RFY+AE+
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 119
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+AL YLH +GIIYRDLK +NVLL GH+ LTD+ + CK L
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM-----CKEGL------------- 161
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF-- 898
P +++F GT YIAPEI+ G + +VDWWALG+L++EM+ G +PF
Sbjct: 162 ---------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212
Query: 899 -------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GA 949
T F IL K ++ P S S+ A ++ L++DPK RLG H G
Sbjct: 213 VGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGF 270
Query: 950 NEIKKHPFFKGVNWALV--RCMNPP 972
+I+ HPFF+ V+W ++ + + PP
Sbjct: 271 ADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-106
Identities = 120/325 (36%), Positives = 177/325 (54%), Gaps = 44/325 (13%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-VHRAC 717
E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 106
Query: 718 AEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ + E V+ Y
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIY 164
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF L K
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL-----SK------------ 207
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYG 894
F+A+ + F GT EY+AP+I+ G GH AVDWW+LG+L+YE+L G
Sbjct: 208 ---------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 895 YTPF----RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGA 949
+PF ++ + IL + +P S AK L+ RLL +DPK RLG A
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDA 316
Query: 950 NEIKKHPFFKGVNWALV--RCMNPP 972
+EIK+H FF+ +NW + + + P
Sbjct: 317 DEIKEHLFFQKINWDDLAAKKVPAP 341
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-105
Identities = 93/322 (28%), Positives = 160/322 (49%), Gaps = 43/322 (13%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA 718
+ D E +N HF ++ +G G G V +V+ + + +AMK M+K + RN+V
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
E +I+ L+HPF+ L+ SFQ + + ++ D GG+L L + KE+ V+ +
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
E+V+AL+YL Q II+RD+KP+N+LL +GHV +TDF++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI-----AA-------------- 163
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA---GAGHTSAVDWWALGILLYEMLYGY 895
M + GT+ Y+APE+ + GAG++ AVDWW+LG+ YE+L G
Sbjct: 164 ---------MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
Query: 896 TPFRGKT---RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952
P+ ++ ++ + +PS+ S L+ +LL +P R +++
Sbjct: 215 RPYHIRSSTSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKLLEPNPDQRFS---QLSDV 269
Query: 953 KKHPFFKGVNWALV--RCMNPP 972
+ P+ +NW V + + P
Sbjct: 270 QNFPYMNDINWDAVFQKRLIPG 291
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 331 bits (851), Expect = e-105
Identities = 110/363 (30%), Positives = 178/363 (49%), Gaps = 45/363 (12%)
Query: 624 PDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTG 683
+ N ++ ++ + + LQ F ++ +G G
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 684 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 742
V LV L + + +AM+ + K ++ + + E+ + +HPF+ L++ FQT++
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ + +Y GG+L + RQ + L E+ RFY+AE+ +AL YLH +GIIYRDLK +NV
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 184
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
LL GH+ LTD+ + CK L P +++F GT
Sbjct: 185 LLDSEGHIKLTDYGM-----CKEGL----------------------RPGDTTSTFCGTP 217
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF---------RGKTRQKTFANILHK 913
YIAPEI+ G + +VDWWALG+L++EM+ G +PF T F IL K
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 914 DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALV--RCM 969
++ P S S+ A ++ L++DPK RLG H G +I+ HPFF+ V+W ++ + +
Sbjct: 278 QIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQV 335
Query: 970 NPP 972
PP
Sbjct: 336 VPP 338
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-104
Identities = 114/460 (24%), Positives = 199/460 (43%), Gaps = 44/460 (9%)
Query: 526 PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
P K++ D +++ + S WN +++ + + + +
Sbjct: 189 PNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDW 248
Query: 586 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPED---------LWAN 636
S+ +E + V + +++ E + + PE +
Sbjct: 249 DLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
K + + + + +++ L F + LG G G V L E G+ +
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDEL 368
Query: 697 FAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQTKTHVCLITDYCPGGE 755
+A+K + K V++ + V E+ +L + PF+ L++ FQT + + +Y GG+
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428
Query: 756 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
L + + KE FYAAE+ + L +L +GIIYRDLK +NV+L GH+ + DF
Sbjct: 429 LMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
+ CK + T + +F GT +YIAPEIIA +
Sbjct: 487 GM-----CKENIWDGVT----------------------TKTFCGTPDYIAPEIIAYQPY 519
Query: 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLL 935
+VDWWA G+LLYEML G PF G+ + F +I+ ++ +P S S A + L+
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS--MSKEAVAICKGLM 577
Query: 936 HRDPKSRLGSHE-GANEIKKHPFFKGVNWALV--RCMNPP 972
+ P RLG G +IK+H FF+ ++W + + + PP
Sbjct: 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 334 bits (857), Expect = e-103
Identities = 96/422 (22%), Positives = 170/422 (40%), Gaps = 49/422 (11%)
Query: 595 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 654
+ + V + + + + P L + + WK
Sbjct: 117 PQAQLFCSFLDAETVARARAGAGDGLFQ-PLLRAVLAHLGQAPFQEFLDSLYFLRFLQWK 175
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH 714
++ + + F + LG G G V ++ +G+ +A K ++K + R
Sbjct: 176 WLEA-----QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230
Query: 715 RACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDA 772
A E++IL + F+ +L +F+TKT +CL+ GG++ + + +E
Sbjct: 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR 290
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
FY A++V LE+LH + IIYRDLKPENVLL +G+V ++D L+
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE------------ 338
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
A + + GT ++APE++ G + +VD++ALG+ LYEM+
Sbjct: 339 --------------LKAGQTKT-KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383
Query: 893 YGYTPFRGK----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE- 947
PFR + ++ +L + + +P S +K LL +DP+ RLG +
Sbjct: 384 AARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDG 441
Query: 948 GANEIKKHPFFKGVNW-ALVRCMNPPELDAPLFA------TDTEKEYKVVDPGMQDLQQN 1000
+ ++ HP F+ ++W L M P D V +
Sbjct: 442 SCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE 501
Query: 1001 VF 1002
F
Sbjct: 502 FF 503
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-103
Identities = 114/431 (26%), Positives = 187/431 (43%), Gaps = 58/431 (13%)
Query: 593 LRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKV-VHPKPHRKDSP 651
+N + + ++ +Q N + +++ P +L E H + V P DS
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSI 165
Query: 652 ------PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
WK +++ + + FR + LG G G V ++ +G+ +A K ++K
Sbjct: 166 YFNRFLQWKWLER-----QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+ R A E++IL+ ++ FV +L +++TK +CL+ GG+L +
Sbjct: 221 RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
E FYAAE+ LE LH + I+YRDLKPEN+LL +GH+ ++D L
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL-----AVH 335
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
+ E VGT Y+APE++ +T + DWWALG
Sbjct: 336 ----------------------VPEGQTI-KGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 886 ILLYEMLYGYTPFRGK----TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 941
LLYEM+ G +PF+ + R++ + ++ S A+ L +LL +DP
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAE 430
Query: 942 RLGSHE-GANEIKKHPFFKGVNW-ALVRCMNPP----------ELDAPLFATDTEKEYKV 989
RLG A E+K+HP FK +N+ L M P D + +
Sbjct: 431 RLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVE 490
Query: 990 VDPGMQDLQQN 1000
++P QD Q
Sbjct: 491 LEPTDQDFYQK 501
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = 3e-99
Identities = 105/387 (27%), Positives = 181/387 (46%), Gaps = 47/387 (12%)
Query: 598 PEATAEESEKLVKQTAENVNEAVKELPDANLTP--EDLWANHSKVVHPKPHRKDSPPWKA 655
+ S+ ++ ++ + K++P P E++ N V K D
Sbjct: 118 LACSHPFSKSAIEHVQGHLVK--KQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFC 175
Query: 656 IQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 715
K ++ + + F + +G G G V+ +G+ +AMK +DK + +
Sbjct: 176 QWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235
Query: 716 ACAEREILDML---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
A ER +L ++ D PF+ + +F T + I D GG+L L + V E
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEAD 293
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+RFYAAE+++ LE++H + ++YRDLKP N+LL +GHV ++D L+
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA-------------- 339
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEM 891
K + ++ VGT Y+APE++ G + S+ DW++LG +L+++
Sbjct: 340 ---CDFSKKK------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 892 LYGYTPFRG---KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-E 947
L G++PFR K + + L ++ P S S + L+ LL RD RLG
Sbjct: 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGR 442
Query: 948 GANEIKKHPFFKGVNWALV--RCMNPP 972
GA E+K+ PFF+ ++W +V + PP
Sbjct: 443 GAQEVKESPFFRSLDWQMVFLQKYPPP 469
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 277 bits (712), Expect = 2e-86
Identities = 92/306 (30%), Positives = 129/306 (42%), Gaps = 37/306 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
Q L+ F +PLG G G+V+L S A+K + K + H+ E EI
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + LY F T V LI +Y P G ++ L + E Y E+ AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 122
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
Y H + +I+RD+KPEN+LL G + + DF S RR
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA------------PSSRRT----- 165
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q
Sbjct: 166 ------------DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964
+T+ I + FP + A+ L+ RLL +P R E+ +HP+ +
Sbjct: 214 ETYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLR----EVLEHPWITANSSK 267
Query: 965 LVRCMN 970
C N
Sbjct: 268 PSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 1e-85
Identities = 83/295 (28%), Positives = 127/295 (43%), Gaps = 37/295 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+ + F +PLG G G+V+L + A+K + K + H+ E EI
Sbjct: 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + +Y F + + L+ ++ P GEL+ L + E + E+ AL
Sbjct: 70 HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADAL 127
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
Y H + +I+RD+KPEN+L+ G + + DF S RR
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA------------PSLRRR----- 170
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ GT +Y+ PE+I G H VD W G+L YE L G PF +
Sbjct: 171 ------------TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+T I++ DLKFP S +K L+ +LL P RL + +HP+ K
Sbjct: 219 ETHRRIVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRL----PLKGVMEHPWVK 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-73
Identities = 71/378 (18%), Positives = 137/378 (36%), Gaps = 90/378 (23%)
Query: 631 EDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVEL 690
+D+ +N+S +++ + K+ + + +R I+ L G + L E
Sbjct: 7 KDILSNYSNLIYLNKYVKE--------------KDKYINDYRIIRTLNQGKFNKIILCE- 51
Query: 691 CGSGQYFAMKAMDKGVMLNRNKVHRACA--------------EREILDMLDHPFVPALYA 736
+++A+K +K ++ + ++ E +I+ + + +
Sbjct: 52 -KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110
Query: 737 SFQTKTHVCLITDYCPGGELF------LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
V +I +Y + +LD+ T + ++ V+ + Y+H +
Sbjct: 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 791 -GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
I +RD+KP N+L+ NG V L+DF S K+
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYM------------VDKKIK---------- 208
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGK-TRQKT 906
GT E++ PE + + + VD W+LGI LY M Y PF K + +
Sbjct: 209 -------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 907 FANILHKDLKFPSSTPT-----------------SLHAKQLMYRLLHRDPKSRLGSHEGA 949
F NI K++++P S + L ++P R+ S
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE--- 318
Query: 950 NEIKKHPFFKGVNWALVR 967
+ KH + N +R
Sbjct: 319 -DALKHEWLADTNIEDLR 335
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-71
Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 40/308 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
F I LG G G V +Y+A+K + K+ +E +L L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLN 60
Query: 728 HPFVPALYASFQ-------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVR 774
H +V YA++ K+ + + +YC G L+ L+ + + D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYW 119
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+++ AL Y+H QGII+RDLKP N+ + + +V + DF L+ N
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-------------KNV 166
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
+ + + + S +GT Y+A E++ G GH +D ++LGI+ +EM+Y
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
G R + ++FP K+++ L+ DP R GA
Sbjct: 227 P--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP----GART 280
Query: 952 IKKHPFFK 959
+ +
Sbjct: 281 LLNSGWLP 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 9e-69
Identities = 72/338 (21%), Positives = 124/338 (36%), Gaps = 45/338 (13%)
Query: 627 NLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKIL---DSGEQINLQHFRPIKPLGSGDTG 683
+L E+L+ + P+ + +Q E Q F+ + LG G G
Sbjct: 12 DLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYG 71
Query: 684 SVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPALYASFQTKT 742
V V G+ +A+K +++ AE + HP L +++
Sbjct: 72 EVFKVRSKEDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG 130
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ L T+ C G L + L E V Y + ++AL +LH QG+++ D+KP N+
Sbjct: 131 ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANI 188
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
L G L DF L V + G
Sbjct: 189 FLGPRGRCKLGDFGLL---------------------------VELGTAGAG-EVQEGDP 220
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT-PFRGKTRQKTFANILHKDLKFPSST 921
Y+APE++ G + +A D ++LG+ + E+ P G+ Q+ L +F +
Sbjct: 221 RYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP--PEFTAG- 276
Query: 922 PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
S + ++ +L DPK R A + P +
Sbjct: 277 -LSSELRSVLVMMLEPDPKLRA----TAEALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-68
Identities = 80/292 (27%), Positives = 125/292 (42%), Gaps = 34/292 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ F+ LG G V+ E +G A+K +DK M V R E +I L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + LY F+ +V L+ + C GE+ L + K E+ R + +++ + YL
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYL 128
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H GI++RDL N+LL N ++ + DF L+ +
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH------------------- 169
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
+ GT YI+PEI + H D W+LG + Y +L G PF T + T
Sbjct: 170 --------YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221
Query: 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
++ D + PS AK L+++LL R+P RL + + HPF
Sbjct: 222 NKVVLADYEMPSFLSIE--AKDLIHQLLRRNPADRL----SLSSVLDHPFMS 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 5e-67
Identities = 78/331 (23%), Positives = 130/331 (39%), Gaps = 37/331 (11%)
Query: 629 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 688
P D V +PP K I ++L + + + + LG G +
Sbjct: 3 APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPR--SRRRYVRGRFLGKGGFAKCFEI 60
Query: 689 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748
+ + FA K + K ++L ++ + E I L H V + F+ V ++
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120
Query: 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808
+ C L L R+ K L E R+Y ++V+ +YLH +I+RDLK N+ L +
Sbjct: 121 ELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178
Query: 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 868
V + DF L+ + GT YIAPE
Sbjct: 179 EVKIGDFGLATKVEYDGERK---------------------------KVLCGTPNYIAPE 211
Query: 869 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAK 928
+++ GH+ VD W++G ++Y +L G PF ++T+ I + P A
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV--AA 269
Query: 929 QLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L+ ++L DP +R NE+ FF
Sbjct: 270 SLIQKMLQTDPTARP----TINELLNDEFFT 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-66
Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 35/293 (11%)
Query: 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML 726
+ + + + LG G + + + FA K + K ++L ++ + E I L
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
H V + F+ V ++ + C L L R+ K L E R+Y ++V+ +Y
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQY 130
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +I+RDLK N+ L + V + DF L+ +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KV-------------- 174
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
GT YIAPE+++ GH+ VD W++G ++Y +L G PF ++T
Sbjct: 175 -----------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET 223
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ I + P A L+ ++L DP +R NE+ FF
Sbjct: 224 YLRIKKNEYSIPKHINPV--AASLIQKMLQTDPTARP----TINELLNDEFFT 270
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 1e-65
Identities = 120/236 (50%), Positives = 150/236 (63%), Gaps = 15/236 (6%)
Query: 465 QKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQ 524
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRN RFLQ
Sbjct: 4 SHHHHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQ 63
Query: 525 GPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQL 584
GPETD ATVRKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQL
Sbjct: 64 GPETDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQL 123
Query: 585 DGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPK 644
DG+EH+ +++ + + + A+ + + + D + L +++ P
Sbjct: 124 DGTEHVRDAAEREGVMLIKKTAENIDEAAKELIK-CVVVGDGAVGKTCLLISYTTNAFPG 182
Query: 645 PHRKDSPPW-KAIQKILDSGEQINLQ--------HFRPIKPLGSGDTGSVHLVELC 691
+ + ++ G+ +NL + ++PL T + +C
Sbjct: 183 EYI--PTVFDNYSANVMVDGKPVNLGLWDTAGLEDYDRLRPLSYPQT---DVFLIC 233
|
| >2wkq_A NPH1-1, RAS-related C3 botulinum toxin substrate 1; transferase, cell adhesion, nucleotide-binding, protein engineering, RAS superfamily LOV2; HET: GTP FMN; 1.60A {Avena sativa} PDB: 2wkr_A* 2wkp_A* Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 48/130 (36%), Positives = 76/130 (58%)
Query: 185 PRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 244
+ L ++ FV++D PD PI++AS F ++T Y+ +E++GRN RFLQG
Sbjct: 7 HHHHGSLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNARFLQGPE 66
Query: 245 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
TD V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ +
Sbjct: 67 TDRATVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGT 126
Query: 305 KHTEGAKDKM 314
+H A ++
Sbjct: 127 EHVRDAAERE 136
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 9e-65
Identities = 123/150 (82%), Positives = 133/150 (88%), Gaps = 7/150 (4%)
Query: 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533
LATTLERIEKNFVITDPRLPDNPIIFASDSFL+LTEYSREEILGRNCRFLQGPETD ATV
Sbjct: 4 LATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRATV 63
Query: 534 RKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPL 593
RKIR AIDNQT+VTVQLINYTKSGKKFWNLFHLQPMRDQKG+VQYFIGVQLDG+EH+
Sbjct: 64 RKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR-- 121
Query: 594 RNSIPEATAEESEKLVKQTAENVNEAVKEL 623
+A E L+K+TAEN++EA KEL
Sbjct: 122 -----DAAEREGVMLIKKTAENIDEAAKEL 146
|
| >2v0u_A NPH1-1, LOV2; kinase, transferase, ATP-binding, serine/threonine-protein kinase, light-induced signal trans phototropin1, nucleotide-binding; HET: FMN; 1.40A {Avena sativa} PDB: 2v0w_A* 2v1b_A* 2v1a_A* 1jnu_A* 1g28_A* Length = 146 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 4e-54
Identities = 53/154 (34%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPE 248
+ + L ++ FV++D PD PI++AS F ++T Y+ +E++GRNCRFLQG TD
Sbjct: 2 EFLATTLERIEKNFVITDPRLPDNPIIFASDSFLQLTEYSREEILGRNCRFLQGPETDRA 61
Query: 249 DVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
V KIR+ + N +L+NY K G FWNL + P++D +G V FIG+Q++ ++H
Sbjct: 62 TVRKIRDAIDNQTEVTVQLINYTKSGKKFWNLFHLQPMRDQKGDVQYFIGVQLDGTEHVR 121
Query: 309 GAKDKMLRPNGLPESLIRYDARQKEMATSSVTEL 342
A ++ E ++ E + EL
Sbjct: 122 DAAER--------EGVMLIKKTA-ENIDEAAKEL 146
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-62
Identities = 68/319 (21%), Positives = 138/319 (43%), Gaps = 38/319 (11%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H + ++ +++ + ++ +G G G LV+ G+ + +K
Sbjct: 1 MHHHHHHS-----SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIK 55
Query: 701 AMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL 760
++ M ++ + + E +L + HP + SF+ + ++ DYC GG+LF +
Sbjct: 56 EINISRMSSKER-EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
Query: 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
+ Q + +ED + + ++ +AL+++H + I++RD+K +N+ L +G V L DF ++ +
Sbjct: 115 NAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
+ +L + +GT Y++PEI + + D
Sbjct: 175 LNSTVELA---------------------------RACIGTPYYLSPEICENKPYNNKSD 207
Query: 881 WWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK 940
WALG +LYE+ F + + I+ P S S + L+ +L R+P+
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPR 266
Query: 941 SRLGSHEGANEIKKHPFFK 959
R N I + F
Sbjct: 267 DRP----SVNSILEKGFIA 281
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-62
Identities = 97/130 (74%), Positives = 112/130 (86%)
Query: 184 LPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGA 243
PRVS +K ALST QQTFVVSDAT+P PI+YAS+GFF MTGY+SKE+VGRNCRFLQG
Sbjct: 1 FPRVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGP 60
Query: 244 GTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
TD +VAKIR+ ++NG+SYCGRLLNYKKDGTPFWNLLT+ PIKDD+G +KFIGMQVEV
Sbjct: 61 DTDKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEV 120
Query: 304 SKHTEGAKDK 313
SK+TEG DK
Sbjct: 121 SKYTEGVNDK 130
|
| >2z6d_A Phototropin-2; PAS-fold, LOV-fold, alternative splicing, ATP-binding, chromophore, flavoprotein, FMN, kinase, membrane, nucleotide-binding; HET: FMN; 2.00A {Arabidopsis thaliana} PDB: 2z6c_A* Length = 130 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 53/127 (41%), Positives = 79/127 (62%)
Query: 469 RKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPET 528
R +L T L +++ FV++D P PI++AS F +T YS +EI+GRNCRFLQGP+T
Sbjct: 3 RVSQELKTALSTLQQTFVVSDATQPHCPIVYASSGFFTMTGYSSKEIVGRNCRFLQGPDT 62
Query: 529 DPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
D V KIR + N +L+NY K G FWNL + P++D +G FIG+Q++ S+
Sbjct: 63 DKNEVAKIRDCVKNGKSYCGRLLNYKKDGTPFWNLLTVTPIKDDQGNTIKFIGMQVEVSK 122
Query: 589 HLEPLRN 595
+ E + +
Sbjct: 123 YTEGVND 129
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-59
Identities = 96/113 (84%), Positives = 103/113 (91%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
E IEKNFVITDPRLPDNPIIFASD FLELTEYSREEILGRN RFLQGPETD ATV+KIR
Sbjct: 3 PEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKIR 62
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL 590
AI +Q + TVQLINYTKSGKKFWNL HLQP+RDQKGE+QYFIGVQLDGS+H+
Sbjct: 63 DAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDHV 115
|
| >4eet_B Phototropin-2; LOV, blue light photoreceptor, signaling protein, flavoprote; HET: FMN; 1.20A {Arabidopsis thaliana} PDB: 4ees_A* 4eer_A* 4eep_A* 4eeu_A* 1jnu_A* 1g28_A* Length = 115 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-55
Identities = 47/113 (41%), Positives = 76/113 (67%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
+ ++ FV++D PD PI++AS GF ++T Y+ +E++GRN RFLQG TD V KI
Sbjct: 2 SPEFIEKNFVITDPRLPDNPIIFASDGFLELTEYSREEILGRNARFLQGPETDQATVQKI 61
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
R+ +++ + +L+NY K G FWNLL + P++D +G++ FIG+Q++ S H
Sbjct: 62 RDAIRDQRETTVQLINYTKSGKKFWNLLHLQPVRDQKGELQYFIGVQLDGSDH 114
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 4e-59
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 47/304 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDML 726
+ + +G G V +GQ FA+K +D + + +RE I ML
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAVRFYAAEVV 781
HP + L ++ + + ++ ++ G +L V E Y +++
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLC---FEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 782 VALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
AL Y H II+RD+KP VLL + V L F ++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA-------------------- 180
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + E + VGT ++APE++ + VD W G++L+ +L G PF
Sbjct: 181 -------IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233
Query: 899 RGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
G T+++ F I+ K + S AK L+ R+L DP R+ E HP
Sbjct: 234 YG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI----TVYEALNHP 288
Query: 957 FFKG 960
+ K
Sbjct: 289 WLKE 292
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-59
Identities = 67/155 (43%), Positives = 91/155 (58%), Gaps = 3/155 (1%)
Query: 440 EIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIF 499
+I + + ++ S +++ + L L+ ++NFVITD LPDNPI++
Sbjct: 6 SLIAQCSPEADTLLTDNPSKANRILEDPDYS---LVKALQMAQQNFVITDASLPDNPIVY 62
Query: 500 ASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK 559
AS FL LT YS ++ILGRNCRFLQGPETDP V KIR AI D +V L+NY + G
Sbjct: 63 ASRGFLTLTGYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTT 122
Query: 560 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLR 594
FWNLF + +RD KG + ++GVQ SE L
Sbjct: 123 FWNLFFVAGLRDSKGNIVNYVGVQSKVSEDYAKLL 157
|
| >3ue6_A Aureochrome1; PAS/LOV domain, FMN-binding blue-light photoreceptor, signal protein; HET: FMN; 2.75A {Vaucheria frigida} PDB: 3ulf_A* Length = 166 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-54
Identities = 56/143 (39%), Positives = 84/143 (58%)
Query: 166 NSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMT 225
+ + + + L + AL QQ FV++DA+ PD PI+YAS GF +T
Sbjct: 12 SPEADTLLTDNPSKANRILEDPDYSLVKALQMAQQNFVITDASLPDNPIVYASRGFLTLT 71
Query: 226 GYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAP 285
GY+ +++GRNCRFLQG TDP V KIR + G LLNY++DGT FWNL +A
Sbjct: 72 GYSLDQILGRNCRFLQGPETDPRAVDKIRNAITKGVDTSVCLLNYRQDGTTFWNLFFVAG 131
Query: 286 IKDDEGKVLKFIGMQVEVSKHTE 308
++D +G ++ ++G+Q +VS+
Sbjct: 132 LRDSKGNIVNYVGVQSKVSEDYA 154
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-59
Identities = 79/310 (25%), Positives = 138/310 (44%), Gaps = 44/310 (14%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG-VMLNRNKVHR 715
++ L I+ F + LGSG G VHLVE SG +K ++K + ++
Sbjct: 11 RENLYFQGTID-DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 716 ACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF--LLLDRQPTKVLKEDAV 773
E E+L LDHP + ++ F+ ++ ++ + C GGEL ++ + K L E V
Sbjct: 70 ---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLP 830
+++ AL Y H Q ++++DLKPEN+L Q + + + DF L+
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------------ 174
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
+ S + GT Y+APE+ T D W+ G+++Y
Sbjct: 175 ---------------ELF-KSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYF 217
Query: 891 MLYGYTPFRGKTRQKTFANILHKDLKFPSS-TPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949
+L G PF G + ++ +K+ + P + A L+ ++L +DP+ R A
Sbjct: 218 LLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP----SA 273
Query: 950 NEIKKHPFFK 959
++ H +FK
Sbjct: 274 AQVLHHEWFK 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 78/365 (21%), Positives = 129/365 (35%), Gaps = 76/365 (20%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H + + S ++ + + +G G G V + + A+K
Sbjct: 1 MHHHHHHSSGR--ENLYFQGGSLLELQ-KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 701 AMDKGVMLNRNKVHRACAERE--ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF- 757
M+K + N + E ++ L HP + LY ++ + ++CL+ + C GG L
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 758 -------------------------------------LLLDRQPTKVLKEDAVRFYAAEV 780
V +E + ++
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
AL YLH QGI +RD+KPEN L + + L DF LS K+
Sbjct: 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLS----------------KEFY 221
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH--TSAVDWWALGILLYEMLYGYT 896
M GT ++APE++ D W+ G+LL+ +L G
Sbjct: 222 KLNNGEYYGMTT-------KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 897 PFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
PF G T + +L+K L F + S A+ L+ LL+R+ R A +
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQ 330
Query: 955 HPFFK 959
HP+
Sbjct: 331 HPWIS 335
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 4e-58
Identities = 88/337 (26%), Positives = 133/337 (39%), Gaps = 58/337 (17%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV 706
R + P S +++ P + LG G + V + + +A+K +D
Sbjct: 2 RDAALPGS------HSTHGFY-ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTG 54
Query: 707 MLNRNKVH----RACAERE--ILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
+ + R +E IL + HP + L +++T T L+ D GELF
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-- 112
Query: 760 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
D KV L E R ++ + LH I++RDLKPEN+LL + ++ LTDF S
Sbjct: 113 -DYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA----- 873
C P L GT Y+APEII +
Sbjct: 172 CQ--LDPGEKLREV--------------------------CGTPSYLAPEIIECSMNDNH 203
Query: 874 -GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQL 930
G+ VD W+ G+++Y +L G PF + + I+ + +F S S K L
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263
Query: 931 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVR 967
+ R L P+ R A E HPFF+ VR
Sbjct: 264 VSRFLVVQPQKRY----TAEEALAHPFFQQYVVEEVR 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-58
Identities = 78/298 (26%), Positives = 129/298 (43%), Gaps = 45/298 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
Q++ +G G G V + G+ A K + K + + ++ + E EI+ LDH
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDH 65
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 787
P + LY +F+ T + L+ + C GGELF +R K +E +V+ A+ Y
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELF---ERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 788 HCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H + +RDLKPEN L + S L DF L+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA-------------------------- 156
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+P + + VGT Y++P+++ G + D W+ G+++Y +L GY PF T
Sbjct: 157 -ARF-KPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS 213
Query: 905 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ I FP S A+ L+ RLL + PK R+ + + +H +F+
Sbjct: 214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 5e-58
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >1n9l_A PHOT-LOV1, putative blue light receptor; phototropin, flavin, electron transport; HET: FMN; 1.90A {Chlamydomonas reinhardtii} SCOP: d.110.3.6 PDB: 1n9n_A* 1n9o_A* Length = 109 | Back alignment and structure |
|---|
Score = 186 bits (476), Expect = 1e-55
Identities = 49/102 (48%), Positives = 66/102 (64%)
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 543
FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 5 TFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKG 64
Query: 544 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 65 EACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 5e-58
Identities = 87/296 (29%), Positives = 133/296 (44%), Gaps = 45/296 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 731
+ LGSG V G+G+ +A K + K + + R V R ERE IL + HP +
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 790
L+ F+ KT V LI + GGELF D K L ED + +++ + YLH +
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELF---DFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 791 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
I + DLKPEN++L N + L DF ++ +
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA--HKIEAG-------------------- 165
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+ + GT E++APEI+ D W++G++ Y +L G +PF G+T+Q+T
Sbjct: 166 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET 219
Query: 907 FANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
NI + F TS AK + RLL +DPK R+ + +H + K
Sbjct: 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM----TIAQSLEHSWIKA 271
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-57
Identities = 76/300 (25%), Positives = 121/300 (40%), Gaps = 42/300 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
++ + LG G G V L + +GQ A+K + K + + E ++L LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 787
P + LY F+ K + L+ + GGELF D K E +V+ + Y+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELF---DEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 788 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H I++RDLKPEN+LL+ + ++ + DF LS
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST------------------------- 177
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
E + +GT YIAPE++ G + D W+ G++LY +L G PF G
Sbjct: 178 ---HFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEY 233
Query: 905 KTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
+ F S AK L+ ++L P R+ A + H + +
Sbjct: 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI----SARDALDHEWIQTYT 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-57
Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 35/304 (11%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
I+ +H+ I+ LG G V LVE G ++A+K + +R + R E ++
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR---EADMHR 81
Query: 725 MLDHPFVPALYASFQTKT----HVCLITDYCPGGELFLLLDRQPTKV--LKEDAVRFYAA 778
+ +HP + L A + L+ + G L+ ++R K L ED + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+ LE +H +G +RDLKP N+LL G L D S + + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG-----SMNQACIHVEGSRQ--- 193
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGY 895
A ++ + T Y APE+ + H D W+LG +LY M++G
Sbjct: 194 ----------ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
Query: 896 TPFRGKTRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
P+ ++ + A + L P S S QL+ ++ DP R +
Sbjct: 244 GPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLS 299
Query: 955 HPFF 958
Sbjct: 300 QLEA 303
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-57
Identities = 81/332 (24%), Positives = 136/332 (40%), Gaps = 43/332 (12%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H S E N + K LG G V +GQ +A K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 701 AMDKGVMLNRNKVHRACAERE--ILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELF 757
+ K R + RA E +L++ P V L+ ++ + + LI +Y GGE+F
Sbjct: 61 FLKKR---RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117
Query: 758 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTD 814
L + +++ E+ V +++ + YLH I++ DLKP+N+LL G + + D
Sbjct: 118 SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F +S +R +GT EY+APEI+
Sbjct: 178 FGMS--RKIGHA-----------------------CELR---EIMGTPEYLAPEILNYDP 209
Query: 875 HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTSLHAKQLMY 932
T+A D W +GI+ Y +L +PF G+ Q+T+ NI ++ + T S A +
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQ 269
Query: 933 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964
LL ++P+ R A H + + ++
Sbjct: 270 SLLVKNPEKRP----TAEICLSHSWLQQWDFE 297
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 4e-57
Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 45/302 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH-RACAERE--ILDM 725
+ + LGSG V +G +A K + K + R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVAL 784
+ H V L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 785 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 901 KTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
T+Q+T ANI F TS AK + +LL ++ + RL E +HP+
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL----TIQEALRHPWI 276
Query: 959 KG 960
Sbjct: 277 TP 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 4e-57
Identities = 70/333 (21%), Positives = 124/333 (37%), Gaps = 50/333 (15%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK 700
+H H S + + + +K +GSG + V V L Q +A+K
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQS-MSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIK 58
Query: 701 AMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASFQTKTHVCLITDYCPGGELFL 758
++ + + E L+ L + LY T ++ ++ + +L
Sbjct: 59 YVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNS 116
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
L ++ K + + Y ++ A+ +H GI++ DLKP N L+ +G + L DF ++
Sbjct: 117 WLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---- 874
+ P T + +S VGT Y+ PE I
Sbjct: 174 -------NQMQPDTTSVVK------------------DSQVGTVNYMPPEAIKDMSSSRE 208
Query: 875 -------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KTFANILHKDLKFPSSTPTSLH 926
+ D W+LG +LY M YG TPF+ Q I+ + +
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 268
Query: 927 AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ ++ L RDPK R+ E+ HP+ +
Sbjct: 269 LQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 297
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-57
Identities = 87/298 (29%), Positives = 133/298 (44%), Gaps = 45/298 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F ++ LGSG V LV+ +G+ FA+K + K + + E +L + H
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 787
+ L +++ TH L+ GGELF DR + E +V+ A++YL
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELF---DRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 788 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H GI++RDLKPEN+L N + +TDF LS K +QN
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS---------------------KMEQN 161
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + GT Y+APE++A ++ AVD W++G++ Y +L GY PF +T
Sbjct: 162 GIMS--------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213
Query: 905 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
K F I +F S S AK + LL +DP R + HP+ G
Sbjct: 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY----TCEKALSHPWIDG 267
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-57
Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 45/296 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAERE--ILDMLDHPFV 731
+ LGSG V +G +A K + K + R V R ERE IL + HP V
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK-VLKEDAVRFYAAEVVVALEYLHCQ 790
L+ ++ KT V LI + GGELF D K L E+ + +++ + YLH
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 791 GIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
I + DLKPEN++L + + DF L+
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA--HKIDFG-------------------- 171
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+ + GT E++APEI+ D W++G++ Y +L G +PF G T+Q+T
Sbjct: 172 ---NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 225
Query: 907 FANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
AN+ + +F TS AK + RLL +DPK R+ + +HP+ K
Sbjct: 226 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKP 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 9e-57
Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 46/300 (15%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 726
++ + LG G V +G FA K ++ + R+ K+ R E I L
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKL 62
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 785
HP + L+ S Q ++ L+ D GGELF + + E +++ ++
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELF---EDIVAREFYSEADASHCIQQILESIA 119
Query: 786 YLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
Y H GI++R+LKPEN+LL V L DF L+
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA------------------------ 155
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
+ + A + F GT Y++PE++ ++ VD WA G++LY +L GY PF +
Sbjct: 156 ---IEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211
Query: 903 RQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ + +A I +PS + AK L+ +L +PK R+ A++ K P+
Sbjct: 212 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWICN 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-56
Identities = 78/292 (26%), Positives = 126/292 (43%), Gaps = 44/292 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
+ LGSG G VH +G+ F K ++ L++ V E I++ L HP + L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINL 113
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 792
+ +F+ K + LI ++ GGELF DR + + E V Y + L+++H I
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELF---DRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 793 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++ D+KPEN++ + V + DF L+
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT----------------------------KLN 202
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +T N+
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262
Query: 911 LHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
D +F S AK + LL ++P+ RL ++ +HP+ KG
Sbjct: 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG 310
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-56
Identities = 85/327 (25%), Positives = 136/327 (41%), Gaps = 62/327 (18%)
Query: 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA-- 718
SG+ + L + +G G G V L Y+AMK + K ++ + R
Sbjct: 5 SSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPR 64
Query: 719 -------------------EREI--LDMLDHPFVPALY--ASFQTKTHVCLITDYCPGGE 755
+EI L LDHP V L + H+ ++ + G
Sbjct: 65 GTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP 124
Query: 756 LFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815
+ + +P L ED RFY +++ +EYLH Q II+RD+KP N+L+ +GH+ + DF
Sbjct: 125 VMEVPTLKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
+S LL T VGT ++APE ++
Sbjct: 182 GVSNEFK-GSDALLSNT--------------------------VGTPAFMAPESLSETRK 214
Query: 876 T---SAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 932
A+D WA+G+ LY ++G PF + + I + L+FP + K L+
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLIT 274
Query: 933 RLLHRDPKSRLGSHEGANEIKKHPFFK 959
R+L ++P+SR+ EIK HP+
Sbjct: 275 RMLDKNPESRI----VVPEIKLHPWVT 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-56
Identities = 66/337 (19%), Positives = 116/337 (34%), Gaps = 76/337 (22%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
+ + + LG G T +V +G FA+K + L V E E+L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 724 DMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 780
L+H + L+A + T H LI ++CP G L+ +L + L E +V
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
V + +L GI++R++KP N++ G LTDF +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA------------------ 163
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGILL 888
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 ---RELEDDEQFV-------SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 889 YEMLYGYTPFRGKTRQKTFANILHK-------------------DLKFPSSTPTSLH--- 926
Y G PFR + +++K + + P S
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 927 -----AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
++ +L D + G ++
Sbjct: 274 GLQVLLTPVLANILEADQEKCW----GFDQFFAETSD 306
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-56
Identities = 83/302 (27%), Positives = 129/302 (42%), Gaps = 45/302 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDK-GVMLNRNKVHRACAERE--ILDM 725
+ + LGSG V +G +A K + K +R V R ERE IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVAL 784
+ HP + L+ ++ +T V LI + GGELF D K L E+ + +++ +
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELF---DFLAQKESLSEEEATSFIKQILDGV 128
Query: 785 EYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
YLH + I + DLKPEN++L H+ L DF L+ +
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIEDG-------------- 172
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ + GT E++APEI+ D W++G++ Y +L G +PF G
Sbjct: 173 ---------VEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 901 KTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
T+Q+T ANI F TS AK + +LL ++ + RL E +HP+
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL----TIQEALRHPWI 276
Query: 959 KG 960
Sbjct: 277 TP 278
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 61/308 (19%), Positives = 111/308 (36%), Gaps = 61/308 (19%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
F+ I+ +GSG G V + G+ + +K + N K R E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAER---EVKALAKLD 62
Query: 728 HPFVPALYASFQ----------------TKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
H + + + + ++C G L ++++ + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
++ ++Y+H + +I RDLKP N+ L V + DF L L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT--------SLKN 174
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
++ GT Y++PE I+ + VD +ALG++L E+
Sbjct: 175 DGKRT--------------------RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 892 LYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
L+ K F ++ +D K L+ +LL + P+ R +E
Sbjct: 215 LHV--CDTAFETSKFFTDL--RDGIISDI--FDKKEKTLLQKLLSKKPEDRP----NTSE 264
Query: 952 IKKHPFFK 959
I +
Sbjct: 265 ILRTLTVW 272
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-56
Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 42/301 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+ + + +G+G G + G+ K +D G M K +E +L L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELK 63
Query: 728 HPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVA 783
HP + Y +T + ++ +YC GG+L ++ + + L E+ V ++ +A
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 784 LEYLH-----CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
L+ H +++RDLKP NV L G +V L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-------------------- 163
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898
+ + A +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 164 -RILNHDTSFA------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216
Query: 899 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
++++ I + S +++ R+L+ R EI ++P
Sbjct: 217 TAFSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRP----SVEEILENPLI 271
Query: 959 K 959
Sbjct: 272 L 272
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-56
Identities = 87/383 (22%), Positives = 153/383 (39%), Gaps = 53/383 (13%)
Query: 586 GSEHLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKP 645
G+E+L S + + + + +P + L + P
Sbjct: 15 GTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFD 74
Query: 646 HRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
HR + A+ + + LG G G VH E +G A K +
Sbjct: 75 HRIVTAKQGAVNSFYTVSKT---------EILGGGRFGQVHKCEETATGLKLAAKIIKTR 125
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
M ++ +V E +++ LDH + LY +F++K + L+ +Y GGELF DR
Sbjct: 126 GMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF---DRIID 179
Query: 766 K--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLT 821
+ L E + ++ + ++H I++ DLKPEN+L + + + DF L+
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLA--- 236
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881
RR+K + E ++ GT E++APE++ + D
Sbjct: 237 ---------------RRYKPR-------EKLK---VNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 882 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDP 939
W++G++ Y +L G +PF G +T NIL S AK+ + +LL ++
Sbjct: 272 WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 940 KSRLGSHEGANEIKKHPFFKGVN 962
R+ A+E KHP+
Sbjct: 332 SWRI----SASEALKHPWLSDHK 350
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-56
Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 45/292 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
+ LG G+ G VH S + + K + ++ V + E IL++ H + L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKK---EISILNIARHRNILHL 66
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGI 792
+ SF++ + +I ++ G ++F +R T L E + Y +V AL++LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIF---ERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 793 IYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+ D++PEN++ Q + + + +F + KP +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPG-----------------------D 158
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
R EY APE+ ++A D W+LG L+Y +L G PF +T Q+ NI
Sbjct: 159 NFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI 215
Query: 911 LHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
++ + F S+ A + RLL ++ KSR+ A+E +HP+ K
Sbjct: 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQ 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 6e-56
Identities = 78/327 (23%), Positives = 136/327 (41%), Gaps = 47/327 (14%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
H + + ++++ + + ++ + LG G V +G FA K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFS-DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 702 MDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
++ + R K+ R E I L HP + L+ S Q ++ L+ D GGELF
Sbjct: 62 INTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-- 116
Query: 760 LDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDF 815
+ + E +++ ++ Y H GI++R+LKPEN+LL V L DF
Sbjct: 117 -EDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 816 DLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH 875
L+ + + A + F GT Y++PE++ +
Sbjct: 176 GLA---------------------------IEV-NDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 876 TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYR 933
+ VD WA G++LY +L GY PF + + + +A I +PS + AK L+
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 934 LLHRDPKSRLGSHEGANEIKKHPFFKG 960
+L +PK R+ A++ K P+
Sbjct: 268 MLTVNPKKRI----TADQALKVPWICN 290
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 7e-56
Identities = 87/352 (24%), Positives = 143/352 (40%), Gaps = 55/352 (15%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINL--------QHFRPIKPLGSGDTGSVHLVELCG 692
+H H Q L + + + + ++ +K LGSG G V L
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 693 SGQYFAMKAMDKGVMLNRN--KVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750
+ A+K + K + + K+ E +L +LDHP + LY F+ K + L+ +
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLE---EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 751 CPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---G 806
GGELF D E +V+ + YLH I++RDLKPEN+LL+
Sbjct: 118 YKGGELF---DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEK 174
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ + + DF LS + E + +GT YIA
Sbjct: 175 DALIKIVDFGLSA----------------------------VFENQKKMKERLGTAYYIA 206
Query: 867 PEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSST--PTS 924
PE++ + D W++G++L+ +L GY PF G+T Q+ + F S S
Sbjct: 207 PEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS 265
Query: 925 LHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 976
AK L+ ++L D + R+ A + +HP+ K + + P L
Sbjct: 266 EGAKDLIKQMLQFDSQRRI----SAQQALEHPWIKEMCSKKESGIELPSLAN 313
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 7e-56
Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 47/316 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN--KVHRACAEREILDML 726
+ + + LG G G V + + Q +A+K ++K N++ + R E E+L L
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKL 78
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALE 785
DHP + L+ + + ++ + GGELF D K E +V +
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 786 YLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
Y+H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--------------------- 174
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 175 -------QQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN 226
Query: 903 RQKTFANILHKDLKFPSST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ F S AK L+ ++L P R+ A + +HP+ +
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
Query: 961 VNWALVRCMNPPELDA 976
+ + P L++
Sbjct: 283 YSSETPTISDLPSLES 298
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 21/238 (8%)
Query: 424 IGRKSQSTDDHDSFENEIIMEGDDDYESDDERPDSVDDKVRQKEMRKGIDLATTLERIEK 483
+GR DD D G D P + D +V + + + +E
Sbjct: 21 MGRDLYDDDDKDHP----FTMGQDRPIDGSGAPGADDTRVEVQPPAQ--WVLDLIEASPI 74
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ 543
V++DPRL DNP+I + +F +LT YS EE +GRNCRFL G T+P KIR +
Sbjct: 75 ASVVSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREH 134
Query: 544 TDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAE 603
V V+++NY K G F N + P+ D E+ YF+G Q++ + +
Sbjct: 135 KPVLVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNM-----GMARR 189
Query: 604 ESEKLVKQTAENVNEAVKELPDANLTPEDLWAN----------HSKVVHPKPHRKDSP 651
E + +T V L + L +++ A H +V K + K S
Sbjct: 190 ERAAEMLKTLSPRQLEVTTLVASGLRNKEVAARLGLSEKTVKMHRGLVMEKLNLKTSA 247
|
| >3p7n_A Sensor histidine kinase; LOV domain, light-activated transcription factor, DNA bindin; HET: FMN; 2.10A {Erythrobacter litoralis} Length = 258 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 4e-54
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 144 VARTSGGDDPNGKPGTSRRNSNNSVRSSGEMSDEGGKEKGLPRVSDIVKDALSTFQQTFV 203
+ R DD P T ++ + D + + V D + V
Sbjct: 21 MGRDLYDDDDKDHPFTMGQDRPIDGSGAPGADDT---RVEVQPPAQWVLDLIEASPIASV 77
Query: 204 VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSY 263
VSD D P++ + F +TGY+ +E VGRNCRFL G+GT+P KIR+ ++ +
Sbjct: 78 VSDPRLADNPLIAINQAFTDLTGYSEEECVGRNCRFLAGSGTEPWLTDKIRQGVREHKPV 137
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTEGAKDKMLRPNGLP-- 321
+LNYKKDGTPF N + +API DD+ ++L F+G QVEV
Sbjct: 138 LVEILNYKKDGTPFRNAVLVAPIYDDDDELLYFLGSQVEVDDDQPNMGMARRERAAEMLK 197
Query: 322 ---------ESLIRYDARQKEMA 335
+L+ R KE+A
Sbjct: 198 TLSPRQLEVTTLVASGLRNKEVA 220
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 49/309 (15%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+ + + +K +GSG + V V L Q +A+K ++ + + E L+
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLN 62
Query: 725 MLDHP--FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
L + LY T ++ ++ + +L L ++ K + + Y ++
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLE 119
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
A+ +H GI++ DLKP N L+ +G + L DF ++ + +
Sbjct: 120 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA------------------NQMQPD 160
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEM 891
V +S VGT Y+ PE I + D W+LG +LY M
Sbjct: 161 TTSVVK-------DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
Query: 892 LYGYTPFRGKTRQ-KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950
YG TPF+ Q I+ + + + ++ L RDPK R+
Sbjct: 214 TYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIP 269
Query: 951 EIKKHPFFK 959
E+ HP+ +
Sbjct: 270 ELLAHPYVQ 278
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-55
Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 43/298 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + LG G G V + + Q +A+K ++K N++ E E+L LDH
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYL 787
P + L+ + + ++ + GGELF D K E +V + Y+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELF---DEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 788 HCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H I++RDLKPEN+LL+ + + + DF LS
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS-------------------------- 171
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ +GT YIAPE++ G + D W+ G++LY +L G PF GK
Sbjct: 172 -TCF-QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 905 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ F S AK L+ ++L P R+ A + +HP+ +
Sbjct: 229 DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 4e-55
Identities = 54/114 (47%), Positives = 77/114 (67%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
E +IT+P LPDNPI+FA+ +FL+LT Y +E++GRNCRFLQG TDPA VR I+
Sbjct: 3 SEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAIK 62
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLE 591
+AI + + + +INY KSG+ FWN H+ P+ + G +Q+F+ QLD + L
Sbjct: 63 SAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLELV 116
|
| >3t50_A Blue-light-activated histidine kinase; PAS superfamily, blue-light photoreceptor, FMN binding, TRAN; HET: FMN; 1.64A {Brucella melitensis} Length = 128 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-53
Identities = 43/113 (38%), Positives = 67/113 (59%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
A ++++ PD PI++A+ F K+TGY + EV+GRNCRFLQG GTDP V I
Sbjct: 2 ASEFTLMPMLITNPHLPDNPIVFANPAFLKLTGYEADEVMGRNCRFLQGHGTDPAHVRAI 61
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
+ + + ++NYKK G FWN L I+P+ + G++ F+ Q++V+
Sbjct: 62 KSAIAAEKPIDIDIINYKKSGEAFWNRLHISPVHNANGRLQHFVSSQLDVTLE 114
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-55
Identities = 76/300 (25%), Positives = 115/300 (38%), Gaps = 54/300 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPA 733
KPLG G S Q FA+K + K E L + + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
L+ F + H L+ + GGELF +R + K E + ++V A+ ++H G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELF---ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 793 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
++RDLKPEN+L + DF + R K N
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA-------------------RLKPPDNQPLK- 167
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT--- 906
+ T Y APE++ G+ + D W+LG++LY ML G PF+ R T
Sbjct: 168 -------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 907 ----FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
I D F S AK L+ LL DP RL + ++ + + +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL----KMSGLRYNEWLQD 276
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 6e-55
Identities = 77/343 (22%), Positives = 122/343 (35%), Gaps = 59/343 (17%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPI-------KPLGSGDTGSVHLVELCGS 693
+H H Q I + + I + LGSG G V L +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 694 GQYFAMKAMDKGVMLNRNKVHRACA----------EREILDMLDHPFVPALYASFQTKTH 743
A+K + K E +L LDHP + L+ F+ K +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 744 VCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
L+T++ GGELF ++ E +++ + YLH I++RD+KPEN+
Sbjct: 121 FYLVTEFYEGGELF---EQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177
Query: 803 LLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFV 859
LL+ ++ + DF LS +
Sbjct: 178 LLENKNSLLNIKIVDFGLSS----------------------------FFSKDYKLRDRL 209
Query: 860 GTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPS 919
GT YIAPE++ + D W+ G+++Y +L GY PF G+ Q + F
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 920 ST--PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ S AK+L+ +L D R A E + K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRC----TAEEALNSRWIKK 307
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-55
Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 5/130 (3%)
Query: 464 RQKEMRKGIDLATTLERIEK---NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR-- 518
R + L T + + E F+I + R+ + +I+ +D F EL YSR E++ R
Sbjct: 8 RGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPC 67
Query: 519 NCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQY 578
C FL GP T +I A+ + V++ Y K G F L + P++++ G V
Sbjct: 68 TCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIM 127
Query: 579 FIGVQLDGSE 588
FI E
Sbjct: 128 FILNFEVVME 137
|
| >2l0w_A Potassium voltage-gated channel, subfamily H (EAG member 2, isoform CRA_B; HERG, PAS domain, voltage-gated potassium channel, membrane; NMR {Homo sapiens} PDB: 2l1m_A 2l4r_A Length = 138 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 32/118 (27%), Positives = 59/118 (50%), Gaps = 2/118 (1%)
Query: 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTD 246
D + + F++++A + ++Y + GF ++ GY+ EV+ R C FL G T
Sbjct: 19 DTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQ 78
Query: 247 PEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
A+I + L + + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 79 RRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 136
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 6e-55
Identities = 80/378 (21%), Positives = 146/378 (38%), Gaps = 57/378 (15%)
Query: 591 EPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDS 650
+P + P + K ++ +V+E K + + + +
Sbjct: 92 KPCEPTAPVLIPGDERK--RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 651 PPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
+ D E+ LG+G G VH V +G FA K + ++
Sbjct: 150 IKHDHVLDHYDIHEE-----------LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK 198
Query: 711 NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK--VL 768
V + E + + +L HP + L+ +F+ + +I ++ GGELF ++ + +
Sbjct: 199 ETVRK---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF---EKVADEHNKM 252
Query: 769 KEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQ 826
ED Y +V L ++H ++ DLKPEN++ + + L DF L+
Sbjct: 253 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA------- 305
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
+P ++ GT E+ APE+ G D W++G+
Sbjct: 306 ---------------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLG 944
L Y +L G +PF G+ +T N+ D S + S K + +LL DP +R+
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM- 403
Query: 945 SHEGANEIKKHPFFKGVN 962
++ +HP+ N
Sbjct: 404 ---TIHQALEHPWLTPGN 418
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-55
Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ ++ + LG G V +GQ +A ++ L+ + E I +L H
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYL 787
P + L+ S + H LI D GGELF + + E +++ A+ +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELF---EDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 788 HCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
H G+++R+LKPEN+LL V L DF L+
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-------------------------- 160
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + +A F GT Y++PE++ + VD WA G++LY +L GY PF + +
Sbjct: 161 -IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219
Query: 905 KTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ + I FPS + AK L+ ++L +P R+ A E KHP+
Sbjct: 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI----TAAEALKHPWISH 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-55
Identities = 73/311 (23%), Positives = 131/311 (42%), Gaps = 43/311 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 726
L F PI+ LG G G V + +A+K + L R KV R E + L L
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 60
Query: 727 DHPFVPALYASFQTKT------------HVCLITDYCPGGELFLLLDRQPTKVLKEDA-V 773
+HP + + ++ K ++ + C L ++ + T +E +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
++ A+E+LH +G+++RDLKP N+ + V + DF L +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDE 172
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY 893
E++ VGT+ Y++PE I G ++ VD ++LG++L+E+LY
Sbjct: 173 EEQTVLTPMPAYARH-------TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 894 GYTPFRGKT-RQKTFANILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
PF + R +T ++ ++LKFP T ++ +L P R A
Sbjct: 226 ---PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP----EAIN 276
Query: 952 IKKHPFFKGVN 962
I ++ F+ ++
Sbjct: 277 IIENAVFEDLD 287
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-54
Identities = 95/384 (24%), Positives = 151/384 (39%), Gaps = 54/384 (14%)
Query: 595 NSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWK 654
N E L E ++ L D +L A K+ +P ++ ++
Sbjct: 16 NKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQ 75
Query: 655 AIQKILDSGEQINLQHFRPI----KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR 710
++ + + + F +G G + V +G FA+K M+
Sbjct: 76 SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 711 NKVHRACAER-----EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQP 764
+ E IL + HP + L S+++ + + L+ D GELF D
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF---DYLT 192
Query: 765 TKV-LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
KV L E R ++ A+ +LH I++RDLKPEN+LL N + L+DF SC
Sbjct: 193 EKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--L 250
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTS 877
+P L GT Y+APEI+ + G+
Sbjct: 251 EPGEKLRE--------------------------LCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 878 AVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLL 935
VD WA G++L+ +L G PF + + I+ +F S S K L+ RLL
Sbjct: 285 EVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLL 344
Query: 936 HRDPKSRLGSHEGANEIKKHPFFK 959
DP++RL A + +HPFF+
Sbjct: 345 QVDPEARL----TAEQALQHPFFE 364
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-54
Identities = 67/343 (19%), Positives = 118/343 (34%), Gaps = 72/343 (20%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + + LG G T +V +G FA+K + L V E E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFE 59
Query: 722 ILDMLDHPFVPALYASFQTKT--HVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAA 778
+L L+H + L+A + T H LI ++CP G L+ +L + L E
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+VV + +L GI++R++KP N++ G LTDF +
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---------------- 163
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--------GHTSAVDWWALGI 886
+ ++ S GTEEY+ P++ A + + VD W++G+
Sbjct: 164 -----RELEDDEQF-------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGV 211
Query: 887 LLYEMLYGYTPFRGKTRQKTFANILHK-------------------DLKFPSSTPTSLH- 926
Y G PFR + +++K + + P S
Sbjct: 212 TFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSL 271
Query: 927 -------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
++ +L D + G + E ++
Sbjct: 272 SRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIH 314
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-54
Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 38/319 (11%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
P P KA++ + L +FR K +G G V+ G A+K +
Sbjct: 9 QGPPVPQFQPQKALRPDMGYNT---LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 703 DKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-- 760
+++ E ++L L+HP V YASF + ++ + G+L ++
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 761 DRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
++ +++ E V Y ++ ALE++H + +++RD+KP NV + G V L D L
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
S K +S VGT Y++PE I G+ D
Sbjct: 186 FSSKTTAA---------------------------HSLVGTPYYMSPERIHENGYNFKSD 218
Query: 881 WWALGILLYEMLYGYTPFRGKTRQKT--FANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 938
W+LG LLYEM +PF G I D S S +QL+ ++ D
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 939 PKSRLGSHEGANEIKKHPF 957
P+ R +
Sbjct: 279 PEKRP----DVTYVYDVAK 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 5e-54
Identities = 82/333 (24%), Positives = 140/333 (42%), Gaps = 49/333 (14%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM--LNRNKVHRACAE 719
+ EQ ++ ++R +K +G G+ V L +G+ A+K +DK + + K+ R E
Sbjct: 8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---E 64
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
I+ +L+HP + L+ +T+ + LI +Y GGE+F L +KE R +
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQ 122
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+V A++Y H + I++RDLK EN+LL + ++ + DF S L
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDA-------- 172
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDWWALGILLYEMLYGYTPF 898
F G Y APE+ G + VD W+LG++LY ++ G PF
Sbjct: 173 ------------------FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 899 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
G+ ++ +L + P S + L+ R L +P R +I K +
Sbjct: 215 DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRFLVLNPIKRG----TLEQIMKDRWI 268
Query: 959 KGVNWALVRCMNPPELDAPLFATDTEKEYKVVD 991
EL + + K +D
Sbjct: 269 N-------AGHEEDELKPFVEPELDISDQKRID 294
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-53
Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 47/295 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G T V+ + G+ + +A+K + K E +L L HP + L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGII 793
F+T T + L+ + GGELF DR K E +++ A+ YLH GI+
Sbjct: 114 KEIFETPTEISLVLELVTGGELF---DRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 794 YRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
+RDLKPEN+L + + + DF LS + + Q+L+ T
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKT------------------- 209
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK-TFAN 909
GT Y APEI+ G + VD W++GI+ Y +L G+ PF + + F
Sbjct: 210 -------VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
Query: 910 ILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
IL+ + F S SL+AK L+ +L+ DPK RL + +HP+ G
Sbjct: 263 ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL----TTFQALQHPWVTGKA 313
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 3/135 (2%)
Query: 457 DSVDDKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEIL 516
V + L + ++ V+ + D +I+ + +F LT YSR+EIL
Sbjct: 13 GLVPRGSHMINAQL---LQSMVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEIL 69
Query: 517 GRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 576
++CRFLQG + D +IR A+ L NY K G FWN + P++ +
Sbjct: 70 YQDCRFLQGDDRDQLGRARIRKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQR 129
Query: 577 QYFIGVQLDGSEHLE 591
YFIG+Q D S +E
Sbjct: 130 TYFIGIQKDVSRQVE 144
|
| >3sw1_A Sensory box protein; light-oxygen-voltage, LOV, PAS, signaling protein; HET: FMN; 2.63A {Pseudomonas putida} Length = 162 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-53
Identities = 42/115 (36%), Positives = 66/115 (57%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
+ VV++ D ++Y +A F +TGY+ E++ ++CRFLQG D A+I
Sbjct: 30 MVDASNDGIVVAEKEGDDTILIYVNAAFEYLTGYSRDEILYQDCRFLQGDDRDQLGRARI 89
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
R+ + G+ L NY+KDG+ FWN L+I P+K D + FIG+Q +VS+ E
Sbjct: 90 RKAMAEGRPCREVLRNYRKDGSAFWNELSITPVKSDFDQRTYFIGIQKDVSRQVE 144
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-53
Identities = 79/322 (24%), Positives = 125/322 (38%), Gaps = 52/322 (16%)
Query: 650 SPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN 709
+ +I + L + + +G G + FA+K +DK +
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----S 58
Query: 710 RNKVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKV 767
+ E EIL HP + L + +V ++T+ GGEL D+ K
Sbjct: 59 KRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL---DKILRQKF 112
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ----GNGHVSLTDFDLSCLTSC 823
E + +EYLH QG+++RDLKP N+L + + DF +
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA----- 167
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
K+ R + + P T ++APE++ G+ +A D W+
Sbjct: 168 -----------KQLRAENG----LLMTP-------CYTANFVAPEVLERQGYDAACDIWS 205
Query: 884 LGILLYEMLYGYTPFRGK---TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRD 938
LG+LLY ML GYTPF T ++ A I S AK L+ ++LH D
Sbjct: 206 LGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD 265
Query: 939 PKSRLGSHEGANEIKKHPFFKG 960
P RL A + +HP+
Sbjct: 266 PHQRL----TAALVLRHPWIVH 283
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 2/107 (1%)
Query: 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGR--NCRFLQGPETDPATVRKIRAAID 541
F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALL 62
Query: 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 63 GAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >1byw_A Protein (human ERG potassium channel); PAS domain, potassium channel domain, membrane protein; 2.60A {Homo sapiens} SCOP: d.110.3.6 Length = 110 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-52
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGR--NCRFLQGAGTDPEDVAKIRETL 257
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-53
Identities = 58/128 (45%), Positives = 80/128 (62%), Gaps = 5/128 (3%)
Query: 478 LERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537
L+ + VITDP L DNPI++ + F+++T Y EEILG+NCRFLQG TDPA V IR
Sbjct: 5 LDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNIR 64
Query: 538 AAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHL---EPLR 594
A+ N+ VTVQ+ NY K G FWN ++ PM + YF+G+Q D ++ + L
Sbjct: 65 TALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEI--EDKTYFVGIQNDITKQKEYEKLLE 122
Query: 595 NSIPEATA 602
+S+ E TA
Sbjct: 123 DSLTEITA 130
|
| >2pr5_A Blue-light photoreceptor; light-oxygen-voltage, LOV, PER-ARNT-SIM, PAS, flavoprotein, protein; HET: FMN; 1.45A {Bacillus subtilis} PDB: 2pr6_A* Length = 132 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 49/115 (42%), Positives = 73/115 (63%), Gaps = 2/115 (1%)
Query: 194 ALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI 253
L + V++D D PI+Y + GF +MTGY ++E++G+NCRFLQG TDP +V I
Sbjct: 4 MLDHVRVGVVITDPALEDNPIVYVNQGFVQMTGYETEEILGKNCRFLQGKHTDPAEVDNI 63
Query: 254 RETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
R LQN + ++ NYKKDGT FWN L I P++ ++ F+G+Q +++K E
Sbjct: 64 RTALQNKEPVTVQIQNYKKDGTMFWNELNIDPMEIEDKTY--FVGIQNDITKQKE 116
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-53
Identities = 87/307 (28%), Positives = 128/307 (41%), Gaps = 51/307 (16%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 723
+ K LGSG G V L + + A+K + K + A EIL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVV 782
L+HP + + F + ++ + GGELF D+ LKE + Y ++++
Sbjct: 70 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 125
Query: 783 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 164
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 896
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 165 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 897 PFRGKTRQKT-FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953
PF Q + I F S A L+ +LL DPK+R E
Sbjct: 218 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEAL 273
Query: 954 KHPFFKG 960
+HP+ +
Sbjct: 274 RHPWLQD 280
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-52
Identities = 46/329 (13%), Positives = 89/329 (27%), Gaps = 83/329 (25%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 723
LG D + +G+ F + N + + E L
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 724 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 765
D++ P + + + +++ + +L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 766 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG- 257
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--------- 874
A + + PE+ A
Sbjct: 258 ------------------------------ARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 875 --HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 932
T + D WALG+++Y + P I P + L+
Sbjct: 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP------VRALLE 341
Query: 933 RLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
L + RL + + P ++ +
Sbjct: 342 GFLRYPKEDRL----LPLQAMETPEYEQL 366
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-52
Identities = 72/353 (20%), Positives = 129/353 (36%), Gaps = 50/353 (14%)
Query: 621 KELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG 680
+P + E A + P KA + + + + +K +GSG
Sbjct: 9 GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANEC-ISVKGRIYSILKQIGSG 67
Query: 681 DTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP--FVPALYASF 738
+ V V L Q +A+K ++ + + E L+ L + LY
Sbjct: 68 GSSKVFQV-LNEKKQIYAIKYVNLE-EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 739 QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 798
T ++ ++ + +L L ++ K + + Y ++ A+ +H GI++ DLK
Sbjct: 126 ITDQYIYMVMECG-NIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLK 182
Query: 799 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 858
P N L+ +G + L DF ++ + P T + +S
Sbjct: 183 PANFLIV-DGMLKLIDFGIA-------NQMQPDTTSVVK------------------DSQ 216
Query: 859 VGTEEYIAPEIIAGAG-----------HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-KT 906
VG Y+ PE I + D W+LG +LY M YG TPF+ Q
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
I+ + + + ++ L RDPK R+ E+ HP+ +
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYVQ 325
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-52
Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 37/297 (12%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
++ + H+ LG G G V + E +G A+K +++ + + + V + E + L
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ HP + LY T T ++ +Y GGELF + + ++E R +++ A
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 169
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 902
G+ Y APE+I+G VD W+ G++LY +L G PF +
Sbjct: 170 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
Query: 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
F I P S L+ +L DP R +I++H +FK
Sbjct: 216 VPTLFKKIRGGVFYIPEYLNRS--VATLLMHMLQVDPLKRATIK----DIREHEWFK 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-52
Identities = 71/359 (19%), Positives = 131/359 (36%), Gaps = 56/359 (15%)
Query: 649 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 708
+ PP + L + E Q + + PLGSG G V + +K + K +L
Sbjct: 4 EEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 709 NRNKVHRACAER-----EILDMLDHPFVPALYASFQTKTHVCLITD-YCPGGELFLLLDR 762
+ + IL ++H + + F+ + L+ + + G +LF +DR
Sbjct: 64 EDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR 123
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
P L E + ++V A+ YL + II+RD+K EN+++ + + L DF +
Sbjct: 124 HPR--LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL- 180
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT-SAVDW 881
+ L T F GT EY APE++ G + ++
Sbjct: 181 -ERGKLFYT--------------------------FCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 882 WALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 941
W+LG+ LY +++ PF + + P S L+ LL P+
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY--LVSKELMSLVSGLLQPVPER 265
Query: 942 RLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQN 1000
R ++ P+ + +N + + E V+ ++
Sbjct: 266 RT----TLEKLVTDPWVT-------QPVNLADYTWEEVFRVNKPESGVLSAASLEMGNR 313
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-52
Identities = 87/307 (28%), Positives = 129/307 (42%), Gaps = 51/307 (16%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER-----EIL 723
+ K LGSG G V L + + A++ + K + A EIL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVV 782
L+HP + + F + ++ + GGELF D+ K LKE + Y ++++
Sbjct: 195 KKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELF---DKVVGNKRLKEATCKLYFYQMLL 250
Query: 783 ALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
A++YLH GII+RDLKPENVLL + + +TDF S
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS--------------------- 289
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYT 896
K M + GT Y+APE++ AG+ AVD W+LG++L+ L GY
Sbjct: 290 KILGETSLM-------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342
Query: 897 PFRGKTRQKT-FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953
PF Q + I F S A L+ +LL DPK+R E
Sbjct: 343 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEAL 398
Query: 954 KHPFFKG 960
+HP+ +
Sbjct: 399 RHPWLQD 405
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-52
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 41/297 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 726
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 785
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL-LLPTTNEKKRRHKGQQN 844
YLH GI +RD+KPEN+LL ++ ++DF L+ + + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------------ 167
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR 903
GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 168 --------------CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213
Query: 904 -QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ +++ K L++++L +P +R+ +IKK ++
Sbjct: 214 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 266
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-52
Identities = 48/141 (34%), Positives = 76/141 (53%), Gaps = 26/141 (18%)
Query: 471 GIDLATTLERI--EKN-------------FVITDPRLPDNPIIFASDSFLELTEYSREEI 515
G D+ L +I N ++ D + D PI++AS++FL +T YS E+
Sbjct: 9 GYDIMGYLIQIMNRPNPQVELGPVDTSVALILCDLKQKDTPIVYASEAFLYMTGYSNAEV 68
Query: 516 LGRNCRFLQGPE-----------TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLF 564
LGRNCRFLQ P+ D T+ +R AID +V V+++N+ K+G++F N
Sbjct: 69 LGRNCRFLQSPDGMVKPKSTRKYVDSNTINTMRKAIDRNAEVQVEVVNFKKNGQRFVNFL 128
Query: 565 HLQPMRDQKGEVQYFIGVQLD 585
+ P+RD+ GE +Y +G Q +
Sbjct: 129 TMIPVRDETGEYRYSMGFQCE 149
|
| >3d72_A Vivid PAS protein VVD; circadian, photoreceptor, blue-light, LOV, signaling protein; HET: FAD; 1.65A {Neurospora crassa} PDB: 3is2_A* 2pd8_A* 3hjk_A* 2pdr_A* 2pd7_A* 2pdt_A* 3hji_A* 3rh8_B* Length = 149 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-49
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG-----------TDPEDV 250
++ D + D PI+YAS F MTGY++ EV+GRNCRFLQ D +
Sbjct: 38 LILCDLKQKDTPIVYASEAFLYMTGYSNAEVLGRNCRFLQSPDGMVKPKSTRKYVDSNTI 97
Query: 251 AKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302
+R+ + ++N+KK+G F N LT+ P++D+ G+ +G Q E
Sbjct: 98 NTMRKAIDRNAEVQVEVVNFKKNGQRFVNFLTMIPVRDETGEYRYSMGFQCE 149
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 9e-52
Identities = 80/313 (25%), Positives = 124/313 (39%), Gaps = 57/313 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPA 733
LG G V + Q +A+K ++K R++V R E E+L H V
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
L F+ + L+ + GG + + E +V AL++LH +GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSIL---SHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 793 IYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+RDLKPEN+L + VS + DFDL
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLG-----------------SGIKLNGDCSPIST 175
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTS-----AVDWWALGILLYEMLYGYTPFRGK--- 901
+ + G+ EY+APE++ + D W+LG++LY +L GY PF G+
Sbjct: 176 PELL---TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232
Query: 902 ------------TRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHE 947
+ F +I +FP S AK L+ +LL RD K RL
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL---- 288
Query: 948 GANEIKKHPFFKG 960
A ++ +HP+ +G
Sbjct: 289 SAAQVLQHPWVQG 301
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-50
Identities = 69/296 (23%), Positives = 124/296 (41%), Gaps = 39/296 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN-RNKVHRACAEREILDML 726
++ + ++ LG G G V L + + A+K +D ++ + + E I ML
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKML 62
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALE 785
+H V Y + L +YC GGELF DR + + E + + +++ +
Sbjct: 63 NHENVVKFYGHRREGNIQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH GI +RD+KPEN+LL ++ ++DF L+ + + L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------------- 166
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTR- 903
GT Y+APE++ H VD W+ GI+L ML G P+ +
Sbjct: 167 ------------MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
Query: 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ +++ K L++++L +P +R+ +IKK ++
Sbjct: 215 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-50
Identities = 81/310 (26%), Positives = 119/310 (38%), Gaps = 45/310 (14%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA 716
LD + + +K +GSG+ G L+ + + A+K +++G V R
Sbjct: 8 TGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQR- 65
Query: 717 CAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFY 776
E L HP + T TH+ +I +Y GGEL+ + ED RF+
Sbjct: 66 --EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFF 121
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+++ + Y H I +RDLK EN LL G+ + + DF S S +T
Sbjct: 122 FQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSVLHSQPKST-- 177
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLY 893
VGT YIAPE++ D W+ G+ LY ML
Sbjct: 178 ------------------------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213
Query: 894 GYTPFRGKTR----QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGA 949
G PF +KT IL P S L+ R+ DP +R+
Sbjct: 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI----SI 269
Query: 950 NEIKKHPFFK 959
EIK H +F
Sbjct: 270 PEIKTHSWFL 279
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 73/313 (23%), Positives = 112/313 (35%), Gaps = 50/313 (15%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN----KVHRACAEREILDMLDHPF 730
LG G G V V + A+K + K + V + E ++L L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKN 67
Query: 731 VPALY--ASFQTKTHVCLITDYCPGG--ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
V L + K + ++ +YC G E+ D P K Y +++ LEY
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC-KPQLLLPTTNEKKRRHKGQQNP 845
LH QGI+++D+KP N+LL G + ++ ++ T+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS------------- 171
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEMLYGYTPFRGKTR 903
G+ + PEI G VD W+ G+ LY + G PF G
Sbjct: 172 -------------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218
Query: 904 QKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF-KGVN 962
K F NI P L+ +L +P R +I++H +F K
Sbjct: 219 YKLFENIGKGSYAIPGDCGPP--LSDLLKGMLEYEPAKRFSIR----QIRQHSWFRKKHP 272
Query: 963 WALVRCMNPPELD 975
A PP D
Sbjct: 273 PAEAPVPIPPSPD 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-50
Identities = 52/357 (14%), Positives = 107/357 (29%), Gaps = 68/357 (19%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINL--QHFRPIKPLGSGDTGSVHLVE-----L 690
S + P ++ W+ + + L + LG G V+
Sbjct: 32 SGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLND 91
Query: 691 CGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750
+ Q F +K N + + E L Y++ + L+ +
Sbjct: 92 AKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148
Query: 751 CPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG- 806
G L ++ P KV+ + V +A ++ +E +H II+ D+KP+N +L
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208
Query: 807 ----------NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASN 856
+ ++L D S P+ +F
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPK-----------------GTIF--------T 243
Query: 857 SFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP--------------FRGKT 902
+ T + E+++ +D++ + +Y ML+G FR
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303
Query: 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ H L P L + L+ + L + + + ++
Sbjct: 304 HLDMWNEFFHVMLNIPD--CHHLPSLDLLRQKLKKVFQQHYTNK---IRALRNRLIV 355
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-50
Identities = 68/305 (22%), Positives = 112/305 (36%), Gaps = 65/305 (21%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFV 731
+ LG G G V +GQ A+K + A +E+ P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYD----------SPKARQEVDHHWQASGGPHI 84
Query: 732 PALYASFQTKTH----VCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 784
+ ++ H + +I + GGELF R + + E ++ A+
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELF---SRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
++LH I +RD+KPEN+L + LTDF + K
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA---------------------KE 180
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ T Y+APE++ + + D W+LG+++Y +L G+ PF
Sbjct: 181 TTQNALQ--------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232
Query: 902 TRQKTFANILHK----DLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955
T Q + + FP+ + S AKQL+ LL DP RL + H
Sbjct: 233 TGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL----TITQFMNH 288
Query: 956 PFFKG 960
P+
Sbjct: 289 PWINQ 293
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-49
Identities = 79/330 (23%), Positives = 132/330 (40%), Gaps = 49/330 (14%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL 723
++ + H+ LG G G V + + +G A+K +++ + + + V + E + L
Sbjct: 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ HP + LY T + + ++ +Y GGELF + + L E R +++
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++Y H +++RDLKPENVLL + + + DF LS + L T
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRT------------ 174
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKT 902
G+ Y APE+I+G VD W+ G++LY +L G PF
Sbjct: 175 --------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220
Query: 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
F I P S L+ +L DP R +I++H +FK
Sbjct: 221 VPTLFKKICDGIFYTPQYLNPS--VISLLKHMLQVDPMKRATIK----DIREHEWFK--- 271
Query: 963 WALVRCMNPPELDAPLFATDTEKEYKVVDP 992
+L LF D ++D
Sbjct: 272 ---------QDLPKYLFPEDPSYSSTMIDD 292
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-49
Identities = 62/410 (15%), Positives = 117/410 (28%), Gaps = 94/410 (22%)
Query: 589 HLEPLRNSIPEATAEESEKLVKQTAENVNEAVKELPDANLTPEDLWANHSKVVHPKPHRK 648
H+E + + + E E + E + E + +W +++ +
Sbjct: 3 HMEAGDSFMRDLLKREEELIGYCREEALKEPAAMV---EAVTATVWPQNAETTVDSLLSQ 59
Query: 649 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 708
+ + ++PL GD V LV + FA+K G
Sbjct: 60 GE------------------RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN 101
Query: 709 NRNKVHRACAEREILDMLDHPFVPALYASFQ--------------------------TKT 742
+R+++ R L +
Sbjct: 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVA 161
Query: 743 HVCLITDYCPG--GELFLLLDRQPTK--VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 798
+ L+ LF LD A+ A+++ L +G+++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221
Query: 799 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 858
P+N+ + +G + L D + +
Sbjct: 222 PDNLFIMPDGRLMLGDVSAL------------------------------WKVGTRGPAS 251
Query: 859 VGTEEYIAPEII--AGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-------RQKTFAN 909
Y E + + A T A++ W LG+ +Y + + PF T ++ +
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L F S TP K L+ R L+ D + RL E + P F
Sbjct: 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPEFL 357
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 7e-49
Identities = 48/339 (14%), Positives = 91/339 (26%), Gaps = 72/339 (21%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL----------- 723
LG D + +G+ F + N + + E L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 724 -----------DMLDHPFVPALYASFQTKTHVCLITDY-------CPGGELFLLLDRQPT 765
D++ P + + + +++ + +L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 766 --KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
K L A +V+ L LH G+++ L+P +++L G V LT F+
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---- 259
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-----TSA 878
A + E A ++ H T A
Sbjct: 260 ----------------------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFA 297
Query: 879 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRD 938
D W LG+ +Y + P I P + L+ L
Sbjct: 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYP 351
Query: 939 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977
+ RL + + P ++ + L + + D
Sbjct: 352 KEDRL----LPLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-48
Identities = 85/301 (28%), Positives = 132/301 (43%), Gaps = 42/301 (13%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
+ + ++ + + LG G G V L + Q A+K + + ++ + R ERE
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRV--ERE 59
Query: 722 I--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
I L +L HP + LY T T + ++ +Y GGELF + + K + ED R + +
Sbjct: 60 ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQ 116
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ A+EY H I++RDLKPEN+LL N +V + DF LS + L T
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKT-------- 166
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPF 898
G+ Y APE+I G VD W+ GI+LY ML G PF
Sbjct: 167 ------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208
Query: 899 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
+ F + P A+ L+ R++ DP R+ EI++ P+F
Sbjct: 209 DDEFIPNLFKKVNSCVYVMPDFLSPG--AQSLIRRMIVADPMQRI----TIQEIRRDPWF 262
Query: 959 K 959
Sbjct: 263 N 263
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-48
Identities = 69/338 (20%), Positives = 118/338 (34%), Gaps = 64/338 (18%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
P P + P + + I + + LG G G V + + + FA+K
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM 94
Query: 702 MDKGVMLNRNKVHRACAEREI---LDMLDHPFVPALYASFQT----KTHVCLITDYCPGG 754
+ A RE+ P + + ++ + + ++ + GG
Sbjct: 95 LQD----------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144
Query: 755 ELFLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811
ELF R + + E + A++YLH I +RD+KPEN+L +
Sbjct: 145 ELF---SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 812 ---LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 868
LTDF + T+ L + T Y+APE
Sbjct: 202 ILKLTDFGFAKETTSHNSL----------------------------TTPCYTPYYVAPE 233
Query: 869 IIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT----FANILHKDLKFPSS--TP 922
++ + + D W+LG+++Y +L GY PF I +FP+ +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 923 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
S K L+ LL +P R+ E HP+
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQ 327
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-47
Identities = 70/343 (20%), Positives = 116/343 (33%), Gaps = 44/343 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ R + L G V+ + GSG+ +A+K + + + E +
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMK 80
Query: 725 ML-DHPFVPALYASFQTKTH--------VCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
L HP + ++ L+T+ C G + L + L D V
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 776 YAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
+ A++++H Q II+RDLK EN+LL G + L DF + S P
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYE 890
+ +N T Y PEII + D WALG +LY
Sbjct: 201 RALVEEEITRN---------------TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
Query: 891 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950
+ + PF + + I++ P L+ +L +P+ RL
Sbjct: 246 LCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIA 297
Query: 951 EIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPG 993
E+ A R +NP L + + G
Sbjct: 298 EVVHQLQ----EIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 179 bits (454), Expect = 4e-47
Identities = 73/325 (22%), Positives = 122/325 (37%), Gaps = 66/325 (20%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + LG+G G V +G+ A+K + L+ R C E +I+ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHP 72
Query: 730 FVPALYASFQTKTHV------CLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVV 782
V + + L +YC GG+L L + LKE +R +++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVS---LTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
AL YLH II+RDLKPEN++LQ + D + L
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTE-------- 182
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
FVGT +Y+APE++ +T VD+W+ G L +E + G+ PF
Sbjct: 183 ------------------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224
Query: 900 GKTRQKTFANILHK--------------DLKFPSSTPTSLH--------AKQLMYRLLHR 937
+ + + + +KF S PT H ++ + +L
Sbjct: 225 PNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW 284
Query: 938 DPKSRLGSHEGANEIKKHPFFKGVN 962
+ R + F+ ++
Sbjct: 285 HQRQRGTDP----QNPNVGCFQALD 305
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-47
Identities = 76/327 (23%), Positives = 118/327 (36%), Gaps = 53/327 (16%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAM 702
+PP + +R LG G G+V A+K +
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI 64
Query: 703 DKGVMLNRNKVHRACA-EREI--LDMLD----HPFVPALYASFQTKTHVCLITDY-CPGG 754
+ +L + + + E+ L + HP V L F+T+ L+ + P
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLT 813
+LF + + L E R + +VV A+++ H +G+++RD+K EN+L+ G L
Sbjct: 125 DLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
Query: 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873
DF L + F GT Y PE I+
Sbjct: 183 DFGSGALL--HDEPY---------------------------TDFDGTRVYSPPEWISRH 213
Query: 874 G-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMY 932
H W+LGILLY+M+ G PF IL +L FP+ S L+
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAH--VSPDCCALIR 265
Query: 933 RLLHRDPKSRLGSHEGANEIKKHPFFK 959
R L P SR EI P+ +
Sbjct: 266 RCLAPKPSSRP----SLEEILLDPWMQ 288
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-46
Identities = 62/311 (19%), Positives = 113/311 (36%), Gaps = 48/311 (15%)
Query: 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAER 720
S + F P LG G G++ + + A+K + A E
Sbjct: 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILP------ECFSFADREV 68
Query: 721 EILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
++L D HP V + + + + + + C L ++ Q +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVE-QKDFAHLGLEPITLLQQ 126
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNE 834
L +LH I++RDLKP N+L+ ++DF L
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC---------------- 170
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEM 891
K+ G+ + + GTE +IAPE+++ T VD ++ G + Y +
Sbjct: 171 -KKLAVGRHSFSRR-------SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 892 L-YGYTPFRGKTRQKTFANILHKDLKFPSSTPT-SLHAKQLMYRLLHRDPKSRLGSHEGA 949
+ G PF +++ + L + A++L+ +++ DP+ R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP----SA 278
Query: 950 NEIKKHPFFKG 960
+ KHPFF
Sbjct: 279 KHVLKHPFFWS 289
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-46
Identities = 52/296 (17%), Positives = 114/296 (38%), Gaps = 26/296 (8%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+H ++ + + + ++ D + + + + + +D
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLS-SPSPMDAPSVKIRRMDPFS 119
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-PTKVLKEDAVRFYAAEVVVALEY 786
K ++ + C L ++R+ + + ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +G+++RDLKP N+ + V + DF L + E++
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT--------AMDQDEEEQTVLTPM---- 227
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
VGT+ Y++PE I G ++ VD ++LG++L+E+LY ++ R +
Sbjct: 228 ---PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST--QMERVRI 282
Query: 907 FANILHKDLKFPS-STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
++ ++LKFP T ++ +L P R A +I ++ F+ +
Sbjct: 283 ITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 20/85 (23%), Positives = 33/85 (38%), Gaps = 4/85 (4%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDML 726
L F PI+ +G G G V + +A+K + L R KV R E + L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR---EVKALAKL 61
Query: 727 DHPFVPALYASFQTKTHVCLITDYC 751
+HP + + ++ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMD 86
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 74/333 (22%), Positives = 123/333 (36%), Gaps = 51/333 (15%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
S +V H A + ++ ++ LGSG GSV+
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71
Query: 698 AMKAMDKGVMLNRNKV-HRACAEREI--LDMLDH--PFVPALYASFQTKTHVCLITDYC- 751
A+K ++K + + ++ + E+ L + V L F+ LI +
Sbjct: 72 AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131
Query: 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHV 810
P +LF + + L+E+ R + +V+ A+ + H G+++RD+K EN+L+ N G +
Sbjct: 132 PVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189
Query: 811 SLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII 870
L DF L K + F GT Y PE I
Sbjct: 190 KLIDFGSGALL--KDTVY---------------------------TDFDGTRVYSPPEWI 220
Query: 871 AGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQ 929
H + W+LGILLY+M+ G PF I+ + F + +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSE--CQH 272
Query: 930 LMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
L+ L P R EI+ HP+ + V
Sbjct: 273 LIRWCLALRPSDRPTFE----EIQNHPWMQDVL 301
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-44
Identities = 72/335 (21%), Positives = 126/335 (37%), Gaps = 69/335 (20%)
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
+ + EQ K LG G +G+V G+ A+K M + A E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI------DFCDIALME 58
Query: 720 REILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDR-----QPTKVLKEDAV 773
++L D HP V Y S T + + + C L L++ + K+ KE
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 774 RFYAAEVVVALEYLHCQGIIYRDLKPENVLL-------------QGNGHVSLTDFDLSCL 820
++ + +LH II+RDLKP+N+L+ N + ++DF L
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC-- 175
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH----- 875
K+ GQ + N+ GT + APE++ + +
Sbjct: 176 ---------------KKLDSGQSS------FRTNLNNPSGTSGWRAPELLEESNNLQTKR 214
Query: 876 --TSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPT-----SLHA 927
T ++D +++G + Y +L G PF K ++ +NI+ A
Sbjct: 215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEA 272
Query: 928 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
L+ +++ DP R A ++ +HP F +
Sbjct: 273 TDLISQMIDHDPLKRP----TAMKVLRHPLFWPKS 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 55/303 (18%), Positives = 105/303 (34%), Gaps = 39/303 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LD 724
F ++ +GSG+ GSV G +A+K K + V A RE+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA---GSVDEQNALREVYAHAV 66
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAEVVV 782
+ H V ++++ H+ + +YC GG L + + KE ++ +V
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK-- 840
L Y+H +++ D+KP N+ + + + +++ K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF----------KIG 176
Query: 841 --GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTP 897
G + + G ++A E++ H D +AL + +
Sbjct: 177 DLG------HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
Query: 898 FRGKTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
R + I L + P S +L+ ++H DP+ R A + KH
Sbjct: 231 PRNG---DQWHEIRQGRLPRIPQV--LSQEFTELLKVMIHPDPERRP----SAMALVKHS 281
Query: 957 FFK 959
Sbjct: 282 VLL 284
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 61/305 (20%), Positives = 100/305 (32%), Gaps = 85/305 (27%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI---LDMLDHPFV 731
+ LG G G V + + + FA+K + A RE+ P +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----------CPKARREVELHWRASQCPHI 73
Query: 732 PALYASFQT----KTHVCLITDYCPGGELFLLLDR---QPTKVLKEDAVRFYAAEVVVAL 784
+ ++ + + ++ + GGELF R + + E + A+
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELF---SRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 785 EYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+YLH I +RD+KPEN+L N + LTDF
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------------ 166
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
A E + + D W+LG+++Y +L GY PF
Sbjct: 167 ------------------------AKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSN 201
Query: 902 TRQKT----FANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955
I +FP+ + S K L+ LL +P R+ E H
Sbjct: 202 HGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNH 257
Query: 956 PFFKG 960
P+
Sbjct: 258 PWIMQ 262
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-41
Identities = 65/328 (19%), Positives = 118/328 (35%), Gaps = 38/328 (11%)
Query: 634 WANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGS 693
+ + + P+ + K +D + + +G G G VH ++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 694 GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753
G A+K + V E L P + LY + + V + + G
Sbjct: 83 GFQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSL 812
G L L+ + L ED +Y + + LEYLH + I++ D+K +NVLL +G +L
Sbjct: 135 GSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAAL 192
Query: 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 872
DF + P + + + + GTE ++APE++ G
Sbjct: 193 CDFGHA----------------------LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 873 AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLM 931
+ VD W+ ++ ML G P+ R I + + Q +
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 932 YRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L ++P R A E+++
Sbjct: 291 QEGLRKEPVHRA----SAMELRRKVGKA 314
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 22/280 (7%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+ LG G G V +G+ MK + + + + E +++
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRC 63
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L+HP V + IT+Y GG L ++ ++ V F A ++ +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMA 122
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH II+RDL N L++ N +V + DF L+ L+ + + + P
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLAR--------LMVDEKTQPEGLRSLKKP 174
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT-RQ 904
+ + VG ++APE+I G + VD ++ GI+L E++ R
Sbjct: 175 DR-----KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 905 KTFANILHK--DLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
F + D P + P S + R DP+ R
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFF--PITVRCCDLDPEKR 267
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 49/289 (16%)
Query: 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE 721
S I+ + + +G G G V + + A+K + + ++ E
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIK-----QIESESERKAFIVELR 53
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEV 780
L ++HP + LY + VCL+ +Y GG L+ +L +P + +
Sbjct: 54 QLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC 111
Query: 781 VVALEYLHC---QGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKK 836
+ YLH + +I+RDLKP N+LL G V + DF +C
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----------------- 154
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYT 896
+ M + G+ ++APE+ G+ ++ D ++ GI+L+E++
Sbjct: 155 ----------DIQTHM---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 897 PFRG-KTRQKTFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 942
PF +H + P + + LM R +DP R
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--ESLMTRCWSKDPSQR 248
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 78/312 (25%), Positives = 124/312 (39%), Gaps = 49/312 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
IN + + +GSG T V + A+K ++ L + + +EI M
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAM 67
Query: 726 --LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL------DRQPTKVLKEDAVRFYA 777
HP + + Y SF K + L+ GG + ++ + VL E +
Sbjct: 68 SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKK 836
EV+ LEYLH G I+RD+K N+LL +G V + DF +S L + T K
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG-----GDITRNKV 182
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGY 895
R +FVGT ++APE++ G+ D W+ GI E+ G
Sbjct: 183 R------------------KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 896 TPFRGKTRQKTFANILHKD---LKFPSSTPTSLHA-----KQLMYRLLHRDPKSRLGSHE 947
P+ K L D L+ L ++++ L +DP+ R
Sbjct: 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP---- 280
Query: 948 GANEIKKHPFFK 959
A E+ +H FF+
Sbjct: 281 TAAELLRHKFFQ 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 70/288 (24%), Positives = 110/288 (38%), Gaps = 39/288 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
LG G G V+ + A+K + + E + L H +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKV-LKEDAVRFYAAEVVVALEYLHCQGIIYR 795
SF + + + PGG L LL + + E + FY +++ L+YLH I++R
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 796 DLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
D+K +NVL+ +G + ++DF S KR +A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----------------KR----------LAGINPC 179
Query: 855 SNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTPFRG-KTRQKTFANIL 911
+ +F GT +Y+APEII G+ A D W+LG + EM G PF Q +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239
Query: 912 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ S AK + + DP R AN++ F K
Sbjct: 240 MFKVHPEIPESMSAEAKAFILKCFEPDPDKRA----CANDLLVDEFLK 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 65/300 (21%), Positives = 118/300 (39%), Gaps = 37/300 (12%)
Query: 649 DSPPWKAIQKILDSGE---QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
D K ++ L + ++ F I LG+G+ G V V SG A K +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-- 67
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+ + ++ E ++L + P++ Y +F + + + ++ GG L +L +
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--A 125
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
+ E + + V+ L YL + I++RD+KP N+L+ G + L DF +S
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------ 179
Query: 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWAL 884
GQ + + M NSFVGT Y++PE + G ++ D W++
Sbjct: 180 ----------------GQ-----LIDSMA--NSFVGTRSYMSPERLQGTHYSVQSDIWSM 216
Query: 885 GILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLG 944
G+ L EM G P ++ + + TP D + +
Sbjct: 217 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMA 276
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/313 (20%), Positives = 113/313 (36%), Gaps = 39/313 (12%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQ--INLQHFRPIKPLGSGDTGSVHLVELCGSG 694
H HP + G+ I + +G+G G+VH E G
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-- 60
Query: 695 QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGG 754
A+K + + +V+ E I+ L HP + + ++ ++T+Y G
Sbjct: 61 SDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 755 ELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVS 811
L+ LL + L E A +V + YLH + I++R+LK N+L+ V
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 871
+ DF LS A +S S GT E++APE++
Sbjct: 180 VCDFGLSR---------------------------LKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 872 GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLK--FPSSTPTSLHAKQ 929
D ++ G++L+E+ P+ + A + K + P + +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV--AA 270
Query: 930 LMYRLLHRDPKSR 942
++ +P R
Sbjct: 271 IIEGCWTNEPWKR 283
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 62/292 (21%), Positives = 116/292 (39%), Gaps = 47/292 (16%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA 736
+G G +V+ + A + L +++ R E E+L L HP + Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 737 SF----QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG- 791
S+ + K + L+T+ G L L R KV+K +R + +++ L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 792 -IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
II+RDLK +N+ + G G V + D L+ L
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------------------------- 185
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+ + +GT E++APE+ + +VD +A G+ + EM P+
Sbjct: 186 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 910 ILHKDLKFPSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ +K P+S K+++ + ++ R ++ H FF+
Sbjct: 241 RVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 287
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 79/298 (26%), Positives = 125/298 (41%), Gaps = 51/298 (17%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--L 726
+ F ++ +G G G V + + A+K +D L + ++EI +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
D P+V Y S+ T + +I +Y GG LL+ L E + E++ L+Y
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDY 134
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH + I+RD+K NVLL +G V L DF ++ QL T+ + +R
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG------QL----TDTQIKR-------- 176
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
N+FVGT ++APE+I + + S D W+LGI E+ G P K
Sbjct: 177 ---------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
Query: 907 FANILHKDLKFPSSTPT-----SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
I + PT S K+ + L+++P R A E+ KH F
Sbjct: 228 LFLIPKNN------PPTLEGNYSKPLKEFVEACLNKEPSFRP----TAKELLKHKFIL 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 76/294 (25%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+G G TG V L SG+ A+K MD + + + E I+ H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQH 101
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
V +Y S+ + ++ ++ GG L ++ + L E+ + V+ AL YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH 158
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
QG+I+RD+K +++LL +G V L+DF Q+ + + +R
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA------QI----SKDVPKR---------- 198
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
S VGT ++APE+I+ + + + VD W+LGI++ EM+ G P+ + +
Sbjct: 199 -------KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251
Query: 909 NILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ LK L + + R+L RDP+ R A E+ HPF
Sbjct: 252 RLRDSPPPKLKNSHKVSPVL--RDFLERMLVRDPQER----ATAQELLDHPFLL 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 71/316 (22%), Positives = 117/316 (37%), Gaps = 54/316 (17%)
Query: 659 ILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR 715
L G Q + + +GSG G V + +G A+K M + NK
Sbjct: 12 YLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR----RSGNKEEN 67
Query: 716 ACAEREI---LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
++ L D P++ + +F T T V + + L ++ + E
Sbjct: 68 KRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKLKKRMQGPIPERI 125
Query: 773 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLP 830
+ +V AL YL + G+I+RD+KP N+LL G + L DF +S L
Sbjct: 126 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-------- 177
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEII-----AGAGHTSAVDWWALG 885
+A + G Y+APE I + D W+LG
Sbjct: 178 ---------------------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 886 ILLYEMLYGYTPFRG-KTRQKTFANILHKDL-KFPSSTPTSLHAKQLMYRLLHRDPKSRL 943
I L E+ G P++ KT + +L ++ P S + + L +D + R
Sbjct: 217 ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
Query: 944 GSHEGANEIKKHPFFK 959
N++ +H F K
Sbjct: 277 ----KYNKLLEHSFIK 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 42/294 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + +G G +G+V+ +GQ A++ M+ + + K E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + S+ + ++ +Y GG L ++ + E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+I+RD+K +N+LL +G V LTDF Q+ T E+ +R
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------QI----TPEQSKR---------- 173
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + +
Sbjct: 174 -------STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 909 NILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
I L+ P + + R L D + R A E+ +H F K
Sbjct: 227 LIATNGTPELQNPEKLSAIF--RDFLNRCLEMDVEKR----GSAKELLQHQFLK 274
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 52/294 (17%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE--RE-- 721
+ K +G G G VH L A+K++ G ++ E RE
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
I+ L+HP + LY ++ ++ P G+L+ L + + +R ++
Sbjct: 76 IMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIA 132
Query: 782 VALEYLHCQG--IIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+ +EY+ Q I++RDL+ N+ L + DF LS +
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV------------ 180
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG--HTSAVDWWALGILLYEML 892
+ + +G +++APE I +T D ++ ++LY +L
Sbjct: 181 ------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 893 YGYTPFRGKTRQK--TFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G PF + K I + L P P L + ++ DPK R
Sbjct: 223 TGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL--RNVIELCWSGDPKKR 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 69/303 (22%), Positives = 119/303 (39%), Gaps = 42/303 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-L 723
++ PI LG G G V + SGQ A+K + +N + R + +I +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISM 60
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+D PF Y + + V + + + F + + ED + A +V
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 783 ALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
ALE+LH + +I+RD+KP NVL+ G V + DF +S G
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS----------------------G 158
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYGYTP 897
+ + + A + G + Y+APE I G++ D W+LGI + E+ P
Sbjct: 159 Y-----LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 898 FRG-KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
+ T + ++ + + S + L ++ K R E+ +HP
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP----TYPELMQHP 268
Query: 957 FFK 959
FF
Sbjct: 269 FFT 271
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 77/317 (24%), Positives = 131/317 (41%), Gaps = 43/317 (13%)
Query: 647 RKDSPPWKAIQKILDSGEQIN-LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKG 705
+ +PP + ++K+ + + F ++ LG G GSV+ +GQ A+K +
Sbjct: 6 QLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP-- 63
Query: 706 VMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT 765
+ + E I+ D P V Y S+ T + ++ +YC G + ++ +
Sbjct: 64 ---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN- 119
Query: 766 KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
K L ED + + LEYLH I+RD+K N+LL GH L DF ++
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG------ 173
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
QL T+ +R N+ +GT ++APE+I G+ D W+LG
Sbjct: 174 QL----TDTMAKR-----------------NTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 886 ILLYEMLYGYTPFRGKTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
I EM G P+ + I + P S + + + L + P+ R
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL--WSDNFTDFVKQCLVKSPEQR 270
Query: 943 LGSHEGANEIKKHPFFK 959
A ++ +HPF +
Sbjct: 271 A----TATQLLQHPFVR 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 62/308 (20%), Positives = 109/308 (35%), Gaps = 49/308 (15%)
Query: 647 RKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMD 703
+ + D E I + +GSG G+V+ G++ A+K ++
Sbjct: 3 KGHHHHHHGSRDAADDWE-IPDGQITVGQRIGSGSFGTVYK------GKWHGDVAVKMLN 55
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
++ E +L H + T + ++T +C G L+ L
Sbjct: 56 VTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS 113
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
TK + + A + ++YLH + II+RDLK N+ L + V + DF L+ S
Sbjct: 114 ETKFEMKKLIDI-ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS- 171
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVD 880
G+ ++APE+I + D
Sbjct: 172 ------------------------RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 881 WWALGILLYEMLYGYTPFRGKT-RQKTFANILHKDLK-----FPSSTPTSLHAKQLMYRL 934
+A GI+LYE++ G P+ R + + L S+ P + K+LM
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM--KRLMAEC 265
Query: 935 LHRDPKSR 942
L + R
Sbjct: 266 LKKKRDER 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 59/368 (16%), Positives = 124/368 (33%), Gaps = 82/368 (22%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSG--DTGSVHLVELCGSGQYFAM 699
H H ++ ++ + L G + + +G G D +V+L +G+Y +
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGG-----CYELLTVIGKGFEDLMTVNLARYKPTGEYVTV 57
Query: 700 KAMDKGVMLNRNKVHRACAEREILDM--LDHPFVPALYASFQTKTHVCLITDYCPGGELF 757
+ ++ + + + E+ +HP + A+F + ++T + G
Sbjct: 58 RRIN---LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 758 LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817
L+ + E A+ + V+ AL+Y+H G ++R +K ++L+ +G V L+
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA--GAGH 875
+ + + +R+ P V +++PE++ G+
Sbjct: 175 NL------SM----ISHGQRQRVVHDFP----------KYSVKVLPWLSPEVLQQNLQGY 214
Query: 876 TSAVDWWALGILLYEMLYGYTPF------------------------------------- 898
+ D +++GI E+ G+ PF
Sbjct: 215 DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSR 274
Query: 899 -------RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
T P S H + + L R+P +R A+
Sbjct: 275 SVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP----SAST 330
Query: 952 IKKHPFFK 959
+ H FFK
Sbjct: 331 LLNHSFFK 338
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 68/292 (23%), Positives = 114/292 (39%), Gaps = 50/292 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREIL 723
+I+ + +G G G V+ G A+KA + ++ E ++
Sbjct: 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 724 DMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVA 783
ML HP + AL + ++CL+ ++ GG L +L + + D + +A ++
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARG 117
Query: 784 LEYLHCQG---IIYRDLKPENVLL--------QGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ YLH + II+RDLK N+L+ N + +TDF L+
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------- 169
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
S G ++APE+I + + D W+ G+LL+E+L
Sbjct: 170 ---------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208
Query: 893 YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G PFRG + L PS+ P +LM + DP SR
Sbjct: 209 TGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF--AKLMEDCWNPDPHSR 258
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + LG G G V+ + +G A K ++ + ++ E EIL DH
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATCDH 75
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P++ L ++ + ++ ++CPGG + ++ + L E ++ +++ AL +LH
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH 134
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+ II+RDLK NVL+ G + L DF +S + ++R
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSA------KN----LKTLQKR---------- 174
Query: 849 AEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
+SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 175 -------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
Query: 904 QKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ I D L PS S+ + + L ++P++R A ++ +HPF
Sbjct: 228 MRVLLKIAKSDPPTLLTPSK--WSVEFRDFLKIALDKNPETRP----SAAQLLEHPFVSS 281
Query: 961 V 961
+
Sbjct: 282 I 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 63/309 (20%), Positives = 107/309 (34%), Gaps = 50/309 (16%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 722
+ + + +G G GSV+ + SGQ A+K + ++ + ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR----STVDEKEQKQLLMDLDV 73
Query: 723 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD--RQPTKVLKEDAVRFYAAE 779
+ D P++ Y + + + + V+ E+ +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 780 VVVALEYLHCQG-IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
V AL +L II+RD+KP N+LL +G++ L DF +S QL + +
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS------GQL----VDSIAKT 183
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG----AGHTSAVDWWALGILLYEMLYG 894
G Y+APE I G+ D W+LGI LYE+ G
Sbjct: 184 R------------------DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 895 YTPFRG-KTRQKTFANILHKD---LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950
P+ + ++ D L S + L +D R
Sbjct: 226 RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP----KYK 281
Query: 951 EIKKHPFFK 959
E+ KHPF
Sbjct: 282 ELLKHPFIL 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 61/310 (19%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLD 727
F ++ +G+G G V+ +GQ A+K MD + ++ E +L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 728 HPFVPALYASFQTKTHVC------LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
H + Y +F K L+ ++C G + L+ LKE+ + + E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L +LH +I+RD+K +NVLL N V L DF +S QL RR
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------QL----DRTVGRR--- 186
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYT 896
N+F+GT ++APE+IA A + D W+LGI EM G
Sbjct: 187 --------------NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 897 PFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL-------MYRLLHRDPKSRLGSHEGA 949
P + I P + L +K+ + L ++ R
Sbjct: 233 PLCDMHPMRALFLI-------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP----AT 281
Query: 950 NEIKKHPFFK 959
++ KHPF +
Sbjct: 282 EQLMKHPFIR 291
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 49/292 (16%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAEREI 722
I + + +G G G V+ G++ A++ +D N +++ E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVY------HGRWHGEVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
H V + + H+ +IT C G L+ ++ R VL + R A E+V
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVK 141
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ YLH +GI+++DLK +NV NG V +TDF L + +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSI---------------SGVLQAG 185
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---------HTSAVDWWALGILLYEMLY 893
+ + G ++APEII + D +ALG + YE+
Sbjct: 186 RREDKLRIQ-------NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
Query: 894 GYTPFRGKTRQKTFANILHKDLKF---PSSTPTSLHAKQLMYRLLHRDPKSR 942
PF+ + + + +K + ++ + + R
Sbjct: 239 REWPFKTQPAEAIIWQM-GTGMKPNLSQIGMGKEI--SDILLFCWAFEQEER 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 45/292 (15%), Positives = 95/292 (32%), Gaps = 46/292 (15%)
Query: 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE 719
++ I+ + + L +G + G +K + + K E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQG--NDIVVKVLKVR-DWSTRKSRDFNEE 57
Query: 720 REILDMLDHPFVPALYASFQT--KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
L + HP V + + Q+ H LIT + P G L+ +L V+ + +A
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 778 AEVVVALEYLHCQG--IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
++ + +LH I L +V++ + ++ D+
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP----------- 166
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEML 892
+ ++APE + + + D W+ +LL+E++
Sbjct: 167 ---------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV 205
Query: 893 YGYTPFRGKTRQKTFANILHKDL--KFPSSTPTSLHAKQLMYRLLHRDPKSR 942
PF + + + + L P + +LM ++ DP R
Sbjct: 206 TREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV--SKLMKICMNEDPAKR 255
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 68/328 (20%), Positives = 111/328 (33%), Gaps = 56/328 (17%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
P R S + ++ + + F ++ +G G G+V+ + + A+K
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDD--PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKK 86
Query: 702 MDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLD 761
M + K E L L HP + + L+ +YC G LL
Sbjct: 87 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 146
Query: 762 RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821
+ K L+E + + L YLH +I+RD+K N+LL G V L DF +
Sbjct: 147 HK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-- 202
Query: 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSA 878
+ NSFVGT ++APE+I +
Sbjct: 203 ----IM-------APA------------------NSFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 879 VDWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQL-------M 931
VD W+LGI E+ P +I + +L + +
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPALQSGHWSEYFRNFV 286
Query: 932 YRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L + P+ R + + KH F
Sbjct: 287 DSCLQKIPQDRP----TSEVLLKHRFVL 310
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-26
Identities = 55/285 (19%), Positives = 102/285 (35%), Gaps = 44/285 (15%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR--ACAER 720
G+ N + I+ LG G +V L ++ AMK ++ + + A E
Sbjct: 32 GDLFN-GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK------VVKSAEHYTETALDEI 84
Query: 721 EILDML-----DHP---FVPALYASFQTK----THVCLITDYCPGGE-LFLLLDRQPTKV 767
+L + + P V L F+ TH+C++ + G L + + +
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQG 142
Query: 768 LKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
L V+ +V+ L+YLH + II+ D+KPEN+LL N +
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRAS-------------------NSFVGTEEYIAP 867
+ V EP A + T +Y +
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 868 EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH 912
E++ G+G+ + D W+ + +E+ G F + ++ + H
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-26
Identities = 51/238 (21%), Positives = 82/238 (34%), Gaps = 50/238 (21%)
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKV 767
A AER+ L + HP + ++ + ++ +Y G L ++
Sbjct: 123 QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---- 178
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
L Y E++ AL YLH G++Y DLKPEN++L + L D
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGA---------- 227
Query: 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
+ + GT + APEI+ G T A D + +G
Sbjct: 228 ---------------------VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRT 265
Query: 888 LYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945
L + G+ L +D T S L+ R + DP+ R +
Sbjct: 266 LAALTLDLPTRNGRYVDG-----LPEDDPVL-KTYDSYGR--LLRRAIDPDPRQRFTT 315
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 67/321 (20%), Positives = 118/321 (36%), Gaps = 78/321 (24%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFV 731
+ +G G G V + G + A+K + + + E EI ML H +
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVK------IFSSREERSWFREAEIYQTVMLRHENI 98
Query: 732 PALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
A+ T T + L++DY G LF L+R V E ++ A L +L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV--EGMIKL-ALSTASGLAHL 155
Query: 788 HCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
H + I +RDLK +N+L++ NG + D L+ RH
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------------------VRH 197
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWALGILLYEMLY 893
+ + + A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 198 DSATDTIDI-----APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
Query: 894 GYT----------PFRGKT-RQKTFANI----LHKDL--KFPS---STPTSLHAKQLMYR 933
+ P+ + + + L P+ S ++M
Sbjct: 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312
Query: 934 LLHRDPKSRLGSHEGANEIKK 954
+ + +RL A IKK
Sbjct: 313 CWYANGAARL----TALRIKK 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 71/332 (21%), Positives = 114/332 (34%), Gaps = 85/332 (25%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 722
I L + +G G G V G + A+K + + E E+
Sbjct: 8 RDITLL-----ECVGKGRYGEVWRGSWQG--ENVAVK------IFSSRDEKSWFRETELY 54
Query: 723 -LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
ML H F+ + S + T + LIT Y G L+ L +R
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRI-V 111
Query: 778 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCL-TSCKPQLL 828
+ L +LH + I +RDLK +N+L++ NG + D L+ + + QL
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA------VDWW 882
+ VGT+ Y+APE++ VD W
Sbjct: 172 VGNNPR------------------------VGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 883 ALGILLYEMLYGYT----------PFRGKT-RQKTFANI----LHKDL--KFPS---STP 922
A G++L+E+ PF +F ++ P+ S P
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 923 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
T +LM +++P +RL A IKK
Sbjct: 268 TLTSLAKLMKECWYQNPSARL----TALRIKK 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/331 (19%), Positives = 120/331 (36%), Gaps = 74/331 (22%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI- 722
++ + + +K +G G G V + + G + A+K V + E EI
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRG--EKVAVK-----VFFTTEE-ASWFRETEIY 83
Query: 723 -LDMLDHPFVPALYAS----FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
++ H + A+ + T + LITDY G L+ L + + ++ A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKL-A 140
Query: 778 AEVVVALEYLHCQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
V L +LH + I +RDLK +N+L++ NG + D L+
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA----------- 189
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS------AVDWWA 883
+ N V + N+ VGT+ Y+ PE++ + + + D ++
Sbjct: 190 -------VKFISDTNEVDI-----PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237
Query: 884 LGILLYEMLYGYT----------PFRGKT-RQKTFANI----LHKDL-----KFPSSTPT 923
G++L+E+ P+ ++ ++ K L SS
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC 297
Query: 924 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
+LM +P SRL + + K
Sbjct: 298 LRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 57/257 (22%), Positives = 95/257 (36%), Gaps = 53/257 (20%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--L 723
++L + + ++ +G G G+V+ L + A+K NR E+ I +
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFA---NRQNFIN---EKNIYRV 61
Query: 724 DMLDHPFVPALYA-----SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
+++H + + + L+ +Y P G L L + A
Sbjct: 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAH 118
Query: 779 EVVVALEYLHCQ---------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
V L YLH + I +RDL NVL++ +G ++DF LS
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--------- 169
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-------GHTSAVDWW 882
V E A+ S VGT Y+APE++ GA VD +
Sbjct: 170 ----------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY 219
Query: 883 ALGILLYEMLYGYTPFR 899
ALG++ +E+ T
Sbjct: 220 ALGLIYWEIFMRCTDLF 236
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 62/326 (19%), Positives = 121/326 (37%), Gaps = 59/326 (18%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
++ + LG G +V+L E A+KA+ + R E L H
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 731 VPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ ++ + L+ +Y G L ++ L D + +++ +++ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM 130
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
I++RD+KP+N+L+ N + + DF ++ S
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS--------------------------ET 164
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT------RQ 904
+ +N +GT +Y +PE G D +++GI+LYEML G PF G+T +
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224
Query: 905 KTFANILHKDLKFPSST-----PTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ + ++ P SL ++ R +D +R + E+K
Sbjct: 225 ------IQDSVPNVTTDVRKDIPQSLSN--VILRATEKDKANRYKT---IQEMKD----- 268
Query: 960 GVNWALVRCMNPPELDAPLFATDTEK 985
L ++ + ++ D K
Sbjct: 269 ----DLSSVLHENRANEDVYELDKMK 290
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 27/101 (26%), Positives = 51/101 (50%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
T I+YA+ F ++ Y +E+VG++ R + + + T+ G + G
Sbjct: 5 TDLQGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNIWQGEF 64
Query: 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKHTE 308
N +KDGT +W TI P+ D+ GK ++I ++ +++ E
Sbjct: 65 CNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKE 105
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 37/186 (19%), Positives = 75/186 (40%), Gaps = 15/186 (8%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
ITD I++A+D+F ++ Y REE++G++ R + A +R + I
Sbjct: 3 SITDL---QGRILYANDNFCAVSRYGREELVGQDHRIVNSGYHGKAYIRDMWRTISRGNI 59
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE------HLEPLRNSIPE 599
+ N K G ++W + P+ D G+ + +I ++ D + L L+ ++
Sbjct: 60 WQGEFCNRRKDGTRYWVDSTIVPLMDNAGKPRQYISIRRDITAQKEAEAQLARLKQAMDA 119
Query: 600 ATAEESEKLVKQTAENVNEAVKELPDANLTPEDLW-ANHSKVVHPKPHRKDSPPWKAIQK 658
+ N A+ + + +L + S + P D A+Q+
Sbjct: 120 NSEMILLTDRAGRIIYANPALCRF--SGMAEGELLGQSPSILDSP---LADQETLAAMQE 174
Query: 659 ILDSGE 664
L +G+
Sbjct: 175 ALQAGQ 180
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRL 267
T I+YA+ + +G E++G++ L D E +A ++E LQ GQ + GRL
Sbjct: 127 TDRAGRIIYANPALCRFSGMAEGELLGQSPSILDSPLADQETLAAMQEALQAGQPWSGRL 186
Query: 268 LNYKK------DGTPFWNLLTIAPIKDDEGKVLKFIGMQ 300
LN ++ D +W ++ PI D ++ ++ +Q
Sbjct: 187 LNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLVGYVQIQ 225
|
| >3ewk_A Sensor protein; PAS domain, alpha/beta fold, kinase, phosphoprotein, transfe flavoprotein; HET: FAD; 2.34A {Methylococcus capsulatus} Length = 227 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 21/128 (16%), Positives = 53/128 (41%), Gaps = 9/128 (7%)
Query: 464 RQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFL 523
+++ + L ++ + ++TD II+A+ + + + E+LG++ L
Sbjct: 103 QKEAEAQLARLKQAMDANSEMILLTDR---AGRIIYANPALCRFSGMAEGELLGQSPSIL 159
Query: 524 QGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKK------FWNLFHLQPMRDQKGEVQ 577
P D T+ ++ A+ + +L+N ++G +W P+ +
Sbjct: 160 DSPLADQETLAAMQEALQAGQPWSGRLLNRRRTGPAPHDAEDYWAEISTTPIHTDGNGLV 219
Query: 578 YFIGVQLD 585
++ +Q D
Sbjct: 220 GYVQIQHD 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 76/324 (23%), Positives = 120/324 (37%), Gaps = 68/324 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
+ I +G G G V +GQ A+K K + + V + A REI L L H
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + L F+ K + L+ +YC + LDR + + E V+ + + A+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCH 119
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
I+RD+KPEN+L+ + + L DF + R + +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA-------------------RLLTGPSDYYD 160
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR---- 903
E V T Y +PE++ G VD WA+G + E+L G + GK+
Sbjct: 161 DE--------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212
Query: 904 QKTF---------------ANILHKDLKFPSSTPT----------SLHAKQLMYRLLHRD 938
N +K P S A L+ LH D
Sbjct: 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272
Query: 939 PKSRLGSHEGANEIKKHPFFKGVN 962
P RL ++ HP+F+ +
Sbjct: 273 PTERL----TCEQLLHHPYFENIR 292
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-23
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 31/222 (13%)
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L P V ++ + + + G +L +L RQ + AV ++ AL+
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVA-IVRQIGSALD 148
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
H G +RD+KPEN+L+ + L DF ++ T+
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----------------------- 185
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
E + + VGT Y+APE + + T D +AL +LYE L G P++G
Sbjct: 186 ---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV 242
Query: 906 TFANILHKDLKFPSSTPTSLHAK--QLMYRLLHRDPKSRLGS 945
A+ +++ + PS+ + ++ R + ++P+ R +
Sbjct: 243 MGAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT 283
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 56/321 (17%), Positives = 103/321 (32%), Gaps = 78/321 (24%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI-- 722
+ ++ G G V +L +Y A+K ++ E E+
Sbjct: 20 YFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQ---DKQSWQN---EYEVYS 71
Query: 723 LDMLDHP----FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
L + H F+ A + LIT + G L L + + + A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 779 EVVVALEYLHCQ----------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
+ L YLH I +RD+K +NVLL+ N + DF L+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA---------- 178
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA-----VDWWA 883
+ + ++ + VGT Y+APE++ GA + +D +A
Sbjct: 179 --------LKFEAGKSAGDT-------HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 884 LGILLYEMLYGYTPFRGKT------------RQKTFANIL------HKDLKFPSSTPTSL 925
+G++L+E+ T G + + ++ K
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA 283
Query: 926 HAK---QLMYRLLHRDPKSRL 943
+ + D ++RL
Sbjct: 284 GMAMLCETIEECWDHDAEARL 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-22
Identities = 76/369 (20%), Positives = 138/369 (37%), Gaps = 84/369 (22%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMK--AMDK--GVMLNRNKVHRACAEREI- 722
++ + + LG G +V+ + + A+K ++ G A RE+
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCT--------AIREVS 52
Query: 723 -LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
L L H + L+ T+ + L+ +Y +L LD + V+ + +++
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLL 110
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L Y H Q +++RDLKP+N+L+ G + L DF L+ R K
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-------------------RAKS 151
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 900
P + ++ V T Y P+I+ G+ ++ +D W +G + YEM G F G
Sbjct: 152 --------IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203
Query: 901 KTR----QKTFANIL----------------HKDLKFPSSTPTSL---------HAKQLM 931
T F IL K +P +L L+
Sbjct: 204 STVEEQLHFIF-RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLL 262
Query: 932 YRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVD 991
+LL + ++R+ A + KHPFF +L ++ +FA + K +
Sbjct: 263 TKLLQFEGRNRI----SAEDAMKHPFF----LSLGERIHKLPDTTSIFALKEIQLQK--E 312
Query: 992 PGMQDLQQN 1000
++ +
Sbjct: 313 ASLRSAHHH 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 62/367 (16%), Positives = 116/367 (31%), Gaps = 109/367 (29%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-ACAERE 721
GE + ++ LG G +V L + + + AMK ++ A E +
Sbjct: 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIK 67
Query: 722 ILDML-----------DHPFVPALYASFQTK----THVCLITDYCPGGELFLLLDRQPTK 766
+L + + L F K HV ++ + G L L+ + +
Sbjct: 68 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR 126
Query: 767 VLKEDAVRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLL------QGNGHVSLTDFDLSC 819
+ V+ + ++++ L+Y+H + GII+ D+KPENVL+ + + + D +C
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+ + + T EY +PE++ GA
Sbjct: 187 WYD--------------EHY----------------TNSIQTREYRSPEVLLGAPWGCGA 216
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILH--------------------------- 912
D W+ L++E++ G F + H
Sbjct: 217 DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFN 276
Query: 913 ---KDLKFPSSTPTSLH-------------AKQ---LMYRLLHRDPKSRLGSHEGANEIK 953
L AK+ + +L DP+ R A +
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLV 332
Query: 954 KHPFFKG 960
HP+ K
Sbjct: 333 NHPWLKD 339
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 61/274 (22%), Positives = 110/274 (40%), Gaps = 60/274 (21%)
Query: 726 LDHPFVPALY----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
L+HP + A+Y A ++ +Y G L ++ + + A+
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADAC 126
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
AL + H GII+RD+KP N+++ V + DF ++ R
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA-------------------RAIA 167
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G
Sbjct: 168 DS-----GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222
Query: 902 T------RQKTFANILHKDLKFPSST----PTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
+ + + +D PS+ L A ++ + L ++P++R + A E
Sbjct: 223 SPVSVAYQH------VREDPIPPSARHEGLSADLDA--VVLKALAKNPENRYQT---AAE 271
Query: 952 IKKHPFFKGVNWALVRCMNPPELDAPLFATDTEK 985
++ LVR N +AP TD E+
Sbjct: 272 MRA---------DLVRVHNGEPPEAPKVLTDAER 296
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 76/340 (22%), Positives = 121/340 (35%), Gaps = 71/340 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDMLDH 728
+ + +G G G V +G+ A+K K + + +K+ + A REI L L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+ L + K L+ ++ + L+ P L V+ Y +++ + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH 141
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
II+RD+KPEN+L+ +G V L DF + R V+
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA-------------------RTLAAPGEVYD 182
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
E V T Y APE++ G AVD WA+G L+ EM G F G +
Sbjct: 183 DE--------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234
Query: 908 ANILH-------------------KDLKFPSSTPT----------SLHAKQLMYRLLHRD 938
+I+ ++ P S L + LH D
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHID 294
Query: 939 PKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPL 978
P R E+ H FF+ + EL +
Sbjct: 295 PDKRP----FCAELLHHDFFQMDGF---AERFSQELQLKV 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-22
Identities = 60/316 (18%), Positives = 116/316 (36%), Gaps = 35/316 (11%)
Query: 629 TPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLV 688
+ L + P + +A+ K D +N + + +G G+ G V
Sbjct: 77 SIPLLIDHLLSTQQPLTKKSGVVLHRAVPK--DKWV-LNHEDLVLGEQIGRGNFGEVFSG 133
Query: 689 ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748
L A+K+ + + + + E IL HP + L K + ++
Sbjct: 134 RLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG 808
+ GG+ L + ++ + ++ + +EYL + I+RDL N L+
Sbjct: 192 ELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYLESKCCIHRDLAARNCLVTEKN 250
Query: 809 HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPE 868
+ ++DF +S + +Q PV ++ APE
Sbjct: 251 VLKISDFGMSREEA---------DGVYAASGGLRQVPV----------------KWTAPE 285
Query: 869 IIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLH 926
+ ++S D W+ GILL+E G +P+ + Q+T + L P P ++
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF 345
Query: 927 AKQLMYRLLHRDPKSR 942
+LM + +P R
Sbjct: 346 --RLMEQCWAYEPGQR 359
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-22
Identities = 84/361 (23%), Positives = 138/361 (38%), Gaps = 80/361 (22%)
Query: 639 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQ---HFRPIKPLGSGDTGSVHLVELCGSGQ 695
+D K + G+ + + K +G+G G V+ +LC SG+
Sbjct: 21 SAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGE 80
Query: 696 YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT------HVCLITD 749
A+K K V+ ++ +R E +I+ LDH + L F + ++ L+ D
Sbjct: 81 LVAIK---K-VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 750 YCPGGELFLLLDRQP--TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807
Y P ++ + + L V+ Y ++ +L Y+H GI +RD+KP+N+LL +
Sbjct: 134 YVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD 192
Query: 808 -GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ L DF + + L+ EP S++ + Y A
Sbjct: 193 TAVLKLCDFGSA-------KQLVRG------------------EPNV---SYICSRYYRA 224
Query: 867 PEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANIL-------------- 911
PE+I GA TS++D W+ G +L E+L G F G + I+
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284
Query: 912 ---HKDLKFPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
+ + KFP A L RLL P +RL E H FF
Sbjct: 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFF 340
Query: 959 K 959
Sbjct: 341 D 341
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 62/276 (22%), Positives = 108/276 (39%), Gaps = 65/276 (23%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
REI L L H + LY TK + L+ ++ +L LLD L+ +
Sbjct: 47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKS 104
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ + Y H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA----------------- 147
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
R G P+R + T Y AP+++ G+ ++ +D W++G + EM+ G
Sbjct: 148 --RAFG--------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
Query: 895 YTPFRGKTR----QKTFANIL----------HKDL-----KFPSSTPTSL---------H 926
F G + + F IL +L F P
Sbjct: 198 TPLFPGVSEADQLMRIF-RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES 256
Query: 927 AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
L+ ++L DP R+ A + +H +FK N
Sbjct: 257 GIDLLSKMLKLDPNQRI----TAKQALEHAYFKENN 288
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 65/275 (23%), Positives = 113/275 (41%), Gaps = 66/275 (24%)
Query: 720 REI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
REI L L HP + +L ++ + L+ ++ +L +LD T L++ ++ Y
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYL 125
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ + + H I++RDLKP+N+L+ +G + L DF L+
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------------------- 166
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 896
R G P+R+ V T Y AP+++ G+ +++VD W++G + EM+ G
Sbjct: 167 RAFG--------IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
Query: 897 PFRGKTR----QKTFANIL----------------HKDLKFPSSTPTSL---------HA 927
F G T K F +IL K F
Sbjct: 219 LFPGVTDDDQLPKIF-SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEG 277
Query: 928 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
L+ +L DP R+ A + HP+FK ++
Sbjct: 278 IDLLSNMLCFDPNKRI----SARDAMNHPYFKDLD 308
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-21
Identities = 66/362 (18%), Positives = 122/362 (33%), Gaps = 86/362 (23%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKA 701
H H + + + + + + +G G G V + A+K
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDV-GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK 59
Query: 702 MDKGVMLNRNKVHRACAEREI--LDMLDHP--------FVPALYASFQTKTHVCLITDYC 751
+ ++ + REI L H + V ++ D
Sbjct: 60 ISP----FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLM 112
Query: 752 PGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVS 811
+L+ LL Q L D + ++ +++ L+Y+H +++RDLKP N+LL +
Sbjct: 113 -ETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 168
Query: 812 LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA 871
+ DF L+ + + F+ E +V T Y APEI+
Sbjct: 169 ICDFGLARVAD-----------------PDHDHTGFLTE-------YVATRWYRAPEIML 204
Query: 872 GAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILH------------------ 912
+ T ++D W++G +L EML F GK +IL
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 913 ------------KDLK--FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958
FP++ +L L+ ++L +P R+ + HP+
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALD---LLDKMLTFNPHKRI----EVEQALAHPYL 317
Query: 959 KG 960
+
Sbjct: 318 EQ 319
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 88/373 (23%), Positives = 149/373 (39%), Gaps = 80/373 (21%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
P + K + +GEQ + + K +G+G G V +L S + A+K
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIA-YTNCKVIGNGSFGVVFQAKLVESDE-VAIK--- 70
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH------VCLITDYCPGGELF 757
K V+ ++ +R E +I+ ++ HP V L A F + + L+ +Y P ++
Sbjct: 71 K-VLQDKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY 125
Query: 758 LLLD--RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTD 814
+ + + ++ Y +++ +L Y+H GI +RD+KP+N+LL G + L D
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F + + + S++ + Y APE+I GA
Sbjct: 186 FGSA-------------------KI---------LIAGEPNVSYICSRYYRAPELIFGAT 217
Query: 875 H-TSAVDWWALGILLYEMLYGYTPFRGKT-----------------RQKTFANILHKDLK 916
+ T+ +D W+ G ++ E++ G F G++ Q N + + K
Sbjct: 218 NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHK 277
Query: 917 FPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966
FP P A L+ RLL P +RL A E HPFF +
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL----TAIEALCHPFFDELRTGEA 333
Query: 967 RCMNPPELDAPLF 979
R N EL PLF
Sbjct: 334 RMPNGRELP-PLF 345
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 59/275 (21%), Positives = 98/275 (35%), Gaps = 68/275 (24%)
Query: 720 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 769
RE+ L+ +HP V L + + V L+ ++ +L LD+ P L
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ ++ + + L++LH I++RDLKPEN+L+ G V L DF L+
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA----------- 167
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
R M + V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------YQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFA 210
Query: 890 EMLYGYTPFRGKTRQKTFANILH----------------KDLKFPSSTPTSL-------- 925
EM F G + I FP P +
Sbjct: 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEME 270
Query: 926 -HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
QL+ +L +P R+ A +H +
Sbjct: 271 ESGAQLLLEMLTFNPHKRI----SAFRALQHSYLH 301
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 8e-21
Identities = 29/92 (31%), Positives = 51/92 (55%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+YA+ F +TGY S+EV+G+N L T + L + + G L+N +KD
Sbjct: 27 ILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVYQALWGRLAQKKPWSGVLVNRRKD 86
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
T + LT+AP+ ++ G+ + ++GM + S+
Sbjct: 87 KTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2gj3_A Nitrogen fixation regulatory protein; PAS domain, FAD, redox sensor, atomic resolution, transferase; HET: FAD; 1.04A {Azotobacter vinelandii} Length = 120 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 5e-16
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 5/116 (4%)
Query: 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATV 533
T+E ITD I++A+ +F +T Y EE+LG+N L T
Sbjct: 7 FRQTVEHAPIAISITDL---KANILYANRAFRTITGYGSEEVLGKNESILSNGTTPRLVY 63
Query: 534 RKIRAAIDNQTDV-TVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ + + Q + L+N K + + P+ ++ GE Y++G+ D SE
Sbjct: 64 QALWGRL-AQKKPWSGVLVNRRKDKTLYLAELTVAPVLNEAGETIYYLGMHRDTSE 118
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 75/332 (22%), Positives = 123/332 (37%), Gaps = 85/332 (25%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 726
+ ++ + P+GSG GSV +G A+K K ++ +H RE+ L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 727 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
H V L S + V L+T G +L ++ Q L +D V+F ++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQI 141
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L+Y+H II+RDLKP N+ + + + + DF L+ RH
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------RHT 182
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
M +V T Y APEI+ H VD W++G ++ E+L G T F
Sbjct: 183 AD----EMTG-------YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231
Query: 900 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 927
G IL + F + P ++
Sbjct: 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD- 290
Query: 928 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L+ ++L D R+ A + H +F
Sbjct: 291 --LLEKMLVLDSDKRI----TAAQALAHAYFA 316
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 69/337 (20%), Positives = 118/337 (35%), Gaps = 79/337 (23%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
F+ LG G G V +G+ A+K ++ + REI L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE--PF--DKPLFALRTLREIKILKH 65
Query: 726 LDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
H P + +F V +I + +L ++ Q L +D ++++
Sbjct: 66 FKHENIITIFNIQRPDSFENFN---EVYIIQELM-QTDLHRVISTQM---LSDDHIQYFI 118
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+ + A++ LH +I+RDLKP N+L+ N + + DF L+ +
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID----------ESAAD 168
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYT 896
+ M E FV T Y APE++ + + A+D W+ G +L E+
Sbjct: 169 NSEPTGQQSGMVE-------FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
Query: 897 PFRGK----------------TRQKTFANIL---------------HKDLK--FPSSTPT 923
F G+ I L+ FP P
Sbjct: 222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPK 281
Query: 924 SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ L+ R+L DP R+ A E +HP+ +
Sbjct: 282 GID---LLQRMLVFDPAKRI----TAKEALEHPYLQT 311
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 74/303 (24%)
Query: 720 REI-----LDMLDHPFVPALY-----ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLK 769
RE+ L+ +HP V L+ + +T + L+ ++ +L LD+ P +
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ ++ +++ L++LH +++RDLKP+N+L+ +G + L DF L+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA----------- 167
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
R M ++ V T Y APE++ + + + VD W++G +
Sbjct: 168 --------RIYS--------FQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 890 EMLYGYTPFRGKTRQKTFANILH----------------KDLKFPSSTPTSL-------- 925
EM FRG + IL F S + +
Sbjct: 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 270
Query: 926 -HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTE 984
K L+ + L +P R+ A HP+F+ + LD+ L +
Sbjct: 271 ELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLE------RCKENLDSHLPPSQNT 320
Query: 985 KEY 987
E
Sbjct: 321 SEL 323
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-20
Identities = 64/302 (21%), Positives = 113/302 (37%), Gaps = 36/302 (11%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
P K + P ++ LG G G V+ A+K +
Sbjct: 195 YPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 254
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDR 762
+ M +V E ++ + HP + L + +IT++ G L L +
Sbjct: 255 EDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 310
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
+V + A ++ A+EYL + I+R+L N L+ N V + DF LS
Sbjct: 311 NRQEVSAVVLLYM-ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---- 365
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
+L+ T + H G + P+ + APE +A + D W
Sbjct: 366 ---RLM---TGDTYTAHAGAKFPIK----------------WTAPESLAYNKFSIKSDVW 403
Query: 883 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPK 940
A G+LL+E+ YG +P+ G + + + ++ P P ++ +LM +P
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPS 461
Query: 941 SR 942
R
Sbjct: 462 DR 463
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 61/281 (21%), Positives = 110/281 (39%), Gaps = 71/281 (25%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV----LKED 771
A REI + L H + LY T+ + L+ ++ +L +D + L+ +
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELN 108
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
V+++ +++ L + H I++RDLKP+N+L+ G + L DF L+
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------------- 155
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYE 890
R G P+ +S V T Y AP+++ G+ ++++D W+ G +L E
Sbjct: 156 ------RAFG--------IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
Query: 891 MLYGYTPFRGKT--------------------------------RQKTFANILHKDLKFP 918
M+ G F G Q+ L + L+
Sbjct: 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH 261
Query: 919 SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ P + ++ LL +P RL A + HP+F
Sbjct: 262 TKEPLDGNLMDFLHGLLQLNPDMRL----SAKQALHHPWFA 298
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 65/322 (20%), Positives = 124/322 (38%), Gaps = 62/322 (19%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 719
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 897 PFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
P+ G + + + L + P ++ +M + D SR
Sbjct: 219 PYDGIPASEISSILEKGERLPQ----PPICTIDVY--MIMRKCWMIDADSR--------- 263
Query: 952 IKKHPFFKGVNWALVRCMNPPE 973
P F+ + + P+
Sbjct: 264 ----PKFRELIIEFSKMARDPQ 281
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-20
Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 631 EDLWANHSKVVHPKPHRKDSPPW---KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 687
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 143 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 202
Query: 688 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 203 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 256
Query: 748 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 315
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 316 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 349
Query: 867 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTS 924
PE T D W+ GILL E+ G P+ G ++ + + P P S
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409
Query: 925 LHAKQLMYRLLHRDPKSR 942
LH LM + ++P+ R
Sbjct: 410 LH--DLMCQCWRKEPEER 425
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 68/333 (20%), Positives = 117/333 (35%), Gaps = 58/333 (17%)
Query: 652 PWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML 708
P +++ ++ + + L ++ LG G G V E A+K + V+
Sbjct: 7 PLQSLTCLIGE-KDLRL-----LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60
Query: 709 NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTK 766
+ E + LDH + LY + ++T+ P G L L R+
Sbjct: 61 QPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQG 116
Query: 767 VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826
+ YA +V + YL + I+RDL N+LL V + DF L
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM-------- 168
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
LP ++ + ++ P + APE + + A D W G+
Sbjct: 169 RALPQNDDHYVMQEHRKVPF----------------AWCAPESLKTRTFSHASDTWMFGV 212
Query: 887 LLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDPKSRL 943
L+EM YG P+ G + I + L P P ++ +M + P+ R
Sbjct: 213 TLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY--NVMVQCWAHKPEDR- 269
Query: 944 GSHEGANEIKKHPFFKGVNWALVRCMNPPELDA 976
P F + L+ P ++ A
Sbjct: 270 ------------PTFVALRDFLLE-AQPTDMRA 289
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 63/342 (18%), Positives = 117/342 (34%), Gaps = 91/342 (26%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREI 722
+ + + SG G+V + G A+K + V + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 723 --LDMLDHP--------FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
L+ HP FV + + L+T+ +L ++ V+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMH---KLYLVTELM-RTDLAQVI-HDQRIVISPQH 135
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
++++ +++ L LH G+++RDL P N+LL N +++ DF+L+
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-------------- 181
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEM 891
R +V Y APE++ T VD W+ G ++ EM
Sbjct: 182 -----REDTADA--NKTH-------YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227
Query: 892 LYGYTPFRGKTRQKTFANILH-------------------------------KDLK--FP 918
FRG T I+ + P
Sbjct: 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287
Query: 919 SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
++ P +L L+ ++L +P+ R+ + +HP+F+
Sbjct: 288 TADPVALD---LIAKMLEFNPQRRI----STEQALRHPYFES 322
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 78/363 (21%), Positives = 122/363 (33%), Gaps = 90/363 (24%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 717
G +N F I+ +G G G V L + + +Y+A+K V+ N K R A
Sbjct: 26 SWKKGMLLN-NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAK 79
Query: 718 AEREILDML------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
E +IL + ++ V + F H+CLI + G L+ ++ R +
Sbjct: 80 IEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE 137
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
++ Y E++ AL YL + + DLKPEN+LL K Q+
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 832 TNEKK-----------RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880
+ K H S + T +Y APE+I G + D
Sbjct: 198 STGIKLIDFGCATFKSDYH----------------GSIINTRQYRAPEVILNLGWDVSSD 241
Query: 881 WWALGILLYEMLYGYTPFRG--------------------------KTRQKTFANILHKD 914
W+ G +L E+ G FR KT + N
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELK 301
Query: 915 LKFPSSTPTSLHAKQ------------------LMYRLLHRDPKSRLGSHEGANEIKKHP 956
L +P + + K +Y +L DP R E+ KH
Sbjct: 302 LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP----SPAELLKHK 357
Query: 957 FFK 959
F +
Sbjct: 358 FLE 360
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 60/277 (21%), Positives = 109/277 (39%), Gaps = 66/277 (23%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A REI L L H + L+ + + L+ ++C +L D L + V+
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKS 105
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+ +++ L + H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA----------------- 148
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
R G P+R ++ V T Y P+++ GA ++++D W+ G + E+
Sbjct: 149 --RAFGI--------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 895 YTP-FRGKTR----QKTFANIL----------HKDL----KFPSSTPT----------SL 925
P F G ++ F +L L +P T +
Sbjct: 199 GRPLFPGNDVDDQLKRIF-RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 926 HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962
+ L+ LL +P R+ A E +HP+F
Sbjct: 258 TGRDLLQNLLKCNPVQRI----SAEEALQHPYFSDFC 290
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 74/333 (22%), Positives = 130/333 (39%), Gaps = 85/333 (25%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 726
+R ++P+GSG G+V +G A+K + + ++++ A RE+ L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR---PFQSELFAKRAYRELRLLKHM 81
Query: 727 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
H V L + T L+ + G +L L+ + L ED ++F ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK---LGEDRIQFLVYQM 137
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L Y+H GII+RDLKP N+ + + + + DF L+ R
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-------------------RQA 178
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
M +V T Y APE+I T VD W++G ++ EM+ G T F+
Sbjct: 179 DS----EMTG-------YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227
Query: 900 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 927
G I+ KD +++P +++
Sbjct: 228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVN- 286
Query: 928 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
L+ ++L D + R+ A E HP+F+
Sbjct: 287 --LLEKMLVLDAEQRV----TAGEALAHPYFES 313
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 76/299 (25%), Positives = 111/299 (37%), Gaps = 68/299 (22%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A REI L L HP + L +F K+++ L+ D+ +L +++ L ++
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV-LTPSHIKA 116
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
Y + LEYLH I++RDLKP N+LL NG + L DF L+
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA----------------- 159
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
+ G P RA V T Y APE++ GA VD WA+G +L E+L
Sbjct: 160 --KSFG--------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
Query: 895 YTPFRGKTR----QKTFANIL----------HKDL----KFPSSTPTSLHAK-------- 928
G + + F L L F S LH
Sbjct: 210 VPFLPGDSDLDQLTRIF-ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL 268
Query: 929 -QLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 986
L+ L +P +R+ A + K +F +L P +T KE
Sbjct: 269 LDLIQGLFLFNPCARI----TATQALKMKYF----SNRPGPTPGCQLPRPNCPVETLKE 319
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 74/333 (22%), Positives = 128/333 (38%), Gaps = 86/333 (25%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDML 726
+ + +GSG GSV SG+ A+K + + ++++ A RE+ L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR---PFQSEIFAKRAYRELLLLKHM 80
Query: 727 DHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
H V L +S + L+ + +L ++ E+ +++ ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM-GLK---FSEEKIQYLVYQM 135
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ L+Y+H G+++RDLKP N+ + + + + DF L+ RH
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA-------------------RHA 176
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899
+ M +V T Y APE+I H VD W++G ++ EML G T F+
Sbjct: 177 DAE----MTG-------YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
Query: 900 GKTRQKTFANILH------------------------------KDLK--FPSSTPTSLHA 927
GK IL KD FP ++P +
Sbjct: 226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAAD- 284
Query: 928 KQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
L+ ++L D RL A + HPFF+
Sbjct: 285 --LLEKMLELDVDKRL----TAAQALTHPFFEP 311
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 65/307 (21%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG----SGQYFAMKAMDKGVMLNRNKVHRACAER 720
Q +H + ++ LG G+ GSV + +G+ A+K + + R E
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EI 62
Query: 721 EILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY 776
EIL L H + + ++ LI +Y P G L +L ++ + + + Y
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQY 119
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKK 836
+++ +EYL + I+RDL N+L++ V + DF L+ +LP E
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT--------KVLPQDKEFF 171
Query: 837 RRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML---- 892
+ + ++P+F + APE + + + A D W+ G++LYE+
Sbjct: 172 KVKEPGESPIF----------------WYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215
Query: 893 ------------YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLL 935
G + L + P P ++ +M
Sbjct: 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR----PDGCPDEIY--MIMTECW 269
Query: 936 HRDPKSR 942
+ + R
Sbjct: 270 NNNVNQR 276
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 46/309 (14%), Positives = 82/309 (26%), Gaps = 73/309 (23%)
Query: 643 PKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL---VELCGSGQYFAM 699
+P R+ S P +Q L G +I +R + G L + A+
Sbjct: 7 REPDRESSAPPDDVQ--LVPGARIANGRYRLLIFHGGVPPLQFWQALDTAL---DRQVAL 61
Query: 700 KAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
+D +L + + + L +D P V + T+ ++ ++ GG L +
Sbjct: 62 TFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEV 121
Query: 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819
D P+ A+R + A + H G+ P V + +G V L
Sbjct: 122 ADTSPSP---VGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP---- 173
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+
Sbjct: 174 -------------------------------------------ATMPDA-------NPQD 183
Query: 880 DWWALGILLYEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAK------QLMYR 933
D +G LY +L P + A +D P + + R
Sbjct: 184 DIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 934 LLHRDPKSR 942
+ D R
Sbjct: 243 SVQGDGGIR 251
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 69/318 (21%), Positives = 121/318 (38%), Gaps = 41/318 (12%)
Query: 631 EDLWANHSKVVHPKPHRKDSPPWK---AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHL 687
+ L A +SK HR + Q + +I + R LG G G V +
Sbjct: 226 QQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWM 285
Query: 688 VELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747
G+ + A+K + G M E +++ L H + LYA ++ + ++
Sbjct: 286 GTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIV 339
Query: 748 TDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
T+Y G L L + V AA++ + Y+ ++RDL+ N+L+
Sbjct: 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVGE 398
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
N + DF L+ +L+ + + +G + P+ + A
Sbjct: 399 NLVCKVADFGLA-------RLI---EDNEYTARQGAKFPIK----------------WTA 432
Query: 867 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTS 924
PE T D W+ GILL E+ G P+ G ++ + + P P S
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492
Query: 925 LHAKQLMYRLLHRDPKSR 942
LH LM + ++P+ R
Sbjct: 493 LH--DLMCQCWRKEPEER 508
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-19
Identities = 16/86 (18%), Positives = 37/86 (43%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+ + G + GY+ ++ +G+ L G +++ ++N + G + KD
Sbjct: 29 IIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGKWTGEIRMLHKD 88
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGM 299
G W PI + +++ +G+
Sbjct: 89 GHIGWIESMCVPIYGENYQMVGALGI 114
|
| >3lyx_A Sensory BOX/ggdef domain protein; structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 2.00A {Colwellia psychrerythraea} Length = 124 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 3e-17
Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 3/103 (2%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
V+TD II + L YS+E+ +G+ L P ++ +A++NQ
Sbjct: 21 VVTDL---QGFIIDWNKGSETLYGYSKEQAIGQPVNMLHVPGDTEHITSEVISAVENQGK 77
Query: 546 VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
T ++ K G W P+ + ++ +G+ D ++
Sbjct: 78 WTGEIRMLHKDGHIGWIESMCVPIYGENYQMVGALGINRDITK 120
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 61/336 (18%), Positives = 121/336 (36%), Gaps = 66/336 (19%)
Query: 636 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG--- 692
+H + + + + D + +H + ++ LG G+ GSV +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67
Query: 693 -SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA--SFQTKTHVCLITD 749
+G+ A+K + + R E EIL L H + + ++ LI +
Sbjct: 68 NTGEVVAVKKLQHSTEEHLRDFER---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 750 YCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807
Y P G L +L ++ + + + Y +++ +EYL + I+RDL N+L++
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE 181
Query: 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAP 867
V + DF L+ +LP E + + ++P+F + AP
Sbjct: 182 NRVKIGDFGLT--------KVLPQDKEYYKVKEPGESPIF----------------WYAP 217
Query: 868 EIIAGAGHTSAVDWWALGILLYEML----------------YGYTPFRGKTRQKTFANI- 910
E + + + A D W+ G++LYE+ G +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 911 ----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
L + P P ++ +M + + R
Sbjct: 278 NNGRLPR----PDGCPDEIY--MIMTECWNNNVNQR 307
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 58/256 (22%), Positives = 101/256 (39%), Gaps = 50/256 (19%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 717
I+ +GE+ + +G G G V ++ A+K ++ N+ A
Sbjct: 45 IVKNGEKWM-DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----IIKNKKAFLNQAQ 98
Query: 718 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
E +L+++ + V L F + H+CL+ + L+ LL + +
Sbjct: 99 IEVRLLELMNKHDTEMKYYIVH-LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 771 DAVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQ 826
+ R +A ++ AL +L II+ DLKPEN+LL + + DF SC
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC------- 209
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGI 886
GQ+ ++ + Y +PE++ G + A+D W+LG
Sbjct: 210 ------------QLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 887 LLYEMLYGYTPFRGKT 902
+L EM G F G
Sbjct: 247 ILVEMHTGEPLFSGAN 262
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-19
Identities = 68/341 (19%), Positives = 127/341 (37%), Gaps = 88/341 (25%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 117
Query: 726 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
++H + +L + + V L+ + L ++ + L + + + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QME---LDHERMSYLLYQ 172
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 211
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
+ M +V T Y APE+I G G+ VD W++G ++ EM+ F
Sbjct: 212 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264
Query: 900 GK-------------------------------------TRQKTFANILHKDLKFPSSTP 922
G+ TF + L S
Sbjct: 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 923 TSLHAKQ---LMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
L A Q L+ ++L DP R+ ++ +HP+
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINV 361
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 64/301 (21%), Positives = 108/301 (35%), Gaps = 56/301 (18%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAERE 721
+H + I LG G+ GSV L G A+K + + R E +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQ 76
Query: 722 ILDMLDHPFVPALYA-SFQTKTH-VCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
IL L F+ S+ + L+ +Y P G L FL ++ L + Y+
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYS 133
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+++ +EYL + ++RDL N+L++ HV + DF L+ LLP +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA--------KLLPLDKDYYV 185
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ Q+P+F + APE ++ + D W+ G++LYE+ Y
Sbjct: 186 VREPGQSPIF----------------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 897 PFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHRDPKS 941
P + P +H +LM P+
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH--ELMKLCWAPSPQD 287
Query: 942 R 942
R
Sbjct: 288 R 288
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 60/254 (23%), Positives = 105/254 (41%), Gaps = 48/254 (18%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHR-AC 717
+ + + + + +K +G G G V Q+ A+K ++ N + HR A
Sbjct: 88 VQVPHDHVAYR-YEVLKVIGKGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAA 141
Query: 718 AEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKE 770
E IL+ L + + +F + H+C+ + L+ L+ + +
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIH-MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 771 DAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGH--VSLTDFDLSCLTSCKPQLL 828
VR +A ++ L+ LH II+ DLKPEN+LL+ G + + DF SC
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH------ 253
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
V+ +++ + Y APE+I GA + +D W+LG +L
Sbjct: 254 ---------------QRVY---------TYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 889 YEMLYGYTPFRGKT 902
E+L GY G+
Sbjct: 290 AELLTGYPLLPGED 303
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 9e-19
Identities = 74/369 (20%), Positives = 115/369 (31%), Gaps = 104/369 (28%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 715
+ G+ + + + + LG G G V VE A+K ++ N K
Sbjct: 10 VCRIGDWLQ-ERYEIVGNLGEGTFGKV--VECLDHARGKSQVALK-----IIRNVGKYRE 61
Query: 716 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
A E +L + V + F H+C+ + G F L +
Sbjct: 62 AARLEINVLKKIKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQP 119
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
VR A ++ AL +LH + + DLKPEN+L +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILF------------------VNSEF 161
Query: 828 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
K K +N F E + V T Y PE+I G
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVILELGWAQ 218
Query: 878 AVDWWALGILLYEMLYGYTPFRGKT------------------------RQKTFANILHK 913
D W++G +L+E G+T F+ +QK F
Sbjct: 219 PCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFY---KG 275
Query: 914 DLKFPSSTPTSLHAKQ---------------------LMYRLLHRDPKSRLGSHEGANEI 952
L + ++ + K+ LM R+L DP R+ E
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI----TLAEA 331
Query: 953 KKHPFFKGV 961
HPFF G+
Sbjct: 332 LLHPFFAGL 340
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 68/308 (22%), Positives = 124/308 (40%), Gaps = 44/308 (14%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
K+ P K PW+ +I + + K LG+G G V + +
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAW------EIPRESLKLEKKLGAGQFGEVWMATYNKHTK-V 215
Query: 698 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELF 757
A+K M G M V AE ++ L H + L+A TK + +IT++ G L
Sbjct: 216 AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLL 270
Query: 758 -LLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
L + +K + F +A++ + ++ + I+RDL+ N+L+ + + DF
Sbjct: 271 DFLKSDEGSKQPLPKLIDF-SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
L+ +++ + + +G + P+ ++ APE I T
Sbjct: 330 LA-------RVI---EDNEYTAREGAKFPI----------------KWTAPEAINFGSFT 363
Query: 877 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRL 934
D W+ GILL E++ YG P+ G + + + + P + P L+ +M R
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY--NIMMRC 421
Query: 935 LHRDPKSR 942
P+ R
Sbjct: 422 WKNRPEER 429
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 68/341 (19%), Positives = 125/341 (36%), Gaps = 88/341 (25%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
L+ ++ +KP+GSG G V + A+K K +N+ H A RE+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 726 LDHPFVPALY------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
++H + L S + V ++ + L ++ + L + + + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI-QME---LDHERMSYLLYQ 135
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ +++LH GII+RDLKP N++++ + + + DF L+
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA--------------------- 174
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
+ M +V T Y APE+I G G+ VD W++G ++ EM+ G F
Sbjct: 175 RTAGTSFMMTP-------YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227
Query: 900 GK-------------------------------------TRQKTFANILHKDLKFPSSTP 922
G +F + L S
Sbjct: 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEH 287
Query: 923 TSLHAKQ---LMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
L A Q L+ ++L D R+ +E +HP+
Sbjct: 288 NKLKASQARDLLSKMLVIDASKRI----SVDEALQHPYINV 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 70/338 (20%), Positives = 120/338 (35%), Gaps = 92/338 (27%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-D 727
++ ++ LG G V + + +K +L K + E +IL+ L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRG 89
Query: 728 HPFVPALYA---SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
P + L ++T L+ ++ + L L + +RFY E++ AL
Sbjct: 90 GPNIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKAL 143
Query: 785 EYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+Y H GI++RD+KP NV++ + + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL-------------------------- 177
Query: 844 NPVFMAE---PMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP-F 898
AE P + N V + + PE++ ++D W+LG +L M++ P F
Sbjct: 178 -----AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232
Query: 899 RGK---------------------------TRQKTFANIL----HKDLK--FPSSTPTSL 925
G F +IL K + S +
Sbjct: 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLV 292
Query: 926 H--AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
A + +LL D +SRL A E +HP+F V
Sbjct: 293 SPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTV 326
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-18
Identities = 70/342 (20%), Positives = 120/342 (35%), Gaps = 94/342 (27%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV--HRACAEREI--- 722
+ F+ + G G G+V L + +G A+K KV RE+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----------KVIQDPRFRNRELQIM 70
Query: 723 --LDMLDHPFVPALYASFQTKTH-------VCLITDYCPGGELFLLLDRQPTK--VLKED 771
L +L HP + L + F T + ++ +Y P L +
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 772 AVRFYAAEVVVALEYLHCQ--GIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLL 828
++ + +++ ++ LH + +RD+KP NVL+ + +G + L DF +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA---------- 179
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGIL 887
+ P + +++ + Y APE+I G H T+AVD W++G +
Sbjct: 180 --------K----------KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 888 LYEMLYGYTPFRGKT-----------------RQKTFANILHKDLKFPSSTPTSLH---- 926
EM+ G FRG N H D+ +S
Sbjct: 222 FAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS 281
Query: 927 ---------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
A L+ LL P+ R+ E HP+F
Sbjct: 282 DHSLKDAKEAYDLLSALLQYLPEERM----KPYEALCHPYFD 319
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 68/367 (18%), Positives = 125/367 (34%), Gaps = 43/367 (11%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
S+ + + S A S QI + +G+G G V +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81
Query: 698 AMKAMDKGVMLNRNKVHRACAEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGE 755
A+K + + + + + REI L+ L+H V + + + D E
Sbjct: 82 AIKKILR---VFEDLIDCKRILREIAILNRLNHDHVVKVL-------DIVIPKDVEKFDE 131
Query: 756 LFLLLDRQPT---------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
L+++L+ + L E ++ ++V ++Y+H GI++RDLKP N L+
Sbjct: 132 LYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ V + DF L+ + R V T Y A
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRA 251
Query: 867 PEIIAGAGH-TSAVDWWALGILLYEMLYGYTP-----------FRGKTRQKTFANILHKD 914
PE+I + T A+D W++G + E+L F G + F +
Sbjct: 252 PELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS---CFPLSPDQK 308
Query: 915 LKFPSSTPTSLHAKQL--MYRLL---HRDPKSRLGSHEGANEIKKHPFFKGVNWA-LVRC 968
T + QL ++ +L + L + I+ P +G + A
Sbjct: 309 AGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA 368
Query: 969 MNPPELD 975
+ +
Sbjct: 369 SSADAIH 375
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 73/366 (19%), Positives = 127/366 (34%), Gaps = 98/366 (26%)
Query: 659 ILDSGEQINLQHFRPIKPLGSGDTGSVHLVE---LCGSGQYFAMKAMDKGVMLNRNKVHR 715
I SG+ ++ + + LG G G V VE G++ A+K ++ N ++
Sbjct: 5 ICQSGDVLS-ARYEIVDTLGEGAFGKV--VECIDHKAGGRHVAVK-----IVKNVDRYCE 56
Query: 716 -ACAEREILDML-------DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
A +E ++L+ L V + F+ H+C++ + G + +
Sbjct: 57 AARSEIQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP 114
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827
+ D +R A ++ ++ +LH + + DLKPEN+L +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILF------------------VQSDY 156
Query: 828 LLPTTNEKKRRHKGQQNPV----------FMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
+ KR + NP + E ++ V T Y APE+I G +
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVILALGWSQ 213
Query: 878 AVDWWALGILLYEMLYGYTPFRGKT------------------------RQKTFANIL-- 911
D W++G +L E G+T F ++K F +
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLD 273
Query: 912 --------------HKDLK--FPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955
K LK S L+ ++L DP R+ E KH
Sbjct: 274 WDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI----TLREALKH 329
Query: 956 PFFKGV 961
PFF +
Sbjct: 330 PFFDLL 335
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 72/364 (19%), Positives = 131/364 (35%), Gaps = 107/364 (29%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
G + + + + K LG+G G V V SG+ FA+K K V+ + +R E +I
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---K-VLQDPRYKNR---ELDI 53
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGG--------------------------EL 756
+ +LDH + L F T P L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 757 FLLLDRQPT-------------KVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803
++++ P + + + + Y ++ A+ ++H GI +RD+KP+N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 804 LQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
+ + L DF + + P S +++ +
Sbjct: 174 VNSKDNTLKLCDFGSA-------------------KK---------LIPSEPSVAYICSR 205
Query: 863 EYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTR-----------------Q 904
Y APE++ GA T ++D W++G + E++ G F G+T Q
Sbjct: 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ 265
Query: 905 KTFANILHKDLKFPSSTPTSLH----------AKQLMYRLLHRDPKSRLGSHEGANEIKK 954
N + +++FP+ A L+ ++L +P R+ E
Sbjct: 266 MIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI----NPYEAMA 321
Query: 955 HPFF 958
HPFF
Sbjct: 322 HPFF 325
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 36/281 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ LG G G V+ A+K + + M +V E ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 64
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELF-LLLDRQPTKVLKEDAVRFYAAEVVVA 783
+ HP + L + +IT++ G L L + +V + A ++ A
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSA 123
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+EYL + I+RDL N L+ N V + DF LS L + + H G +
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----------GDTYTAHAGAK 173
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
P+ ++ APE +A + D WA G+LL+E+ YG +P+ G
Sbjct: 174 FPI----------------KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 217
Query: 903 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + + ++ P P ++ +LM +P R
Sbjct: 218 LSQVYELLEKDYRMERPEGCPEKVY--ELMRACWQWNPSDR 256
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 74/315 (23%), Positives = 119/315 (37%), Gaps = 42/315 (13%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
K+ P+ + + + + +I K +GSGD+G V L GQ
Sbjct: 17 QGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQR 76
Query: 697 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPG 753
A+KA+ G + + +E I+ DHP + L ++T+Y
Sbjct: 77 DVPVAIKALKAGYTERQRR--DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134
Query: 754 GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLT 813
G L L + V V + YL G ++RDL NVL+ N ++
Sbjct: 135 GSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873
DF LS +L + G + P+ + APE IA
Sbjct: 194 DFGLSR--------VLEDDPDAAYTTTGGKIPI----------------RWTAPEAIAFR 229
Query: 874 GHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHA 927
+SA D W+ G++++E+L YG P+ T + +++ L P P +LH
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA----PMGCPHALH- 284
Query: 928 KQLMYRLLHRDPKSR 942
QLM H+D R
Sbjct: 285 -QLMLDCWHKDRAQR 298
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 21/241 (8%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL---D 724
L+ + +K LG G G V +G+ A+K K +N REI+ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTE 64
Query: 725 MLDHPFVPALYASFQTKT--HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ H + L + V L+ DY +L ++ L+ ++ +++
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQLIK 120
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQLLLPTTNEKKRRHKG 841
++YLH G+++RD+KP N+LL HV + DF LS + + + +
Sbjct: 121 VIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRG 900
+ + + +V T Y APEI+ G+ T +D W+LG +L E+L G F G
Sbjct: 181 DDDQPILTD-------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233
Query: 901 K 901
Sbjct: 234 S 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 41/287 (14%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAMDKGVMLNRNKVHRACAE 719
+ F+ IK LGSG G+V+ G+ A+K + + E
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDE 67
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
++ +D+P V L + V LIT P G L ++ R+ + + +
Sbjct: 68 AYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWC 123
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ + YL + +++RDL NVL++ HV +TDF L+ +LL EK+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA-------KLL--GAEEKEY 174
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+G + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 175 HAEGGKVPI----------------KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 897 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
P+ G + + + + L P ++ +M + D SR
Sbjct: 219 PYDGIPASEISSILEKGERLPQPPICTIDVY--MIMVKCWMIDADSR 263
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 63/338 (18%), Positives = 116/338 (34%), Gaps = 81/338 (23%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
+ +KPLG G G V + A+K K ++ + A REI +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---K--IVLTDPQSVKHALREIKIIRR 64
Query: 726 LDHPFVPALYASF--QTKTHVCLITDYCPGGELFLLLDRQPT--------KVLKEDAVRF 775
LDH + ++ + ++++ + T L E+ R
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLL-QGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+ +++ L+Y+H +++RDLKP N+ + + + + DF L+ +
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------------ 172
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
+ ++E + T+ Y +P ++ + T A+D WA G + EML
Sbjct: 173 -----PHYSHKGHLSE-------GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 894 GYTPFRGKTRQKTFANILH-----------------------------KDLK--FPSSTP 922
G T F G + IL K L P +
Sbjct: 221 GKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280
Query: 923 TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
++ + ++L P RL A E HP+
Sbjct: 281 EAVD---FLEQILTFSPMDRL----TAEEALSHPYMSI 311
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 60/279 (21%), Positives = 103/279 (36%), Gaps = 72/279 (25%)
Query: 718 AEREI--LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRF 775
A RE+ L L H + L + + LI +Y +L +D+ P + ++
Sbjct: 80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIKS 136
Query: 776 YAAEVVVALEYLHCQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLP 830
+ +++ + + H + ++RDLKP+N+LL + + DF L+
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------------ 184
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLY 889
R G P+R + T Y PEI+ G+ H +++VD W++ +
Sbjct: 185 -------RAFG--------IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229
Query: 890 EMLYGYTPFRGKTR----QKTFANIL----------HKDL-----KFPSSTPTSL----- 925
EML F G + K F +L L FP +L
Sbjct: 230 EMLMKTPLFPGDSEIDQLFKIF-EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLG 288
Query: 926 -----HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
L+ +L DP R+ A +HP+F
Sbjct: 289 ALLDDEGLDLLTAMLEMDPVKRI----SAKNALEHPYFS 323
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 61/274 (22%), Positives = 109/274 (39%), Gaps = 38/274 (13%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LGSG+ G+V A+K + + AE ++ LD+P++
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 81
Query: 733 ALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ 790
+ L+ + G L +L +R +K+ + +V + ++YL
Sbjct: 82 RMIG-ICEAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES 136
Query: 791 GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAE 850
++RDL NVLL + ++DF LS + L N K + G+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLS-------KALRADENYYKAQTHGKW------- 182
Query: 851 PMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFAN 909
P++ + APE I +S D W+ G+L++E YG P+RG + A
Sbjct: 183 PVK----------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 232
Query: 910 ILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + + P+ P ++ LM D ++R
Sbjct: 233 LEKGERMGCPAGCPREMY--DLMNLCWTYDVENR 264
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 60/341 (17%), Positives = 122/341 (35%), Gaps = 58/341 (17%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI--LDM 725
++ +G G G V+L + + A+K +++ + + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR---MFEDLIDCKRILREITILNR 81
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPT---------KVLKEDAVRFY 776
L ++ LY + + D EL+++L+ + L E+ ++
Sbjct: 82 LKSDYIIRLY-------DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTI 134
Query: 777 AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL--SCLTSCKPQLLLPTTNE 834
+++ ++H GII+RDLKP N LL + V + DF L + + ++
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLY 893
++ + + V T Y APE+I + T ++D W+ G + E+L
Sbjct: 195 EEPGPHNKNLKKQLTS-------HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 894 GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPK------------- 940
+ L FP S+ L + ++ + +
Sbjct: 248 MLQSHINDPTNR-------FPL-FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 941 -----SRLGSHEGANEIKKHPFFKGVNWA-LVRCMNPPELD 975
+ E IK P K +N ++ ++
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN 340
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 68/343 (19%), Positives = 124/343 (36%), Gaps = 52/343 (15%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
++ ++ + P Q +L +I+ K +G+G+ G V+ L S
Sbjct: 16 TTENLYFQGAMGSDPN----QAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK 71
Query: 697 F----AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752
A+K + G + E I+ H + L + +IT+Y
Sbjct: 72 KEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129
Query: 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSL 812
G L L + + V + ++YL ++RDL N+L+ N +
Sbjct: 130 NGALDKFLREKDGEFSVLQLVGM-LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 188
Query: 813 TDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG 872
+DF LS +L E G + P+ + APE I+
Sbjct: 189 SDFGLSR--------VLEDDPEATYTTSGGKIPI----------------RWTAPEAISY 224
Query: 873 AGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQL 930
TSA D W+ GI+++E++ YG P+ + + I L P P++++ QL
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY--QL 282
Query: 931 MYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPE 973
M + ++ R P F + L + + P+
Sbjct: 283 MMQCWQQERARR-------------PKFADIVSILDKLIRAPD 312
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 61/305 (20%), Positives = 104/305 (34%), Gaps = 61/305 (20%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 718
+ + I+ LG G G V L G A+K++ + G +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----K 72
Query: 719 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
E EIL L H + + + LI ++ P G L +L + +
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQL 129
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
YA ++ ++YL + ++RDL NVL++ V + DF L+ + T E
Sbjct: 130 KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT--------KAIETDKE 181
Query: 835 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
+ +PVF APE + + A D W+ G+ L+E+L
Sbjct: 182 YYTVKDDRDSPVFWY-----------------APECLMQSKFYIASDVWSFGVTLHELLT 224
Query: 893 YGYTPFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHR 937
Y + H + P + P ++ QLM +
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY--QLMRKCWEF 282
Query: 938 DPKSR 942
P +R
Sbjct: 283 QPSNR 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 63/310 (20%), Positives = 121/310 (39%), Gaps = 51/310 (16%)
Query: 639 KVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFA 698
+++ PK + SG +N++ + ++ +G G+ G V L G Y
Sbjct: 166 RLIKPKVMEGTVAAQDEFYR---SGWALNMKELKLLQTIGKGEFGDVML------GDYRG 216
Query: 699 MKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL 756
K K + + +A AE ++ L H + L + K + ++T+Y G L
Sbjct: 217 NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274
Query: 757 --FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
+L R + + + ++F + +V A+EYL ++RDL NVL+ + ++D
Sbjct: 275 VDYLR-SRGRSVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F L+ E + PV ++ APE +
Sbjct: 333 FGLTK--------------EASSTQDTGKLPV----------------KWTAPEALREKK 362
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMY 932
++ D W+ GILL+E+ +G P+ + + + P P +++ +M
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY--DVMK 420
Query: 933 RLLHRDPKSR 942
H D +R
Sbjct: 421 NCWHLDAATR 430
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 75/363 (20%), Positives = 131/363 (36%), Gaps = 61/363 (16%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMK 700
PH + P Q + + ++++ + K +G+G+ G V L + A+K
Sbjct: 24 DPHTFEDP----TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 701 AMDKGVML-NRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLL 759
+ G R E I+ DHP + L V ++T+Y G L
Sbjct: 80 TLKVGYTEKQRRDFLG---EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 760 LDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819
L + + V + ++YL G ++RDL N+L+ N ++DF L
Sbjct: 137 LRKHDAQFTVIQLVGM-LRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR 195
Query: 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+L E +G + P+ + +PE IA TSA
Sbjct: 196 --------VLEDDPEAAYTTRGGKIPI----------------RWTSPEAIAYRKFTSAS 231
Query: 880 DWWALGILLYEML-YGYTPFRGKTRQKTFANI-----LHKDLKFPSSTPTSLHAKQLMYR 933
D W+ GI+L+E++ YG P+ + Q + L P P +L+ QLM
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP----PMDCPAALY--QLMLD 285
Query: 934 LLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPG 993
+D +R P F+ + L + + P + + ++D
Sbjct: 286 CWQKDRNNR-------------PKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQS 332
Query: 994 MQD 996
D
Sbjct: 333 NVD 335
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 7e-17
Identities = 64/318 (20%), Positives = 117/318 (36%), Gaps = 35/318 (11%)
Query: 630 PEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKP-LGSGDTGSVHLV 688
P + + P P+ +++ D + + LG G+ GSV
Sbjct: 296 PARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQG 355
Query: 689 ELCGSGQYF--AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746
+ A+K + +G + E +I+ LD+P++ L + L
Sbjct: 356 VYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIVRLIG-VCQAEALML 412
Query: 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG 806
+ + GG L L + + V +V + ++YL + ++R+L NVLL
Sbjct: 413 VMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
Query: 807 NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIA 866
+ ++DF LS + L + R G+ P++ + A
Sbjct: 472 RHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK----------WYA 507
Query: 867 PEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTS 924
PE I +S D W+ G+ ++E L YG P++ + A I K ++ P P
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 567
Query: 925 LHAKQLMYRLLHRDPKSR 942
L+ LM + R
Sbjct: 568 LY--ALMSDCWIYKWEDR 583
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-17
Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 44/284 (15%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
I+ ++ +GSG G VHL + A+K + +G M E E++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAM----SEEDFIEEAEVMM 58
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + LY + +CL+T++ G L L Q E + +V +
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM-CLDVCEGM 117
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
YL +I+RDL N L+ N + ++DF ++ +++ G +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF----------VLDDQYTSSTGTKF 167
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV ++ +PE+ + + ++S D W+ G+L++E+ G P+ ++
Sbjct: 168 PV----------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211
Query: 904 QKTFANI-----LHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ +I L+K P T ++ Q+M P+ R
Sbjct: 212 SEVVEDISTGFRLYK----PRLASTHVY--QIMNHCWRERPEDR 249
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 70/340 (20%), Positives = 110/340 (32%), Gaps = 76/340 (22%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACA 718
+ ++ + I+ LG G G V L + A+KA+ D G
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK----Q 82
Query: 719 EREILDMLDHPFVPALYA--SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
E +IL L H + + L+ +Y P G L +L L
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLL---- 138
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
+A ++ + YLH Q I+RDL NVLL + V + DF L+ +P +E
Sbjct: 139 -FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA--------KAVPEGHE 189
Query: 835 KKRRHKGQQNPVF-MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
R + +PVF APE + A D W+ G+ LYE+L
Sbjct: 190 YYRVREDGDSPVFWY-----------------APECLKEYKFYYASDVWSFGVTLYELLT 232
Query: 893 YGYTPFRGKTRQKTFANILHKDLKF---------------PSSTPTSLHAKQLMYRLLHR 937
+ + T+ I + P P ++ LM
Sbjct: 233 HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY--HLMKNCWET 290
Query: 938 DPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAP 977
+ R P F+ + L + AP
Sbjct: 291 EASFR-------------PTFENLIPILKTVHEKYQGQAP 317
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 68/302 (22%), Positives = 122/302 (40%), Gaps = 51/302 (16%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KP +D W ++ + + ++ LG+G G V + G + A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLK 46
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL-DR 762
+G M + AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSMSPDAFL----AEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTP 101
Query: 763 QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
K+ + AA++ + ++ + I+RDL+ N+L+ + DF L+
Sbjct: 102 SGIKLTINKLLDM-AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA---- 156
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
+L+ +G + P+ ++ APE I T D W
Sbjct: 157 ---RLIEDNEYT---AREGAKFPI----------------KWTAPEAINYGTFTIKSDVW 194
Query: 883 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPK 940
+ GILL E++ +G P+ G T + N+ + P + P L+ QLM P+
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY--QLMRLCWKERPE 252
Query: 941 SR 942
R
Sbjct: 253 DR 254
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 56/287 (19%), Positives = 106/287 (36%), Gaps = 45/287 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYF----AMKAM--DKGVMLNRNKVHRACAE 719
R +K LGSG G+VH G+ +K + G +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT----DH 65
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYA 777
+ LDH + L + + L+T Y P G L + RQ L + +
Sbjct: 66 MLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWG 121
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
++ + YL G+++R+L NVLL+ V + DF ++ L ++K+
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP---------PDDKQL 172
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
+ + P+ +++A E I +T D W+ G+ ++E++ +G
Sbjct: 173 LYSEAKTPI----------------KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 897 PFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
P+ G + + + L P ++ +M + D R
Sbjct: 217 PYAGLRLAEVPDLLEKGERLAQPQICTIDVY--MVMVKCWMIDENIR 261
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 74/316 (23%), Positives = 120/316 (37%), Gaps = 54/316 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 721
+I + + +G G G VH A+K + + + E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEAL 68
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 779
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 69 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQ 124
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 177
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 178 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
Query: 899 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+G I + + L P + P +L+ LM + DP R P
Sbjct: 219 QGVKNNDVIGRIENGERLPMPPNCPPTLY--SLMTKCWAYDPSRR-------------PR 263
Query: 958 FKGVNWALVRCMNPPE 973
F + L + +
Sbjct: 264 FTELKAQLSTILEEEK 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-16
Identities = 75/317 (23%), Positives = 121/317 (38%), Gaps = 54/317 (17%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAERE 721
+I + + +G G G VH A+K + + + E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE--KFLQEAL 443
Query: 722 ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAE 779
+ DHP + L T+ V +I + C GEL FL + L ++ YA +
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQ 499
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ AL YL + ++RD+ NVL+ N V L DF LS + + +T K +
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKG 552
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
K P++ ++APE I TSA D W G+ ++E+L +G PF
Sbjct: 553 K---------LPIK----------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593
Query: 899 RGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+G I + + L P + P +L+ LM + DP R P
Sbjct: 594 QGVKNNDVIGRIENGERLPMPPNCPPTLY--SLMTKCWAYDPSRR-------------PR 638
Query: 958 FKGVNWALVRCMNPPEL 974
F + L + +L
Sbjct: 639 FTELKAQLSTILEEEKL 655
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 59/280 (21%), Positives = 107/280 (38%), Gaps = 36/280 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + +K LGSG G V L + G A+K + +G M E + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSM----SEDEFFQEAQTMM 58
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L HP + Y + + ++T+Y G L L + + +V +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM-CYDVCEGM 117
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+L I+RDL N L+ + V ++DF ++ +++ G +
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY----------VLDDQYVSSVGTKF 167
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV ++ APE+ ++S D WA GIL++E+ G P+ T
Sbjct: 168 PV----------------KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211
Query: 904 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + L P +++ Q+MY H P+ R
Sbjct: 212 SEVVLKVSQGHRLYRPHLASDTIY--QIMYSCWHELPEKR 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 46/281 (16%)
Query: 674 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 726
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 83
Query: 727 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 783
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 84 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 140
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
++YL + ++RDL N +L V + DF L+ + + G +
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEYYSVHNKTGAK 193
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 194 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237
Query: 903 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+L L P P L+ ++M + H + R
Sbjct: 238 TFDITVYLLQGRRLLQPEYCPDPLY--EVMLKCWHPKAEMR 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 60/271 (22%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 677 LGSGDTGSVHLVELCGSGQYF--AMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPA 733
LG G+ GSV + A+K + +G E +I+ LD+P++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVR 74
Query: 734 LYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGII 793
L Q + + L+ + GG L L + ++ + +V + ++YL + +
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL-LHQVSMGMKYLEEKNFV 132
Query: 794 YRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMR 853
+RDL NVLL + ++DF LS + L + R G+ P++
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLS-------KALGADDSYYTARSAGKW-------PLK 178
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH 912
+ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 179 ----------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228
Query: 913 KD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
++ P P L+ LM + R
Sbjct: 229 GKRMECPPECPPELY--ALMSDCWIYKWEDR 257
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 63/284 (22%), Positives = 99/284 (34%), Gaps = 72/284 (25%)
Query: 718 AEREI--LDMLDHPFVPALY--------ASFQTKTHVCLITDYCPGGELFLLLDRQPTKV 767
A REI L +L H V L + K + L+ D+C +L LL K
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK- 120
Query: 768 LKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS-CLTSCKPQ 826
++ ++ L Y+H I++RD+K NVL+ +G + L DF L+ + K
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALG 885
TN V T Y PE++ G +D W G
Sbjct: 181 QPNRYTNR------------------------VVTLWYRPPELLLGERDYGPPIDLWGAG 216
Query: 886 ILLYEMLYGYTPFRGKTRQKTFANI-------------------LHKDLKFPSSTPTSL- 925
++ EM +G T Q A I L++ L+ +
Sbjct: 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVK 276
Query: 926 ----------HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+A L+ +LL DP R+ +++ H FF
Sbjct: 277 DRLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDALNHDFFW 316
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 46/281 (16%)
Query: 674 IKPLGSGDTGSVH---LVELCGSGQYFAMKAMDKGVMLNRNKVHRACA----EREILDML 726
+ +G G G V+ L++ G + A+K LNR + E I+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVK------SLNRITDIGEVSQFLTEGIIMKDF 147
Query: 727 DHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVA 783
HP V +L +++ ++ Y G+L F+ + V +D + F +V
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGF-GLQVAKG 204
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+++L + ++RDL N +L V + DF L+ + + + G +
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEFDSVHNKTGAK 257
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKT 902
PV +++A E + T+ D W+ G+LL+E++ G P+
Sbjct: 258 LPV----------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 903 RQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+L L P P L+ ++M + H + R
Sbjct: 302 TFDITVYLLQGRRLLQPEYCPDPLY--EVMLKCWHPKAEMR 340
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 62/293 (21%), Positives = 116/293 (39%), Gaps = 44/293 (15%)
Query: 654 KAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKV 713
A + SG +N++ + ++ +G G+ G V L + G A+K + +
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVK------CIKNDAT 57
Query: 714 HRA-CAEREILDMLDHPFVPALYAS-FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKED 771
+A AE ++ L H + L + K + ++T+Y G L L + VL D
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 772 AVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPT 831
+ ++ +V A+EYL ++RDL NVL+ + ++DF L+
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------------- 164
Query: 832 TNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEM 891
E + PV ++ APE + ++ D W+ GILL+E+
Sbjct: 165 -KEASSTQDTGKLPV----------------KWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 892 L-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+G P+ + + + P P +++ ++M H D R
Sbjct: 208 YSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY--EVMKNCWHLDAAMR 258
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 69/306 (22%), Positives = 119/306 (38%), Gaps = 49/306 (16%)
Query: 649 DSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKG 705
DS ++ +L E++ + +G G G V+ E Q A+K
Sbjct: 4 DSALLAEVKDVLIPHERVVTHS---DRVIGKGHFGVVYHGEYIDQAQNRIQCAIK----- 55
Query: 706 VMLNRNKVHRACA----EREILDMLDHPFVPALYA-SFQTKTHVCLITDYCPGGEL--FL 758
L+R + E ++ L+HP V AL + ++ Y G+L F+
Sbjct: 56 -SLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114
Query: 759 LLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
++ V +D + F +V +EYL Q ++RDL N +L + V + DF L+
Sbjct: 115 RSPQRNPTV--KDLISF-GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
+ +L ++H+ + PV ++ A E + T+
Sbjct: 172 -------RDILDREYYSVQQHRHARLPV----------------KWTALESLQTYRFTTK 208
Query: 879 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLH 936
D W+ G+LL+E+L G P+R + L P P SL+ Q+M +
Sbjct: 209 SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY--QVMQQCWE 266
Query: 937 RDPKSR 942
DP R
Sbjct: 267 ADPAVR 272
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 63/280 (22%), Positives = 109/280 (38%), Gaps = 36/280 (12%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
+I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMM 74
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
L H + LY + + +IT+Y G L L + + + +V A+
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM-CKDVCEAM 133
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + ++RDL N L+ G V ++DF LS + +L G +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS-------RYVLDDEYT---SSVGSKF 183
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTR 903
PV + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 184 PV----------------RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227
Query: 904 QKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+T +I L P ++ +MY H R
Sbjct: 228 SETAEHIAQGLRLYRPHLASEKVY--TIMYSCWHEKADER 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 78.7 bits (193), Expect = 7e-15
Identities = 114/691 (16%), Positives = 190/691 (27%), Gaps = 232/691 (33%)
Query: 192 KDALSTFQQTFV-------VSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAG 244
KD LS F+ FV V D K I+ + +E+
Sbjct: 19 KDILSVFEDAFVDNFDCKDVQDMPKS---IL------------SKEEI------------ 51
Query: 245 TDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + ++ + + RL FW LL+ K +E V KF+
Sbjct: 52 ---DHIIMSKDAVS--GTL--RL---------FWTLLS----KQEEM-VQKFVE------ 84
Query: 305 KHTEGAKDKMLRPN-GLPESLIRYDARQKEMATSSVTELVQAMKK-PRSLSE-STNRPPI 361
++LR N S I+ + RQ M T E + + ++ + +R
Sbjct: 85 --------EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 362 IRKSEGGVEEERA-------GALGRRKS-------ENVPPPRRNSYG------GGCRTSM 401
K + E R G LG K+ + + + C +
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 402 QRISEVPEKKKQKSGRRSFMGLIGRKSQSTDDHDS---FENEIIMEGDDDYESDDERPDS 458
+ + QK + I S DH S I +
Sbjct: 197 TVL-----EMLQK-----LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246
Query: 459 ---VDDKVRQKEMRKGID-----LATTLERIEKNFVITDPRLPDNPIIFASDSFLE-LTE 509
+ + V+ + + L TT + +TD + D LT
Sbjct: 247 LLVLLN-VQNAKAWNAFNLSCKILLTT-----RFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 510 YSREEILGR--NCRFLQGPE----TDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563
+ +L + +CR P T+P + I +I + G W+
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI--------------RDGLATWDN 346
Query: 564 FHLQPMRDQKGEVQYFIGVQLDGSEHLEP--LRNS------------IPEAT-------- 601
+ D+ + I L LEP R IP
Sbjct: 347 W-KHVNCDKLTTI---IESSL---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 602 -AEESE----KLVKQT--AENVNEAVKELPDANL----TPEDLWANHSKVVHPKPHRKDS 650
+ KL K + + E+ +P L E+ +A H +V K
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 651 PPWKAIQKILDSGEQIN--LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML 708
I LD H +G HL + + M V L
Sbjct: 460 DSDDLIPPYLD-----QYFYSH------IGH------HLKN-IEHPERMTLFRM---VFL 498
Query: 709 N----RNKVHRA----CAEREILDML-DHPFVPALYASFQTKTH------VCLITDYCPG 753
+ K+ A IL+ L F Y + V I D+ P
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKF----YKPYICDNDPKYERLVNAILDFLPK 554
Query: 754 GELFLLLDR----------QPTKVLKEDAVR 774
E L+ + + + E+A +
Sbjct: 555 IEENLICSKYTDLLRIALMAEDEAIFEEAHK 585
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 8e-09
Identities = 68/489 (13%), Positives = 140/489 (28%), Gaps = 145/489 (29%)
Query: 560 FWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQTAENVNEA 619
FW L + Q+ VQ F+ E L + E +Q +
Sbjct: 68 FWTL-----LSKQEEMVQKFVE------EVLRINYKFLMSPIKTEQ----RQPSMMTRMY 112
Query: 620 VKELPDANLTPEDLWANHSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPL-- 677
+++ + L+ N ++V K + P+ +++ L RP K +
Sbjct: 113 IEQR-------DRLY-NDNQVF-AKYNVSRLQPYLKLRQ--------ALLELRPAKNVLI 155
Query: 678 -GSGDTG-SVHLVELCGSGQYFAMKAMDKGVM-LNRNKVHRACAEREILDMLDHPFVPAL 734
G +G + +++C S Y MD + LN + +L+ML L
Sbjct: 156 DGVLGSGKTWVALDVCLS--YKVQCKMDFKIFWLNLKNCNS---PETVLEMLQ-----KL 205
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
++ + + + ++ + R ++ Y +C ++
Sbjct: 206 LYQIDP--------NWTSRSDHSSNI-KLRIHSIQAELRRLLKSK-----PYENCL-LVL 250
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEK---------KRRHK--GQQ 843
+++ F+LSC ++LL TT K H
Sbjct: 251 LNVQNAKAW---------NAFNLSC------KILL-TTRFKQVTDFLSAATTTHISLDHH 294
Query: 844 NPVFM-AEPMRASNSFVGTEEY--------IAPEIIAGAG-----HTSAVDWW------A 883
+ E ++ P ++ + D W
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK 354
Query: 884 LGILL---YEMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSL-----------HAKQ 929
L ++ +L P + + + P+ + + +
Sbjct: 355 LTTIIESSLNVL---EPAEYRKMFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 930 LM-YRLLHRDPK-SRLGSH--------EGANEIKKHPFFKGVNWALVRCMNPPE-LDAPL 978
L Y L+ + PK S + + NE H ++V N P+ D+
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR-------SIVDHYNIPKTFDSDD 463
Query: 979 FATDTEKEY 987
+Y
Sbjct: 464 LIPPYLDQY 472
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 67/298 (22%), Positives = 101/298 (33%), Gaps = 67/298 (22%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVML-NRNKVHRACAER 720
I + + LG G G V+ A+K K L N+ K E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EA 64
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAA 778
I+ LDHP + L + +I + P GEL +L + LK + Y+
Sbjct: 65 VIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSL 120
Query: 779 EVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
++ A+ YL ++RD+ N+L+ V L DF LS
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS-------------------- 160
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYI------------APEIIAGAGHTSAVDWWALGI 886
R + E+Y +PE I T+A D W +
Sbjct: 161 --------------RY----IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 887 LLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
++E+L +G PF + + D L P P L+ LM R DP R
Sbjct: 203 CMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY--TLMTRCWDYDPSDR 258
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 49/324 (15%), Positives = 95/324 (29%), Gaps = 68/324 (20%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF-------AMKAMDKGVMLNRNKVHRAC 717
+I + + LG G + G Y +K +DK
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-- 61
Query: 718 AEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYA 777
++ L H + Y L+ ++ G L L + + + A
Sbjct: 62 -AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV-A 119
Query: 778 AEVVVALEYLHCQGIIYRDLKPENVLLQG--------NGHVSLTDFDLSCLTSCKPQLLL 829
++ A+ +L +I+ ++ +N+LL + L+D +S +L
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVL 172
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILL 888
P ++ + ++ PE I + A D W+ G L
Sbjct: 173 PKDILQE--------------RIP----------WVPPECIENPKNLNLATDKWSFGTTL 208
Query: 889 YEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE 947
+E+ G P Q+ + P+ L L+ + +P R
Sbjct: 209 WEICSGGDKPLSALDSQRKLQFY-EDRHQLPAPKAAELA--NLINNCMDYEPDHR----- 260
Query: 948 GANEIKKHPFFKGVNWALVRCMNP 971
P F+ + L P
Sbjct: 261 --------PSFRAIIRDLNSLFTP 276
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 67/295 (22%), Positives = 118/295 (40%), Gaps = 50/295 (16%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF---AMKAMDKGVMLNRNKVHRACAER 720
+Q L + LG G+ GSV +L F A+K + ++ + + E
Sbjct: 23 QQFTL-----GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREA 76
Query: 721 EILDMLDHPFVPALYA------SFQTKTHVCLITDYCPGGEL--FLLLDR---QPTKVLK 769
+ DHP V L + +I + G+L FLL R P +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ VRF ++ +EYL + I+RDL N +L + V + DF LS +
Sbjct: 137 QTLVRF-MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS--------RKI 187
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
+ + ++ + P++ ++A E +A +T D WA G+ ++
Sbjct: 188 YSGDYYRQGCASKL-------PVK----------WLALESLADNLYTVHSDVWAFGVTMW 230
Query: 890 EML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
E++ G TP+ G + + ++ + LK P ++ LMY+ DPK R
Sbjct: 231 EIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVY--DLMYQCWSADPKQR 283
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 70/354 (19%), Positives = 119/354 (33%), Gaps = 93/354 (26%)
Query: 692 GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH--VCLITD 749
+ +A+K ++ + AC E +L L HP V +L F + V L+ D
Sbjct: 46 KDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100
Query: 750 YCPGGELFLLLDRQPTKVLKEDAVRFYAAEV-------VVALEYLHCQGIIYRDLKPENV 802
Y +L+ ++ + V+ V + + YLH +++RDLKP N+
Sbjct: 101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 159
Query: 803 LLQG----NGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSF 858
L+ G G V + D + R +P+ +P+ +
Sbjct: 160 LVMGEGPERGRVKIADMGFA-------------------RLFN--SPL---KPLADLDPV 195
Query: 859 VGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKT--------------- 902
V T Y APE++ GA H T A+D WA+G + E+L F +
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255
Query: 903 ------------------------------RQKTFANILHKDLKFPSSTPTSLHAKQLMY 932
R+ T+ N A L+
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315
Query: 933 RLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 986
+LL DP R+ + + + P+F ++ P TE+E
Sbjct: 316 KLLTMDPIKRI----TSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEE 365
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 54/260 (20%), Positives = 103/260 (39%), Gaps = 42/260 (16%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
+R + +GSG G ++L +G+ A+K + K + E +I M+
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGG 64
Query: 729 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+P + + ++ + G +LF R+ + LK V A +++ +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFS--LK--TVLLLADQMISRI 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
EY+H + I+RD+KP+N L+ V + DF L+ + + +H
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK----------KYRDARTHQHI- 167
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG- 900
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 168 ---------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
Query: 901 --KTRQKTFANILHKDLKFP 918
T+++ + I K + P
Sbjct: 219 KAATKRQKYERISEKKMSTP 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 55/263 (20%), Positives = 101/263 (38%), Gaps = 46/263 (17%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 65
Query: 729 PFVPALYASFQTKTHVCLITDYCPG---GELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
+P +Y Q H L+ D G +L L R+ + +K V A +++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFS--VK--TVAMAAKQMLARVQ 120
Query: 786 YLHCQGIIYRDLKPENVLL-QGNGH----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+H + ++YRD+KP+N L+ + N + + DF + K R
Sbjct: 121 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV----------------KFYRDP 164
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV--DWWALGILLYEMLYGYTPF 898
+ + P R + GT Y++ I G + D ALG + L G P+
Sbjct: 165 VTKQHI----PYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218
Query: 899 RG---KTRQKTFANILHKDLKFP 918
+G T ++ + I K P
Sbjct: 219 QGLKAATNKQKYERIGEKKQSTP 241
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 65/321 (20%), Positives = 113/321 (35%), Gaps = 65/321 (20%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
LG G G V L E A+KA+ + R R E E+L ML H
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTMLQH 102
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FL------------LLDRQPTKVLKEDAVR 774
+ + + ++ +Y G+L FL D P + +
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 775 FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNE 834
A++V + YL ++RDL N L+ V + DF +S + +T+
Sbjct: 163 V-ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--------RDIYSTDY 213
Query: 835 KKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-Y 893
+ + P+R ++ PE I T+ D W+ G++L+E+ Y
Sbjct: 214 YRVGGRTML-------PIR----------WMPPESILYRKFTTESDVWSFGVVLWEIFTY 256
Query: 894 GYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952
G P+ + + I ++L+ P + P ++ +M R+P+ R
Sbjct: 257 GKQPWYQLSNTEAIDCITQGRELERPRACPPEVY--AIMRGCWQREPQQR---------- 304
Query: 953 KKHPFFKGVNWALVRCMNPPE 973
K V+ L P
Sbjct: 305 ---HSIKDVHARLQALAQAPP 322
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 69/321 (21%), Positives = 123/321 (38%), Gaps = 49/321 (15%)
Query: 637 HSKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQY 696
H R ++ ++ + L K LG G+ GSV L
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLIL-----GKILGEGEFGSVMEGNLKQEDGT 61
Query: 697 F---AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYA-----SFQTKTHVCLIT 748
A+K M ++ ++ +E + HP V L S Q +I
Sbjct: 62 SLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 749 DYCPGGEL--FLLLDR---QPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803
+ G+L +LL R P + + ++F ++ + +EYL + ++RDL N +
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF-MVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 804 LQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEE 863
L+ + V + DF LS + + + ++ + P++
Sbjct: 180 LRDDMTVCVADFGLS--------KKIYSGDYYRQGRIAKM-------PVK---------- 214
Query: 864 YIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSST 921
+IA E +A +TS D WA G+ ++E+ G TP+ G + + +LH LK P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDC 274
Query: 922 PTSLHAKQLMYRLLHRDPKSR 942
L+ ++MY DP R
Sbjct: 275 LDELY--EIMYSCWRTDPLDR 293
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/328 (17%), Positives = 117/328 (35%), Gaps = 59/328 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
+ LG G G V+ G + A+K +++ + R + E ++ +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EASVMKEFN 86
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR------FYAAE 779
V L +I + G+L +L R A A E
Sbjct: 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
+ + YL+ ++RDL N ++ + V + DF ++ + T+ ++
Sbjct: 147 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT--------RDIYETDYYRKGG 198
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPF 898
KG P+R +++PE + T+ D W+ G++L+E+ P+
Sbjct: 199 KGLL-------PVR----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 241
Query: 899 RGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
+G + ++ ++ L P + P L +LM +PK R P
Sbjct: 242 QGLSNEQVLRFVMEGGLLDKPDNCPDMLF--ELMRMCWQYNPKMR-------------PS 286
Query: 958 FKGVNWALVRCMNPPELDAPLFATDTEK 985
F + ++ M P + + ++ K
Sbjct: 287 FLEIISSIKEEMEPGFREVSFYYSEENK 314
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 61/324 (18%), Positives = 116/324 (35%), Gaps = 64/324 (19%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 91
Query: 728 HPFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEV 780
H + S Q+ ++ + GG+L FL R QP+ + D + A ++
Sbjct: 92 HQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDI 149
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKR 837
+YL I+RD+ N LL G + DF ++ + + ++
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRASYYRK 201
Query: 838 RHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYT 896
P++ ++ PE TS D W+ G+LL+E+ GY
Sbjct: 202 GGCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244
Query: 897 PFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955
P+ K+ Q+ + + P + P ++ ++M + P+ R
Sbjct: 245 PYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY--RIMTQCWQHQPEDR------------- 289
Query: 956 PFFKGVNWALVRCM-NPPELDAPL 978
P F + + C +P ++ L
Sbjct: 290 PNFAIILERIEYCTQDPDVINTAL 313
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 62/291 (21%), Positives = 107/291 (36%), Gaps = 53/291 (18%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ LG G G V L E A+KA+ + R R E E+L L H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNLQH 76
Query: 729 PFVPALYA-SFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR----------- 774
+ Y + ++ +Y G+L FL +L + R
Sbjct: 77 EHIVKFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 775 -FYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
A+++ + YL Q ++RDL N L+ N V + DF +S + +T+
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS--------RDVYSTD 187
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
+ P+R ++ PE I T+ D W+ G++L+E+
Sbjct: 188 YYRVGGHTML-------PIR----------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 893 YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
YG P+ + + I + L+ P P ++ +M R+P+ R
Sbjct: 231 YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY--DVMLGCWQREPQQR 279
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-12
Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 2/87 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAK-IRETLQNGQSYCGRLLNYKK 272
I + + +++GR+ L + + E + + I + SY + +
Sbjct: 24 IEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDRIMKRA 83
Query: 273 DGTPFWNLLTIAPIKDDEGKVLKFIGM 299
G FW +T + D + +
Sbjct: 84 GGELFWCHVTGRAL-DRTAPLAAGVWT 109
|
| >3mqq_A Transcriptional regulator, LUXR family; PAS domain, PSI, MCSG, structural genomics, center for structural genomics; 1.65A {Burkholderia thailandensis} PDB: 3mqo_A Length = 120 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 6e-10
Identities = 14/95 (14%), Positives = 30/95 (31%), Gaps = 2/95 (2%)
Query: 492 LPDNPIIFASDSFLELTEYSREEILGRNCRFLQ-GPETDPATVRKIRAAIDNQTDVTVQL 550
D I +D + +R +++GR+ L + +I +
Sbjct: 19 SRDRVIEDCNDELAAIFRCARADLIGRSFEVLYPSSDEFERIGERISPVMIAHGSYADDR 78
Query: 551 INYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
I G+ FW + + D+ + + D
Sbjct: 79 IMKRAGGELFWCHVTGRAL-DRTAPLAAGVWTFED 112
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 59/323 (18%), Positives = 112/323 (34%), Gaps = 62/323 (19%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
I+ LG G G V+ ++ G A+K + + E I+ +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EALIISKFN 132
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDR----QPTKVLKEDAVRFYAAEVV 781
H + ++ + GG+L FL R QP+ + D + A ++
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV-ARDIA 191
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
+YL I+RD+ N LL G + DF ++ + ++
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------RDIYRAGYYRKG 243
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTP 897
P++ ++ PE TS D W+ G+LL+E+ GY P
Sbjct: 244 GCAML-------PVK----------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 898 FRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
+ K+ Q+ + + P + P ++ ++M + P+ R P
Sbjct: 287 YPSKSNQEVLEFVTSGGRMDPPKNCPGPVY--RIMTQCWQHQPEDR-------------P 331
Query: 957 FFKGVNWALVRCM-NPPELDAPL 978
F + + C +P ++ L
Sbjct: 332 NFAIILERIEYCTQDPDVINTAL 354
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 62/291 (21%), Positives = 104/291 (35%), Gaps = 52/291 (17%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
++ LG G V+ L G A+K + R + E + L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRARLQ 70
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF---------- 775
HP V L + +I YC G+L FL++ + V D R
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 776 --YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTN 833
A++ +EYL ++++DL NVL+ +V ++D L + +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF--------REVYAAD 182
Query: 834 EKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML- 892
K P+R ++APE I + D W+ G++L+E+
Sbjct: 183 YYKLLGNSLL-------PIR----------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
Query: 893 YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
YG P+ G + Q I + + L P P ++ LM + P R
Sbjct: 226 YGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVY--ALMIECWNEFPSRR 274
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 49/286 (17%), Positives = 97/286 (33%), Gaps = 42/286 (14%)
Query: 636 NHSKVVHPKPHRKDSPPWKAIQKILDSGEQ---INLQHFRPIKPLGSGDTGSVHLVELCG 692
+HS V + L +G + + ++ + G ++
Sbjct: 6 HHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTS 65
Query: 693 SG--------QYFAMK--AMDKGVMLNRNKVHRACAEREI-----LDMLDHPFVPALYAS 737
+ Q F++K A D + +N RA ++ L +P
Sbjct: 66 TLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGF 125
Query: 738 -FQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796
+ L+ G L LD P VL E +V A ++ ALE+LH ++ +
Sbjct: 126 GVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184
Query: 797 LKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
+ EN+ + + V+L + + + G+ +
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFA----------------FRYCPSGKHVA----YVEGS 224
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ G E+I+ ++ G G + D +LG + + LYG+ P+
Sbjct: 225 RSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 44/262 (16%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
+FR K +G G+ G + L + + +Y A+K + +++ + E L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 729 PFVPALYASFQTKTHVCLITDYCPGG----ELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+P +Y + ++ + G +LF L DR + LK V A +++ +
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFS--LK--TVLMIAIQLISRM 118
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGH-----VSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
EY+H + +IYRD+KPEN L+ G+ + + DF L+ K+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA----------------KEYID 162
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
+ + P R S GT Y++ G + D ALG + L G P++
Sbjct: 163 PETKKHI----PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ 218
Query: 900 G---KTRQKTFANILHKDLKFP 918
G T ++ + I P
Sbjct: 219 GLKADTLKERYQKIGDTKRATP 240
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 48/235 (20%), Positives = 92/235 (39%), Gaps = 31/235 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DH 728
FR + +GSG G ++L + + A+K + + K + E +I +L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYESKIYRILQGG 62
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+P + + L+ D G L L + K+ + + A +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLML-ADQMINRVEFVH 120
Query: 789 CQGIIYRDLKPENVLLQGNGH---VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+ ++RD+KP+N L+ V + DF L+ + +H
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK----------KYRDTSTHQHI----- 165
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
P R + + GT Y + G + D +LG +L L G P++G
Sbjct: 166 -----PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 50/285 (17%), Positives = 92/285 (32%), Gaps = 44/285 (15%)
Query: 642 HPKPHRKDSPPWKAIQKI-LDSGEQINL---QHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
H Q + G+ ++ + K +GSG G ++L +
Sbjct: 6 HHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKD 65
Query: 698 AMKAM-----DKGVMLNRNKV-HRACAEREILDM-----LDHPFVPALYAS----FQTKT 742
A + + G + + K R + I LD+ +P Y S F+ ++
Sbjct: 66 ARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS 125
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ ++ + G +L + + T V ++ LEY+H ++ D+K N+
Sbjct: 126 YRFMVMERL-GIDLQKISGQNGTFKKS--TVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182
Query: 803 LL-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVG 860
LL N V L D+ LS + G G
Sbjct: 183 LLGYKNPDQVYLADYGLS----------------YRYCPNGNHKQY----QENPRKGHNG 222
Query: 861 TEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
T E+ + + G + D LG + L G P+ +
Sbjct: 223 TIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 61/322 (18%)
Query: 642 HPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF--AM 699
H H + P I +LD I Q +G G+ G V + G A+
Sbjct: 4 HHHHHHGKNNPDPTIYPVLDW-NDIKFQ-----DVIGEGNFGQVLKARIKKDGLRMDAAI 57
Query: 700 KAMDKGVMLNRNKVHRA-CAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL- 756
K M + HR E E+L L HP + L + + + ++ L +Y P G L
Sbjct: 58 KRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 757 -FLLLDRQPTKVLK-------------EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
FL R + + F AA+V ++YL + I+RDL N+
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF-AADVARGMDYLSQKQFIHRDLAARNI 173
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
L+ N + DF LS ++ G+ P+R
Sbjct: 174 LVGENYVAKIADFGLS-----------RGQEVYVKKTMGRL-------PVR--------- 206
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSS 920
++A E + + +T+ D W+ G+LL+E++ G TP+ G T + + + L+ P +
Sbjct: 207 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 265
Query: 921 TPTSLHAKQLMYRLLHRDPKSR 942
++ LM + P R
Sbjct: 266 CDDEVY--DLMRQCWREKPYER 285
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 52/284 (18%), Positives = 99/284 (34%), Gaps = 44/284 (15%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINL---QHFRPIKPLGSGDTGSVHLVEL-----CGSGQ 695
+ S + + + GE I ++ P+G G G ++L ++ GS
Sbjct: 7 AQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDA 66
Query: 696 YFAMKAM--DKGVMLNRNKVHRACAEREILDM------LDHPFVPALYAS----FQTKTH 743
+K D G + K ++ A+ E + L + VP + S K++
Sbjct: 67 PCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSY 126
Query: 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVL 803
+I D G +L + + + V + ++ LEY+H ++ D+K N+L
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKR-FSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184
Query: 804 L-QGNGH-VSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGT 861
L N V L D+ L+ + +G GT
Sbjct: 185 LNYKNPDQVYLVDYGLA----------------YRYCPEGVHKAY----AADPKRCHDGT 224
Query: 862 EEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
E+ + + G + D LG + + L G+ P+ +
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 48/248 (19%), Positives = 98/248 (39%), Gaps = 51/248 (20%)
Query: 719 EREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF- 775
E +L ++HP V LY + + LI +Y G L FL R+
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 776 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
+A ++ ++YL +++RDL N+L+ + ++DF
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
LS + + +R +G+ P++ ++A E + +T
Sbjct: 196 LS--------RDVYEEDSYVKRSQGR-------IPVK----------WMAIESLFDHIYT 230
Query: 877 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRL 934
+ D W+ G+LL+E++ G P+ G ++ F + ++ P + ++ +LM +
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY--RLMLQC 288
Query: 935 LHRDPKSR 942
++P R
Sbjct: 289 WKQEPDKR 296
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 59/296 (19%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 726
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 94
Query: 727 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 775
H + L + + +I +Y G L +L R P D R
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 776 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 206
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 207 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 889 YEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+E+ G +P+ G ++ F + + P++ L+ +M H P R
Sbjct: 250 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY--MMMRDCWHAVPSQR 303
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 66/330 (20%), Positives = 111/330 (33%), Gaps = 73/330 (22%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYF-----AMKAMDKGVMLN-RNKVHRACAEREILDMLD 727
++ +G G G V G Y A+K + + + + R E ++ D
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAEFD 108
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFY--------- 776
+P + L +CL+ +Y G+L FL T +
Sbjct: 109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 777 -----------AAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825
A +V + YL + ++RDL N L+ N V + DF LS
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------- 221
Query: 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALG 885
+ + + K P+R ++ PE I +T+ D WA G
Sbjct: 222 -RNIYSADYYKADGNDAI-------PIR----------WMPPESIFYNRYTTESDVWAYG 263
Query: 886 ILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL 943
++L+E+ YG P+ G ++ + L P + P L+ LM + P R
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELY--NLMRLCWSKLPADR- 320
Query: 944 GSHEGANEIKKHPFFKGVNWALVRCMNPPE 973
P F ++ L R E
Sbjct: 321 ------------PSFCSIHRILQRMCERAE 338
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 71/355 (20%), Positives = 122/355 (34%), Gaps = 75/355 (21%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 726
KPLG G G V L E G + + V ML + E+++ D++
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----ATEKDLSDLISEMEMM 128
Query: 727 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 775
H + L + + +I +Y G L +L R P +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 776 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH------ 242
Query: 829 LPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887
+ ++ + PV +M APE + +T D W+ G+L
Sbjct: 243 ---HIDYYKKTTNGRLPVKWM-----------------APEALFDRIYTHQSDVWSFGVL 282
Query: 888 LYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945
L+E+ G +P+ G ++ F + + PS+ L+ +M H P R
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY--MMMRDCWHAVPSQR--- 337
Query: 946 HEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYKVVDPGMQDLQQN 1000
P FK + L R + + + + P ++L N
Sbjct: 338 ----------PTFKQLVEDLDRIVALTS-NQEMGYYHHHHHHDYDIPTTENLYFN 381
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 54/243 (22%), Positives = 93/243 (38%), Gaps = 46/243 (18%)
Query: 719 EREILDMLD-HPFVPALY-ASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
E +IL + H V L A + + +I ++C G L +L R K
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 775 F------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822
Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---- 195
Query: 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWW 882
+ + R+ + P++ ++APE I +T D W
Sbjct: 196 ----RDIYKDPDYVRKGDAR-------LPLK----------WMAPETIFDRVYTIQSDVW 234
Query: 883 ALGILLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPSSTPTSLHAKQLMYRLLHRDP 939
+ G+LL+E+ G +P+ G + F L + ++ P T ++ Q M H +P
Sbjct: 235 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY--QTMLDCWHGEP 292
Query: 940 KSR 942
R
Sbjct: 293 SQR 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 63/296 (21%), Positives = 112/296 (37%), Gaps = 59/296 (19%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGV-MLNRNKVHRACAEREILDML------ 726
KPLG G G V + E G + +A+ V ML + E+++ D++
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----ATEKDLSDLVSEMEMM 140
Query: 727 ----DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF----- 775
H + L + + +I +Y G L +L R P D R
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 776 -------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828
++ +EYL Q I+RDL NVL+ N + + DF L+
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA--------RD 252
Query: 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILL 888
+ + K+ G+ P++ ++APE + +T D W+ G+L+
Sbjct: 253 INNIDYYKKTTNGR-------LPVK----------WMAPEALFDRVYTHQSDVWSFGVLM 295
Query: 889 YEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+E+ G +P+ G ++ F + + P++ L+ +M H P R
Sbjct: 296 WEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY--MMMRDCWHAVPSQR 349
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 4e-08
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 42/226 (18%)
Query: 677 LGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA-CAEREILDMLDHPFVPALY 735
+G G G V+ + + A+K + V + ++ + E +++ H + L
Sbjct: 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 736 ASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKED-AVRFY----AAEVVVALEYLHC 789
+CL+ Y P G L L T L +R AA + +LH
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL--SWHMRCKIAQGAAN---GINFLHE 151
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
I+RD+K N+LL ++DF L+ + Q +
Sbjct: 152 NHHIHRDIKSANILLDEAFTAKISDFGLA-----R---ASEK---------FAQTVM--- 191
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYG 894
++ VGT Y+APE + G T D ++ G++L E++ G
Sbjct: 192 -----TSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITG 230
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-08
Identities = 14/88 (15%), Positives = 29/88 (32%), Gaps = 1/88 (1%)
Query: 498 IFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSG 557
+ S + E +ILG + + PE R + + + G
Sbjct: 26 LAVSRRWREDYGLGDGDILGMSHYDI-FPEIGEEWKSVHRRGLAGEVIRVEEDCFVRADG 84
Query: 558 KKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
+ W + ++P + +G V + D
Sbjct: 85 RTQWLRWEVRPWYEGEGRVGGVVIFTED 112
|
| >3luq_A Sensor protein; PAS, histidine, kinase, PSI, MCSG, structural genomics, midwest center for structural genomics; HET: PGE; 2.49A {Geobacter sulfurreducens} Length = 114 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 7e-05
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 17/93 (18%)
Query: 215 MYASAGFFKMTGYTSKEVVGRNCRFLQGAGTD----PEDVAKIRET----LQNGQSYCGR 266
+ S + + G +++G + PE + + L
Sbjct: 26 LAVSRRWREDYGLGDGDILGM---------SHYDIFPEIGEEWKSVHRRGLAGEVIRVEE 76
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+ DG W + P + EG+V +
Sbjct: 77 DCFVRADGRTQWLRWEVRPWYEGEGRVGGVVIF 109
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 48/263 (18%), Positives = 94/263 (35%), Gaps = 34/263 (12%)
Query: 687 LVELCGSG--QYFAMKAMDKGVMLNRNKVHRACAER--EILDMLDHPFVPALYASFQTKT 742
+VE C G + ++ V + + + + ++ +S + +
Sbjct: 105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164
Query: 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENV 802
+ E + L + + Y+ +V +E+L + I+RDL N+
Sbjct: 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224
Query: 803 LLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTE 862
LL V + DF L+ + R + P+
Sbjct: 225 LLSEKNVVKICDFGLARDI---------YKDPDYVRKGDARLPL---------------- 259
Query: 863 EYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD--LKFPS 919
+++APE I +T D W+ G+LL+E+ G +P+ G + F L + ++ P
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 319
Query: 920 STPTSLHAKQLMYRLLHRDPKSR 942
T ++ Q M H +P R
Sbjct: 320 YTTPEMY--QTMLDCWHGEPSQR 340
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 20/81 (24%), Positives = 37/81 (45%), Gaps = 2/81 (2%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I YA+ + ++K +V ++ Q D+A + + LQ+GQS + + D
Sbjct: 29 IRYANPAAELLFSQSAKRIVEQSLS--QLIQHASLDLALLTQPLQSGQSITDSDVTFVVD 86
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G P +T++PI +L
Sbjct: 87 GRPLMLEVTVSPITWQRQLML 107
|
| >3b33_A Sensor protein; structural genomics, PAS domain, nitrogen regulation protein APC91440.4, PSI-2; HET: MSE; 1.83A {Vibrio parahaemolyticus rimd 2210633} Length = 115 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-05
Identities = 14/92 (15%), Positives = 35/92 (38%), Gaps = 7/92 (7%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNC-RFLQGPETDPATVRKIRAAIDNQT 544
+I D I +A+ + L S + I+ ++ + +Q D A + + +
Sbjct: 21 LILDD---GLAIRYANPAAELLFSQSAKRIVEQSLSQLIQHASLDLAL---LTQPLQSGQ 74
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 576
+T + + G+ + P+ Q+ +
Sbjct: 75 SITDSDVTFVVDGRPLMLEVTVSPITWQRQLM 106
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-07
Identities = 13/93 (13%), Positives = 28/93 (30%), Gaps = 12/93 (12%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCGR 266
+ + + GYT E + + L + D +L G+
Sbjct: 29 AEGHYLDVNPAICSAIGYTRDEFLALDWGVL----SRGVDSGWAAASLARIVGGEPLREE 84
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGM 299
+ ++G L+ + D K +G+
Sbjct: 85 RTVWTRNGDQLTVELSAHLLPDG-----KILGI 112
|
| >2r78_A Sensor protein; sensory box sensor histidine kinase/response regulator, structural genomics, PSI, MCSG; 1.60A {Geobacter sulfurreducens pca} Length = 117 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-07
Identities = 10/86 (11%), Positives = 28/86 (32%), Gaps = 6/86 (6%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
+ + + Y+R+E L + L + + + + + +T++
Sbjct: 33 YLDVNPAICSAIGYTRDEFLALDWGVLSRGVDSGWAAASLARIVGGEP-LREERTVWTRN 91
Query: 557 GKKFWNLFHLQPMRDQKGEVQYFIGV 582
G + + D K +G+
Sbjct: 92 GDQLTVELSAHLLPDGK-----ILGI 112
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 52/246 (21%), Positives = 87/246 (35%), Gaps = 49/246 (19%)
Query: 718 AEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVR 774
+E ++L L +H + L + +IT+YC G+L FL R K
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 775 F--------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820
++ +V + +L + I+RDL N+LL + DF L+
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA-- 192
Query: 821 TSCKPQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879
+ + + + PV +M APE I +T
Sbjct: 193 ------RDIKNDSNYVVKGNA-RLPVKWM-----------------APESIFNCVYTFES 228
Query: 880 DWWALGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLH 936
D W+ GI L+E+ G +P+ G K + I + P P ++ +M
Sbjct: 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY--DIMKTCWD 286
Query: 937 RDPKSR 942
DP R
Sbjct: 287 ADPLKR 292
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-07
Identities = 19/99 (19%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCG---R 266
+ I+Y SA GY E++G + ED + N R
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTF----LHEEDQFLVESYFYNEHHLMPCTFR 72
Query: 267 LLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSK 305
+ KKD T W + + + + I ++++V +
Sbjct: 73 FI--KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >2vlg_A Sporulation kinase A; histidine kinase, two-component regulatory system, two-component signal transduction, transferase, phosphorylation, SCOD; 1.7A {Bacillus subtilis} Length = 111 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 3e-04
Identities = 15/96 (15%), Positives = 32/96 (33%), Gaps = 3/96 (3%)
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552
+ II+ S + Y + E++G + E D V + T + I
Sbjct: 17 SNGRIIYISANSKLHLGYLQGEMIGSFLKTFLHEE-DQFLVESYFYNEHHLMPCTFRFI- 74
Query: 553 YTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
K W ++ + + + I +++ E
Sbjct: 75 -KKDHTIVWVEAAVEIVTTRAERTEREIILKMKVLE 109
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 5e-07
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 47/242 (19%)
Query: 719 EREILDMLD-HPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLK------ 769
E +I+ L H + L + V +IT+YC G+L FL + +
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 770 -----EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCK 824
D + F +++V + +L + I+RD+ NVLL + DF L+
Sbjct: 159 STASTRDLLHF-SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------ 211
Query: 825 PQLLLPTTNEKKRRHKGQQNPV-FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
+ + + + PV +M APE I +T D W+
Sbjct: 212 --RDIMNDSNYIVKGNARL-PVKWM-----------------APESIFDCVYTVQSDVWS 251
Query: 884 LGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPK 940
GILL+E+ G P+ G K + + + P+ P +++ +M +P
Sbjct: 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIY--SIMQACWALEPT 309
Query: 941 SR 942
R
Sbjct: 310 HR 311
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 6e-07
Identities = 15/98 (15%), Positives = 26/98 (26%), Gaps = 6/98 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+ D D I + F Y E+LGR+ D V+ +
Sbjct: 30 IDVLDA---DGTICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDE 85
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
+ + + G HL F+ +
Sbjct: 86 RRKFEGLYERRDGSTMSVEVHLLRFNL--EGEDRFLAI 121
|
| >3bwl_A Sensor protein; structural genomics, APC87707.1, PAS domain, HTR-like protei protein structure initiative; HET: MSE I3A; 1.73A {Haloarcula marismortui atcc 43049} Length = 126 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 7e-07
Identities = 15/81 (18%), Positives = 25/81 (30%), Gaps = 1/81 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I + F GY EV+GR+ D EDV + L ++D
Sbjct: 39 ICEVNQRFCAELGYDESEVLGRSIWEF-DLMFDAEDVQTQLSGFSVDERRKFEGLYERRD 97
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G+ + + +
Sbjct: 98 GSTMSVEVHLLRFNLEGEDRF 118
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 12/98 (12%), Positives = 32/98 (32%), Gaps = 6/98 (6%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+I + + +++A+ + + Y+ EE++ + + A KI A +
Sbjct: 12 ILIINR---EGRLLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGK 67
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
++ L K G + + +
Sbjct: 68 KESLPLSLEKKEGTSIPAKARIWQGKW--HNEPCLFAI 103
|
| >3mjq_A Uncharacterized protein; NESG, structural genomics, PSI-2, protein structure initiati northeast structural genomics consortium; 2.60A {Desulfitobacterium hafniense} Length = 126 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 1/81 (1%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
++YA+ K GYT +E++ + + + + KI L G+ L KK+
Sbjct: 21 LLYANTAVPKKLGYTHEELMSMHILTIT-SAGKMAEGEKILAELFAGKKESLPLSLEKKE 79
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
GT I K L
Sbjct: 80 GTSIPAKARIWQGKWHNEPCL 100
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 56/241 (23%), Positives = 85/241 (35%), Gaps = 50/241 (20%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRA----CAEREILDML 726
F LG G G V+ L G A+K L + E E++ M
Sbjct: 32 FSNKNILGRGGFGKVYKGRL-ADGTLVAVK------RLKEERTQGGELQFQTEVEMISMA 84
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGEL-FLLLDRQPTKVLKEDAVRFY----AAEVV 781
H + L T T L+ Y G + L +R ++ + R +A
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR-- 142
Query: 782 VALEYLHCQG---IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRR 838
L YLH II+RD+K N+LL + DF L+ K L+ +
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-----K---LMDYKDT---- 189
Query: 839 HKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTP 897
H + + GT +IAPE G + D + G++L E++ G
Sbjct: 190 H--------------VTTAVRGTIGHIAPE-YLSTGKSSEKTDVFGYGVMLLELITGQRA 234
Query: 898 F 898
F
Sbjct: 235 F 235
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 17/35 (48%), Positives = 23/35 (65%)
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
L YLH + II+RD+K N+LL N +TDF +S
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 18/98 (18%), Positives = 37/98 (37%), Gaps = 10/98 (10%)
Query: 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT 544
+ ++ +D+ +TEYSRE++L N + + D I +
Sbjct: 26 SFCLGD---NWQFLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKN 77
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
+ T + ++SG+ F L + DQ+ +
Sbjct: 78 NYTFKTRYRSQSGRIFLVEMSLTFLEDQERR--FSCVF 113
|
| >3olo_A Two-component sensor histidine kinase; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG, TRA; 2.09A {Nostoc SP} Length = 118 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 12/81 (14%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
+Y + +MT Y+ ++++ N + + D + E ++ +Y + +
Sbjct: 35 FLYVNDATCRMTEYSREQLLSMNLQDI-----DVDFALHDWEEIRQKNNYTFKTRYRSQS 89
Query: 274 GTPFWNLLTIAPIKDDEGKVL 294
G F +++ ++D E +
Sbjct: 90 GRIFLVEMSLTFLEDQERRFS 110
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 47/249 (18%), Positives = 90/249 (36%), Gaps = 52/249 (20%)
Query: 719 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRF 775
E +++ L H + L + + LI +YC G+L +L R+ + +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 776 -------------------YAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
+A +V +E+L + ++RDL NVL+ V + DF
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
L+ + + + R + P++ ++APE + +T
Sbjct: 218 LA--------RDIMSDSNYVVRGNAR-------LPVK----------WMAPESLFEGIYT 252
Query: 877 SAVDWWALGILLYEML-YGYTPFRG-KTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYR 933
D W+ GILL+E+ G P+ G + I + + P ++ +M
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY--IIMQS 310
Query: 934 LLHRDPKSR 942
D + R
Sbjct: 311 CWAFDSRKR 319
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-05
Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 6/86 (6%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKS 556
I+ + S + ++G+ + E + ++A++N T +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTATRSE---DAVG 97
Query: 557 GKKFWNLFHLQPMRDQKGEVQYFIGV 582
G+ + N + P+ + F V
Sbjct: 98 GRHYHNQYI--PVDSH-RKSDTFQLV 120
|
| >3fc7_A HTR-like protein, sensor protein; APC87712.1, HTR-like protein,haloarcula marismortui ATCC 430 structural genomics, PSI-2; 2.65A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 12/86 (13%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKD 273
I+ + G +VG+ + + + + + ++NG +
Sbjct: 41 ILSVNPSMAGRLGADPDTLVGQQLSAVMDSEAANQRLEAGKSAVENGTA---TRSEDAVG 97
Query: 274 GTPFWNLLTIAPIKDDEGKVLKFIGM 299
G + N P+ D K F +
Sbjct: 98 GRHYHN--QYIPV-DSHRKSDTFQLV 120
|
| >3eeh_A Putative light and redox sensing histidine kinase; structural genomic MCSG, protein structure initiative, midwest center for STRU genomics; HET: PG5; 1.95A {Haloarcula marismortui} Length = 125 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 3e-05
Identities = 18/90 (20%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 214 IMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ---NGQSYCG--RLL 268
++ ++ + + G + ++ FL G PED +++T+Q +G+S R+
Sbjct: 34 VLVINSAYEDIWGRSVAKLRENPHDFLNG--IHPEDRELMKDTMQSLMDGESADVECRVN 91
Query: 269 NYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
+ W + PI +D G+ ++ G
Sbjct: 92 A--TEEYQRWVWIQGEPITNDAGETVRVAG 119
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 3e-05
Identities = 16/99 (16%), Positives = 28/99 (28%), Gaps = 12/99 (12%)
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQG--PETDPATVRK-IRAAIDNQTDVTVQ 549
I F +FL+ E L + D + + + +T+
Sbjct: 24 GQATIRFRPPAFLKT--LVSEHAGTTRLNTLSMIHHD-DRHMLSNAYSKLREAKHSLTLV 80
Query: 550 LINY---TKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
Y T GK W H++ G G+ +
Sbjct: 81 ---YRIVTPEGKLHWIEDHMRSSFSDDGLFSGIDGILCE 116
|
| >3icy_A Sensor protein; sensory box histidine kinase/response regulator domain, kinase, chlorobium tepidum TLS, PSI-2; 2.68A {Chlorobaculum tepidum} Length = 118 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 12/95 (12%), Positives = 21/95 (22%), Gaps = 12/95 (12%)
Query: 210 PDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ----NGQSYCG 265
I + F K N + +D + S
Sbjct: 24 GQATIRFRPPAFLKTLVSEHAGTTRLNTL----SMIHHDDRHMLSNAYSKLREAKHSLTL 79
Query: 266 --RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIG 298
R++ +G W + D+G G
Sbjct: 80 VYRIVT--PEGKLHWIEDHMRSSFSDDGLFSGIDG 112
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 6e-05
Identities = 28/226 (12%), Positives = 62/226 (27%), Gaps = 25/226 (11%)
Query: 737 SFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQ-GIIYR 795
F + ++ ++ GG L++ TK+ + ++ +L +R
Sbjct: 130 DFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186
Query: 796 DLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV--FMAEPMR 853
DL NVLL+ L G Q + + +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNG--------------KSSTIPSCGLQVSIIDYTLSRLE 232
Query: 854 ASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANILHK 913
V + + ++ G G + + Y P+ + + K
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292
Query: 914 DLKFPSSTPTSLHAKQLM-YRLLHRDPKSRLGSHEGANEIKKHPFF 958
+ F + T + + HR + + A ++
Sbjct: 293 QMTFKTKCNTPAMKQIKRKIQEFHR----TMLNFSSATDLLCQHSL 334
|
| >3kx0_X Uncharacterized protein RV1364C/MT1410; PAS domain, sensory domain, mycobacteium tuberculos molecule binding domain; 2.30A {Mycobacterium tuberculosis} Length = 185 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 12/125 (9%), Positives = 40/125 (32%), Gaps = 9/125 (7%)
Query: 497 IIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN-----QTDVTVQLI 551
+ + ++ + + +G+ R + + ++ +Q
Sbjct: 60 FVAVNAAYRGFSP--LLDTVGQPAREVYPELEGQQIYEMLDRVYQTGEPQSGSEWRLQTD 117
Query: 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEHLEPLRNSIPEATAEESEKLVKQ 611
++ + F + P R G ++ + D + + + + EA EE + +
Sbjct: 118 YDGSGVEERYFDFVVTPRRRADGSIEGVQLIVDDVTSRVRARQAA--EARVEELSERYRN 175
Query: 612 TAENV 616
++
Sbjct: 176 VRDSA 180
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1002 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-79 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-71 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-69 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-68 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-67 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-66 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-65 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-65 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-64 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-63 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-63 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-62 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-62 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-62 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-52 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-51 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-47 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-39 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 1e-24 | |
| d1n9la_ | 109 | d.110.3.6 (A:) Putative blue light receptor, phot- | 2e-24 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 5e-23 | |
| d1jnua_ | 104 | d.110.3.6 (A:) Photoreceptor phy3 flavin-binding d | 5e-21 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 6e-16 | |
| d1bywa_ | 110 | d.110.3.6 (A:) Erg potassium channel, N-terminal d | 9e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 1e-06 | |
| d1xj3a1 | 106 | d.110.3.2 (A:154-259) Histidine kinase FixL heme d | 1e-05 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 8e-06 | |
| d1ew0a_ | 130 | d.110.3.2 (A:) Histidine kinase FixL heme domain { | 4e-05 | |
| d1ll8a_ | 114 | d.110.3.5 (A:) N-terminal PAS domain of Pas kinase | 8e-05 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 4e-04 | |
| d1p97a_ | 114 | d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-t | 0.001 | |
| d1mzua_ | 110 | d.110.3.1 (A:) PYP domain of sensor histidine kina | 0.001 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 258 bits (660), Expect = 2e-79
Identities = 102/309 (33%), Positives = 150/309 (48%), Gaps = 31/309 (10%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
F+ K LG G +V L + + +A+K ++K ++ NKV ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
F LY +FQ + Y GEL + + E RFY AE+V ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
+GII+RDLKPEN+LL + H+ +TDF + + S +
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE------------------------- 161
Query: 850 EPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909
+NSFVGT +Y++PE++ + D WALG ++Y+++ G PFR F
Sbjct: 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221
Query: 910 ILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVR 967
I+ + FP A+ L+ +LL D RLG E G +K HPFF+ V W +
Sbjct: 222 IIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279
Query: 968 CMNPPELDA 976
PP+L A
Sbjct: 280 QQTPPKLTA 288
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 2e-71
Identities = 88/293 (30%), Positives = 124/293 (42%), Gaps = 37/293 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+ F +PLG G G+V+L S A+K + K + H+ E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + LY F T V LI +Y P G ++ L + E Y E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + +I+RD+KPEN+LL G + + DF S
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-------------------------- 156
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
P + GT +Y+ PE+I G H VD W+LG+L YE L G PF T Q+T+
Sbjct: 157 ---PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213
Query: 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
I + FP A+ L+ RLL +P R E+ +HP+
Sbjct: 214 KRISRVEFTFPDFVTEG--ARDLISRLLKHNPSQRP----MLREVLEHPWITA 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-69
Identities = 105/349 (30%), Positives = 173/349 (49%), Gaps = 48/349 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-L 726
++ F K LG G G V L E + Q+FA+KA+ K V+L + V E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
+HPF+ ++ +FQTK ++ + +Y GG+L + FYAAE+++ L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
LH +GI+YRDLK +N+LL +GH+ + DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--------------------------- 151
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+N+F GT +YIAPEI+ G + +VDWW+ G+LLYEML G +PF G+ ++
Sbjct: 152 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211
Query: 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966
F +I + +P AK L+ +L R+P+ RLG +I++HP F+ +NW +
Sbjct: 212 FHSIRMDNPFYPRWLEKE--AKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEEL 266
Query: 967 --RCMNPP-------ELDAPLFATDTEKEYKVVDPG----MQDLQQNVF 1002
+ ++PP D F + E + + + QN+F
Sbjct: 267 ERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMF 315
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 229 bits (584), Expect = 2e-68
Identities = 120/346 (34%), Positives = 176/346 (50%), Gaps = 46/346 (13%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
LQ F+ ++ LG+G G VHL+ +G+Y+AMK + K +++ +V ER +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HPF+ ++ +FQ + +I DY GGELF LL + +FYAAEV +ALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYL 120
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + IIYRDLKPEN+LL NGH+ +TDF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---------------------- 158
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
+ GT +YIAPE+++ + ++DWW+ GIL+YEML GYTPF KT+
Sbjct: 159 --------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWA-- 964
IL+ +L+FP K L+ RL+ RD RLG+ G ++K HP+FK V W
Sbjct: 211 EKILNAELRFPPFFNED--VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 965 LVRCMNPP--------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
L R + P + D F E++ G D ++F
Sbjct: 269 LSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGE-DPYADLF 313
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 7e-68
Identities = 113/347 (32%), Positives = 173/347 (49%), Gaps = 41/347 (11%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+ + F +K LG G G V LV +G+Y+AMK + K V++ +++V E +L
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
HPF+ AL +FQT +C + +Y GGELF L R+ E+ RFY AE+V ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALE 119
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH + ++YRD+K EN++L +GH+ +TDF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-------------------------- 153
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+F GT EY+APE++ + AVDWW LG+++YEM+ G PF + ++
Sbjct: 154 -EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
Query: 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWA 964
F IL ++++FP + AK L+ LL +DPK RLG A E+ +H FF +NW
Sbjct: 213 LFELILMEEIRFPRTLSPE--AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 965 LV--RCMNPP-------ELDAPLFATDTEKEYKVVDPGMQDLQQNVF 1002
V + + PP E+D F + + + P + +
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLL 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 227 bits (579), Expect = 3e-67
Identities = 76/322 (23%), Positives = 134/322 (41%), Gaps = 40/322 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L H+ + LG+G G VH V +G FA K + ++ V + E + + +L
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLR 81
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L+ +F+ + +I ++ GGELF + + K + ED Y +V L ++
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHM 140
Query: 788 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
H ++ DLKPEN++ + + + L DF L+
Sbjct: 141 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-------------------------- 174
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+P ++ GT E+ APE+ G D W++G+L Y +L G +PF G+ +
Sbjct: 175 --HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
Query: 906 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
T N+ D S + + K + +LL DP +R+ ++ +HP+ N
Sbjct: 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNA 288
Query: 964 ALVRCMNPPELDAPLFATDTEK 985
P + + K
Sbjct: 289 PGRDSQIPSSRYTKIRDSIKTK 310
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 226 bits (576), Expect = 1e-66
Identities = 78/312 (25%), Positives = 136/312 (43%), Gaps = 40/312 (12%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ ++ LGSG G VH +G+ F K ++ L++ V E I++ L
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLH 84
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L+ +F+ K + LI ++ GGELF + + K + E V Y + L+++
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 788 HCQGIIYRDLKPENVLL--QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
H I++ D+KPEN++ + V + DF L+ +
Sbjct: 144 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN----------------------- 180
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
P T E+ APEI+ D WA+G+L Y +L G +PF G+ +
Sbjct: 181 -----PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 906 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
T N+ D +F +S+ AK + LL ++P+ RL ++ +HP+ KG +
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHS 291
Query: 964 ALVRCMNPPELD 975
L + +
Sbjct: 292 NLTSRIPSSRYN 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-65
Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ I LG G G V+ + + A K +D + ++ E +IL DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ L +F + ++ ++ ++C GG + ++ + L E ++ + + AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMA 849
II+RDLK N+L +G + L DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSA---------------------------KNT 161
Query: 850 EPMRASNSFVGTEEYIAPEIIAG-----AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
++ +SF+GT ++APE++ + D W+LGI L EM P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 905 KTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+ I + + S + K + + L ++ +R +++ +HPF
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFVTV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 221 bits (563), Expect = 6e-65
Identities = 103/356 (28%), Positives = 167/356 (46%), Gaps = 54/356 (15%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
+ + F + +G G G V+ +G+ +AMK +DK + + A ER +L +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 726 L---DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ D PF+ + +F T + I D GG+L L + E +RFYAAE+++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIIL 118
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
LE++H + ++YRDLKP N+LL +GHV ++D L+C S K
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----------------- 161
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
++ VGT Y+APE++ G + S+ DW++LG +L+++L G++PFR
Sbjct: 162 ------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209
Query: 902 TRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFF 958
+ I L P S + L+ LL RD RLG GA E+K+ PFF
Sbjct: 210 KTKDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 959 KGVNWALV--RCMNPP------------ELDAPLFATDTEKEYKVVDPGMQDLQQN 1000
+ ++W +V + PP D F + K K++D Q+L +N
Sbjct: 269 RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDS-DQELYRN 323
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 217 bits (554), Expect = 3e-64
Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 40/294 (13%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ F ++ +G G G+V+ + + A+K M + K E L L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + + L+ +YC G LL + K L+E + + L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+I+RD+K N+LL G V L DF + +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------------------- 164
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGH---TSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
M +NSFVGT ++APE+I VD W+LGI E+ P
Sbjct: 165 ---MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+I + S S + + + L + P+ R + + KH F
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFVL 271
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 213 bits (542), Expect = 4e-63
Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 49/306 (16%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK------VHRACAEREI 722
+++ P + LG G + V + + +A+K +D + + E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 723 LDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
L + HP + L +++T T L+ D GELF L + T L E R ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+ LH I++RDLKPEN+LL + ++ LTDF SC
Sbjct: 121 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--------------------- 159
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA------GHTSAVDWWALGILLYEMLYGY 895
+P GT Y+APEII + G+ VD W+ G+++Y +L G
Sbjct: 160 -------LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
Query: 896 TPFRGKTRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHEGANEIK 953
PF + + I+ + +F S K L+ R L P+ R A E
Sbjct: 213 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEAL 268
Query: 954 KHPFFK 959
HPFF+
Sbjct: 269 AHPFFQ 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 4e-63
Identities = 122/325 (37%), Positives = 176/325 (54%), Gaps = 38/325 (11%)
Query: 658 KILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNK-V 713
+ E++ +++F +K LG+G G V LV +G+ +AMK + K ++ + K
Sbjct: 13 NLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT 72
Query: 714 HRACAEREILDMLDH-PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
ER++L+ + PF+ L+ +FQT+T + LI DY GGELF L ++ E
Sbjct: 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHE 130
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
V+ Y E+V+ALE+LH GIIYRD+K EN+LL NGHV LTDF LS
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------------- 177
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG--AGHTSAVDWWALGILLYE 890
F+A+ + F GT EY+AP+I+ G +GH AVDWW+LG+L+YE
Sbjct: 178 -------------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 891 MLYGYTPFRGKTRQKTFANILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGS-HE 947
+L G +PF + + A I + LK P S AK L+ RLL +DPK RLG
Sbjct: 225 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284
Query: 948 GANEIKKHPFFKGVNWALVRCMNPP 972
A+EIK+H FF+ +NW + P
Sbjct: 285 DADEIKEHLFFQKINWDDLAAKKVP 309
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (544), Expect = 5e-63
Identities = 82/316 (25%), Positives = 134/316 (42%), Gaps = 49/316 (15%)
Query: 653 WKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK 712
WK + I D + LG+G V L E + + A+K + K + K
Sbjct: 1 WKQAEDIRD--------IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGK 50
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
E +L + HP + AL +++ H+ LI GGELF + + E
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERD 108
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLL 829
+V+ A++YLH GI++RDLKPEN+L + + ++DF LS +
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED------- 161
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
P ++ GT Y+APE++A ++ AVD W++G++ Y
Sbjct: 162 ---------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200
Query: 890 EMLYGYTPFRGKTRQKTFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGSHE 947
+L GY PF + K F IL + +F S + AK + L+ +DP+ R
Sbjct: 201 ILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---- 256
Query: 948 GANEIKKHPFFKGVNW 963
+ +HP+ G
Sbjct: 257 TCEQALQHPWIAGDTA 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-62
Identities = 67/345 (19%), Positives = 120/345 (34%), Gaps = 80/345 (23%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ F I LG+G+ G V V SG A K + + ++ E ++L
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ P++ Y +F + + + ++ GG L +L + + E + + V+ L
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGL 117
Query: 785 EYLH-CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
YL I++RD+KP N+L+ G + L DF +S
Sbjct: 118 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---------------------- 155
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
+NSFVGT Y++PE + G ++ D W++G+ L EM G P
Sbjct: 156 -------IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 904 QKTFANILHKDLKFPSSTPT---------------------------------------- 923
++ + + TP
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268
Query: 924 --SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966
SL + + + L ++P R ++ H F K + V
Sbjct: 269 VFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDAEEV 309
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-62
Identities = 68/294 (23%), Positives = 123/294 (41%), Gaps = 35/294 (11%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ + ++ LG G G V L + + A+K +D ++ + E I ML+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
H V Y + L +YC GGELF ++ + E + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H GI +RD+KPEN+LL ++ ++DF L+ + +
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--------------------- 158
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQ-K 905
R N GT Y+APE++ H VD W+ GI+L ML G P+ + +
Sbjct: 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+++ K L++++L +P +R+ +IKK ++
Sbjct: 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-62
Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 42/294 (14%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+ + + +G G +G+V+ +GQ A++ M+ + + E ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
P + S+ + ++ +Y GG L ++ E + E + ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH 133
Query: 789 CQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFM 848
+I+RD+K +N+LL +G V LTDF +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA---------------------------QI 166
Query: 849 AEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFA 908
++ VGT ++APE++ + VD W+LGI+ EM+ G P+ + +
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 909 NILHK---DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
I +L+ P + + R L D + R A E+ +H F K
Sbjct: 227 LIATNGTPELQNPEKLSAI--FRDFLNRCLDMDVEKRG----SAKELLQHQFLK 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 3e-62
Identities = 107/334 (32%), Positives = 159/334 (47%), Gaps = 44/334 (13%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
L F IK LG+G G V LV+ SG ++AMK +DK ++ ++ E+ IL
Sbjct: 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
++ PF+ L SF+ +++ ++ +Y GGE+F L R E RFYAA++V+
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYLH +IYRDLKPEN+L+ G++ +TDF +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------------------------- 189
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ + GT E +APEII G+ AVDWWALG+L+YEM GY PF
Sbjct: 190 -----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNW 963
+ + I+ ++FPS + K L+ LL D R G+ G N+IK H +F +W
Sbjct: 245 QIYEKIVSGKVRFPSHFSSD--LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302
Query: 964 ALV--RCMNPP-------ELDAPLFATDTEKEYK 988
+ R + P D F E+E +
Sbjct: 303 IAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIR 336
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 4e-61
Identities = 87/317 (27%), Positives = 139/317 (43%), Gaps = 45/317 (14%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML-NRNKVHRACAERE--ILDML 726
++ + LGSG V +G +A K + K +R V R ERE IL +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 727 DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
HP V L+ ++ KT V LI + GGELF L + + L E+ + +++ + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 787 LHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
LH I + DLKPEN++L + + DF L+
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH----------------------- 165
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902
+ + GT E++APEI+ D W++G++ Y +L G +PF G T
Sbjct: 166 -----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 903 RQKTFANILHKDLKFPSSTP--TSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960
+Q+T AN+ + +F TS AK + RLL +DPK R+ + +HP+ K
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKP 276
Query: 961 VNW--ALVRCMNPPELD 975
+ AL + P+ +
Sbjct: 277 KDTQQALSSAWSHPQFE 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-61
Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 42/296 (14%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ + +G+G G + G+ K +D G M + +E +L L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPN 64
Query: 731 VPALYASF--QTKTHVCLITDYCPGGELFLLLDR--QPTKVLKEDAVRFYAAEVVVALEY 786
+ Y +T T + ++ +YC GG+L ++ + + + L E+ V ++ +AL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 787 LHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
H + +++RDLKP NV L G +V L DF L+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---------------------- 162
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ + +FVGT Y++PE + + D W+LG LLYE+ PF
Sbjct: 163 -----ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 217
Query: 902 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPF 957
++++ I + S +++ R+L+ R EI ++P
Sbjct: 218 SQKELAGKIREGKFRRIPYR-YSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-60
Identities = 67/294 (22%), Positives = 121/294 (41%), Gaps = 41/294 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + LG G+ G VH S + + K + E IL++ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 730 FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ L+ SF++ + +I ++ G ++F ++ + L E + Y +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 790 QGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
I + D++PEN++ Q + + + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------------------- 160
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907
EY APE+ ++A D W+LG L+Y +L G PF +T Q+
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 908 ANILHKDLKFPSSTPT--SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
NI++ + F S+ A + RLL ++ KSR+ A+E +HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLK 262
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-58
Identities = 60/305 (19%), Positives = 119/305 (39%), Gaps = 45/305 (14%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
G + + + +G G +V+ + A + L +++ R E E+
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR-KLTKSERQRFKEEAEM 61
Query: 723 LDMLDHPFVPALYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAA 778
L L HP + Y S+++ K + L+T+ G L L R KV+K +R +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCR 119
Query: 779 EVVVALEYLHCQG--IIYRDLKPENVLLQG-NGHVSLTDFDLSCLTSCKPQLLLPTTNEK 835
+++ L++LH + II+RDLK +N+ + G G V + D L+ L
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--------------- 164
Query: 836 KRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGY 895
+ + + +GT E++APE+ + +VD +A G+ + EM
Sbjct: 165 --------------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE 209
Query: 896 TPFRGK-TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954
P+ + + + K+++ + ++ R ++
Sbjct: 210 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLN 265
Query: 955 HPFFK 959
H FF+
Sbjct: 266 HAFFQ 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 193 bits (490), Expect = 5e-56
Identities = 58/282 (20%), Positives = 115/282 (40%), Gaps = 32/282 (11%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + LG G VHL + A+K + + + + R E + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 730 FVPALYASFQTKTH----VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
+ A+Y + + +T ++ +Y G L ++ + + A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+ H GII+RD+KP N+++ V + DF ++ +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN------------------- 166
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+ + + +GT +Y++PE G + D ++LG +LYE+L G PF G +
Sbjct: 167 -----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221
Query: 906 TFANILHKDLKFPSSTPTSL--HAKQLMYRLLHRDPKSRLGS 945
+ +D PS+ L ++ + L ++P++R +
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 263
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-53
Identities = 57/284 (20%), Positives = 106/284 (37%), Gaps = 38/284 (13%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I + +GSG G+V+ + G A+K ++ ++ E +L
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRK 60
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
H + + T + ++T +C G L+ L TK + + A + ++
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YLH + II+RDLK N+ L + V + DF L+ + S
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS----------------------- 155
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAG---HTSAVDWWALGILLYEMLYGYTPFRGKT 902
G+ ++APE+I ++ D +A GI+LYE++ G P+
Sbjct: 156 --RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213
Query: 903 RQKTFANILHKDLKFPSSTPTSLH----AKQLMYRLLHRDPKSR 942
+ ++ + P + + K+LM L + R
Sbjct: 214 NRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 66/299 (22%), Positives = 109/299 (36%), Gaps = 49/299 (16%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVH---RACAEREILDML 726
++ LGSG GSV+ A+K ++K + + ++ R E +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 727 D--HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
V L F+ LI + + + L+E+ R + +V+ A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAV 123
Query: 785 EYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ H G+++RD+K EN+L+ N G + L DF L
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----------------- 166
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKT 902
F GT Y PE I + + W+LGILLY+M+ G PF
Sbjct: 167 ------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
Query: 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
I+ + F + + L+ L P R EI+ HP+ + V
Sbjct: 215 ------EIIRGQVFFRQRVSSE--CQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-52
Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 54/299 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREIL-DMLDHPFVPA 733
+ LG G G V + + + FA+K + R E E+ P +
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 69
Query: 734 LYASFQT----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC 789
+ ++ + + ++ + GGELF + + + E + A++YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 790 QGIIYRDLKPENVLL---QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
I +RD+KPEN+L + N + LTDF +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--------------------------- 162
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
+ + T Y+APE++ + + D W+LG+++Y +L GY PF
Sbjct: 163 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 907 FANILHK------DLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ + + P + S K L+ LL +P R+ E HP+
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIM 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-51
Identities = 59/293 (20%), Positives = 110/293 (37%), Gaps = 35/293 (11%)
Query: 675 KPLGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVP 732
K LGSG+ G+V + A+K + + AE ++ LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIV 71
Query: 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGI 792
+ + ++ L+ + G L L + +K+ + +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 793 IYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPM 852
++RDL NVLL + ++DF LS
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADEN------------------------YY 164
Query: 853 RASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANIL 911
+A ++ APE I +S D W+ G+L++E YG P+RG + A +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
Query: 912 H-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
+ + P+ P + LM D ++R G ++ ++ VN
Sbjct: 225 KGERMGCPAGCPREM--YDLMNLCWTYDVENRPGFAA-VELRLRNYYYDVVNE 274
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-51
Identities = 59/281 (20%), Positives = 93/281 (33%), Gaps = 30/281 (10%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
I + R ++ LG G G V E G A+K + V+ + E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ LDH + LY T + ++T+ P G L L + + YA +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
+ YL + I+RDL N+LL V + DF L
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN------------------ 164
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 901
+ + APE + + A D W G+ L+EM YG P+ G
Sbjct: 165 ------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218
Query: 902 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ I + + P +M + P+ R
Sbjct: 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 60/298 (20%), Positives = 110/298 (36%), Gaps = 43/298 (14%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
G +N++ + ++ +G G+ G V L + G A+K + AE +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-----DATAQAFLAEASV 53
Query: 723 LDMLDHPFVPALYASF-QTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
+ L H + L + K + ++T+Y G L L + VL D + ++ +V
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
A+EYL ++RDL NVL+ + ++DF L+ S
Sbjct: 114 EAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----------------- 156
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRG 900
++ ++ APE + ++ D W+ GILL+E+ +G P+
Sbjct: 157 -------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203
Query: 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN---EIKKH 955
+ + K K + ++M H D R + IK H
Sbjct: 204 IPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-51
Identities = 74/327 (22%), Positives = 111/327 (33%), Gaps = 62/327 (18%)
Query: 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAERE--ILDMLDHPFV 731
+ LG G +V+ + Q A+K + G A RE +L L HP +
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 732 PALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG 791
L +F K+++ L+ D+ ++ D VL ++ Y + LEYLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 792 IIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEP 851
I++RDLKP N+LL NG + L DF L+ P
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 852 MRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFANI 910
RA V T Y APE++ GA + VD WA+G +L E+L G + I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 911 LHKDLKFPSST--------------------------PTSLHAKQLMYRLLHRDPKSRLG 944
L+ L +P +R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 945 SHEGANEIKKHPFFKGVNWALVRCMNP 971
A + K +F C P
Sbjct: 273 ---TATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-50
Identities = 60/278 (21%), Positives = 105/278 (37%), Gaps = 34/278 (12%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I+ + +K LG+G G V + G A+K + +G M E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSED----EFIEEAKVMMN 55
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L H + LY + + +IT+Y G L L + + + +V A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 114
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL + ++RDL N L+ G V ++DF LS
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY------------------------- 149
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
+ + +S + PE++ + +S D WA G+L++E+ G P+ T
Sbjct: 150 -VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+T +I + L+ S +MY H R
Sbjct: 209 ETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADER 245
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 58/287 (20%), Positives = 103/287 (35%), Gaps = 35/287 (12%)
Query: 677 LGSGDTGSVHLVELC--GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPAL 734
LG G+ GSV A+K + +G + E +I+ LD+P++ L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 735 YASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIY 794
Q + + L+ + GG L L + + V +V + ++YL + ++
Sbjct: 75 IGVCQAE-ALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRA 854
RDL NVLL + ++DF LS +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---------------------- 170
Query: 855 SNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH- 912
+ ++ APE I +S D W+ G+ ++E L YG P++ + A I
Sbjct: 171 --AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 228
Query: 913 KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
K ++ P P L LM + R + + ++
Sbjct: 229 KRMECPPECPPEL--YALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-48
Identities = 69/323 (21%), Positives = 118/323 (36%), Gaps = 61/323 (18%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+++F+ ++ +G G G V+ +G+ A+K + A E +L L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELN 59
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
HP + L T+ + L+ ++ L +D + ++ Y +++ L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H +++RDLKP+N+L+ G + L DF L+
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------------------------A 151
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTRQKT 906
P+R V T Y APEI+ G + S AVD W+LG + EM+ F G +
Sbjct: 152 FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
Query: 907 FANILHKDLKFPSST---------------------------PTSLHAKQLMYRLLHRDP 939
I P + L+ ++LH DP
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
Query: 940 KSRLGSHEGANEIKKHPFFKGVN 962
R+ A HPFF+ V
Sbjct: 272 NKRI----SAKAALAHPFFQDVT 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 3e-48
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 33/300 (11%)
Query: 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAER 720
++I++ + + +G+G+ G V L G+ + A+K + G + +E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEA 78
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
I+ DHP V L T V +IT++ G L RQ + +
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF-LRQNDGQFTVIQLVGMLRGI 137
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
++YL ++RDL N+L+ N ++DF LS
Sbjct: 138 AAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD------------- 184
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFR 899
++ + APE I TSA D W+ GI+++E++ YG P+
Sbjct: 185 ---------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN---EIKKHP 956
T Q I +D + P QLM +D R + N ++ ++P
Sbjct: 236 DMTNQDVINAIE-QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-48
Identities = 79/351 (22%), Positives = 130/351 (37%), Gaps = 76/351 (21%)
Query: 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF 730
+ K +G+G G V+ +LC SG+ A+K + + E +I+ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 731 VPALYASFQT------KTHVCLITDYCPGGELFLLLDR-QPTKVLKEDAVRFYAAEVVVA 783
+ L F + + ++ L+ DY P + + + L V+ Y ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 784 LEYLHCQGIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
L Y+H GI +RD+KP+N+LL + V L DF +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------------- 174
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAP-EIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+ S++ + Y AP I +TS++D W+ G +L E+L G F G
Sbjct: 175 --------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 902 TRQKTFANIL-----------------HKDLKFPSSTP----------TSLHAKQLMYRL 934
+ I+ + + KFP T A L RL
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 935 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEK 985
L P +RL E H FF + V+ N + LF T++
Sbjct: 287 LEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRDTP-ALFNFTTQE 332
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 9e-48
Identities = 69/319 (21%), Positives = 118/319 (36%), Gaps = 55/319 (17%)
Query: 644 KPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMD 703
KP +D W ++ + + ++ LG+G G V + G A+K++
Sbjct: 1 KPWWEDE--W-----------EVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK 46
Query: 704 KGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ 763
+G M AE ++ L H + LYA T+ + +IT+Y G L L
Sbjct: 47 QGSM----SPDAFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTP 101
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
L + + AA++ + ++ + I+RDL+ N+L+ + DF L+ L
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--- 158
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
A ++ APE I T D W+
Sbjct: 159 -----------------------IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 884 LGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKS 941
GILL E++ +G P+ G T + N+ + P + P L QLM P+
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL--YQLMRLCWKERPED 253
Query: 942 RLGSHEGANEIKK--HPFF 958
R + ++ FF
Sbjct: 254 RP----TFDYLRSVLEDFF 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 9e-48
Identities = 57/305 (18%), Positives = 104/305 (34%), Gaps = 55/305 (18%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAER 720
++ K LGSG G V G + A+K + + + ++ +E
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSEL 91
Query: 721 EILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTK------------- 766
+++ L H + L + + LI +YC G+L L + K
Sbjct: 92 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 767 --------VLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
VL + + +A +V +E+L + ++RDL NVL+ V + DF L+
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878
++ +++APE + +T
Sbjct: 212 RDIMSDSNYVVRGN-------------------------ARLPVKWMAPESLFEGIYTIK 246
Query: 879 VDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHR 937
D W+ GILL+E+ G P+ G F ++ K + +M
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 938 DPKSR 942
D + R
Sbjct: 307 DSRKR 311
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-48
Identities = 68/329 (20%), Positives = 122/329 (37%), Gaps = 68/329 (20%)
Query: 669 QHFRPIKPLGSGDTGSVHLV-ELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML- 726
Q + + +G G G V +L G++ A+K + E +L L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLE 65
Query: 727 --DHPFVPALYASFQT-----KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
+HP V L+ +T + L+ ++ L D+ P + + ++ +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQ 124
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRH 839
++ L++LH +++RDLKP+N+L+ +G + L DF L+ + S
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS----------------- 167
Query: 840 KGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899
A S V T Y APE++ + + + VD W++G + EM FR
Sbjct: 168 -----------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 900 GKTRQKTFANILH-----------KDLKFPSS--------------TPTSLHAKQLMYRL 934
G + IL +D+ P T K L+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 935 LHRDPKSRLGSHEGANEIKKHPFFKGVNW 963
L +P R+ A HP+F+ +
Sbjct: 277 LTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (428), Expect = 2e-47
Identities = 54/278 (19%), Positives = 93/278 (33%), Gaps = 30/278 (10%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ LG G G V+ A+K + + + +V E ++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 68
Query: 725 MLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
+ HP + L + +IT++ G L L + + + + A ++ A+
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
EYL + I+RDL N L+ N V + DF LS L
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL------------------------ 164
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ A ++ APE +A + D WA G+LL+E+
Sbjct: 165 --MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+L KD + +LM +P R
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 51/277 (18%), Positives = 102/277 (36%), Gaps = 32/277 (11%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I+ ++ +GSG G VHL + A+K + +G M + + E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIE----EAEVMMK 56
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L HP + LY + +CL+ ++ G L R + + + +V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
YL +I+RDL N L+ N + ++DF ++
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF------------------------- 150
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+ + +S ++ +PE+ + + ++S D W+ G+L++E+
Sbjct: 151 -VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209
Query: 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ + S H Q+M P+ R
Sbjct: 210 EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-47
Identities = 65/329 (19%), Positives = 105/329 (31%), Gaps = 69/329 (20%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + +G G G V +GQ A+K + A E +IL +L H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHE 69
Query: 730 FVPALYASFQTKT--------HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
V L +TK + L+ D+C LL + ++ ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLL 127
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
L Y+H I++RD+K NVL+ +G + L DF L+ S
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--------------- 172
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900
+ V T Y PE++ G + +D W G ++ EM +G
Sbjct: 173 --------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
Query: 901 KTRQKTFANILHKDLKFPSSTP------------------------------TSLHAKQL 930
T Q A I +A L
Sbjct: 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
Query: 931 MYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
+ +LL DP R+ +++ H FF
Sbjct: 285 IDKLLVLDPAQRI----DSDDALNHDFFW 309
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-47
Identities = 59/297 (19%), Positives = 106/297 (35%), Gaps = 40/297 (13%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM 725
I + R LG G G V + G+ + A+K + G M E +++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPE----AFLQEAQVMKK 68
Query: 726 LDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
L H + LYA ++ + ++T+Y G L L + K L+ + AA++ +
Sbjct: 69 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+ ++RDL+ N+L+ N + DF L+ L
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL------------------------- 162
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGKTRQ 904
A ++ APE T D W+ GILL E+ G P+ G +
Sbjct: 163 -IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFK 959
+ + + + P LM + ++P+ R ++ +F
Sbjct: 222 EVLDQVE-RGYRMPCPPECPESLHDLMCQCWRKEPEERP----TFEYLQAFLEDYFT 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (411), Expect = 3e-45
Identities = 60/320 (18%), Positives = 117/320 (36%), Gaps = 63/320 (19%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
++ + ++ +G G G V+ + G+ FA+K + + E IL L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLE-KEDEGIPSTTIREISILKELK 58
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
H + LY TK + L+ ++ LL + L+ + + +++ + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + +++RDLKP+N+L+ G + + DF L+
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR---------------------------A 149
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906
P+R + T Y AP+++ G+ +++ +D W++G + EM+ G F G +
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209
Query: 907 FANILHKDLKFPSSTP---------------------------TSLHAKQLMYRLLHRDP 939
I S L+ ++L DP
Sbjct: 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 940 KSRLGSHEGANEIKKHPFFK 959
R+ A + +H +FK
Sbjct: 270 NQRI----TAKQALEHAYFK 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 9e-45
Identities = 66/351 (18%), Positives = 120/351 (34%), Gaps = 67/351 (19%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+ + +G G G V + A+K + ++ R E +IL H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHE 66
Query: 730 FVPALYASFQTKTHV----CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALE 785
+ + + T + + G +L+ LL Q L D + ++ +++ L+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGLK 123
Query: 786 YLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
Y+H +++RDLKP N+LL + + DF L+ +
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-------------------- 163
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIA-GAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904
+ +V T Y APEI+ G+T ++D W++G +L EML F GK
Sbjct: 164 ----DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 219
Query: 905 KTFANIL--------------------HKDLKFPSSTPTSLH---------AKQLMYRLL 935
+IL + L P + A L+ ++L
Sbjct: 220 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279
Query: 936 HRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKE 986
+P R+ + HP+ + + + D KE
Sbjct: 280 TFNPHKRI----EVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKE 326
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (409), Expect = 2e-44
Identities = 69/367 (18%), Positives = 125/367 (34%), Gaps = 87/367 (23%)
Query: 638 SKVVHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYF 697
++V + W +++ G N ++ ++ LG G V + +
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWG---NQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 698 AMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTKTH--VCLITDYCPGG 754
+K + K + E +IL+ L P + L + L+ ++
Sbjct: 64 VVKILKP------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 755 ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-NGHVSLT 813
+ L L + +RFY E++ AL+Y H GI++RD+KP NV++ + + L
Sbjct: 118 DFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 172
Query: 814 DFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA 873
D+ L+ P + N V + + PE++
Sbjct: 173 DWGLAE----------------------------FYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 874 -GHTSAVDWWALGILLYEMLYGYTPFR-GKTRQKTFANI-----------------LHKD 914
+ ++D W+LG +L M++ PF G I + D
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 915 LKFPSSTPT------------------SLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHP 956
+F S A + +LL D +SRL A E +HP
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHP 320
Query: 957 FFKGVNW 963
+F V
Sbjct: 321 YFYTVVK 327
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 58/321 (18%), Positives = 116/321 (36%), Gaps = 63/321 (19%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
+Q + ++ +G G G+V + + + A+K + + A E +L L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELK 59
Query: 728 HPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYL 787
H + L+ + + L+ ++C L + V+ + +++ L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 788 HCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVF 847
H + +++RDLKP+N+L+ NG + L +F L+
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARA--------------------------- 150
Query: 848 MAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTP-FRGKTRQK 905
P+R ++ V T Y P+++ GA +++++D W+ G + E+ P F G
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
Query: 906 TFANILHKDLKFPSSTPTSLH---------------------------AKQLMYRLLHRD 938
I S+ + L+ LL +
Sbjct: 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270
Query: 939 PKSRLGSHEGANEIKKHPFFK 959
P R+ A E +HP+F
Sbjct: 271 PVQRI----SAEEALQHPYFS 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-44
Identities = 54/294 (18%), Positives = 99/294 (33%), Gaps = 45/294 (15%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD 724
++ + +G G+ G V + G +++ E E+L
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65
Query: 725 ML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQPTKVLK 769
L HP + L + + + ++ L +Y P G L L L
Sbjct: 66 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 770 EDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLL 829
+ +AA+V ++YL + I+RDL N+L+ N + DF LS
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------- 174
Query: 830 PTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLY 889
E ++A E + + +T+ D W+ G+LL+
Sbjct: 175 -----------------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217
Query: 890 EML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
E++ G TP+ G T + + + + + LM + P R
Sbjct: 218 EIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-43
Identities = 57/307 (18%), Positives = 102/307 (33%), Gaps = 58/307 (18%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 719
+ + ++ +G G G V G A+K + + + + E
Sbjct: 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 66
Query: 720 REILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ---------------- 763
++ D+P + L +CL+ +Y G+L L
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 764 ------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817
L A +V + YL + ++RDL N L+ N V + DF L
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS 877
S ++ A+ +A + ++ PE I +T+
Sbjct: 187 SRN-------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221
Query: 878 AVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLL 935
D WA G++L+E+ YG P+ G ++ + + L P + P L LM
Sbjct: 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLEL--YNLMRLCW 279
Query: 936 HRDPKSR 942
+ P R
Sbjct: 280 SKLPADR 286
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 2e-43
Identities = 49/300 (16%), Positives = 100/300 (33%), Gaps = 38/300 (12%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
+R + +GSG G ++L +G+ A+K + + K + E +I M+
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGG 62
Query: 730 -FVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+P + + ++ + L ++ V A +++ +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDL--FNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 789 CQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNP 845
+ I+RD+KP+N L+ V + DF L+ K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--------------------KYRDAR 160
Query: 846 VFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
P R + + GT Y + G + D +LG +L G P++G
Sbjct: 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 906 TFANILHKDLKFPSSTPTSLH------AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959
K S+ L + + + ++ ++ F +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP-DYSYLRQLFRNLFHR 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 57/309 (18%), Positives = 101/309 (32%), Gaps = 50/309 (16%)
Query: 657 QKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRN 711
Q D + K LG+G G V G + A+K + +
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLT 68
Query: 712 KVHRACAEREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQ------- 763
+ +E ++L L +H + L + +IT+YC G+L L R+
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 764 ---------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTD 814
L + + ++ +V + +L + I+RDL N+LL + D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874
F L+ + +++APE I
Sbjct: 189 FGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCV 223
Query: 875 HTSAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYR 933
+T D W+ GI L+E+ G +P+ G F ++ + + S +M
Sbjct: 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKT 283
Query: 934 LLHRDPKSR 942
DP R
Sbjct: 284 CWDADPLKR 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 75/345 (21%), Positives = 128/345 (37%), Gaps = 42/345 (12%)
Query: 655 AIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNK-- 712
A+ +IL E F+ IK LGSG G+V+ G+ + K + +
Sbjct: 1 ALLRILKETE------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54
Query: 713 VHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
E ++ +D+P V L T T LIT P G L + +
Sbjct: 55 NKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQY 112
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ + ++ + YL + +++RDL NVL++ HV +TDF L+ L +
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------- 164
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
E + +++A E I +T D W+ G+ ++E++
Sbjct: 165 -----------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 207
Query: 893 -YGYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951
+G P+ G + +IL K + P ++ +M + D SR E E
Sbjct: 208 TFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
Query: 952 ---IKKHPFFKGVNWALVRCMNPPELDAPLFA--TDTEKEYKVVD 991
+ + P V R P D+ + D E VVD
Sbjct: 267 FSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-43
Identities = 68/295 (23%), Positives = 107/295 (36%), Gaps = 41/295 (13%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
I + + +G G G VH A+K + + + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALT 61
Query: 723 LDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVV 782
+ DHP + L T+ V +I + C GEL L + L ++ YA ++
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 119
Query: 783 ALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQ 842
AL YL + ++RD+ NVL+ N V L DF LS
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-------------------- 159
Query: 843 QNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML-YGYTPFRGK 901
++ +++APE I TSA D W G+ ++E+L +G PF+G
Sbjct: 160 ------DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 902 TRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955
I + + L P + P +L LM + DP R E+K
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTL--YSLMTKCWAYDPSRRP----RFTELKAQ 262
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-42
Identities = 71/328 (21%), Positives = 120/328 (36%), Gaps = 67/328 (20%)
Query: 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH 728
+R ++P+GSG G+V +G A+K + + + RA E +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRH 76
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGEL--FLLLDRQPTKVLKEDAVRFYAAEVVVALEY 786
V L F + TD+ L + L ED ++F +++ L Y
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 787 LHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPV 846
+H GII+RDLKP N+ + + + + DF L+ +
Sbjct: 137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---------------------- 174
Query: 847 FMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905
+V T Y APE+I +T VD W++G ++ EM+ G T F+G
Sbjct: 175 --------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
Query: 906 TFANILHKDLKFPSSTP-----------------------------TSLHAKQLMYRLLH 936
I+ P+ S A L+ ++L
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286
Query: 937 RDPKSRLGSHEGANEIKKHPFFKGVNWA 964
D + R+ A E HP+F+ ++
Sbjct: 287 LDAEQRV----TAGEALAHPYFESLHDT 310
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (391), Expect = 2e-42
Identities = 49/285 (17%), Positives = 92/285 (32%), Gaps = 39/285 (13%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH- 728
H++ + +G G G + + Q A+K + R+ + E +L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC 60
Query: 729 PFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
+P +Y Q H L+ D LL + V A +++ ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 789 CQGIIYRDLKPENVLL-----QGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQ 843
+ ++YRD+KP+N L+ + + + DF +
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR--------------------D 158
Query: 844 NPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903
P R + GT Y++ G + D ALG + L G P++G
Sbjct: 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218
Query: 904 QKTFANILHKDLKFPSSTPTSLHA------KQLMYRLLHRDPKSR 942
K S+ L A + M+ + +
Sbjct: 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-42
Identities = 69/369 (18%), Positives = 135/369 (36%), Gaps = 86/369 (23%)
Query: 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD 727
L+ ++ +KP+GSG G V + A+K + + N+ RA E ++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVN 74
Query: 728 HPFVPALYASFQTK------THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVV 781
H + +L F + V L+ + ++ + + + +++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQML 129
Query: 782 VALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKG 841
+++LH GII+RDLKP N++++ + + + DF L+ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-------------- 175
Query: 842 QQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901
+V T Y APE+I G G+ VD W++G ++ EM+ F G+
Sbjct: 176 --------------TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 902 TRQKTFANIL---------------------------HKDLKFPSSTPTSLH-------- 926
+ ++ + L FP P SL
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 927 -----AKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLF-- 979
A+ L+ ++L DP R+ ++ +HP+ PP++
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDE 337
Query: 980 ATDTEKEYK 988
T +E+K
Sbjct: 338 REHTIEEWK 346
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 60/301 (19%), Positives = 105/301 (34%), Gaps = 53/301 (17%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACA 718
+ KPLG G G V L E G A+K + + +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLIS 67
Query: 719 EREILDML-DHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------------DRQ 763
E E++ M+ H + L + + +I +Y G L L
Sbjct: 68 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
P + L + A +V +EYL + I+RDL NVL+ + + + DF L+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH- 186
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
+ + + + +++APE + +T D W+
Sbjct: 187 ------------------------HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 884 LGILLYEML-YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKS 941
G+LL+E+ G +P+ G ++ F + + PS+ L +M H P
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNEL--YMMMRDCWHAVPSQ 280
Query: 942 R 942
R
Sbjct: 281 R 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-40
Identities = 51/314 (16%), Positives = 105/314 (33%), Gaps = 46/314 (14%)
Query: 666 INLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAER 720
+ + + LG G G V+ G A+K +++ + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 74
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLL--------DRQPTKVLKEDA 772
++ + V L +I + G+L L +
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 773 VRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832
+ A E+ + YL+ ++RDL N ++ + V +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG------------------- 175
Query: 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEML 892
G ++ + R + +++PE + T+ D W+ G++L+E+
Sbjct: 176 ------DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 893 -YGYTPFRGKTRQKTFANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN 950
P++G + ++ ++ L P + P L +LM +PK R E +
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 287
Query: 951 EIKK--HPFFKGVN 962
IK+ P F+ V+
Sbjct: 288 SIKEEMEPGFREVS 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 51/282 (18%), Positives = 95/282 (33%), Gaps = 31/282 (10%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAER 720
+I+ K +G+G+ G V+ L S A+K + G + E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEA 60
Query: 721 EILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEV 780
I+ H + L + +IT+Y G R+ + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 781 VVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
++YL ++RDL N+L+ N ++DF LS + P+ T+
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------- 171
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900
+ APE I+ TSA D W+ GI+++E++
Sbjct: 172 ----------------GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215
Query: 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
+ ++ + P+ QLM + ++ R
Sbjct: 216 ELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-40
Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 53/313 (16%)
Query: 665 QINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAE 719
+ + KPLG G G V + G + + A+K + +G + ++ + E
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--E 66
Query: 720 REILDMLDHPF--VPALYASFQTKTHVCLITDYCPGGELFLLLDRQ-------------- 763
+IL + H V L A + + +I ++C G L L +
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 764 PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823
L + + Y+ +V +E+L + I+RDL N+LL V + DF L+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD--- 183
Query: 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWA 883
++ +++APE I +T D W+
Sbjct: 184 ----------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 884 LGILLYEMLYGY-TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSR 942
G+LL+E+ +P+ G + F L + + + T+ Q M H +P R
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281
Query: 943 LGSHEGANEIKKH 955
+E+ +H
Sbjct: 282 P----TFSELVEH 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 57/308 (18%), Positives = 118/308 (38%), Gaps = 37/308 (12%)
Query: 641 VHPKPHRKDSPPWKAIQKILDSGEQINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYF 697
VH + +A+Q ++ + + HF + +G G G V+ L G +
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSLIV-HFNEV--IGRGHFGCVYHGTLLDNDGKKIHC 58
Query: 698 AMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY-ASFQTKTHVCLITDYCPGGEL 756
A+K++++ + + +V + E I+ HP V +L +++ ++ Y G+L
Sbjct: 59 AVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 757 FLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFD 816
+ + +D + F +V +++L + ++RDL N +L V + DF
Sbjct: 117 RNFIRNETHNPTVKDLIGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFG 175
Query: 817 LSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876
L+ K + + +++A E + T
Sbjct: 176 LARDMYDK-----------------------EFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 877 SAVDWWALGILLYEML-YGYTPFRGKTRQKTFANILH-KDLKFPSSTPTSLHAKQLMYRL 934
+ D W+ G+LL+E++ G P+ +L + L P P L ++M +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL--YEVMLKC 270
Query: 935 LHRDPKSR 942
H + R
Sbjct: 271 WHPKAEMR 278
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 7e-39
Identities = 70/354 (19%), Positives = 122/354 (34%), Gaps = 73/354 (20%)
Query: 670 HFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHP 729
++ + P+GSG GSV +G A+K + + + R E +L + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77
Query: 730 FVPALYASFQTKTHVC-----LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVAL 784
V L F + + + G +L ++ Q L +D V+F +++ L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 785 EYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQN 844
+Y+H II+RDLKP N+ + + + + DF L+ T +
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM------------------- 175
Query: 845 PVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTS-AVDWWALGILLYEMLYGYTPFRGKTR 903
+V T Y APEI+ H + VD W++G ++ E+L G T F G
Sbjct: 176 -----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224
Query: 904 QKTFANILHKDLKFPSSTP-----------------------------TSLHAKQLMYRL 934
IL + + A L+ ++
Sbjct: 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284
Query: 935 LHRDPKSRLGSHEGANEIKKHPFFKGVNWALVRCMNPPELDAPLFATDTEKEYK 988
L D R+ A + H +F + + P + E+K
Sbjct: 285 LVLDSDKRI----TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 334
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 57/309 (18%), Positives = 103/309 (33%), Gaps = 74/309 (23%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM--LDHPFVP 732
+ +G G G V + G+ A+K + + + E EI L H +
Sbjct: 9 ESIGKGRFGEVWRGKW--RGEEVAVK------IFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 733 ALYASFQ----TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLH 788
A+ T T + L++DY G LF L+R + + + A L +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLH 117
Query: 789 CQ--------GIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHK 840
+ I +RDLK +N+L++ NG + D L+ +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI------------ 165
Query: 841 GQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH------TSAVDWWALGILLYEMLYG 894
A N VGT+ Y+APE++ + + D +A+G++ +E+
Sbjct: 166 -----------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214
Query: 895 YTPFRGKTRQKTFANILHK-----------------DLKFP---SSTPTSLHAKQLMYRL 934
+ + L P S ++M
Sbjct: 215 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 274
Query: 935 LHRDPKSRL 943
+ + +RL
Sbjct: 275 WYANGAARL 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 1e-30
Identities = 57/357 (15%), Positives = 110/357 (30%), Gaps = 87/357 (24%)
Query: 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREI 722
GE + ++ LG G +V L + + + AMK + + + +
Sbjct: 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 66
Query: 723 -------LDMLDHPFVPALYASFQTKT---HVCLITDYCPGGELFLLLDRQPTKVLKEDA 772
D + + L F K ++ G L L+ + + +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 773 VRFYAAEVVVALEYLHCQ-GIIYRDLKPENVLLQGNGHVS-LTDFDLSCLTSCKPQLLLP 830
V+ + ++++ L+Y+H + GII+ D+KPENVL++ L ++ L +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC------ 180
Query: 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYE 890
+ + T EY +PE++ GA D W+ L++E
Sbjct: 181 -------------------WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 221
Query: 891 MLYGYTPFRGKTRQKTFANILH-------------------------------------- 912
++ G F + H
Sbjct: 222 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 281
Query: 913 --------KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961
K+ S + + +L DP+ R A + HP+ K
Sbjct: 282 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKDT 334
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 96.9 bits (240), Expect = 1e-24
Identities = 65/107 (60%), Positives = 86/107 (80%)
Query: 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETL 257
+ TFVV+DAT PD P++YAS GF+ MTGY EV+G NCRFLQG GTDP++V KIR+ +
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ G++ RLLNY+KDGTPFWNLLT+ PIK +G+V KF+G+QV+V+
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVDVT 108
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 109 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 96.9 bits (240), Expect = 2e-24
Identities = 49/105 (46%), Positives = 67/105 (63%)
Query: 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAI 540
+ FV+ D LPD P+++AS+ F +T Y +E+LG NCRFLQG TDP V+KIR AI
Sbjct: 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAI 61
Query: 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
+V+L+NY K G FWNL + P++ G V F+GVQ+D
Sbjct: 62 KKGEACSVRLLNYRKDGTPFWNLLTVTPIKTPDGRVSKFVGVQVD 106
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 92.7 bits (229), Expect = 5e-23
Identities = 75/103 (72%), Positives = 86/103 (83%)
Query: 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDN 542
K+FVITDPRLPDNPIIFASD FLELTEY+REE+LG NCRFLQG TD V+ IR A+
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 543 QTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585
Q DVTVQ++NYTK G+ FWNLFHLQ MRD+ G+VQYFIGVQ +
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQE 103
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} Length = 104 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Score = 86.9 bits (214), Expect = 5e-21
Identities = 46/104 (44%), Positives = 69/104 (66%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQN 259
++FV++D PD PI++AS F ++T YT +EV+G NCRFLQG GTD + V IR+ ++
Sbjct: 1 KSFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKE 60
Query: 260 GQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303
+ ++LNY K G FWNL + ++D+ G V FIG+Q E+
Sbjct: 61 QRDVTVQVLNYTKGGRAFWNLFHLQVMRDENGDVQYFIGVQQEM 104
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.4 bits (176), Expect = 6e-16
Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 2/108 (1%)
Query: 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC--RFLQGPETDPATVRKIRAAI 540
+ F+I + R+ + +I+ +D F EL YSR E++ R C FL GP T +I A+
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 541 DNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSE 588
+ V++ Y K G F L + P++++ G V FI E
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVME 109
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 9e-13
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 2/107 (1%)
Query: 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNC--RFLQGAGTDPEDVAKIRETL 257
+ F++++A + ++Y + GF ++ GY+ EV+ R C FL G T A+I + L
Sbjct: 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQAL 61
Query: 258 QNGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ + Y+KDG+ F L+ + P+K+++G V+ FI V
Sbjct: 62 LGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVM 108
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 2e-13
Identities = 25/159 (15%), Positives = 46/159 (28%), Gaps = 30/159 (18%)
Query: 675 KPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN-KVHRACAERE------------ 721
K +G G +V +K G + K R +
Sbjct: 6 KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 722 --ILDMLDHPFVPALYASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAE 779
L L VP +YA ++ + ++ +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPDEVLDM 111
Query: 780 VVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLS 818
++ + + +GI++ DL NVL+ G + DF S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGIW-IIDFPQS 149
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 45.9 bits (107), Expect = 1e-06
Identities = 20/108 (18%), Positives = 34/108 (31%), Gaps = 9/108 (8%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKI----RAAID 541
++ D I S + L +S E +G+N L I +
Sbjct: 4 IVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDP 60
Query: 542 NQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589
+ + + + G F + M+ G YF G D +EH
Sbjct: 61 HIIGIGRIVTGKRRDGTTFPMHLSIGEMQS--GGEPYFTGFVRDLTEH 106
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} Length = 106 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Score = 43.2 bits (100), Expect = 1e-05
Identities = 17/103 (16%), Positives = 36/103 (34%), Gaps = 6/103 (5%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKI----RETLQNGQSY 263
I S ++ G++ E +G+N L + I + +
Sbjct: 6 IDGHGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGI 65
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306
+ ++DGT F L+I ++ F G ++++H
Sbjct: 66 GRIVTGKRRDGTTFPMHLSIGEMQSGGEPY--FTGFVRDLTEH 106
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 44.3 bits (103), Expect = 8e-06
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 6/101 (5%)
Query: 208 TKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQ----SY 263
+ D I+ +A + GY +EV+G+N R L E ++ + G+
Sbjct: 32 SATDGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQRYMATGEKRIIGI 91
Query: 264 CGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304
+ +KDG+ F L + ++ + F G +++
Sbjct: 92 DRVVSGQRKDGSTFPMKLAVGEMRSGGERF--FTGFIRDLT 130
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Score = 42.3 bits (98), Expect = 4e-05
Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 13/129 (10%)
Query: 461 DKVRQKEMRKGIDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNC 520
D VR ++ L + L+ + V++ D I+ + + + Y+ EE++G+N
Sbjct: 9 DVVRARDAH----LRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNL 61
Query: 521 RFLQG----PETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLFHLQPMRDQKGEV 576
R L E D R + + + K G F + MR G
Sbjct: 62 RILMPEPYRHEHDGYLQRYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRS--GGE 119
Query: 577 QYFIGVQLD 585
++F G D
Sbjct: 120 RFFTGFIRD 128
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (95), Expect = 8e-05
Identities = 15/101 (14%), Positives = 34/101 (33%), Gaps = 8/101 (7%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD 545
D + I+ A+D L YS ++++G+ ++
Sbjct: 12 FTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGH 69
Query: 546 VTV----QLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGV 582
V + ++SG+K ++ MR ++ + V
Sbjct: 70 AAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRL--CCVVV 108
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 4e-04
Identities = 19/97 (19%), Positives = 30/97 (30%), Gaps = 1/97 (1%)
Query: 493 PDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLIN 552
D + D EL Y EE+LGR+ + + V+ Q
Sbjct: 14 MDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRM 73
Query: 553 YTKSGKKFWNLFHLQPMRDQK-GEVQYFIGVQLDGSE 588
K G W + + + + Q + V SE
Sbjct: 74 LAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLSE 110
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 114 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (85), Expect = 0.001
Identities = 18/107 (16%), Positives = 33/107 (30%), Gaps = 3/107 (2%)
Query: 199 QQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQ 258
+TF+ D Y ++ GY +E++GR+ A +
Sbjct: 5 SKTFLSR--HSMDMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCT 62
Query: 259 NGQSYCGRLLNYKKDGTPFWNLLTIAPIKDDE-GKVLKFIGMQVEVS 304
GQ G+ K G W I + + + + +S
Sbjct: 63 KGQVVSGQYRMLAKHGGYVWLETQGTVIYNPRNLQPQCIMCVNYVLS 109
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} Length = 110 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Score = 37.4 bits (86), Expect = 0.001
Identities = 12/96 (12%), Positives = 25/96 (26%), Gaps = 5/96 (5%)
Query: 486 VITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVR-KIRAAIDNQT 544
+ D I + + L+ E ++GRN P T+ + + + T
Sbjct: 17 IQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGT 73
Query: 545 DVTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFI 580
+ +Q F+
Sbjct: 74 LDARFDFVFDFQMAPVRVQIRMQNAGVP-DRYWIFV 108
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1002 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.86 | |
| d1n9la_ | 109 | Putative blue light receptor, phot-lov1 domain {Gr | 99.83 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.8 | |
| d1bywa_ | 110 | Erg potassium channel, N-terminal domain {Human (H | 99.79 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.78 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.77 | |
| d1jnua_ | 104 | Photoreceptor phy3 flavin-binding domain, lov2 {Ma | 99.74 | |
| d1ew0a_ | 130 | Histidine kinase FixL heme domain {Rhizobium melil | 99.74 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.66 | |
| d1p97a_ | 114 | Hypoxia-inducible factor Hif2a, C-terminal domain | 99.66 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.61 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.59 | |
| d1v9ya_ | 113 | Direct oxygen sensor protein, DOS {Escherichia col | 99.57 | |
| d1xj3a1 | 106 | Histidine kinase FixL heme domain {Bradyrhizobium | 99.56 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.46 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.43 | |
| d1nwza_ | 125 | Photoactive yellow protein, PYP {Ectothiorhodospir | 99.4 | |
| d1mzua_ | 110 | PYP domain of sensor histidine kinase Ppr {Rhodosp | 99.33 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.31 | |
| d1ll8a_ | 114 | N-terminal PAS domain of Pas kinase {Human (Homo s | 99.2 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 99.01 | |
| d1oj5a_ | 109 | PAS domain of steroid receptor coactivator 1A, NCo | 99.01 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.61 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.54 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.73 | |
| d2oola2 | 114 | Sensor protein PhyB2 {Rhodopseudomonas palustris [ | 96.68 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 92.95 | |
| d2veaa3 | 127 | Phytochrome-like protein Cph1 {Synechocystis sp. p | 92.71 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 92.69 | |
| d2o9ca2 | 127 | Bacteriophytochrome BphP {Deinococcus radiodurans | 92.35 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=418.19 Aligned_cols=279 Identities=40% Similarity=0.763 Sum_probs=246.6
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 34689422321166693899999991799199999940542248578999999999999579998442478986088299
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (1002)
+.+++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+|++++||||+++++++...+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCC
T ss_conf 84474289889831768499999998999899999981565449799999999999998679998877876403564211
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCC
Q ss_conf 99961689835677731799999999999999999999999998494317899995898059929998426775457898
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~ 825 (1002)
+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred CCEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC-
T ss_conf 100035798605555325--67759999999999965211343159622464777847658998888205652003567-
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77778512332114699997422356666665546876445200038888883059999999999990999999999689
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 905 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+...
T Consensus 159 --------------------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 159 --------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp --------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred --------------------------CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH
T ss_conf --------------------------862055100889966665048988833310223067889987899999969999
Q ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH-CHHHHHCCCCCCCCCHHHH--HCCCCCCCC
Q ss_conf 999998279999999988898999999802049388799734-0999981998679981133--405999889
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE-GANEIKKHPFFKGVNWALV--RCMNPPELD 975 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~-~a~elL~Hpff~~~~~~~~--~~~~~~~~~ 975 (1002)
.+..+......+|. .++.++++||.+||.+||.+|++... .+.++++||||++++|..+ ....||..|
T Consensus 213 ~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P 283 (337)
T d1o6la_ 213 LFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283 (337)
T ss_dssp HHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHHHHHCCCCCCCC--CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 99998528998986--689999999986663893442256523499997291503699999984789989788
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=422.50 Aligned_cols=279 Identities=36% Similarity=0.652 Sum_probs=246.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++++++||||+++++++...+.+|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 98778988985087909999999899979999998657755777899999999999876888861799999989988999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
||||+||+|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|........
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~- 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 163 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCC-
T ss_conf 9704898777765315--9999999999999999999762165088476774123668885388603210242256776-
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 77851233211469999742235666666554687644520003888888305999999999999099999999968999
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 907 (1002)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 164 ------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 164 ------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp ------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ------------------------43335556775525844002689896662304569999980388998995999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH--CHHHHHCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 9998279999999988898999999802049388799734--0999981998679981133405999889
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHE--GANEIKKHPFFKGVNWALVRCMNPPELD 975 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~--~a~elL~Hpff~~~~~~~~~~~~~~~~~ 975 (1002)
..+......++. .++..+.+||.+||..||.+|||+.+ ....+++||||++++|..+....||.++
T Consensus 220 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 220 QKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHTTCCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHHHCCCCCCCC
T ss_conf 999718999985--47999999999985579768919789737789876976478998896157999999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=413.53 Aligned_cols=275 Identities=37% Similarity=0.678 Sum_probs=243.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+|+.++||||+++++++.....+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC
T ss_conf 23708988961176808999999899989999998267745889999999999999974877274034444322222322
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
|||+.+|+|..++... +.+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|.....
T Consensus 120 ~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred CCCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCC----
T ss_conf 2233466226667515--8989999999999999989999859986176799993607789788610103332256----
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 77851233211469999742235666666554687644520003888888305999999999999099999999968999
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 907 (1002)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 194 --------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 247 (350)
T d1rdqe_ 194 --------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247 (350)
T ss_dssp --------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred --------------------------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf --------------------------664336763567889971799885331145007899997588998995999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC-CCHHCHHHHHCCCCCCCCCHHHHH--CCCCCCCCC
Q ss_conf 999827999999998889899999980204938879-973409999819986799811334--059998899
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRL-GSHEGANEIKKHPFFKGVNWALVR--CMNPPELDA 976 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rp-t~~~~a~elL~Hpff~~~~~~~~~--~~~~~~~~~ 976 (1002)
..+......++. .++..+.+||.+||..||.+|+ +.++.++++++||||++++|..+. ...||.+|.
T Consensus 248 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~ 317 (350)
T d1rdqe_ 248 EKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp HHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf 998617988976--6899999999998340998606553454999971905158998999836789693688
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=408.03 Aligned_cols=273 Identities=41% Similarity=0.805 Sum_probs=241.3
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
+++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568528800567
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
||||.|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECC----
T ss_conf 6503786322343222--2111007999999998765541247677055681050386899889831752167124----
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 77851233211469999742235666666554687644520003888888305999999999999099999999968999
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 907 (1002)
...+.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 157 --------------------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 210 (316)
T d1fota_ 157 --------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210 (316)
T ss_dssp --------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred --------------------------CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHH
T ss_conf --------------------------564345763435999983899980430465333689997598999996999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC-HHCHHHHHCCCCCCCCCHHHHH--CCCCCCC
Q ss_conf 99982799999999888989999998020493887997-3409999819986799811334--0599988
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS-HEGANEIKKHPFFKGVNWALVR--CMNPPEL 974 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~--~~~~~~~ 974 (1002)
..+......++. .++..+.+++.+||..||.+|++. ++.++++|+||||++++|..+. ...+|..
T Consensus 211 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~ 278 (316)
T d1fota_ 211 EKILNAELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYE 278 (316)
T ss_dssp HHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCC
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 999708988997--78999999999995449976664310219999819351467989998378996988
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=402.31 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=226.8
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++..... .....+.+|+.++++++||||+++++++...+.+|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 1053887898128582999999989998999999843017---2799999999999867999880585779889998999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 96 mEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-- 170 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (293)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EEECCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC--
T ss_conf 9703798089886415---99999999999999999999998797226776888688789968642515641321366--
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 77851233211469999742235666666554687644520003888888305999999999999099999999968999
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 907 (1002)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 171 -------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 225 (293)
T d1yhwa1 171 -------------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (293)
T ss_dssp -------------------------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred -------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf -------------------------6444444477736826644799880120313729999980488998997999999
Q ss_pred HHHHHCC-CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 9998279-9999999888989999998020493887997340999981998679
Q 001865 908 ANILHKD-LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 908 ~~i~~~~-~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~ 960 (1002)
..+.... ..+..+..++..+.+||.+||..||.+||| +.|+|+||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS----AKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC----HHHHTTCGGGGG
T ss_pred HHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCC
T ss_conf 99985799988885537999999999986699668909----999964996577
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=403.36 Aligned_cols=263 Identities=28% Similarity=0.461 Sum_probs=233.0
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+. .......+.+|+.+|++++||||+++++++...+.+|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 65758988984076819999998899989999998452---431699999999999867997999299999989999999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC--CCCEEEEECCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805--9929998426775457898
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG--NGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~--~~~ikL~DFG~a~~~~~~~ 825 (1002)
||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|......
T Consensus 102 mE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EECCCCCCHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC-
T ss_conf 9857998899999762-37899999999999999999999756976000154673641688986999545210442565-
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77778512332114699997422356666665546876445200038888883059999999999990999999999689
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 905 (1002)
....+..||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 180 ---------------------------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 232 (350)
T d1koaa2 180 ---------------------------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232 (350)
T ss_dssp ---------------------------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ---------------------------CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf ---------------------------43200068624218899758998726765546599999985989989979999
Q ss_pred HHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCHHHH
Q ss_conf 999998279999999--9888989999998020493887997340999981998679981133
Q 001865 906 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV 966 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~--~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 966 (1002)
.+..+......++.. ..++..+.+||.+||..||.+||| +.|+|+||||+..++...
T Consensus 233 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 233 TLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT----IHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC----HHHHHHSTTTSCTTCCSC
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCCCCCCC
T ss_conf 99999847889894223589999999999975689667908----999862913288988875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=403.20 Aligned_cols=277 Identities=32% Similarity=0.581 Sum_probs=226.2
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHH---HHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 4689422321166693899999991799199999940542248578999999---9999995799984424789860882
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACA---EREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~---E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (1002)
..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+ ++.+++.++||||+++++++...+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 77768510188428890999999999997999999845875426679999999999999850899858899999998998
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 99999616898356777317999999999999999999999999984943178999958980599299984267754578
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~ 823 (1002)
+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCC
T ss_conf 89999914898389998732--5532789999999999999999977962204442216785889679822010233378
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9877778512332114699997422356666665546876445200038-888883059999999999990999999999
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 902 (1002)
. .....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+
T Consensus 160 ~-----------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 160 K-----------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp S-----------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred C-----------------------------CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8-----------------------------64331134554216876038999844104677899999985999888899
Q ss_pred HHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH-HCHHHHHCCCCCCCCCHHHHH--CCCCCCC
Q ss_conf 6899999982-7999999998889899999980204938879973-409999819986799811334--0599988
Q 001865 903 RQKTFANILH-KDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVR--CMNPPEL 974 (1002)
Q Consensus 903 ~~~~~~~i~~-~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~--~~~~~~~ 974 (1002)
.......... .......+..++..+.+||.+||..||.+|||.. ..|+++++||||++++|..+. .+.||..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~ 286 (364)
T d1omwa3 211 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 286 (364)
T ss_dssp SSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHHHHCCCCCCCCC
T ss_conf 8999999986046888788778999999999985669888088743579999749102378987996288995937
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.57 Aligned_cols=256 Identities=34% Similarity=0.571 Sum_probs=230.7
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999989998999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 85 mEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---- 158 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---- 158 (263)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----
T ss_pred EEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCC----
T ss_conf 8504798589887504--8999999999999999999999988946522023441466899871155563354488----
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 77851233211469999742235666666554687644520003888888305999999999999099999999968999
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 907 (1002)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 159 -------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 213 (263)
T d2j4za1 159 -------------------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213 (263)
T ss_dssp -------------------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred -------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf -------------------------8523557887634999975899893144046759999983299998889999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 99982799999999888989999998020493887997340999981998679
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~ 960 (1002)
..+......++. .++..+.+||.+||..||.+||| +.|+|+||||++
T Consensus 214 ~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R~t----~~eil~hp~~~~ 260 (263)
T d2j4za1 214 KRISRVEFTFPD--FVTEGARDLISRLLKHNPSQRPM----LREVLEHPWITA 260 (263)
T ss_dssp HHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC----HHHHHTCHHHHH
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCC
T ss_conf 999718999986--68999999999976479768909----999971907078
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=400.10 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=230.1
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+.. ......+.+|+.+|++++||||++++++|..++.+|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 403599899931778299999998999799999988726---46799999999999867997989199999989999999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE--CCCCEEEEECCCCCCCCCCC
Q ss_conf 9616898356777317999999999999999999999999984943178999958980--59929998426775457898
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ--GNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~--~~~~ikL~DFG~a~~~~~~~ 825 (1002)
||||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|......
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EECCCCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC-
T ss_conf 9828998088889863-89989999999999999999999977926513144553113467884899525630343788-
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77778512332114699997422356666665546876445200038888883059999999999990999999999689
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 905 (1002)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 183 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 235 (352)
T d1koba_ 183 ---------------------------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235 (352)
T ss_dssp ---------------------------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred ---------------------------CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf ---------------------------72010047645348999747998976333898999999996889989979999
Q ss_pred HHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 999998279999999--98889899999980204938879973409999819986799
Q 001865 906 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~--~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~ 961 (1002)
.+..+......++.. ..++..+.+||.+||..||.+||| +.|+|+||||++.
T Consensus 236 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHTSTTTSSC
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCCC
T ss_conf 99999847889893002479999999999975699668918----9999609734888
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=406.95 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=222.2
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 43468942232116669389999999179919999994054224857899999999999957999844247898608829
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (1002)
++..++|++++.||+|+||.||+|.++.++..||+|++++.. .......+.+|+.+|+.++||||++++++|...+.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 787568889789712778099999998999699999987540--978999999999999867999999499999989999
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 999961689835677731799999999999999999999999998-4943178999958980599299984267754578
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 745 ~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~-~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~ 823 (1002)
|+||||++|++|.+++.+. +.+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|.....
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 9999767998689987424--99999999999999999999999859997144577994687899899954877625678
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 98777785123321146999974223566666655468764452000388888830599999999999909999999996
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 903 (1002)
....+.+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.
T Consensus 158 -----------------------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 -----------------------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp -----------------------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred -----------------------------CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf -----------------------------862111377141194687589989488899899999999988899899887
Q ss_pred HHHHH------------------------------------------HHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
Q ss_conf 89999------------------------------------------998279999999988898999999802049388
Q 001865 904 QKTFA------------------------------------------NILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKS 941 (1002)
Q Consensus 904 ~~~~~------------------------------------------~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~ 941 (1002)
..... .+.....+.......+.++.+||.+||.+||.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 288 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 89999998875177545774212333221111222354134778876650268766764448999999999986899467
Q ss_pred CCCCHHCHHHHHCCCCCCCCCHHH
Q ss_conf 799734099998199867998113
Q 001865 942 RLGSHEGANEIKKHPFFKGVNWAL 965 (1002)
Q Consensus 942 Rpt~~~~a~elL~Hpff~~~~~~~ 965 (1002)
||| +.|+|+||||++.++..
T Consensus 289 R~t----a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 289 RAD----LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp SCC----HHHHHTSHHHHHHHHSC
T ss_pred CCC----HHHHHHCHHHCCCCCCC
T ss_conf 908----99996098647698231
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=397.32 Aligned_cols=273 Identities=29% Similarity=0.462 Sum_probs=236.7
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 689422321166693899999991799199999940542248---57899999999999957999844247898608829
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN---RNKVHRACAEREILDMLDHPFVPALYASFQTKTHV 744 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 744 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+..... ......+.+|+.+|++++||||+++++++...+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC----CEEEEECCCCCC
Q ss_conf 9999616898356777317999999999999999999999999984943178999958980599----299984267754
Q 001865 745 CLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG----HVSLTDFDLSCL 820 (1002)
Q Consensus 745 ~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~----~ikL~DFG~a~~ 820 (1002)
|+|||||+||+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEECCCCCCCCCHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHH
T ss_conf 9999867786431001035--64215578999999999987666254221133301279825898666469643344210
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 57898777785123321146999974223566666655468764452000388888830599999999999909999999
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 900 (1002)
.... .......|++.|+|||++.+..++.++||||+||++|+|++|+.||.+
T Consensus 167 ~~~~----------------------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 167 IDFG----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp CTTS----------------------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCC----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
T ss_conf 5777----------------------------631224777743099998189999766522140999999708899889
Q ss_pred CCHHHHHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCHHHH--HCCCCCCC
Q ss_conf 99689999998279999999--9888989999998020493887997340999981998679981133--40599988
Q 001865 901 KTRQKTFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWALV--RCMNPPEL 974 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~--~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~--~~~~~~~~ 974 (1002)
.+....+..+......++.. ..++..+.+||.+||..||.+||| +.|+|+||||+..+|... ....+|++
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~~~~~~~l~~~~~~P~f 292 (293)
T d1jksa_ 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQALSSAWSHPQF 292 (293)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSTTTCC-------------CCC
T ss_pred CCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCCCHHHHHCCCCCCCCC
T ss_conf 9999999999816888870104788999999999986389668919----9999619041888705764568899298
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=398.98 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=229.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 89422321166693899999991799199999940542248578999999999999579998442478986088299999
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV~ 748 (1002)
..|+.++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|++++||||+++++++...+.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61689835677731799999999999999999999999998494317899995898059929998426775457898777
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~~ 828 (1002)
|||.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred EECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCC------
T ss_conf 806999457899737--999999999999999999999986897666788421798799978984436533467------
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 78512332114699997422356666665546876445200038---888883059999999999990999999999689
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG---AGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 905 (1002)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...
T Consensus 167 -------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 167 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp -------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -------------------------CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf -------------------------7873134766368899834678886721454558999999987889999979999
Q ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 9999982799999999888989999998020493887997340999981998679
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~ 960 (1002)
.+..+.....+......++..+.+|+.+||..||.+||| +.|+|+||||..
T Consensus 222 ~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHTTCHHHHS
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHCHHHCC
T ss_conf 999998289998887888999999999977379657918----999971997537
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=398.10 Aligned_cols=257 Identities=30% Similarity=0.497 Sum_probs=228.0
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.+.|++.+.||+|+||.||+|.++.+++.||+|++.+.... .....+.+|+.+|++++||||+++++++..++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 66669988994065839999999999989999998157731--2899999999999867998999198999989988898
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEE---CCCCEEEEECCCCCCCCCC
Q ss_conf 9616898356777317999999999999999999999999984943178999958980---5992999842677545789
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQ---GNGHVSLTDFDLSCLTSCK 824 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~---~~~~ikL~DFG~a~~~~~~ 824 (1002)
||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|......
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC
T ss_conf 8526898488865303--67887899999999999987524130556870463001104688824998315435872589
Q ss_pred CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 87777851233211469999742235666666554687644520003888888305999999999999099999999968
Q 001865 825 PQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQ 904 (1002)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~ 904 (1002)
....+.+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..
T Consensus 164 ----------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 215 (307)
T d1a06a_ 164 ----------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215 (307)
T ss_dssp -------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ----------------------------CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf ----------------------------7044003284225918873799980787345159999998597999998999
Q ss_pred HHHHHHHHCCCCCCC--CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 999999827999999--99888989999998020493887997340999981998679
Q 001865 905 KTFANILHKDLKFPS--STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~--~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~ 960 (1002)
.....+......++. ...++..+.+||.+||.+||.+||| +.|+|+||||++
T Consensus 216 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHHSTTTTS
T ss_pred HHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCC
T ss_conf 999998616877787666678999999999976089757918----999862984479
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=398.15 Aligned_cols=271 Identities=37% Similarity=0.739 Sum_probs=235.0
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 89422321166693899999991799199999940542248578999999999999-57999844247898608829999
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILD-MLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
++|++++.||+|+||.||+|.++.+++.||+|++.+...........+..|..++. .++||||+++++++..++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--- 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT---
T ss_pred EEECCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC---
T ss_conf 7503798089986404--78999999999999999999998689340347654044448996301555302323566---
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 77851233211469999742235666666554687644520003888888305999999999999099999999968999
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTF 907 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~ 907 (1002)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+
T Consensus 157 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~ 212 (320)
T d1xjda_ 157 ------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212 (320)
T ss_dssp ------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ------------------------53345457877768999982799883232011227898987388999998999999
Q ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHH-HHHCCCCCCCCCHHHHH--CCCCCCC
Q ss_conf 9998279999999988898999999802049388799734099-99819986799811334--0599988
Q 001865 908 ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGAN-EIKKHPFFKGVNWALVR--CMNPPEL 974 (1002)
Q Consensus 908 ~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~-elL~Hpff~~~~~~~~~--~~~~~~~ 974 (1002)
..+......++. .++..+.+|+.+||..||.+||+ +. ++++||||++++|..+. ...||..
T Consensus 213 ~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R~s----~~~~l~~hpff~~~~~~~l~~~~~~pp~~ 276 (320)
T d1xjda_ 213 HSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPFR 276 (320)
T ss_dssp HHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC---
T ss_pred HHHHCCCCCCCC--CCCHHHHHHHHHHCCCCCCCCCC----HHHHHHHCCHHCCCCHHHHHHCCCCCCCC
T ss_conf 999718998975--67999999999965448987838----89999809013158999998368998977
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.68 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=222.1
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++..... ......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf 7460899897217480999999999997999999845664--12799999999999857998884696540467436798
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC--
T ss_conf 8645898089997537--999999999999999999999997598357546899788789987983231422404688--
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 778512332114699997422356666665546876445200038888-8830599999999999909999999996899
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 906 (1002)
........+||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+....
T Consensus 158 -----------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 158 -----------------------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp -----------------------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred -----------------------CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf -----------------------653111325574742872861899999710161737999999829978888985999
Q ss_pred -HHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf -999982799999999888989999998020493887997340999981998679
Q 001865 907 -FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 907 -~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~ 960 (1002)
+..+.......+....++..+.+||.+||..||.+||| +.|+|+||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 215 EYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTCTTTTC
T ss_pred HHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCC
T ss_conf 999986388878864469999999999976799668909----999961984585
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=396.56 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=225.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 89422321166693899999991799199999940542248578999999999999579998442478986088299999
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLIT 748 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV~ 748 (1002)
+.|++++.||+|+||.||+|.++.++..||+|++.+. .......+.+|+++|++++||||+++++++...+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 3759847993077819999999999939999998728---9999999999999998679999884988980099589999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 61689835677731799999999999999999999999998494317899995898059929998426775457898777
Q 001865 749 DYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLL 828 (1002)
Q Consensus 749 E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~~ 828 (1002)
|||+||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~----- 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 162 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH-----
T ss_pred ECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCC-----
T ss_conf 627998188999862-89999999999999999999999988988714070031487899989971612303577-----
Q ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 7851233211469999742235666666554687644520003-----88888830599999999999909999999996
Q 001865 829 LPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIA-----GAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~-----~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 903 (1002)
.........||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.
T Consensus 163 ----------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 163 ----------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp ----------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred ----------------------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ----------------------8641001025626479999832025788888066578789999998208899999899
Q ss_pred HHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 89999998279999-99998889899999980204938879973409999819986799
Q 001865 904 QKTFANILHKDLKF-PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~-~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~ 961 (1002)
...+..+.....+. .....++.++.+||.+||..||.+||| +.|+|+||||+.-
T Consensus 221 ~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t----~~ell~hp~~~~~ 275 (288)
T d2jfla1 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT----TSQLLQHPFVTVD 275 (288)
T ss_dssp GGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGCCC
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCC
T ss_conf 999999970799877765669999999999976699668919----9999629231889
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=390.18 Aligned_cols=257 Identities=25% Similarity=0.455 Sum_probs=225.3
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEE
Q ss_conf 894223211666938999999917991999999405422485789999999999995799984424789860--882999
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT--KTHVCL 746 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~i 746 (1002)
++|++++.||+|+||.||+|.++.+++.||+|.+..... .......+.+|+.++++++||||+++++++.+ .+.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 337996798308891999999999997999999874657-9799999999999999778999824899999178998999
Q ss_pred EEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf 99616898356777317--9999999999999999999999999849-----4317899995898059929998426775
Q 001865 747 ITDYCPGGELFLLLDRQ--PTKVLKEDAVRFYAAEVVVALEYLHCQG-----IIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 747 V~E~~~g~sL~~~l~~~--~~~~l~~~~i~~i~~qIl~aL~~LH~~~-----IiHrDLkP~NIli~~~~~ikL~DFG~a~ 819 (1002)
|||||++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 45789877778512332114699997422356666665546876445200038888883059999999999990999999
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 899 (1002)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 163 ~~~~~---------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~ 215 (269)
T d2java1 163 ILNHD---------------------------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215 (269)
T ss_dssp HC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ECCCC---------------------------CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCC
T ss_conf 22457---------------------------775566778823279999839999938988752789999801889989
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCC
Q ss_conf 99968999999827999999998889899999980204938879973409999819986
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff 958 (1002)
+.+..+....+..+.... .+..++.++.+|+.+||..||.+||| +.|+|+|||+
T Consensus 216 ~~~~~~~~~~i~~~~~~~-~~~~~s~~l~~li~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 216 AFSQKELAGKIREGKFRR-IPYRYSDELNEIITRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp CSSHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred CCCHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHCCCC
T ss_conf 989999999997189988-97435999999999976799557918----9999729819
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.21 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=215.3
Q ss_pred CCCC-CCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE----CC
Q ss_conf 6894-223211666938999999917991999999405422485789999999999995799984424789860----88
Q 001865 668 LQHF-RPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT----KT 742 (1002)
Q Consensus 668 ~~~y-~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~ 742 (1002)
.++| ++.+.||+|+||.||+|.+..++..||+|.+..... .......+.+|+++|++++||||+++++++.. ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 88778851697008284999999999995999999851227-98999999999999985799985069999840334588
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEE-CCCCEEEEECCCCC
Q ss_conf 2999996168983567773179999999999999999999999999849--43178999958980-59929998426775
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQG--IIYRDLKPENVLLQ-GNGHVSLTDFDLSC 819 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~--IiHrDLkP~NIli~-~~~~ikL~DFG~a~ 819 (1002)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|.
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf 899999578989489997513--554699999999999999999997899799687674351166799988980057654
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 45789877778512332114699997422356666665546876445200038888883059999999999990999999
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~ 899 (1002)
.... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.
T Consensus 164 ~~~~-----------------------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 164 LKRA-----------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp GCCT-----------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred ECCC-----------------------------CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCC
T ss_conf 2368-----------------------------76677553813008988478-99986711007999999987889998
Q ss_pred CCCHHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 99968999-9998279999999988898999999802049388799734099998199867
Q 001865 900 GKTRQKTF-ANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 900 ~~~~~~~~-~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~ 959 (1002)
+......+ ..+..+..+.......++++.+|+.+||.+||++||| +.|+|+||||+
T Consensus 214 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 214 ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp TCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGC
T ss_pred CCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCC
T ss_conf 7655999999997389986567557899999999976379758929----99996775409
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=386.74 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=227.6
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+. ......+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC----CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 01058878983177839999999899969999997578----66599999999999857997989098999889988999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC--CCEEEEECCCCCCCCCCC
Q ss_conf 961689835677731799999999999999999999999998494317899995898059--929998426775457898
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN--GHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~--~~ikL~DFG~a~~~~~~~ 825 (1002)
||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EECCCCCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC-
T ss_conf 9538998088998753-89999999999999999999999876997513554443443788518997644111003467-
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 77778512332114699997422356666665546876445200038888883059999999999990999999999689
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQK 905 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~ 905 (1002)
.......+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 158 ---------------------------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 158 ---------------------------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp ---------------------------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH
T ss_conf ---------------------------75321223322234021048777840113027999999982899999989999
Q ss_pred HHHHHHHCCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 999998279999999--9888989999998020493887997340999981998679
Q 001865 906 TFANILHKDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~--~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~ 960 (1002)
.+..+......++.. ..++.++.+||.+||..||.+||| +.|+|+||||+.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHS
T ss_pred HHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCC
T ss_conf 99999838999880223678999999999986699668909----999963996566
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=377.06 Aligned_cols=260 Identities=30% Similarity=0.452 Sum_probs=227.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC------HHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 689422321166693899999991799199999940542248------578999999999999579-9984424789860
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN------RNKVHRACAEREILDMLD-HPFVPALYASFQT 740 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~------~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 740 (1002)
.++|++.+.||+|+||.||+|++..+++.||+|++.+..... ......+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 88299999616898356777317999999999999999999999999984943178999958980599299984267754
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~ 820 (1002)
++.+|+|||||+|++|.+++..+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCEEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEE
T ss_conf 76059999768986689999865--9999999999999999999999875994323462548986899838712403167
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHCC
Q ss_conf 5789877778512332114699997422356666665546876445200038------8888830599999999999909
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG------AGHTSAVDWWALGILLYEMLYG 894 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~------~~~~~~sDIwSlG~il~eLltG 894 (1002)
.... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|
T Consensus 160 ~~~~----------------------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g 211 (277)
T d1phka_ 160 LDPG----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211 (277)
T ss_dssp CCTT----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCC----------------------------CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCC
T ss_conf 2688----------------------------721345246788898886053445678899233185656023103228
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCC--CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 999999996899999982799999--9998889899999980204938879973409999819986799
Q 001865 895 YTPFRGKTRQKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGV 961 (1002)
Q Consensus 895 ~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~ 961 (1002)
+.||.+.+.......+..+...++ ....+|.++.+|+.+||.+||.+||| +.|+|+||||+..
T Consensus 212 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~~ 276 (277)
T d1phka_ 212 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQY 276 (277)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHHHH
T ss_conf 8898899999999999818988898543468999999999976589668919----9999739787975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.93 Aligned_cols=268 Identities=27% Similarity=0.368 Sum_probs=220.2
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCH--HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
Q ss_conf 23211666938999999917991999999405422485--7899999999999957999844247898608829999961
Q 001865 673 PIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNR--NKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDY 750 (1002)
Q Consensus 673 i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV~E~ 750 (1002)
.++.||+|+||.||+|.++.+++.||+|++........ .....+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 68983567773179999999999999999999999999849431789999589805992999842677545789877778
Q 001865 751 CPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLP 830 (1002)
Q Consensus 751 ~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~~~~ 830 (1002)
+.++++..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred HCCHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC------
T ss_conf 345077655412--667789999999999999998863163550357762588537784114657610005787------
Q ss_pred CCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 5123321146999974223566666655468764452000388-888830599999999999909999999996899999
Q 001865 831 TTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKTFAN 909 (1002)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~~~~ 909 (1002)
.......+||+.|+|||++... .++.++|||||||++|+|++|.+||.+.+..+.+..
T Consensus 154 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 154 ---------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp ---------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ---------------------CCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHH
T ss_conf ---------------------55433020473336399972677888056436304289999859699999999999999
Q ss_pred HHHCCC-----CCC---------------C------CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCH
Q ss_conf 982799-----999---------------9------99888989999998020493887997340999981998679981
Q 001865 910 ILHKDL-----KFP---------------S------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNW 963 (1002)
Q Consensus 910 i~~~~~-----~~~---------------~------~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 963 (1002)
+.+... .++ . ....+..+.+||.+||.+||.+||| |.|+|+||||++...
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p~ 288 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPG 288 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSC
T ss_pred HHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCCCCC
T ss_conf 9985189972545210002134430347898867856568999999999976389456908----999967996578999
Q ss_pred HHHHCCCCCCCCCC
Q ss_conf 13340599988999
Q 001865 964 ALVRCMNPPELDAP 977 (1002)
Q Consensus 964 ~~~~~~~~~~~~~~ 977 (1002)
+.- +.++|.|
T Consensus 289 p~~----~~~~p~p 298 (299)
T d1ua2a_ 289 PTP----GCQLPRP 298 (299)
T ss_dssp CCC----SSSSCCC
T ss_pred CCC----CCCCCCC
T ss_conf 989----8889999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.02 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=213.6
Q ss_pred CCCCCCCC-CCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEEEEEE----C
Q ss_conf 68942232-11666938999999917991999999405422485789999999999995-799984424789860----8
Q 001865 668 LQHFRPIK-PLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDM-LDHPFVPALYASFQT----K 741 (1002)
Q Consensus 668 ~~~y~i~~-~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~----~ 741 (1002)
.++|+++. .||+|+||.||+|.+..+++.||+|++... ....+|+.++.+ .+||||++++++|.. .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCC
T ss_conf 148798107965454869999998899989999998974--------779999999998669999782989995034689
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC---CCCEEEEECCCC
Q ss_conf 82999996168983567773179999999999999999999999999849431789999589805---992999842677
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLS 818 (1002)
Q Consensus 742 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~---~~~ikL~DFG~a 818 (1002)
..+|+|||||+||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 78999997789984999998627877579999999999999999999769864441002201135555663113545512
Q ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 54578987777851233211469999742235666666554687644520003888888305999999999999099999
Q 001865 819 CLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf 898 (1002)
...... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 162 ~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf 213 (335)
T d2ozaa1 162 KETTSH----------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213 (335)
T ss_dssp EECCCC----------------------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSC
T ss_pred EECCCC----------------------------CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf 333688----------------------------8643226775637927774898888888876451677886588998
Q ss_pred CCCCHHHHHHHHHH----CCCCCCCC--CCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 99996899999982----79999999--9888989999998020493887997340999981998679
Q 001865 899 RGKTRQKTFANILH----KDLKFPSS--TPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKG 960 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~----~~~~~~~~--~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~ 960 (1002)
.+.+.......+.. ....++.. ..++.++.+||.+||..||.+||| +.|+|+||||+.
T Consensus 214 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 214 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp EETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHHC
T ss_conf 8988778899999998538888898543469999999999975699657909----999970987617
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.81 Aligned_cols=262 Identities=26% Similarity=0.450 Sum_probs=220.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++...+.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 9997765177237680999999999997999999802225-758999999999999867998388744533224320378
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
|||+ ++++..++.......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||.|......
T Consensus 80 ~e~~-~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--- 155 (298)
T d1gz8a_ 80 FEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--- 155 (298)
T ss_dssp EECC-SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred EEEC-CCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCC---
T ss_conf 8623-774455544202568888999999999999999865288992135711401134676210357861343688---
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 77851233211469999742235666666554687644520003888-88830599999999999909999999996899
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 906 (1002)
........||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+....
T Consensus 156 ------------------------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~ 211 (298)
T d1gz8a_ 156 ------------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211 (298)
T ss_dssp ------------------------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------64100103652154112213665777422103333134279668799898899999
Q ss_pred HHHHHHCCCC------------------CCC---------CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 9999827999------------------999---------9988898999999802049388799734099998199867
Q 001865 907 FANILHKDLK------------------FPS---------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 907 ~~~i~~~~~~------------------~~~---------~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~ 959 (1002)
+..+...... ++. ....+..+++||.+||..||.+||| +.|+|+||||+
T Consensus 212 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~ 287 (298)
T d1gz8a_ 212 LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQ 287 (298)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGT
T ss_pred HHHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHC
T ss_conf 99999832898333144422242124345432222044416678999999999976399557918----99996787014
Q ss_pred CCC
Q ss_conf 998
Q 001865 960 GVN 962 (1002)
Q Consensus 960 ~~~ 962 (1002)
+++
T Consensus 288 ~~~ 290 (298)
T d1gz8a_ 288 DVT 290 (298)
T ss_dssp TCC
T ss_pred CCC
T ss_conf 699
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.19 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=214.2
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCC-CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCCCEEEEEEEE--
Q ss_conf 468942232116669389999999179-919999994054224857899999999999957---99984424789860--
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGS-GQYFAMKAMDKGVMLNRNKVHRACAEREILDML---DHPFVPALYASFQT-- 740 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~-~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~-- 740 (1002)
..++|++++.||+|+||.||+|.+..+ ++.||+|++...... ........+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 7589798889921558699999998889989999998023245-167999999999999874258988023663221466
Q ss_pred ---CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCC
Q ss_conf ---88299999616898356777317999999999999999999999999984943178999958980599299984267
Q 001865 741 ---KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDL 817 (1002)
Q Consensus 741 ---~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~ 817 (1002)
...+|++||++.++.+..... .....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||.
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCCCEEEEEEEECCCCCHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 666746999997405871444443-0378999899999999999999999758898357986278985899754210001
Q ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 75457898777785123321146999974223566666655468764452000388888830599999999999909999
Q 001865 818 SCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 818 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~P 897 (1002)
+..... ........||+.|+|||++.+..++.++||||+||++|+|++|++|
T Consensus 163 ~~~~~~----------------------------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~p 214 (305)
T d1blxa_ 163 ARIYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214 (305)
T ss_dssp CCCCCG----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHHCC----------------------------CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCC
T ss_conf 011002----------------------------3457776548511483100179888111000328999999878799
Q ss_pred CCCCCHHHHHHHHHHCCC-----CC--------------------CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 999996899999982799-----99--------------------99998889899999980204938879973409999
Q 001865 898 FRGKTRQKTFANILHKDL-----KF--------------------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 898 f~~~~~~~~~~~i~~~~~-----~~--------------------~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~el 952 (1002)
|.+.+..+.+..+..... .+ ......+..+.+||.+||.+||.+||| +.|+
T Consensus 215 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~ 290 (305)
T d1blxa_ 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSA 290 (305)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 899898999999998407996110532111103330223456454404458999999999987489667918----9999
Q ss_pred HCCCCCCCCCH
Q ss_conf 81998679981
Q 001865 953 KKHPFFKGVNW 963 (1002)
Q Consensus 953 L~Hpff~~~~~ 963 (1002)
|+||||+++++
T Consensus 291 L~Hpff~~i~~ 301 (305)
T d1blxa_ 291 LSHPYFQDLER 301 (305)
T ss_dssp HTSGGGTTCCC
T ss_pred HCCHHHCCCHH
T ss_conf 66963407521
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=370.72 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=220.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 45434689422321166693899999991799199999940542248578999999999999579998442478986088
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (1002)
.|++..++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+.+|++++||||+++++++...+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCCCCEECCCCCEEECC
T ss_conf 51745799398659820888089999999999699999977761----03999999999998679998826775274578
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 29999961689835677731799999999999999999999999998494317899995898059929998426775457
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~ 822 (1002)
.+|+|||||++|+|.+++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 54787631467606777530355415799999999999997888987893057604576899899928983244546537
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 89877778512332114699997422356666665546876445200038888883059999999999990999999999
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKT 902 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~ 902 (1002)
.... .......|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 167 ~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 167 GDTY--------------------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp SSSS--------------------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCC--------------------------EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8872--------------------------21035566546669278727999810430217899999986799887742
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 6899999982799999999888989999998020493887997340999981
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~ 954 (1002)
....+..++......+.+..++..+.+|+.+||..||.+||| +.++++
T Consensus 221 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS----FAEIHQ 268 (287)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 599999998558888887433099999999975779768939----999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.91 Aligned_cols=259 Identities=28% Similarity=0.433 Sum_probs=220.1
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf 689422321166693899999991799199999940542248578999999999999579998442478986088-----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (1002)
.++|++++.||+|+||.||+|.++.+++.||+|++.+.. ........+.+|+.+|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 771899889801778199999999999899999985222-5969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf -2999996168983567773179999999999999999999999999849431789999589805992999842677545
Q 001865 743 -HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 743 -~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~ 821 (1002)
.+|+||||+ +.+|..+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEECC-CCCHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECC
T ss_conf 1599998405-5218999874---02269999999999999999987378764566851111210012211343102206
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 7898777785123321146999974223566666655468764452000388-888830599999999999909999999
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~ 900 (1002)
.. ......||+.|+|||++.+. .++.++||||+||++|+|++|++||.+
T Consensus 172 ~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 172 DS------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CS------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC------------------------------CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCC
T ss_conf 87------------------------------631024553335889981787899650103003899999978699888
Q ss_pred CCHHHHHHHHHHCCCC-----------------------C------CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHH
Q ss_conf 9968999999827999-----------------------9------9999888989999998020493887997340999
Q 001865 901 KTRQKTFANILHKDLK-----------------------F------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANE 951 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~-----------------------~------~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~e 951 (1002)
.+....+..+...... . ......+..+.+||.+||..||.+||| +.|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e 297 (346)
T d1cm8a_ 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGE 297 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHH
T ss_pred CCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHH
T ss_conf 9768999999850378848888653000344331157866655667755689999999999977299557929----999
Q ss_pred HHCCCCCCCCCHHH
Q ss_conf 98199867998113
Q 001865 952 IKKHPFFKGVNWAL 965 (1002)
Q Consensus 952 lL~Hpff~~~~~~~ 965 (1002)
+|+||||+.+....
T Consensus 298 iL~Hp~f~~~~~~~ 311 (346)
T d1cm8a_ 298 ALAHPYFESLHDTE 311 (346)
T ss_dssp HHHSGGGTTTC---
T ss_pred HHCCHHHCCCCCCC
T ss_conf 96396237587766
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.49 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=224.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCE-----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 6454346894223211666938999999917991-----9999994054224857899999999999957-999844247
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQ-----YFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (1002)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~-----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 735 (1002)
..|++..++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+.+|+.++.++ +||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 44657789939701983078819999998578855420499999966335--8789999999999999715899686877
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 898608829999961689835677731799---------------------99999999999999999999999849431
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPT---------------------KVLKEDAVRFYAAEVVVALEYLHCQGIIY 794 (1002)
Q Consensus 736 ~~~~~~~~~~iV~E~~~g~sL~~~l~~~~~---------------------~~l~~~~i~~i~~qIl~aL~~LH~~~IiH 794 (1002)
+++...+.+|+|||||++|+|.+++..... ..+++..++.++.||+.||+|||+++|+|
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 88862995899997279995999998625777510221000012220012577899999999999999999997399050
Q ss_pred CCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 78999958980599299984267754578987777851233211469999742235666666554687644520003888
Q 001865 795 RDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG 874 (1002)
Q Consensus 795 rDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~ 874 (1002)
|||||+|||++.++.+||+|||+|+....... .....+..||+.|+|||++.+..
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN-------------------------YVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-------------------------SEEETTEEECGGGCCHHHHHHCC
T ss_pred CCCCHHCCCCCCCCEEEEEECCCCCCCCCCCC-------------------------EEEECCCCCCCCCCCHHHHCCCC
T ss_conf 52703214434598289851422220457786-------------------------15623435787657838872799
Q ss_pred CCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHH
Q ss_conf 8883059999999999990-999999999689999998279999999988898999999802049388799734099998
Q 001865 875 HTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 875 ~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL 953 (1002)
++.++|||||||++|+|++ |++||.+.+....+..++.....++.+..++..+.+|+.+||..||++||| +.|++
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~ 318 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLT 318 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHH
T ss_pred CCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHH
T ss_conf 99633030003999999838999999989899999998569989988767899999999975889668939----99999
Q ss_pred CC
Q ss_conf 19
Q 001865 954 KH 955 (1002)
Q Consensus 954 ~H 955 (1002)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
T ss_conf 99
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.53 Aligned_cols=288 Identities=41% Similarity=0.722 Sum_probs=231.6
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEEC---CCCEEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEE
Q ss_conf 434689422321166693899999991---79919999994054224-85789999999999995799-98442478986
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELC---GSGQYFAMKAMDKGVML-NRNKVHRACAEREILDMLDH-PFVPALYASFQ 739 (1002)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~---~~~~~vaiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~ 739 (1002)
.+..++|++++.||+|+||.||+|.+. .+++.||+|++.+.... +......+.+|+.++++++| |||+++++++.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred CCCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 34510259998983287839999998765887948999998367721016899999999999986467983999620002
Q ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf 08829999961689835677731799999999999999999999999998494317899995898059929998426775
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 740 ~~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~ 819 (1002)
....++++|||+.+++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred CCCCEEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 487300123123411799998730--454378888889999999988514998965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 457898777785123321146999974223566666655468764452000388--888830599999999999909999
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA--GHTSAVDWWALGILLYEMLYGYTP 897 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~sDIwSlG~il~eLltG~~P 897 (1002)
...... ........|++.|++||.+.+. .++.++|||||||+||+|++|+.|
T Consensus 178 ~~~~~~--------------------------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P 231 (322)
T d1vzoa_ 178 EFVADE--------------------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231 (322)
T ss_dssp ECCGGG--------------------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred HHCCCC--------------------------CCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCC
T ss_conf 203444--------------------------432212223333310687605776887132517777999999768999
Q ss_pred CCCCCHHHHHHHHH----HCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH-HCHHHHHCCCCCCCCCHHHHHCCCCC
Q ss_conf 99999689999998----27999999998889899999980204938879973-40999981998679981133405999
Q 001865 898 FRGKTRQKTFANIL----HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSH-EGANEIKKHPFFKGVNWALVRCMNPP 972 (1002)
Q Consensus 898 f~~~~~~~~~~~i~----~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~~~~ 972 (1002)
|.+.+.......+. .....++ ..++..+.+||.+||.+||.+||+.. ..++|+|+||||++++|........|
T Consensus 232 F~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 232 FTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309 (322)
T ss_dssp TSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCHHHHHHHHHHHCCCCCCCCC--CCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHHHHHHCCCC
T ss_conf 8888777799999983356899886--54799999999997445898819997450999974972348998899737898
Q ss_pred CCCCCCCCCC
Q ss_conf 8899988773
Q 001865 973 ELDAPLFATD 982 (1002)
Q Consensus 973 ~~~~~~~~~~ 982 (1002)
.--.|.+..+
T Consensus 310 ~p~~p~~~~~ 319 (322)
T d1vzoa_ 310 APFKPVIRDE 319 (322)
T ss_dssp CSCCCCCCC-
T ss_pred CCCCCCCCCC
T ss_conf 5989999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.12 Aligned_cols=269 Identities=23% Similarity=0.422 Sum_probs=220.9
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------C
Q ss_conf 6894223211666938999999917991999999405422485789999999999995799984424789860------8
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------K 741 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~ 741 (1002)
.++|++++.||+|+||+||+|.++.+++.||||++.+.. ........+.+|+.++++++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 377599889621758599999999999899999988233-6979999999999999864898764899897025643457
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf 82999996168983567773179999999999999999999999999849431789999589805992999842677545
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~ 821 (1002)
.++|+||||+.+ ++...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++...
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CEEEEEEECCCH-HHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCC
T ss_conf 626999841446-7787650----38999999999999999998865221124567763211365443132010232114
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 78987777851233211469999742235666666554687644520003888888305999999999999099999999
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 901 (1002)
... ......+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.
T Consensus 170 ~~~----------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 170 GTS----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCC----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCC
T ss_conf 666----------------------------5533221465555813314777787743335662578986598998889
Q ss_pred CHHHHHHHHHHCC----------------------CCCCCC------------------CCCCHHHHHHHHHCCCCCCCC
Q ss_conf 9689999998279----------------------999999------------------988898999999802049388
Q 001865 902 TRQKTFANILHKD----------------------LKFPSS------------------TPTSLHAKQLMYRLLHRDPKS 941 (1002)
Q Consensus 902 ~~~~~~~~i~~~~----------------------~~~~~~------------------~~~s~~l~~LL~~mL~~dP~~ 941 (1002)
+.......+.... ...... ...+..+.+||.+||..||++
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 301 (355)
T d2b1pa1 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHH
T ss_conf 77889999997205898799987656677776417543566642126433354321013337999999999987699457
Q ss_pred CCCCHHCHHHHHCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 799734099998199867998113340599988
Q 001865 942 RLGSHEGANEIKKHPFFKGVNWALVRCMNPPEL 974 (1002)
Q Consensus 942 Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~ 974 (1002)
||| |.|+|+||||+..-++......+|++
T Consensus 302 R~t----a~elL~Hpw~~~~~~~~~~~~~~~~~ 330 (355)
T d2b1pa1 302 RIS----VDDALQHPYINVWYDPAEVEAPPPQI 330 (355)
T ss_dssp SCC----HHHHHTSTTTGGGCCHHHHTCCCC--
T ss_pred CCC----HHHHHCCCCCCCCCCCCCCCCCCCCC
T ss_conf 908----99996694208788810045899987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.49 Aligned_cols=254 Identities=27% Similarity=0.371 Sum_probs=213.8
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHH---HHHHHHHHHHHHHHCC--CCCCCEEEEEEEECC
Q ss_conf 68942232116669389999999179919999994054224857---8999999999999579--998442478986088
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRN---KVHRACAEREILDMLD--HPFVPALYASFQTKT 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~ 742 (1002)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+....... ....+.+|+.++++++ ||||+++++++...+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEECCCC-CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC-CCEEEEECCCCCC
Q ss_conf 29999961689-835677731799999999999999999999999998494317899995898059-9299984267754
Q 001865 743 HVCLITDYCPG-GELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN-GHVSLTDFDLSCL 820 (1002)
Q Consensus 743 ~~~iV~E~~~g-~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~-~~ikL~DFG~a~~ 820 (1002)
..|+||||+.+ +++.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEE
T ss_conf 6899998336862289998615--89999999999999999999998779755667611147744788489775465353
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 5789877778512332114699997422356666665546876445200038888-883059999999999990999999
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGH-TSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~sDIwSlG~il~eLltG~~Pf~ 899 (1002)
... ....+..||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.
T Consensus 161 ~~~-----------------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 161 LKD-----------------------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CCS-----------------------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCC-----------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCC
T ss_conf 244-----------------------------455665658774799998489978865332554034536756889988
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCCHH
Q ss_conf 99968999999827999999998889899999980204938879973409999819986799811
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 964 (1002)
+.+ .+......++. .++.++.+|+.+||..||.+||| +.|+|+||||+++..+
T Consensus 212 ~~~------~i~~~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s----~~eil~hp~~~~~~~p 264 (273)
T d1xwsa_ 212 HDE------EIIRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPT----FEEIQNHPWMQDVLLP 264 (273)
T ss_dssp SHH------HHHHCCCCCSS--CCCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSCCCH
T ss_pred CCH------HHHHCCCCCCC--CCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHHCCCCCC
T ss_conf 736------77615447787--79999999999976089758939----9998539866788788
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.34 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=209.5
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEE--CCE
Q ss_conf 468942232116669389999999179919999994054224857899999999999957-99984424789860--882
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQT--KTH 743 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~ 743 (1002)
+.++|++++.||+|+||+||+|.++.+++.||+|++++. ....+.+|+.+|+.+ +||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCC
T ss_conf 986718978983174819999998899979999998889------99999999999985157998767999998168771
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC-CEEEEECCCCCCCC
Q ss_conf 99999616898356777317999999999999999999999999984943178999958980599-29998426775457
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCLTS 822 (1002)
Q Consensus 744 ~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~-~ikL~DFG~a~~~~ 822 (1002)
+|+||||+.+++|..+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+|....
T Consensus 107 ~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EEEEEEECCCCCHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 268886317985899746-----899999999999999999887643344345644123774899836641565426646
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 898777785123321146999974223566666655468764452000388-8888305999999999999099999999
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~ 901 (1002)
.. ......++|+.|+|||.+.+. .++.++||||+||++|++++|+.||...
T Consensus 182 ~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 182 PG----------------------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp TT----------------------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CC----------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
T ss_conf 88----------------------------74443224864247610268888884523233545558760488999887
Q ss_pred CHH-HHHHHHHH-------------CC----------------------CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 968-99999982-------------79----------------------9999999888989999998020493887997
Q 001865 902 TRQ-KTFANILH-------------KD----------------------LKFPSSTPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 902 ~~~-~~~~~i~~-------------~~----------------------~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~ 945 (1002)
... .....+.. .. ........++.++.+||.+||.+||.+|||
T Consensus 234 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t- 312 (328)
T d3bqca1 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT- 312 (328)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC-
T ss_pred CHHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC-
T ss_conf 6018999999998788415555542254447430000033343311211552112448999999999986699568908-
Q ss_pred HHCHHHHHCCCCCCCCCHH
Q ss_conf 3409999819986799811
Q 001865 946 HEGANEIKKHPFFKGVNWA 964 (1002)
Q Consensus 946 ~~~a~elL~Hpff~~~~~~ 964 (1002)
++|+|+||||+.+.|.
T Consensus 313 ---a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 ---AREAMEHPYFYTVVKD 328 (328)
T ss_dssp ---HHHHHTSGGGTTSCCC
T ss_pred ---HHHHHCCCCCCCCCCC
T ss_conf ---9999649355887979
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=363.80 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=223.8
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----E
Q ss_conf 689422321166693899999991799199999940542248578999999999999579998442478986088----2
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----H 743 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~ 743 (1002)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+....+......+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 99999616898356777317999999999999999999999999984943178999958980599299984267754578
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~ 823 (1002)
+|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++..+|+|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEEHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCC
T ss_conf 99999778898710112035--8999999999999999999999857952763467556657543201003444322123
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 98777785123321146999974223566666655468764452000388888830599999999999909999999996
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 903 (1002)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 164 ~~~------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 219 (277)
T d1o6ya_ 164 SGN------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219 (277)
T ss_dssp ---------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCC------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH
T ss_conf 544------------------------33334642576243699998399999663202652899999769799899699
Q ss_pred HHHHHHHHHCCCCCC--CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCC
Q ss_conf 899999982799999--9998889899999980204938879973409999819986
Q 001865 904 QKTFANILHKDLKFP--SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 904 ~~~~~~i~~~~~~~~--~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff 958 (1002)
......+.......+ ....++..+.+||.+||.+||.+||+. ++++ .|+|+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~s---a~~l-~~~l~ 272 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT---AAEM-RADLV 272 (277)
T ss_dssp HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSS---HHHH-HHHHH
T ss_pred HHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHH---HHHH-HHHHH
T ss_conf 99999998469999710034789999999999866797677739---9999-99999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.70 Aligned_cols=257 Identities=29% Similarity=0.437 Sum_probs=209.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------CC
Q ss_conf 894223211666938999999917991999999405422485789999999999995799984424789860------88
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------KT 742 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~ 742 (1002)
-+|+.++.||+|+||+||+|.++.+++.||||++.+... ...+|+.+|++++||||++++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 776751698217683999999999997999999881606-------8999999998668989873878997447657731
Q ss_pred EEEEEEECCCCCCHHHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC-CEEEEECCCCCC
Q ss_conf 2999996168983567773-17999999999999999999999999984943178999958980599-299984267754
Q 001865 743 HVCLITDYCPGGELFLLLD-RQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNG-HVSLTDFDLSCL 820 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~-~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~-~ikL~DFG~a~~ 820 (1002)
++|+|||||+++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 89999841688607888863103689999999999999999999998668764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 5789877778512332114699997422356666665546876445200038-888883059999999999990999999
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~ 899 (1002)
.... ....+.+|++.|+|||.+.+ ..++.++||||+||++|+|++|++||.
T Consensus 173 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 173 LVRG----------------------------EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CCTT----------------------------SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCCC----------------------------CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCC
T ss_conf 0477----------------------------653200255555682776404688821000246527785502879989
Q ss_pred CCCHHHHHHHHHHC-----------------CCCCC----------CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 99968999999827-----------------99999----------9998889899999980204938879973409999
Q 001865 900 GKTRQKTFANILHK-----------------DLKFP----------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~-----------------~~~~~----------~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~el 952 (1002)
+.+....+..+.+. ...++ .....+..+.+||.+||.+||.+||| +.|+
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~ 300 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEA 300 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHH
T ss_pred CCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 879999999999974898177654306210110355445674444315689999999999976589557929----9999
Q ss_pred HCCCCCCCCCHH
Q ss_conf 819986799811
Q 001865 953 KKHPFFKGVNWA 964 (1002)
Q Consensus 953 L~Hpff~~~~~~ 964 (1002)
|+||||+.+.-+
T Consensus 301 L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 301 CAHSFFDELRDP 312 (350)
T ss_dssp HTSGGGGGGGCT
T ss_pred HCCHHHCCCCCC
T ss_conf 669845246677
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.29 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=214.8
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----
Q ss_conf 689422321166693899999991799199999940542248578999999999999579998442478986088-----
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT----- 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 742 (1002)
..+|++++.||+|+||.||+|.+..+++.||||++.+.. .......+.+|+.+|++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf 898599789940648099999999999499999980310--958999999999999976898988588899505645541
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 29999961689835677731799999999999999999999999998494317899995898059929998426775457
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~ 822 (1002)
.+|++++ +.+++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~l~~~-~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 85 DVYLVTH-LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp CEEEEEE-CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEE-ECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 4999996-2598656644058---99999999999999999999997898677787643788799977875457056504
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 89877778512332114699997422356666665546876445200038-88888305999999999999099999999
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAG-AGHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~sDIwSlG~il~eLltG~~Pf~~~ 901 (1002)
.... ........+|++.|+|||++.. ..++.++||||+||++|+|++|+.||.+.
T Consensus 161 ~~~~------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 161 PDHD------------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp GGGC------------------------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCC------------------------CCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCC
T ss_conf 7776------------------------4101011026520003878604788874101004670133776697997888
Q ss_pred CHHHHHHHHHHCC----------------------CCCC-------CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 9689999998279----------------------9999-------9998889899999980204938879973409999
Q 001865 902 TRQKTFANILHKD----------------------LKFP-------SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 902 ~~~~~~~~i~~~~----------------------~~~~-------~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~el 952 (1002)
+............ .+.. .....+..+++|+.+||.+||.+||| +.|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~ 292 (345)
T d1pmea_ 217 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQA 292 (345)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 889999987652069975664234332222024467755778777837899999999999976489567908----9998
Q ss_pred HCCCCCCCCCHH
Q ss_conf 819986799811
Q 001865 953 KKHPFFKGVNWA 964 (1002)
Q Consensus 953 L~Hpff~~~~~~ 964 (1002)
|+||||+.....
T Consensus 293 L~hpf~~~~~~~ 304 (345)
T d1pmea_ 293 LAHPYLEQYYDP 304 (345)
T ss_dssp HTSGGGTTTCCG
T ss_pred HCCHHHCCCCCC
T ss_conf 619865558897
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=358.81 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=218.0
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCCE---EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC
Q ss_conf 4346894223211666938999999917991---9999994054224857899999999999957999844247898608
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQ---YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK 741 (1002)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~---~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 741 (1002)
.+..+.|++.+.||+|+||.||+|.++.+++ .+|+|.+.... .......+.+|+.+|++++||||+++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred HHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEC
T ss_conf 208004278569802788299999995799788999999978445--989999999999999857998886189999628
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf 82999996168983567773179999999999999999999999999849431789999589805992999842677545
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~ 821 (1002)
+.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEECCCCCCEEEECCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 8779999722798530021045-679999999999999999889885279835761504489889991998884431575
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCC
Q ss_conf 789877778512332114699997422356666665546876445200038888883059999999999990-9999999
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 900 (1002)
....... .........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+
T Consensus 179 ~~~~~~~----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 179 EDDTSDP----------------------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ---------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCCCC----------------------EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 6777765----------------------365025666883003878883699786121445357899998679999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 996899999982799999999888989999998020493887997340999981
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~ 954 (1002)
.+..+....+..+. ..+.+..++..+.+|+.+||..||.+||| +.|+++
T Consensus 237 ~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~ei~~ 285 (299)
T d1jpaa_ 237 MTNQDVINAIEQDY-RLPPPMDCPSALHQLMLDCWQKDRNHRPK----FGQIVN 285 (299)
T ss_dssp CCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHH
T ss_pred CCHHHHHHHHHCCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 99999999997378-89997422699999999975879768929----999999
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.82 Aligned_cols=258 Identities=21% Similarity=0.288 Sum_probs=213.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 45434689422321166693899999991799199999940542248578999999999999579998442478986088
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (1002)
.|++..++|++.+.||+|+||.||+|.. +..||||+++... ........+.+|+.++++++||||+++++++.. +
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~ 76 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P 76 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CCCCCCCCEEEEEEEEECCCCEEEEEEE---CCEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-C
T ss_conf 7131545189988983078858999999---9989999997346-998999999999999984799878645679715-5
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 29999961689835677731799999999999999999999999998494317899995898059929998426775457
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~ 822 (1002)
.+|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+|....
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEEEEEECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECC
T ss_conf 8999996589988899985235-789999999999999999888750999516147899798189978875002213335
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 898777785123321146999974223566666655468764452000388---88883059999999999990999999
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA---GHTSAVDWWALGILLYEMLYGYTPFR 899 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~---~~~~~sDIwSlG~il~eLltG~~Pf~ 899 (1002)
.... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~ 210 (276)
T d1uwha_ 156 RWSG-------------------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS 210 (276)
T ss_dssp -----------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCC-------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 5677-------------------------631256655743179999950568999953151635999999997889989
Q ss_pred CCCHHHHHHHHHHCCCCCC----CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9996899999982799999----9998889899999980204938879973409999819
Q 001865 900 GKTRQKTFANILHKDLKFP----SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~----~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
+.+....+..........+ ....++..+.+|+.+||..||.+||| +.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 211 NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp TCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9896999999996588898600036555499999999975889768929----9999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.28 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=216.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-----C
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608-----8
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTK-----T 742 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 742 (1002)
.++|++++.||+|+||+||+|.+..+++.||||++.+. .........+.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT-TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCH-HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 98718888983178839999999999979999998820-02868999999999999866898742599999634645668
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 29999961689835677731799999999999999999999999998494317899995898059929998426775457
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~ 822 (1002)
..+++|+++.|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred CEEEEEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCC
T ss_conf 64999996258862320022---453099999999999999999973887651667763345543220013210001257
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 898777785123321146999974223566666655468764452000388-8888305999999999999099999999
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~ 901 (1002)
.......|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.
T Consensus 173 ------------------------------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 173 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp ------------------------------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ------------------------------CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf ------------------------------54444345435558355337756785512432058999997688997889
Q ss_pred CHHHHHHHHHHCCCCC-----------------------CC------CCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH
Q ss_conf 9689999998279999-----------------------99------998889899999980204938879973409999
Q 001865 902 TRQKTFANILHKDLKF-----------------------PS------STPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI 952 (1002)
Q Consensus 902 ~~~~~~~~i~~~~~~~-----------------------~~------~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~el 952 (1002)
+.......+....... +. ....+..+++||.+||..||.+||| +.|+
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~el 298 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQA 298 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHH
T ss_pred CHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHH
T ss_conf 889999999973079975773200102445444303557875556626789999999999977588345938----9998
Q ss_pred HCCCCCCCCC
Q ss_conf 8199867998
Q 001865 953 KKHPFFKGVN 962 (1002)
Q Consensus 953 L~Hpff~~~~ 962 (1002)
|+||||+++.
T Consensus 299 L~Hp~f~~~~ 308 (348)
T d2gfsa1 299 LAHAYFAQYH 308 (348)
T ss_dssp HTSGGGTTTC
T ss_pred HCCHHHCCCC
T ss_conf 5599548799
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.51 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=215.0
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-------
Q ss_conf 6894223211666938999999917991999999405422485789999999999995799984424789860-------
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT------- 740 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 740 (1002)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|++++||||+.+++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf 2798899997227482999999989997999999842224-637899999999999983599966067654024654444
Q ss_pred -CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf -8829999961689835677731799999999999999999999999998494317899995898059929998426775
Q 001865 741 -KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 741 -~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~ 819 (1002)
.+.+|+|||++.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCEEEEEEECCCCCCCCHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEE
T ss_conf 57638999853578741012220--3443308999999999999988522998856767222036689968763135002
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 457898777785123321146999974223566666655468764452000388-8888305999999999999099999
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPF 898 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf 898 (1002)
....... .........+||+.|+|||++.+. .++.++||||+||++|+|++|++||
T Consensus 166 ~~~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 166 AFSLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp ECCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ECCCCCC-----------------------CCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCC
T ss_conf 2355444-----------------------32113566024978742899707999891787006786466174487998
Q ss_pred CCCCHHHHHHHHHHCCCCCCCC------------------------------CCCCHHHHHHHHHCCCCCCCCCCCCHHC
Q ss_conf 9999689999998279999999------------------------------9888989999998020493887997340
Q 001865 899 RGKTRQKTFANILHKDLKFPSS------------------------------TPTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~~~~~------------------------------~~~s~~l~~LL~~mL~~dP~~Rpt~~~~ 948 (1002)
.+.+.......+.+.....+.. ...+..+.+||.+||.+||++|||
T Consensus 223 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---- 298 (318)
T d3blha1 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---- 298 (318)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----
T ss_pred CCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----
T ss_conf 9989999999999841899825534432034443320133445550334044459989999999987389658909----
Q ss_pred HHHHHCCCCCCC
Q ss_conf 999981998679
Q 001865 949 ANEIKKHPFFKG 960 (1002)
Q Consensus 949 a~elL~Hpff~~ 960 (1002)
+.|+|+||||+.
T Consensus 299 a~elL~Hpff~~ 310 (318)
T d3blha1 299 SDDALNHDFFWS 310 (318)
T ss_dssp HHHHHHSGGGSS
T ss_pred HHHHHCCHHHCC
T ss_conf 999974950156
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=359.69 Aligned_cols=258 Identities=23% Similarity=0.374 Sum_probs=216.4
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
+++|+++++||+|+||.||+|.++ +++.||+|++..... .......+.+|+.+|++++||||+++++++...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEE
T ss_conf 999634318722778189999968-999999999812326-858999999999999867998687660120467731589
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
|+++.++.+..+.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEEEHHHHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCC---
T ss_conf 9740045678998604--77514456899999999999860574882678775056868997873236643011467---
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 7785123321146999974223566666655468764452000388-888830599999999999909999999996899
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGA-GHTSAVDWWALGILLYEMLYGYTPFRGKTRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~sDIwSlG~il~eLltG~~Pf~~~~~~~~ 906 (1002)
........|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..+.
T Consensus 154 ------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~ 209 (286)
T d1ob3a_ 154 ------------------------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209 (286)
T ss_dssp --------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------65410102431101378871788888410021117589999779799898898999
Q ss_pred HHHHHHCCCC------------------C---------CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 9999827999------------------9---------999988898999999802049388799734099998199867
Q 001865 907 FANILHKDLK------------------F---------PSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 907 ~~~i~~~~~~------------------~---------~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~ 959 (1002)
+..+...... . ......+..+.+|+.+||.+||++||| +.|+|+||||+
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~ 285 (286)
T d1ob3a_ 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFK 285 (286)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGG
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCC
T ss_conf 99999863899711042123332214333335676466651258999999999986689668909----99985692207
Q ss_pred C
Q ss_conf 9
Q 001865 960 G 960 (1002)
Q Consensus 960 ~ 960 (1002)
.
T Consensus 286 ~ 286 (286)
T d1ob3a_ 286 E 286 (286)
T ss_dssp C
T ss_pred C
T ss_conf 4
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.51 Aligned_cols=264 Identities=22% Similarity=0.332 Sum_probs=220.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf 05645434689422321166693899999991799199999940542248578999999999999579998442478986
Q 001865 660 LDSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQ 739 (1002)
Q Consensus 660 ~~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 739 (1002)
+...|++..++|++.+.||+|+||.||+|.++ ++..||||++.... .....+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEEC
T ss_conf 98770038899388679810798289999999-99999999986476----88899999999998679998857873104
Q ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf 08829999961689835677731799999999999999999999999998494317899995898059929998426775
Q 001865 740 TKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 740 ~~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~ 819 (1002)
. +.+|+||||+++|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred C-CCEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEE
T ss_conf 5-976999995789828888751478988788999999999999999974895467564225156202440423410147
Q ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCC
Q ss_conf 45789877778512332114699997422356666665546876445200038888883059999999999990-99999
Q 001865 820 LTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPF 898 (1002)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf 898 (1002)
...... ........|++.|+|||++....++.++|||||||++|+|++ |.+||
T Consensus 158 ~~~~~~--------------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 158 LIEDNE--------------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp ECSSSC--------------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ECCCCC--------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 735886--------------------------442035677444458289837999824564525799999996898888
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC--CCCCCC
Q ss_conf 99996899999982799999999888989999998020493887997340999981--998679
Q 001865 899 RGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKG 960 (1002)
Q Consensus 899 ~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~--Hpff~~ 960 (1002)
...+....+..+..+. ..+.+..++..+.+|+.+||..||++||| +.++++ |+||..
T Consensus 212 ~~~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~Rpt----~~ei~~~L~~~fts 270 (272)
T d1qpca_ 212 PGMTNPEVIQNLERGY-RMVRPDNCPEELYQLMRLCWKERPEDRPT----FDYLRSVLEDFFTA 270 (272)
T ss_dssp TTCCHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHHHHHC
T ss_conf 8889999999997068-88896557199999999975889768939----99999986113213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.38 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=218.3
Q ss_pred CCCCCCCCCCC-CCCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 34689422321-1666938999999917--99199999940542248578999999999999579998442478986088
Q 001865 666 INLQHFRPIKP-LGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 666 ~~~~~y~i~~~-LG~G~~g~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (1002)
+..+.|.+... ||+|+||.||+|.++. ++..||||+++... .......+.+|+.+|++++||||+++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-C
T ss_conf 54447188784873060809999999608976899999988203--97899999999999986799888068656036-8
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 29999961689835677731799999999999999999999999998494317899995898059929998426775457
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~ 822 (1002)
.+|+|||||++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 079999807899689975212-5699999999999999998789986881057676466045468854203313421155
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 89877778512332114699997422356666665546876445200038888883059999999999990-99999999
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 901 (1002)
..... ........||+.|+|||++....++.++|||||||++|+|++ |+.||.+.
T Consensus 161 ~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~ 216 (285)
T d1u59a_ 161 ADDSY------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 216 (285)
T ss_dssp TCSCE------------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCCC------------------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf 43432------------------------113562113743358688727999954123220178999993899999997
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 9689999998279999999988898999999802049388799734099998199867
Q 001865 902 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 902 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~ 959 (1002)
+..+....+..+.. .+.+..++.++.+|+.+||..||++|||+.+ +.+.|+|+|+.
T Consensus 217 ~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~-i~~~L~~~~~~ 272 (285)
T d1u59a_ 217 KGPEVMAFIEQGKR-MECPPECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272 (285)
T ss_dssp CTHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHH
T ss_conf 99999999981899-9999767899999999975779768909999-99999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.02 Aligned_cols=260 Identities=21% Similarity=0.347 Sum_probs=217.2
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 68942232116669389999999179919999994054224857899999999999957999844247898608829999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV 747 (1002)
+++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+++.++||||+++++++......+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999786269712868199999999999699999980321-7868999999999999856757888213544444311588
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
++++.+++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.......
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--
T ss_pred EEECCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC--
T ss_conf 6302332221121235--654036789999999999877433998600146761211337826652046011046887--
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCC-CCHHH
Q ss_conf 77851233211469999742235666666554687644520003888-88830599999999999909999999-99689
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG-HTSAVDWWALGILLYEMLYGYTPFRG-KTRQK 905 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~sDIwSlG~il~eLltG~~Pf~~-~~~~~ 905 (1002)
.......+++.|+|||++.... ++.++||||+||++|+|++|+.||.. .+...
T Consensus 156 -------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 210 (292)
T d1unla_ 156 -------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp -------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred -------------------------CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHH
T ss_conf -------------------------5100103443101466750698888044402654188998518999988999999
Q ss_pred HHHHHHHCCC---------------------------CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCC
Q ss_conf 9999982799---------------------------9999998889899999980204938879973409999819986
Q 001865 906 TFANILHKDL---------------------------KFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFF 958 (1002)
Q Consensus 906 ~~~~i~~~~~---------------------------~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff 958 (1002)
.+..+..... ........+..+.+||.+||.+||.+||| |+|+|+||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f 286 (292)
T d1unla_ 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYF 286 (292)
T ss_dssp HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGG
T ss_pred HHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCHHH
T ss_conf 999998611899735513443222113344454431043306568999999999986499668909----9999649534
Q ss_pred CCC
Q ss_conf 799
Q 001865 959 KGV 961 (1002)
Q Consensus 959 ~~~ 961 (1002)
+++
T Consensus 287 ~~~ 289 (292)
T d1unla_ 287 SDF 289 (292)
T ss_dssp SSC
T ss_pred CCC
T ss_conf 079
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.52 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=215.2
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 34689422321166693899999991799199999940542248578999999999999579998442478986088299
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVC 745 (1002)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 745 (1002)
++..+|++++.||+|+||.||+|.+. ++..||||.+.... .....+.+|+.++++++||||+++++++...+..|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEE
T ss_conf 89699588889820888299999988-99999999987886----76899999999999668997565352431599337
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCC
Q ss_conf 99961689835677731799999999999999999999999998494317899995898059929998426775457898
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKP 825 (1002)
Q Consensus 746 iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~ 825 (1002)
+||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC
T ss_conf 999836999189975201-3478899999999999998776531643104431532666688776865532100236887
Q ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHH
Q ss_conf 77778512332114699997422356666665546876445200038888883059999999999990-99999999968
Q 001865 826 QLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQ 904 (1002)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~ 904 (1002)
. .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||...+..
T Consensus 156 ~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 156 Y--------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred C--------------------------EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 3--------------------------35043001766678578607999840332105999999987898887789999
Q ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 999999827999999998889899999980204938879973409999819
Q 001865 905 KTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 905 ~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
..+..+..+.. ...+..++..+.+|+.+||..||++||| ++++++|
T Consensus 210 ~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 210 EVVEDISTGFR-LYKPRLASTHVYQIMNHCWKERPEDRPA----FSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 99999980688-8995436799999999976579768919----9999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.78 Aligned_cols=252 Identities=23% Similarity=0.338 Sum_probs=217.9
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 46894223211666938999999917991999999405422485789999999999995799984424789860882999
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 746 (1002)
+.++|++++.||+|+||.||+|.+ .++..||||.+++... ....+.+|+.++++++||||+++++++...+.+++
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
T ss_conf 969979968982078839999998-8998999999874757----78999999999996689860158899850781699
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCC
Q ss_conf 99616898356777317999999999999999999999999984943178999958980599299984267754578987
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQ 826 (1002)
Q Consensus 747 V~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~ 826 (1002)
||||+++|+|..++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 77 v~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp EEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred EEECCCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC-
T ss_conf 99704899388864102-4677689999999999999998754684346654135887699847988614420235787-
Q ss_pred CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHH
Q ss_conf 7778512332114699997422356666665546876445200038888883059999999999990-999999999689
Q 001865 827 LLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQK 905 (1002)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~ 905 (1002)
........||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+
T Consensus 155 -------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 155 -------------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp -------------------------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred -------------------------CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH
T ss_conf -------------------------2252465788775780786379988521033643246739755999988999999
Q ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 99999827999999998889899999980204938879973409999819
Q 001865 906 TFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 906 ~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
....+..+. ..+.+...+..+.+|+.+||+.||++||| +.++++|
T Consensus 210 ~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 210 TAEHIAQGL-RLYRPHLASEKVYTIMYSCWHEKADERPT----FKILLSN 254 (258)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 999998079-78996546599999999976689768939----9999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.27 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=220.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 56454346894223211666938999999917991999999405422485789999999999995799984424789860
Q 001865 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 661 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (1002)
...|.+..++|++.+.||+|+||.||+|.++.+ ..||+|++.... .....+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCEECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 756074779979846993079809999999999-999999988044----888999999999986666788689999823
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 88299999616898356777317999999999999999999999999984943178999958980599299984267754
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~ 820 (1002)
+.+|+||||+++|+|..++.......+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHH
T ss_conf -9759999944799435420000355305999999999999999987541143353123079998999299844255542
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCC
Q ss_conf 57898777785123321146999974223566666655468764452000388888830599999999999909-99999
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG-YTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG-~~Pf~ 899 (1002)
...... .......|++.|+|||++....++.++||||||+++|+|++| .+||.
T Consensus 163 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 163 IEDNEY--------------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ---------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCCCC--------------------------EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCC
T ss_conf 568873--------------------------352454556654580898379989177413235899999868999998
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC--CCCCCCC
Q ss_conf 9996899999982799999999888989999998020493887997340999981--9986799
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK--HPFFKGV 961 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~--Hpff~~~ 961 (1002)
+......+..+..+ ...+....++..+.+|+.+||..||++||+ +.++++ ++||+..
T Consensus 217 ~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 217 GMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRKEPEERPT----FEYLQAFLEDYFTST 275 (285)
T ss_dssp TCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHTTTSCS
T ss_pred CCCHHHHHHHHHHC-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHHHHCCC
T ss_conf 88899999999826-899998323799999999975669758919----999999876662389
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.51 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=212.4
Q ss_pred CCCCCCCCEEEEEEEECC--CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
Q ss_conf 211666938999999917--991999999405422485789999999999995799984424789860882999996168
Q 001865 675 KPLGSGDTGSVHLVELCG--SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 675 ~~LG~G~~g~Vy~a~~~~--~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iV~E~~~ 752 (1002)
++||+|+||.||+|.+.. +++.||+|+++... .+......+.+|+.+|++++||||+++++++.. +..|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010-898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 98356777317999999999999999999999999984943178999958980599299984267754578987777851
Q 001865 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTT 832 (1002)
Q Consensus 753 g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~~~~~~ 832 (1002)
+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~----- 163 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----- 163 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-----
T ss_pred CCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCC-----
T ss_conf 89689997522--57899999999999999976687479556777611310235675123413453313432344-----
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHH
Q ss_conf 2332114699997422356666665546876445200038888883059999999999990-999999999689999998
Q 001865 833 NEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKTRQKTFANIL 911 (1002)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~ 911 (1002)
........||+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus 164 -------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~ 224 (277)
T d1xbba_ 164 -------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224 (277)
T ss_dssp -------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred -------------------CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf -------------------3224456778420391665379998434430340313289658999999989999999998
Q ss_pred HCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHH---HCCCCCCCCC
Q ss_conf 27999999998889899999980204938879973409999---8199867998
Q 001865 912 HKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEI---KKHPFFKGVN 962 (1002)
Q Consensus 912 ~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~el---L~Hpff~~~~ 962 (1002)
.+. ..+.+..++..+.+|+.+||..||.+||| +.++ |+|+|+.-++
T Consensus 225 ~~~-~~~~p~~~~~~~~~li~~cl~~dp~~RPs----~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 225 KGE-RMGCPAGCPREMYDLMNLCWTYDVENRPG----FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHHHHHHHHHHHHH
T ss_pred CCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHCHHHHCCC
T ss_conf 289-99998656799999999975889768909----89999985288750479
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.91 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=213.3
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCC----EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 434689422321166693899999991799----1999999405422485789999999999995799984424789860
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSG----QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~----~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (1002)
++....|++.+.||+|+||.||+|.++.++ ..||||.+.... .......+.+|+.++++++||||+++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 5788996861598117790999999968998787999999988445--96899999999999985689878323677833
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 88299999616898356777317999999999999999999999999984943178999958980599299984267754
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~ 820 (1002)
.+..++||||+.++++.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCEEEEEEECCCCCCHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 88038999721357402221023-45420899999999999854121212342576564427888998499845510300
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCC
Q ss_conf 57898777785123321146999974223566666655468764452000388888830599999999999909-99999
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYG-YTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG-~~Pf~ 899 (1002)
....... ........||+.|+|||++.+..++.++||||||+++|+|++| .+||.
T Consensus 160 ~~~~~~~------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 160 LEDDPEA------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCCCC------------------------CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 3578765------------------------2674267777343488887049999735563448989999967988655
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 9996899999982799999999888989999998020493887997340999981
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~ 954 (1002)
+.+....+..+..+ ...+.+..++..+.+|+.+||..||++||| +.++++
T Consensus 216 ~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 216 ELSNHEVMKAINDG-FRLPTPMDCPSAIYQLMMQCWQQERARRPK----FADIVS 265 (283)
T ss_dssp TCCHHHHHHHHHTT-CCCCCCTTCBHHHHHHHHHHTCSSTTTSCC----HHHHHH
T ss_pred CCCHHHHHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 68999999998635-789985045799999999977679768939----999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.12 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=218.5
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 543468942232116669389999999179---91999999405422485789999999999995799984424789860
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT 740 (1002)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 740 (1002)
+++..++|++.+.||+|+||.||+|.+..+ +..+|+|.+... ........+.+|+.++++++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-
T ss_conf 976889969877993078829999999369964499999993656--68799999999999998689999856988995-
Q ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf 88299999616898356777317999999999999999999999999984943178999958980599299984267754
Q 001865 741 KTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 741 ~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~ 820 (1002)
.+.+|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred CCEEEEEEEECCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf 37479999840698077654224-78999999999999998775230226744141026553206789678765034213
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCC
Q ss_conf 5789877778512332114699997422356666665546876445200038888883059999999999990-999999
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFR 899 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~ 899 (1002)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 158 ~~~~~--------------------------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 158 MEDST--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp ---------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCC--------------------------CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 36776--------------------------2330540058310326675169988745244424789999826999988
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 99968999999827999999998889899999980204938879973409999819
Q 001865 900 GKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 900 ~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
+.+..+.+..+..+.. .+.+..++..+.+|+.+||..||.+||| +.++++|
T Consensus 212 ~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 212 GVKNNDVIGRIENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp TCCGGGHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 8999999999981899-9898777999999999976879768929----9999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.22 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=214.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCC-----CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEE
Q ss_conf 4543468942232116669389999999179-----919999994054224857899999999999957-9998442478
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGS-----GQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYA 736 (1002)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~-----~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 736 (1002)
.|.+..++|++.+.||+|+||.||+|.+... ++.||+|.+.... .......+.+|..++.++ +|+||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf 5261679979844984167839999998677755578399999986001--71789999999999886149984997411
Q ss_pred EEEE-CCEEEEEEECCCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9860-882999996168983567773179--------------9999999999999999999999998494317899995
Q 001865 737 SFQT-KTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPEN 801 (1002)
Q Consensus 737 ~~~~-~~~~~iV~E~~~g~sL~~~l~~~~--------------~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~N 801 (1002)
++.. ...+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 54047975799998458992999998536666653222023321468999999999999999998873797178677310
Q ss_pred EEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q ss_conf 89805992999842677545789877778512332114699997422356666665546876445200038888883059
Q 001865 802 VLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDW 881 (1002)
Q Consensus 802 Ili~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDI 881 (1002)
||++.++.+||+|||+|+....... ........||+.|+|||++.+..++.++||
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDi 219 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPD-------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDV 219 (299)
T ss_dssp EEECGGGCEEECC------CCSCTT-------------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHH
T ss_pred EEECCCCCEEECCCCCHHHCCCCCC-------------------------CCCCCCEEECCCCCCHHHHHCCCCCCCCCE
T ss_conf 6577998289845752001135665-------------------------222475166721020368646889966322
Q ss_pred HHHHHHHHHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9999999999909-9999999968999999827999999998889899999980204938879973409999819
Q 001865 882 WALGILLYEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 882 wSlG~il~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
|||||++|+|++| .+||.+......+...+......+.+..++..+.+|+.+||..||++||| +.|+++|
T Consensus 220 wS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 220 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred EEHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 1367899999868899998999899999999638988888657899999999976779667919----9999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.39 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=212.7
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCE----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCE
Q ss_conf 6894223211666938999999917991----999999405422485789999999999995799984424789860882
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQ----YFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKTH 743 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 743 (1002)
..+|++++.||+|+||.||+|.+..+++ +||+|.+.... .......+.+|+.++++++||||+++++++..+ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-C
T ss_conf 8999783198208992999999958998898999999965134--979999999999999867998881589999619-8
Q ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCC
Q ss_conf 99999616898356777317999999999999999999999999984943178999958980599299984267754578
Q 001865 744 VCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 744 ~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~ 823 (1002)
.+++|+++.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEEEECCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 36999842687401011133-45799999999999999999999876950476212031167998758602552223354
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 9877778512332114699997422356666665546876445200038888883059999999999990-999999999
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGKT 902 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~~ 902 (1002)
... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 164 ~~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 164 EEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp TCC---------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred CCC-------------------------CCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 445-------------------------3223651058644670887469998356544079999999977999999999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 68999999827999999998889899999980204938879973409999819
Q 001865 903 RQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 903 ~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
.......+..+. ..+.+..++..+.+|+.+||..||.+||| +.++++|
T Consensus 219 ~~~~~~~i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 266 (317)
T d1xkka_ 219 ASEISSILEKGE-RLPQPPICTIDVYMIMVKCWMIDADSRPK----FRELIIE 266 (317)
T ss_dssp GGGHHHHHHHTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 899999997599-89998556899999999847899346919----9999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.26 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=221.7
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEEEECCC---CEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECC
Q ss_conf 3468942232116669389999999179---9199999940542248578999999999999579998442478986088
Q 001865 666 INLQHFRPIKPLGSGDTGSVHLVELCGS---GQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQTKT 742 (1002)
Q Consensus 666 ~~~~~y~i~~~LG~G~~g~Vy~a~~~~~---~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 742 (1002)
++.++|++.+.||+|+||.||+|..... ...||+|++.+...........+.+|+.+|++++||||+++++++.. .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-C
T ss_conf 864891997898038883999999988999079999999983555798999999999999986899998789877740-1
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCC
Q ss_conf 29999961689835677731799999999999999999999999998494317899995898059929998426775457
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTS 822 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~ 822 (1002)
.+++||||+++++|.+++..+. ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CHHEEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 0011465423861254442126-899999999999999999987521787520566888156556543325611555303
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCC
Q ss_conf 89877778512332114699997422356666665546876445200038888883059999999999990-99999999
Q 001865 823 CKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRGK 901 (1002)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~~ 901 (1002)
.... .........|+..|+|||++.+..++.++||||||+++|+|++ |+.||.+.
T Consensus 163 ~~~~------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 163 QNDD------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp C-CC------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CCCC------------------------CCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 5887------------------------5265476325731079999837999942156614899999996899999996
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHH
Q ss_conf 9689999998279999999988898999999802049388799734099998
Q 001865 902 TRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIK 953 (1002)
Q Consensus 902 ~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL 953 (1002)
+..+.+..+.+....++....++..+.+|+.+||..||++||| +.+++
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt----~~ei~ 266 (273)
T d1u46a_ 219 NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT----FVALR 266 (273)
T ss_dssp CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHH
T ss_pred CHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHH
T ss_conf 9999999998479999985445399999999976889667929----99999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.88 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=220.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCC-------EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCC
Q ss_conf 5645434689422321166693899999991799-------19999994054224857899999999999957-999844
Q 001865 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCGSG-------QYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVP 732 (1002)
Q Consensus 661 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~-------~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv 732 (1002)
.+.|.+..++|++.+.||+|+||.||+|.+..++ ..||+|.+++.. .......+.+|...+.++ +||||+
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEE
T ss_conf 97672258996970098516782899999857875556675499999988112--8688999999999999813999697
Q ss_pred EEEEEEEECCEEEEEEECCCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 24789860882999996168983567773179--------------9999999999999999999999998494317899
Q 001865 733 ALYASFQTKTHVCLITDYCPGGELFLLLDRQP--------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLK 798 (1002)
Q Consensus 733 ~l~~~~~~~~~~~iV~E~~~g~sL~~~l~~~~--------------~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLk 798 (1002)
++++++..++.+|+||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++|||||||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred ECCCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEEC
T ss_conf 34652201886899997369990999998606776432223345743467999999999999999987663797863022
Q ss_pred CCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 99589805992999842677545789877778512332114699997422356666665546876445200038888883
Q 001865 799 PENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSA 878 (1002)
Q Consensus 799 P~NIli~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~ 878 (1002)
|+|||++.++.+||+|||.+........ ........|++.|+|||++.+..++.+
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~l~~~~y~~k 217 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQ 217 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCT-------------------------TCCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred CCCEEECCCCCEEECCCHHHCCCCCCCC-------------------------CCCCCCCCCCHHHHHHHHHCCCCCCCH
T ss_conf 1022454789767622111011355555-------------------------431466788846632667517988825
Q ss_pred HHHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 059999999999990-9999999996899999982799999999888989999998020493887997340999981
Q 001865 879 VDWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 879 sDIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~ 954 (1002)
+||||||+++|+|++ |.+||.+.+....+..+..+ ...+.+..++..+.+|+.+||..||.+||| +.|+++
T Consensus 218 ~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 218 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 554775888887401798989999999999999728-888987435299999999976679767939----999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.89 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=222.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEEEEEC-----CCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEE
Q ss_conf 645434689422321166693899999991-----79919999994054224857899999999999957-999844247
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELC-----GSGQYFAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALY 735 (1002)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 735 (1002)
..|++..++|++.+.||+|+||.||+|... .+++.||+|.+++.. .......+.+|..++..+ +||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 02637789969854982068829999998066447788699999987424--8779999999999987626999887899
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 89860882999996168983567773179----------------99999999999999999999999984943178999
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQP----------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKP 799 (1002)
Q Consensus 736 ~~~~~~~~~~iV~E~~~g~sL~~~l~~~~----------------~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP 799 (1002)
+++...+.+|+|||||++++|.+++.... ...+++..+..++.||+.||+|||+++++||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 89831997899997379987999998535665444445332223345889999999999999999988757926662410
Q ss_pred CCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
Q ss_conf 95898059929998426775457898777785123321146999974223566666655468764452000388888830
Q 001865 800 ENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAV 879 (1002)
Q Consensus 800 ~NIli~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~s 879 (1002)
+||+++.++.++|+|||.+........ ........||+.|+|||++....++.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSN-------------------------YVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTT-------------------------SEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred CCCCCCCCCCCCCCCCCHHEECCCCCC-------------------------CEEEEECCCCHHHCCHHHHCCCCCCCCC
T ss_conf 210000257521023401023367886-------------------------1586201359687677886179999740
Q ss_pred HHHHHHHHHHHHHC-CCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 59999999999990-9999999996899999982799999999888989999998020493887997340999981
Q 001865 880 DWWALGILLYEMLY-GYTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 880 DIwSlG~il~eLlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~ 954 (1002)
||||||+++|+|++ |.+||.+.+....+..++............+..+.+|+.+||..||.+||| +.++++
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 010258999999858998877899899999998668988985436599999999975779657929----999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.44 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=216.9
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEEEEECCCCEE--EEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEEC
Q ss_conf 43468942232116669389999999179919--999994054224857899999999999957-999844247898608
Q 001865 665 QINLQHFRPIKPLGSGDTGSVHLVELCGSGQY--FAMKAMDKGVMLNRNKVHRACAEREILDML-DHPFVPALYASFQTK 741 (1002)
Q Consensus 665 ~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~--vaiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~ 741 (1002)
.++.++|++.+.||+|+||.||+|.++.++.. ||||.+.... .......+.+|+++|.++ +||||+++++++...
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred CCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC
T ss_conf 66879968877982078828999999899969999999978233--8579999999999998622899883678888418
Q ss_pred CEEEEEEECCCCCCHHHHHHHC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 8299999616898356777317--------------99999999999999999999999998494317899995898059
Q 001865 742 THVCLITDYCPGGELFLLLDRQ--------------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 742 ~~~~iV~E~~~g~sL~~~l~~~--------------~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~ 807 (1002)
+.+|+||||+++|+|.+++... ....++...+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCC
T ss_conf 73699998028986999986403555551231012345789999999999999999876630895455505204898688
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 92999842677545789877778512332114699997422356666665546876445200038888883059999999
Q 001865 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (1002)
Q Consensus 808 ~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~i 887 (1002)
+.+||+|||++..... ........||..|+|||.+.+..++.++||||||++
T Consensus 164 ~~~kl~DfG~a~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvi 215 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215 (309)
T ss_dssp GCEEECCTTCEESSCE----------------------------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHH
T ss_pred CCEEECCCCCCCCCCC----------------------------CCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHH
T ss_conf 7638743443224442----------------------------234553013775555387526999962215313889
Q ss_pred HHHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9999909-9999999968999999827999999998889899999980204938879973409999819
Q 001865 888 LYEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 888 l~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
+|+|++| .+||.+.+....+..+..+. ..+.+..++..+.+|+.+||..||++||| +.++++|
T Consensus 216 l~ell~~~~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 216 LWEIVSLGGTPYCGMTCAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 9999836899999999999999998268-88887667899999999976789668949----9999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.61 Aligned_cols=270 Identities=18% Similarity=0.231 Sum_probs=225.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 56454346894223211666938999999917-----9919999994054224857899999999999957999844247
Q 001865 661 DSGEQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALY 735 (1002)
Q Consensus 661 ~~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 735 (1002)
...|.+..++|++.+.||+|+||.||+|.+.. ++..||||.++... .......+.+|+.++++++||||++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred CCCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 610042689918835982078818999998786447789689999987012--868999999999999976999884125
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHC--------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECC
Q ss_conf 8986088299999616898356777317--------99999999999999999999999998494317899995898059
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQ--------PTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGN 807 (1002)
Q Consensus 736 ~~~~~~~~~~iV~E~~~g~sL~~~l~~~--------~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~ 807 (1002)
+++...+..++||||+++|+|.+++... ....++...+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 169 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred EEEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCC
T ss_conf 47842881067776048998899987503321134446887999999999999999998764796543286775403599
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 92999842677545789877778512332114699997422356666665546876445200038888883059999999
Q 001865 808 GHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGIL 887 (1002)
Q Consensus 808 ~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~i 887 (1002)
+.+||+|||++....... .........|++.|+|||.+.+..++.++||||||++
T Consensus 170 ~~~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224 (308)
T ss_dssp CCEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CEEEEEECCCCEECCCCC-------------------------CEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHH
T ss_conf 649994245420235776-------------------------3031340231632378888736998833344437899
Q ss_pred HHHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC------CCCCCC
Q ss_conf 9999909-999999996899999982799999999888989999998020493887997340999981------998679
Q 001865 888 LYEMLYG-YTPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK------HPFFKG 960 (1002)
Q Consensus 888 l~eLltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~------Hpff~~ 960 (1002)
+|+|++| .+||.+.+..+.+..+..+.. .+....++..+.+|+.+||+.+|++||| +.++++ +|+|++
T Consensus 225 l~El~t~~~~p~~~~~~~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHH
T ss_pred HHHHHHCCCCCCCCCCHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHHHHHHHCCCCCCC
T ss_conf 99999689999999899999999980888-8886335399999999975779658939----999999978761778757
Q ss_pred CC
Q ss_conf 98
Q 001865 961 VN 962 (1002)
Q Consensus 961 ~~ 962 (1002)
++
T Consensus 300 ~~ 301 (308)
T d1p4oa_ 300 VS 301 (308)
T ss_dssp HC
T ss_pred CC
T ss_conf 78
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=337.62 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=218.0
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEEEEEECC-----CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf 54346894223211666938999999917-----9919999994054224857899999999999957999844247898
Q 001865 664 EQINLQHFRPIKPLGSGDTGSVHLVELCG-----SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASF 738 (1002)
Q Consensus 664 ~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~-----~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 738 (1002)
.++..++|++++.||+|+||.||+|..+. ++..||||.+.... .......+.+|+.++++++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 138988938867982078839999998887657788299999988210--857999999999999966899765524666
Q ss_pred EECCEEEEEEECCCCCCHHHHHHHCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 60882999996168983567773179----------------------99999999999999999999999984943178
Q 001865 739 QTKTHVCLITDYCPGGELFLLLDRQP----------------------TKVLKEDAVRFYAAEVVVALEYLHCQGIIYRD 796 (1002)
Q Consensus 739 ~~~~~~~iV~E~~~g~sL~~~l~~~~----------------------~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrD 796 (1002)
...+..+++|||+++++|.+++.... ...++...+..++.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 05980389998158992999998527554210000111001210346788989999999999999985541357868548
Q ss_pred CCCCCEEEECCCCEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99995898059929998426775457898777785123321146999974223566666655468764452000388888
Q 001865 797 LKPENVLLQGNGHVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHT 876 (1002)
Q Consensus 797 LkP~NIli~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~ 876 (1002)
|||+|||++.++.+||+|||+|....... ......+..|++.|+|||++.+..++
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~t 220 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSAD-------------------------YYKADGNDAIPIRWMPPESIFYNRYT 220 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG-------------------------CBC----CCBCGGGCCHHHHHHCCCC
T ss_pred ECCCCEEECCCCCEEECCCHHHEECCCCC-------------------------CCCCCCCCCCCCCCCCHHHHCCCCCC
T ss_conf 84011689899928983314421136776-------------------------41115777767676798997268898
Q ss_pred CHHHHHHHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHC
Q ss_conf 8305999999999999099-99999996899999982799999999888989999998020493887997340999981
Q 001865 877 SAVDWWALGILLYEMLYGY-TPFRGKTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKK 954 (1002)
Q Consensus 877 ~~sDIwSlG~il~eLltG~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~ 954 (1002)
.++|||||||++|+|++|. +||.+.+..+....+..+.. .+.+..++..+.+|+.+||..+|++||| +.|+++
T Consensus 221 ~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 221 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC-CCCCCCCHHHHHHHHHHHCCCCHHHCCC----HHHHHH
T ss_conf 0563025236299998068999999899999999973997-8887325299999999974889657939----999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.03 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=215.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-C
Q ss_conf 454346894223211666938999999917991999999405422485789999999999995799984424789860-8
Q 001865 663 GEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-K 741 (1002)
Q Consensus 663 ~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~ 741 (1002)
||.+..++|++.+.||+|+||.||+|.+ ++..||+|+++.. .....+.+|+.++++++||||+++++++.. .
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CCCCCHHHEEEEEEEECCCCEEEEEEEE--CCEEEEEEEECCH-----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 9955789948857982079808999999--9909999998857-----77999999999998678989854987887238
Q ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCC
Q ss_conf 82999996168983567773179999999999999999999999999849431789999589805992999842677545
Q 001865 742 THVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLT 821 (1002)
Q Consensus 742 ~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~ 821 (1002)
+.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CCEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEEC
T ss_conf 92899996369998999987457888899999999999985232113376553666567601468997763245600344
Q ss_pred CCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCC
Q ss_conf 789877778512332114699997422356666665546876445200038888883059999999999990-9999999
Q 001865 822 SCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLY-GYTPFRG 900 (1002)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLlt-G~~Pf~~ 900 (1002)
.. ......+++.|+|||++.+..++.++||||||+++|+|++ |++||..
T Consensus 154 ~~------------------------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 154 SS------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CC------------------------------CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 78------------------------------776556664677817872798885887775799999999789999999
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9968999999827999999998889899999980204938879973409999819
Q 001865 901 KTRQKTFANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 901 ~~~~~~~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
.+....+..+..+. ..+....++..+.+|+.+||..||.+||| +.+++++
T Consensus 204 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~~l~~~ 253 (262)
T d1byga_ 204 IPLKDVVPRVEKGY-KMDAPDGCPPAVYEVMKNCWHLDAAMRPS----FLQLREQ 253 (262)
T ss_dssp SCGGGHHHHHTTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 99999999998089-99997657999999999975669768939----9999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.49 Aligned_cols=253 Identities=18% Similarity=0.217 Sum_probs=205.7
Q ss_pred CCCCCCCCCCCEEEEEEEECCCC---EEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEE
Q ss_conf 22321166693899999991799---1999999405422485789999999999995799984424789860-8829999
Q 001865 672 RPIKPLGSGDTGSVHLVELCGSG---QYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPFVPALYASFQT-KTHVCLI 747 (1002)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iV 747 (1002)
...+.||+|+||.||+|.+..++ ..||||.+.+. .+......+.+|+++|++++||||+++++++.. ++..++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 2666981368809999999779987999999998843--69789999999999998678999867867898069943899
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEECCCCCCCCCCCCC
Q ss_conf 96168983567773179999999999999999999999999849431789999589805992999842677545789877
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDFDLSCLTSCKPQL 827 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~~~~~~~~ 827 (1002)
||||++++|.+++... ...++...+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEECCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 9874067414421013-454048999999999887652003367625776687576779998899106523225566555
Q ss_pred CCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-CHHHH
Q ss_conf 77851233211469999742235666666554687644520003888888305999999999999099999999-96899
Q 001865 828 LLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGK-TRQKT 906 (1002)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~-~~~~~ 906 (1002)
.........||+.|+|||.+....++.++||||||+++|+|++|..||... +....
T Consensus 187 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~ 243 (311)
T d1r0pa_ 187 -----------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243 (311)
T ss_dssp -----------------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C
T ss_pred -----------------------CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf -----------------------310025655564556768874379997457466199999999789999888999999
Q ss_pred HHHHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9999827999999998889899999980204938879973409999819
Q 001865 907 FANILHKDLKFPSSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKH 955 (1002)
Q Consensus 907 ~~~i~~~~~~~~~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~H 955 (1002)
...+..+. ..+.+..++..+.+|+.+||..||++||+ +.|+++|
T Consensus 244 ~~~i~~g~-~~~~p~~~~~~l~~li~~cl~~dP~~RPs----~~ei~~~ 287 (311)
T d1r0pa_ 244 TVYLLQGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPS----FSELVSR 287 (311)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHHH
T ss_conf 99998089-88996447599999999976889768939----9999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=325.62 Aligned_cols=264 Identities=18% Similarity=0.209 Sum_probs=206.5
Q ss_pred CCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEEEE
Q ss_conf 689422321166693899999991799199999940542248578999999999999579998-4424789860882999
Q 001865 668 LQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF-VPALYASFQTKTHVCL 746 (1002)
Q Consensus 668 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~~~i 746 (1002)
.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|.++++.++|++ |+.+..++...+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
T ss_conf 8889996898507880999999988998999999721005-----88899999999970389960179999951987789
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC---CCCEEEEECCCCCCCCC
Q ss_conf 996168983567773179999999999999999999999999849431789999589805---99299984267754578
Q 001865 747 ITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG---NGHVSLTDFDLSCLTSC 823 (1002)
Q Consensus 747 V~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~---~~~ikL~DFG~a~~~~~ 823 (1002)
||||+ +++|...+... ...+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|.....
T Consensus 81 vme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEC-CCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 99873-87133324430-68876899999999999999999979944266787660643357776156504675134255
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 98777785123321146999974223566666655468764452000388888830599999999999909999999996
Q 001865 824 KPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRGKTR 903 (1002)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~~~~ 903 (1002)
..... ..+........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 159 ~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 159 ARTHQ--------------------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp TTTCC--------------------BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCCC--------------------CEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCH
T ss_conf 44554--------------------1000135776787353299999189989832188617789999849876655305
Q ss_pred HHHHHHHH---HCC--CCCC-CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 89999998---279--9999-99988898999999802049388799734099998199867
Q 001865 904 QKTFANIL---HKD--LKFP-SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFK 959 (1002)
Q Consensus 904 ~~~~~~i~---~~~--~~~~-~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~ 959 (1002)
......+. ... .+.+ ....++.++.+|+.+||..+|++||++.. +.++|+|+|.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~-i~~~l~~~~~~ 279 (299)
T d1ckia_ 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHR 279 (299)
T ss_dssp ------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHH-HHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH-HHHHHHHHHHH
T ss_conf 77999999852356789835753478899999999984399557919999-99999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=322.45 Aligned_cols=263 Identities=23% Similarity=0.383 Sum_probs=203.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CCC
Q ss_conf 645434689422321166693899999991799199999940542248578999999999999579-----------998
Q 001865 662 SGEQINLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-----------HPF 730 (1002)
Q Consensus 662 ~~~~~~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-----------hp~ 730 (1002)
.|+.+..++|++++.||+|+||+||+|.++.+++.||||++.+. ........+|+.+++.++ |+|
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCCCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC----CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCC
T ss_conf 88884478579989975077818999999999979999998343----13368999999999984014555554227676
Q ss_pred CCEEEEEEEE--CCEEEEEEECCCCC-CHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEEEC
Q ss_conf 4424789860--88299999616898-35677731799999999999999999999999998-49431789999589805
Q 001865 731 VPALYASFQT--KTHVCLITDYCPGG-ELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-QGIIYRDLKPENVLLQG 806 (1002)
Q Consensus 731 Iv~l~~~~~~--~~~~~iV~E~~~g~-sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~-~~IiHrDLkP~NIli~~ 806 (1002)
|+++++++.. ....+++|.++..+ .............+++..++.++.||+.||.|||+ .||+||||||+|||++.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred EEEEEEEEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEEC
T ss_conf 47899876312565202343200035420000012234678689999999999999888764058646567705705630
Q ss_pred CC------CEEEEECCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf 99------299984267754578987777851233211469999742235666666554687644520003888888305
Q 001865 807 NG------HVSLTDFDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVD 880 (1002)
Q Consensus 807 ~~------~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sD 880 (1002)
++ .++++|||.+.... ......+||+.|+|||++....++.++|
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 211 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYD------------------------------EHYTNSIQTREYRSPEVLLGAPWGCGAD 211 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETT------------------------------BCCCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred CCCCCCCCEEEEEECCCCCCCC------------------------------CCCCCCCCCCCCCCHHHCCCCCCCCCCC
T ss_conf 5765644305675314421234------------------------------4542236652105713214667776432
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHH--CCC----------------------CCC------------
Q ss_conf 999999999999099999999968------99999982--799----------------------999------------
Q 001865 881 WWALGILLYEMLYGYTPFRGKTRQ------KTFANILH--KDL----------------------KFP------------ 918 (1002)
Q Consensus 881 IwSlG~il~eLltG~~Pf~~~~~~------~~~~~i~~--~~~----------------------~~~------------ 918 (1002)
|||+||++++|++|+.||...... ........ +.. ...
T Consensus 212 iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCC
T ss_conf 01237899999878899898755432102689999999837998788624532200013201220243235776444210
Q ss_pred ----CCCCCCHHHHHHHHHCCCCCCCCCCCCHHCHHHHHCCCCCCCCC
Q ss_conf ----99988898999999802049388799734099998199867998
Q 001865 919 ----SSTPTSLHAKQLMYRLLHRDPKSRLGSHEGANEIKKHPFFKGVN 962 (1002)
Q Consensus 919 ----~~~~~s~~l~~LL~~mL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 962 (1002)
.....+..+.+||.+||.+||.+||| |.|+|+||||+++.
T Consensus 292 ~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNHPWLKDTL 335 (362)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTCGGGTTCT
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCC----HHHHHCCCCCCCCC
T ss_conf 001567435899999999987799457908----99996693407898
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=315.63 Aligned_cols=252 Identities=19% Similarity=0.228 Sum_probs=204.1
Q ss_pred CCCCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEEE
Q ss_conf 46894223211666938999999917991999999405422485789999999999995799-98442478986088299
Q 001865 667 NLQHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDH-PFVPALYASFQTKTHVC 745 (1002)
Q Consensus 667 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~ 745 (1002)
..++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|++.++.+.| ++++.+++++......|
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCE
T ss_conf 89806997998417882999999988997999999750258-----2999999999999648999877999960188117
Q ss_pred EEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC-----CCCEEEEECCCCCC
Q ss_conf 9996168983567773179999999999999999999999999849431789999589805-----99299984267754
Q 001865 746 LITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQG-----NGHVSLTDFDLSCL 820 (1002)
Q Consensus 746 iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~-----~~~ikL~DFG~a~~ 820 (1002)
+||||+ +++|.+++... ...++...+..++.|++.||.|||++||+||||||+|||++. ++.++|+|||+|+.
T Consensus 78 ~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEC-CCCHHHHHHHH-CCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 999964-88879999752-0311068999999999999999997796626677131523475434479568723660577
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 57898777785123321146999974223566666655468764452000388888830599999999999909999999
Q 001865 821 TSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAGHTSAVDWWALGILLYEMLYGYTPFRG 900 (1002)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~sDIwSlG~il~eLltG~~Pf~~ 900 (1002)
........ ..+.......+||+.|+|||++.+..++.++||||||+++|+|++|+.||.+
T Consensus 156 ~~~~~~~~--------------------~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 156 YRDPVTKQ--------------------HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp SBCTTTCC--------------------BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CCCCCCCC--------------------CEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 14676654--------------------1110246762775102679896488888699989831999999869876788
Q ss_pred CCH---HHHHHHHHHCCC--CCC-CCCCCCHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 996---899999982799--999-999888989999998020493887997
Q 001865 901 KTR---QKTFANILHKDL--KFP-SSTPTSLHAKQLMYRLLHRDPKSRLGS 945 (1002)
Q Consensus 901 ~~~---~~~~~~i~~~~~--~~~-~~~~~s~~l~~LL~~mL~~dP~~Rpt~ 945 (1002)
... ...+..+..... +.+ ....++.++.+++..|+..+|++||+.
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 216 LKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp CCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred CCCHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCH
T ss_conf 530219999999970567999589657998999999999843993008599
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.13 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=189.2
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHH--HHHHHHCCCCCCCEEEEEEEECC----
Q ss_conf 894223211666938999999917991999999405422485789999999--99999579998442478986088----
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAE--REILDMLDHPFVPALYASFQTKT---- 742 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E--~~il~~l~hp~Iv~l~~~~~~~~---- 742 (1002)
.+|.+.+.||+|+||.||+|.. +++.||||++... ......+| +..+..++||||+++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
T ss_conf 6899988982078819999999--9989999998720------0467999999999962799868326889983798604
Q ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEEECCCCEEEEE
Q ss_conf 29999961689835677731799999999999999999999999998--------4943178999958980599299984
Q 001865 743 HVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC--------QGIIYRDLKPENVLLQGNGHVSLTD 814 (1002)
Q Consensus 743 ~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~--------~~IiHrDLkP~NIli~~~~~ikL~D 814 (1002)
.+|+|||||++|+|.+++... .+++..+..++.|++.||.|+|. ++|+||||||+|||++.++.+||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf 899999646698989998658---99989999999999999999887665204689866153173135786887768876
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCHHHHHHHHHHH
Q ss_conf 267754578987777851233211469999742235666666554687644520003888------88830599999999
Q 001865 815 FDLSCLTSCKPQLLLPTTNEKKRRHKGQQNPVFMAEPMRASNSFVGTEEYIAPEIIAGAG------HTSAVDWWALGILL 888 (1002)
Q Consensus 815 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~------~~~~sDIwSlG~il 888 (1002)
||++.......... ........||+.|+|||++.+.. ++.++|||||||++
T Consensus 152 FGl~~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl 208 (303)
T d1vjya_ 152 LGLAVRHDSATDTI-----------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 208 (303)
T ss_dssp CTTCEEEETTTTEE-----------------------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCCE-----------------------ECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 38662346777620-----------------------0135525035476782210565454677767501220159999
Q ss_pred HHHHCCCCCCCCC---------------CHHHHHHHHHHCCC--CCCCCC---CCCHHHHHHHHHCCCCCCCCCCCCHHC
Q ss_conf 9999099999999---------------96899999982799--999999---888989999998020493887997340
Q 001865 889 YEMLYGYTPFRGK---------------TRQKTFANILHKDL--KFPSST---PTSLHAKQLMYRLLHRDPKSRLGSHEG 948 (1002)
Q Consensus 889 ~eLltG~~Pf~~~---------------~~~~~~~~i~~~~~--~~~~~~---~~s~~l~~LL~~mL~~dP~~Rpt~~~~ 948 (1002)
|+|++|..||... ........+..... .++... .....+.+|+.+||..||.+|||
T Consensus 209 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps---- 284 (303)
T d1vjya_ 209 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT---- 284 (303)
T ss_dssp HHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----
T ss_pred HHHHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCC----
T ss_conf 9996289988766311241012255643099999987502468887765577689999999999976069858959----
Q ss_pred HHHHHC
Q ss_conf 999981
Q 001865 949 ANEIKK 954 (1002)
Q Consensus 949 a~elL~ 954 (1002)
+.|+++
T Consensus 285 ~~ei~~ 290 (303)
T d1vjya_ 285 ALRIKK 290 (303)
T ss_dssp HHHHHH
T ss_pred HHHHHH
T ss_conf 999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.2e-24 Score=165.77 Aligned_cols=137 Identities=19% Similarity=0.142 Sum_probs=106.2
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCC---------------CHHHHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 42232116669389999999179919999994054224---------------857899999999999957999844247
Q 001865 671 FRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVML---------------NRNKVHRACAEREILDMLDHPFVPALY 735 (1002)
Q Consensus 671 y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~---------------~~~~~~~~~~E~~il~~l~hp~Iv~l~ 735 (1002)
+-+.++||+|+||.||+|.+ .+++.||+|+++..... ..........|...+.++.+.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEEC-CCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 02277802485659999997-99999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEEEC
Q ss_conf 89860882999996168983567773179999999999999999999999999849431789999589805992999842
Q 001865 736 ASFQTKTHVCLITDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENVLLQGNGHVSLTDF 815 (1002)
Q Consensus 736 ~~~~~~~~~~iV~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~~~IiHrDLkP~NIli~~~~~ikL~DF 815 (1002)
+... .+++|||+++..+.. ++...+..++.|++.+|.|||++||+||||||+|||+++ +.++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TEEEECCC
T ss_pred EECC----CEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEEC-CCEEEEEC
T ss_conf 8628----889999504565420---------015789999999999999982688898368903611428-98999877
Q ss_pred CCCCCCC
Q ss_conf 6775457
Q 001865 816 DLSCLTS 822 (1002)
Q Consensus 816 G~a~~~~ 822 (1002)
|.|....
T Consensus 147 G~a~~~~ 153 (191)
T d1zara2 147 PQSVEVG 153 (191)
T ss_dssp TTCEETT
T ss_pred CCCCCCC
T ss_conf 8843089
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.86 E-value=1.4e-20 Score=140.65 Aligned_cols=108 Identities=60% Similarity=1.139 Sum_probs=96.1
Q ss_pred CCCCEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 37829999378999968980658899809996678199987556999996899999999984993999999982299689
Q 001865 198 FQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPF 277 (1002)
Q Consensus 198 ~~~~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~ 277 (1002)
+.++++++|+..+||+|+|||++|++++||+.+|++|+++.++.+++........++..+..+..+++|++.++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CCCEEEEEECCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEEEECCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCEEE
T ss_conf 66569999598998969999589999888699998587300311355787784223457653985031278870688399
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCHH
Q ss_conf 9988865666699998999999943404
Q 001865 278 WNLLTIAPIKDDEGKVLKFIGMQVEVSK 305 (1002)
Q Consensus 278 w~~~~~spi~d~~G~v~~~i~~~~DITe 305 (1002)
|++++++|++|++|.+.+++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
T ss_conf 9998998899999999999999997799
|
| >d1n9la_ d.110.3.6 (A:) Putative blue light receptor, phot-lov1 domain {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Putative blue light receptor, phot-lov1 domain species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.83 E-value=2.6e-19 Score=132.86 Aligned_cols=108 Identities=45% Similarity=0.912 Sum_probs=99.8
Q ss_pred CCCCEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 14529998488999977852588899829996656399976446999996899999999963993999999994599599
Q 001865 481 IEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (1002)
Q Consensus 481 a~~~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~ 560 (1002)
..++++++|+..+|++|+|||++|++++||+++|++|+++..+.+++......+.+...+..+..+++|+++++|||+.+
T Consensus 2 i~~~~vi~Da~~pdg~Ii~vN~a~~~~~Gy~~~El~G~~~~~l~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~kdG~~~ 81 (109)
T d1n9la_ 2 LRHTFVVADATLPDCPLVYASEGFYAMTGYGPDEVLGHNCRFLQGEGTDPKEVQKIRDAIKKGEACSVRLLNYRKDGTPF 81 (109)
T ss_dssp CSCEEEEEETTSTTCCEEEECHHHHHHHCCCHHHHTTSCGGGGCCTTCCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEE
T ss_pred CCCEEEEEECCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEEEECCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCEEE
T ss_conf 66569999598998969999589999888699998587300311355787784223457653985031278870688399
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCC
Q ss_conf 9999998655489989999999963875
Q 001865 561 WNLFHLQPMRDQKGEVQYFIGVQLDGSE 588 (1002)
Q Consensus 561 wv~~~~~pi~d~~G~v~~~ig~~~DITe 588 (1002)
|+.+++.|++|++|++.+++++++|||.
T Consensus 82 w~~~~~~pi~d~~G~v~~~v~~~~DITa 109 (109)
T d1n9la_ 82 WNLLTVTPIKTPDGRVSKFVGVQVDVTS 109 (109)
T ss_dssp EEEEEEEEEECTTSCEEEEEEEEEECCC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCC
T ss_conf 9998998899999999999999997799
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.1e-18 Score=128.99 Aligned_cols=106 Identities=29% Similarity=0.580 Sum_probs=83.1
Q ss_pred CEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEE
Q ss_conf 29999378999968980658899809996678199987--5569999968999999999849939999999822996899
Q 001865 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR--FLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFW 278 (1002)
Q Consensus 201 ~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~--~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w 278 (1002)
.++++|+...|+.|+|+|++|++++||+.+|++|+++. ++.+++........++.++..+..+..+++.++++|+.+|
T Consensus 3 ~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~w 82 (110)
T d1bywa_ 3 KFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFL 82 (110)
T ss_dssp EEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEEE
T ss_pred EEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCCCCCCEEEHEECCCCCCCCHHHCCCCCCCCEEEEEECCCCEEE
T ss_conf 19997598999989999489999859988895336743112101000000000100000012111110002201322011
Q ss_pred EEEEEEEEECCCCCEEEEEEEEECCHHH
Q ss_conf 9888656666999989999999434043
Q 001865 279 NLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (1002)
Q Consensus 279 ~~~~~spi~d~~G~v~~~i~~~~DITer 306 (1002)
+.++++|++|++|++.+++++++|||||
T Consensus 83 ~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 83 CLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEECCCCCEEEEEEEEEECCCC
T ss_conf 2336778998999999999999978899
|
| >d1bywa_ d.110.3.6 (A:) Erg potassium channel, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Erg potassium channel, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=2.9e-18 Score=126.40 Aligned_cols=107 Identities=30% Similarity=0.527 Sum_probs=97.6
Q ss_pred CCEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCC--CCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEE
Q ss_conf 5299984889999778525888998299966563999764--46999996899999999963993999999994599599
Q 001865 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRF--LQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKF 560 (1002)
Q Consensus 483 ~~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~--l~~~~~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~ 560 (1002)
..++++|+++.|++|+|+|++|++++||+.+|++|++... +.+++........+...+..+..+..+++.++++|+.+
T Consensus 2 ~~f~i~~~~~~d~~I~~~N~a~~~l~G~~~~eiiG~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~e~~~~~~~g~~~ 81 (110)
T d1bywa_ 2 RKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPCTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCF 81 (110)
T ss_dssp CEEEEEETTSSSCBEEEECHHHHHHHTCCHHHHTTSBTTCGGGCCTTCCHHHHHHHHHHHHTTCCEEEEEEEECTTSCEE
T ss_pred CEEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCCCCCCEEEHEECCCCCCCCHHHCCCCCCCCEEEEEECCCCEE
T ss_conf 61999759899998999948999985998889533674311210100000000010000001211111000220132201
Q ss_pred EEEEEEEEEECCCCCEEEEEEEEECCCCC
Q ss_conf 99999986554899899999999638756
Q 001865 561 WNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (1002)
Q Consensus 561 wv~~~~~pi~d~~G~v~~~ig~~~DITer 589 (1002)
|+.++.+|++|++|++++++++++|||||
T Consensus 82 w~~~~~~pi~d~~G~v~~~i~~~~DITer 110 (110)
T d1bywa_ 82 LCLVDVVPVKNEDGAVIMFILNFEVVMEK 110 (110)
T ss_dssp EEEEEEEEEECTTCCEEEEEEEEEEEEEC
T ss_pred EEEEEEEEEECCCCCEEEEEEEEEECCCC
T ss_conf 12336778998999999999999978899
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.78 E-value=3.8e-18 Score=125.66 Aligned_cols=103 Identities=45% Similarity=0.866 Sum_probs=88.2
Q ss_pred CEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 29999378999968980658899809996678199987556999996899999999984993999999982299689998
Q 001865 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNL 280 (1002)
Q Consensus 201 ~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~ 280 (1002)
.++++|+..+||+|+|+|++|++++||+.+|++|+++..+.++.........+...+..+..+.+|++.+++||+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEECCCCCCCHHHHHHHHHHHHCCCEEEEEEEEEECCCCEEEEE
T ss_conf 59998599998989999689999888698997786210010110016777642356525963576899996055428988
Q ss_pred EEEEEEECCCCCEEEEEEEEECC
Q ss_conf 88656666999989999999434
Q 001865 281 LTIAPIKDDEGKVLKFIGMQVEV 303 (1002)
Q Consensus 281 ~~~spi~d~~G~v~~~i~~~~DI 303 (1002)
++++|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEECC
T ss_conf 78888999999999999999829
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.77 E-value=7.3e-19 Score=130.08 Aligned_cols=124 Identities=21% Similarity=0.263 Sum_probs=70.7
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 22211124534189999999843782999937899996898065889980999667819998755699999689999999
Q 001865 176 DEGGKEKGLPRVSDIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRE 255 (1002)
Q Consensus 176 ~~~~~e~~L~~s~~~~~~ile~~~~~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~ 255 (1002)
+..+++++|+++++.+++++++++++|+++|. +|+|+++|+++++++||+.+|++|+++..++++.........+..
T Consensus 3 ~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~---~g~i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~ 79 (130)
T d1ew0a_ 3 HMLETEDVVRARDAHLRSILDTVPDATVVSAT---DGTIVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQR 79 (130)
T ss_dssp HHHHHHHHHHHHTSCHHHHHTTCSSEEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCCCEEEEEEC---CCCEEEEHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHHHHH
T ss_conf 69999999999999999999719772999908---964998788877751699889628752233331026778899999
Q ss_pred HHHCCCC----EEEEEEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECCH
Q ss_conf 9984993----999999982299689998886566669999899999994340
Q 001865 256 TLQNGQS----YCGRLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (1002)
Q Consensus 256 ~l~~g~~----~~~e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~i~~~~DIT 304 (1002)
.+..+.. ...++...++||..+|++++++|+.++++ ..++++++|||
T Consensus 80 ~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 80 YMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEEEEEECCE--EEEEEEEEECC
T ss_conf 9971887544410158898589979999999999997993--89999999787
|
| >d1jnua_ d.110.3.6 (A:) Photoreceptor phy3 flavin-binding domain, lov2 {Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Flavin-binding PAS domain domain: Photoreceptor phy3 flavin-binding domain, lov2 species: Maidenhair fern (Adiantum capillus-veneris) [TaxId: 13818]
Probab=99.74 E-value=2.9e-17 Score=120.18 Aligned_cols=103 Identities=72% Similarity=1.188 Sum_probs=96.6
Q ss_pred CEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEE
Q ss_conf 29998488999977852588899829996656399976446999996899999999963993999999994599599999
Q 001865 484 NFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNL 563 (1002)
Q Consensus 484 ~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~wv~ 563 (1002)
.++++|+...|++|+|+|++|++++||+.+|++|+++..+.+++........+...+..+..+.+|++.+++||+.+|+.
T Consensus 2 ~fvi~d~~~pd~~I~y~N~a~~~~~G~s~~e~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~~~~~~ 81 (104)
T d1jnua_ 2 SFVITDPRLPDNPIIFASDRFLELTEYTREEVLGNNCRFLQGRGTDRKAVQLIRDAVKEQRDVTVQVLNYTKGGRAFWNL 81 (104)
T ss_dssp EEEEECTTSTTCCEEEECHHHHHHHTCCHHHHTTSCGGGGCCTTSCHHHHHHHHHHHHHTCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEECCCCCCCEEEEECHHHHHHHCCCHHHHCCCCCEECCCCCCCHHHHHHHHHHHHCCCEEEEEEEEEECCCCEEEEE
T ss_conf 59998599998989999689999888698997786210010110016777642356525963576899996055428988
Q ss_pred EEEEEEECCCCCEEEEEEEEECC
Q ss_conf 99986554899899999999638
Q 001865 564 FHLQPMRDQKGEVQYFIGVQLDG 586 (1002)
Q Consensus 564 ~~~~pi~d~~G~v~~~ig~~~DI 586 (1002)
+++.|++|++|++.+++++.+||
T Consensus 82 ~~~~pi~d~~G~v~~~i~i~~DI 104 (104)
T d1jnua_ 82 FHLQVMRDENGDVQYFIGVQQEM 104 (104)
T ss_dssp EEEEEECTTTSSCCEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEECC
T ss_conf 78888999999999999999829
|
| >d1ew0a_ d.110.3.2 (A:) Histidine kinase FixL heme domain {Rhizobium meliloti [TaxId: 382]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Rhizobium meliloti [TaxId: 382]
Probab=99.74 E-value=2.1e-17 Score=121.05 Aligned_cols=124 Identities=16% Similarity=0.204 Sum_probs=104.2
Q ss_pred HHHHHHHHHHHHC-CCHHHHHHHCCCCEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 3268988866201-119999985145299984889999778525888998299966563999764469999968999999
Q 001865 459 VDDKVRQKEMRKG-IDLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIR 537 (1002)
Q Consensus 459 ~~~~~~e~~l~~~-~~l~~i~e~a~~~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~ 537 (1002)
++.+..++++++. ..|+.++++++++|+++|.+|. |+++|+++++++||+++|++|+++..+.++.........+.
T Consensus 2 s~l~~~e~~l~~~e~~~~~i~~~~~~~i~~~d~~g~---i~~~N~~~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~ 78 (130)
T d1ew0a_ 2 SHMLETEDVVRARDAHLRSILDTVPDATVVSATDGT---IVSFNAAAVRQFGYAEEEVIGQNLRILMPEPYRHEHDGYLQ 78 (130)
T ss_dssp CHHHHHHHHHHHHTSCHHHHHTTCSSEEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTTGGGHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHCCCCEEEEEECCCC---EEEEHHHHHHHHCCCHHHHCCCCCCCCCCCCHHHHHHHHHH
T ss_conf 769999999999999999999719772999908964---99878887775169988962875223333102677889999
Q ss_pred HHHHCCCC----EEEEEEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 99963993----999999994599599999999865548998999999996387
Q 001865 538 AAIDNQTD----VTVQLINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (1002)
Q Consensus 538 ~~l~~~~~----~~~e~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~ig~~~DIT 587 (1002)
..+..+.. ...++...++||..+|+.+++.++.++.+ ..++++++|||
T Consensus 79 ~~~~~~~~~~~~~~~e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~i~rDIT 130 (130)
T d1ew0a_ 79 RYMATGEKRIIGIDRVVSGQRKDGSTFPMKLAVGEMRSGGE--RFFTGFIRDLT 130 (130)
T ss_dssp HHHHHCCCSSTTSCEEEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEECC
T ss_pred HHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEEEEEECCE--EEEEEEEEECC
T ss_conf 99971887544410158898589979999999999997993--89999999787
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=2.3e-16 Score=114.71 Aligned_cols=104 Identities=17% Similarity=0.144 Sum_probs=53.7
Q ss_pred EEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEEE
Q ss_conf 99984889999778525888998299966563999764469999968999999999639939999999945995999999
Q 001865 485 FVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTDVTVQLINYTKSGKKFWNLF 564 (1002)
Q Consensus 485 i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~~~~~~~e~~~~~kdG~~~wv~~ 564 (1002)
|+..+++|+ |+|+|+++++++||+.+|++|+++..+++|++.....+.+...+.++..+..+++++++||+.+|+.+
T Consensus 9 i~r~~~dG~---i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~~~wv~~ 85 (114)
T d1p97a_ 9 LSRHSMDMK---FTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGGYVWLET 85 (114)
T ss_dssp EEEECTTTS---CSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSCEEEEEE
T ss_pred EEEECCCCC---EEEECHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCEEECCEEEEEECCCCEEEEE
T ss_conf 999979995---99998799977499713055200000000012431100100001111100011000000476517999
Q ss_pred EEEEEECC-CCCEEEEEEEEECCCCCCC
Q ss_conf 99865548-9989999999963875632
Q 001865 565 HLQPMRDQ-KGEVQYFIGVQLDGSEHLE 591 (1002)
Q Consensus 565 ~~~pi~d~-~G~v~~~ig~~~DITerk~ 591 (1002)
+.+|++++ +|++.+++++.+||||+|+
T Consensus 86 ~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 86 QGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred EEEEEEECCCCCEEEEEEEEEECCHHHC
T ss_conf 9889996899989999999998972423
|
| >d1p97a_ d.110.3.7 (A:) Hypoxia-inducible factor Hif2a, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Hypoxia-inducible factor Hif2a, C-terminal domain domain: Hypoxia-inducible factor Hif2a, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.5e-16 Score=115.83 Aligned_cols=108 Identities=15% Similarity=0.178 Sum_probs=93.1
Q ss_pred CCCCEEE--EECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCEEEEEEEEECCCC
Q ss_conf 3782999--93789999689806588998099966781999875569999968999999999849939999999822996
Q 001865 198 FQQTFVV--SDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQSYCGRLLNYKKDGT 275 (1002)
Q Consensus 198 ~~~~i~i--~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~~~~kdG~ 275 (1002)
+....++ .|. ||+|+|+|+++++++||+.+|++|+++..++++++.....+.+...+..+..+..+++.+++||+
T Consensus 3 ~d~~~fi~r~~~---dG~i~~~N~~~~~~~G~~~~el~g~~~~~~~~~ed~~~~~~~~~~~~~~~~~~~~e~~~~~kdG~ 79 (114)
T d1p97a_ 3 MDSKTFLSRHSM---DMKFTYCDDRITELIGYHPEELLGRSAYEFYHALDSENMTKSHQNLCTKGQVVSGQYRMLAKHGG 79 (114)
T ss_dssp CCCEEEEEEECT---TTSCSEECTTHHHHTSSCHHHHTTSCHHHHSCSSSHHHHHHHHHHHTTTSEEEEEEEEEECTTSC
T ss_pred CCCCEEEEEECC---CCCEEEECHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCEEECCEEEEEECCC
T ss_conf 676779999979---99599998799977499713055200000000012431100100001111100011000000476
Q ss_pred EEEEEEEEEEEECC-CCCEEEEEEEEECCHHHHH
Q ss_conf 89998886566669-9998999999943404359
Q 001865 276 PFWNLLTIAPIKDD-EGKVLKFIGMQVEVSKHTE 308 (1002)
Q Consensus 276 ~~w~~~~~spi~d~-~G~v~~~i~~~~DITerk~ 308 (1002)
.+|++++.+|++|+ +|.+.+++++.+||||+|+
T Consensus 80 ~~wv~~~~~~~~~~~~~~~~~ii~~~~dite~k~ 113 (114)
T d1p97a_ 80 YVWLETQGTVIYNPRNLQPQCIMCVNYVLSEIEK 113 (114)
T ss_dssp EEEEEEEEEEEECTTTCSEEEEEEEEEEEEEEEC
T ss_pred CEEEEEEEEEEEECCCCCEEEEEEEEEECCHHHC
T ss_conf 5179999889996899989999999998972423
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.61 E-value=2.3e-15 Score=108.49 Aligned_cols=108 Identities=21% Similarity=0.359 Sum_probs=62.7
Q ss_pred HHHHHHHHCCCCEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCC----CCEEE
Q ss_conf 99999984378299993789999689806588998099966781999875569999968999999999849----93999
Q 001865 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG----QSYCG 265 (1002)
Q Consensus 190 ~~~~ile~~~~~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g----~~~~~ 265 (1002)
+|.+++++++++|+++|. +|+|+++|++|++++||+.+|++|+++..+.+..........+...+..+ .....
T Consensus 2 ~~~~~~e~~~d~i~~~d~---~g~i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 78 (113)
T d1v9ya_ 2 IFFPALEQNMMGAVLINE---NDEVMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSR 78 (113)
T ss_dssp CHHHHHHTCSSEEEEECT---TSBEEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------C
T ss_pred HHHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 789998708471899929---99999986168665201366653752000332111111000001100124320011000
Q ss_pred EEEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEEC
Q ss_conf 9999822996899988865666699998999999943
Q 001865 266 RLLNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVE 302 (1002)
Q Consensus 266 e~~~~~kdG~~~w~~~~~spi~d~~G~v~~~i~~~~D 302 (1002)
+...+++||+.+|++++++|+.+++| ..++++++|
T Consensus 79 e~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 79 ELQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred EEEECCCCCEEEEEEEEEEEEEECCE--EEEEEEEEC
T ss_conf 24410245416999999999998990--899999999
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.59 E-value=8.8e-15 Score=104.92 Aligned_cols=102 Identities=19% Similarity=0.262 Sum_probs=72.5
Q ss_pred CCEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEEECCCC
Q ss_conf 829999378999968980658899809996678199987556999996899999999984993----9999999822996
Q 001865 200 QTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYKKDGT 275 (1002)
Q Consensus 200 ~~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~kdG~ 275 (1002)
+||+++|. +|+|+++|+++++++||+.+|++|+++..++++.........+...+..... ...++..+++||.
T Consensus 1 dgi~~~D~---~G~I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDG---HGIIQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEET---TSBEEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECC---CCCEEEECHHHHHHHHHCHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEEEEEECCCE
T ss_conf 98999979---993997738999876434186618974224221210001122234443023211111100013301436
Q ss_pred EEEEEEEEEEEECCCCCEEEEEEEEECCHHH
Q ss_conf 8999888656666999989999999434043
Q 001865 276 PFWNLLTIAPIKDDEGKVLKFIGMQVEVSKH 306 (1002)
Q Consensus 276 ~~w~~~~~spi~d~~G~v~~~i~~~~DITer 306 (1002)
.+|++++++|+.++++ .+++++++||||.
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCE--EEEEEEEEECCCC
T ss_conf 9988899999997993--7999999968898
|
| >d1v9ya_ d.110.3.2 (A:) Direct oxygen sensor protein, DOS {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Direct oxygen sensor protein, DOS species: Escherichia coli [TaxId: 562]
Probab=99.57 E-value=1.3e-14 Score=103.89 Aligned_cols=107 Identities=23% Similarity=0.366 Sum_probs=88.0
Q ss_pred HHHHHHHCCCCEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCC----CCEEEE
Q ss_conf 9999985145299984889999778525888998299966563999764469999968999999999639----939999
Q 001865 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQ----TDVTVQ 549 (1002)
Q Consensus 474 l~~i~e~a~~~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~~----~~~~~e 549 (1002)
|.+++++++++|+++|.+|+ |+++|++|++++||+.+|++|++...+.++.........+...+..+ .....|
T Consensus 3 ~~~~~e~~~d~i~~~d~~g~---i~~~N~~~~~l~Gy~~~e~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 79 (113)
T d1v9ya_ 3 FFPALEQNMMGAVLINENDE---VMFFNPAAEKLWGYKREEVIGNNIDMLIPRDLRPAHPEYIRHNREGGKARVEGMSRE 79 (113)
T ss_dssp HHHHHHTCSSEEEEECTTSB---EEEECHHHHHHHSCCGGGTTTSBGGGGSCGGGTTTHHHHHHHHHC----------CE
T ss_pred HHHHHHCCCCCEEEEECCCC---EEEECHHHHHHHCCCHHHHCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 89998708471899929999---999861686652013666537520003321111110000011001243200110002
Q ss_pred EEEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEEC
Q ss_conf 999945995999999998655489989999999963
Q 001865 550 LINYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLD 585 (1002)
Q Consensus 550 ~~~~~kdG~~~wv~~~~~pi~d~~G~v~~~ig~~~D 585 (1002)
...+++||+.+|+.+++.|+.++.| ..++++++|
T Consensus 80 ~~~~~~dG~~~~v~~~~~~i~~~~~--~~~~~v~rD 113 (113)
T d1v9ya_ 80 LQLEKKDGSKIWTRFALSKVSAEGK--VYYLALVRD 113 (113)
T ss_dssp EEEECTTSCEEEEEEEEEEEEETTE--EEEEEEEEC
T ss_pred EEECCCCCEEEEEEEEEEEEEECCE--EEEEEEEEC
T ss_conf 4410245416999999999998990--899999999
|
| >d1xj3a1 d.110.3.2 (A:154-259) Histidine kinase FixL heme domain {Bradyrhizobium japonicum [TaxId: 375]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: Heme-binding PAS domain domain: Histidine kinase FixL heme domain species: Bradyrhizobium japonicum [TaxId: 375]
Probab=99.56 E-value=1e-14 Score=104.47 Aligned_cols=102 Identities=19% Similarity=0.205 Sum_probs=84.8
Q ss_pred CCEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCC----CEEEEEEEEECCCC
Q ss_conf 52999848899997785258889982999665639997644699999689999999996399----39999999945995
Q 001865 483 KNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQT----DVTVQLINYTKSGK 558 (1002)
Q Consensus 483 ~~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~~~----~~~~e~~~~~kdG~ 558 (1002)
+||+++|.+|+ |+++|+++++++||+.+|++|++...+.++.........+...+.... ....+...+++||.
T Consensus 1 dgi~~~D~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~dg~ 77 (106)
T d1xj3a1 1 DAMIVIDGHGI---IQLFSTAAERLFGWSELEAIGQNVNILMPEPDRSRHDSYISRYRTTSDPHIIGIGRIVTGKRRDGT 77 (106)
T ss_dssp CCEEEEETTSB---EEEECHHHHHHHCCCHHHHTTSBGGGGSCTTHHHHHHHHHHHHHHHCCCSSTTTCEEEEEECTTSC
T ss_pred CEEEEECCCCC---EEEECHHHHHHHHHCHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCEEEEEECCCE
T ss_conf 98999979993---997738999876434186618974224221210001122234443023211111100013301436
Q ss_pred EEEEEEEEEEEECCCCCEEEEEEEEECCCCC
Q ss_conf 9999999986554899899999999638756
Q 001865 559 KFWNLFHLQPMRDQKGEVQYFIGVQLDGSEH 589 (1002)
Q Consensus 559 ~~wv~~~~~pi~d~~G~v~~~ig~~~DITer 589 (1002)
.+|+.++++|+.++.+ .+++++++||||+
T Consensus 78 ~~~v~~~~~~~~~~~~--~~~~~~~~DITE~ 106 (106)
T d1xj3a1 78 TFPMHLSIGEMQSGGE--PYFTGFVRDLTEH 106 (106)
T ss_dssp EEEEEEEEEEEEETTE--EEEEEEEEECHHH
T ss_pred EEEEEEEEEEEEECCE--EEEEEEEEECCCC
T ss_conf 9988899999997993--7999999968898
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.46 E-value=2.1e-13 Score=96.48 Aligned_cols=108 Identities=19% Similarity=0.146 Sum_probs=72.5
Q ss_pred HHHHHHHHHCCCCEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCEEEEE
Q ss_conf 999999984378299993789999689806588998099966781999875-5699999689999999998499399999
Q 001865 189 DIVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRF-LQGAGTDPEDVAKIRETLQNGQSYCGRL 267 (1002)
Q Consensus 189 ~~~~~ile~~~~~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~-l~~~~~~~~~~~~i~~~l~~g~~~~~e~ 267 (1002)
.++..+++++|+|++++|. +|+|+++|+++++++||+++|++|+++.. +.|+.........+...+..+.....+.
T Consensus 17 ~~~d~~ld~~p~gi~~lD~---~G~i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~ 93 (125)
T d1nwza_ 17 KMDDGQLDGLAFGAIQLDG---DGNILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFE 93 (125)
T ss_dssp TCCHHHHTTCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEE
T ss_pred HHHHHHHHCCCCCEEEEEC---CCCEEEECHHHHHHHCCCHHHHCCCCHHHCCCCHHHHHHEEEECEEEEECCCCCEEEE
T ss_conf 9999998578752999908---9989998179997624562766399777726956661002000000210477545888
Q ss_pred EEEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECC
Q ss_conf 998229968999888656666999989999999434
Q 001865 268 LNYKKDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEV 303 (1002)
Q Consensus 268 ~~~~kdG~~~w~~~~~spi~d~~G~v~~~i~~~~DI 303 (1002)
..++++|..+|+++++.+..+ |+-. ..+++||
T Consensus 94 ~~~~~~G~~~~v~v~l~~~~~--g~~~--~v~V~di 125 (125)
T d1nwza_ 94 YTFDYQMTPTKVKVHMKKALS--GDSY--WVFVKRV 125 (125)
T ss_dssp EEECTTSCCEEEEEEEEECSS--SSEE--EEEEEEC
T ss_pred EEECCCCCEEEEEEEEEEECC--CCEE--EEEEEEC
T ss_conf 874037947999999999469--9989--9999989
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.43 E-value=1.1e-12 Score=92.01 Aligned_cols=96 Identities=10% Similarity=0.065 Sum_probs=67.2
Q ss_pred HHHHHHHHCCCCEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCEEEEEE
Q ss_conf 9999998437829999378999968980658899809996678199987-556999996899999999984993999999
Q 001865 190 IVKDALSTFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCR-FLQGAGTDPEDVAKIRETLQNGQSYCGRLL 268 (1002)
Q Consensus 190 ~~~~ile~~~~~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~-~l~~~~~~~~~~~~i~~~l~~g~~~~~e~~ 268 (1002)
.+.++++++|++|+++|. +|+|++||+++++|+||+++|++|+++. .+.|+.........+.+.+..|........
T Consensus 4 ~~~A~ld~~p~gvi~~D~---~G~I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~ 80 (110)
T d1mzua_ 4 MGTAEFDALPVGAIQVDG---SGVIHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDF 80 (110)
T ss_dssp --CTTGGGCSSEEEEEET---TCBEEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEE
T ss_pred HHHHHHHCCCCEEEEECC---CCCEEEEHHHHHHHHCCCHHHHCCCCHHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 779998478937999969---99999857789998867999985997899649864668999999999865565741379
Q ss_pred EEECCCCEEEEEEEEEEEEC
Q ss_conf 98229968999888656666
Q 001865 269 NYKKDGTPFWNLLTIAPIKD 288 (1002)
Q Consensus 269 ~~~kdG~~~w~~~~~spi~d 288 (1002)
.++++|..+++++++.+..+
T Consensus 81 ~l~~~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 81 VFDFQMAPVRVQIRMQNAGV 100 (110)
T ss_dssp EEECSSCEEEEEEEEEECSS
T ss_pred EEECCCCEEEEEEEEEEECC
T ss_conf 99307963899999999347
|
| >d1nwza_ d.110.3.1 (A:) Photoactive yellow protein, PYP {Ectothiorhodospira halophila [TaxId: 1053]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: Photoactive yellow protein, PYP species: Ectothiorhodospira halophila [TaxId: 1053]
Probab=99.40 E-value=2.2e-12 Score=90.18 Aligned_cols=107 Identities=11% Similarity=0.025 Sum_probs=87.1
Q ss_pred CHHHHHHHCCCCEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCC-CCCHHHHHHHHHHHHCCCCEEEEEE
Q ss_conf 199999851452999848899997785258889982999665639997644699-9996899999999963993999999
Q 001865 473 DLATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGP-ETDPATVRKIRAAIDNQTDVTVQLI 551 (1002)
Q Consensus 473 ~l~~i~e~a~~~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~-~~~~~~~~~l~~~l~~~~~~~~e~~ 551 (1002)
.+..+++++|+|++++|.+|+ |+++|+++++++||+++|++|+++..+++| +....+...+.+.+..+.....+..
T Consensus 18 ~~d~~ld~~p~gi~~lD~~G~---i~~~N~a~~~l~G~~~~e~iG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~ 94 (125)
T d1nwza_ 18 MDDGQLDGLAFGAIQLDGDGN---ILQYNAAEGDITGRDPKQVIGKNFFKDVAPCTDSPEFYGKFKEGVASGNLNTMFEY 94 (125)
T ss_dssp CCHHHHTTCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHHTCCEEEEEE
T ss_pred HHHHHHHCCCCCEEEEECCCC---EEEECHHHHHHHCCCHHHHCCCCHHHCCCCHHHHHHEEEECEEEEECCCCCEEEEE
T ss_conf 999998578752999908998---99981799976245627663997777269566610020000002104775458888
Q ss_pred EEECCCCEEEEEEEEEEEECCCCCEEEEEEEEECC
Q ss_conf 99459959999999986554899899999999638
Q 001865 552 NYTKSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDG 586 (1002)
Q Consensus 552 ~~~kdG~~~wv~~~~~pi~d~~G~v~~~ig~~~DI 586 (1002)
..+++|..+|+.+++.+.. .|+-. ..+++||
T Consensus 95 ~~~~~G~~~~v~v~l~~~~--~g~~~--~v~V~di 125 (125)
T d1nwza_ 95 TFDYQMTPTKVKVHMKKAL--SGDSY--WVFVKRV 125 (125)
T ss_dssp EECTTSCCEEEEEEEEECS--SSSEE--EEEEEEC
T ss_pred EECCCCCEEEEEEEEEEEC--CCCEE--EEEEEEC
T ss_conf 7403794799999999946--99989--9999989
|
| >d1mzua_ d.110.3.1 (A:) PYP domain of sensor histidine kinase Ppr {Rhodospirillum centenum [TaxId: 34018]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PYP-like domain: PYP domain of sensor histidine kinase Ppr species: Rhodospirillum centenum [TaxId: 34018]
Probab=99.33 E-value=6.7e-12 Score=87.17 Aligned_cols=95 Identities=12% Similarity=-0.032 Sum_probs=78.0
Q ss_pred HHHHHHHCCCCEEEECCCCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCC-CCCCHHHHHHHHHHHHCCCCEEEEEEE
Q ss_conf 9999985145299984889999778525888998299966563999764469-999968999999999639939999999
Q 001865 474 LATTLERIEKNFVITDPRLPDNPIIFASDSFLELTEYSREEILGRNCRFLQG-PETDPATVRKIRAAIDNQTDVTVQLIN 552 (1002)
Q Consensus 474 l~~i~e~a~~~i~i~d~~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~-~~~~~~~~~~l~~~l~~~~~~~~e~~~ 552 (1002)
+.++++++|+||+++|.+|+ |++||+++++|+||+++|++|+++..++. +.....+...+.+.+..|.........
T Consensus 5 ~~A~ld~~p~gvi~~D~~G~---I~~~N~aa~~~~G~~~eellG~~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~ 81 (110)
T d1mzua_ 5 GTAEFDALPVGAIQVDGSGV---IHRYNRTESRLSGRIPERVIGRNFFTEVAPCTNIPAFSGRFMDGVTSGTLDARFDFV 81 (110)
T ss_dssp -CTTGGGCSSEEEEEETTCB---EEEECHHHHHHHCCCHHHHTTSBCCCCCCGGGCSTTTHHHHHHHHHTSCCEEEEEEE
T ss_pred HHHHHHCCCCEEEEECCCCC---EEEEHHHHHHHHCCCHHHHCCCCHHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 79998478937999969999---998577899988679999859978996498646689999999998655657413799
Q ss_pred EECCCCEEEEEEEEEEEEC
Q ss_conf 9459959999999986554
Q 001865 553 YTKSGKKFWNLFHLQPMRD 571 (1002)
Q Consensus 553 ~~kdG~~~wv~~~~~pi~d 571 (1002)
.+++|..+++.++.....+
T Consensus 82 l~~~G~~~~v~v~~~~~~~ 100 (110)
T d1mzua_ 82 FDFQMAPVRVQIRMQNAGV 100 (110)
T ss_dssp EECSSCEEEEEEEEEECSS
T ss_pred EECCCCEEEEEEEEEEECC
T ss_conf 9307963899999999347
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=4.2e-13 Score=94.59 Aligned_cols=105 Identities=12% Similarity=0.163 Sum_probs=70.2
Q ss_pred HHCCCCEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEEE
Q ss_conf 8437829999378999968980658899809996678199987556999996899999999984993----999999982
Q 001865 196 STFQQTFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS----YCGRLLNYK 271 (1002)
Q Consensus 196 e~~~~~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~----~~~e~~~~~ 271 (1002)
+.+.++|+++|.. +|+|+++|+++++++||+.+|++|+++..+.++.........+...+..+.. +..++..++
T Consensus 5 ~~~n~AI~~id~~--~G~I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 82 (114)
T d1ll8a_ 5 PEFNKAIFTVDAK--TTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIIS 82 (114)
T ss_dssp TTTTCEEEEEETT--TCBEEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECC
T ss_pred HHCCCEEEEEECC--CCEEEEECHHHHHHHCCCHHHHCCCCEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEC
T ss_conf 1009689999999--99999977899975468978983997221428104999999999998567773100367888880
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEECCH
Q ss_conf 299689998886566669999899999994340
Q 001865 272 KDGTPFWNLLTIAPIKDDEGKVLKFIGMQVEVS 304 (1002)
Q Consensus 272 kdG~~~w~~~~~spi~d~~G~v~~~i~~~~DIT 304 (1002)
++|..+|++++++++..++ +. .++++++||+
T Consensus 83 ~~G~~~pvevs~~~i~~~~-~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 83 RSGEKIPVSVWMKRMRQER-RL-CCVVVLEPVE 113 (114)
T ss_dssp TTCCCEEEECCEECCBSSS-SB-EEEEEEEECC
T ss_pred CCCCEEEEEEEEEEEEECC-EE-EEEEEEEECC
T ss_conf 4991999999999999999-67-9999999775
|
| >d1ll8a_ d.110.3.5 (A:) N-terminal PAS domain of Pas kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: N-terminal PAS domain of Pas kinase domain: N-terminal PAS domain of Pas kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.20 E-value=3e-12 Score=89.34 Aligned_cols=103 Identities=15% Similarity=0.158 Sum_probs=82.0
Q ss_pred HCCCCEEEECC-CCCCCCEEECCHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC----EEEEEEEEE
Q ss_conf 51452999848-8999977852588899829996656399976446999996899999999963993----999999994
Q 001865 480 RIEKNFVITDP-RLPDNPIIFASDSFLELTEYSREEILGRNCRFLQGPETDPATVRKIRAAIDNQTD----VTVQLINYT 554 (1002)
Q Consensus 480 ~a~~~i~i~d~-~G~~~~i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~l~~~l~~~~~----~~~e~~~~~ 554 (1002)
.+.++|+++|. +|. |+++|++++++|||+.+|++|+++..+.++++.......+...+..+.. +..+..+++
T Consensus 6 ~~n~AI~~id~~~G~---I~~~N~a~~~l~Gy~~~el~g~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 82 (114)
T d1ll8a_ 6 EFNKAIFTVDAKTTE---ILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIIS 82 (114)
T ss_dssp TTTCEEEEEETTTCB---EEEECTTHHHHHTCCTTTTTTSBGGGGSSCTTTHHHHHTTSSTTSSSSCSSCCCSSSEEECC
T ss_pred HCCCEEEEEECCCCE---EEEECHHHHHHHCCCHHHHCCCCEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEC
T ss_conf 009689999999999---99977899975468978983997221428104999999999998567773100367888880
Q ss_pred CCCCEEEEEEEEEEEECCCCCEEEEEEEEECCC
Q ss_conf 599599999999865548998999999996387
Q 001865 555 KSGKKFWNLFHLQPMRDQKGEVQYFIGVQLDGS 587 (1002)
Q Consensus 555 kdG~~~wv~~~~~pi~d~~G~v~~~ig~~~DIT 587 (1002)
++|..+|++++++++..+ |+. .++++++||+
T Consensus 83 ~~G~~~pvevs~~~i~~~-~~~-~~l~vi~dV~ 113 (114)
T d1ll8a_ 83 RSGEKIPVSVWMKRMRQE-RRL-CCVVVLEPVE 113 (114)
T ss_dssp TTCCCEEEECCEECCBSS-SSB-EEEEEEEECC
T ss_pred CCCCEEEEEEEEEEEEEC-CEE-EEEEEEEECC
T ss_conf 499199999999999999-967-9999999775
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.01 E-value=1.3e-10 Score=79.12 Aligned_cols=82 Identities=11% Similarity=0.032 Sum_probs=41.0
Q ss_pred CCCEEEECHHHHHHCCCCH-HHHCCCCCCCCCCCCCCH--HHHHHHHHHHHCCCCEEEEEEEEECCCCEEEEEEEEEEEE
Q ss_conf 9968980658899809996-678199987556999996--8999999999849939999999822996899988865666
Q 001865 211 DYPIMYASAGFFKMTGYTS-KEVVGRNCRFLQGAGTDP--EDVAKIRETLQNGQSYCGRLLNYKKDGTPFWNLLTIAPIK 287 (1002)
Q Consensus 211 dg~Il~vN~a~~~l~Gys~-eEliG~~~~~l~~~~~~~--~~~~~i~~~l~~g~~~~~e~~~~~kdG~~~w~~~~~spi~ 287 (1002)
+|+|+++|+++.+++||.+ +|++|+++..+++|++.. .........+..|.....++|+++|||+.+|++.+..+++
T Consensus 11 ~g~~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vWv~t~~~~~~ 90 (109)
T d1oj5a_ 11 TGKIISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLSAHTRCKLCY 90 (109)
T ss_dssp TCCEEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEEEEEEEEEEC
T ss_pred CCEEEEECHHHHHHHHCCCHHHHCCCCHHHEECCCCCHHHHHHHHHHHHHHHCCCCHHHHHHHHCCCCEEEEEEEEEEEE
T ss_conf 96299998789667533787898597598849801332777667899887302223055644023683899999999999
Q ss_pred CCCCC
Q ss_conf 69999
Q 001865 288 DDEGK 292 (1002)
Q Consensus 288 d~~G~ 292 (1002)
|+.|+
T Consensus 91 ~~~~~ 95 (109)
T d1oj5a_ 91 PQSPD 95 (109)
T ss_dssp C----
T ss_pred CCCCC
T ss_conf 99999
|
| >d1oj5a_ d.110.3.8 (A:) PAS domain of steroid receptor coactivator 1A, NCo-A1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: PAS domain of steroid receptor coactivator 1A, NCo-A1 domain: PAS domain of steroid receptor coactivator 1A, NCo-A1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.01 E-value=1.5e-10 Score=78.75 Aligned_cols=95 Identities=12% Similarity=0.104 Sum_probs=76.9
Q ss_pred EEEECCCCCCCCEEECCHHHHHHCCCCH-HHHCCCCCCCCCCCCCCHH--HHHHHHHHHHCCCCEEEEEEEEECCCCEEE
Q ss_conf 9998488999977852588899829996-6563999764469999968--999999999639939999999945995999
Q 001865 485 FVITDPRLPDNPIIFASDSFLELTEYSR-EEILGRNCRFLQGPETDPA--TVRKIRAAIDNQTDVTVQLINYTKSGKKFW 561 (1002)
Q Consensus 485 i~i~d~~G~~~~i~~vN~a~~~l~Gys~-eEliG~~~~~l~~~~~~~~--~~~~l~~~l~~~~~~~~e~~~~~kdG~~~w 561 (1002)
+.-.|.+|+ |+++|+++++++||.+ +|++|+++..++||++.+. ....+...+..|.....++++++|||.++|
T Consensus 5 ~trh~~~g~---~~~vd~~~~~~~gy~~~eelig~s~~~f~HPeD~~~~~~~~~~~~~~~~g~~~~~~yR~~~kdG~~vW 81 (109)
T d1oj5a_ 5 MTKQDTTGK---IISIDTSSLRAAGRTGWEDLVRKCIYAFFQPQGREPSYARQLFQEVMTRGTASSPSYRFILNDGTMLS 81 (109)
T ss_dssp EEEECTTCC---EEEEECHHHHTTCCSCHHHHHHHHHHHHTSCBTTBCCHHHHHHHHHHHHSEEECCCEEEECTTSCEEE
T ss_pred EEEECCCCE---EEEECHHHHHHHHCCCHHHHCCCCHHHEECCCCCHHHHHHHHHHHHHHHCCCCHHHHHHHHCCCCEEE
T ss_conf 999879962---99998789667533787898597598849801332777667899887302223055644023683899
Q ss_pred EEEEEEEEECCCCC-EEEEEEE
Q ss_conf 99999865548998-9999999
Q 001865 562 NLFHLQPMRDQKGE-VQYFIGV 582 (1002)
Q Consensus 562 v~~~~~pi~d~~G~-v~~~ig~ 582 (1002)
+..+..++++..|. +.+++|+
T Consensus 82 v~t~~~~~~~~~~~~~~~Ii~~ 103 (109)
T d1oj5a_ 82 AHTRCKLCYPQSPDMQPFIMGI 103 (109)
T ss_dssp EEEEEEEECC----CCCEEEEE
T ss_pred EEEEEEEEECCCCCCCCEEEEE
T ss_conf 9999999999999963589999
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.91 E-value=1.1e-08 Score=67.41 Aligned_cols=139 Identities=12% Similarity=0.069 Sum_probs=93.8
Q ss_pred CCCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEEEE
Q ss_conf 89422321166693899999991799199999940542248578999999999999579-99844247898608829999
Q 001865 669 QHFRPIKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTHVCLI 747 (1002)
Q Consensus 669 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iV 747 (1002)
..|+.++..+.+..+.||++.. ++..+++|......... ...+.+|...++.+. +-.+++++.+...++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCCC---HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEE
T ss_conf 3527997678998771899990--89869999848876532---556999999999876069987289997508964999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q ss_conf 961689835677731799999999999999999999999998--------------------------------------
Q 001865 748 TDYCPGGELFLLLDRQPTKVLKEDAVRFYAAEVVVALEYLHC-------------------------------------- 789 (1002)
Q Consensus 748 ~E~~~g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~aL~~LH~-------------------------------------- 789 (1002)
|++++|.++....... .. ...++.++...+..||+
T Consensus 89 ~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEECCCCCCCCCCCCC----CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 9860433435433440----26---9999998999999985568421435764465655577899877655554303323
Q ss_pred ---------------C------CCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf ---------------4------94317899995898059929998426775
Q 001865 790 ---------------Q------GIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 790 ---------------~------~IiHrDLkP~NIli~~~~~ikL~DFG~a~ 819 (1002)
. .++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 200579999999984498678178986004764236499659996023144
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.61 E-value=1.9e-07 Score=59.68 Aligned_cols=81 Identities=15% Similarity=0.130 Sum_probs=53.5
Q ss_pred CCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCC----HHHHHHHHHHHHHHHHCC-C--CCCCEEEEEEEECCEEEE
Q ss_conf 321166693899999991799199999940542248----578999999999999579-9--984424789860882999
Q 001865 674 IKPLGSGDTGSVHLVELCGSGQYFAMKAMDKGVMLN----RNKVHRACAEREILDMLD-H--PFVPALYASFQTKTHVCL 746 (1002)
Q Consensus 674 ~~~LG~G~~g~Vy~a~~~~~~~~vaiK~i~~~~~~~----~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~~~~~~~~~i 746 (1002)
.+.+|.|....||++.+..+++.+++|.-.+..... +....+...|.+.|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCCH
Q ss_conf 9961689835
Q 001865 747 ITDYCPGGEL 756 (1002)
Q Consensus 747 V~E~~~g~sL 756 (1002)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.44 E-value=9.8e-07 Score=55.32 Aligned_cols=127 Identities=14% Similarity=0.096 Sum_probs=81.5
Q ss_pred CCCCCCC-EEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECCEEEEEEECCC
Q ss_conf 1166693-899999991799199999940542248578999999999999579--9984424789860882999996168
Q 001865 676 PLGSGDT-GSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD--HPFVPALYASFQTKTHVCLITDYCP 752 (1002)
Q Consensus 676 ~LG~G~~-g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~~~iV~E~~~ 752 (1002)
.+..|.. +.||++.. ..+..+++|...... ...+..|...++.+. .-.+++++.+....+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred ECCCCCCCCEEEEEEE-CCCCEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEE
T ss_conf 7678654775899993-898789999589667------768999999999998659998861322245661599987441
Q ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHH-------------------------------------------------
Q ss_conf 9835677731799999999999999999999-------------------------------------------------
Q 001865 753 GGELFLLLDRQPTKVLKEDAVRFYAAEVVVA------------------------------------------------- 783 (1002)
Q Consensus 753 g~sL~~~l~~~~~~~l~~~~i~~i~~qIl~a------------------------------------------------- 783 (1002)
|.++.... +.... ++.++...
T Consensus 90 G~~~~~~~-------~~~~~---~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 90 GQDLLSSH-------LAPAE---KVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp SEETTTSC-------CCHHH---HHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCCCCCCC-------CCHHH---HHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH
T ss_conf 35543221-------26899---999999999987368854488755412468899999987541101134011213799
Q ss_pred --HHHHHHC-------CCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf --9999984-------94317899995898059929998426775
Q 001865 784 --LEYLHCQ-------GIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 784 --L~~LH~~-------~IiHrDLkP~NIli~~~~~ikL~DFG~a~ 819 (1002)
+..+... .++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 999999871876579567867888763577379658999853326
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.13 E-value=1.3e-05 Score=48.38 Aligned_cols=77 Identities=19% Similarity=0.283 Sum_probs=52.3
Q ss_pred CCCCCCCCCCCEEEEEEEECC-------CCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCE
Q ss_conf 223211666938999999917-------99199999940542248578999999999999579-9984424789860882
Q 001865 672 RPIKPLGSGDTGSVHLVELCG-------SGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLD-HPFVPALYASFQTKTH 743 (1002)
Q Consensus 672 ~i~~~LG~G~~g~Vy~a~~~~-------~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 743 (1002)
..+++|+.|-...+|++.... ....+++++.... .......+|..+++.+. +.-.+++++++..
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-----CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC---
T ss_conf 69999178533434899968877544578981799965996-----1165899999999999757999808998189---
Q ss_pred EEEEEECCCCCCHH
Q ss_conf 99999616898356
Q 001865 744 VCLITDYCPGGELF 757 (1002)
Q Consensus 744 ~~iV~E~~~g~sL~ 757 (1002)
.+|++|++|.+|.
T Consensus 117 -g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 -GRLEEYIPSRPLS 129 (395)
T ss_dssp -EEEECCCCEEECC
T ss_pred -CEEEEEECCCCCC
T ss_conf -5699973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.59 E-value=0.00023 Score=40.66 Aligned_cols=131 Identities=15% Similarity=0.087 Sum_probs=64.3
Q ss_pred EEEEEEEECCCCEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC--CCEEE-----EEEEECCEEEEEEECCCCCC
Q ss_conf 899999991799199999940542248578999999999999579998--44247-----89860882999996168983
Q 001865 683 GSVHLVELCGSGQYFAMKAMDKGVMLNRNKVHRACAEREILDMLDHPF--VPALY-----ASFQTKTHVCLITDYCPGGE 755 (1002)
Q Consensus 683 g~Vy~a~~~~~~~~vaiK~i~~~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~-----~~~~~~~~~~iV~E~~~g~s 755 (1002)
..||++.. .+|..|++|+..++. .....+..|...+..|.... ++... ..+...+..+.++++++|..
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CEEEEEEC-CCCCEEEEEEECCCC----CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCC
T ss_conf 02699983-899979999847877----8899999999999999855998787520689805665347999986527768
Q ss_pred HHH-----H------HHH-----CC------------------------CCCCCHH---HHHHHHHHHHHHHHHHHH---
Q ss_conf 567-----7------731-----79------------------------9999999---999999999999999998---
Q 001865 756 LFL-----L------LDR-----QP------------------------TKVLKED---AVRFYAAEVVVALEYLHC--- 789 (1002)
Q Consensus 756 L~~-----~------l~~-----~~------------------------~~~l~~~---~i~~i~~qIl~aL~~LH~--- 789 (1002)
+.. + +.+ .. ...++.. .....+.+++..+..+-.
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 89999999999899999988630357865567789788766568999874769988989999999999999998454568
Q ss_pred -CCCCCCCCCCCCEEEECCCCEEEEECCCCCC
Q ss_conf -4943178999958980599299984267754
Q 001865 790 -QGIIYRDLKPENVLLQGNGHVSLTDFDLSCL 820 (1002)
Q Consensus 790 -~~IiHrDLkP~NIli~~~~~ikL~DFG~a~~ 820 (1002)
.++||+|+.|.|||++ ++ ..++||+-++.
T Consensus 191 p~~liHgDlh~~NvL~~-~~-~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWR-DG-PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEES-SS-EEECCCTTCCE
T ss_pred CCEEECCCCCCCCEEEE-CC-CEEEECHHCCC
T ss_conf 71202478880428783-89-35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.54 E-value=4e-05 Score=45.41 Aligned_cols=30 Identities=37% Similarity=0.674 Sum_probs=26.6
Q ss_pred CCCCCCCCCCCCEEEECCCCEEEEECCCCC
Q ss_conf 494317899995898059929998426775
Q 001865 790 QGIIYRDLKPENVLLQGNGHVSLTDFDLSC 819 (1002)
Q Consensus 790 ~~IiHrDLkP~NIli~~~~~ikL~DFG~a~ 819 (1002)
.|+||+|+.++||+++.+..+-++||+.++
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 503337863656402045412674222123
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.73 E-value=0.0007 Score=37.74 Aligned_cols=31 Identities=13% Similarity=0.051 Sum_probs=16.0
Q ss_pred EEECCHHHHHHCCCCHHHHCCCCCCCCCCCC
Q ss_conf 7852588899829996656399976446999
Q 001865 497 IIFASDSFLELTEYSREEILGRNCRFLQGPE 527 (1002)
Q Consensus 497 i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~ 527 (1002)
|++++++...++|+++++++|+++..+++++
T Consensus 30 I~~vS~N~~~lLG~~~~~llG~~l~dll~~~ 60 (114)
T d2oola2 30 IASVSANVEDLLRQPPASLLNVPIAHYLTAA 60 (114)
T ss_dssp EEEEETTHHHHHSSCGGGGTTCBGGGGBCHH
T ss_pred EEEECCCHHHHHCCCHHHHCCCCHHHHCCHH
T ss_conf 9999488899848892887599889968998
|
| >d2oola2 d.110.3.9 (A:26-139) Sensor protein PhyB2 {Rhodopseudomonas palustris [TaxId: 1076]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Sensor protein PhyB2 species: Rhodopseudomonas palustris [TaxId: 1076]
Probab=96.68 E-value=0.00075 Score=37.55 Aligned_cols=54 Identities=17% Similarity=0.195 Sum_probs=39.8
Q ss_pred CEEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 299993789999689806588998099966781999875569999968999999999849
Q 001865 201 TFVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNG 260 (1002)
Q Consensus 201 ~i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g 260 (1002)
.++++|. .+|+|+|++++...++|+++++++|+++..++++.. ...++..+...
T Consensus 19 ~Llvld~--~d~~I~~vS~N~~~lLG~~~~~llG~~l~dll~~~~----~~~i~~~l~~~ 72 (114)
T d2oola2 19 YLFVVSE--TDLRIASVSANVEDLLRQPPASLLNVPIAHYLTAAS----AARLTHALHGG 72 (114)
T ss_dssp EEEEECT--TTCBEEEEETTHHHHHSSCGGGGTTCBGGGGBCHHH----HHHHHHHHCC-
T ss_pred EEEEEEC--CCCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHHH----HHHHHHHHHCC
T ss_conf 8999988--999899994888998488928875998899689989----99999987427
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=92.95 E-value=0.034 Score=27.30 Aligned_cols=32 Identities=22% Similarity=0.140 Sum_probs=16.0
Q ss_pred EEECCHHHHHHCCCCHHHHCCCCCCCCCCCCC
Q ss_conf 78525888998299966563999764469999
Q 001865 497 IIFASDSFLELTEYSREEILGRNCRFLQGPET 528 (1002)
Q Consensus 497 i~~vN~a~~~l~Gys~eEliG~~~~~l~~~~~ 528 (1002)
|..++.....++|.++++++|+++..+++++.
T Consensus 39 I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~ 70 (127)
T d2veaa3 39 ISQISANCTGILGRSPEDLLGRTLGEVFDSFQ 70 (127)
T ss_dssp EEEEETTHHHHTSCCTTTSSTTTTTTTSBCC-
T ss_pred EEEECCCHHHHHCCCHHHHCCCCHHHHCCHHH
T ss_conf 99985798988485969983999889879899
|
| >d2veaa3 d.110.3.9 (A:4-130) Phytochrome-like protein Cph1 {Synechocystis sp. pcc 6803 [TaxId: 1148]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Phytochrome-like protein Cph1 species: Synechocystis sp. pcc 6803 [TaxId: 1148]
Probab=92.71 E-value=0.051 Score=26.26 Aligned_cols=45 Identities=22% Similarity=0.225 Sum_probs=35.9
Q ss_pred EEEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHH
Q ss_conf 99993789999689806588998099966781999875569999968
Q 001865 202 FVVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPE 248 (1002)
Q Consensus 202 i~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~ 248 (1002)
++++|. .+++|+.++.....++|+++++++|+++..++++.....
T Consensus 29 LLald~--~~~~I~~aS~N~~~~lG~~~~~lLG~~l~~ll~~~~~~~ 73 (127)
T d2veaa3 29 VVVLQE--PDLTISQISANCTGILGRSPEDLLGRTLGEVFDSFQIDP 73 (127)
T ss_dssp EEEEET--TTTEEEEEETTHHHHTSCCTTTSSTTTTTTTSBCC----
T ss_pred EEEEEC--CCCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHHHHHH
T ss_conf 999988--999899985798988485969983999889879899999
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=92.69 E-value=0.12 Score=23.85 Aligned_cols=28 Identities=11% Similarity=0.012 Sum_probs=13.9
Q ss_pred EEECCHHHHHHCCCCHHHHCCCCCCCCC
Q ss_conf 7852588899829996656399976446
Q 001865 497 IIFASDSFLELTEYSREEILGRNCRFLQ 524 (1002)
Q Consensus 497 i~~vN~a~~~l~Gys~eEliG~~~~~l~ 524 (1002)
|+.++.....++|++.++++|++...+.
T Consensus 48 I~~~S~N~~~~lG~~~~~llG~~l~~ll 75 (127)
T d2o9ca2 48 VLQMSLNAATFLGQEPTVLRGQTLAALL 75 (127)
T ss_dssp EEEEETTHHHHHSSCHHHHTTCBHHHHC
T ss_pred EEEECCCHHHHHCCCHHHHCCCCHHHHC
T ss_conf 9998789899838796898499989988
|
| >d2o9ca2 d.110.3.9 (A:4-130) Bacteriophytochrome BphP {Deinococcus radiodurans [TaxId: 1299]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Profilin-like superfamily: PYP-like sensor domain (PAS domain) family: BphP N-terminal domain-like domain: Bacteriophytochrome BphP species: Deinococcus radiodurans [TaxId: 1299]
Probab=92.35 E-value=0.2 Score=22.64 Aligned_cols=77 Identities=10% Similarity=-0.003 Sum_probs=47.8
Q ss_pred CCCE-EEEECCCCCCCEEEECHHHHHHCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHCCCC--EEEEEEEEECCCC
Q ss_conf 7829-999378999968980658899809996678199987556999996899999999984993--9999999822996
Q 001865 199 QQTF-VVSDATKPDYPIMYASAGFFKMTGYTSKEVVGRNCRFLQGAGTDPEDVAKIRETLQNGQS--YCGRLLNYKKDGT 275 (1002)
Q Consensus 199 ~~~i-~i~D~~~~dg~Il~vN~a~~~l~Gys~eEliG~~~~~l~~~~~~~~~~~~i~~~l~~g~~--~~~e~~~~~kdG~ 275 (1002)
+.|+ +++|.. ++.|+.++....+++|++.++++|+++..+++.. ...+...+..... ..........+|.
T Consensus 34 phG~LLald~~--~~~I~~~S~N~~~~lG~~~~~llG~~l~~ll~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 106 (127)
T d2o9ca2 34 PHGALLTADGH--SGEVLQMSLNAATFLGQEPTVLRGQTLAALLPEQ-----WPALQAALPPGCPDALQYRATLDWPAAG 106 (127)
T ss_dssp TTSEEEEEETT--TCBEEEEETTHHHHHSSCHHHHTTCBHHHHCTTT-----HHHHHHHSCTTCCTTCCEEEEECCSSSS
T ss_pred CCEEEEEEECC--CCEEEEECCCHHHHHCCCHHHHCCCCHHHHCCHH-----HHHHHHHHHHCCCCCCCCEEEEECCCCC
T ss_conf 88489999889--9979998789899838796898499989988888-----9999998653586322230354068993
Q ss_pred EEEEEEE
Q ss_conf 8999888
Q 001865 276 PFWNLLT 282 (1002)
Q Consensus 276 ~~w~~~~ 282 (1002)
.+|+.+.
T Consensus 107 ~f~~~~H 113 (127)
T d2o9ca2 107 HLSLTVH 113 (127)
T ss_dssp EEEEEEE
T ss_pred EEEEEEE
T ss_conf 6999999
|